data_2n2e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n2e _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.285 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -70.07 128.4 36.18 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.3 t -132.07 135.36 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -80.93 140.13 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -55.71 127.86 32.05 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.306 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -55.83 -26.94 49.03 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.784 -1.198 . . . . 0.0 111.054 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -101.76 -8.31 21.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.946 1.299 . . . . 0.0 113.634 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.06 107.22 3.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.6 m -64.94 -14.14 59.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.253 1.821 . . . . 0.0 111.846 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -99.6 0.58 42.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.016 1.726 . . . . 0.0 112.029 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -117.69 158.44 24.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.068 0.461 . . . . 0.0 110.33 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.5 mm -126.29 132.61 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.12 99.14 8.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 102.069 -3.308 . . . . 0.0 102.069 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -135.71 127.07 28.45 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.347 -1.471 . . . . 0.0 107.607 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 12.9 mtt 60.44 30.16 19.57 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.558 1.143 . . . . 0.0 109.769 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.12 -0.34 31.5 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 123.808 0.718 . . . . 0.0 111.75 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -90.62 164.37 14.21 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.5 mm -123.99 123.63 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.657 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.66 131.11 53.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.294 1.038 . . . . 0.0 109.039 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.1 t -113.1 151.24 31.03 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.785 1.234 . . . . 0.0 108.374 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.2 mt -110.76 118.59 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.074 0.95 . . . . 0.0 108.744 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.3 t -89.04 -107.75 0.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -160.23 99.48 1.33 Allowed 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 85.5 m -138.33 114.44 10.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 115.865 -2.017 . . . . 0.0 107.128 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.5 m -75.62 125.59 29.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 122.448 2.386 . . . . 0.0 106.617 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.6 t -99.63 111.83 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.868 1.267 . . . . 0.0 108.152 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.9 m -75.77 161.18 29.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.75 0.82 . . . . 0.0 109.733 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.7 -30.48 68.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.42 1.088 . . . . 0.0 112.043 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.87 -24.24 64.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.31 -0.244 . . . . 0.0 110.891 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -96.44 -27.1 15.06 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.324 0.649 . . . . 0.0 109.515 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.6 tp -68.11 148.7 50.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.193 1.397 . . . . 0.0 109.286 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.74 -101.99 2.65 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.62 1.105 . . . . 0.0 111.158 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -135.07 171.19 14.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.313 1.845 . . . . 0.0 111.221 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -64.12 136.82 57.59 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.421 1.088 . . . . 0.0 110.189 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -117.19 -52.63 2.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.152 0.981 . . . . 0.0 113.168 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -157.59 158.4 35.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.098 0.863 . . . . 0.0 111.695 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.05 137.99 45.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 119.241 0.928 . . . . 0.0 111.165 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.57 165.19 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.487 1.915 . . . . 0.0 111.09 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.58 65.81 0.07 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.156 0.982 . . . . 0.0 111.192 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -157.98 167.76 29.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 t -144.18 148.39 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -142.05 166.61 24.24 Favored 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 120.872 -1.143 . . . . 0.0 108.558 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.09 129.72 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.63 168.86 18.75 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.179 0.9 . . . . 0.0 111.203 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -101.65 102.14 12.77 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.3 t -50.77 -19.19 0.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 129.361 3.064 . . . . 0.0 115.965 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.7 m -55.99 -46.95 80.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.3 m -123.98 -23.24 4.66 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.144 1.777 . . . . 0.0 114.276 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 103.7 7.87 41.14 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.289 1.899 . . . . 0.0 112.864 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 113.2 1.54 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.675 1.737 . . . . 0.0 112.942 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 p -63.2 140.56 58.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.154 0.982 . . . . 0.0 108.567 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.89 147.34 34.31 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.48 159.72 19.61 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.479 2.786 . . . . 0.0 110.089 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -64.44 -17.61 63.97 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 121.377 -0.827 . . . . 0.0 111.708 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.6 p -74.53 -11.14 60.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.367 -0.833 . . . . 0.0 111.711 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -111.1 -3.89 15.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.32 1.448 . . . . 0.0 112.251 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.6 m0 . . . . . 0 N--CA 1.465 0.303 0 C-N-CA 125.375 1.47 . . . . 0.0 114.397 -179.702 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 99.8 m -139.96 130.43 25.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -113.54 105.31 13.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.407 1.883 . . . . 0.0 107.547 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -110.3 127.89 55.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.941 0.896 . . . . 0.0 109.736 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -96.75 126.98 42.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.478 1.911 . . . . 0.0 107.399 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -75.66 100.96 4.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.896 1.331 . . . . 0.0 111.522 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -95.4 159.28 22.47 Favored Glycine 0 N--CA 1.431 -1.649 1 C-N-CA 130.727 4.013 . . . . 0.0 108.335 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.78 152.46 45.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 124.16 1.933 . . . . 0.0 111.029 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 67.7 mt -96.68 141.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.868 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -135.38 151.7 50.73 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.549 1.54 . . . . 0.0 109.233 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.9 p -77.48 173.27 12.17 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.246 1.018 . . . . 0.0 110.798 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 60.1 mt -126.34 137.52 57.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -67.49 124.21 22.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.48 1.512 . . . . 0.0 108.883 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.84 12.24 84.38 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 117.922 -1.488 . . . . 0.0 114.666 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -141.4 142.7 33.71 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.743 1.772 . . . . 0.0 111.255 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 24.5 m -90.02 151.24 21.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.837 0.827 . . . . 0.0 109.114 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -31.83 67.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.088 0.955 . . . . 0.0 111.183 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.4 p -68.69 -10.03 53.82 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 129.352 3.061 . . . . 0.0 114.624 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -120.51 -46.79 2.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.836 1.254 . . . . 0.0 107.764 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.16 147.91 5.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.593 0.711 . . . . 0.0 110.571 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -152.83 176.16 12.11 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.167 0.587 . . . . 0.0 110.098 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.64 137.63 47.18 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.02 130.23 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 125.26 1.424 . . . . 0.0 110.879 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.54 107.68 4.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 33.0 mm -120.74 120.7 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 52.98 45.53 28.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.421 0.688 . . . . 0.0 109.901 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 64.27 13.3 7.85 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.537 1.535 . . . . 0.0 112.623 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.18 122.15 36.22 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.165 -0.959 . . . . 0.0 108.687 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -69.42 115.93 9.25 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 120.512 -1.368 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -111.02 145.81 37.81 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.467 1.507 . . . . 0.0 113.09 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -80.64 128.8 34.03 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.929 1.291 . . . . 0.0 111.547 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -115.29 141.62 47.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.05 143.35 50.84 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.508 0.723 . . . . 0.0 110.535 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -55.41 138.53 45.78 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 CA--C 1.536 0.416 0 C-N-CA 126.84 2.056 . . . . 0.0 105.761 176.469 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -59.17 146.43 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 98.5 t -150.29 120.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.164 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -68.13 118.17 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.135 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.34 123.62 13.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -20.36 66.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -90.47 -33.11 16.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.04 104.67 6.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -67.18 -13.59 62.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 47.6 ptt85 -94.89 -7.13 40.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.854 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -101.71 159.93 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.6 mm -128.02 131.52 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.139 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -107.7 103.65 12.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -135.79 129.77 33.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.2 mtt 59.69 39.73 20.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 63.4 20.46 63.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.443 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -113.43 172.81 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 36.3 mm -131.36 129.01 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -125.42 152.31 45.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 t -121.18 152.04 39.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.7 mt -123.26 111.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.122 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -92.74 -90.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -169.86 93.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 26.4 m -140.64 104.63 4.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 m -62.94 113.18 2.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.83 119.48 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.4 m -84.74 171.41 12.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.77 -26.31 64.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.09 -25.1 68.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -104.66 -26.12 12.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.61 137.75 58.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.38 -105.78 2.65 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.516 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -134.24 169.92 16.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.93 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -56.23 142.09 38.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -125.43 -51.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.953 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -147.37 159.87 43.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 5.3 p -119.56 129.93 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 195' ' ' TYR . 3.3 mm? -110.9 166.01 11.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.67 70.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -166.41 175.34 8.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.3 t -144.87 149.45 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.103 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.74 155.54 42.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -124.59 123.32 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.114 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -144.85 155.44 43.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -74.34 124.49 26.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.12 -4.35 32.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.5 m -77.93 -44.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.16 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.7 t -123.36 -30.12 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.09 33.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.434 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -69.9 127.93 34.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.844 0.354 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.83 155.11 37.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.47 139.83 35.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.584 0.707 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 154.98 67.1 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.645 2.23 . . . . 0.0 112.366 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -58.98 -21.71 59.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 m -73.86 -7.66 53.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.09 -12.46 14.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 31.8 m0 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 98.9 m -137.77 120.41 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.69 105.52 17.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -110.35 116.78 32.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.96 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -84.55 126.55 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.411 ' HB3' ' HB3' ' A' ' 157' ' ' LEU . 13.4 m-30 -65.21 103.83 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 213' ' ' GLU . . . -101.28 162.84 17.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.484 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.28 139.35 58.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.798 0.333 . . . . 0.0 110.861 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.1 mt -91.21 143.39 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -131.68 143.14 50.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.78 172.26 3.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 71.1 mt -130.8 141.83 45.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -69.3 122.16 18.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 76.02 27.12 62.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -149.34 146.28 27.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.326 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -106.0 145.11 31.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.855 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.24 -17.15 62.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 67.4 p -82.59 -9.41 59.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.65 -51.56 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.09 146.32 24.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.069 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -154.44 176.44 12.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -110.4 125.36 53.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.084 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.0 p -117.68 125.39 74.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.142 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . 0.442 ' HB3' ' HA3' ' A' ' 196' ' ' GLY . 18.9 tt0 -70.43 101.55 1.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 48.4 mm -120.39 120.25 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 60.53 43.94 12.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.37 14.88 9.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -137.49 122.11 18.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.52 125.06 26.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -116.62 140.69 49.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 3.3 tm? -76.37 121.76 23.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.54 139.29 40.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.21 138.33 50.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -64.97 122.12 16.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 94.4 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 179.915 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.063 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -73.9 134.5 43.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 84.2 t -135.2 124.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -73.12 140.23 18.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -66.19 127.12 30.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -65.55 -27.05 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.462 -0.774 . . . . 0.0 111.705 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -80.67 -45.5 17.1 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.721 1.209 . . . . 0.0 110.057 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.08 100.59 6.8 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.4 t -62.67 -7.66 5.23 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.872 -1.142 . . . . 0.0 110.95 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -94.3 -4.87 47.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.867 2.067 . . . . 0.0 110.257 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -110.84 158.81 18.28 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.6 mm -125.34 138.41 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.92 103.48 11.71 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 102.923 -2.992 . . . . 0.0 102.923 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -137.69 132.37 32.78 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.1 mtt 57.97 25.35 12.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.995 0.918 . . . . 0.0 111.077 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.42 -0.6 68.58 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.429 -0.795 . . . . 0.0 112.412 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -93.69 166.26 12.3 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.552 1.541 . . . . 0.0 108.006 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.7 mm -123.18 137.18 57.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -131.08 156.77 44.64 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.814 1.246 . . . . 0.0 108.454 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.2 t -140.37 155.67 46.68 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 107.986 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.7 mt -114.37 117.8 56.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.284 1.433 . . . . 0.0 110.795 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.6 t -86.63 -111.01 0.05 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -162.46 101.26 1.06 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 103.563 -2.755 . . . . 0.0 103.563 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 49.2 m -134.88 111.82 10.18 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.1 m -70.93 120.54 16.65 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.37 122.41 45.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.5 m -82.2 154.44 25.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.81 -26.9 67.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.54 1.136 . . . . 0.0 112.036 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.72 -19.07 62.78 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.415 -0.803 . . . . 0.0 110.471 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -106.19 -16.22 14.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.46 1.904 . . . . 0.0 110.086 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.8 tp -80.19 118.42 21.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 128.105 2.562 . . . . 0.0 107.103 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.45 -103.78 0.11 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 123.687 0.661 . . . . 0.0 111.486 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.68 170.01 16.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.559 1.144 . . . . 0.0 110.069 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -61.89 142.92 57.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.572 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -125.64 -48.95 1.65 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.559 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.77 160.74 43.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.093 1.315 . . . . 0.0 110.714 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.83 135.19 60.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.835 1.254 . . . . 0.0 111.561 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.8 164.87 12.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.805 2.042 . . . . 0.0 111.522 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.15 54.89 0.06 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.953 0.901 . . . . 0.0 112.124 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.44 172.33 15.13 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.338 -1.476 . . . . 0.0 107.517 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.38 147.53 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -145.18 166.24 26.02 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 120.576 -1.327 . . . . 0.0 108.521 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.1 t -129.24 133.31 65.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -147.97 160.59 42.66 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.48 0.582 . . . . 0.0 111.71 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.34 106.29 7.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.5 t -61.07 -20.25 62.37 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.23 -33.33 19.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 120.823 -1.173 . . . . 0.0 113.978 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.0 t -122.03 -25.45 4.94 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.061 0.945 . . . . 0.0 112.241 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.83 -0.14 56.42 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.064 1.792 . . . . 0.0 112.073 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -52.98 112.23 0.81 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.147 1.474 . . . . 0.0 110.421 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.4 m -70.99 157.67 37.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 119.294 0.952 . . . . 0.0 111.627 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.0 129.28 25.48 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.901 2.08 . . . . 0.0 106.375 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.44 157.73 48.93 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.322 2.681 . . . . 0.0 109.196 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -52.31 -32.27 37.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.892 0.877 . . . . 0.0 112.673 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.4 m -64.74 -12.97 52.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.09 -6.82 15.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.842 2.057 . . . . 0.0 111.747 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.5 m0 . . . . . 0 C--O 1.233 0.229 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.141 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.1 m -154.12 150.81 28.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -127.63 104.76 8.04 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -114.15 117.03 30.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.816 1.246 . . . . 0.0 110.557 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.27 129.38 34.58 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.975 2.11 . . . . 0.0 108.833 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -76.34 100.83 5.27 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.244 0.617 . . . . 0.0 109.776 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.43 158.87 23.04 Favored Glycine 0 CA--C 1.531 1.054 1 C-N-CA 133.483 5.325 . . . . 0.0 107.228 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.85 154.18 42.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 123.87 1.795 . . . . 0.0 111.603 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 58.2 mt -100.83 139.11 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.013 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -131.9 149.54 52.41 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.458 1.503 . . . . 0.0 109.585 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.2 t -78.65 173.65 12.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.241 1.016 . . . . 0.0 109.611 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 75.7 mt -131.49 143.9 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.674 1.189 . . . . 0.0 110.626 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -65.63 131.27 45.94 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.651 1.18 . . . . 0.0 108.877 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 62.92 22.38 64.52 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.152 -1.36 . . . . 0.0 115.22 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -140.23 148.08 40.98 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.122 1.461 . . . . 0.0 107.819 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.1 m -105.87 146.62 29.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.01 -31.31 60.94 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.078 1.351 . . . . 0.0 110.544 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.4 p -70.54 -12.65 61.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.607 1.963 . . . . 0.0 114.729 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -125.06 -39.37 2.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.863 1.665 . . . . 0.0 112.205 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.33 139.74 5.92 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.159 0.983 . . . . 0.0 110.797 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -150.19 174.31 12.94 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.958 0.903 . . . . 0.0 109.534 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.56 138.67 47.8 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.133 0.573 . . . . 0.0 111.864 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.6 p -132.65 131.07 59.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.895 1.278 . . . . 0.0 110.747 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.79 106.23 7.26 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 39.7 mm -122.06 129.81 75.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.653 1.181 . . . . 0.0 110.759 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 53.94 37.75 27.34 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.382 -0.824 . . . . 0.0 112.123 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 74.77 5.51 4.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.246 1.818 . . . . 0.0 111.311 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -130.8 134.9 47.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.74 1.155 . . . . 0.0 112.351 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -70.86 130.24 41.14 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 121.056 -1.027 . . . . 0.0 110.447 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -125.66 148.49 48.99 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.997 1.319 . . . . 0.0 109.617 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.437 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -84.06 126.69 33.31 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.106 1.362 . . . . 0.0 112.065 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -109.78 143.25 39.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 1.1 p -125.67 148.23 49.08 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.47 1.508 . . . . 0.0 111.616 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -55.56 139.98 42.31 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.245 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -77.78 121.45 24.07 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 124.822 1.249 . . . . 0.0 108.136 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.2 t -125.86 128.44 72.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 125.58 1.552 . . . . 0.0 109.095 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -72.87 140.03 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -61.63 129.94 43.5 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.247 -0.908 . . . . 0.0 111.098 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -67.33 -11.49 57.75 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.337 -0.852 . . . . 0.0 111.687 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -106.23 -14.54 15.1 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.789 1.236 . . . . 0.0 112.962 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.82 115.21 5.12 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.97 0.805 . . . . 0.0 109.496 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.435 ' HB2' ' CD1' ' A' ' 163' ' ' PHE . 73.6 m -63.81 -17.57 63.24 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.95 -1.093 . . . . 0.0 111.784 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -94.56 -1.7 52.87 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.97 1.708 . . . . 0.0 112.012 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -105.97 156.34 18.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.431 1.014 . . . . 0.0 111.628 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.2 mm -128.03 136.39 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -116.07 107.32 14.78 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.497 2.319 . . . . 0.0 105.657 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -145.07 133.97 22.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.9 mtt 58.22 33.22 22.95 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.396 1.478 . . . . 0.0 111.061 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.1 22.62 70.82 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -116.78 163.84 15.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 28.6 mm -121.6 128.96 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.972 0.909 . . . . 0.0 109.294 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -125.46 157.8 36.02 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.9 t -141.96 157.98 44.31 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.828 1.251 . . . . 0.0 108.861 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.3 mt -110.54 130.49 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.23 1.012 . . . . 0.0 109.698 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -106.76 -116.51 0.26 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 102.591 -3.115 . . . . 0.0 102.591 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -157.41 100.06 1.79 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 93.6 m -136.39 109.35 7.65 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.118 1.767 . . . . 0.0 107.004 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.7 m -68.97 125.68 27.41 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.8 t -93.78 113.0 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 120.63 1.559 . . . . 0.0 108.496 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 m -68.56 155.13 40.56 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.704 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.54 -25.41 68.03 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.644 1.178 . . . . 0.0 110.981 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.32 -25.78 63.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.845 0.858 . . . . 0.0 109.848 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -94.57 -33.85 12.87 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.569 1.148 . . . . 0.0 110.151 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.19 121.18 7.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.766 1.626 . . . . 0.0 108.37 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -88.47 -110.52 1.1 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.1 170.15 16.34 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.666 1.186 . . . . 0.0 112.153 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -55.94 128.64 36.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.528 1.531 . . . . 0.0 111.333 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -118.39 -38.39 3.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.661 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.22 161.74 14.63 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 121.256 1.844 . . . . 0.0 111.377 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.03 139.83 47.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 120.066 1.303 . . . . 0.0 110.837 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.43 164.71 12.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.646 1.978 . . . . 0.0 109.145 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -162.11 33.17 0.12 Allowed 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.42 174.02 11.07 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 120.309 -1.494 . . . . 0.0 109.031 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.7 t -139.98 147.85 23.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -144.5 162.46 36.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 87.6 t -127.52 136.46 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 128' ' ' SER . 49.8 p90 -146.63 166.54 26.24 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.29 0.636 . . . . 0.0 111.316 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.85 101.3 13.39 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.1 t -47.75 -22.54 0.55 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 130.179 3.392 . . . . 0.0 116.863 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -57.86 -51.61 68.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 125.65 1.58 . . . . 0.0 109.947 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . 0.257 24.6 m -121.58 -27.54 4.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.471 1.508 . . . . 0.0 112.843 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 111.94 6.98 24.04 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.125 1.345 . . . . 0.0 114.248 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.436 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -53.5 113.0 1.01 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.582 2.191 . . . . 0.0 111.704 -178.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.4 m -69.0 152.74 44.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 119.428 1.013 . . . . 0.0 108.971 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.79 140.92 28.28 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.854 1.662 . . . . 0.0 108.792 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.5 160.36 38.57 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.127 2.551 . . . . 0.0 109.686 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -60.93 -30.36 70.17 Favored 'General case' 0 CA--C 1.519 -0.24 0 O-C-N 121.438 -0.789 . . . . 0.0 110.869 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 p -64.53 -7.06 8.83 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.892 -1.052 . . . . 0.0 113.407 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.87 -8.64 13.7 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.344 1.429 . . . . 0.0 111.08 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.5 m0 . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 -178.175 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 . . . . . 0 N--CA 1.46 0.071 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 95.6 m -144.99 138.12 26.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 126.922 2.089 . . . . 0.0 107.302 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -112.76 110.17 20.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.797 1.639 . . . . 0.0 108.19 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -111.73 118.77 36.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.6 1.16 . . . . 0.0 111.067 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.56 127.08 36.14 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -76.47 101.02 5.43 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.382 1.473 . . . . 0.0 111.421 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.1 159.71 23.67 Favored Glycine 0 N--CA 1.435 -1.378 1 C-N-CA 132.646 4.927 . . . . 0.0 107.546 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.89 154.6 41.22 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 122.972 1.368 . . . . 0.0 112.767 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 54.8 mt -102.74 121.62 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 125.628 1.571 . . . . 0.0 111.874 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -111.31 154.25 24.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.294 1.045 . . . . 0.0 110.309 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.9 t -73.77 172.86 10.73 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.925 1.29 . . . . 0.0 108.163 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 77.7 mt -135.19 132.78 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -59.17 119.85 8.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.209 1.404 . . . . 0.0 108.229 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.13 12.44 84.03 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.261 -1.3 . . . . 0.0 115.308 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -134.56 133.43 40.25 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.863 1.831 . . . . 0.0 109.881 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.8 m -83.59 146.89 28.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -25.21 61.51 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.574 1.15 . . . . 0.0 111.101 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.5 p -75.64 -14.4 60.36 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.825 2.05 . . . . 0.0 113.642 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -119.74 -43.0 2.59 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.986 0.914 . . . . 0.0 111.367 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.62 139.88 8.02 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 118.799 0.727 . . . . 0.0 109.143 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -152.33 176.64 11.41 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.507 1.123 . . . . 0.0 109.515 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.56 131.82 54.71 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.614 1.166 . . . . 0.0 111.845 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.1 129.74 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 C-N-CA 123.958 0.903 . . . . 0.0 109.432 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -74.33 104.76 5.21 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 36.5 mm -121.64 127.2 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 O-C-N 120.49 -1.381 . . . . 0.0 107.511 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 53.28 43.62 31.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.206 0.457 . . . . 0.0 110.304 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.6 t0 61.11 19.13 9.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.362 0.665 . . . . 0.0 112.167 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.09 122.53 24.24 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.753 -1.217 . . . . 0.0 109.188 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.42 115.96 12.3 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.981 -1.074 . . . . 0.0 112.77 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -106.15 152.38 23.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.102 0.961 . . . . 0.0 111.99 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.8 tm? -88.37 119.44 28.8 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.191 1.396 . . . . 0.0 107.939 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.6 148.58 27.16 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.8 p -127.42 151.16 49.17 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.778 0.674 . . . . 0.0 112.26 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -57.58 141.44 48.0 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.382 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -69.76 136.69 51.22 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.106 0.963 . . . . 0.0 108.602 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.6 t -134.98 124.59 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 mp -76.44 134.22 29.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.54 134.95 51.1 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.832 1.301 . . . . 0.0 110.544 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -18.56 64.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.486 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -104.09 -36.5 7.69 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.23 0.468 . . . . 0.0 111.354 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.84 105.14 11.64 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 122.202 1.001 . . . . 0.0 109.985 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.7 t -61.73 -11.48 12.27 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.112 1.365 . . . . 0.0 111.825 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -100.02 -8.98 23.19 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.787 1.635 . . . . 0.0 111.873 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -102.16 154.73 18.74 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 119.418 1.008 . . . . 0.0 111.276 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.5 mm -126.58 127.46 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.11 105.31 15.44 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -141.37 136.04 31.05 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.773 -1.204 . . . . 0.0 107.813 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.2 mtt 54.44 21.21 3.14 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.59 0.29 89.27 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.561 1.077 . . . . 0.0 112.336 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -90.13 172.58 8.71 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.282 1.433 . . . . 0.0 108.021 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.8 mm -133.66 124.76 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -119.17 154.21 33.69 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.1 t -138.36 159.45 42.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.2 mt -115.7 134.75 57.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.798 0.808 . . . . 0.0 111.234 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.3 t -104.76 -130.56 0.28 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 101.713 -3.44 . . . . 0.0 101.713 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -154.35 98.81 2.15 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 121.918 2.144 . . . . 0.0 106.672 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.6 m -135.76 121.09 19.14 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 128.244 2.618 . . . . 0.0 106.521 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.7 m -72.07 123.34 22.62 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 76.1 t -93.88 111.84 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.6 m -77.17 159.77 29.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.438 0.637 . . . . 0.0 109.694 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -64.6 -17.76 64.28 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 111.669 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -77.0 -11.71 59.84 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.755 0.822 . . . . 0.0 109.473 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -115.21 -28.4 6.94 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.381 1.072 . . . . 0.0 109.38 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.95 132.67 50.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.126 2.17 . . . . 0.0 107.148 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -101.39 -98.31 2.34 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.309 0.957 . . . . 0.0 114.289 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -134.68 159.43 41.28 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.272 1.429 . . . . 0.0 111.906 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.0 133.27 55.37 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.832 1.653 . . . . 0.0 109.658 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.79 -43.22 2.9 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 116.538 -1.696 . . . . 0.0 111.69 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -165.5 158.25 15.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 121.144 1.793 . . . . 0.0 110.462 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.22 137.37 44.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.17 163.35 13.69 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.951 1.7 . . . . 0.0 110.752 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.0 38.98 0.15 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.441 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 1.9 tt0 -139.78 175.34 9.66 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 120.023 -1.673 . . . . 0.0 110.759 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.2 t -144.88 150.51 16.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -147.09 164.0 34.48 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.848 0.832 . . . . 0.0 109.018 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.0 t -128.78 129.1 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 126.38 1.872 . . . . 0.0 107.412 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -147.89 160.93 42.26 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.07 0.948 . . . . 0.0 112.684 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.51 100.09 12.8 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 102.255 -3.239 . . . . 0.0 102.255 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 12.7 t -47.61 -25.88 1.3 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.154 2.581 . . . . 0.0 116.451 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.3 m -57.68 -45.98 86.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.04 1.736 . . . . 0.0 111.11 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.2 m -122.73 -21.76 5.53 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.024 1.33 . . . . 0.0 113.09 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.78 10.83 48.76 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.652 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.04 112.49 2.99 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.134 1.467 . . . . 0.0 110.669 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 44.2 m -72.38 152.03 42.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.647 0.658 . . . . 0.0 109.488 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.59 147.51 36.9 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.79 159.78 31.21 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.18 2.587 . . . . 0.0 109.902 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 ttt-85 -57.39 -32.34 66.73 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 45.0 m -65.19 -8.28 16.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.241 -1.362 . . . . 0.0 113.308 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.99 -9.14 16.32 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.354 1.434 . . . . 0.0 111.672 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.0 m0 . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 127.121 2.168 . . . . 0.0 115.143 -178.821 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.405 HH11 ' HG2' ' A' ' 190' ' ' ARG . 8.2 mtt-85 . . . . . 0 CA--C 1.51 -0.575 0 CA-C-O 120.968 0.413 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.6 m -130.27 117.4 19.76 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.83 105.89 18.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.599 1.959 . . . . 0.0 106.527 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.9 m0 -110.97 116.26 30.89 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 118.496 0.589 . . . . 0.0 110.45 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -81.94 131.77 35.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.441 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.8 m-30 -78.55 107.51 11.26 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.958 1.703 . . . . 0.0 106.807 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -107.85 159.41 14.43 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 129.532 3.444 . . . . 0.0 112.64 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -66.89 140.88 57.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 124.652 2.168 . . . . 0.0 111.692 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.0 mt -93.13 140.84 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.673 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -136.25 151.3 49.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 123.194 1.474 . . . . 0.0 109.293 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.1 t -75.39 172.92 11.64 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.997 1.719 . . . . 0.0 107.523 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.3 mt -126.93 137.26 58.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -62.96 131.15 47.72 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.13 22.95 72.89 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.842 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -139.3 155.11 47.95 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.778 1.789 . . . . 0.0 108.094 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 57.8 m -106.08 140.41 39.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.04 -24.65 55.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.144 0.977 . . . . 0.0 109.123 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.4 p -69.71 -14.63 62.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.263 1.825 . . . . 0.0 112.898 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -120.34 -41.34 2.62 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.248 1.019 . . . . 0.0 110.619 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.34 150.72 9.29 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.922 0.889 . . . . 0.0 110.657 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -158.38 176.14 12.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.247 1.019 . . . . 0.0 109.752 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.39 136.66 48.46 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 110.844 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.71 128.15 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 124.061 0.945 . . . . 0.0 109.624 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.65 107.36 3.88 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.3 mm -121.85 126.67 74.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 54.78 43.32 30.25 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.25 -4.83 1.2 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.05 1.74 . . . . 0.0 113.006 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -117.04 122.7 44.94 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.623 -1.298 . . . . 0.0 111.632 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -63.04 115.63 4.61 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.37 -1.456 . . . . 0.0 113.537 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -103.97 150.16 24.48 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 126.435 1.894 . . . . 0.0 111.442 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -88.79 122.19 31.93 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.607 1.163 . . . . 0.0 108.593 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -106.66 150.22 26.44 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 1.5 p -129.49 152.11 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.51 1.124 . . . . 0.0 110.307 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -69.67 124.05 22.95 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.454 -0.231 0 C-N-CA 123.999 0.92 . . . . 0.0 108.67 179.571 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 103.971 -2.604 . . . . 0.0 103.971 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -69.21 145.1 53.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.647 0.779 . . . . 0.0 110.225 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.0 t -137.95 128.25 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 mp -82.01 129.45 37.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.57 122.22 11.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.769 1.271 . . . . 0.0 109.592 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -59.03 -24.23 62.66 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.212 -0.93 . . . . 0.0 111.843 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -90.68 -31.59 16.54 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.901 1.28 . . . . 0.0 112.196 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.84 100.21 4.69 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.7 p -65.3 -11.34 40.63 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.407 -0.808 . . . . 0.0 111.511 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -90.01 -3.83 57.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.002 2.121 . . . . 0.0 110.209 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -113.57 158.52 20.68 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.356 0.98 . . . . 0.0 109.001 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.5 mm -129.09 139.59 51.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -118.48 108.36 14.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -142.82 140.45 31.31 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.0 mtt 56.87 22.45 7.09 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.656 0.782 . . . . 0.0 112.834 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.22 18.55 78.18 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -123.78 159.65 29.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.311 1.056 . . . . 0.0 108.218 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.1 mm -110.35 140.44 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -131.79 144.37 50.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 t -124.55 148.71 47.63 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 126.804 2.042 . . . . 0.0 107.351 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.6 mt -113.31 123.56 69.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 124.627 1.171 . . . . 0.0 110.026 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -93.36 -143.61 0.23 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -142.16 98.81 3.39 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 102.685 -3.079 . . . . 0.0 102.685 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.9 m -136.54 109.87 7.87 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 111.642 -2.526 . . . . 0.0 106.241 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 m -69.88 131.91 45.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 120.756 1.617 . . . . 0.0 106.752 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.3 t -94.69 114.18 30.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.776 1.63 . . . . 0.0 106.664 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.9 m -71.02 159.34 34.92 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.907 0.384 . . . . 0.0 110.786 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.72 -26.51 67.23 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.238 1.415 . . . . 0.0 111.294 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.1 -13.66 60.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.522 0.729 . . . . 0.0 111.36 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -105.71 -26.74 11.68 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.315 1.446 . . . . 0.0 108.883 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.7 mt -62.01 142.3 57.57 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.42 -103.42 2.46 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -134.99 166.84 22.11 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.086 1.354 . . . . 0.0 109.443 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -58.79 144.38 44.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.609 0.764 . . . . 0.0 109.942 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.23 -49.36 1.94 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 117.265 -1.35 . . . . 0.0 111.217 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.64 157.83 22.43 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 120.745 1.612 . . . . 0.0 110.828 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.4 p -105.59 138.64 29.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.547 1.165 . . . . 0.0 110.408 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.0 mp -113.41 163.16 15.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.536 2.734 . . . . 0.0 108.407 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -172.25 68.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.861 0.864 . . . . 0.0 109.957 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -160.67 175.83 12.21 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.837 -1.165 . . . . 0.0 109.036 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.3 t -144.76 149.28 17.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.71 154.96 40.35 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.5 t -123.63 130.51 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 124.498 1.119 . . . . 0.0 108.077 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -147.86 160.54 42.66 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.609 1.164 . . . . 0.0 111.579 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -85.49 100.98 12.26 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.6 t -56.26 -11.73 1.31 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.109 1.364 . . . . 0.0 114.613 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.3 m -65.74 -40.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.137 -0.977 . . . . 0.0 110.033 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.0 t -124.26 -28.35 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.723 1.209 . . . . 0.0 113.195 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.54 5.78 36.3 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.738 1.637 . . . . 0.0 111.166 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -57.31 112.32 1.36 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.053 1.741 . . . . 0.0 111.026 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.6 p -64.37 154.25 36.03 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.906 1.683 . . . . 0.0 110.749 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.45 152.14 60.75 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.365 1.066 . . . . 0.0 108.365 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.64 162.56 16.6 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.93 3.086 . . . . 0.0 108.513 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -58.75 -28.89 66.32 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.903 -1.123 . . . . 0.0 111.69 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 95.9 p -68.93 -8.8 47.77 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -104.22 -4.76 22.64 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 120.414 -1.429 . . . . 0.0 109.069 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 34.3 m0 . . . . . 0 CA--C 1.551 1.011 0 O-C-N 120.872 -1.142 . . . . 0.0 111.831 179.524 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 10.6 mtt85 . . . . . 0 CA--C 1.519 -0.241 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.7 m -142.14 123.86 15.1 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -100.92 109.1 21.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -110.4 116.21 31.03 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.17 117.51 21.78 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 128.471 2.708 . . . . 0.0 107.463 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -68.78 106.95 2.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.567 1.147 . . . . 0.0 107.986 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -107.56 159.27 14.58 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 129.677 3.513 . . . . 0.0 110.945 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.52 149.65 50.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 124.927 2.299 . . . . 0.0 112.109 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 40.9 mt -98.18 140.94 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 111.752 -2.476 . . . . 0.0 110.713 -176.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -134.04 151.78 51.56 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.986 1.714 . . . . 0.0 109.873 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.3 p -77.63 173.39 12.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 58.8 mt -125.41 141.29 45.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -64.14 132.04 49.27 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.919 1.288 . . . . 0.0 108.076 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.6 18.93 70.55 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 118.554 -1.137 . . . . 0.0 114.69 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -135.87 157.86 45.81 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 120.025 1.912 . . . . 0.0 109.172 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 73.8 m -106.38 140.98 38.45 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.94 -26.54 48.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 77.1 p -68.24 -12.99 61.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.643 2.377 . . . . 0.0 113.866 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -119.99 -42.72 2.58 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 118.833 -0.603 . . . . 0.0 109.532 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.02 155.43 18.57 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.335 0.588 . . . . 0.0 110.765 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -157.54 175.63 13.69 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.577 0.751 . . . . 0.0 109.972 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.75 134.26 53.43 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.887 1.275 . . . . 0.0 110.861 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.04 132.71 56.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.256 1.022 . . . . 0.0 108.345 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -70.18 102.82 2.18 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.482 ' HB ' ' HE2' ' A' ' 219' ' ' LYS . 39.3 mm -121.42 123.16 69.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 O-C-N 121.075 -1.016 . . . . 0.0 108.282 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 53.44 48.39 21.96 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.98 0.912 . . . . 0.0 109.074 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 62.19 9.0 2.93 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.59 1.156 . . . . 0.0 114.081 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -131.19 122.56 26.78 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.189 0.904 . . . . 0.0 109.028 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -61.94 118.71 7.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.286 0.634 . . . . 0.0 109.931 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.482 ' HE2' ' HB ' ' A' ' 214' ' ' ILE . 16.7 mtmm -114.23 149.06 36.39 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.4 1.095 . . . . 0.0 110.088 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -81.29 123.76 28.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.306 1.842 . . . . 0.0 111.871 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -110.3 145.28 37.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.62 145.37 51.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.68 1.192 . . . . 0.0 110.92 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -64.15 120.81 12.8 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 C--N 1.326 -0.427 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.211 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -57.86 138.42 55.72 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.9 2.48 . . . . 0.0 112.818 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.4 t -140.54 142.17 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.5 1.92 . . . . 0.0 106.941 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -90.27 139.63 17.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -68.35 131.46 45.36 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 122.669 1.223 . . . . 0.0 112.495 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -70.19 -16.95 63.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.125 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -93.17 -31.13 14.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.959 1.254 . . . . 0.0 112.517 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.23 110.69 6.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 t -64.85 -14.75 60.47 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.444 1.475 . . . . 0.0 111.311 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -82.26 -5.26 58.41 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.216 1.006 . . . . 0.0 110.689 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -107.37 158.43 17.17 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 118.264 0.484 . . . . 0.0 111.941 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.5 mm -130.18 131.31 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.692 1.197 . . . . 0.0 107.78 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -103.52 97.45 7.49 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -131.37 126.4 35.12 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.839 -1.163 . . . . 0.0 109.339 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.1 mtt 57.16 33.54 23.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.047 1.739 . . . . 0.0 110.554 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.45 0.59 54.5 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.297 -0.877 . . . . 0.0 111.336 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -92.74 161.01 14.71 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -121.15 134.08 65.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -129.84 159.71 35.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.9 t -138.41 156.65 47.38 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.469 1.108 . . . . 0.0 108.045 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.4 mt -112.47 129.92 67.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.842 0.857 . . . . 0.0 109.688 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.4 t -100.54 -110.16 0.2 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . 0.257 8.4 p-10 -162.4 99.03 1.04 Allowed 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 126.966 2.107 . . . . 0.0 107.668 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 97.5 m -137.93 108.34 6.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 115.961 -1.971 . . . . 0.0 109.072 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.6 m -67.29 122.68 18.43 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 122.163 2.256 . . . . 0.0 105.75 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.3 t -99.7 110.99 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.822 1.192 . . . . 0.0 108.036 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -79.38 164.66 23.85 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -61.45 -31.21 71.16 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.204 1.002 . . . . 0.0 111.426 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.28 -16.45 63.57 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.739 1.215 . . . . 0.0 111.384 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.93 -29.21 8.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.386 1.075 . . . . 0.0 110.003 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.1 tp -61.14 142.73 56.5 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.86 1.264 . . . . 0.0 109.082 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -96.51 -102.08 2.01 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.48 166.34 23.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.942 1.697 . . . . 0.0 110.644 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.87 146.48 26.32 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.999 0.92 . . . . 0.0 109.968 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -126.0 -52.33 1.54 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.09 -1.433 . . . . 0.0 112.689 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -157.25 154.66 29.49 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.745 1.612 . . . . 0.0 110.283 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.8 p -111.69 137.12 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 119.129 0.877 . . . . 0.0 110.013 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -112.02 165.03 12.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.535 2.334 . . . . 0.0 109.66 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -169.57 66.29 0.05 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.713 1.205 . . . . 0.0 109.563 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -156.4 173.47 16.84 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.34 147.83 16.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 O-C-N 121.179 -0.95 . . . . 0.0 108.63 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.23 161.41 38.35 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.865 0.757 . . . . 0.0 109.765 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.23 125.29 63.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 126.476 1.911 . . . . 0.0 108.768 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -142.91 163.95 31.4 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.065 1.346 . . . . 0.0 112.099 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.85 110.38 21.32 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.89 -18.84 36.73 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.69 1.596 . . . . 0.0 115.069 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.15 -40.46 82.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 O-C-N 121.284 -0.885 . . . . 0.0 112.044 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.446 ' HB3' ' HE2' ' A' ' 169' ' ' LYS . 0.4 OUTLIER -123.26 -12.98 7.78 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.684 0.794 . . . . 0.0 112.631 -178.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.18 12.67 75.89 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.302 0.953 . . . . 0.0 111.739 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.446 ' HE2' ' HB3' ' A' ' 167' ' ' SER . 25.1 mtmt -71.89 112.62 8.14 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.969 1.308 . . . . 0.0 110.507 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.2 m -73.33 157.48 36.91 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.1 1.36 . . . . 0.0 109.933 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.44 151.68 51.79 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.221 0.608 . . . . 0.0 110.205 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 160.26 39.03 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.461 2.108 . . . . 0.0 108.778 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -60.0 -22.15 62.2 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.924 -1.11 . . . . 0.0 111.186 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -14.64 44.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.033 1.333 . . . . 0.0 112.345 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -116.62 3.15 13.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.052 0.941 . . . . 0.0 112.032 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 24.8 m0 . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -179.642 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 . . . . . 0 C--O 1.233 0.194 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 93.5 m -144.22 124.29 13.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.803 2.041 . . . . 0.0 106.62 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -101.15 112.19 24.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -110.14 116.74 32.08 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.91 1.284 . . . . 0.0 110.658 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -83.2 125.18 31.28 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.676 2.39 . . . . 0.0 107.91 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -77.11 100.91 5.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -93.95 158.22 23.14 Favored Glycine 0 N--CA 1.438 -1.191 1 C-N-CA 130.806 4.05 . . . . 0.0 107.911 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -69.05 153.96 42.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.711 1.72 . . . . 0.0 111.041 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.9 mt -99.49 143.12 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 113.158 -1.837 . . . . 0.0 108.593 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -133.15 150.24 52.03 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.927 1.691 . . . . 0.0 109.429 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 19.4 m -79.33 171.59 14.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 69.4 mt -125.61 147.69 30.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 O-C-N 121.0 -1.063 . . . . 0.0 108.502 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 50.8 mtt-85 -67.5 125.59 26.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 65.52 26.78 72.02 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.008 -0.885 . . . . 0.0 114.484 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -141.79 140.52 33.04 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.6 m -94.52 145.68 24.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -20.77 59.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.449 1.1 . . . . 0.0 109.851 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 15.3 p -75.62 -10.81 59.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.716 2.407 . . . . 0.0 113.041 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -125.21 -48.65 1.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.906 1.682 . . . . 0.0 111.251 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.71 144.31 19.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.656 0.662 . . . . 0.0 110.666 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -149.97 175.91 11.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.12 0.568 . . . . 0.0 109.567 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.13 134.57 52.63 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.29 1.036 . . . . 0.0 111.702 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.79 130.59 68.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 C-N-CA 124.706 1.202 . . . . 0.0 110.591 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -72.24 107.87 5.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 36.7 mm -121.54 115.04 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.653 1.181 . . . . 0.0 108.94 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 59.46 48.8 9.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.281 1.032 . . . . 0.0 108.477 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.8 t70 64.14 9.48 4.76 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.231 1.013 . . . . 0.0 113.586 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -126.66 122.83 36.08 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.913 -1.117 . . . . 0.0 109.603 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -69.05 121.95 17.72 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.758 -1.214 . . . . 0.0 111.905 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -117.31 144.04 45.29 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.67 1.588 . . . . 0.0 112.883 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.4 tm? -78.52 132.48 37.23 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.665 0.786 . . . . 0.0 110.357 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -118.69 143.44 46.85 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.3 p -121.55 146.7 46.69 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.887 0.875 . . . . 0.0 111.585 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -61.91 138.36 58.35 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 83.5 t . . . . . 0 N--CA 1.453 -0.306 0 C-N-CA 125.205 1.402 . . . . 0.0 107.612 179.565 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.521 -0.156 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -76.42 115.12 15.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -118.4 129.19 75.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 124.436 1.094 . . . . 0.0 110.067 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 mp -77.99 137.95 21.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -58.51 130.06 44.98 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.495 1.14 . . . . 0.0 110.979 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -12.25 61.25 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.54 -41.75 5.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.385 1.074 . . . . 0.0 108.95 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -116.05 103.91 11.04 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 125.18 1.392 . . . . 0.0 114.1 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.485 ' HB2' ' CD1' ' A' ' 163' ' ' PHE . 67.1 m -68.83 -7.5 34.94 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 119.906 -1.746 . . . . 0.0 111.406 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.33 -9.36 36.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.452 1.901 . . . . 0.0 109.814 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.3 mttt -115.06 160.6 19.43 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 121.116 1.78 . . . . 0.0 113.02 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.2 mm -124.91 144.19 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 C-N-CA 125.267 1.427 . . . . 0.0 107.981 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -116.39 106.17 13.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.86 2.464 . . . . 0.0 104.58 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -135.26 123.56 23.17 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 20.8 mtp 64.8 27.71 12.95 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.387 1.475 . . . . 0.0 109.727 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.75 17.83 73.52 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.721 -1.044 . . . . 0.0 110.917 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -109.19 156.73 19.54 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.1 mm -110.65 134.8 51.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 123.522 0.729 . . . . 0.0 109.801 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -129.83 153.09 48.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.0 t -133.48 158.52 42.9 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.312 1.045 . . . . 0.0 108.529 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.0 mt -117.93 115.99 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.919 1.288 . . . . 0.0 110.369 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -88.78 -125.77 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 102.062 -3.31 . . . . 0.0 102.062 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -152.84 100.41 2.51 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 176.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 55.0 m -134.85 107.2 7.25 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 112.751 -2.022 . . . . 0.0 105.755 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.5 m -65.9 124.04 21.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.6 t -94.71 142.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.1 m -114.77 162.68 16.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.017 1.327 . . . . 0.0 109.442 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.84 -26.72 67.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 111.262 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.42 -21.08 63.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.385 0.674 . . . . 0.0 110.296 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -105.8 -18.9 13.92 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.85 0.86 . . . . 0.0 110.496 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 24.2 mt -67.16 141.6 57.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.513 0.673 . . . . 0.0 109.594 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.48 -101.24 1.84 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -135.5 167.53 20.91 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.936 2.494 . . . . 0.0 109.706 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -63.27 148.16 49.01 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -126.1 -52.58 1.53 Allowed 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 121.254 -0.904 . . . . 0.0 111.744 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -151.59 147.52 26.87 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 119.038 0.835 . . . . 0.0 110.549 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.68 134.41 40.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.4 mp -112.05 159.24 18.67 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.618 2.367 . . . . 0.0 108.78 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -169.56 53.25 0.04 OUTLIER 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.111 0.564 . . . . 0.0 112.225 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -147.38 173.11 12.93 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.785 -1.197 . . . . 0.0 108.985 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.3 t -145.45 145.38 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -141.05 166.1 25.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.6 t -131.08 132.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 128' ' ' SER . 55.1 p90 -144.99 171.62 14.21 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.944 0.878 . . . . 0.0 112.49 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.09 104.67 15.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.819 2.448 . . . . 0.0 105.341 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.0 t -65.07 -11.96 45.29 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.448 1.931 . . . . 0.0 112.721 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.7 m -64.83 -40.48 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 O-C-N 120.513 -1.367 . . . . 0.0 110.683 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.5 t -123.8 -23.6 4.65 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.623 1.169 . . . . 0.0 113.831 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.34 3.24 57.66 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.524 2.012 . . . . 0.0 110.611 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -54.55 113.03 1.14 Allowed 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.634 1.974 . . . . 0.0 109.676 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.2 m -64.33 158.14 24.28 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.382 0.673 . . . . 0.0 110.882 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.27 144.18 48.33 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.545 1.538 . . . . 0.0 107.554 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -81.35 162.43 19.78 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.565 2.843 . . . . 0.0 109.893 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -59.77 -22.32 61.96 Favored 'General case' 0 C--O 1.228 -0.068 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 42.5 m -70.74 -7.86 47.98 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.404 -0.81 . . . . 0.0 111.925 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.88 2.93 12.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.748 1.219 . . . . 0.0 111.732 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.0 m0 . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -179.463 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 . . . . . 0 C--O 1.233 0.214 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.1 m -136.64 136.59 39.26 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.324 1.85 . . . . 0.0 106.778 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -117.78 106.92 13.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.374 1.47 . . . . 0.0 108.931 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -110.25 116.8 32.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.887 2.075 . . . . 0.0 107.657 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.93 116.56 25.08 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.968 2.507 . . . . 0.0 107.093 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -64.88 102.54 0.61 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.644 1.577 . . . . 0.0 109.151 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.26 158.98 17.3 Favored Glycine 0 N--CA 1.435 -1.411 1 C-N-CA 131.264 4.269 . . . . 0.0 107.845 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -66.13 154.25 40.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.282 1.991 . . . . 0.0 114.057 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.4 mt -101.38 141.47 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 112.589 -2.096 . . . . 0.0 109.069 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.1 153.01 49.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.674 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.8 t -78.21 172.68 13.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.142 1.777 . . . . 0.0 106.556 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 18.3 mt -131.47 149.79 33.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 122.751 1.263 . . . . 0.0 113.128 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -69.03 121.03 15.83 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.217 1.807 . . . . 0.0 109.431 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.14 24.77 76.71 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 117.587 -1.674 . . . . 0.0 113.418 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -149.55 144.52 26.29 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.811 1.805 . . . . 0.0 112.358 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.9 m -92.02 151.37 20.5 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.2 -33.53 65.41 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.294 -0.879 . . . . 0.0 110.046 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.3 p -66.21 -14.71 62.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.691 1.996 . . . . 0.0 114.29 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.67 -37.98 4.11 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.47 1.108 . . . . 0.0 110.055 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.35 145.07 2.63 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.141 0.976 . . . . 0.0 110.895 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -148.58 171.68 15.75 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.24 138.16 46.01 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.869 0.468 . . . . 0.0 110.564 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 4.1 p -133.13 129.84 57.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 123.544 0.737 . . . . 0.0 111.719 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -74.86 105.82 6.09 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.5 122.6 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.403 1.481 . . . . 0.0 108.863 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 54.8 44.16 28.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.083 0.856 . . . . 0.0 108.973 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 62.34 6.91 2.06 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.405 1.482 . . . . 0.0 114.282 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.33 121.96 36.42 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -66.39 128.68 37.1 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.265 1.026 . . . . 0.0 110.493 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -123.61 151.14 43.31 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.433 0.693 . . . . 0.0 110.763 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.8 tm? -83.79 117.87 23.56 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.68 1.192 . . . . 0.0 112.452 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -100.54 151.72 21.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.0 p -135.71 150.35 49.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.84 0.856 . . . . 0.0 110.838 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.94 140.37 57.77 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.842 1.257 . . . . 0.0 107.814 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 C--O 1.23 0.069 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.455 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -77.05 137.63 39.08 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.2 t -138.29 129.97 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 126.162 1.785 . . . . 0.0 108.355 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -73.84 140.12 18.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -65.2 130.42 43.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 123.006 1.384 . . . . 0.0 109.455 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -63.47 -24.03 67.65 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.686 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -89.31 -40.71 12.61 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.435 0.694 . . . . 0.0 110.727 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.71 113.15 16.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.719 1.208 . . . . 0.0 111.374 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.5 m -68.12 -11.14 58.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.604 1.962 . . . . 0.0 111.664 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -96.96 -4.33 40.08 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.978 1.711 . . . . 0.0 111.489 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -110.32 157.99 18.91 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.241 0.928 . . . . 0.0 110.632 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.4 mm -124.42 137.95 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -117.21 106.28 13.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.176 1.79 . . . . 0.0 106.48 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -127.42 125.35 40.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.6 mtt 61.94 17.78 9.27 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.721 1.208 . . . . 0.0 110.899 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.41 0.07 88.38 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.758 -1.023 . . . . 0.0 111.369 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -86.52 168.43 13.71 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.1 mm -124.81 132.71 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.646 1.112 . . . . 0.0 109.851 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -126.63 152.79 46.2 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.885 0.874 . . . . 0.0 108.936 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.7 t -137.35 147.17 45.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.227 1.011 . . . . 0.0 108.422 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.53 125.33 62.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 126.433 1.893 . . . . 0.0 110.712 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -91.89 -104.67 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -166.71 99.52 0.57 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 45.8 m -136.23 115.07 12.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.8 m -76.68 123.8 26.69 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 121.227 1.831 . . . . 0.0 106.431 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.82 142.05 14.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.7 m -114.42 164.68 13.62 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.375 1.07 . . . . 0.0 111.125 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -27.66 66.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.587 1.155 . . . . 0.0 112.44 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.08 -13.26 62.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.698 0.799 . . . . 0.0 110.359 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -119.43 -25.86 5.95 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.761 1.224 . . . . 0.0 110.965 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.1 tp -68.1 129.06 38.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.07 -98.17 0.77 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.13 163.39 30.03 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.272 1.429 . . . . 0.0 110.259 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -63.88 143.91 57.48 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -126.23 -47.52 1.61 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -151.46 158.67 43.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.992 1.269 . . . . 0.0 111.037 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.4 p -115.45 139.33 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.1 0.96 . . . . 0.0 108.591 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.26 164.67 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.998 1.719 . . . . 0.0 110.518 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -165.9 54.13 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -154.05 167.86 28.38 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.024 -1.673 . . . . 0.0 106.999 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.5 t -145.17 148.49 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -146.54 164.37 32.79 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.4 t -130.39 131.58 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -138.72 168.18 20.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.525 0.678 . . . . 0.0 111.479 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -80.51 111.53 17.0 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.7 t -51.51 -18.69 1.17 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 130.319 3.448 . . . . 0.0 115.074 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.9 -52.08 17.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 124.564 1.146 . . . . 0.0 113.46 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . 0.27 18.5 m -121.69 -27.08 4.77 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.186 1.794 . . . . 0.0 113.592 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.75 12.26 13.09 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.38 1.467 . . . . 0.0 113.441 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.466 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -57.1 112.45 1.36 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.597 2.198 . . . . 0.0 110.03 -178.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 43.2 p -63.13 151.89 38.86 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.79 145.37 41.1 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 125.147 1.379 . . . . 0.0 107.735 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.02 159.04 27.19 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.299 2.666 . . . . 0.0 108.868 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -55.62 -37.56 68.33 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 125.665 1.586 . . . . 0.0 111.867 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.9 m -63.51 -13.05 37.14 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 118.701 -1.2 . . . . 0.0 113.75 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.31 -15.3 20.82 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.403 1.481 . . . . 0.0 108.933 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.3 m0 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.42 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.6 m -128.59 124.78 36.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -106.25 109.51 21.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -115.51 116.14 27.68 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.13 136.57 32.95 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . 0.253 4.8 m-30 -82.02 101.42 10.31 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.217 1.008 . . . . 0.0 110.967 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -93.38 158.55 23.71 Favored Glycine 0 CA--C 1.532 1.111 1 C-N-CA 135.355 6.217 . . . . 0.0 107.162 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -68.23 156.84 36.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 123.3 1.524 . . . . 0.0 112.757 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 74.3 mt -103.49 139.64 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 126.541 1.936 . . . . 0.0 110.241 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -134.27 153.5 51.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.543 1.537 . . . . 0.0 110.21 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.4 p -76.98 173.02 12.26 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.712 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 43.9 mt -127.22 133.57 67.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 122.198 0.999 . . . . 0.0 108.877 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -62.8 127.87 33.29 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.151 1.78 . . . . 0.0 108.647 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.19 13.23 76.53 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.157 -1.357 . . . . 0.0 114.625 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -137.01 139.2 41.24 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 120.329 2.065 . . . . 0.0 110.725 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.9 m -84.44 144.65 28.62 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -23.13 65.55 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 120.56 -1.337 . . . . 0.0 109.531 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 31.6 p -76.71 -6.85 53.86 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.262 2.225 . . . . 0.0 113.814 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -121.38 -45.99 2.3 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.248 1.019 . . . . 0.0 109.362 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.49 143.21 13.15 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.377 0.535 . . . . 0.0 111.004 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -149.12 175.81 11.02 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.301 -0.25 . . . . 0.0 110.628 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.17 134.4 51.78 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.67 1.188 . . . . 0.0 113.021 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.58 127.85 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 125.326 1.451 . . . . 0.0 111.602 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -74.2 110.01 8.15 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 37.0 mm -121.53 117.92 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 56.06 39.88 30.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.14 0.576 . . . . 0.0 110.125 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.4 t70 76.32 -8.39 1.65 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.424 1.889 . . . . 0.0 112.02 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -104.97 122.23 45.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 119.906 -1.746 . . . . 0.0 110.189 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -71.03 119.34 15.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -110.27 145.86 36.65 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.564 1.145 . . . . 0.0 111.331 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.8 tm? -82.03 130.51 35.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -120.43 142.15 49.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.2 p -118.61 150.28 39.95 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.599 0.714 . . . . 0.0 110.963 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -64.96 143.63 57.83 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.725 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -73.94 151.64 40.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.1 t -145.87 136.89 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -81.76 134.93 26.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -58.5 119.43 6.99 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.598 1.19 . . . . 0.0 109.964 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -58.24 -22.53 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.174 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -94.54 -21.84 18.6 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.73 1.212 . . . . 0.0 111.955 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.97 104.88 4.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.519 1.128 . . . . 0.0 109.212 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.3 t -69.06 -3.56 13.68 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.522 -1.361 . . . . 0.0 110.867 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -98.13 -3.2 38.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.718 2.007 . . . . 0.0 110.397 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -117.54 169.7 9.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.541 1.136 . . . . 0.0 112.224 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.3 mm -130.32 151.16 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 C-N-CA 126.165 1.786 . . . . 0.0 107.878 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.19 102.5 8.17 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 130.119 3.368 . . . . 0.0 103.603 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -142.7 131.93 23.35 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.643 -1.286 . . . . 0.0 109.589 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.5 mtt 57.61 32.91 22.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.353 1.461 . . . . 0.0 113.026 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.49 7.34 82.75 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.453 -1.193 . . . . 0.0 112.449 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -113.08 168.36 9.77 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.131 1.372 . . . . 0.0 108.099 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -119.54 145.46 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -133.3 155.69 48.94 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.2 t -134.91 151.59 51.01 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.039 1.736 . . . . 0.0 108.22 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.3 mt -112.82 123.34 68.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.956 1.302 . . . . 0.0 108.971 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.1 t -97.72 -118.27 0.13 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 101.884 -3.376 . . . . 0.0 101.884 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -158.05 99.36 1.66 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 120.622 1.555 . . . . 0.0 106.935 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 m -137.95 115.31 11.11 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 127.209 2.204 . . . . 0.0 106.326 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.9 m -71.72 129.79 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.81 111.05 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.5 m -75.45 164.46 26.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.068 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.9 -29.37 70.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.545 0.688 . . . . 0.0 111.753 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.74 -11.61 60.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.594 1.158 . . . . 0.0 111.265 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.77 -24.62 11.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.552 1.541 . . . . 0.0 109.534 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.09 127.92 33.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.825 1.25 . . . . 0.0 111.85 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.63 -106.06 1.31 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -133.77 163.0 30.45 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.128 1.371 . . . . 0.0 109.307 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -60.41 145.65 47.33 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.52 -42.02 1.98 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 116.507 -1.711 . . . . 0.0 114.494 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -161.28 160.86 30.33 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 121.066 1.757 . . . . 0.0 110.489 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.4 p -121.84 133.15 69.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.57 1.148 . . . . 0.0 108.402 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -107.83 166.33 10.78 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.181 2.193 . . . . 0.0 110.591 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -164.08 41.04 0.09 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -138.71 172.23 13.18 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 120.039 -1.663 . . . . 0.0 109.568 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.76 149.36 17.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -145.46 167.02 23.98 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.35 131.89 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -138.02 166.72 23.4 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.461 0.704 . . . . 0.0 110.193 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -86.07 116.03 24.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.38 -14.46 1.91 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 127.032 2.133 . . . . 0.0 115.179 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.4 m -77.34 -46.85 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 124.044 0.937 . . . . 0.0 112.451 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.23 -28.42 3.69 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.37 12.73 16.59 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.067 1.318 . . . . 0.0 112.299 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 112.78 2.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.968 1.384 . . . . 0.0 111.253 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.1 m -69.35 154.75 41.54 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.588 1.085 . . . . 0.0 110.476 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.31 147.66 66.72 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.659 1.584 . . . . 0.0 110.828 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.53 157.71 22.07 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.499 3.466 . . . . 0.0 110.502 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -53.17 -25.1 12.46 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 m -70.54 -22.06 62.65 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 118.056 -0.973 . . . . 0.0 113.468 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.2 -12.45 28.24 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.555 1.525 . . . . 0.0 110.753 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.5 m0 . . . . . 0 N--CA 1.443 -0.824 0 C-N-CA 124.924 1.29 . . . . 0.0 111.771 -179.771 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 49.3 mmt-85 . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 122.19 0.995 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.0 m -122.36 129.39 52.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 126.944 2.098 . . . . 0.0 105.557 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -115.94 106.54 13.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.349 1.859 . . . . 0.0 107.41 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -110.52 117.44 33.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.295 1.838 . . . . 0.0 108.701 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -87.88 127.21 35.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -73.31 101.45 3.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.029 0.932 . . . . 0.0 109.561 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.82 159.06 22.81 Favored Glycine 0 N--CA 1.442 -0.921 1 C-N-CA 132.694 4.95 . . . . 0.0 107.544 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -68.1 151.17 47.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 123.544 1.64 . . . . 0.0 111.536 -176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 63.9 mt -99.38 143.99 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 C-N-CA 126.463 1.905 . . . . 0.0 110.299 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -137.99 153.27 49.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.734 1.613 . . . . 0.0 110.095 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.8 p -80.47 173.22 12.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 66.4 mt -124.8 136.46 60.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.381 1.072 . . . . 0.0 109.015 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -64.88 119.12 10.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.66 10.89 72.19 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 118.148 -1.362 . . . . 0.0 116.083 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -137.38 130.44 30.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 120.473 2.136 . . . . 0.0 110.295 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 15.0 m -71.49 145.08 49.42 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.62 -24.96 65.91 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.052 0.941 . . . . 0.0 109.158 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 17.1 p -75.53 -9.76 58.86 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.83 2.452 . . . . 0.0 112.798 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -119.77 -47.61 2.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.582 1.153 . . . . 0.0 109.386 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.35 145.38 19.11 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.902 0.774 . . . . 0.0 111.01 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -152.08 175.73 12.26 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.859 -0.526 . . . . 0.0 110.716 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.51 134.71 52.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.871 1.669 . . . . 0.0 112.29 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.0 p -129.83 131.56 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 124.821 1.249 . . . . 0.0 109.436 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.41 106.75 5.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 28.2 mm -121.42 128.97 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 53.81 36.63 24.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.995 0.816 . . . . 0.0 111.65 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t0 68.74 9.66 7.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.553 1.541 . . . . 0.0 112.825 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -124.92 122.98 38.9 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.519 1.128 . . . . 0.0 108.743 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -69.12 119.37 13.3 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.828 -1.17 . . . . 0.0 110.373 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -116.07 147.19 41.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 123.41 1.576 . . . . 0.0 111.679 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -80.93 122.61 27.46 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.486 1.914 . . . . 0.0 113.074 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -112.45 140.07 47.5 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.3 p -120.54 145.51 47.25 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.621 1.168 . . . . 0.0 110.765 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -60.36 135.41 57.73 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.451 -0.385 0 C-N-CA 122.965 0.506 . . . . 0.0 109.816 178.666 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -70.43 130.7 42.61 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.6 t -131.46 134.92 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.0 mm -69.78 131.53 34.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -68.35 129.39 39.77 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.523 0.678 . . . . 0.0 109.988 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -71.26 -18.37 62.44 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.139 -0.976 . . . . 0.0 110.329 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -82.05 -34.21 29.58 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.644 1.178 . . . . 0.0 111.261 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.38 121.17 9.9 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.5 t -59.35 -25.21 64.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.526 1.057 . . . . 0.0 110.48 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -90.47 3.02 55.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.224 1.81 . . . . 0.0 112.946 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -109.13 155.98 20.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.2 mm -126.69 142.04 44.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -115.25 104.25 11.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 128.111 2.564 . . . . 0.0 105.166 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -132.58 128.63 37.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.8 mtt 61.76 21.77 12.47 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.221 1.408 . . . . 0.0 110.841 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.72 14.64 81.85 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.515 -1.159 . . . . 0.0 111.878 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -113.1 157.92 21.02 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.0 mm -114.65 143.93 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.561 0.696 . . . . 0.0 111.507 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -131.12 155.31 47.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.571 1.948 . . . . 0.0 109.63 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.6 t -145.18 147.38 32.4 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 mt -102.85 120.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 126.665 1.986 . . . . 0.0 112.03 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -90.33 -116.6 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 1 N-CA-C 99.881 -4.118 . . . . 0.0 99.881 176.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -160.25 99.82 1.34 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.4 m -136.63 121.41 18.61 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 m -81.24 136.73 35.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 120.671 1.578 . . . . 0.0 107.05 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.35 112.25 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 74.3 m -79.82 166.22 21.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.975 0.91 . . . . 0.0 109.1 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -58.27 -32.01 68.0 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.345 1.058 . . . . 0.0 111.091 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.82 -8.03 39.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.167 1.787 . . . . 0.0 112.044 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -122.33 -12.14 8.27 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 127.72 2.408 . . . . 0.0 110.001 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 20.3 mt -83.09 123.03 29.11 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.23 -101.46 0.84 Allowed Glycine 0 CA--C 1.507 -0.424 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -134.75 167.05 21.57 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.379 1.071 . . . . 0.0 108.8 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -61.02 143.05 56.1 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.0 0.92 . . . . 0.0 111.374 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.06 -41.41 1.94 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 116.907 -1.521 . . . . 0.0 113.3 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -160.27 150.36 18.17 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.707 1.594 . . . . 0.0 110.792 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.1 p -109.26 135.79 47.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.1 mp -110.66 163.21 13.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.934 2.094 . . . . 0.0 110.95 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -165.33 64.34 0.12 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -153.01 173.19 15.73 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.564 -1.335 . . . . 0.0 108.763 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.2 t -149.57 138.07 14.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 126.103 1.761 . . . . 0.0 106.368 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.75 166.05 25.7 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.49 126.9 55.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -142.08 164.01 31.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.561 1.144 . . . . 0.0 110.759 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -92.95 103.57 15.88 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 104.284 -2.488 . . . . 0.0 104.284 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.35 -15.72 0.69 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.365 2.266 . . . . 0.0 116.127 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.6 m -57.71 -51.0 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.168 0.987 . . . . 0.0 108.406 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.2 m -123.45 -26.7 4.19 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.397 1.879 . . . . 0.0 114.437 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 103.4 16.56 20.09 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.499 1.523 . . . . 0.0 113.615 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 113.04 4.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.76 1.78 . . . . 0.0 109.261 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.0 m -75.21 145.25 42.17 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.26 143.07 26.97 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.17 160.51 42.41 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.167 2.578 . . . . 0.0 111.028 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -57.32 -28.62 63.24 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.065 0.546 . . . . 0.0 111.913 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.5 m -61.32 -14.22 25.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.071 0.949 . . . . 0.0 112.148 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -119.12 4.91 11.3 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.903 1.681 . . . . 0.0 111.951 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.8 m0 . . . . . 0 CA--C 1.532 0.261 0 O-C-N 120.752 -1.218 . . . . 0.0 113.895 179.236 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.488 0.661 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.4 m -141.84 132.53 25.58 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.478 1.911 . . . . 0.0 106.018 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -115.35 104.77 12.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -110.63 116.6 31.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.013 1.325 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -83.27 128.23 34.32 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 127.212 2.205 . . . . 0.0 105.861 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.55 102.3 6.02 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.68 159.27 16.84 Favored Glycine 0 N--CA 1.442 -0.96 1 C-N-CA 131.489 4.376 . . . . 0.0 109.918 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.12 154.98 39.9 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 124.294 1.997 . . . . 0.0 113.717 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.4 mt -102.26 140.97 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.299 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -131.58 151.52 51.53 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 109.604 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 11.4 m -76.3 172.27 13.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.778 0.831 . . . . 0.0 108.984 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 78.8 mt -131.91 138.15 53.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.902 0.858 . . . . 0.0 110.509 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -65.5 119.04 10.34 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.22 14.73 76.09 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 118.821 -0.989 . . . . 0.0 115.378 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -140.78 126.2 18.81 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 119.771 1.785 . . . . 0.0 109.782 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 16.3 m -76.48 146.71 38.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.31 -27.8 56.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.541 1.136 . . . . 0.0 110.393 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 36.9 p -74.33 -9.74 58.9 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.433 1.893 . . . . 0.0 114.362 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -120.69 -43.88 2.46 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.26 1.424 . . . . 0.0 109.547 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.15 144.28 14.35 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.115 0.566 . . . . 0.0 110.13 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -148.13 176.38 10.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.803 0.841 . . . . 0.0 109.152 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -108.62 130.73 55.31 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.455 1.102 . . . . 0.0 109.727 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.1 p -124.28 126.97 72.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 124.48 1.112 . . . . 0.0 111.678 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -73.89 108.42 6.7 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 35.4 mm -121.74 120.2 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 54.17 40.39 31.62 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.8 t70 70.68 -4.83 1.57 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.381 2.272 . . . . 0.0 113.2 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -106.15 122.26 45.84 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 120.279 -1.513 . . . . 0.0 108.953 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.85 120.49 16.52 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -112.46 151.58 29.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.818 1.247 . . . . 0.0 112.671 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -88.81 117.07 27.53 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.067 0.947 . . . . 0.0 110.711 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.89 156.23 17.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.9 143.3 40.77 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 123.158 0.583 . . . . 0.0 109.908 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -54.82 125.82 21.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.865 0.866 . . . . 0.0 110.162 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 C--O 1.218 -0.569 0 C-N-CA 126.387 1.875 . . . . 0.0 107.986 179.828 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.821 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -69.56 140.91 53.89 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.879 1.272 . . . . 0.0 110.264 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.4 t -141.24 141.34 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -80.28 121.13 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -48.61 122.13 5.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.087 0.946 . . . . 0.0 111.475 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -65.72 -17.54 64.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.785 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -94.96 -20.38 19.43 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.956 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.17 122.2 9.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 120.038 1.29 . . . . 0.0 108.127 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.5 m -65.12 -18.86 65.66 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 120.182 -1.574 . . . . 0.0 110.699 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -94.12 -0.48 55.28 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.943 1.297 . . . . 0.0 113.095 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -108.0 159.59 16.44 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.466 0.575 . . . . 0.0 110.104 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.2 mm -126.81 138.51 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -118.63 108.67 15.22 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -146.39 134.1 21.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.8 mtt 58.69 26.91 15.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.747 2.019 . . . . 0.0 113.531 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.17 23.52 71.14 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -121.99 164.7 17.19 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.3 mm -123.77 126.36 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.89 150.19 41.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.7 t -130.75 150.04 52.12 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.004 1.322 . . . . 0.0 109.201 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 mt -111.36 124.21 67.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 125.602 1.561 . . . . 0.0 110.725 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.6 t -95.31 -126.95 0.13 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 103.188 -2.893 . . . . 0.0 103.188 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -149.73 99.37 2.86 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 94.5 m -136.89 111.79 8.88 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 128.094 2.558 . . . . 0.0 109.654 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.1 m -69.05 124.34 23.51 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 54.6 t -94.46 119.58 42.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 119.675 1.125 . . . . 0.0 109.157 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.2 m -80.65 159.13 25.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.643 0.735 . . . . 0.0 109.858 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.35 -29.34 70.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.956 1.302 . . . . 0.0 112.008 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.43 -16.11 61.83 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.311 1.044 . . . . 0.0 111.892 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -103.9 -25.95 12.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.818 0.847 . . . . 0.0 108.867 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 mt -62.14 137.58 58.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.757 1.223 . . . . 0.0 109.923 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -89.39 -105.71 1.12 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -135.04 169.43 17.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.057 1.743 . . . . 0.0 109.805 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -59.68 142.39 53.13 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -125.74 -48.97 1.63 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 116.595 -1.669 . . . . 0.0 111.902 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -155.73 150.81 26.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.9 1.682 . . . . 0.0 112.217 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.8 p -105.5 133.59 49.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 122.482 1.134 . . . . 0.0 111.332 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mp -113.1 161.93 16.53 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.562 2.745 . . . . 0.0 109.702 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.66 48.71 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.524 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 3.5 mt-10 -143.72 176.68 9.05 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.85 2.06 . . . . 0.0 111.579 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.49 150.56 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.593 -1.317 . . . . 0.0 110.508 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.38 157.49 43.28 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.408 1.483 . . . . 0.0 109.606 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.5 t -140.51 114.18 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -141.58 167.98 20.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.356 0.598 . . . . 0.0 112.212 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.21 104.24 13.23 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.436 ' HG ' ' CB ' ' A' ' 191' ' ' THR . 2.5 m -64.48 -14.99 59.97 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 122.145 2.248 . . . . 0.0 114.526 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.6 m -69.57 -35.17 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 O-C-N 121.823 -0.548 . . . . 0.0 112.001 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.29 -19.19 6.03 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.384 1.473 . . . . 0.0 113.015 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.26 -10.84 69.47 Favored Glycine 0 CA--C 1.543 1.796 0 C-N-CA 126.969 2.223 . . . . 0.0 112.582 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -47.69 115.4 1.13 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 128.369 2.667 . . . . 0.0 113.64 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.6 p -67.04 158.12 31.8 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 109.965 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.0 134.79 24.44 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.49 156.78 49.72 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.672 2.248 . . . . 0.0 110.005 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.435 ' HA ' ' CD1' ' A' ' 176' ' ' TRP . 42.7 ttt180 -56.58 -30.46 63.2 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t -66.96 -7.59 23.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.352 0.978 . . . . 0.0 111.753 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.06 -7.59 14.91 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.14 1.376 . . . . 0.0 110.885 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.435 ' CD1' ' HA ' ' A' ' 173' ' ' ARG . 34.2 m0 . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.436 ' CB ' ' HG ' ' A' ' 165' ' ' SER . 99.9 m -139.96 115.65 10.14 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -94.06 112.55 24.38 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -121.9 115.87 23.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.71 138.12 48.28 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.235 1.414 . . . . 0.0 109.151 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.524 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.6 m-30 -88.55 102.01 14.51 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 177.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.31 159.11 17.21 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 130.399 3.857 . . . . 0.0 107.753 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -66.51 158.25 30.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.162 1.934 . . . . 0.0 112.581 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 41.8 mt -105.02 142.09 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.599 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -132.52 151.62 51.85 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.226 1.41 . . . . 0.0 109.654 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 55.2 p -76.23 173.19 11.68 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.1 mt -125.41 146.13 31.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 122.127 0.965 . . . . 0.0 109.316 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -68.65 125.03 25.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.14 26.31 73.39 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.287 1.423 . . . . 0.0 113.867 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -145.93 152.38 39.35 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.6 m -106.64 151.12 25.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -55.56 -27.69 50.59 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.122 0.569 . . . . 0.0 110.711 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 7.7 p -71.66 -13.42 61.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.122 2.169 . . . . 0.0 114.443 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -124.69 -38.5 2.37 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.234 1.414 . . . . 0.0 112.077 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.18 142.07 5.77 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.517 1.053 . . . . 0.0 110.528 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -154.23 174.5 14.69 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.608 0.363 . . . . 0.0 111.494 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -110.65 132.19 54.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.98 1.312 . . . . 0.0 109.7 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.69 124.95 66.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.467 1.507 . . . . 0.0 109.357 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -71.54 109.51 5.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.37 124.17 71.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 54.26 44.08 29.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.682 0.674 . . . . 0.0 110.006 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 26.7 t70 59.08 20.55 8.45 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.3 0.64 . . . . 0.0 112.059 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.405 ' HB3' ' HE2' ' A' ' 219' ' ' LYS . 0.5 OUTLIER -129.61 122.45 29.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.958 1.303 . . . . 0.0 108.579 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -71.24 117.84 13.27 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.33 -1.481 . . . . 0.0 110.093 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 217' ' ' ASP . 51.0 mmtt -111.38 147.63 34.78 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.708 1.603 . . . . 0.0 110.329 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.79 139.44 36.04 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.235 1.014 . . . . 0.0 111.198 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.89 139.35 52.66 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.332 1.453 . . . . 0.0 107.122 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.1 p -126.23 155.48 41.78 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.141 0.976 . . . . 0.0 111.683 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -64.9 143.12 58.16 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.784 -0.572 . . . . 0.0 111.072 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.972 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -68.81 146.4 52.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.4 t -140.02 132.68 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -77.21 122.58 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -56.85 128.05 34.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.811 1.291 . . . . 0.0 109.507 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -70.37 -22.89 62.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.444 1.098 . . . . 0.0 110.382 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.07 -42.2 19.54 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 123.637 0.775 . . . . 0.0 109.86 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -133.16 105.62 7.13 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.5 m -62.27 -23.48 66.72 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.189 -1.57 . . . . 0.0 112.478 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -81.27 -2.68 49.86 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.028 1.331 . . . . 0.0 111.125 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -109.89 159.8 16.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.453 0.701 . . . . 0.0 109.848 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.1 mm -125.47 133.0 70.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.31 111.16 23.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 101.477 -3.527 . . . . 0.0 101.477 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -147.8 137.97 22.88 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.16 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.3 mtt 51.72 28.73 5.09 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.22 18.0 79.71 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.406 -0.809 . . . . 0.0 111.522 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -120.43 163.71 17.48 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.472 1.109 . . . . 0.0 108.654 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.6 mm -119.14 134.08 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -126.97 148.92 50.07 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.8 t -131.51 130.32 42.22 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.464 2.306 . . . . 0.0 110.589 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.63 130.39 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.462 1.505 . . . . 0.0 108.819 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.3 t -102.57 -134.88 0.32 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 101.494 -3.521 . . . . 0.0 101.494 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -145.65 98.31 3.11 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 102.526 -3.138 . . . . 0.0 102.526 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.6 m -136.4 111.38 8.88 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 130.752 3.621 . . . . 0.0 108.999 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.9 m -68.7 127.85 34.54 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.714 1.597 . . . . 0.0 107.775 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.6 t -94.66 126.19 47.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.6 m -87.97 159.51 18.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.59 0.71 . . . . 0.0 110.213 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -56.56 -35.6 68.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.843 1.657 . . . . 0.0 109.913 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.56 -19.36 62.08 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.201 1.0 . . . . 0.0 111.809 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.72 -27.87 11.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.227 1.411 . . . . 0.0 110.763 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.97 112.79 2.73 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.596 1.558 . . . . 0.0 109.68 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.48 -102.44 0.08 OUTLIER Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.031 0.824 . . . . 0.0 111.865 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -134.76 161.82 34.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.735 1.214 . . . . 0.0 110.289 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -56.46 130.63 45.73 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.527 1.131 . . . . 0.0 109.969 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -109.11 -48.93 3.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 117.286 -1.34 . . . . 0.0 112.394 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -164.3 158.76 19.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.07 1.304 . . . . 0.0 109.406 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.3 p -108.02 141.12 24.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.579 1.152 . . . . 0.0 111.271 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mp -112.85 163.22 14.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.006 2.523 . . . . 0.0 110.365 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -166.81 39.57 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.519 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 21.4 mt-10 -141.86 176.71 8.72 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.181 -2.199 . . . . 0.0 110.35 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.9 t -138.12 151.47 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 120.071 1.305 . . . . 0.0 111.007 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.468 ' HE ' ' CB ' ' A' ' 193' ' ' TRP . 0.2 OUTLIER -130.34 156.91 43.9 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 120.953 -1.092 . . . . 0.0 109.683 177.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.1 t -138.22 113.89 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -134.23 158.3 44.08 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.621 -0.674 . . . . 0.0 110.212 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -85.26 99.99 11.49 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 103.103 -2.925 . . . . 0.0 103.103 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.422 ' HG ' ' CB ' ' A' ' 191' ' ' THR . 3.7 m -59.28 -9.06 1.94 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 126.735 2.014 . . . . 0.0 116.267 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.8 m -66.12 -38.82 82.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.422 ' HB3' ' HE2' ' A' ' 169' ' ' LYS . 0.4 OUTLIER -123.43 -24.12 4.67 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.648 1.579 . . . . 0.0 112.286 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.18 8.53 60.08 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 127.224 2.345 . . . . 0.0 110.564 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 167' ' ' SER . 27.2 mtmt -61.27 115.95 4.22 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.074 1.75 . . . . 0.0 110.253 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 70.4 p -67.28 153.75 42.94 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.119 0.968 . . . . 0.0 112.366 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.58 136.31 26.5 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.2 163.72 24.96 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.548 2.165 . . . . 0.0 110.998 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -58.44 -21.87 52.47 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.578 1.551 . . . . 0.0 114.737 -178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.3 m -80.46 -7.57 59.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.982 0.81 . . . . 0.0 110.517 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -113.1 9.32 18.55 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.648 1.579 . . . . 0.0 110.945 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 39.1 m0 . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 125.254 1.422 . . . . 0.0 114.068 177.943 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.414 0.626 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.422 ' CB ' ' HG ' ' A' ' 165' ' ' SER . 37.6 m -139.72 135.67 33.4 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 177.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -113.15 106.87 15.17 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.883 1.673 . . . . 0.0 107.321 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . 0.468 ' CB ' ' HE ' ' A' ' 161' ' ' ARG . 24.6 m0 -110.78 115.63 29.88 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.612 0.765 . . . . 0.0 110.385 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.21 138.34 38.6 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.777 1.631 . . . . 0.0 106.838 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.519 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.9 m-30 -85.97 105.91 16.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -105.8 158.67 15.62 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 127.801 2.62 . . . . 0.0 108.037 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.11 156.49 36.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 124.741 2.21 . . . . 0.0 113.05 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 38.9 mt -100.9 141.0 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 111.795 -2.457 . . . . 0.0 110.179 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -133.83 152.51 51.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.548 1.539 . . . . 0.0 109.64 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 91.5 p -74.69 172.69 11.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.459 0.704 . . . . 0.0 110.152 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 5.3 mt -127.71 135.46 63.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 121.458 -0.776 . . . . 0.0 110.257 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -65.14 126.15 27.21 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.85 12.44 84.43 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.205 -1.331 . . . . 0.0 116.01 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -138.75 157.75 45.5 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.617 1.709 . . . . 0.0 108.175 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 62.1 m -106.48 145.72 31.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.63 -31.14 64.04 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 29.8 p -66.32 -12.37 56.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.178 1.791 . . . . 0.0 113.903 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -124.66 -35.39 2.73 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.688 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.27 145.36 6.94 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 119.217 0.917 . . . . 0.0 110.964 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.57 173.23 16.61 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.048 0.385 . . . . 0.0 111.221 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.62 132.52 54.06 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 124.509 1.124 . . . . 0.0 111.774 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.81 130.36 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.947 1.299 . . . . 0.0 108.513 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -69.91 103.11 2.13 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 33.8 mm -121.56 123.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.293 1.437 . . . . 0.0 110.251 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 61.52 38.15 15.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.194 0.997 . . . . 0.0 109.317 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 65.31 16.31 10.47 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.617 1.567 . . . . 0.0 111.313 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.56 129.15 38.65 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -67.97 122.23 17.77 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 119.962 -1.711 . . . . 0.0 109.15 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -119.02 146.2 45.23 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.815 1.246 . . . . 0.0 111.387 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -78.83 133.12 37.04 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.937 1.295 . . . . 0.0 112.032 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -121.69 131.31 54.02 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.81 150.21 33.82 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.189 0.596 . . . . 0.0 110.025 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -70.08 122.09 18.73 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.329 -0.302 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.222 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.208 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -75.96 124.56 27.56 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.0 t -124.78 136.88 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 126.029 1.732 . . . . 0.0 107.026 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -86.43 138.89 18.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -64.27 123.3 18.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 123.03 1.395 . . . . 0.0 108.419 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -61.02 -27.05 68.04 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.788 1.235 . . . . 0.0 111.105 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -80.87 -46.09 15.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.21 105.61 8.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.428 1.491 . . . . 0.0 112.946 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -58.67 -19.5 39.96 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 120.343 -1.473 . . . . 0.0 112.258 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -85.21 -7.85 58.84 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.278 -0.889 . . . . 0.0 110.658 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -101.41 149.47 24.02 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.838 0.744 . . . . 0.0 109.559 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.1 mm -126.86 119.15 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.09 97.29 9.82 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 128.372 2.669 . . . . 0.0 109.114 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -132.41 142.5 49.31 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 121.576 1.989 . . . . 0.0 109.975 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 8.4 mtt 49.87 23.32 1.02 Allowed 'General case' 0 CA--C 1.544 0.739 0 O-C-N 119.992 -1.693 . . . . 0.0 114.714 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.64 5.25 78.68 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 119.604 1.093 . . . . 0.0 112.089 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -100.23 172.86 6.9 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 125.099 1.36 . . . . 0.0 111.626 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.5 mm -136.4 125.7 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -114.13 161.07 18.24 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.9 t -143.04 139.32 30.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.434 1.494 . . . . 0.0 109.999 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.1 mt -100.85 137.68 27.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 123.929 0.892 . . . . 0.0 109.233 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.7 m -118.17 -112.79 0.34 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -159.98 98.72 1.34 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 122.689 2.495 . . . . 0.0 108.109 175.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.3 m -137.42 113.88 10.21 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 127.323 2.249 . . . . 0.0 105.537 175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.6 m -76.61 126.9 31.79 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 104.419 -2.438 . . . . 0.0 104.419 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.7 t -93.72 111.7 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.1 m -74.61 158.27 33.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.959 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.96 -28.82 67.97 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.998 0.519 . . . . 0.0 111.481 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.71 -12.58 61.59 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.94 -0.475 . . . . 0.0 111.222 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -114.04 -24.1 9.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.507 1.523 . . . . 0.0 110.791 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.2 mt -65.63 135.38 54.95 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.62 -106.14 0.91 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 107.401 -2.28 . . . . 0.0 107.401 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.31 167.04 21.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.595 1.958 . . . . 0.0 109.325 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -57.63 150.07 20.18 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.097 0.951 . . . . 0.0 112.532 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -125.99 -50.75 1.57 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.901 -1.524 . . . . 0.0 112.325 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.93 163.17 29.23 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 121.297 1.862 . . . . 0.0 110.619 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.2 139.75 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 119.122 0.874 . . . . 0.0 111.716 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.93 164.8 12.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.452 2.301 . . . . 0.0 110.462 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.6 59.92 0.07 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.086 0.954 . . . . 0.0 112.619 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -156.34 172.8 17.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.879 -1.138 . . . . 0.0 108.287 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 t -143.98 149.41 17.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.91 164.6 31.47 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 63.0 t -131.28 136.74 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -147.62 163.85 35.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.65 0.78 . . . . 0.0 111.994 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.55 100.67 10.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -62.53 -12.35 21.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.5 m -65.58 -44.14 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 121.674 -0.642 . . . . 0.0 110.827 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.431 ' HB2' ' HE2' ' A' ' 169' ' ' LYS . 32.3 m -121.62 -20.57 6.47 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 125.54 1.536 . . . . 0.0 113.233 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.48 5.78 57.74 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.457 1.027 . . . . 0.0 111.753 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 167' ' ' SER . 45.1 mtmt -61.27 112.8 2.29 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.49 1.116 . . . . 0.0 108.162 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 p -63.29 151.31 40.99 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.22 141.68 26.8 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.912 1.285 . . . . 0.0 107.664 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -82.43 160.2 17.18 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.955 2.437 . . . . 0.0 108.488 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 ttp85 -53.12 -27.28 20.02 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.225 1.01 . . . . 0.0 113.372 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.2 t -65.67 -13.66 59.65 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.074 1.749 . . . . 0.0 112.4 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.58 -1.55 13.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 119.706 -1.871 . . . . 0.0 110.598 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.5 m0 . . . . . 0 CA--C 1.541 0.628 0 O-C-N 121.556 -0.715 . . . . 0.0 109.901 179.183 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.1 mtt85 . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 110.661 -0.126 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.9 m -144.86 132.69 21.2 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 127.187 2.195 . . . . 0.0 107.025 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -108.76 109.67 20.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.859 2.063 . . . . 0.0 106.609 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -115.72 116.78 28.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.764 1.225 . . . . 0.0 112.281 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -84.0 133.32 34.68 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.103 1.361 . . . . 0.0 109.318 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.14 101.33 7.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.47 1.108 . . . . 0.0 109.417 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -96.11 158.45 21.79 Favored Glycine 0 CA--C 1.534 1.27 1 C-N-CA 134.549 5.833 . . . . 0.0 107.608 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -68.25 157.16 36.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.338 1.569 . . . . 0.0 113.13 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 62.2 mt -101.11 139.81 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 126.744 2.018 . . . . 0.0 109.583 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -133.1 152.33 51.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.502 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 18.9 t -76.99 172.96 12.35 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 35.8 mt -129.06 141.9 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 122.824 1.297 . . . . 0.0 107.691 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 -65.81 121.49 15.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.175 1.39 . . . . 0.0 109.351 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.54 15.4 80.5 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.395 -1.225 . . . . 0.0 113.612 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -136.49 132.19 34.99 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.992 1.896 . . . . 0.0 110.018 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.4 m -81.13 150.63 28.64 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.77 -29.84 63.01 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.345 -0.847 . . . . 0.0 109.951 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.1 p -67.54 -20.64 65.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.151 2.18 . . . . 0.0 114.025 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -112.13 -41.71 3.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 117.787 -1.101 . . . . 0.0 110.313 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.71 142.69 3.77 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.124 0.874 . . . . 0.0 109.863 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -151.47 175.62 12.11 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.691 0.796 . . . . 0.0 109.426 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.56 132.7 53.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.239 1.415 . . . . 0.0 110.327 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.48 124.77 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 C-N-CA 125.316 1.446 . . . . 0.0 107.836 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -72.9 109.49 6.51 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 50.4 mm -121.83 118.07 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 126.071 1.749 . . . . 0.0 109.224 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.58 47.4 16.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.242 1.017 . . . . 0.0 109.511 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.82 10.98 6.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.52 1.128 . . . . 0.0 111.441 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.26 123.46 38.17 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.205 -1.559 . . . . 0.0 110.588 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -69.79 116.95 10.78 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.02 -1.05 . . . . 0.0 108.565 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -112.55 150.52 31.21 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.019 1.328 . . . . 0.0 109.756 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -82.38 135.07 35.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.21 1.004 . . . . 0.0 109.944 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.03 125.16 44.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.71 152.17 26.86 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.525 0.73 . . . . 0.0 112.001 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -60.8 139.18 58.01 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 122.205 -0.309 . . . . 0.0 110.319 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.757 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.227 -0.125 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -64.67 147.45 52.98 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.334 0.97 . . . . 0.0 108.597 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.2 t -150.53 132.11 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -72.18 139.5 19.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -60.31 118.64 6.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -19.59 37.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.749 -0.594 . . . . 0.0 111.749 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -96.04 -19.6 19.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.601 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.8 111.49 5.03 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.843 1.656 . . . . 0.0 108.731 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.415 ' HB3' ' CD1' ' A' ' 163' ' ' PHE . 6.0 t -54.88 -32.83 61.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.055 1.342 . . . . 0.0 112.93 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.5 ptt85 -79.05 -1.27 34.91 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.236 -0.915 . . . . 0.0 112.32 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -110.35 157.09 19.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 118.585 0.629 . . . . 0.0 112.523 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.3 mm -127.31 141.74 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -115.68 103.0 10.25 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 129.404 3.082 . . . . 0.0 104.159 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -143.15 133.88 25.22 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.074 -1.016 . . . . 0.0 109.317 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 22.3 mtp 56.88 30.23 17.56 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.845 1.258 . . . . 0.0 112.615 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.71 8.73 73.12 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.899 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -106.97 168.64 9.06 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.602 1.561 . . . . 0.0 107.635 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.6 mm -120.23 141.2 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -133.04 143.91 49.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.7 t -135.19 151.25 50.47 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.774 1.229 . . . . 0.0 109.112 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 mt -101.0 137.75 27.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.788 0.835 . . . . 0.0 110.419 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.9 t -101.57 -111.17 0.21 Allowed 'General case' 0 CA--C 1.537 0.46 1 N-CA-C 98.714 -4.551 . . . . 0.0 98.714 175.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -166.9 99.12 0.55 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.8 m -135.67 112.97 10.56 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 127.764 2.426 . . . . 0.0 105.583 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.1 m -68.54 123.29 20.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.67 116.14 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.8 m -83.96 158.64 21.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.167 0.508 . . . . 0.0 110.964 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -57.32 -32.75 67.0 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.188 1.795 . . . . 0.0 111.386 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.82 -8.79 55.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.88 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -121.72 -20.93 6.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.436 1.094 . . . . 0.0 109.658 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.0 tp -66.26 151.36 47.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.31 -102.59 2.72 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -134.65 165.15 25.89 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.85 0.86 . . . . 0.0 110.942 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.562 ' HH ' ' HB ' ' A' ' 156' ' ' VAL . 40.5 t80 -62.44 143.31 57.24 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -123.59 -52.05 1.82 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.878 -1.058 . . . . 0.0 111.535 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.82 173.86 16.35 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.924 0.783 . . . . 0.0 110.071 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.562 ' HB ' ' HH ' ' A' ' 153' ' ' TYR . 14.8 p -129.92 147.29 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.78 166.54 11.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.274 3.029 . . . . 0.0 112.952 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -162.87 45.61 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.68 174.46 10.95 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 119.802 -1.811 . . . . 0.0 108.621 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.0 t -142.22 149.81 19.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.308 1.043 . . . . 0.0 108.351 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -145.18 161.11 40.31 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.893 -1.129 . . . . 0.0 108.847 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.2 t -127.32 126.93 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 128' ' ' SER . 52.9 p90 -148.17 165.34 31.19 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.535 0.734 . . . . 0.0 111.18 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -80.88 109.67 15.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.119 1.767 . . . . 0.0 108.195 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.9 t -50.49 -23.44 2.48 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.713 2.805 . . . . 0.0 115.269 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.47 -39.56 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.4 t -122.12 -24.99 4.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.73 -1.02 52.38 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.89 1.233 . . . . 0.0 112.52 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -51.69 112.35 0.75 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.39 1.876 . . . . 0.0 110.23 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 25.9 p -72.7 156.48 38.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.633 0.73 . . . . 0.0 110.52 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.58 136.79 25.6 Favored Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.81 162.87 32.05 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.722 2.282 . . . . 0.0 109.561 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -58.71 -31.85 68.64 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.558 0.343 . . . . 0.0 111.864 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.8 m -67.54 -4.39 11.46 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.28 -0.93 10.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.829 1.252 . . . . 0.0 110.274 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 42.2 m0 . . . . . 0 N--CA 1.464 0.251 0 O-C-N 120.064 -1.648 . . . . 0.0 111.751 -179.312 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 121.055 0.455 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.3 147.21 51.88 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 130.721 3.609 . . . . 0.0 105.881 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -129.11 104.94 7.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 102.923 -2.992 . . . . 0.0 102.923 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -111.49 116.21 30.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -83.53 129.34 34.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.261 1.424 . . . . 0.0 107.956 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -74.76 100.71 4.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.497 0.719 . . . . 0.0 109.239 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.3 159.66 27.56 Favored Glycine 0 CA--C 1.53 1.019 1 C-N-CA 132.631 4.92 . . . . 0.0 110.267 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.43 162.7 22.49 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 122.403 1.097 . . . . 0.0 109.304 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 97.4 mt -109.31 131.77 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 127.262 2.225 . . . . 0.0 112.072 -176.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -128.2 149.99 50.21 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.121 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 63.3 m -79.24 172.53 13.68 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.03 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 72.0 mt -128.62 139.02 53.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.315 1.446 . . . . 0.0 107.284 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -68.99 122.18 18.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.18 13.43 77.01 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 118.763 -1.02 . . . . 0.0 113.457 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -139.9 123.78 17.52 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 119.499 1.649 . . . . 0.0 109.988 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 54.8 m -79.6 150.91 30.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.01 -23.54 54.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.878 0.871 . . . . 0.0 110.284 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 17.0 p -76.09 -9.49 58.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.316 2.246 . . . . 0.0 113.513 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -123.95 -47.26 1.93 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.894 1.277 . . . . 0.0 110.081 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.88 148.27 13.77 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -155.14 175.84 13.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -108.36 144.44 35.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.56 124.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.767 2.027 . . . . 0.0 109.172 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -73.97 107.5 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 47.4 mm -121.84 125.76 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 109.76 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 54.32 44.43 28.99 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.013 0.824 . . . . 0.0 109.748 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 65.42 0.21 1.33 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.642 1.977 . . . . 0.0 113.974 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -121.23 127.87 51.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.949 0.795 . . . . 0.0 109.111 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -66.0 136.6 56.27 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.329 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -128.87 145.95 51.07 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.928 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.35 133.08 35.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.899 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -121.71 138.19 54.45 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 23.9 p -120.78 149.41 42.6 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 123.677 0.611 . . . . 0.0 112.632 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -61.12 143.01 56.27 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 177.345 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.786 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -71.59 127.67 33.32 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 129.508 3.123 . . . . 0.0 106.285 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.7 126.11 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -68.88 133.17 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -66.27 128.23 35.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.42 -22.4 66.95 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.627 0.771 . . . . 0.0 111.135 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -81.25 -47.33 13.51 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.557 1.143 . . . . 0.0 109.605 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -140.74 106.05 5.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.366 1.466 . . . . 0.0 108.742 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 m -62.69 -12.28 22.63 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 120.362 -1.461 . . . . 0.0 112.259 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -85.13 1.84 46.17 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.417 1.087 . . . . 0.0 109.446 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -113.98 162.11 16.83 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.558 1.143 . . . . 0.0 109.06 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.9 mm -132.94 128.23 56.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -106.16 110.46 22.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.533 2.333 . . . . 0.0 106.567 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -146.26 128.76 16.0 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.455 1.102 . . . . 0.0 108.755 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.2 mtt 60.82 39.94 16.47 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.953 1.701 . . . . 0.0 112.329 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 63.59 21.63 65.06 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.918 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -114.46 173.46 6.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.1 mm -132.9 132.41 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -124.55 156.19 37.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.7 t -131.11 150.62 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.934 1.694 . . . . 0.0 108.949 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.8 mt -120.34 127.63 75.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.9 t -103.97 -104.51 0.3 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -164.76 101.79 0.79 Allowed 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 178.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 86.6 m -135.37 113.66 11.44 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 126.728 2.011 . . . . 0.0 107.38 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.7 m -66.98 115.98 7.3 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.574 1.533 . . . . 0.0 109.399 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 66.7 t -95.27 115.55 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 m -82.26 158.55 23.45 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -63.76 -26.59 68.71 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.972 0.909 . . . . 0.0 111.559 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -66.99 -23.77 65.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.175 0.443 . . . . 0.0 110.533 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -99.82 -21.03 15.91 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.937 0.895 . . . . 0.0 110.014 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.23 148.91 48.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.819 1.248 . . . . 0.0 108.03 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.15 -106.54 2.69 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.37 170.67 15.58 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.62 1.168 . . . . 0.0 110.349 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -56.92 138.0 54.55 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.394 1.478 . . . . 0.0 109.154 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -126.3 -52.89 1.5 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -139.66 156.6 46.74 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.548 0.613 . . . . 0.0 110.217 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.3 p -120.36 133.45 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.381 0.61 . . . . 0.0 111.833 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -112.3 164.15 13.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.954 2.102 . . . . 0.0 112.252 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.44 42.05 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.749 1.22 . . . . 0.0 112.536 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -140.39 175.59 9.47 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 119.068 -2.27 . . . . 0.0 108.987 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 t -143.08 149.52 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.84 165.8 26.53 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.3 t -133.75 129.19 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -141.99 157.36 45.04 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 119.881 1.219 . . . . 0.0 111.414 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -62.19 121.17 12.42 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.877 0.871 . . . . 0.0 109.574 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.15 -14.2 59.99 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.52 -38.68 12.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.0 t -123.0 -27.13 4.27 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.24 6.62 53.34 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.258 0.932 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -55.68 114.44 1.87 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.761 1.624 . . . . 0.0 108.517 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.08 132.84 55.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.022 0.828 . . . . 0.0 109.198 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -92.76 144.46 28.62 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.36 153.78 45.37 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.59 2.193 . . . . 0.0 110.201 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -56.95 -36.31 70.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.565 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.6 t -63.39 -2.63 1.59 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -118.18 -1.26 11.39 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.202 1.364 . . . . 0.0 111.966 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 36.5 m0 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 125.242 1.417 . . . . 0.0 113.653 -179.861 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.242 0.544 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.0 m -91.88 137.41 32.39 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.701 2.0 . . . . 0.0 106.388 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -119.48 109.88 16.25 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.842 2.057 . . . . 0.0 106.949 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -115.38 119.62 36.85 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.768 2.027 . . . . 0.0 110.797 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -86.82 134.46 33.55 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 128.363 2.665 . . . . 0.0 110.031 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -80.35 102.28 9.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.475 1.51 . . . . 0.0 110.477 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -95.49 158.66 22.22 Favored Glycine 0 CA--C 1.533 1.196 1 C-N-CA 133.042 5.115 . . . . 0.0 107.475 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.85 159.42 30.44 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 123.62 1.676 . . . . 0.0 110.62 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 57.7 mt -111.73 141.1 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.705 1.602 . . . . 0.0 109.982 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -134.43 147.5 50.45 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.324 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.61 173.44 6.07 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.8 mt -128.89 141.4 46.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.206 1.403 . . . . 0.0 108.509 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.87 124.7 24.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.4 17.35 76.26 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-O 117.493 -1.726 . . . . 0.0 114.841 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -147.63 134.44 20.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.105 1.952 . . . . 0.0 111.255 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.0 m -84.87 151.16 24.49 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.22 -30.64 62.61 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.327 -0.858 . . . . 0.0 109.864 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 66.9 p -73.18 -4.25 31.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.928 1.691 . . . . 0.0 114.458 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -125.12 -40.98 2.1 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.831 1.652 . . . . 0.0 109.515 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.05 144.6 2.71 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 118.858 0.754 . . . . 0.0 109.736 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -152.41 175.63 12.5 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.966 0.907 . . . . 0.0 109.198 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -112.47 134.72 53.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.041 1.336 . . . . 0.0 110.547 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.5 124.54 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 C-N-CA 124.153 0.981 . . . . 0.0 108.635 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -70.29 104.39 2.66 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 41.5 mm -121.77 133.22 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 54.77 39.7 31.53 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.06 3.31 2.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.837 2.455 . . . . 0.0 113.642 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -119.43 125.29 48.58 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.706 1.203 . . . . 0.0 111.492 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -64.28 113.19 3.43 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.571 0.748 . . . . 0.0 112.635 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -105.97 147.29 28.99 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 122.184 0.992 . . . . 0.0 110.908 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.429 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -86.18 123.12 31.11 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.428 1.491 . . . . 0.0 108.805 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -107.54 144.23 34.82 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.7 p -118.05 147.37 43.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.784 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -62.15 142.81 57.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.646 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.031 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -75.11 138.56 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.0 t -139.55 132.01 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -78.64 128.63 38.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 177.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -61.56 122.34 15.0 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.51 1.148 . . . . 0.0 108.892 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.1 pttt -62.27 -23.01 66.46 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.362 -0.836 . . . . 0.0 110.358 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -85.01 -22.92 28.88 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.605 1.162 . . . . 0.0 110.603 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.84 102.45 2.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 119.667 1.122 . . . . 0.0 108.294 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.0 m -57.53 -24.93 58.85 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.884 0.873 . . . . 0.0 112.756 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.6 ptt85 -81.23 -3.79 53.46 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.923 0.889 . . . . 0.0 111.302 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -108.25 151.86 25.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.634 0.73 . . . . 0.0 110.089 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 14.2 mm -120.8 142.02 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -117.45 104.06 10.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.904 2.482 . . . . 0.0 106.051 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -127.26 133.97 50.12 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.0 mtt 56.3 13.44 1.26 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.043 -1.661 . . . . 0.0 113.281 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.73 6.6 65.49 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.879 1.228 . . . . 0.0 110.66 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -97.61 154.11 17.76 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 119.055 1.427 . . . . 0.0 107.917 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mm -118.09 140.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 O-C-N 124.358 1.036 . . . . 0.0 110.058 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -123.35 168.85 11.97 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.76 1.224 . . . . 0.0 110.528 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.47 135.51 25.16 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.453 1.501 . . . . 0.0 109.412 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 mt -97.89 119.0 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.1 t -94.87 -105.25 0.14 Allowed 'General case' 0 C--O 1.234 0.255 1 N-CA-C 99.717 -4.179 . . . . 0.0 99.717 176.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -167.03 99.34 0.53 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.5 m -136.29 121.46 19.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 128.332 2.653 . . . . 0.0 103.93 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.5 m -76.59 128.42 34.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.27 111.69 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.435 1.016 . . . . 0.0 109.583 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.2 m -81.96 162.95 22.49 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.027 0.531 . . . . 0.0 110.347 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.44 -27.0 65.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.248 1.819 . . . . 0.0 112.521 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.35 -22.07 61.95 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.204 -0.31 . . . . 0.0 110.213 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.82 -26.79 13.01 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.287 1.035 . . . . 0.0 109.433 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.8 tp -65.08 152.68 42.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -111.2 -102.64 2.67 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 125.037 1.303 . . . . 0.0 109.925 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -134.54 167.49 20.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.532 1.133 . . . . 0.0 110.858 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -60.07 140.93 56.53 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.024 1.33 . . . . 0.0 108.178 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -124.49 -47.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.598 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.99 158.16 40.19 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.325 1.42 . . . . 0.0 111.197 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.35 135.1 57.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.754 0.788 . . . . 0.0 111.292 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.27 165.92 11.53 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.041 2.936 . . . . 0.0 110.324 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.46 51.99 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.652 1.181 . . . . 0.0 113.143 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.36 175.85 9.6 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 119.618 -1.926 . . . . 0.0 107.681 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.66 142.58 23.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.93 161.1 38.15 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 71.6 t -129.89 124.2 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.74 169.24 18.09 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.289 0.95 . . . . 0.0 110.877 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -81.08 117.78 21.95 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -15.74 60.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.7 m -82.96 -41.19 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.0 -1.063 . . . . 0.0 113.779 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.2 m -122.36 -27.61 4.43 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 125.294 1.438 . . . . 0.0 113.456 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.32 7.59 37.21 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 117.118 1.607 . . . . 0.0 117.118 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.409 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -60.51 113.25 2.33 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.982 1.313 . . . . 0.0 110.551 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.2 p -70.58 149.48 47.04 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.749 1.22 . . . . 0.0 109.793 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.41 139.3 25.94 Favored Pre-proline 0 N--CA 1.44 -0.964 0 C-N-CA 125.527 1.531 . . . . 0.0 107.236 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.56 153.4 20.49 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.798 2.332 . . . . 0.0 109.33 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -51.21 -33.47 27.79 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.821 1.249 . . . . 0.0 111.573 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -3.47 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.556 1.142 . . . . 0.0 113.283 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -129.72 6.93 5.18 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.359 1.863 . . . . 0.0 113.242 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 40.9 m0 . . . . . 0 CA--C 1.547 0.83 0 C-N-CA 124.409 1.083 . . . . 0.0 112.713 179.351 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.0 mmp_? . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 28.7 m -128.61 150.77 50.08 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 128.363 2.665 . . . . 0.0 105.99 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -124.37 109.02 12.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -110.44 116.26 31.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.829 1.652 . . . . 0.0 110.903 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.29 123.67 31.03 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 128.119 2.568 . . . . 0.0 107.405 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -72.19 101.18 2.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 118.951 0.796 . . . . 0.0 109.468 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.2 159.0 27.19 Favored Glycine 0 N--CA 1.44 -1.094 1 C-N-CA 131.67 4.462 . . . . 0.0 107.392 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -68.26 160.06 30.03 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.43 1.586 . . . . 0.0 111.267 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 77.6 mt -106.76 141.13 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.136 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -132.91 151.8 51.99 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.574 1.55 . . . . 0.0 110.528 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.4 t -78.29 173.05 12.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.904 0.882 . . . . 0.0 108.662 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.1 mt -129.63 140.3 49.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 122.477 1.132 . . . . 0.0 108.721 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -66.26 119.64 11.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.303 1.441 . . . . 0.0 107.821 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.88 2.44 88.5 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.31 -1.272 . . . . 0.0 114.962 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -126.39 132.79 51.46 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.91 1.855 . . . . 0.0 109.075 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 16.2 m -85.78 150.73 24.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -28.37 63.29 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 124.202 1.001 . . . . 0.0 110.075 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.6 p -72.02 -11.18 60.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.115 2.166 . . . . 0.0 114.195 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -120.47 -47.62 2.33 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.514 1.526 . . . . 0.0 109.549 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.25 144.51 12.76 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 111.084 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -150.05 175.77 11.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.738 0.415 . . . . 0.0 109.984 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.15 128.89 55.39 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.828 0.851 . . . . 0.0 110.324 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.0 128.27 71.74 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 C-N-CA 124.697 1.199 . . . . 0.0 107.855 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.05 110.26 7.2 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.6 mm -121.77 124.08 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 53.5 48.14 22.44 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.092 0.86 . . . . 0.0 109.087 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 65.48 -4.26 0.59 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.649 2.379 . . . . 0.0 115.014 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -114.9 135.59 54.03 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.094 0.861 . . . . 0.0 109.771 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -72.92 115.36 12.13 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.152 0.981 . . . . 0.0 110.26 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 146.98 34.36 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -79.31 136.79 37.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.86 1.264 . . . . 0.0 108.229 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.05 137.36 53.63 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.0 p -121.3 150.38 41.5 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.41 0.444 . . . . 0.0 111.974 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -55.01 133.51 48.59 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.222 -0.367 0 C-N-CA 126.401 1.881 . . . . 0.0 108.017 179.065 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.23 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 155' ' ' ASP . 18.9 p90 -66.43 149.78 49.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 97.3 t -149.72 126.25 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -71.94 134.13 30.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.52 117.52 6.32 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -24.49 19.97 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.71 0.804 . . . . 0.0 111.53 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -89.19 -22.59 22.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.368 1.467 . . . . 0.0 112.396 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.11 104.33 3.67 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 119.565 1.075 . . . . 0.0 108.273 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.4 t -60.14 -22.33 62.73 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.342 -0.849 . . . . 0.0 112.814 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.0 ptt85 -80.69 -4.83 55.8 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.35 -0.844 . . . . 0.0 110.598 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -109.6 159.28 17.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.816 0.817 . . . . 0.0 111.409 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.8 mm -130.38 146.77 33.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.04 104.75 9.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -141.06 134.43 29.74 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.05 1.34 . . . . 0.0 109.898 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.0 mtt 58.21 36.42 25.73 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.605 1.162 . . . . 0.0 112.109 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.05 22.85 63.16 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -121.88 161.51 22.66 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mm -116.37 145.24 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -135.15 156.94 48.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.0 t -139.19 165.14 27.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.4 mt -117.13 134.75 59.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.714 0.769 . . . . 0.0 110.699 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.31 -114.6 0.2 Allowed 'General case' 0 CA--C 1.539 0.521 1 N-CA-C 99.371 -4.307 . . . . 0.0 99.371 175.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -167.53 100.33 0.49 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 94.5 m -136.25 121.8 19.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.81 2.044 . . . . 0.0 106.75 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 m -71.5 121.45 18.69 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.87 110.68 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.5 m -70.85 159.53 34.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.06 0.457 . . . . 0.0 110.944 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.28 -29.86 69.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.546 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.95 -12.36 60.63 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -108.54 -23.04 12.01 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.485 1.114 . . . . 0.0 109.13 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.46 133.99 53.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.98 -105.86 0.74 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -135.85 166.86 22.31 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.613 1.565 . . . . 0.0 108.601 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -64.63 139.92 58.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -123.26 -48.03 1.99 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.573 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.413 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 28.3 m-20 -152.65 166.6 31.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.982 1.265 . . . . 0.0 111.32 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.24 143.17 40.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.572 1.149 . . . . 0.0 111.142 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -111.2 166.5 11.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.875 2.87 . . . . 0.0 112.706 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.15 58.83 0.29 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.182 0.993 . . . . 0.0 112.631 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -161.99 175.98 11.25 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.974 -1.704 . . . . 0.0 111.605 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -144.59 150.12 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.112 1.765 . . . . 0.0 108.557 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.8 164.71 29.36 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.039 1.29 . . . . 0.0 109.236 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.0 t -132.17 132.97 60.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -141.72 168.59 19.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.658 0.783 . . . . 0.0 111.271 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -89.49 102.86 15.54 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 127.022 2.129 . . . . 0.0 108.067 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.7 t -47.03 -21.23 0.2 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 129.507 3.123 . . . . 0.0 114.8 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.03 -50.91 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.432 1.493 . . . . 0.0 110.898 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.9 t -123.21 -23.84 4.81 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.858 1.663 . . . . 0.0 114.05 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.95 0.87 42.04 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.24 1.4 . . . . 0.0 110.364 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -48.13 113.5 0.75 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 127.712 2.405 . . . . 0.0 111.003 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 39.9 p -61.02 154.98 21.27 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.852 1.261 . . . . 0.0 111.299 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.99 142.44 41.19 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.28 1.032 . . . . 0.0 108.826 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.22 157.25 46.2 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.203 2.602 . . . . 0.0 108.98 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -57.68 -32.25 67.16 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.683 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -7.8 9.67 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 118.103 -0.951 . . . . 0.0 113.287 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -110.79 -8.59 14.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.4 1.454 . . . . 0.0 109.835 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.6 m0 . . . . . 0 C--O 1.236 0.363 0 CA-C-N 119.668 1.122 . . . . 0.0 112.176 -178.779 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.2 m -132.64 135.46 45.87 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 127.946 2.499 . . . . 0.0 106.626 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -114.42 108.34 16.75 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -110.23 123.87 50.56 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.591 1.556 . . . . 0.0 109.73 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -90.46 125.2 35.5 Favored 'General case' 0 N--CA 1.441 -0.893 1 C-N-CA 133.244 4.618 . . . . 0.0 109.087 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -77.74 101.88 6.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 127.327 2.251 . . . . 0.0 107.72 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -97.79 159.35 20.89 Favored Glycine 0 CA--C 1.533 1.218 1 C-N-CA 134.377 5.751 . . . . 0.0 108.049 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -66.6 163.19 19.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.939 1.369 . . . . 0.0 110.569 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 73.7 mt -109.31 134.95 49.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 128.138 2.575 . . . . 0.0 111.735 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -130.02 151.29 50.73 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.947 1.299 . . . . 0.0 110.239 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.3 p -78.59 173.53 12.32 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.3 mt -128.29 136.59 59.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 O-C-N 121.255 -0.903 . . . . 0.0 109.805 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -63.03 127.34 30.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.3 12.09 84.91 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.478 -1.179 . . . . 0.0 113.915 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -138.85 156.16 47.54 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 120.365 2.083 . . . . 0.0 109.168 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.2 m -103.32 146.62 28.19 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -23.34 58.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.875 0.87 . . . . 0.0 109.74 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 23.7 p -79.11 -9.5 59.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.721 1.608 . . . . 0.0 114.105 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -123.73 -40.63 2.31 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.678 0.791 . . . . 0.0 112.215 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.48 140.02 8.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -150.57 176.13 11.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -107.93 143.13 37.01 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.45 121.9 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.647 1.579 . . . . 0.0 108.768 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.85 104.37 4.0 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.1 mm -122.15 126.03 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 126.49 1.916 . . . . 0.0 109.273 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 58.54 34.76 24.15 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.844 -1.16 . . . . 0.0 112.236 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 66.1 13.77 9.28 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.366 1.066 . . . . 0.0 113.187 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.62 120.23 21.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.318 1.847 . . . . 0.0 108.634 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -65.6 136.65 56.62 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 120.103 -1.623 . . . . 0.0 109.965 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -127.15 147.9 50.18 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.026 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -84.86 115.1 22.57 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.056 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.48 147.8 24.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.59 143.18 50.15 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 118.0 0.364 . . . . 0.0 110.571 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -50.86 135.3 24.41 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.209 1.404 . . . . 0.0 110.061 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.55 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -65.0 118.51 9.22 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.722 1.609 . . . . 0.0 110.103 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.4 t -121.76 135.55 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -83.0 118.93 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -47.4 118.77 2.33 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.187 1.395 . . . . 0.0 110.486 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -59.98 -21.45 61.28 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.507 -0.746 . . . . 0.0 111.701 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -88.53 -20.05 25.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.083 0.953 . . . . 0.0 111.257 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.05 112.25 2.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.965 1.257 . . . . 0.0 110.64 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 m -60.27 -21.91 62.46 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 119.957 -1.714 . . . . 0.0 113.428 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.7 ptt85 -80.84 1.23 31.53 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 120.858 -1.151 . . . . 0.0 110.015 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -111.93 158.68 19.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.867 0.841 . . . . 0.0 110.277 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.0 mm -133.43 127.59 53.89 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 136' ' ' ASN . 4.7 t0 -96.91 105.0 17.05 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 128.086 2.554 . . . . 0.0 104.14 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -139.5 143.11 37.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.083 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 8.9 mtt 55.24 22.87 5.03 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.853 -1.154 . . . . 0.0 113.749 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.04 17.86 71.11 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.504 1.049 . . . . 0.0 110.983 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 8.9 p30 -117.28 173.84 6.46 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 126.588 1.955 . . . . 0.0 112.88 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.2 mm -130.04 132.33 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -119.33 163.55 17.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 t -140.02 148.12 41.39 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.578 1.551 . . . . 0.0 106.925 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 mt -114.08 121.74 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -94.85 -113.5 0.12 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -158.3 99.63 1.63 Allowed 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 65.0 m -136.95 116.42 12.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.004 2.522 . . . . 0.0 104.89 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.6 m -78.35 122.3 25.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 121.235 1.834 . . . . 0.0 106.595 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.7 t -94.67 113.05 28.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.018 1.327 . . . . 0.0 109.225 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.0 m -75.14 163.84 27.13 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.523 1.129 . . . . 0.0 111.18 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.24 -29.34 68.7 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.264 1.025 . . . . 0.0 110.168 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.02 -16.48 64.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.363 0.665 . . . . 0.0 112.062 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -105.35 -30.68 9.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.63 1.572 . . . . 0.0 109.83 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -55.67 127.27 29.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.951 1.3 . . . . 0.0 110.141 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.48 -104.83 1.25 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 125.235 1.398 . . . . 0.0 110.066 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -134.44 168.31 19.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.397 1.479 . . . . 0.0 109.296 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.42 136.95 58.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -115.18 -52.37 2.68 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.414 0.686 . . . . 0.0 111.784 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -160.37 159.9 31.68 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.77 1.168 . . . . 0.0 109.038 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 p -114.75 133.13 61.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.665 1.186 . . . . 0.0 111.402 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.61 164.9 12.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.966 2.106 . . . . 0.0 111.114 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.87 29.36 0.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.85 174.12 6.8 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 119.924 -1.735 . . . . 0.0 108.133 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.9 t -143.67 149.98 17.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.22 164.91 33.45 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.8 t -127.72 131.28 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -144.23 167.81 21.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.442 0.639 . . . . 0.0 110.172 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -79.99 119.16 22.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.1 t -66.21 -13.92 61.07 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.4 m -83.77 -43.61 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.7 m -122.19 -26.97 4.6 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.728 1.211 . . . . 0.0 113.919 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.31 -1.38 31.09 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.455 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -52.86 112.49 0.85 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.36 1.08 . . . . 0.0 111.599 -179.288 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.99 140.57 56.37 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.2 mp -106.88 143.39 26.99 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.32 1.848 . . . . 0.0 108.327 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.25 148.53 18.98 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.692 2.928 . . . . 0.0 110.896 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -53.38 -31.5 45.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.752 0.821 . . . . 0.0 112.892 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 t -68.76 -6.23 25.32 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.715 0.806 . . . . 0.0 112.998 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -116.4 -12.71 11.04 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.872 1.669 . . . . 0.0 110.201 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 40.3 m0 . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.733 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 . . . . . 0 C--O 1.233 0.208 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.412 HG21 ' CD1' ' A' ' 193' ' ' TRP . 95.5 m -128.66 117.78 21.77 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -95.03 113.12 24.79 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . 0.412 ' CD1' HG21 ' A' ' 191' ' ' THR . 12.4 m0 -123.38 124.5 43.06 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.702 1.601 . . . . 0.0 110.256 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.72 135.03 34.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.036 2.134 . . . . 0.0 107.512 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -78.3 100.52 6.76 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.69 159.55 23.1 Favored Glycine 0 N--CA 1.441 -0.984 1 C-N-CA 130.818 4.056 . . . . 0.0 107.514 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -68.14 154.33 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 123.655 1.693 . . . . 0.0 111.61 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.66 141.04 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 112.997 -1.911 . . . . 0.0 108.205 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -134.2 153.63 51.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 112.957 -1.929 . . . . 0.0 108.316 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.72 173.11 12.19 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 81.6 mt -124.14 137.5 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -55.71 119.58 5.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.162 1.385 . . . . 0.0 108.24 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.46 12.1 82.34 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.412 -1.215 . . . . 0.0 115.436 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -126.05 133.01 51.83 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 120.961 2.381 . . . . 0.0 109.568 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 67.9 m -83.53 142.78 30.64 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.47 -32.23 57.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.272 1.029 . . . . 0.0 110.501 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.2 p -70.12 -10.55 59.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.277 1.431 . . . . 0.0 114.516 -178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.02 -41.36 2.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.712 1.205 . . . . 0.0 109.097 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -166.93 151.61 7.3 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.002 0.819 . . . . 0.0 110.258 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -156.48 175.63 13.77 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.113 0.965 . . . . 0.0 109.565 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -112.13 137.0 50.81 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.889 1.276 . . . . 0.0 110.093 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.04 131.63 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.135 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -71.0 106.22 3.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 40.4 mm -122.4 125.16 72.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.1 m120 56.35 36.71 27.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 13.7 t0 70.87 -4.94 1.59 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.539 1.936 . . . . 0.0 112.095 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.6 127.31 52.96 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 118.931 -2.356 . . . . 0.0 110.73 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -74.43 116.52 15.21 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.583 -1.323 . . . . 0.0 109.979 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -107.11 147.81 29.57 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.766 0.826 . . . . 0.0 109.809 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.4 tm? -83.85 128.03 34.25 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.49 1.516 . . . . 0.0 109.296 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -111.54 151.72 28.36 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.085 0.954 . . . . 0.0 109.167 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.2 p -133.2 147.9 52.02 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.75 1.22 . . . . 0.0 111.088 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -59.94 128.86 38.96 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.717 -0.615 . . . . 0.0 112.042 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.214 -0.772 0 C-N-CA 125.596 1.558 . . . . 0.0 109.722 -179.726 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.821 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 121' ' ' PHE . 2.7 p90 -71.49 132.16 44.34 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 127.719 2.407 . . . . 0.0 106.569 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 93.4 t -133.91 125.54 49.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mp -69.4 134.71 29.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -57.4 118.28 4.98 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.73 -18.02 63.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.549 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -94.38 -28.05 15.73 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.076 0.951 . . . . 0.0 111.491 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -138.96 106.73 5.63 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.743 1.217 . . . . 0.0 109.66 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.431 ' HB3' ' CD2' ' A' ' 163' ' ' PHE . 22.7 t -58.74 -24.93 62.43 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 120.592 -1.318 . . . . 0.0 112.687 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -82.53 -1.67 51.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.441 1.096 . . . . 0.0 111.106 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -116.13 159.29 21.95 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.447 0.642 . . . . 0.0 111.934 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.4 mm -127.54 144.77 36.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -121.4 106.1 11.13 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 128.115 2.566 . . . . 0.0 105.126 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -138.9 130.92 27.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.7 mtt 60.45 22.54 12.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.259 1.424 . . . . 0.0 112.243 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.61 16.16 79.69 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -109.42 162.58 14.22 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.1 mm -123.3 132.08 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -120.33 159.13 25.65 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.7 t -145.65 155.49 43.04 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 mt -111.83 115.98 51.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 123.872 0.869 . . . . 0.0 111.643 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.5 t -87.15 -116.67 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -158.32 99.15 1.61 Allowed 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 55.4 m -137.04 129.6 30.12 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 131.151 3.78 . . . . 0.0 108.188 177.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.0 126.09 31.56 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.64 1.976 . . . . 0.0 107.511 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.2 t -94.77 111.85 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 120.621 1.555 . . . . 0.0 107.425 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.1 m -75.31 156.71 35.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.023 0.916 . . . . 0.0 109.801 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -55.85 -30.87 62.16 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 127.997 2.519 . . . . 0.0 112.885 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -72.86 -26.8 61.59 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.981 0.913 . . . . 0.0 111.455 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -97.84 -19.88 17.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.33 1.052 . . . . 0.0 110.097 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 mt -69.52 123.51 21.49 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.209 1.804 . . . . 0.0 109.504 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.16 -117.92 0.51 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 125.27 1.414 . . . . 0.0 110.96 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -130.13 165.14 22.92 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.535 1.134 . . . . 0.0 111.617 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -60.83 120.54 10.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.634 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -102.83 -52.71 3.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 118.003 -0.998 . . . . 0.0 111.119 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -153.44 166.01 34.04 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.487 0.585 . . . . 0.0 112.037 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.33 138.8 50.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 124.435 1.094 . . . . 0.0 109.324 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.74 165.5 11.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.501 2.32 . . . . 0.0 109.598 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -171.07 65.97 0.04 OUTLIER 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.398 0.679 . . . . 0.0 111.881 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.52 166.51 30.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.3 t -145.11 149.73 16.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -146.99 164.83 31.7 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.1 122.18 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 128' ' ' SER . 37.2 p90 -140.0 177.3 8.07 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.376 1.444 . . . . 0.0 113.347 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -84.14 128.93 34.88 Favored 'General case' 0 C--N 1.347 0.488 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.3 t -66.05 -16.64 64.1 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.312 1.415 . . . . 0.0 113.372 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.63 -55.27 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 118.676 0.671 . . . . 0.0 112.468 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.3 m -121.73 -22.19 5.89 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.891 1.276 . . . . 0.0 113.004 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.46 15.3 25.55 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-O 118.455 -1.191 . . . . 0.0 115.714 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.479 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.3 OUTLIER -59.44 116.83 4.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.399 1.599 . . . . 0.0 109.981 179.523 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.08 153.45 41.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.735 1.152 . . . . 0.0 109.424 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.31 142.06 24.82 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.39 147.18 46.37 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.796 2.331 . . . . 0.0 109.959 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -56.54 -30.06 62.65 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.793 -0.567 . . . . 0.0 112.438 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.7 m -66.43 -7.09 17.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.621 1.169 . . . . 0.0 113.19 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -120.34 -4.84 9.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.123 1.769 . . . . 0.0 111.338 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.0 m0 . . . . . 0 N--CA 1.472 0.658 0 O-C-N 121.23 -0.919 . . . . 0.0 113.332 -178.676 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 . . . . . 0 CA--C 1.505 -0.759 0 CA-C-O 121.649 0.738 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.0 m -131.17 131.01 43.75 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -112.56 113.22 25.26 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -114.85 121.41 43.15 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.659 1.584 . . . . 0.0 108.761 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -89.3 131.76 35.24 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 128.905 2.882 . . . . 0.0 106.649 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -80.25 103.17 9.94 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.09 158.55 26.95 Favored Glycine 0 CA--C 1.53 1.03 1 C-N-CA 134.588 5.851 . . . . 0.0 107.056 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.72 160.08 31.01 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.147 1.474 . . . . 0.0 112.301 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 61.4 mt -109.06 139.02 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 126.12 1.768 . . . . 0.0 111.159 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -130.51 151.13 51.33 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.528 1.531 . . . . 0.0 109.446 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 13.6 p -75.9 174.17 10.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.159 0.584 . . . . 0.0 110.729 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 60.9 mt -132.61 139.43 49.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.135 1.374 . . . . 0.0 108.473 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -55.32 122.88 12.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.532 1.533 . . . . 0.0 109.832 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 66.34 13.27 60.08 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.343 -1.254 . . . . 0.0 115.498 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -131.05 124.37 30.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 120.05 1.925 . . . . 0.0 108.867 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 69.6 m -80.5 151.81 29.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.39 -26.35 40.97 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.846 1.258 . . . . 0.0 109.472 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.2 p -70.38 -17.1 63.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.917 2.087 . . . . 0.0 113.377 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -120.54 -43.5 2.49 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.78 1.232 . . . . 0.0 112.009 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.5 146.0 6.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.051 0.94 . . . . 0.0 109.539 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -158.26 176.66 12.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.73 1.212 . . . . 0.0 108.805 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.23 132.57 53.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.467 1.507 . . . . 0.0 110.955 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.6 p -129.63 125.96 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 C-N-CA 124.312 1.045 . . . . 0.0 110.62 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -72.53 112.87 8.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 30.0 mm -122.59 119.83 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 55.14 33.61 20.84 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.274 0.943 . . . . 0.0 111.952 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.6 t70 80.33 -9.18 1.42 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.844 2.857 . . . . 0.0 111.977 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.91 122.64 43.14 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.843 -1.16 . . . . 0.0 108.836 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -73.81 112.53 10.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -104.01 145.94 29.43 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.102 0.961 . . . . 0.0 111.434 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.3 tm? -81.66 126.82 32.23 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -116.28 146.39 42.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.9 p -127.58 158.42 37.52 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.415 0.686 . . . . 0.0 111.19 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -64.92 122.11 16.2 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 84.8 t . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 122.671 1.224 . . . . 0.0 108.271 179.784 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.56 141.23 14.44 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 128.561 2.744 . . . . 0.0 105.1 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -70.07 128.4 36.18 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.3 t -132.07 135.36 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -80.93 140.13 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -55.71 127.86 32.05 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.306 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -55.83 -26.94 49.03 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.784 -1.198 . . . . 0.0 111.054 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -101.76 -8.31 21.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.946 1.299 . . . . 0.0 113.634 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.06 107.22 3.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.6 m -64.94 -14.14 59.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.253 1.821 . . . . 0.0 111.846 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -99.6 0.58 42.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.016 1.726 . . . . 0.0 112.029 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -117.69 158.44 24.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.068 0.461 . . . . 0.0 110.33 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.5 mm -126.29 132.61 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.12 99.14 8.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 102.069 -3.308 . . . . 0.0 102.069 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -135.71 127.07 28.45 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.347 -1.471 . . . . 0.0 107.607 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 12.9 mtt 60.44 30.16 19.57 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.558 1.143 . . . . 0.0 109.769 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.12 -0.34 31.5 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 123.808 0.718 . . . . 0.0 111.75 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -90.62 164.37 14.21 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.5 mm -123.99 123.63 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.657 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.66 131.11 53.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.294 1.038 . . . . 0.0 109.039 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.1 t -113.1 151.24 31.03 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.785 1.234 . . . . 0.0 108.374 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.2 mt -110.76 118.59 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.074 0.95 . . . . 0.0 108.744 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.3 t -89.04 -107.75 0.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -160.23 99.48 1.33 Allowed 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 85.5 m -138.33 114.44 10.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 115.865 -2.017 . . . . 0.0 107.128 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.5 m -75.62 125.59 29.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 122.448 2.386 . . . . 0.0 106.617 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.6 t -99.63 111.83 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.868 1.267 . . . . 0.0 108.152 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.9 m -75.77 161.18 29.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.75 0.82 . . . . 0.0 109.733 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.7 -30.48 68.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.42 1.088 . . . . 0.0 112.043 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.87 -24.24 64.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.31 -0.244 . . . . 0.0 110.891 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -96.44 -27.1 15.06 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.324 0.649 . . . . 0.0 109.515 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.6 tp -68.11 148.7 50.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.193 1.397 . . . . 0.0 109.286 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.74 -101.99 2.65 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.62 1.105 . . . . 0.0 111.158 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -135.07 171.19 14.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.313 1.845 . . . . 0.0 111.221 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -64.12 136.82 57.59 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.421 1.088 . . . . 0.0 110.189 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -117.19 -52.63 2.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.152 0.981 . . . . 0.0 113.168 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -157.59 158.4 35.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.098 0.863 . . . . 0.0 111.695 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.05 137.99 45.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 119.241 0.928 . . . . 0.0 111.165 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.57 165.19 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.487 1.915 . . . . 0.0 111.09 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.58 65.81 0.07 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.156 0.982 . . . . 0.0 111.192 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -157.98 167.76 29.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 t -144.18 148.39 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -142.05 166.61 24.24 Favored 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 120.872 -1.143 . . . . 0.0 108.558 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.09 129.72 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.63 168.86 18.75 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.179 0.9 . . . . 0.0 111.203 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -101.65 102.14 12.77 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.3 t -50.77 -19.19 0.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 129.361 3.064 . . . . 0.0 115.965 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.7 m -55.99 -46.95 80.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.3 m -123.98 -23.24 4.66 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.144 1.777 . . . . 0.0 114.276 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 103.7 7.87 41.14 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.289 1.899 . . . . 0.0 112.864 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 113.2 1.54 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.675 1.737 . . . . 0.0 112.942 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 p -63.2 140.56 58.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.154 0.982 . . . . 0.0 108.567 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.89 147.34 34.31 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.48 159.72 19.61 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.479 2.786 . . . . 0.0 110.089 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -64.44 -17.61 63.97 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 121.377 -0.827 . . . . 0.0 111.708 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.6 p -74.53 -11.14 60.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.367 -0.833 . . . . 0.0 111.711 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -111.1 -3.89 15.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.32 1.448 . . . . 0.0 112.251 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -66.08 -7.81 19.76 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.375 1.47 . . . . 0.0 114.397 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -134.84 -53.66 0.07 OUTLIER Glycine 0 CA--C 1.519 0.33 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -86.27 94.59 9.37 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.416 ' CG1' ' H ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -63.3 -82.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.416 ' H ' ' CG1' ' A' ' 179' ' ' ILE . 7.6 t0 -170.75 144.81 2.35 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.986 2.514 . . . . 0.0 106.567 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -97.46 -8.95 28.14 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 117.266 -1.349 . . . . 0.0 113.586 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.47 -21.09 0.48 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.83 1.195 . . . . 0.0 111.929 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -48.82 -17.5 0.85 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.21 1.862 . . . . 0.0 116.331 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 186' ' ' SER . 6.9 t 49.39 75.94 0.14 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.848 2.059 . . . . 0.0 110.269 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.38 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.264 1.825 . . . . 0.0 113.005 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.457 ' H ' ' C ' ' A' ' 184' ' ' SER . 1.2 t -54.83 -11.84 0.69 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.643 3.177 . . . . 0.0 115.339 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -131.9 26.8 4.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.93 1.692 . . . . 0.0 109.255 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -133.65 118.82 18.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 t -117.23 95.56 5.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.187 0.995 . . . . 0.0 110.311 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -68.06 154.62 41.27 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 99.8 m -139.96 130.43 25.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -113.54 105.31 13.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.407 1.883 . . . . 0.0 107.547 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -110.3 127.89 55.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.941 0.896 . . . . 0.0 109.736 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -96.75 126.98 42.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.478 1.911 . . . . 0.0 107.399 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -75.66 100.96 4.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.896 1.331 . . . . 0.0 111.522 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -95.4 159.28 22.47 Favored Glycine 0 N--CA 1.431 -1.649 1 C-N-CA 130.727 4.013 . . . . 0.0 108.335 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.78 152.46 45.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 124.16 1.933 . . . . 0.0 111.029 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 67.7 mt -96.68 141.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.868 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -135.38 151.7 50.73 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.549 1.54 . . . . 0.0 109.233 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.9 p -77.48 173.27 12.17 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.246 1.018 . . . . 0.0 110.798 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 60.1 mt -126.34 137.52 57.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -67.49 124.21 22.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.48 1.512 . . . . 0.0 108.883 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.84 12.24 84.38 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 117.922 -1.488 . . . . 0.0 114.666 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -141.4 142.7 33.71 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.743 1.772 . . . . 0.0 111.255 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 24.5 m -90.02 151.24 21.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.837 0.827 . . . . 0.0 109.114 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -31.83 67.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.088 0.955 . . . . 0.0 111.183 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.4 p -68.69 -10.03 53.82 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 129.352 3.061 . . . . 0.0 114.624 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -120.51 -46.79 2.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.836 1.254 . . . . 0.0 107.764 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.16 147.91 5.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.593 0.711 . . . . 0.0 110.571 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -152.83 176.16 12.11 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.167 0.587 . . . . 0.0 110.098 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.64 137.63 47.18 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.02 130.23 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 125.26 1.424 . . . . 0.0 110.879 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.54 107.68 4.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 33.0 mm -120.74 120.7 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 52.98 45.53 28.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.421 0.688 . . . . 0.0 109.901 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 64.27 13.3 7.85 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.537 1.535 . . . . 0.0 112.623 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.18 122.15 36.22 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.165 -0.959 . . . . 0.0 108.687 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -69.42 115.93 9.25 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 120.512 -1.368 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -111.02 145.81 37.81 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.467 1.507 . . . . 0.0 113.09 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -80.64 128.8 34.03 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.929 1.291 . . . . 0.0 111.547 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -115.29 141.62 47.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.05 143.35 50.84 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.508 0.723 . . . . 0.0 110.535 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -55.41 138.53 45.78 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.69 161.33 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 126.84 2.056 . . . . 0.0 105.761 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -98.51 9.72 62.69 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.169 -0.957 . . . . 0.0 114.233 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 C--O 1.248 0.993 0 CA-C-N 119.187 1.493 . . . . 0.0 108.642 -179.372 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.825 0.345 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.46 130.92 3.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -59.17 146.43 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 98.5 t -150.29 120.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.164 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -68.13 118.17 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.135 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.34 123.62 13.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -20.36 66.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -90.47 -33.11 16.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.04 104.67 6.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -67.18 -13.59 62.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 47.6 ptt85 -94.89 -7.13 40.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.854 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -101.71 159.93 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.6 mm -128.02 131.52 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.139 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -107.7 103.65 12.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -135.79 129.77 33.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.2 mtt 59.69 39.73 20.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 63.4 20.46 63.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.443 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -113.43 172.81 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 36.3 mm -131.36 129.01 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -125.42 152.31 45.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 t -121.18 152.04 39.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.7 mt -123.26 111.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.122 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -92.74 -90.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -169.86 93.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 26.4 m -140.64 104.63 4.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 m -62.94 113.18 2.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.83 119.48 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.4 m -84.74 171.41 12.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.77 -26.31 64.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.09 -25.1 68.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -104.66 -26.12 12.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.61 137.75 58.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.38 -105.78 2.65 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.516 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -134.24 169.92 16.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.93 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -56.23 142.09 38.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -125.43 -51.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.953 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -147.37 159.87 43.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 5.3 p -119.56 129.93 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 195' ' ' TYR . 3.3 mm? -110.9 166.01 11.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.67 70.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -166.41 175.34 8.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.3 t -144.87 149.45 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.103 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.74 155.54 42.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -124.59 123.32 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.114 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -144.85 155.44 43.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -74.34 124.49 26.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.12 -4.35 32.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.5 m -77.93 -44.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.16 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.7 t -123.36 -30.12 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.09 33.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.434 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -69.9 127.93 34.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.844 0.354 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.83 155.11 37.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.47 139.83 35.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.584 0.707 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 154.98 67.1 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.645 2.23 . . . . 0.0 112.366 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -58.98 -21.71 59.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 m -73.86 -7.66 53.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.09 -12.46 14.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -57.1 -25.78 59.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -132.92 25.85 3.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.496 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -138.14 73.42 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 110.903 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.4 mt -53.2 -65.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.141 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.48 115.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -77.6 -22.5 50.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -75.1 -28.12 60.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 110.15 74.57 0.79 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.436 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.7 m -142.75 62.77 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -105.67 51.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.94 -56.3 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -97.17 71.89 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -141.8 140.91 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.6 m -168.92 65.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -68.94 168.88 12.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 98.9 m -137.77 120.41 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.69 105.52 17.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 13.5 m0 -110.35 116.78 32.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.96 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -84.55 126.55 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.411 ' HB3' ' HB3' ' A' ' 157' ' ' LEU . 13.4 m-30 -65.21 103.83 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 213' ' ' GLU . . . -101.28 162.84 17.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.484 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.28 139.35 58.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.798 0.333 . . . . 0.0 110.861 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 10.1 mt -91.21 143.39 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -131.68 143.14 50.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.78 172.26 3.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 71.1 mt -130.8 141.83 45.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -69.3 122.16 18.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 76.02 27.12 62.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -149.34 146.28 27.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.326 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -106.0 145.11 31.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.855 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.24 -17.15 62.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 67.4 p -82.59 -9.41 59.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.65 -51.56 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.09 146.32 24.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.069 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -154.44 176.44 12.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -110.4 125.36 53.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.084 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.0 p -117.68 125.39 74.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.142 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.442 ' HB3' ' HA3' ' A' ' 196' ' ' GLY . 18.9 tt0 -70.43 101.55 1.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 48.4 mm -120.39 120.25 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 60.53 43.94 12.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.37 14.88 9.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -137.49 122.11 18.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.52 125.06 26.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -116.62 140.69 49.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 3.3 tm? -76.37 121.76 23.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.54 139.29 40.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.21 138.33 50.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -64.97 122.12 16.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 94.4 t -127.07 129.52 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -100.25 55.4 0.86 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.498 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.994 ' C ' ' O ' ' A' ' 226' ' ' ASN . 5.9 m120 . . . . . 1 C--O 2.0 40.559 1 CA-C-O 161.134 19.54 . . . . 0.0 110.907 -179.902 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.93 141.31 15.31 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 127.728 2.411 . . . . 0.0 106.124 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -73.9 134.5 43.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 84.2 t -135.2 124.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -73.12 140.23 18.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -66.19 127.12 30.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -65.55 -27.05 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.462 -0.774 . . . . 0.0 111.705 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -80.67 -45.5 17.1 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.721 1.209 . . . . 0.0 110.057 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.08 100.59 6.8 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.4 t -62.67 -7.66 5.23 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.872 -1.142 . . . . 0.0 110.95 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -94.3 -4.87 47.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.867 2.067 . . . . 0.0 110.257 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -110.84 158.81 18.28 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.6 mm -125.34 138.41 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.92 103.48 11.71 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 102.923 -2.992 . . . . 0.0 102.923 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -137.69 132.37 32.78 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.1 mtt 57.97 25.35 12.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.995 0.918 . . . . 0.0 111.077 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.42 -0.6 68.58 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.429 -0.795 . . . . 0.0 112.412 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -93.69 166.26 12.3 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.552 1.541 . . . . 0.0 108.006 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.7 mm -123.18 137.18 57.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -131.08 156.77 44.64 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.814 1.246 . . . . 0.0 108.454 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.2 t -140.37 155.67 46.68 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 107.986 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.7 mt -114.37 117.8 56.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.284 1.433 . . . . 0.0 110.795 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.6 t -86.63 -111.01 0.05 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -162.46 101.26 1.06 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 103.563 -2.755 . . . . 0.0 103.563 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 49.2 m -134.88 111.82 10.18 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.1 m -70.93 120.54 16.65 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.37 122.41 45.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.5 m -82.2 154.44 25.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.81 -26.9 67.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.54 1.136 . . . . 0.0 112.036 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.72 -19.07 62.78 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.415 -0.803 . . . . 0.0 110.471 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -106.19 -16.22 14.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.46 1.904 . . . . 0.0 110.086 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.8 tp -80.19 118.42 21.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 128.105 2.562 . . . . 0.0 107.103 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.45 -103.78 0.11 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 123.687 0.661 . . . . 0.0 111.486 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.68 170.01 16.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.559 1.144 . . . . 0.0 110.069 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -61.89 142.92 57.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.572 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -125.64 -48.95 1.65 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.559 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.77 160.74 43.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.093 1.315 . . . . 0.0 110.714 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.83 135.19 60.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.835 1.254 . . . . 0.0 111.561 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.8 164.87 12.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.805 2.042 . . . . 0.0 111.522 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.15 54.89 0.06 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.953 0.901 . . . . 0.0 112.124 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.44 172.33 15.13 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.338 -1.476 . . . . 0.0 107.517 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.38 147.53 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -145.18 166.24 26.02 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 120.576 -1.327 . . . . 0.0 108.521 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.1 t -129.24 133.31 65.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -147.97 160.59 42.66 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.48 0.582 . . . . 0.0 111.71 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.34 106.29 7.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.5 t -61.07 -20.25 62.37 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.23 -33.33 19.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 120.823 -1.173 . . . . 0.0 113.978 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.0 t -122.03 -25.45 4.94 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.061 0.945 . . . . 0.0 112.241 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.83 -0.14 56.42 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.064 1.792 . . . . 0.0 112.073 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -52.98 112.23 0.81 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.147 1.474 . . . . 0.0 110.421 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.4 m -70.99 157.67 37.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 119.294 0.952 . . . . 0.0 111.627 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.0 129.28 25.48 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.901 2.08 . . . . 0.0 106.375 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.44 157.73 48.93 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.322 2.681 . . . . 0.0 109.196 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -52.31 -32.27 37.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.892 0.877 . . . . 0.0 112.673 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.4 m -64.74 -12.97 52.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.09 -6.82 15.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.842 2.057 . . . . 0.0 111.747 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -56.27 -40.24 73.91 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -106.28 -7.24 35.35 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.219 1.39 . . . . 0.0 112.809 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.76 79.05 1.77 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.219 1.808 . . . . 0.0 112.559 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 43.6 mt -67.16 -42.32 87.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -51.62 106.21 0.13 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.661 1.985 . . . . 0.0 110.436 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -129.14 -21.41 3.27 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 112.838 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -141.21 21.7 2.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.8 0.84 . . . . 0.0 111.109 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 61.23 -4.02 0.41 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 127.608 2.528 . . . . 0.0 115.712 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.8 t -74.71 -80.15 0.08 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.991 1.316 . . . . 0.0 110.442 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 56.24 10.68 0.66 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.034 1.334 . . . . 0.0 112.639 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.2 t -33.72 -59.21 0.41 Allowed 'General case' 0 C--N 1.341 0.211 0 C-N-CA 128.585 2.754 . . . . 0.0 114.759 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -147.57 134.12 19.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -161.68 155.57 21.86 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.246 0.619 . . . . 0.0 109.743 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.3 t -142.1 85.37 1.92 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.845 0.858 . . . . 0.0 108.705 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -80.98 177.93 8.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.1 m -154.12 150.81 28.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -127.63 104.76 8.04 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -114.15 117.03 30.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.816 1.246 . . . . 0.0 110.557 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.27 129.38 34.58 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.975 2.11 . . . . 0.0 108.833 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -76.34 100.83 5.27 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.244 0.617 . . . . 0.0 109.776 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.43 158.87 23.04 Favored Glycine 0 CA--C 1.531 1.054 1 C-N-CA 133.483 5.325 . . . . 0.0 107.228 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.85 154.18 42.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 123.87 1.795 . . . . 0.0 111.603 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 58.2 mt -100.83 139.11 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.013 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -131.9 149.54 52.41 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.458 1.503 . . . . 0.0 109.585 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.2 t -78.65 173.65 12.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.241 1.016 . . . . 0.0 109.611 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 75.7 mt -131.49 143.9 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.674 1.189 . . . . 0.0 110.626 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -65.63 131.27 45.94 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.651 1.18 . . . . 0.0 108.877 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 62.92 22.38 64.52 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.152 -1.36 . . . . 0.0 115.22 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -140.23 148.08 40.98 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.122 1.461 . . . . 0.0 107.819 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.1 m -105.87 146.62 29.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.01 -31.31 60.94 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.078 1.351 . . . . 0.0 110.544 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.4 p -70.54 -12.65 61.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.607 1.963 . . . . 0.0 114.729 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -125.06 -39.37 2.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.863 1.665 . . . . 0.0 112.205 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.33 139.74 5.92 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.159 0.983 . . . . 0.0 110.797 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -150.19 174.31 12.94 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.958 0.903 . . . . 0.0 109.534 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.56 138.67 47.8 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.133 0.573 . . . . 0.0 111.864 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.6 p -132.65 131.07 59.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.895 1.278 . . . . 0.0 110.747 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.79 106.23 7.26 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 39.7 mm -122.06 129.81 75.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.653 1.181 . . . . 0.0 110.759 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 53.94 37.75 27.34 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.382 -0.824 . . . . 0.0 112.123 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 74.77 5.51 4.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.246 1.818 . . . . 0.0 111.311 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -130.8 134.9 47.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.74 1.155 . . . . 0.0 112.351 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -70.86 130.24 41.14 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 121.056 -1.027 . . . . 0.0 110.447 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -125.66 148.49 48.99 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.997 1.319 . . . . 0.0 109.617 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.437 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -84.06 126.69 33.31 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.106 1.362 . . . . 0.0 112.065 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -109.78 143.25 39.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 1.1 p -125.67 148.23 49.08 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.47 1.508 . . . . 0.0 111.616 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -55.56 139.98 42.31 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.09 150.94 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -120.75 19.6 8.93 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.233 1.397 . . . . 0.0 113.243 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 47.1 t30 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 127.827 2.451 . . . . 0.0 105.187 179.789 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.8 t0 . . . . . 0 CA--C 1.518 -0.267 0 CA-C-O 120.632 0.253 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.64 141.26 39.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.084 2.554 . . . . 0.0 104.96 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -77.78 121.45 24.07 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 124.822 1.249 . . . . 0.0 108.136 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.2 t -125.86 128.44 72.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 125.58 1.552 . . . . 0.0 109.095 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -72.87 140.03 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -61.63 129.94 43.5 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.247 -0.908 . . . . 0.0 111.098 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -67.33 -11.49 57.75 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.337 -0.852 . . . . 0.0 111.687 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -106.23 -14.54 15.1 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.789 1.236 . . . . 0.0 112.962 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.82 115.21 5.12 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.97 0.805 . . . . 0.0 109.496 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.435 ' HB2' ' CD1' ' A' ' 163' ' ' PHE . 73.6 m -63.81 -17.57 63.24 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.95 -1.093 . . . . 0.0 111.784 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -94.56 -1.7 52.87 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.97 1.708 . . . . 0.0 112.012 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -105.97 156.34 18.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.431 1.014 . . . . 0.0 111.628 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.2 mm -128.03 136.39 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -116.07 107.32 14.78 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.497 2.319 . . . . 0.0 105.657 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -145.07 133.97 22.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.9 mtt 58.22 33.22 22.95 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.396 1.478 . . . . 0.0 111.061 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.1 22.62 70.82 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -116.78 163.84 15.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 28.6 mm -121.6 128.96 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.972 0.909 . . . . 0.0 109.294 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -125.46 157.8 36.02 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.9 t -141.96 157.98 44.31 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.828 1.251 . . . . 0.0 108.861 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.3 mt -110.54 130.49 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.23 1.012 . . . . 0.0 109.698 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -106.76 -116.51 0.26 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 102.591 -3.115 . . . . 0.0 102.591 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -157.41 100.06 1.79 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 93.6 m -136.39 109.35 7.65 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.118 1.767 . . . . 0.0 107.004 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.7 m -68.97 125.68 27.41 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.8 t -93.78 113.0 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 120.63 1.559 . . . . 0.0 108.496 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 m -68.56 155.13 40.56 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.704 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.54 -25.41 68.03 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.644 1.178 . . . . 0.0 110.981 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.32 -25.78 63.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.845 0.858 . . . . 0.0 109.848 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -94.57 -33.85 12.87 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.569 1.148 . . . . 0.0 110.151 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.19 121.18 7.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.766 1.626 . . . . 0.0 108.37 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -88.47 -110.52 1.1 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.1 170.15 16.34 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.666 1.186 . . . . 0.0 112.153 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -55.94 128.64 36.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.528 1.531 . . . . 0.0 111.333 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -118.39 -38.39 3.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.661 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.22 161.74 14.63 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 121.256 1.844 . . . . 0.0 111.377 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.03 139.83 47.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 120.066 1.303 . . . . 0.0 110.837 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.43 164.71 12.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.646 1.978 . . . . 0.0 109.145 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -162.11 33.17 0.12 Allowed 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.42 174.02 11.07 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 120.309 -1.494 . . . . 0.0 109.031 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.7 t -139.98 147.85 23.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -144.5 162.46 36.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 87.6 t -127.52 136.46 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 128' ' ' SER . 49.8 p90 -146.63 166.54 26.24 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.29 0.636 . . . . 0.0 111.316 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.85 101.3 13.39 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.1 t -47.75 -22.54 0.55 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 130.179 3.392 . . . . 0.0 116.863 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -57.86 -51.61 68.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 125.65 1.58 . . . . 0.0 109.947 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . 0.257 24.6 m -121.58 -27.54 4.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.471 1.508 . . . . 0.0 112.843 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 111.94 6.98 24.04 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.125 1.345 . . . . 0.0 114.248 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.436 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -53.5 113.0 1.01 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.582 2.191 . . . . 0.0 111.704 -178.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.4 m -69.0 152.74 44.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 119.428 1.013 . . . . 0.0 108.971 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.79 140.92 28.28 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.854 1.662 . . . . 0.0 108.792 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.5 160.36 38.57 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.127 2.551 . . . . 0.0 109.686 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -60.93 -30.36 70.17 Favored 'General case' 0 CA--C 1.519 -0.24 0 O-C-N 121.438 -0.789 . . . . 0.0 110.869 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 p -64.53 -7.06 8.83 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.892 -1.052 . . . . 0.0 113.407 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.87 -8.64 13.7 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.344 1.429 . . . . 0.0 111.08 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -61.92 -2.61 0.92 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -166.63 16.17 0.08 OUTLIER Glycine 0 CA--C 1.521 0.453 0 C-N-CA 126.137 1.827 . . . . 0.0 110.982 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -124.46 87.42 2.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.29 -77.07 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.548 ' HB3' ' H ' ' A' ' 184' ' ' SER . 3.5 t70 -168.25 157.66 9.44 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.409 1.884 . . . . 0.0 106.802 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 31.8 tttm -46.58 -59.85 2.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.285 1.834 . . . . 0.0 111.304 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -78.07 -39.12 42.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.829 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.13 76.33 0.62 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.548 ' H ' ' HB3' ' A' ' 180' ' ' ASP . 23.8 p -68.11 4.76 1.12 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.859 2.064 . . . . 0.0 112.447 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -50.22 -25.7 3.91 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.806 1.642 . . . . 0.0 113.378 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.4 m -60.06 -9.81 3.58 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.271 1.828 . . . . 0.0 112.281 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -137.85 54.6 1.8 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.614 1.566 . . . . 0.0 109.781 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -133.14 166.89 21.4 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.256 1.822 . . . . 0.0 108.56 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.95 49.08 0.45 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.656 -1.277 . . . . 0.0 111.029 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 -83.52 166.08 18.57 Favored 'General case' 0 N--CA 1.46 0.071 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 95.6 m -144.99 138.12 26.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 126.922 2.089 . . . . 0.0 107.302 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -112.76 110.17 20.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.797 1.639 . . . . 0.0 108.19 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -111.73 118.77 36.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.6 1.16 . . . . 0.0 111.067 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.56 127.08 36.14 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -76.47 101.02 5.43 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.382 1.473 . . . . 0.0 111.421 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.1 159.71 23.67 Favored Glycine 0 N--CA 1.435 -1.378 1 C-N-CA 132.646 4.927 . . . . 0.0 107.546 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.89 154.6 41.22 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 122.972 1.368 . . . . 0.0 112.767 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 54.8 mt -102.74 121.62 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 125.628 1.571 . . . . 0.0 111.874 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -111.31 154.25 24.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.294 1.045 . . . . 0.0 110.309 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.9 t -73.77 172.86 10.73 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.925 1.29 . . . . 0.0 108.163 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 77.7 mt -135.19 132.78 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -59.17 119.85 8.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.209 1.404 . . . . 0.0 108.229 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.13 12.44 84.03 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.261 -1.3 . . . . 0.0 115.308 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -134.56 133.43 40.25 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.863 1.831 . . . . 0.0 109.881 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.8 m -83.59 146.89 28.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -25.21 61.51 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.574 1.15 . . . . 0.0 111.101 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.5 p -75.64 -14.4 60.36 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.825 2.05 . . . . 0.0 113.642 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -119.74 -43.0 2.59 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.986 0.914 . . . . 0.0 111.367 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.62 139.88 8.02 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 118.799 0.727 . . . . 0.0 109.143 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -152.33 176.64 11.41 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.507 1.123 . . . . 0.0 109.515 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.56 131.82 54.71 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.614 1.166 . . . . 0.0 111.845 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.1 129.74 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 C-N-CA 123.958 0.903 . . . . 0.0 109.432 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -74.33 104.76 5.21 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 36.5 mm -121.64 127.2 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 O-C-N 120.49 -1.381 . . . . 0.0 107.511 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 53.28 43.62 31.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.206 0.457 . . . . 0.0 110.304 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.6 t0 61.11 19.13 9.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.362 0.665 . . . . 0.0 112.167 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.09 122.53 24.24 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.753 -1.217 . . . . 0.0 109.188 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.42 115.96 12.3 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.981 -1.074 . . . . 0.0 112.77 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -106.15 152.38 23.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.102 0.961 . . . . 0.0 111.99 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.8 tm? -88.37 119.44 28.8 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.191 1.396 . . . . 0.0 107.939 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.6 148.58 27.16 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.8 p -127.42 151.16 49.17 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.778 0.674 . . . . 0.0 112.26 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -57.58 141.44 48.0 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.5 p -134.79 146.2 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 50.1 44.38 42.29 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.356 1.455 . . . . 0.0 110.502 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.455 HD21 ' C ' ' A' ' 226' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--O 1.246 0.87 0 CA-C-O 116.794 -1.575 . . . . 0.0 111.227 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.512 -0.518 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.86 139.72 24.01 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -69.76 136.69 51.22 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.106 0.963 . . . . 0.0 108.602 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.6 t -134.98 124.59 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 mp -76.44 134.22 29.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.54 134.95 51.1 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.832 1.301 . . . . 0.0 110.544 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -18.56 64.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.486 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -104.09 -36.5 7.69 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.23 0.468 . . . . 0.0 111.354 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.84 105.14 11.64 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 122.202 1.001 . . . . 0.0 109.985 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.7 t -61.73 -11.48 12.27 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.112 1.365 . . . . 0.0 111.825 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -100.02 -8.98 23.19 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.787 1.635 . . . . 0.0 111.873 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -102.16 154.73 18.74 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 119.418 1.008 . . . . 0.0 111.276 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.5 mm -126.58 127.46 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.11 105.31 15.44 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -141.37 136.04 31.05 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.773 -1.204 . . . . 0.0 107.813 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.2 mtt 54.44 21.21 3.14 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.59 0.29 89.27 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.561 1.077 . . . . 0.0 112.336 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -90.13 172.58 8.71 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.282 1.433 . . . . 0.0 108.021 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.8 mm -133.66 124.76 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -119.17 154.21 33.69 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.1 t -138.36 159.45 42.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.2 mt -115.7 134.75 57.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.798 0.808 . . . . 0.0 111.234 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.3 t -104.76 -130.56 0.28 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 101.713 -3.44 . . . . 0.0 101.713 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -154.35 98.81 2.15 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 121.918 2.144 . . . . 0.0 106.672 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.6 m -135.76 121.09 19.14 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 128.244 2.618 . . . . 0.0 106.521 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.7 m -72.07 123.34 22.62 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 76.1 t -93.88 111.84 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.6 m -77.17 159.77 29.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.438 0.637 . . . . 0.0 109.694 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -64.6 -17.76 64.28 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 111.669 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -77.0 -11.71 59.84 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.755 0.822 . . . . 0.0 109.473 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -115.21 -28.4 6.94 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.381 1.072 . . . . 0.0 109.38 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.95 132.67 50.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.126 2.17 . . . . 0.0 107.148 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -101.39 -98.31 2.34 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.309 0.957 . . . . 0.0 114.289 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -134.68 159.43 41.28 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.272 1.429 . . . . 0.0 111.906 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.0 133.27 55.37 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.832 1.653 . . . . 0.0 109.658 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.79 -43.22 2.9 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 116.538 -1.696 . . . . 0.0 111.69 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -165.5 158.25 15.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 121.144 1.793 . . . . 0.0 110.462 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.22 137.37 44.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.17 163.35 13.69 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.951 1.7 . . . . 0.0 110.752 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.0 38.98 0.15 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.441 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 1.9 tt0 -139.78 175.34 9.66 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 120.023 -1.673 . . . . 0.0 110.759 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.2 t -144.88 150.51 16.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -147.09 164.0 34.48 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.848 0.832 . . . . 0.0 109.018 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.0 t -128.78 129.1 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 126.38 1.872 . . . . 0.0 107.412 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -147.89 160.93 42.26 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.07 0.948 . . . . 0.0 112.684 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.51 100.09 12.8 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 102.255 -3.239 . . . . 0.0 102.255 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 12.7 t -47.61 -25.88 1.3 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.154 2.581 . . . . 0.0 116.451 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.3 m -57.68 -45.98 86.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.04 1.736 . . . . 0.0 111.11 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.2 m -122.73 -21.76 5.53 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.024 1.33 . . . . 0.0 113.09 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.78 10.83 48.76 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.652 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.04 112.49 2.99 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.134 1.467 . . . . 0.0 110.669 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 44.2 m -72.38 152.03 42.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.647 0.658 . . . . 0.0 109.488 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.59 147.51 36.9 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.79 159.78 31.21 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.18 2.587 . . . . 0.0 109.902 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 ttt-85 -57.39 -32.34 66.73 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 45.0 m -65.19 -8.28 16.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.241 -1.362 . . . . 0.0 113.308 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.99 -9.14 16.32 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.354 1.434 . . . . 0.0 111.672 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -62.96 6.04 0.11 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.121 2.168 . . . . 0.0 115.143 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -159.11 20.5 0.28 Allowed Glycine 0 CA--C 1.524 0.629 0 O-C-N 120.444 -1.41 . . . . 0.0 111.132 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -98.29 40.54 1.18 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.785 1.292 . . . . 0.0 113.177 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 49.7 mm -64.01 -50.38 77.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -137.28 80.27 1.8 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.047 1.739 . . . . 0.0 112.047 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -140.84 -44.99 0.39 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.6 29.33 1.03 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.027 0.931 . . . . 0.0 110.05 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 170.92 -172.86 44.52 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 120.715 -1.24 . . . . 0.0 111.461 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 86.4 p -114.23 162.32 16.7 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.297 1.039 . . . . 0.0 110.984 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -139.74 81.22 1.81 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.1 m -115.05 -5.36 12.48 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 13.67 0.85 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -106.76 173.97 6.09 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.801 1.641 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.8 t -163.11 147.4 11.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.405 HH11 ' HG2' ' A' ' 190' ' ' ARG . 8.2 mtt-85 -137.21 157.44 46.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.097 0.559 . . . . 0.0 110.611 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.6 m -130.27 117.4 19.76 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.83 105.89 18.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.599 1.959 . . . . 0.0 106.527 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.9 m0 -110.97 116.26 30.89 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 118.496 0.589 . . . . 0.0 110.45 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -81.94 131.77 35.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.441 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.8 m-30 -78.55 107.51 11.26 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.958 1.703 . . . . 0.0 106.807 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -107.85 159.41 14.43 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 129.532 3.444 . . . . 0.0 112.64 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -66.89 140.88 57.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 124.652 2.168 . . . . 0.0 111.692 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.0 mt -93.13 140.84 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.673 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -136.25 151.3 49.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 123.194 1.474 . . . . 0.0 109.293 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.1 t -75.39 172.92 11.64 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.997 1.719 . . . . 0.0 107.523 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.3 mt -126.93 137.26 58.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -62.96 131.15 47.72 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.13 22.95 72.89 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.842 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -139.3 155.11 47.95 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.778 1.789 . . . . 0.0 108.094 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 57.8 m -106.08 140.41 39.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.04 -24.65 55.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.144 0.977 . . . . 0.0 109.123 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.4 p -69.71 -14.63 62.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.263 1.825 . . . . 0.0 112.898 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -120.34 -41.34 2.62 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.248 1.019 . . . . 0.0 110.619 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.34 150.72 9.29 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.922 0.889 . . . . 0.0 110.657 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -158.38 176.14 12.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.247 1.019 . . . . 0.0 109.752 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.39 136.66 48.46 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 110.844 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.71 128.15 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 124.061 0.945 . . . . 0.0 109.624 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.65 107.36 3.88 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.3 mm -121.85 126.67 74.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 54.78 43.32 30.25 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.25 -4.83 1.2 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.05 1.74 . . . . 0.0 113.006 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -117.04 122.7 44.94 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.623 -1.298 . . . . 0.0 111.632 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -63.04 115.63 4.61 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.37 -1.456 . . . . 0.0 113.537 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -103.97 150.16 24.48 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 126.435 1.894 . . . . 0.0 111.442 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -88.79 122.19 31.93 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.607 1.163 . . . . 0.0 108.593 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -106.66 150.22 26.44 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 1.5 p -129.49 152.11 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.51 1.124 . . . . 0.0 110.307 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -69.67 124.05 22.95 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.65 107.75 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 123.999 0.92 . . . . 0.0 108.67 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -101.06 12.77 58.96 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.165 1.364 . . . . 0.0 112.508 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 124.895 1.278 . . . . 0.0 107.84 179.563 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.75 130.76 24.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 103.971 -2.604 . . . . 0.0 103.971 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -69.21 145.1 53.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.647 0.779 . . . . 0.0 110.225 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.0 t -137.95 128.25 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 mp -82.01 129.45 37.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.57 122.22 11.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.769 1.271 . . . . 0.0 109.592 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -59.03 -24.23 62.66 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.212 -0.93 . . . . 0.0 111.843 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -90.68 -31.59 16.54 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.901 1.28 . . . . 0.0 112.196 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.84 100.21 4.69 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.7 p -65.3 -11.34 40.63 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.407 -0.808 . . . . 0.0 111.511 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -90.01 -3.83 57.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.002 2.121 . . . . 0.0 110.209 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -113.57 158.52 20.68 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.356 0.98 . . . . 0.0 109.001 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.5 mm -129.09 139.59 51.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -118.48 108.36 14.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -142.82 140.45 31.31 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.0 mtt 56.87 22.45 7.09 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.656 0.782 . . . . 0.0 112.834 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.22 18.55 78.18 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -123.78 159.65 29.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.311 1.056 . . . . 0.0 108.218 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.1 mm -110.35 140.44 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -131.79 144.37 50.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 t -124.55 148.71 47.63 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 126.804 2.042 . . . . 0.0 107.351 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.6 mt -113.31 123.56 69.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 124.627 1.171 . . . . 0.0 110.026 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -93.36 -143.61 0.23 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -142.16 98.81 3.39 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 102.685 -3.079 . . . . 0.0 102.685 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.9 m -136.54 109.87 7.87 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 111.642 -2.526 . . . . 0.0 106.241 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 m -69.88 131.91 45.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 120.756 1.617 . . . . 0.0 106.752 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.3 t -94.69 114.18 30.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.776 1.63 . . . . 0.0 106.664 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.9 m -71.02 159.34 34.92 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.907 0.384 . . . . 0.0 110.786 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.72 -26.51 67.23 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.238 1.415 . . . . 0.0 111.294 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.1 -13.66 60.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.522 0.729 . . . . 0.0 111.36 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -105.71 -26.74 11.68 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.315 1.446 . . . . 0.0 108.883 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.7 mt -62.01 142.3 57.57 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.42 -103.42 2.46 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -134.99 166.84 22.11 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.086 1.354 . . . . 0.0 109.443 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -58.79 144.38 44.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.609 0.764 . . . . 0.0 109.942 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.23 -49.36 1.94 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 117.265 -1.35 . . . . 0.0 111.217 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.64 157.83 22.43 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 120.745 1.612 . . . . 0.0 110.828 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.4 p -105.59 138.64 29.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.547 1.165 . . . . 0.0 110.408 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.0 mp -113.41 163.16 15.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.536 2.734 . . . . 0.0 108.407 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -172.25 68.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.861 0.864 . . . . 0.0 109.957 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -160.67 175.83 12.21 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.837 -1.165 . . . . 0.0 109.036 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.3 t -144.76 149.28 17.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.71 154.96 40.35 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.5 t -123.63 130.51 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 124.498 1.119 . . . . 0.0 108.077 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -147.86 160.54 42.66 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.609 1.164 . . . . 0.0 111.579 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -85.49 100.98 12.26 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.6 t -56.26 -11.73 1.31 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.109 1.364 . . . . 0.0 114.613 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.3 m -65.74 -40.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.137 -0.977 . . . . 0.0 110.033 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.0 t -124.26 -28.35 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.723 1.209 . . . . 0.0 113.195 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.54 5.78 36.3 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.738 1.637 . . . . 0.0 111.166 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -57.31 112.32 1.36 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.053 1.741 . . . . 0.0 111.026 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.6 p -64.37 154.25 36.03 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.906 1.683 . . . . 0.0 110.749 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.45 152.14 60.75 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.365 1.066 . . . . 0.0 108.365 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.64 162.56 16.6 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.93 3.086 . . . . 0.0 108.513 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -58.75 -28.89 66.32 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.903 -1.123 . . . . 0.0 111.69 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 95.9 p -68.93 -8.8 47.77 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 177' ' ' GLY . 1.3 mm-40 -104.22 -4.76 22.64 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 120.414 -1.429 . . . . 0.0 109.069 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -72.34 16.2 0.14 Allowed 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.872 -1.142 . . . . 0.0 111.831 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 175' ' ' GLU . . . 121.26 36.43 0.75 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.423 1.487 . . . . 0.0 112.311 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -130.76 38.09 3.74 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.14 1.47 . . . . 0.0 108.192 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 52.8 mt -72.2 -69.29 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.11 52.97 11.79 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.764 1.745 . . . . 0.0 109.832 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -153.05 148.34 26.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.81 3.644 . . . . 0.0 103.665 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.13 28.12 5.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.221 0.608 . . . . 0.0 109.931 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.1 -60.6 5.1 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.143 0.877 . . . . 0.0 112.685 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.1 m -169.24 104.97 0.38 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.442 1.097 . . . . 0.0 109.818 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -118.37 21.25 12.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.09 1.356 . . . . 0.0 110.767 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.6 p -63.52 160.61 16.14 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 129.319 3.047 . . . . 0.0 113.786 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.9 mtmm 45.65 24.24 0.19 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.601 1.96 . . . . 0.0 114.368 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -86.41 130.56 34.46 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.2 t -145.41 87.96 1.83 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 10.6 mtt85 -90.99 161.45 15.14 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.7 m -142.14 123.86 15.1 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -100.92 109.1 21.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -110.4 116.21 31.03 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.17 117.51 21.78 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 128.471 2.708 . . . . 0.0 107.463 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -68.78 106.95 2.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.567 1.147 . . . . 0.0 107.986 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -107.56 159.27 14.58 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 129.677 3.513 . . . . 0.0 110.945 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.52 149.65 50.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 124.927 2.299 . . . . 0.0 112.109 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 40.9 mt -98.18 140.94 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 111.752 -2.476 . . . . 0.0 110.713 -176.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -134.04 151.78 51.56 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.986 1.714 . . . . 0.0 109.873 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.3 p -77.63 173.39 12.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 58.8 mt -125.41 141.29 45.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -64.14 132.04 49.27 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.919 1.288 . . . . 0.0 108.076 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.6 18.93 70.55 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 118.554 -1.137 . . . . 0.0 114.69 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -135.87 157.86 45.81 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 120.025 1.912 . . . . 0.0 109.172 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 73.8 m -106.38 140.98 38.45 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.94 -26.54 48.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 77.1 p -68.24 -12.99 61.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.643 2.377 . . . . 0.0 113.866 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -119.99 -42.72 2.58 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 118.833 -0.603 . . . . 0.0 109.532 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.02 155.43 18.57 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.335 0.588 . . . . 0.0 110.765 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -157.54 175.63 13.69 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.577 0.751 . . . . 0.0 109.972 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.75 134.26 53.43 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.887 1.275 . . . . 0.0 110.861 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.04 132.71 56.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.256 1.022 . . . . 0.0 108.345 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -70.18 102.82 2.18 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.482 ' HB ' ' HE2' ' A' ' 219' ' ' LYS . 39.3 mm -121.42 123.16 69.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 O-C-N 121.075 -1.016 . . . . 0.0 108.282 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 53.44 48.39 21.96 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.98 0.912 . . . . 0.0 109.074 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 62.19 9.0 2.93 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.59 1.156 . . . . 0.0 114.081 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -131.19 122.56 26.78 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.189 0.904 . . . . 0.0 109.028 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -61.94 118.71 7.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.286 0.634 . . . . 0.0 109.931 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.482 ' HE2' ' HB ' ' A' ' 214' ' ' ILE . 16.7 mtmm -114.23 149.06 36.39 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.4 1.095 . . . . 0.0 110.088 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -81.29 123.76 28.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.306 1.842 . . . . 0.0 111.871 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -110.3 145.28 37.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.62 145.37 51.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.68 1.192 . . . . 0.0 110.92 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -64.15 120.81 12.8 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.8 t -136.46 140.54 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -127.3 30.58 4.04 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.404 1.478 . . . . 0.0 112.086 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 C--O 1.247 0.96 0 C-N-CA 126.537 1.935 . . . . 0.0 106.127 179.517 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.36 144.41 42.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.479 2.711 . . . . 0.0 105.613 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -57.86 138.42 55.72 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.9 2.48 . . . . 0.0 112.818 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.4 t -140.54 142.17 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.5 1.92 . . . . 0.0 106.941 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -90.27 139.63 17.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -68.35 131.46 45.36 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 122.669 1.223 . . . . 0.0 112.495 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -70.19 -16.95 63.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.125 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -93.17 -31.13 14.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.959 1.254 . . . . 0.0 112.517 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.23 110.69 6.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 t -64.85 -14.75 60.47 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.444 1.475 . . . . 0.0 111.311 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -82.26 -5.26 58.41 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.216 1.006 . . . . 0.0 110.689 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -107.37 158.43 17.17 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 118.264 0.484 . . . . 0.0 111.941 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.5 mm -130.18 131.31 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.692 1.197 . . . . 0.0 107.78 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -103.52 97.45 7.49 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -131.37 126.4 35.12 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.839 -1.163 . . . . 0.0 109.339 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.1 mtt 57.16 33.54 23.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.047 1.739 . . . . 0.0 110.554 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.45 0.59 54.5 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.297 -0.877 . . . . 0.0 111.336 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -92.74 161.01 14.71 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -121.15 134.08 65.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -129.84 159.71 35.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.9 t -138.41 156.65 47.38 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.469 1.108 . . . . 0.0 108.045 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.4 mt -112.47 129.92 67.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.842 0.857 . . . . 0.0 109.688 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.4 t -100.54 -110.16 0.2 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . 0.257 8.4 p-10 -162.4 99.03 1.04 Allowed 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 126.966 2.107 . . . . 0.0 107.668 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 97.5 m -137.93 108.34 6.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 115.961 -1.971 . . . . 0.0 109.072 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.6 m -67.29 122.68 18.43 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 122.163 2.256 . . . . 0.0 105.75 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.3 t -99.7 110.99 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.822 1.192 . . . . 0.0 108.036 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -79.38 164.66 23.85 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -61.45 -31.21 71.16 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.204 1.002 . . . . 0.0 111.426 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.28 -16.45 63.57 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.739 1.215 . . . . 0.0 111.384 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.93 -29.21 8.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.386 1.075 . . . . 0.0 110.003 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.1 tp -61.14 142.73 56.5 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.86 1.264 . . . . 0.0 109.082 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -96.51 -102.08 2.01 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.48 166.34 23.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.942 1.697 . . . . 0.0 110.644 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.87 146.48 26.32 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.999 0.92 . . . . 0.0 109.968 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -126.0 -52.33 1.54 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.09 -1.433 . . . . 0.0 112.689 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -157.25 154.66 29.49 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.745 1.612 . . . . 0.0 110.283 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.8 p -111.69 137.12 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 119.129 0.877 . . . . 0.0 110.013 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -112.02 165.03 12.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.535 2.334 . . . . 0.0 109.66 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -169.57 66.29 0.05 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.713 1.205 . . . . 0.0 109.563 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -156.4 173.47 16.84 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.34 147.83 16.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 O-C-N 121.179 -0.95 . . . . 0.0 108.63 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.23 161.41 38.35 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.865 0.757 . . . . 0.0 109.765 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.23 125.29 63.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 126.476 1.911 . . . . 0.0 108.768 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -142.91 163.95 31.4 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.065 1.346 . . . . 0.0 112.099 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.85 110.38 21.32 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.89 -18.84 36.73 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.69 1.596 . . . . 0.0 115.069 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.15 -40.46 82.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 O-C-N 121.284 -0.885 . . . . 0.0 112.044 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.446 ' HB3' ' HE2' ' A' ' 169' ' ' LYS . 0.4 OUTLIER -123.26 -12.98 7.78 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.684 0.794 . . . . 0.0 112.631 -178.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.18 12.67 75.89 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.302 0.953 . . . . 0.0 111.739 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.446 ' HE2' ' HB3' ' A' ' 167' ' ' SER . 25.1 mtmt -71.89 112.62 8.14 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.969 1.308 . . . . 0.0 110.507 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.2 m -73.33 157.48 36.91 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.1 1.36 . . . . 0.0 109.933 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.44 151.68 51.79 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.221 0.608 . . . . 0.0 110.205 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 160.26 39.03 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.461 2.108 . . . . 0.0 108.778 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -60.0 -22.15 62.2 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.924 -1.11 . . . . 0.0 111.186 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -14.64 44.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.033 1.333 . . . . 0.0 112.345 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -116.62 3.15 13.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.052 0.941 . . . . 0.0 112.032 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -61.98 -2.8 0.99 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -144.67 9.71 1.87 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.955 1.264 . . . . 0.0 110.774 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.05 92.73 3.21 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.022 1.329 . . . . 0.0 112.247 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 25.7 mm -128.4 -51.15 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.628 1.171 . . . . 0.0 109.834 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -75.54 166.16 23.99 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.7 tttp 62.7 -23.4 0.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -72.35 -18.29 61.77 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.993 1.317 . . . . 0.0 112.689 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 128.06 -157.81 21.28 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.8 m -59.94 -10.35 3.99 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.8 m120 21.86 78.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 129.936 3.294 . . . . 0.0 113.808 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 31.6 t -135.19 -38.03 0.78 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.152 0.981 . . . . 0.0 111.113 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.44 -8.52 56.22 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.278 0.945 . . . . 0.0 112.191 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.509 HE21 ' CZ ' ' A' ' 190' ' ' ARG . 0.6 OUTLIER -72.76 154.16 40.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t -165.22 127.02 2.07 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.509 ' CZ ' HE21 ' A' ' 188' ' ' GLN . 50.4 mtt180 -130.12 169.32 15.48 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.67 0.788 . . . . 0.0 109.988 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 93.5 m -144.22 124.29 13.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.803 2.041 . . . . 0.0 106.62 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -101.15 112.19 24.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -110.14 116.74 32.08 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.91 1.284 . . . . 0.0 110.658 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -83.2 125.18 31.28 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.676 2.39 . . . . 0.0 107.91 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -77.11 100.91 5.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -93.95 158.22 23.14 Favored Glycine 0 N--CA 1.438 -1.191 1 C-N-CA 130.806 4.05 . . . . 0.0 107.911 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -69.05 153.96 42.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.711 1.72 . . . . 0.0 111.041 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.9 mt -99.49 143.12 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 113.158 -1.837 . . . . 0.0 108.593 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -133.15 150.24 52.03 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.927 1.691 . . . . 0.0 109.429 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 19.4 m -79.33 171.59 14.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 69.4 mt -125.61 147.69 30.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 O-C-N 121.0 -1.063 . . . . 0.0 108.502 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 50.8 mtt-85 -67.5 125.59 26.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 65.52 26.78 72.02 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.008 -0.885 . . . . 0.0 114.484 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -141.79 140.52 33.04 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.6 m -94.52 145.68 24.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -20.77 59.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.449 1.1 . . . . 0.0 109.851 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 15.3 p -75.62 -10.81 59.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.716 2.407 . . . . 0.0 113.041 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -125.21 -48.65 1.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.906 1.682 . . . . 0.0 111.251 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.71 144.31 19.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.656 0.662 . . . . 0.0 110.666 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -149.97 175.91 11.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.12 0.568 . . . . 0.0 109.567 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.13 134.57 52.63 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.29 1.036 . . . . 0.0 111.702 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.79 130.59 68.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 C-N-CA 124.706 1.202 . . . . 0.0 110.591 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -72.24 107.87 5.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 36.7 mm -121.54 115.04 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.653 1.181 . . . . 0.0 108.94 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 59.46 48.8 9.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.281 1.032 . . . . 0.0 108.477 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.8 t70 64.14 9.48 4.76 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.231 1.013 . . . . 0.0 113.586 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -126.66 122.83 36.08 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.913 -1.117 . . . . 0.0 109.603 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -69.05 121.95 17.72 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.758 -1.214 . . . . 0.0 111.905 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -117.31 144.04 45.29 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.67 1.588 . . . . 0.0 112.883 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.4 tm? -78.52 132.48 37.23 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.665 0.786 . . . . 0.0 110.357 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -118.69 143.44 46.85 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.3 p -121.55 146.7 46.69 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.887 0.875 . . . . 0.0 111.585 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -61.91 138.36 58.35 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 83.5 t -132.13 122.45 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.205 1.402 . . . . 0.0 107.612 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 176.47 47.34 0.06 OUTLIER Glycine 0 C--O 1.228 -0.237 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 . . . . . 0 C--O 1.249 1.039 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.641 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t0 . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.09 138.04 27.98 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -76.42 115.12 15.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -118.4 129.19 75.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 124.436 1.094 . . . . 0.0 110.067 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 mp -77.99 137.95 21.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -58.51 130.06 44.98 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.495 1.14 . . . . 0.0 110.979 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -12.25 61.25 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.54 -41.75 5.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.385 1.074 . . . . 0.0 108.95 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -116.05 103.91 11.04 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 125.18 1.392 . . . . 0.0 114.1 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.485 ' HB2' ' CD1' ' A' ' 163' ' ' PHE . 67.1 m -68.83 -7.5 34.94 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 119.906 -1.746 . . . . 0.0 111.406 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.33 -9.36 36.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.452 1.901 . . . . 0.0 109.814 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.3 mttt -115.06 160.6 19.43 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 121.116 1.78 . . . . 0.0 113.02 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.2 mm -124.91 144.19 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 C-N-CA 125.267 1.427 . . . . 0.0 107.981 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -116.39 106.17 13.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.86 2.464 . . . . 0.0 104.58 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -135.26 123.56 23.17 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 20.8 mtp 64.8 27.71 12.95 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.387 1.475 . . . . 0.0 109.727 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.75 17.83 73.52 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.721 -1.044 . . . . 0.0 110.917 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -109.19 156.73 19.54 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.1 mm -110.65 134.8 51.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 123.522 0.729 . . . . 0.0 109.801 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -129.83 153.09 48.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.0 t -133.48 158.52 42.9 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.312 1.045 . . . . 0.0 108.529 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.0 mt -117.93 115.99 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.919 1.288 . . . . 0.0 110.369 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -88.78 -125.77 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 102.062 -3.31 . . . . 0.0 102.062 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -152.84 100.41 2.51 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 176.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 55.0 m -134.85 107.2 7.25 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 112.751 -2.022 . . . . 0.0 105.755 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.5 m -65.9 124.04 21.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.6 t -94.71 142.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.1 m -114.77 162.68 16.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.017 1.327 . . . . 0.0 109.442 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.84 -26.72 67.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 111.262 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.42 -21.08 63.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.385 0.674 . . . . 0.0 110.296 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -105.8 -18.9 13.92 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.85 0.86 . . . . 0.0 110.496 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 24.2 mt -67.16 141.6 57.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.513 0.673 . . . . 0.0 109.594 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.48 -101.24 1.84 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -135.5 167.53 20.91 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.936 2.494 . . . . 0.0 109.706 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -63.27 148.16 49.01 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -126.1 -52.58 1.53 Allowed 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 121.254 -0.904 . . . . 0.0 111.744 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -151.59 147.52 26.87 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 119.038 0.835 . . . . 0.0 110.549 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.68 134.41 40.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.4 mp -112.05 159.24 18.67 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.618 2.367 . . . . 0.0 108.78 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -169.56 53.25 0.04 OUTLIER 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.111 0.564 . . . . 0.0 112.225 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -147.38 173.11 12.93 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.785 -1.197 . . . . 0.0 108.985 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.3 t -145.45 145.38 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -141.05 166.1 25.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.6 t -131.08 132.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 128' ' ' SER . 55.1 p90 -144.99 171.62 14.21 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.944 0.878 . . . . 0.0 112.49 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.09 104.67 15.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.819 2.448 . . . . 0.0 105.341 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.0 t -65.07 -11.96 45.29 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.448 1.931 . . . . 0.0 112.721 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.7 m -64.83 -40.48 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 O-C-N 120.513 -1.367 . . . . 0.0 110.683 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.5 t -123.8 -23.6 4.65 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.623 1.169 . . . . 0.0 113.831 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.34 3.24 57.66 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.524 2.012 . . . . 0.0 110.611 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -54.55 113.03 1.14 Allowed 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.634 1.974 . . . . 0.0 109.676 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.2 m -64.33 158.14 24.28 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.382 0.673 . . . . 0.0 110.882 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.27 144.18 48.33 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.545 1.538 . . . . 0.0 107.554 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -81.35 162.43 19.78 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.565 2.843 . . . . 0.0 109.893 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -59.77 -22.32 61.96 Favored 'General case' 0 C--O 1.228 -0.068 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 42.5 m -70.74 -7.86 47.98 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.404 -0.81 . . . . 0.0 111.925 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.88 2.93 12.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.748 1.219 . . . . 0.0 111.732 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -69.17 -9.59 53.61 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -135.57 -24.91 0.53 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.035 1.779 . . . . 0.0 109.825 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.63 102.99 7.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 29.1 mm -66.33 -71.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -167.27 162.94 15.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.614 1.166 . . . . 0.0 109.457 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.5 -14.44 2.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 129.014 2.926 . . . . 0.0 113.045 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.14 -36.19 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.545 1.938 . . . . 0.0 113.419 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -110.33 -175.94 20.75 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 124.46 1.029 . . . . 0.0 114.168 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 89.0 p -85.77 154.01 21.89 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.869 0.867 . . . . 0.0 110.663 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -83.28 -39.35 20.96 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 124.282 1.033 . . . . 0.0 108.609 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 33.5 t -49.09 -54.6 15.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.263 1.825 . . . . 0.0 111.896 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -79.14 8.83 5.19 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -129.51 149.3 51.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 120.094 1.315 . . . . 0.0 110.827 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 79.5 p -160.55 160.41 31.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.983 0.913 . . . . 0.0 108.893 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -137.09 171.2 14.86 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.977 1.711 . . . . 0.0 107.963 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.1 m -136.64 136.59 39.26 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.324 1.85 . . . . 0.0 106.778 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -117.78 106.92 13.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.374 1.47 . . . . 0.0 108.931 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -110.25 116.8 32.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.887 2.075 . . . . 0.0 107.657 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.93 116.56 25.08 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.968 2.507 . . . . 0.0 107.093 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -64.88 102.54 0.61 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.644 1.577 . . . . 0.0 109.151 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.26 158.98 17.3 Favored Glycine 0 N--CA 1.435 -1.411 1 C-N-CA 131.264 4.269 . . . . 0.0 107.845 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -66.13 154.25 40.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.282 1.991 . . . . 0.0 114.057 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.4 mt -101.38 141.47 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 112.589 -2.096 . . . . 0.0 109.069 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.1 153.01 49.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.674 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.8 t -78.21 172.68 13.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.142 1.777 . . . . 0.0 106.556 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 18.3 mt -131.47 149.79 33.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 122.751 1.263 . . . . 0.0 113.128 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -69.03 121.03 15.83 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.217 1.807 . . . . 0.0 109.431 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.14 24.77 76.71 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 117.587 -1.674 . . . . 0.0 113.418 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -149.55 144.52 26.29 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.811 1.805 . . . . 0.0 112.358 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.9 m -92.02 151.37 20.5 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.2 -33.53 65.41 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.294 -0.879 . . . . 0.0 110.046 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.3 p -66.21 -14.71 62.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.691 1.996 . . . . 0.0 114.29 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.67 -37.98 4.11 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.47 1.108 . . . . 0.0 110.055 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.35 145.07 2.63 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.141 0.976 . . . . 0.0 110.895 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -148.58 171.68 15.75 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.24 138.16 46.01 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.869 0.468 . . . . 0.0 110.564 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 4.1 p -133.13 129.84 57.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 123.544 0.737 . . . . 0.0 111.719 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -74.86 105.82 6.09 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.5 122.6 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.403 1.481 . . . . 0.0 108.863 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 54.8 44.16 28.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.083 0.856 . . . . 0.0 108.973 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 62.34 6.91 2.06 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.405 1.482 . . . . 0.0 114.282 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.33 121.96 36.42 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -66.39 128.68 37.1 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.265 1.026 . . . . 0.0 110.493 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -123.61 151.14 43.31 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.433 0.693 . . . . 0.0 110.763 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.8 tm? -83.79 117.87 23.56 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.68 1.192 . . . . 0.0 112.452 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -100.54 151.72 21.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.0 p -135.71 150.35 49.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.84 0.856 . . . . 0.0 110.838 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.94 140.37 57.77 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.842 1.257 . . . . 0.0 107.814 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.436 HG11 ' H ' ' A' ' 226' ' ' ASN . 45.1 t -134.54 132.69 54.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -81.62 -12.78 81.2 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.936 -0.924 . . . . 0.0 114.447 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.436 ' H ' HG11 ' A' ' 224' ' ' VAL . 1.8 p-10 . . . . . 0 C--O 1.254 1.296 0 C-N-CA 125.264 1.426 . . . . 0.0 112.175 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.33 151.97 49.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -77.05 137.63 39.08 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.2 t -138.29 129.97 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 126.162 1.785 . . . . 0.0 108.355 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -73.84 140.12 18.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -65.2 130.42 43.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 123.006 1.384 . . . . 0.0 109.455 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -63.47 -24.03 67.65 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.686 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -89.31 -40.71 12.61 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.435 0.694 . . . . 0.0 110.727 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.71 113.15 16.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.719 1.208 . . . . 0.0 111.374 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.5 m -68.12 -11.14 58.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.604 1.962 . . . . 0.0 111.664 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -96.96 -4.33 40.08 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.978 1.711 . . . . 0.0 111.489 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -110.32 157.99 18.91 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.241 0.928 . . . . 0.0 110.632 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.4 mm -124.42 137.95 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -117.21 106.28 13.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.176 1.79 . . . . 0.0 106.48 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -127.42 125.35 40.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.6 mtt 61.94 17.78 9.27 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.721 1.208 . . . . 0.0 110.899 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.41 0.07 88.38 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.758 -1.023 . . . . 0.0 111.369 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -86.52 168.43 13.71 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.1 mm -124.81 132.71 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.646 1.112 . . . . 0.0 109.851 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -126.63 152.79 46.2 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.885 0.874 . . . . 0.0 108.936 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.7 t -137.35 147.17 45.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.227 1.011 . . . . 0.0 108.422 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.53 125.33 62.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 126.433 1.893 . . . . 0.0 110.712 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -91.89 -104.67 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -166.71 99.52 0.57 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 45.8 m -136.23 115.07 12.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.8 m -76.68 123.8 26.69 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 121.227 1.831 . . . . 0.0 106.431 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.82 142.05 14.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.7 m -114.42 164.68 13.62 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.375 1.07 . . . . 0.0 111.125 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -27.66 66.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.587 1.155 . . . . 0.0 112.44 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.08 -13.26 62.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.698 0.799 . . . . 0.0 110.359 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -119.43 -25.86 5.95 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.761 1.224 . . . . 0.0 110.965 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.1 tp -68.1 129.06 38.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.07 -98.17 0.77 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.13 163.39 30.03 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.272 1.429 . . . . 0.0 110.259 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -63.88 143.91 57.48 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -126.23 -47.52 1.61 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -151.46 158.67 43.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.992 1.269 . . . . 0.0 111.037 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.4 p -115.45 139.33 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.1 0.96 . . . . 0.0 108.591 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.26 164.67 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.998 1.719 . . . . 0.0 110.518 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -165.9 54.13 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -154.05 167.86 28.38 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.024 -1.673 . . . . 0.0 106.999 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.5 t -145.17 148.49 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -146.54 164.37 32.79 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.4 t -130.39 131.58 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -138.72 168.18 20.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.525 0.678 . . . . 0.0 111.479 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -80.51 111.53 17.0 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.7 t -51.51 -18.69 1.17 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 130.319 3.448 . . . . 0.0 115.074 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.9 m -76.9 -52.08 17.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 124.564 1.146 . . . . 0.0 113.46 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . 0.27 18.5 m -121.69 -27.08 4.77 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.186 1.794 . . . . 0.0 113.592 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.75 12.26 13.09 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.38 1.467 . . . . 0.0 113.441 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.466 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -57.1 112.45 1.36 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.597 2.198 . . . . 0.0 110.03 -178.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 43.2 p -63.13 151.89 38.86 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.79 145.37 41.1 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 125.147 1.379 . . . . 0.0 107.735 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.02 159.04 27.19 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.299 2.666 . . . . 0.0 108.868 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -55.62 -37.56 68.33 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 125.665 1.586 . . . . 0.0 111.867 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.9 m -63.51 -13.05 37.14 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 118.701 -1.2 . . . . 0.0 113.75 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.31 -15.3 20.82 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.403 1.481 . . . . 0.0 108.933 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -60.99 -11.64 8.79 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -120.34 -20.2 3.68 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.661 1.601 . . . . 0.0 110.32 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.31 71.62 1.47 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.249 1.819 . . . . 0.0 107.794 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.0 mt -50.24 -43.75 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.643 1.177 . . . . 0.0 109.018 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.5 t0 28.4 44.25 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 131.255 3.822 . . . . 0.0 117.35 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -63.03 -59.96 4.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 121.473 -0.767 . . . . 0.0 112.002 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -116.15 3.95 13.56 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.412 1.485 . . . . 0.0 111.7 -178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 93.48 -13.92 66.45 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 120.839 -1.163 . . . . 0.0 111.904 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 74.3 p -144.07 160.54 40.72 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.177 1.391 . . . . 0.0 108.959 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.36 33.29 0.56 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.375 1.083 . . . . 0.0 111.992 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.6 t -69.61 109.98 4.59 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.431 1.493 . . . . 0.0 111.32 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.1 tttm 45.39 31.38 0.85 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.393 2.277 . . . . 0.0 114.721 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -139.31 139.17 37.24 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 t -157.92 159.61 36.73 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.81 177.8 4.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.6 m -128.59 124.78 36.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -106.25 109.51 21.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -115.51 116.14 27.68 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.13 136.57 32.95 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . 0.253 4.8 m-30 -82.02 101.42 10.31 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.217 1.008 . . . . 0.0 110.967 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -93.38 158.55 23.71 Favored Glycine 0 CA--C 1.532 1.111 1 C-N-CA 135.355 6.217 . . . . 0.0 107.162 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -68.23 156.84 36.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 123.3 1.524 . . . . 0.0 112.757 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 74.3 mt -103.49 139.64 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 126.541 1.936 . . . . 0.0 110.241 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -134.27 153.5 51.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.543 1.537 . . . . 0.0 110.21 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.4 p -76.98 173.02 12.26 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.712 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 43.9 mt -127.22 133.57 67.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 122.198 0.999 . . . . 0.0 108.877 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -62.8 127.87 33.29 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.151 1.78 . . . . 0.0 108.647 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.19 13.23 76.53 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.157 -1.357 . . . . 0.0 114.625 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -137.01 139.2 41.24 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 120.329 2.065 . . . . 0.0 110.725 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.9 m -84.44 144.65 28.62 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -23.13 65.55 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 120.56 -1.337 . . . . 0.0 109.531 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 31.6 p -76.71 -6.85 53.86 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.262 2.225 . . . . 0.0 113.814 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -121.38 -45.99 2.3 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.248 1.019 . . . . 0.0 109.362 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.49 143.21 13.15 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.377 0.535 . . . . 0.0 111.004 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -149.12 175.81 11.02 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.301 -0.25 . . . . 0.0 110.628 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.17 134.4 51.78 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.67 1.188 . . . . 0.0 113.021 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.58 127.85 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 125.326 1.451 . . . . 0.0 111.602 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -74.2 110.01 8.15 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 37.0 mm -121.53 117.92 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 56.06 39.88 30.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.14 0.576 . . . . 0.0 110.125 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.4 t70 76.32 -8.39 1.65 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.424 1.889 . . . . 0.0 112.02 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -104.97 122.23 45.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 119.906 -1.746 . . . . 0.0 110.189 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -71.03 119.34 15.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -110.27 145.86 36.65 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.564 1.145 . . . . 0.0 111.331 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.8 tm? -82.03 130.51 35.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -120.43 142.15 49.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.2 p -118.61 150.28 39.95 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.599 0.714 . . . . 0.0 110.963 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -64.96 143.63 57.83 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 97.4 t -123.51 157.79 29.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -157.67 58.3 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 105.389 -3.085 . . . . 0.0 105.389 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 10.4 m120 . . . . . 0 C--O 1.245 0.826 0 C-N-CA 125.735 1.614 . . . . 0.0 109.552 -179.335 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.509 -0.62 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.06 141.62 24.37 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 128.582 2.753 . . . . 0.0 104.01 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -73.94 151.64 40.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.1 t -145.87 136.89 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -81.76 134.93 26.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -58.5 119.43 6.99 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.598 1.19 . . . . 0.0 109.964 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -58.24 -22.53 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.174 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -94.54 -21.84 18.6 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.73 1.212 . . . . 0.0 111.955 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.97 104.88 4.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.519 1.128 . . . . 0.0 109.212 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.3 t -69.06 -3.56 13.68 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.522 -1.361 . . . . 0.0 110.867 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -98.13 -3.2 38.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.718 2.007 . . . . 0.0 110.397 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -117.54 169.7 9.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.541 1.136 . . . . 0.0 112.224 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.3 mm -130.32 151.16 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 C-N-CA 126.165 1.786 . . . . 0.0 107.878 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.19 102.5 8.17 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 130.119 3.368 . . . . 0.0 103.603 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -142.7 131.93 23.35 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.643 -1.286 . . . . 0.0 109.589 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.5 mtt 57.61 32.91 22.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.353 1.461 . . . . 0.0 113.026 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.49 7.34 82.75 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.453 -1.193 . . . . 0.0 112.449 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -113.08 168.36 9.77 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.131 1.372 . . . . 0.0 108.099 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -119.54 145.46 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -133.3 155.69 48.94 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.2 t -134.91 151.59 51.01 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.039 1.736 . . . . 0.0 108.22 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.3 mt -112.82 123.34 68.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.956 1.302 . . . . 0.0 108.971 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.1 t -97.72 -118.27 0.13 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 101.884 -3.376 . . . . 0.0 101.884 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -158.05 99.36 1.66 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 120.622 1.555 . . . . 0.0 106.935 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 m -137.95 115.31 11.11 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 127.209 2.204 . . . . 0.0 106.326 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.9 m -71.72 129.79 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.81 111.05 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.5 m -75.45 164.46 26.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.068 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.9 -29.37 70.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.545 0.688 . . . . 0.0 111.753 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.74 -11.61 60.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.594 1.158 . . . . 0.0 111.265 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.77 -24.62 11.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.552 1.541 . . . . 0.0 109.534 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.09 127.92 33.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.825 1.25 . . . . 0.0 111.85 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.63 -106.06 1.31 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -133.77 163.0 30.45 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.128 1.371 . . . . 0.0 109.307 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -60.41 145.65 47.33 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.52 -42.02 1.98 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 116.507 -1.711 . . . . 0.0 114.494 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -161.28 160.86 30.33 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 121.066 1.757 . . . . 0.0 110.489 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.4 p -121.84 133.15 69.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.57 1.148 . . . . 0.0 108.402 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -107.83 166.33 10.78 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.181 2.193 . . . . 0.0 110.591 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -164.08 41.04 0.09 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -138.71 172.23 13.18 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 120.039 -1.663 . . . . 0.0 109.568 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.76 149.36 17.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -145.46 167.02 23.98 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.35 131.89 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -138.02 166.72 23.4 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.461 0.704 . . . . 0.0 110.193 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -86.07 116.03 24.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.38 -14.46 1.91 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 127.032 2.133 . . . . 0.0 115.179 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.4 m -77.34 -46.85 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 124.044 0.937 . . . . 0.0 112.451 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.23 -28.42 3.69 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.37 12.73 16.59 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.067 1.318 . . . . 0.0 112.299 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 112.78 2.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.968 1.384 . . . . 0.0 111.253 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.1 m -69.35 154.75 41.54 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.588 1.085 . . . . 0.0 110.476 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.31 147.66 66.72 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.659 1.584 . . . . 0.0 110.828 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.53 157.71 22.07 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.499 3.466 . . . . 0.0 110.502 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -53.17 -25.1 12.46 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 m -70.54 -22.06 62.65 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 118.056 -0.973 . . . . 0.0 113.468 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.2 -12.45 28.24 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.555 1.525 . . . . 0.0 110.753 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.5 m0 -62.38 -10.21 10.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.924 1.29 . . . . 0.0 111.771 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -144.91 6.37 1.58 Allowed Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.155 -1.358 . . . . 0.0 113.336 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.9 96.57 3.55 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.308 2.054 . . . . 0.0 108.062 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.3 mm -73.85 -61.81 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 57.79 51.59 9.07 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.79 2.036 . . . . 0.0 111.684 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -139.04 167.37 22.21 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.681 1.193 . . . . 0.0 110.272 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -59.34 4.68 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.431 2.692 . . . . 0.0 110.839 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 170.08 31.65 0.02 OUTLIER Glycine 0 N--CA 1.468 0.819 0 O-C-N 121.361 -0.837 . . . . 0.0 114.272 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.3 t -65.08 -25.17 67.69 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.644 1.177 . . . . 0.0 112.756 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -79.66 33.06 0.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.247 1.019 . . . . 0.0 111.951 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 44.6 t -78.6 -50.07 12.15 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.92 2.088 . . . . 0.0 111.677 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -125.9 5.86 7.32 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.368 1.867 . . . . 0.0 110.752 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.6 153.22 51.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.919 1.688 . . . . 0.0 108.59 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.1 t -171.44 178.82 3.09 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.914 1.686 . . . . 0.0 107.751 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 49.3 mmt-85 -87.96 177.41 6.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 122.19 0.995 . . . . 0.0 111.632 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.0 m -122.36 129.39 52.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 126.944 2.098 . . . . 0.0 105.557 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -115.94 106.54 13.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.349 1.859 . . . . 0.0 107.41 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -110.52 117.44 33.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.295 1.838 . . . . 0.0 108.701 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -87.88 127.21 35.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -73.31 101.45 3.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.029 0.932 . . . . 0.0 109.561 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.82 159.06 22.81 Favored Glycine 0 N--CA 1.442 -0.921 1 C-N-CA 132.694 4.95 . . . . 0.0 107.544 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -68.1 151.17 47.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 123.544 1.64 . . . . 0.0 111.536 -176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 63.9 mt -99.38 143.99 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 C-N-CA 126.463 1.905 . . . . 0.0 110.299 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -137.99 153.27 49.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.734 1.613 . . . . 0.0 110.095 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.8 p -80.47 173.22 12.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 66.4 mt -124.8 136.46 60.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.381 1.072 . . . . 0.0 109.015 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -64.88 119.12 10.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.66 10.89 72.19 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 118.148 -1.362 . . . . 0.0 116.083 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -137.38 130.44 30.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 120.473 2.136 . . . . 0.0 110.295 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 15.0 m -71.49 145.08 49.42 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.62 -24.96 65.91 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.052 0.941 . . . . 0.0 109.158 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 17.1 p -75.53 -9.76 58.86 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.83 2.452 . . . . 0.0 112.798 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -119.77 -47.61 2.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.582 1.153 . . . . 0.0 109.386 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.35 145.38 19.11 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.902 0.774 . . . . 0.0 111.01 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -152.08 175.73 12.26 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.859 -0.526 . . . . 0.0 110.716 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.51 134.71 52.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.871 1.669 . . . . 0.0 112.29 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 8.0 p -129.83 131.56 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 124.821 1.249 . . . . 0.0 109.436 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.41 106.75 5.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 28.2 mm -121.42 128.97 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 53.81 36.63 24.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.995 0.816 . . . . 0.0 111.65 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t0 68.74 9.66 7.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.553 1.541 . . . . 0.0 112.825 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -124.92 122.98 38.9 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.519 1.128 . . . . 0.0 108.743 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -69.12 119.37 13.3 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.828 -1.17 . . . . 0.0 110.373 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -116.07 147.19 41.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 123.41 1.576 . . . . 0.0 111.679 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -80.93 122.61 27.46 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.486 1.914 . . . . 0.0 113.074 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -112.45 140.07 47.5 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.3 p -120.54 145.51 47.25 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.621 1.168 . . . . 0.0 110.765 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -60.36 135.41 57.73 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 9.8 p -135.75 153.92 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 122.965 0.506 . . . . 0.0 109.816 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.8 -70.15 0.97 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 105.399 -3.08 . . . . 0.0 105.399 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.244 0.787 0 C-N-CA 124.629 1.171 . . . . 0.0 110.901 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 CA--C 1.519 -0.24 0 CA-C-O 121.787 0.803 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.72 139.86 31.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 128.329 2.652 . . . . 0.0 106.34 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -70.43 130.7 42.61 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.6 t -131.46 134.92 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.0 mm -69.78 131.53 34.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -68.35 129.39 39.77 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.523 0.678 . . . . 0.0 109.988 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -71.26 -18.37 62.44 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.139 -0.976 . . . . 0.0 110.329 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -82.05 -34.21 29.58 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.644 1.178 . . . . 0.0 111.261 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.38 121.17 9.9 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.5 t -59.35 -25.21 64.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.526 1.057 . . . . 0.0 110.48 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -90.47 3.02 55.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.224 1.81 . . . . 0.0 112.946 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -109.13 155.98 20.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.2 mm -126.69 142.04 44.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -115.25 104.25 11.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 128.111 2.564 . . . . 0.0 105.166 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -132.58 128.63 37.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.8 mtt 61.76 21.77 12.47 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.221 1.408 . . . . 0.0 110.841 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.72 14.64 81.85 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.515 -1.159 . . . . 0.0 111.878 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -113.1 157.92 21.02 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.0 mm -114.65 143.93 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.561 0.696 . . . . 0.0 111.507 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -131.12 155.31 47.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.571 1.948 . . . . 0.0 109.63 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.6 t -145.18 147.38 32.4 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 mt -102.85 120.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 126.665 1.986 . . . . 0.0 112.03 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -90.33 -116.6 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 1 N-CA-C 99.881 -4.118 . . . . 0.0 99.881 176.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -160.25 99.82 1.34 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.4 m -136.63 121.41 18.61 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 m -81.24 136.73 35.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 120.671 1.578 . . . . 0.0 107.05 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.35 112.25 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 74.3 m -79.82 166.22 21.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.975 0.91 . . . . 0.0 109.1 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -58.27 -32.01 68.0 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.345 1.058 . . . . 0.0 111.091 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.82 -8.03 39.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.167 1.787 . . . . 0.0 112.044 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -122.33 -12.14 8.27 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 127.72 2.408 . . . . 0.0 110.001 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 20.3 mt -83.09 123.03 29.11 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.23 -101.46 0.84 Allowed Glycine 0 CA--C 1.507 -0.424 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -134.75 167.05 21.57 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.379 1.071 . . . . 0.0 108.8 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -61.02 143.05 56.1 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.0 0.92 . . . . 0.0 111.374 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.06 -41.41 1.94 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 116.907 -1.521 . . . . 0.0 113.3 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -160.27 150.36 18.17 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.707 1.594 . . . . 0.0 110.792 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.1 p -109.26 135.79 47.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.1 mp -110.66 163.21 13.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.934 2.094 . . . . 0.0 110.95 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -165.33 64.34 0.12 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -153.01 173.19 15.73 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.564 -1.335 . . . . 0.0 108.763 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.2 t -149.57 138.07 14.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 126.103 1.761 . . . . 0.0 106.368 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.75 166.05 25.7 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.49 126.9 55.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -142.08 164.01 31.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.561 1.144 . . . . 0.0 110.759 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -92.95 103.57 15.88 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 104.284 -2.488 . . . . 0.0 104.284 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.35 -15.72 0.69 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.365 2.266 . . . . 0.0 116.127 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.6 m -57.71 -51.0 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.168 0.987 . . . . 0.0 108.406 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.2 m -123.45 -26.7 4.19 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.397 1.879 . . . . 0.0 114.437 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 103.4 16.56 20.09 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.499 1.523 . . . . 0.0 113.615 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 113.04 4.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.76 1.78 . . . . 0.0 109.261 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.0 m -75.21 145.25 42.17 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.26 143.07 26.97 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.17 160.51 42.41 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.167 2.578 . . . . 0.0 111.028 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -57.32 -28.62 63.24 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.065 0.546 . . . . 0.0 111.913 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.5 m -61.32 -14.22 25.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.071 0.949 . . . . 0.0 112.148 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -119.12 4.91 11.3 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.903 1.681 . . . . 0.0 111.951 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -68.16 -15.98 63.81 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.752 -1.218 . . . . 0.0 113.895 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -127.23 -46.91 0.19 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -81.24 86.76 6.17 Favored 'General case' 0 C--N 1.337 0.024 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 89.3 mt -70.76 -80.82 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.42 161.83 34.34 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.859 1.264 . . . . 0.0 108.731 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -64.19 -37.98 89.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.31 0.644 . . . . 0.0 109.705 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -84.49 -48.94 9.09 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.872 1.669 . . . . 0.0 106.896 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 95.4 3.75 61.24 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.504 1.526 . . . . 0.0 113.892 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.8 p -35.36 -58.67 0.56 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 127.771 2.428 . . . . 0.0 113.843 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 57.96 -9.96 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.034 2.134 . . . . 0.0 116.466 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.5 t -46.58 -23.49 0.4 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -109.64 12.12 24.38 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 121.131 1.787 . . . . 0.0 112.352 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -116.55 160.0 21.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 119.86 1.209 . . . . 0.0 108.792 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.04 84.03 1.45 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -76.57 158.8 30.86 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.488 0.661 . . . . 0.0 110.232 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.4 m -141.84 132.53 25.58 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.478 1.911 . . . . 0.0 106.018 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -115.35 104.77 12.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -110.63 116.6 31.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.013 1.325 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -83.27 128.23 34.32 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 127.212 2.205 . . . . 0.0 105.861 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.55 102.3 6.02 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.68 159.27 16.84 Favored Glycine 0 N--CA 1.442 -0.96 1 C-N-CA 131.489 4.376 . . . . 0.0 109.918 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.12 154.98 39.9 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 124.294 1.997 . . . . 0.0 113.717 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.4 mt -102.26 140.97 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.299 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -131.58 151.52 51.53 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 109.604 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 11.4 m -76.3 172.27 13.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.778 0.831 . . . . 0.0 108.984 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 78.8 mt -131.91 138.15 53.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.902 0.858 . . . . 0.0 110.509 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -65.5 119.04 10.34 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.22 14.73 76.09 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 118.821 -0.989 . . . . 0.0 115.378 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -140.78 126.2 18.81 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 119.771 1.785 . . . . 0.0 109.782 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 16.3 m -76.48 146.71 38.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.31 -27.8 56.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.541 1.136 . . . . 0.0 110.393 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 36.9 p -74.33 -9.74 58.9 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.433 1.893 . . . . 0.0 114.362 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -120.69 -43.88 2.46 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.26 1.424 . . . . 0.0 109.547 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.15 144.28 14.35 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.115 0.566 . . . . 0.0 110.13 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -148.13 176.38 10.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.803 0.841 . . . . 0.0 109.152 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -108.62 130.73 55.31 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.455 1.102 . . . . 0.0 109.727 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.1 p -124.28 126.97 72.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 124.48 1.112 . . . . 0.0 111.678 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -73.89 108.42 6.7 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 35.4 mm -121.74 120.2 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 54.17 40.39 31.62 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.8 t70 70.68 -4.83 1.57 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.381 2.272 . . . . 0.0 113.2 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -106.15 122.26 45.84 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 120.279 -1.513 . . . . 0.0 108.953 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.85 120.49 16.52 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -112.46 151.58 29.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.818 1.247 . . . . 0.0 112.671 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -88.81 117.07 27.53 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.067 0.947 . . . . 0.0 110.711 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.89 156.23 17.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.9 143.3 40.77 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 123.158 0.583 . . . . 0.0 109.908 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -54.82 125.82 21.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.865 0.866 . . . . 0.0 110.162 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.7 t -134.71 130.52 53.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 C-N-CA 126.387 1.875 . . . . 0.0 107.986 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.97 -15.48 21.13 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.196 -0.78 . . . . 0.0 112.656 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . 0.321 1.0 OUTLIER . . . . . 0 C--O 1.247 0.96 0 C-N-CA 131.199 3.799 . . . . 0.0 113.7 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 CA--C 1.507 -0.687 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.68 152.04 45.03 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.128 1.771 . . . . 0.0 106.568 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -69.56 140.91 53.89 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.879 1.272 . . . . 0.0 110.264 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.4 t -141.24 141.34 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -80.28 121.13 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -48.61 122.13 5.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.087 0.946 . . . . 0.0 111.475 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -65.72 -17.54 64.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.785 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -94.96 -20.38 19.43 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.956 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.17 122.2 9.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 120.038 1.29 . . . . 0.0 108.127 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.5 m -65.12 -18.86 65.66 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 120.182 -1.574 . . . . 0.0 110.699 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -94.12 -0.48 55.28 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.943 1.297 . . . . 0.0 113.095 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -108.0 159.59 16.44 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.466 0.575 . . . . 0.0 110.104 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.2 mm -126.81 138.51 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -118.63 108.67 15.22 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -146.39 134.1 21.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.8 mtt 58.69 26.91 15.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.747 2.019 . . . . 0.0 113.531 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.17 23.52 71.14 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -121.99 164.7 17.19 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.3 mm -123.77 126.36 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.89 150.19 41.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.7 t -130.75 150.04 52.12 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.004 1.322 . . . . 0.0 109.201 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 mt -111.36 124.21 67.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 125.602 1.561 . . . . 0.0 110.725 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.6 t -95.31 -126.95 0.13 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 103.188 -2.893 . . . . 0.0 103.188 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -149.73 99.37 2.86 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 94.5 m -136.89 111.79 8.88 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 128.094 2.558 . . . . 0.0 109.654 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.1 m -69.05 124.34 23.51 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 54.6 t -94.46 119.58 42.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 119.675 1.125 . . . . 0.0 109.157 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.2 m -80.65 159.13 25.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.643 0.735 . . . . 0.0 109.858 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.35 -29.34 70.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.956 1.302 . . . . 0.0 112.008 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.43 -16.11 61.83 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.311 1.044 . . . . 0.0 111.892 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -103.9 -25.95 12.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.818 0.847 . . . . 0.0 108.867 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 mt -62.14 137.58 58.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.757 1.223 . . . . 0.0 109.923 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -89.39 -105.71 1.12 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -135.04 169.43 17.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.057 1.743 . . . . 0.0 109.805 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -59.68 142.39 53.13 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -125.74 -48.97 1.63 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 116.595 -1.669 . . . . 0.0 111.902 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -155.73 150.81 26.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.9 1.682 . . . . 0.0 112.217 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.8 p -105.5 133.59 49.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 122.482 1.134 . . . . 0.0 111.332 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mp -113.1 161.93 16.53 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.562 2.745 . . . . 0.0 109.702 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.66 48.71 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.524 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 3.5 mt-10 -143.72 176.68 9.05 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.85 2.06 . . . . 0.0 111.579 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.49 150.56 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.593 -1.317 . . . . 0.0 110.508 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.38 157.49 43.28 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.408 1.483 . . . . 0.0 109.606 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.5 t -140.51 114.18 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -141.58 167.98 20.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.356 0.598 . . . . 0.0 112.212 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.21 104.24 13.23 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.436 ' HG ' ' CB ' ' A' ' 191' ' ' THR . 2.5 m -64.48 -14.99 59.97 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 122.145 2.248 . . . . 0.0 114.526 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.6 m -69.57 -35.17 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 O-C-N 121.823 -0.548 . . . . 0.0 112.001 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.29 -19.19 6.03 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.384 1.473 . . . . 0.0 113.015 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.26 -10.84 69.47 Favored Glycine 0 CA--C 1.543 1.796 0 C-N-CA 126.969 2.223 . . . . 0.0 112.582 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -47.69 115.4 1.13 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 128.369 2.667 . . . . 0.0 113.64 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.6 p -67.04 158.12 31.8 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 109.965 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.0 134.79 24.44 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.49 156.78 49.72 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.672 2.248 . . . . 0.0 110.005 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.435 ' HA ' ' CD1' ' A' ' 176' ' ' TRP . 42.7 ttt180 -56.58 -30.46 63.2 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t -66.96 -7.59 23.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.352 0.978 . . . . 0.0 111.753 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.06 -7.59 14.91 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.14 1.376 . . . . 0.0 110.885 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.435 ' CD1' ' HA ' ' A' ' 173' ' ' ARG . 34.2 m0 -60.71 -14.93 24.11 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -119.81 13.03 10.75 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.721 2.105 . . . . 0.0 110.837 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -106.68 76.68 1.13 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.854 1.661 . . . . 0.0 107.558 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 12.6 mm -105.09 -77.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -118.46 66.89 0.77 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.64 1.576 . . . . 0.0 112.731 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -128.8 -4.45 5.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.421 1.488 . . . . 0.0 110.285 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -136.06 5.13 3.03 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.629 1.572 . . . . 0.0 113.866 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 73.92 -1.87 44.94 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.996 1.284 . . . . 0.0 115.196 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.4 m -75.24 -11.82 60.15 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.291 2.046 . . . . 0.0 114.211 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -50.07 -2.06 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.72 2.808 . . . . 0.0 117.945 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.9 m -64.38 -75.92 0.08 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.516 -1.365 . . . . 0.0 110.133 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -93.09 54.69 2.19 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.939 -1.101 . . . . 0.0 110.434 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -135.76 147.31 48.35 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.3 t -168.52 152.37 5.74 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.72 2.008 . . . . 0.0 106.127 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -139.21 174.42 10.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.618 1.567 . . . . 0.0 108.823 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.436 ' CB ' ' HG ' ' A' ' 165' ' ' SER . 99.9 m -139.96 115.65 10.14 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -94.06 112.55 24.38 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -121.9 115.87 23.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.71 138.12 48.28 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.235 1.414 . . . . 0.0 109.151 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.524 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.6 m-30 -88.55 102.01 14.51 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 177.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.31 159.11 17.21 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 130.399 3.857 . . . . 0.0 107.753 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -66.51 158.25 30.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.162 1.934 . . . . 0.0 112.581 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 41.8 mt -105.02 142.09 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.599 -177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -132.52 151.62 51.85 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.226 1.41 . . . . 0.0 109.654 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 55.2 p -76.23 173.19 11.68 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.1 mt -125.41 146.13 31.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 122.127 0.965 . . . . 0.0 109.316 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -68.65 125.03 25.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.14 26.31 73.39 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.287 1.423 . . . . 0.0 113.867 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -145.93 152.38 39.35 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.6 m -106.64 151.12 25.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -55.56 -27.69 50.59 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.122 0.569 . . . . 0.0 110.711 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 7.7 p -71.66 -13.42 61.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.122 2.169 . . . . 0.0 114.443 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -124.69 -38.5 2.37 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.234 1.414 . . . . 0.0 112.077 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.18 142.07 5.77 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.517 1.053 . . . . 0.0 110.528 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -154.23 174.5 14.69 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.608 0.363 . . . . 0.0 111.494 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -110.65 132.19 54.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.98 1.312 . . . . 0.0 109.7 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.69 124.95 66.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.467 1.507 . . . . 0.0 109.357 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -71.54 109.51 5.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.37 124.17 71.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 54.26 44.08 29.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.682 0.674 . . . . 0.0 110.006 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 26.7 t70 59.08 20.55 8.45 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.3 0.64 . . . . 0.0 112.059 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.405 ' HB3' ' HE2' ' A' ' 219' ' ' LYS . 0.5 OUTLIER -129.61 122.45 29.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.958 1.303 . . . . 0.0 108.579 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -71.24 117.84 13.27 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.33 -1.481 . . . . 0.0 110.093 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 217' ' ' ASP . 51.0 mmtt -111.38 147.63 34.78 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.708 1.603 . . . . 0.0 110.329 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.79 139.44 36.04 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.235 1.014 . . . . 0.0 111.198 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.89 139.35 52.66 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.332 1.453 . . . . 0.0 107.122 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.1 p -126.23 155.48 41.78 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.141 0.976 . . . . 0.0 111.683 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -64.9 143.12 58.16 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.784 -0.572 . . . . 0.0 111.072 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.5 163.67 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -105.68 -40.7 1.98 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 125.386 1.47 . . . . 0.0 109.529 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.032 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.518 -0.286 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.86 130.52 39.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -68.81 146.4 52.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.4 t -140.02 132.68 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -77.21 122.58 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -56.85 128.05 34.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.811 1.291 . . . . 0.0 109.507 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -70.37 -22.89 62.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.444 1.098 . . . . 0.0 110.382 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.07 -42.2 19.54 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 123.637 0.775 . . . . 0.0 109.86 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -133.16 105.62 7.13 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.5 m -62.27 -23.48 66.72 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.189 -1.57 . . . . 0.0 112.478 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -81.27 -2.68 49.86 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.028 1.331 . . . . 0.0 111.125 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -109.89 159.8 16.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.453 0.701 . . . . 0.0 109.848 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.1 mm -125.47 133.0 70.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.31 111.16 23.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 101.477 -3.527 . . . . 0.0 101.477 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -147.8 137.97 22.88 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.16 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.3 mtt 51.72 28.73 5.09 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.22 18.0 79.71 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.406 -0.809 . . . . 0.0 111.522 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -120.43 163.71 17.48 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.472 1.109 . . . . 0.0 108.654 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.6 mm -119.14 134.08 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -126.97 148.92 50.07 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.8 t -131.51 130.32 42.22 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.464 2.306 . . . . 0.0 110.589 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.63 130.39 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.462 1.505 . . . . 0.0 108.819 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.3 t -102.57 -134.88 0.32 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 101.494 -3.521 . . . . 0.0 101.494 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -145.65 98.31 3.11 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 102.526 -3.138 . . . . 0.0 102.526 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.6 m -136.4 111.38 8.88 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 130.752 3.621 . . . . 0.0 108.999 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.9 m -68.7 127.85 34.54 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.714 1.597 . . . . 0.0 107.775 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.6 t -94.66 126.19 47.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.6 m -87.97 159.51 18.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.59 0.71 . . . . 0.0 110.213 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -56.56 -35.6 68.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.843 1.657 . . . . 0.0 109.913 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.56 -19.36 62.08 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.201 1.0 . . . . 0.0 111.809 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.72 -27.87 11.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.227 1.411 . . . . 0.0 110.763 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.97 112.79 2.73 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.596 1.558 . . . . 0.0 109.68 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.48 -102.44 0.08 OUTLIER Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.031 0.824 . . . . 0.0 111.865 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -134.76 161.82 34.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.735 1.214 . . . . 0.0 110.289 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -56.46 130.63 45.73 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.527 1.131 . . . . 0.0 109.969 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -109.11 -48.93 3.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 117.286 -1.34 . . . . 0.0 112.394 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -164.3 158.76 19.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.07 1.304 . . . . 0.0 109.406 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.3 p -108.02 141.12 24.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.579 1.152 . . . . 0.0 111.271 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mp -112.85 163.22 14.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.006 2.523 . . . . 0.0 110.365 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -166.81 39.57 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.519 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 21.4 mt-10 -141.86 176.71 8.72 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.181 -2.199 . . . . 0.0 110.35 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.9 t -138.12 151.47 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 120.071 1.305 . . . . 0.0 111.007 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.468 ' HE ' ' CB ' ' A' ' 193' ' ' TRP . 0.2 OUTLIER -130.34 156.91 43.9 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 120.953 -1.092 . . . . 0.0 109.683 177.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.1 t -138.22 113.89 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -134.23 158.3 44.08 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.621 -0.674 . . . . 0.0 110.212 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -85.26 99.99 11.49 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 103.103 -2.925 . . . . 0.0 103.103 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.422 ' HG ' ' CB ' ' A' ' 191' ' ' THR . 3.7 m -59.28 -9.06 1.94 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 126.735 2.014 . . . . 0.0 116.267 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.8 m -66.12 -38.82 82.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.422 ' HB3' ' HE2' ' A' ' 169' ' ' LYS . 0.4 OUTLIER -123.43 -24.12 4.67 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.648 1.579 . . . . 0.0 112.286 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.18 8.53 60.08 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 127.224 2.345 . . . . 0.0 110.564 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 167' ' ' SER . 27.2 mtmt -61.27 115.95 4.22 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.074 1.75 . . . . 0.0 110.253 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 70.4 p -67.28 153.75 42.94 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.119 0.968 . . . . 0.0 112.366 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.58 136.31 26.5 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.2 163.72 24.96 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.548 2.165 . . . . 0.0 110.998 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -58.44 -21.87 52.47 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.578 1.551 . . . . 0.0 114.737 -178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.3 m -80.46 -7.57 59.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.982 0.81 . . . . 0.0 110.517 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -113.1 9.32 18.55 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.648 1.579 . . . . 0.0 110.945 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -81.45 -17.25 49.43 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.254 1.422 . . . . 0.0 114.068 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -135.7 -44.22 0.1 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 120.986 -1.072 . . . . 0.0 113.65 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 35.8 ttt-85 -77.98 89.51 4.15 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.4 mm -73.0 -56.23 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.2 t70 39.42 44.12 1.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.97 2.108 . . . . 0.0 112.121 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.11 153.58 34.13 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.041 1.336 . . . . 0.0 111.343 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -54.01 -17.5 2.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.562 2.745 . . . . 0.0 114.321 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -153.01 -59.84 0.01 OUTLIER Glycine 0 C--N 1.337 0.584 0 O-C-N 121.274 -0.891 . . . . 0.0 111.537 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 57.6 m -155.68 166.84 32.28 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 120.912 -1.346 . . . . 0.0 110.729 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -61.4 -22.39 64.95 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.102 0.961 . . . . 0.0 111.3 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 38.5 m -54.47 172.19 0.1 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.667 1.987 . . . . 0.0 113.236 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt 67.24 -5.69 0.69 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 129.06 2.944 . . . . 0.0 113.91 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -80.19 -58.91 2.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.03 1.332 . . . . 0.0 110.081 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.8 m 57.21 56.46 5.17 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 126.301 1.841 . . . . 0.0 111.305 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -70.95 168.84 16.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.695 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.422 ' CB ' ' HG ' ' A' ' 165' ' ' SER . 37.6 m -139.72 135.67 33.4 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 177.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -113.15 106.87 15.17 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.883 1.673 . . . . 0.0 107.321 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . 0.468 ' CB ' ' HE ' ' A' ' 161' ' ' ARG . 24.6 m0 -110.78 115.63 29.88 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.612 0.765 . . . . 0.0 110.385 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.21 138.34 38.6 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.777 1.631 . . . . 0.0 106.838 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.519 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.9 m-30 -85.97 105.91 16.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -105.8 158.67 15.62 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 127.801 2.62 . . . . 0.0 108.037 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.11 156.49 36.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 124.741 2.21 . . . . 0.0 113.05 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 38.9 mt -100.9 141.0 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 111.795 -2.457 . . . . 0.0 110.179 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -133.83 152.51 51.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.548 1.539 . . . . 0.0 109.64 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 91.5 p -74.69 172.69 11.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.459 0.704 . . . . 0.0 110.152 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 5.3 mt -127.71 135.46 63.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 121.458 -0.776 . . . . 0.0 110.257 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -65.14 126.15 27.21 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.85 12.44 84.43 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.205 -1.331 . . . . 0.0 116.01 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -138.75 157.75 45.5 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.617 1.709 . . . . 0.0 108.175 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 62.1 m -106.48 145.72 31.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.63 -31.14 64.04 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 29.8 p -66.32 -12.37 56.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.178 1.791 . . . . 0.0 113.903 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -124.66 -35.39 2.73 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.688 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.27 145.36 6.94 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 119.217 0.917 . . . . 0.0 110.964 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.57 173.23 16.61 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.048 0.385 . . . . 0.0 111.221 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.62 132.52 54.06 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 124.509 1.124 . . . . 0.0 111.774 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.81 130.36 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.947 1.299 . . . . 0.0 108.513 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -69.91 103.11 2.13 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 33.8 mm -121.56 123.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.293 1.437 . . . . 0.0 110.251 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 61.52 38.15 15.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.194 0.997 . . . . 0.0 109.317 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 65.31 16.31 10.47 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.617 1.567 . . . . 0.0 111.313 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.56 129.15 38.65 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -67.97 122.23 17.77 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 119.962 -1.711 . . . . 0.0 109.15 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -119.02 146.2 45.23 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.815 1.246 . . . . 0.0 111.387 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -78.83 133.12 37.04 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.937 1.295 . . . . 0.0 112.032 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -121.69 131.31 54.02 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.81 150.21 33.82 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.189 0.596 . . . . 0.0 110.025 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -70.08 122.09 18.73 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.46 127.25 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -92.72 27.97 10.05 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.448 -1.195 . . . . 0.0 112.85 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 . . . . . 0 C--O 1.245 0.859 0 C-N-CA 126.793 2.037 . . . . 0.0 107.325 -179.349 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 t70 . . . . . 0 N--CA 1.464 0.228 0 CA-C-O 121.173 0.511 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.91 143.58 17.11 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.0 2.12 . . . . 0.0 106.155 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -75.96 124.56 27.56 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.0 t -124.78 136.88 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 126.029 1.732 . . . . 0.0 107.026 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -86.43 138.89 18.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -64.27 123.3 18.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 123.03 1.395 . . . . 0.0 108.419 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -61.02 -27.05 68.04 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.788 1.235 . . . . 0.0 111.105 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -80.87 -46.09 15.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.21 105.61 8.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.428 1.491 . . . . 0.0 112.946 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -58.67 -19.5 39.96 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 120.343 -1.473 . . . . 0.0 112.258 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -85.21 -7.85 58.84 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.278 -0.889 . . . . 0.0 110.658 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -101.41 149.47 24.02 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.838 0.744 . . . . 0.0 109.559 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.1 mm -126.86 119.15 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.09 97.29 9.82 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 128.372 2.669 . . . . 0.0 109.114 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -132.41 142.5 49.31 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 121.576 1.989 . . . . 0.0 109.975 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 8.4 mtt 49.87 23.32 1.02 Allowed 'General case' 0 CA--C 1.544 0.739 0 O-C-N 119.992 -1.693 . . . . 0.0 114.714 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.64 5.25 78.68 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 119.604 1.093 . . . . 0.0 112.089 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -100.23 172.86 6.9 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 125.099 1.36 . . . . 0.0 111.626 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.5 mm -136.4 125.7 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -114.13 161.07 18.24 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.9 t -143.04 139.32 30.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.434 1.494 . . . . 0.0 109.999 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.1 mt -100.85 137.68 27.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 123.929 0.892 . . . . 0.0 109.233 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.7 m -118.17 -112.79 0.34 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -159.98 98.72 1.34 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 122.689 2.495 . . . . 0.0 108.109 175.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.3 m -137.42 113.88 10.21 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 127.323 2.249 . . . . 0.0 105.537 175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.6 m -76.61 126.9 31.79 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 104.419 -2.438 . . . . 0.0 104.419 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.7 t -93.72 111.7 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.1 m -74.61 158.27 33.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.959 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.96 -28.82 67.97 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.998 0.519 . . . . 0.0 111.481 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.71 -12.58 61.59 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.94 -0.475 . . . . 0.0 111.222 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -114.04 -24.1 9.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.507 1.523 . . . . 0.0 110.791 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.2 mt -65.63 135.38 54.95 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.62 -106.14 0.91 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 107.401 -2.28 . . . . 0.0 107.401 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.31 167.04 21.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.595 1.958 . . . . 0.0 109.325 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -57.63 150.07 20.18 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.097 0.951 . . . . 0.0 112.532 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -125.99 -50.75 1.57 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.901 -1.524 . . . . 0.0 112.325 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.93 163.17 29.23 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 121.297 1.862 . . . . 0.0 110.619 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.2 139.75 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 119.122 0.874 . . . . 0.0 111.716 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.93 164.8 12.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.452 2.301 . . . . 0.0 110.462 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.6 59.92 0.07 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.086 0.954 . . . . 0.0 112.619 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -156.34 172.8 17.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.879 -1.138 . . . . 0.0 108.287 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 t -143.98 149.41 17.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.91 164.6 31.47 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 63.0 t -131.28 136.74 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -147.62 163.85 35.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.65 0.78 . . . . 0.0 111.994 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.55 100.67 10.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -62.53 -12.35 21.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.5 m -65.58 -44.14 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 121.674 -0.642 . . . . 0.0 110.827 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.431 ' HB2' ' HE2' ' A' ' 169' ' ' LYS . 32.3 m -121.62 -20.57 6.47 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 125.54 1.536 . . . . 0.0 113.233 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.48 5.78 57.74 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.457 1.027 . . . . 0.0 111.753 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 167' ' ' SER . 45.1 mtmt -61.27 112.8 2.29 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.49 1.116 . . . . 0.0 108.162 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 p -63.29 151.31 40.99 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.22 141.68 26.8 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.912 1.285 . . . . 0.0 107.664 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -82.43 160.2 17.18 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.955 2.437 . . . . 0.0 108.488 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 ttp85 -53.12 -27.28 20.02 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.225 1.01 . . . . 0.0 113.372 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.2 t -65.67 -13.66 59.65 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.074 1.749 . . . . 0.0 112.4 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.58 -1.55 13.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 119.706 -1.871 . . . . 0.0 110.598 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.5 m0 -68.48 -25.25 64.88 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.556 -0.715 . . . . 0.0 109.901 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 179.25 30.65 0.05 OUTLIER Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.799 1.19 . . . . 0.0 113.341 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -133.24 40.99 3.15 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.676 1.738 . . . . 0.0 110.017 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.7 mp -75.04 -82.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -155.53 -175.56 5.5 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.691 1.597 . . . . 0.0 107.795 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -101.56 -27.32 13.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.377 1.871 . . . . 0.0 109.306 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -97.19 -24.03 15.91 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.234 1.014 . . . . 0.0 110.802 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -30.65 113.64 0.05 OUTLIER Glycine 0 C--N 1.341 0.822 0 C-N-CA 128.407 2.908 . . . . 0.0 113.9 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.6 t -49.14 -39.94 30.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.581 1.952 . . . . 0.0 111.563 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 33.75 57.23 0.57 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.827 2.851 . . . . 0.0 114.01 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.5 t -122.54 -46.18 2.16 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.799 0.84 . . . . 0.0 109.642 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -73.32 16.47 0.18 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.929 1.292 . . . . 0.0 112.05 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -124.33 131.09 53.5 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.406 1.882 . . . . 0.0 108.086 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 90.0 p -131.95 100.24 5.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.701 1.2 . . . . 0.0 109.685 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.1 mtt85 -103.15 173.24 6.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.63 1.172 . . . . 0.0 110.661 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.9 m -144.86 132.69 21.2 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 127.187 2.195 . . . . 0.0 107.025 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -108.76 109.67 20.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.859 2.063 . . . . 0.0 106.609 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -115.72 116.78 28.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.764 1.225 . . . . 0.0 112.281 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -84.0 133.32 34.68 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.103 1.361 . . . . 0.0 109.318 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.14 101.33 7.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.47 1.108 . . . . 0.0 109.417 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -96.11 158.45 21.79 Favored Glycine 0 CA--C 1.534 1.27 1 C-N-CA 134.549 5.833 . . . . 0.0 107.608 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -68.25 157.16 36.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.338 1.569 . . . . 0.0 113.13 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 62.2 mt -101.11 139.81 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 126.744 2.018 . . . . 0.0 109.583 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -133.1 152.33 51.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.502 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 18.9 t -76.99 172.96 12.35 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 35.8 mt -129.06 141.9 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 122.824 1.297 . . . . 0.0 107.691 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 -65.81 121.49 15.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.175 1.39 . . . . 0.0 109.351 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.54 15.4 80.5 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.395 -1.225 . . . . 0.0 113.612 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -136.49 132.19 34.99 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.992 1.896 . . . . 0.0 110.018 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.4 m -81.13 150.63 28.64 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.77 -29.84 63.01 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.345 -0.847 . . . . 0.0 109.951 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.1 p -67.54 -20.64 65.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.151 2.18 . . . . 0.0 114.025 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -112.13 -41.71 3.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 117.787 -1.101 . . . . 0.0 110.313 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.71 142.69 3.77 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.124 0.874 . . . . 0.0 109.863 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -151.47 175.62 12.11 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.691 0.796 . . . . 0.0 109.426 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.56 132.7 53.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.239 1.415 . . . . 0.0 110.327 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.48 124.77 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 C-N-CA 125.316 1.446 . . . . 0.0 107.836 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -72.9 109.49 6.51 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 50.4 mm -121.83 118.07 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 126.071 1.749 . . . . 0.0 109.224 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.58 47.4 16.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.242 1.017 . . . . 0.0 109.511 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.82 10.98 6.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.52 1.128 . . . . 0.0 111.441 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.26 123.46 38.17 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.205 -1.559 . . . . 0.0 110.588 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -69.79 116.95 10.78 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.02 -1.05 . . . . 0.0 108.565 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -112.55 150.52 31.21 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.019 1.328 . . . . 0.0 109.756 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -82.38 135.07 35.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.21 1.004 . . . . 0.0 109.944 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.03 125.16 44.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.71 152.17 26.86 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.525 0.73 . . . . 0.0 112.001 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -60.8 139.18 58.01 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 122.205 -0.309 . . . . 0.0 110.319 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.4 p -130.16 167.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -170.46 23.46 0.09 OUTLIER Glycine 0 CA--C 1.525 0.679 0 CA-C-O 119.366 -0.686 . . . . 0.0 111.628 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 . . . . . 0 C--O 1.249 1.048 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.42 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.223 -0.305 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.48 129.68 2.34 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 127.73 2.412 . . . . 0.0 105.806 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -64.67 147.45 52.98 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.334 0.97 . . . . 0.0 108.597 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.2 t -150.53 132.11 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -72.18 139.5 19.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -60.31 118.64 6.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -19.59 37.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.749 -0.594 . . . . 0.0 111.749 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -96.04 -19.6 19.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.601 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.8 111.49 5.03 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.843 1.656 . . . . 0.0 108.731 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.415 ' HB3' ' CD1' ' A' ' 163' ' ' PHE . 6.0 t -54.88 -32.83 61.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.055 1.342 . . . . 0.0 112.93 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.5 ptt85 -79.05 -1.27 34.91 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.236 -0.915 . . . . 0.0 112.32 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -110.35 157.09 19.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 118.585 0.629 . . . . 0.0 112.523 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.3 mm -127.31 141.74 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -115.68 103.0 10.25 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 129.404 3.082 . . . . 0.0 104.159 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -143.15 133.88 25.22 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.074 -1.016 . . . . 0.0 109.317 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 22.3 mtp 56.88 30.23 17.56 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.845 1.258 . . . . 0.0 112.615 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.71 8.73 73.12 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.899 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -106.97 168.64 9.06 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.602 1.561 . . . . 0.0 107.635 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.6 mm -120.23 141.2 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -133.04 143.91 49.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.7 t -135.19 151.25 50.47 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.774 1.229 . . . . 0.0 109.112 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 mt -101.0 137.75 27.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.788 0.835 . . . . 0.0 110.419 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.9 t -101.57 -111.17 0.21 Allowed 'General case' 0 CA--C 1.537 0.46 1 N-CA-C 98.714 -4.551 . . . . 0.0 98.714 175.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -166.9 99.12 0.55 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.8 m -135.67 112.97 10.56 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 127.764 2.426 . . . . 0.0 105.583 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.1 m -68.54 123.29 20.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.67 116.14 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.8 m -83.96 158.64 21.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.167 0.508 . . . . 0.0 110.964 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -57.32 -32.75 67.0 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.188 1.795 . . . . 0.0 111.386 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.82 -8.79 55.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.88 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -121.72 -20.93 6.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.436 1.094 . . . . 0.0 109.658 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.0 tp -66.26 151.36 47.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.31 -102.59 2.72 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -134.65 165.15 25.89 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.85 0.86 . . . . 0.0 110.942 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.562 ' HH ' ' HB ' ' A' ' 156' ' ' VAL . 40.5 t80 -62.44 143.31 57.24 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -123.59 -52.05 1.82 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.878 -1.058 . . . . 0.0 111.535 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.82 173.86 16.35 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.924 0.783 . . . . 0.0 110.071 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.562 ' HB ' ' HH ' ' A' ' 153' ' ' TYR . 14.8 p -129.92 147.29 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.78 166.54 11.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.274 3.029 . . . . 0.0 112.952 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -162.87 45.61 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.68 174.46 10.95 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 119.802 -1.811 . . . . 0.0 108.621 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.0 t -142.22 149.81 19.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.308 1.043 . . . . 0.0 108.351 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -145.18 161.11 40.31 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.893 -1.129 . . . . 0.0 108.847 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.2 t -127.32 126.93 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 128' ' ' SER . 52.9 p90 -148.17 165.34 31.19 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.535 0.734 . . . . 0.0 111.18 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -80.88 109.67 15.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.119 1.767 . . . . 0.0 108.195 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.9 t -50.49 -23.44 2.48 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.713 2.805 . . . . 0.0 115.269 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.47 -39.56 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.4 t -122.12 -24.99 4.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.73 -1.02 52.38 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.89 1.233 . . . . 0.0 112.52 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -51.69 112.35 0.75 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.39 1.876 . . . . 0.0 110.23 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 25.9 p -72.7 156.48 38.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.633 0.73 . . . . 0.0 110.52 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.58 136.79 25.6 Favored Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.81 162.87 32.05 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.722 2.282 . . . . 0.0 109.561 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -58.71 -31.85 68.64 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.558 0.343 . . . . 0.0 111.864 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.8 m -67.54 -4.39 11.46 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.28 -0.93 10.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.829 1.252 . . . . 0.0 110.274 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -62.69 -32.84 74.0 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.064 -1.648 . . . . 0.0 111.751 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -151.38 18.31 0.9 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.221 0.915 . . . . 0.0 112.214 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -132.6 68.67 1.49 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 123.242 1.496 . . . . 0.0 108.97 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.2 mt -115.33 -50.61 4.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -143.82 154.74 43.71 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.14 1.776 . . . . 0.0 107.586 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -114.35 -36.87 4.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.691 1.196 . . . . 0.0 110.276 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.96 -25.47 68.15 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 129.347 3.059 . . . . 0.0 111.734 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.35 174.13 23.49 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.37 1.938 . . . . 0.0 110.556 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.419 ' C ' HD21 ' A' ' 185' ' ' ASN . 33.5 t -64.43 162.44 15.15 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 122.157 0.979 . . . . 0.0 111.957 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.419 HD21 ' C ' ' A' ' 184' ' ' SER . 1.5 m120 -130.76 21.33 5.03 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.613 2.365 . . . . 0.0 108.94 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 65.7 p -67.3 -161.16 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.573 1.549 . . . . 0.0 113.678 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -63.55 99.34 0.21 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.975 0.91 . . . . 0.0 109.131 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -109.39 -42.72 4.28 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 127.148 2.179 . . . . 0.0 107.003 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.24 31.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -118.57 175.13 5.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.589 0.756 . . . . 0.0 110.977 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.3 147.21 51.88 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 130.721 3.609 . . . . 0.0 105.881 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -129.11 104.94 7.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 102.923 -2.992 . . . . 0.0 102.923 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -111.49 116.21 30.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -83.53 129.34 34.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.261 1.424 . . . . 0.0 107.956 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -74.76 100.71 4.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.497 0.719 . . . . 0.0 109.239 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.3 159.66 27.56 Favored Glycine 0 CA--C 1.53 1.019 1 C-N-CA 132.631 4.92 . . . . 0.0 110.267 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.43 162.7 22.49 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 122.403 1.097 . . . . 0.0 109.304 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 97.4 mt -109.31 131.77 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 127.262 2.225 . . . . 0.0 112.072 -176.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -128.2 149.99 50.21 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.121 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 63.3 m -79.24 172.53 13.68 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.03 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 72.0 mt -128.62 139.02 53.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.315 1.446 . . . . 0.0 107.284 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -68.99 122.18 18.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.18 13.43 77.01 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 118.763 -1.02 . . . . 0.0 113.457 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -139.9 123.78 17.52 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 119.499 1.649 . . . . 0.0 109.988 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 54.8 m -79.6 150.91 30.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.01 -23.54 54.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.878 0.871 . . . . 0.0 110.284 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 17.0 p -76.09 -9.49 58.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.316 2.246 . . . . 0.0 113.513 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -123.95 -47.26 1.93 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.894 1.277 . . . . 0.0 110.081 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.88 148.27 13.77 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -155.14 175.84 13.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -108.36 144.44 35.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.56 124.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.767 2.027 . . . . 0.0 109.172 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -73.97 107.5 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 47.4 mm -121.84 125.76 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 109.76 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 54.32 44.43 28.99 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.013 0.824 . . . . 0.0 109.748 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 65.42 0.21 1.33 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.642 1.977 . . . . 0.0 113.974 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -121.23 127.87 51.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.949 0.795 . . . . 0.0 109.111 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -66.0 136.6 56.27 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.329 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -128.87 145.95 51.07 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.928 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.35 133.08 35.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.899 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -121.71 138.19 54.45 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 23.9 p -120.78 149.41 42.6 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 123.677 0.611 . . . . 0.0 112.632 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -61.12 143.01 56.27 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 4.7 t -130.61 151.81 36.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.68 -24.91 76.52 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.187 -0.946 . . . . 0.0 111.936 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 127.251 2.22 . . . . 0.0 105.813 179.148 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 CA--C 1.506 -0.72 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.43 147.09 27.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.372 1.069 . . . . 0.0 108.512 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -71.59 127.67 33.32 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 129.508 3.123 . . . . 0.0 106.285 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.7 126.11 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -68.88 133.17 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -66.27 128.23 35.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.42 -22.4 66.95 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.627 0.771 . . . . 0.0 111.135 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -81.25 -47.33 13.51 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.557 1.143 . . . . 0.0 109.605 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -140.74 106.05 5.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.366 1.466 . . . . 0.0 108.742 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 m -62.69 -12.28 22.63 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 120.362 -1.461 . . . . 0.0 112.259 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -85.13 1.84 46.17 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.417 1.087 . . . . 0.0 109.446 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -113.98 162.11 16.83 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.558 1.143 . . . . 0.0 109.06 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.9 mm -132.94 128.23 56.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -106.16 110.46 22.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.533 2.333 . . . . 0.0 106.567 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -146.26 128.76 16.0 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.455 1.102 . . . . 0.0 108.755 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.2 mtt 60.82 39.94 16.47 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.953 1.701 . . . . 0.0 112.329 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 63.59 21.63 65.06 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.918 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -114.46 173.46 6.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.1 mm -132.9 132.41 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -124.55 156.19 37.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.7 t -131.11 150.62 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.934 1.694 . . . . 0.0 108.949 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.8 mt -120.34 127.63 75.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.9 t -103.97 -104.51 0.3 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -164.76 101.79 0.79 Allowed 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 178.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 86.6 m -135.37 113.66 11.44 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 126.728 2.011 . . . . 0.0 107.38 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.7 m -66.98 115.98 7.3 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.574 1.533 . . . . 0.0 109.399 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 66.7 t -95.27 115.55 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 m -82.26 158.55 23.45 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -63.76 -26.59 68.71 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.972 0.909 . . . . 0.0 111.559 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -66.99 -23.77 65.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.175 0.443 . . . . 0.0 110.533 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -99.82 -21.03 15.91 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.937 0.895 . . . . 0.0 110.014 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.23 148.91 48.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.819 1.248 . . . . 0.0 108.03 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.15 -106.54 2.69 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.37 170.67 15.58 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.62 1.168 . . . . 0.0 110.349 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -56.92 138.0 54.55 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.394 1.478 . . . . 0.0 109.154 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -126.3 -52.89 1.5 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -139.66 156.6 46.74 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.548 0.613 . . . . 0.0 110.217 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.3 p -120.36 133.45 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.381 0.61 . . . . 0.0 111.833 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -112.3 164.15 13.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.954 2.102 . . . . 0.0 112.252 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.44 42.05 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.749 1.22 . . . . 0.0 112.536 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -140.39 175.59 9.47 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 119.068 -2.27 . . . . 0.0 108.987 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 t -143.08 149.52 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.84 165.8 26.53 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.3 t -133.75 129.19 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -141.99 157.36 45.04 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 119.881 1.219 . . . . 0.0 111.414 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -62.19 121.17 12.42 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.877 0.871 . . . . 0.0 109.574 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.15 -14.2 59.99 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.52 -38.68 12.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.0 t -123.0 -27.13 4.27 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.24 6.62 53.34 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.258 0.932 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -55.68 114.44 1.87 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.761 1.624 . . . . 0.0 108.517 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.08 132.84 55.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.022 0.828 . . . . 0.0 109.198 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -92.76 144.46 28.62 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.36 153.78 45.37 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.59 2.193 . . . . 0.0 110.201 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -56.95 -36.31 70.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.565 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.6 t -63.39 -2.63 1.59 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -118.18 -1.26 11.39 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.202 1.364 . . . . 0.0 111.966 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -68.22 -3.86 12.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.242 1.417 . . . . 0.0 113.653 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 173.89 49.99 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.05 52.63 1.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.759 0.824 . . . . 0.0 108.898 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 16.4 mt -134.43 -59.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 49.62 51.07 17.16 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.273 1.829 . . . . 0.0 108.863 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -73.77 130.63 40.36 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -53.82 -50.76 65.44 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 128.931 2.892 . . . . 0.0 108.696 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -79.59 59.63 4.4 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.154 1.359 . . . . 0.0 111.994 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 61.5 p 28.35 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 131.407 3.883 . . . . 0.0 116.235 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.1 m120 53.32 18.39 1.28 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.397 1.079 . . . . 0.0 111.4 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.1 t -45.18 -44.88 11.23 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.064 2.145 . . . . 0.0 111.773 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.89 -1.39 37.48 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.4 mp0 -142.86 80.26 1.68 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.805 0.842 . . . . 0.0 111.476 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 7.8 t -141.21 154.32 45.75 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.384 1.874 . . . . 0.0 106.838 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.65 171.56 14.22 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.683 1.193 . . . . 0.0 110.351 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.0 m -91.88 137.41 32.39 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.701 2.0 . . . . 0.0 106.388 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -119.48 109.88 16.25 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.842 2.057 . . . . 0.0 106.949 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -115.38 119.62 36.85 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.768 2.027 . . . . 0.0 110.797 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -86.82 134.46 33.55 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 128.363 2.665 . . . . 0.0 110.031 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -80.35 102.28 9.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.475 1.51 . . . . 0.0 110.477 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -95.49 158.66 22.22 Favored Glycine 0 CA--C 1.533 1.196 1 C-N-CA 133.042 5.115 . . . . 0.0 107.475 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.85 159.42 30.44 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 123.62 1.676 . . . . 0.0 110.62 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 57.7 mt -111.73 141.1 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.705 1.602 . . . . 0.0 109.982 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -134.43 147.5 50.45 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.324 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.61 173.44 6.07 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.8 mt -128.89 141.4 46.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.206 1.403 . . . . 0.0 108.509 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.87 124.7 24.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.4 17.35 76.26 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-O 117.493 -1.726 . . . . 0.0 114.841 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -147.63 134.44 20.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.105 1.952 . . . . 0.0 111.255 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.0 m -84.87 151.16 24.49 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.22 -30.64 62.61 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.327 -0.858 . . . . 0.0 109.864 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 66.9 p -73.18 -4.25 31.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.928 1.691 . . . . 0.0 114.458 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -125.12 -40.98 2.1 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.831 1.652 . . . . 0.0 109.515 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.05 144.6 2.71 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 118.858 0.754 . . . . 0.0 109.736 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -152.41 175.63 12.5 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.966 0.907 . . . . 0.0 109.198 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -112.47 134.72 53.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.041 1.336 . . . . 0.0 110.547 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.5 124.54 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 C-N-CA 124.153 0.981 . . . . 0.0 108.635 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -70.29 104.39 2.66 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 41.5 mm -121.77 133.22 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 54.77 39.7 31.53 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.06 3.31 2.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.837 2.455 . . . . 0.0 113.642 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -119.43 125.29 48.58 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.706 1.203 . . . . 0.0 111.492 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -64.28 113.19 3.43 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.571 0.748 . . . . 0.0 112.635 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -105.97 147.29 28.99 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 122.184 0.992 . . . . 0.0 110.908 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.429 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -86.18 123.12 31.11 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.428 1.491 . . . . 0.0 108.805 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -107.54 144.23 34.82 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.7 p -118.05 147.37 43.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.784 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -62.15 142.81 57.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.646 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.0 p -135.85 167.85 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 156.9 -18.05 0.4 Allowed Glycine 0 CA--C 1.525 0.657 0 O-C-N 120.53 -1.356 . . . . 0.0 112.58 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 124.488 1.115 . . . . 0.0 109.443 178.556 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.73 129.0 6.68 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 120.422 1.465 . . . . 0.0 109.777 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -75.11 138.56 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.0 t -139.55 132.01 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -78.64 128.63 38.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 177.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -61.56 122.34 15.0 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.51 1.148 . . . . 0.0 108.892 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.1 pttt -62.27 -23.01 66.46 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.362 -0.836 . . . . 0.0 110.358 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -85.01 -22.92 28.88 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.605 1.162 . . . . 0.0 110.603 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.84 102.45 2.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 119.667 1.122 . . . . 0.0 108.294 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.0 m -57.53 -24.93 58.85 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.884 0.873 . . . . 0.0 112.756 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.6 ptt85 -81.23 -3.79 53.46 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.923 0.889 . . . . 0.0 111.302 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -108.25 151.86 25.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.634 0.73 . . . . 0.0 110.089 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 14.2 mm -120.8 142.02 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -117.45 104.06 10.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.904 2.482 . . . . 0.0 106.051 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -127.26 133.97 50.12 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.0 mtt 56.3 13.44 1.26 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.043 -1.661 . . . . 0.0 113.281 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.73 6.6 65.49 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.879 1.228 . . . . 0.0 110.66 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -97.61 154.11 17.76 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 119.055 1.427 . . . . 0.0 107.917 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mm -118.09 140.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 O-C-N 124.358 1.036 . . . . 0.0 110.058 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -123.35 168.85 11.97 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.76 1.224 . . . . 0.0 110.528 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.47 135.51 25.16 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.453 1.501 . . . . 0.0 109.412 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 mt -97.89 119.0 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.1 t -94.87 -105.25 0.14 Allowed 'General case' 0 C--O 1.234 0.255 1 N-CA-C 99.717 -4.179 . . . . 0.0 99.717 176.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -167.03 99.34 0.53 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.5 m -136.29 121.46 19.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 128.332 2.653 . . . . 0.0 103.93 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.5 m -76.59 128.42 34.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.27 111.69 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.435 1.016 . . . . 0.0 109.583 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.2 m -81.96 162.95 22.49 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.027 0.531 . . . . 0.0 110.347 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.44 -27.0 65.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.248 1.819 . . . . 0.0 112.521 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.35 -22.07 61.95 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.204 -0.31 . . . . 0.0 110.213 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.82 -26.79 13.01 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.287 1.035 . . . . 0.0 109.433 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.8 tp -65.08 152.68 42.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -111.2 -102.64 2.67 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 125.037 1.303 . . . . 0.0 109.925 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -134.54 167.49 20.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.532 1.133 . . . . 0.0 110.858 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -60.07 140.93 56.53 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.024 1.33 . . . . 0.0 108.178 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -124.49 -47.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.598 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.99 158.16 40.19 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.325 1.42 . . . . 0.0 111.197 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.35 135.1 57.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.754 0.788 . . . . 0.0 111.292 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.27 165.92 11.53 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.041 2.936 . . . . 0.0 110.324 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.46 51.99 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.652 1.181 . . . . 0.0 113.143 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.36 175.85 9.6 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 119.618 -1.926 . . . . 0.0 107.681 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.66 142.58 23.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.93 161.1 38.15 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 71.6 t -129.89 124.2 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.74 169.24 18.09 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.289 0.95 . . . . 0.0 110.877 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -81.08 117.78 21.95 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -15.74 60.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.7 m -82.96 -41.19 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.0 -1.063 . . . . 0.0 113.779 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 68.2 m -122.36 -27.61 4.43 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 125.294 1.438 . . . . 0.0 113.456 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.32 7.59 37.21 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 117.118 1.607 . . . . 0.0 117.118 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.409 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -60.51 113.25 2.33 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.982 1.313 . . . . 0.0 110.551 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.2 p -70.58 149.48 47.04 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.749 1.22 . . . . 0.0 109.793 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.41 139.3 25.94 Favored Pre-proline 0 N--CA 1.44 -0.964 0 C-N-CA 125.527 1.531 . . . . 0.0 107.236 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.56 153.4 20.49 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.798 2.332 . . . . 0.0 109.33 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -51.21 -33.47 27.79 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.821 1.249 . . . . 0.0 111.573 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -3.47 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.556 1.142 . . . . 0.0 113.283 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -129.72 6.93 5.18 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.359 1.863 . . . . 0.0 113.242 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -62.76 3.33 0.23 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.409 1.083 . . . . 0.0 112.713 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.72 19.2 5.77 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 117.928 -1.485 . . . . 0.0 113.594 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.364 0.4 OUTLIER -89.93 18.27 5.91 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.231 2.016 . . . . 0.0 113.751 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 5.0 mp -70.06 -55.8 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 54.8 35.26 23.75 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.254 2.221 . . . . 0.0 114.348 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -167.42 1.61 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.96 -33.48 75.48 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -48.82 126.23 16.74 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.7 p -74.89 58.35 0.84 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.75 2.02 . . . . 0.0 110.171 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -65.26 -8.02 15.86 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 115.795 -2.05 . . . . 0.0 113.79 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.8 t -5.72 -72.19 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 130.323 3.449 . . . . 0.0 111.071 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.83 -5.99 2.17 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.796 0.838 . . . . 0.0 112.191 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 55.79 9.53 0.44 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.147 2.979 . . . . 0.0 111.721 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t 78.27 39.93 0.14 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.423 2.689 . . . . 0.0 109.808 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.0 mmp_? -104.7 177.56 4.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.403 1.481 . . . . 0.0 107.817 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 28.7 m -128.61 150.77 50.08 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 128.363 2.665 . . . . 0.0 105.99 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -124.37 109.02 12.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -110.44 116.26 31.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.829 1.652 . . . . 0.0 110.903 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.29 123.67 31.03 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 128.119 2.568 . . . . 0.0 107.405 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -72.19 101.18 2.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 118.951 0.796 . . . . 0.0 109.468 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.2 159.0 27.19 Favored Glycine 0 N--CA 1.44 -1.094 1 C-N-CA 131.67 4.462 . . . . 0.0 107.392 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -68.26 160.06 30.03 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.43 1.586 . . . . 0.0 111.267 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 77.6 mt -106.76 141.13 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.136 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -132.91 151.8 51.99 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.574 1.55 . . . . 0.0 110.528 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.4 t -78.29 173.05 12.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.904 0.882 . . . . 0.0 108.662 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.1 mt -129.63 140.3 49.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 122.477 1.132 . . . . 0.0 108.721 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -66.26 119.64 11.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.303 1.441 . . . . 0.0 107.821 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.88 2.44 88.5 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.31 -1.272 . . . . 0.0 114.962 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -126.39 132.79 51.46 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.91 1.855 . . . . 0.0 109.075 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 16.2 m -85.78 150.73 24.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -28.37 63.29 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 124.202 1.001 . . . . 0.0 110.075 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.6 p -72.02 -11.18 60.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.115 2.166 . . . . 0.0 114.195 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -120.47 -47.62 2.33 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.514 1.526 . . . . 0.0 109.549 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.25 144.51 12.76 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 111.084 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -150.05 175.77 11.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.738 0.415 . . . . 0.0 109.984 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.15 128.89 55.39 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.828 0.851 . . . . 0.0 110.324 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.0 128.27 71.74 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 C-N-CA 124.697 1.199 . . . . 0.0 107.855 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.05 110.26 7.2 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.6 mm -121.77 124.08 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 53.5 48.14 22.44 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.092 0.86 . . . . 0.0 109.087 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 65.48 -4.26 0.59 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.649 2.379 . . . . 0.0 115.014 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -114.9 135.59 54.03 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.094 0.861 . . . . 0.0 109.771 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -72.92 115.36 12.13 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.152 0.981 . . . . 0.0 110.26 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 146.98 34.36 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -79.31 136.79 37.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.86 1.264 . . . . 0.0 108.229 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.05 137.36 53.63 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.0 p -121.3 150.38 41.5 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.41 0.444 . . . . 0.0 111.974 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -55.01 133.51 48.59 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.0 p -134.81 137.76 50.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 126.401 1.881 . . . . 0.0 108.017 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 60.25 16.58 42.67 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.371 -1.238 . . . . 0.0 115.475 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.6 m120 . . . . . 0 C--O 1.25 1.117 0 C-N-CA 129.259 3.024 . . . . 0.0 113.335 179.647 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.5 131.42 15.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 128.972 2.909 . . . . 0.0 105.995 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 155' ' ' ASP . 18.9 p90 -66.43 149.78 49.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 97.3 t -149.72 126.25 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -71.94 134.13 30.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.52 117.52 6.32 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -24.49 19.97 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.71 0.804 . . . . 0.0 111.53 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -89.19 -22.59 22.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.368 1.467 . . . . 0.0 112.396 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.11 104.33 3.67 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 119.565 1.075 . . . . 0.0 108.273 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.4 t -60.14 -22.33 62.73 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.342 -0.849 . . . . 0.0 112.814 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.0 ptt85 -80.69 -4.83 55.8 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.35 -0.844 . . . . 0.0 110.598 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -109.6 159.28 17.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.816 0.817 . . . . 0.0 111.409 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.8 mm -130.38 146.77 33.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.04 104.75 9.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -141.06 134.43 29.74 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.05 1.34 . . . . 0.0 109.898 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.0 mtt 58.21 36.42 25.73 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.605 1.162 . . . . 0.0 112.109 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.05 22.85 63.16 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -121.88 161.51 22.66 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mm -116.37 145.24 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -135.15 156.94 48.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.0 t -139.19 165.14 27.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.4 mt -117.13 134.75 59.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.714 0.769 . . . . 0.0 110.699 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.31 -114.6 0.2 Allowed 'General case' 0 CA--C 1.539 0.521 1 N-CA-C 99.371 -4.307 . . . . 0.0 99.371 175.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -167.53 100.33 0.49 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 94.5 m -136.25 121.8 19.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.81 2.044 . . . . 0.0 106.75 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 m -71.5 121.45 18.69 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.87 110.68 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.5 m -70.85 159.53 34.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.06 0.457 . . . . 0.0 110.944 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.28 -29.86 69.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.546 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.95 -12.36 60.63 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -108.54 -23.04 12.01 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.485 1.114 . . . . 0.0 109.13 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.46 133.99 53.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.98 -105.86 0.74 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -135.85 166.86 22.31 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.613 1.565 . . . . 0.0 108.601 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -64.63 139.92 58.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -123.26 -48.03 1.99 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.573 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.413 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 28.3 m-20 -152.65 166.6 31.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.982 1.265 . . . . 0.0 111.32 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.24 143.17 40.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.572 1.149 . . . . 0.0 111.142 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -111.2 166.5 11.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.875 2.87 . . . . 0.0 112.706 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.15 58.83 0.29 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.182 0.993 . . . . 0.0 112.631 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -161.99 175.98 11.25 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.974 -1.704 . . . . 0.0 111.605 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -144.59 150.12 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.112 1.765 . . . . 0.0 108.557 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.8 164.71 29.36 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.039 1.29 . . . . 0.0 109.236 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.0 t -132.17 132.97 60.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -141.72 168.59 19.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.658 0.783 . . . . 0.0 111.271 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -89.49 102.86 15.54 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 127.022 2.129 . . . . 0.0 108.067 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.7 t -47.03 -21.23 0.2 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 129.507 3.123 . . . . 0.0 114.8 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.03 -50.91 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.432 1.493 . . . . 0.0 110.898 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.9 t -123.21 -23.84 4.81 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.858 1.663 . . . . 0.0 114.05 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.95 0.87 42.04 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.24 1.4 . . . . 0.0 110.364 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -48.13 113.5 0.75 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 127.712 2.405 . . . . 0.0 111.003 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 39.9 p -61.02 154.98 21.27 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.852 1.261 . . . . 0.0 111.299 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.99 142.44 41.19 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.28 1.032 . . . . 0.0 108.826 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.22 157.25 46.2 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.203 2.602 . . . . 0.0 108.98 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -57.68 -32.25 67.16 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.683 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -7.8 9.67 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 118.103 -0.951 . . . . 0.0 113.287 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -110.79 -8.59 14.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.4 1.454 . . . . 0.0 109.835 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.6 m0 -59.43 -38.1 79.81 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 119.668 1.122 . . . . 0.0 112.176 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -112.34 2.18 26.6 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.248 1.404 . . . . 0.0 111.254 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.98 42.97 3.23 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.373 1.469 . . . . 0.0 108.022 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.6 mt -63.71 -48.71 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -119.9 179.11 4.36 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 130.302 3.441 . . . . 0.0 112.574 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -126.74 -20.73 4.22 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.904 2.482 . . . . 0.0 112.25 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.41 -14.47 60.46 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.632 2.373 . . . . 0.0 113.356 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 77.39 30.5 53.89 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.31 157.34 20.05 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.518 1.927 . . . . 0.0 106.743 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -126.54 91.53 3.37 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.564 0.746 . . . . 0.0 109.902 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.0 t -94.98 -69.57 0.75 Allowed 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 125.155 1.382 . . . . 0.0 108.243 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -73.75 6.7 2.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.031 1.733 . . . . 0.0 115.448 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -144.4 151.23 38.97 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.832 1.253 . . . . 0.0 109.243 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.2 t -162.0 125.13 3.03 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -118.33 177.94 4.63 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.795 -1.191 . . . . 0.0 110.56 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.2 m -132.64 135.46 45.87 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 127.946 2.499 . . . . 0.0 106.626 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -114.42 108.34 16.75 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -110.23 123.87 50.56 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.591 1.556 . . . . 0.0 109.73 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -90.46 125.2 35.5 Favored 'General case' 0 N--CA 1.441 -0.893 1 C-N-CA 133.244 4.618 . . . . 0.0 109.087 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -77.74 101.88 6.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 127.327 2.251 . . . . 0.0 107.72 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -97.79 159.35 20.89 Favored Glycine 0 CA--C 1.533 1.218 1 C-N-CA 134.377 5.751 . . . . 0.0 108.049 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -66.6 163.19 19.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.939 1.369 . . . . 0.0 110.569 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 73.7 mt -109.31 134.95 49.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 128.138 2.575 . . . . 0.0 111.735 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -130.02 151.29 50.73 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.947 1.299 . . . . 0.0 110.239 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.3 p -78.59 173.53 12.32 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.3 mt -128.29 136.59 59.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 O-C-N 121.255 -0.903 . . . . 0.0 109.805 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -63.03 127.34 30.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.3 12.09 84.91 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.478 -1.179 . . . . 0.0 113.915 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -138.85 156.16 47.54 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 120.365 2.083 . . . . 0.0 109.168 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.2 m -103.32 146.62 28.19 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -23.34 58.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.875 0.87 . . . . 0.0 109.74 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 23.7 p -79.11 -9.5 59.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.721 1.608 . . . . 0.0 114.105 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -123.73 -40.63 2.31 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.678 0.791 . . . . 0.0 112.215 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.48 140.02 8.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -150.57 176.13 11.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -107.93 143.13 37.01 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.45 121.9 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.647 1.579 . . . . 0.0 108.768 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.85 104.37 4.0 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.1 mm -122.15 126.03 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 126.49 1.916 . . . . 0.0 109.273 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 58.54 34.76 24.15 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.844 -1.16 . . . . 0.0 112.236 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 66.1 13.77 9.28 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.366 1.066 . . . . 0.0 113.187 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.62 120.23 21.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.318 1.847 . . . . 0.0 108.634 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -65.6 136.65 56.62 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 120.103 -1.623 . . . . 0.0 109.965 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -127.15 147.9 50.18 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.026 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -84.86 115.1 22.57 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.056 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.48 147.8 24.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.59 143.18 50.15 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 118.0 0.364 . . . . 0.0 110.571 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -50.86 135.3 24.41 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.209 1.404 . . . . 0.0 110.061 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.27 158.92 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -133.12 32.85 2.68 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.3 t30 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 127.299 2.24 . . . . 0.0 108.452 -178.169 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.04 141.82 25.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.663 1.574 . . . . 0.0 108.966 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -65.0 118.51 9.22 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.722 1.609 . . . . 0.0 110.103 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.4 t -121.76 135.55 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -83.0 118.93 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -47.4 118.77 2.33 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.187 1.395 . . . . 0.0 110.486 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -59.98 -21.45 61.28 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.507 -0.746 . . . . 0.0 111.701 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -88.53 -20.05 25.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.083 0.953 . . . . 0.0 111.257 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.05 112.25 2.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.965 1.257 . . . . 0.0 110.64 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 m -60.27 -21.91 62.46 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 119.957 -1.714 . . . . 0.0 113.428 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.7 ptt85 -80.84 1.23 31.53 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 120.858 -1.151 . . . . 0.0 110.015 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -111.93 158.68 19.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.867 0.841 . . . . 0.0 110.277 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.0 mm -133.43 127.59 53.89 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 136' ' ' ASN . 4.7 t0 -96.91 105.0 17.05 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 128.086 2.554 . . . . 0.0 104.14 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -139.5 143.11 37.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.083 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 8.9 mtt 55.24 22.87 5.03 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.853 -1.154 . . . . 0.0 113.749 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.04 17.86 71.11 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.504 1.049 . . . . 0.0 110.983 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 8.9 p30 -117.28 173.84 6.46 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 126.588 1.955 . . . . 0.0 112.88 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.2 mm -130.04 132.33 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -119.33 163.55 17.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 t -140.02 148.12 41.39 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.578 1.551 . . . . 0.0 106.925 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 mt -114.08 121.74 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -94.85 -113.5 0.12 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -158.3 99.63 1.63 Allowed 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 65.0 m -136.95 116.42 12.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.004 2.522 . . . . 0.0 104.89 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.6 m -78.35 122.3 25.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 121.235 1.834 . . . . 0.0 106.595 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.7 t -94.67 113.05 28.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.018 1.327 . . . . 0.0 109.225 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.0 m -75.14 163.84 27.13 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.523 1.129 . . . . 0.0 111.18 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.24 -29.34 68.7 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.264 1.025 . . . . 0.0 110.168 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.02 -16.48 64.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.363 0.665 . . . . 0.0 112.062 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -105.35 -30.68 9.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.63 1.572 . . . . 0.0 109.83 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -55.67 127.27 29.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.951 1.3 . . . . 0.0 110.141 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.48 -104.83 1.25 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 125.235 1.398 . . . . 0.0 110.066 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -134.44 168.31 19.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.397 1.479 . . . . 0.0 109.296 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.42 136.95 58.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -115.18 -52.37 2.68 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.414 0.686 . . . . 0.0 111.784 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -160.37 159.9 31.68 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.77 1.168 . . . . 0.0 109.038 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 p -114.75 133.13 61.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.665 1.186 . . . . 0.0 111.402 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.61 164.9 12.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.966 2.106 . . . . 0.0 111.114 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.87 29.36 0.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.85 174.12 6.8 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 119.924 -1.735 . . . . 0.0 108.133 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.9 t -143.67 149.98 17.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.22 164.91 33.45 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.8 t -127.72 131.28 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -144.23 167.81 21.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.442 0.639 . . . . 0.0 110.172 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -79.99 119.16 22.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.1 t -66.21 -13.92 61.07 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.4 m -83.77 -43.61 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.7 m -122.19 -26.97 4.6 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.728 1.211 . . . . 0.0 113.919 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.31 -1.38 31.09 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.455 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -52.86 112.49 0.85 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.36 1.08 . . . . 0.0 111.599 -179.288 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.99 140.57 56.37 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.2 mp -106.88 143.39 26.99 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.32 1.848 . . . . 0.0 108.327 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.25 148.53 18.98 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.692 2.928 . . . . 0.0 110.896 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -53.38 -31.5 45.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.752 0.821 . . . . 0.0 112.892 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 t -68.76 -6.23 25.32 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.715 0.806 . . . . 0.0 112.998 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -116.4 -12.71 11.04 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.872 1.669 . . . . 0.0 110.201 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -52.7 -40.26 62.79 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -114.22 13.06 21.58 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.077 1.322 . . . . 0.0 111.823 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -134.48 79.83 1.82 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.3 mm -50.43 -77.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 126.741 2.016 . . . . 0.0 109.424 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -170.67 174.45 4.99 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.165 0.986 . . . . 0.0 108.834 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -114.05 -54.38 2.6 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.838 2.055 . . . . 0.0 106.54 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.31 -48.84 31.12 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.019 1.328 . . . . 0.0 108.958 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -83.92 163.06 39.62 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-O 121.758 0.643 . . . . 0.0 112.238 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.1 m -141.52 142.41 33.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.952 0.901 . . . . 0.0 109.911 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -74.07 92.03 2.13 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.961 0.904 . . . . 0.0 109.96 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.9 m -117.02 -27.93 6.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -139.27 12.89 2.6 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.74 1.216 . . . . 0.0 111.76 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.547 ' NE2' HH22 ' A' ' 190' ' ' ARG . 70.9 mt-30 -117.29 163.39 16.4 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.414 1.086 . . . . 0.0 110.55 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.21 108.84 0.17 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.547 HH22 ' NE2' ' A' ' 188' ' ' GLN . 14.0 mmt180 -75.57 177.42 6.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.412 HG21 ' CD1' ' A' ' 193' ' ' TRP . 95.5 m -128.66 117.78 21.77 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -95.03 113.12 24.79 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . 0.412 ' CD1' HG21 ' A' ' 191' ' ' THR . 12.4 m0 -123.38 124.5 43.06 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.702 1.601 . . . . 0.0 110.256 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.72 135.03 34.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.036 2.134 . . . . 0.0 107.512 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -78.3 100.52 6.76 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.69 159.55 23.1 Favored Glycine 0 N--CA 1.441 -0.984 1 C-N-CA 130.818 4.056 . . . . 0.0 107.514 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -68.14 154.33 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 123.655 1.693 . . . . 0.0 111.61 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.66 141.04 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 112.997 -1.911 . . . . 0.0 108.205 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -134.2 153.63 51.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 112.957 -1.929 . . . . 0.0 108.316 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.72 173.11 12.19 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 81.6 mt -124.14 137.5 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -55.71 119.58 5.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.162 1.385 . . . . 0.0 108.24 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.46 12.1 82.34 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.412 -1.215 . . . . 0.0 115.436 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -126.05 133.01 51.83 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 120.961 2.381 . . . . 0.0 109.568 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 67.9 m -83.53 142.78 30.64 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.47 -32.23 57.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.272 1.029 . . . . 0.0 110.501 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.2 p -70.12 -10.55 59.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.277 1.431 . . . . 0.0 114.516 -178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.02 -41.36 2.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.712 1.205 . . . . 0.0 109.097 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -166.93 151.61 7.3 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.002 0.819 . . . . 0.0 110.258 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -156.48 175.63 13.77 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.113 0.965 . . . . 0.0 109.565 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -112.13 137.0 50.81 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.889 1.276 . . . . 0.0 110.093 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.04 131.63 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.135 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -71.0 106.22 3.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 40.4 mm -122.4 125.16 72.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.1 m120 56.35 36.71 27.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 13.7 t0 70.87 -4.94 1.59 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.539 1.936 . . . . 0.0 112.095 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.6 127.31 52.96 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 118.931 -2.356 . . . . 0.0 110.73 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -74.43 116.52 15.21 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.583 -1.323 . . . . 0.0 109.979 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -107.11 147.81 29.57 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.766 0.826 . . . . 0.0 109.809 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.4 tm? -83.85 128.03 34.25 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.49 1.516 . . . . 0.0 109.296 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -111.54 151.72 28.36 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.085 0.954 . . . . 0.0 109.167 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.2 p -133.2 147.9 52.02 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.75 1.22 . . . . 0.0 111.088 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -59.94 128.86 38.96 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.717 -0.615 . . . . 0.0 112.042 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.5 t -135.14 133.59 53.12 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 C-N-CA 125.596 1.558 . . . . 0.0 109.722 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -105.36 60.35 0.4 Allowed Glycine 0 CA--C 1.519 0.333 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 124.996 1.319 . . . . 0.0 107.634 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.505 -0.76 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.28 149.86 41.82 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.273 2.229 . . . . 0.0 107.307 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 121' ' ' PHE . 2.7 p90 -71.49 132.16 44.34 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 127.719 2.407 . . . . 0.0 106.569 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 93.4 t -133.91 125.54 49.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mp -69.4 134.71 29.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -57.4 118.28 4.98 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.73 -18.02 63.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.549 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -94.38 -28.05 15.73 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.076 0.951 . . . . 0.0 111.491 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -138.96 106.73 5.63 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.743 1.217 . . . . 0.0 109.66 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.431 ' HB3' ' CD2' ' A' ' 163' ' ' PHE . 22.7 t -58.74 -24.93 62.43 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 120.592 -1.318 . . . . 0.0 112.687 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -82.53 -1.67 51.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.441 1.096 . . . . 0.0 111.106 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -116.13 159.29 21.95 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.447 0.642 . . . . 0.0 111.934 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.4 mm -127.54 144.77 36.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -121.4 106.1 11.13 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 128.115 2.566 . . . . 0.0 105.126 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -138.9 130.92 27.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.7 mtt 60.45 22.54 12.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.259 1.424 . . . . 0.0 112.243 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.61 16.16 79.69 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -109.42 162.58 14.22 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.1 mm -123.3 132.08 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -120.33 159.13 25.65 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.7 t -145.65 155.49 43.04 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 mt -111.83 115.98 51.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 123.872 0.869 . . . . 0.0 111.643 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.5 t -87.15 -116.67 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -158.32 99.15 1.61 Allowed 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 55.4 m -137.04 129.6 30.12 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 131.151 3.78 . . . . 0.0 108.188 177.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.0 126.09 31.56 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.64 1.976 . . . . 0.0 107.511 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.2 t -94.77 111.85 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 120.621 1.555 . . . . 0.0 107.425 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.1 m -75.31 156.71 35.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.023 0.916 . . . . 0.0 109.801 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -55.85 -30.87 62.16 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 127.997 2.519 . . . . 0.0 112.885 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -72.86 -26.8 61.59 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.981 0.913 . . . . 0.0 111.455 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -97.84 -19.88 17.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.33 1.052 . . . . 0.0 110.097 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 mt -69.52 123.51 21.49 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.209 1.804 . . . . 0.0 109.504 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.16 -117.92 0.51 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 125.27 1.414 . . . . 0.0 110.96 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -130.13 165.14 22.92 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.535 1.134 . . . . 0.0 111.617 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -60.83 120.54 10.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.634 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -102.83 -52.71 3.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 118.003 -0.998 . . . . 0.0 111.119 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -153.44 166.01 34.04 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.487 0.585 . . . . 0.0 112.037 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.33 138.8 50.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 124.435 1.094 . . . . 0.0 109.324 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.74 165.5 11.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.501 2.32 . . . . 0.0 109.598 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -171.07 65.97 0.04 OUTLIER 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.398 0.679 . . . . 0.0 111.881 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.52 166.51 30.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.3 t -145.11 149.73 16.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -146.99 164.83 31.7 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.1 122.18 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.431 ' CD2' ' HB3' ' A' ' 128' ' ' SER . 37.2 p90 -140.0 177.3 8.07 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.376 1.444 . . . . 0.0 113.347 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -84.14 128.93 34.88 Favored 'General case' 0 C--N 1.347 0.488 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.3 t -66.05 -16.64 64.1 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.312 1.415 . . . . 0.0 113.372 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.63 -55.27 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 118.676 0.671 . . . . 0.0 112.468 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.3 m -121.73 -22.19 5.89 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.891 1.276 . . . . 0.0 113.004 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.46 15.3 25.55 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-O 118.455 -1.191 . . . . 0.0 115.714 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.479 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.3 OUTLIER -59.44 116.83 4.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.399 1.599 . . . . 0.0 109.981 179.523 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.08 153.45 41.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.735 1.152 . . . . 0.0 109.424 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.31 142.06 24.82 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.39 147.18 46.37 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.796 2.331 . . . . 0.0 109.959 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -56.54 -30.06 62.65 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.793 -0.567 . . . . 0.0 112.438 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.7 m -66.43 -7.09 17.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.621 1.169 . . . . 0.0 113.19 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -120.34 -4.84 9.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.123 1.769 . . . . 0.0 111.338 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -58.37 -35.05 71.38 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.23 -0.919 . . . . 0.0 113.332 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -133.94 13.52 4.71 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.805 1.193 . . . . 0.0 111.322 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.67 91.11 2.8 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.583 ' CD1' ' H ' ' A' ' 187' ' ' LYS . 15.7 mt -123.5 -92.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 181' ' ' LYS . 17.4 t70 -114.61 -168.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.646 1.978 . . . . 0.0 106.493 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.402 ' H ' ' CG ' ' A' ' 180' ' ' ASP . 30.1 mtmm -62.87 173.23 1.4 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.241 1.417 . . . . 0.0 107.771 178.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.41 11.48 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.4 2.28 . . . . 0.0 116.132 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -74.79 -164.13 11.53 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 127.161 2.315 . . . . 0.0 112.12 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.7 m -78.52 -9.07 59.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.523 1.529 . . . . 0.0 114.82 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -89.06 70.62 8.46 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 75.1 m -157.29 149.82 23.07 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 120.927 -1.108 . . . . 0.0 109.411 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.583 ' H ' ' CD1' ' A' ' 179' ' ' ILE . 20.7 pttm 42.66 31.6 0.31 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.818 2.447 . . . . 0.0 112.957 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -91.22 130.3 37.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 75.7 33.16 0.65 Allowed 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 126.786 2.034 . . . . 0.0 111.285 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -130.85 149.47 52.47 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.649 0.738 . . . . 0.0 110.157 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.0 m -131.17 131.01 43.75 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -112.56 113.22 25.26 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -114.85 121.41 43.15 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.659 1.584 . . . . 0.0 108.761 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -89.3 131.76 35.24 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 128.905 2.882 . . . . 0.0 106.649 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -80.25 103.17 9.94 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.09 158.55 26.95 Favored Glycine 0 CA--C 1.53 1.03 1 C-N-CA 134.588 5.851 . . . . 0.0 107.056 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.72 160.08 31.01 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.147 1.474 . . . . 0.0 112.301 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 61.4 mt -109.06 139.02 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 126.12 1.768 . . . . 0.0 111.159 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -130.51 151.13 51.33 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.528 1.531 . . . . 0.0 109.446 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 13.6 p -75.9 174.17 10.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.159 0.584 . . . . 0.0 110.729 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 60.9 mt -132.61 139.43 49.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.135 1.374 . . . . 0.0 108.473 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -55.32 122.88 12.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.532 1.533 . . . . 0.0 109.832 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 66.34 13.27 60.08 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.343 -1.254 . . . . 0.0 115.498 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -131.05 124.37 30.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 120.05 1.925 . . . . 0.0 108.867 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 69.6 m -80.5 151.81 29.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.39 -26.35 40.97 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.846 1.258 . . . . 0.0 109.472 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.2 p -70.38 -17.1 63.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.917 2.087 . . . . 0.0 113.377 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -120.54 -43.5 2.49 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.78 1.232 . . . . 0.0 112.009 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.5 146.0 6.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.051 0.94 . . . . 0.0 109.539 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -158.26 176.66 12.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.73 1.212 . . . . 0.0 108.805 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.23 132.57 53.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.467 1.507 . . . . 0.0 110.955 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.6 p -129.63 125.96 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 C-N-CA 124.312 1.045 . . . . 0.0 110.62 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -72.53 112.87 8.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 30.0 mm -122.59 119.83 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 55.14 33.61 20.84 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.274 0.943 . . . . 0.0 111.952 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.6 t70 80.33 -9.18 1.42 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.844 2.857 . . . . 0.0 111.977 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.91 122.64 43.14 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.843 -1.16 . . . . 0.0 108.836 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -73.81 112.53 10.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -104.01 145.94 29.43 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.102 0.961 . . . . 0.0 111.434 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.3 tm? -81.66 126.82 32.23 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -116.28 146.39 42.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.9 p -127.58 158.42 37.52 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.415 0.686 . . . . 0.0 111.19 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -64.92 122.11 16.2 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.56 101.29 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.671 1.224 . . . . 0.0 108.271 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -114.82 15.39 19.22 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.66 1.6 . . . . 0.0 112.454 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.6 m120 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 127.671 2.388 . . . . 0.0 107.598 -179.605 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.285 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -70.07 128.4 36.18 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.3 t -132.07 135.36 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -80.93 140.13 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -55.71 127.86 32.05 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.306 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -55.83 -26.94 49.03 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.784 -1.198 . . . . 0.0 111.054 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -101.76 -8.31 21.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.946 1.299 . . . . 0.0 113.634 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.06 107.22 3.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.6 m -64.94 -14.14 59.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.253 1.821 . . . . 0.0 111.846 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -99.6 0.58 42.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.016 1.726 . . . . 0.0 112.029 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -117.69 158.44 24.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.068 0.461 . . . . 0.0 110.33 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.5 mm -126.29 132.61 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.12 99.14 8.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 102.069 -3.308 . . . . 0.0 102.069 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -135.71 127.07 28.45 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.347 -1.471 . . . . 0.0 107.607 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 12.9 mtt 60.44 30.16 19.57 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.558 1.143 . . . . 0.0 109.769 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.12 -0.34 31.5 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 123.808 0.718 . . . . 0.0 111.75 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -90.62 164.37 14.21 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.5 mm -123.99 123.63 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.657 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.66 131.11 53.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.294 1.038 . . . . 0.0 109.039 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.1 t -113.1 151.24 31.03 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.785 1.234 . . . . 0.0 108.374 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.2 mt -110.76 118.59 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.074 0.95 . . . . 0.0 108.744 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.3 t -89.04 -107.75 0.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -160.23 99.48 1.33 Allowed 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 85.5 m -138.33 114.44 10.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 115.865 -2.017 . . . . 0.0 107.128 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.5 m -75.62 125.59 29.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 122.448 2.386 . . . . 0.0 106.617 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.6 t -99.63 111.83 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.868 1.267 . . . . 0.0 108.152 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.9 m -75.77 161.18 29.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.75 0.82 . . . . 0.0 109.733 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.7 -30.48 68.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.42 1.088 . . . . 0.0 112.043 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.87 -24.24 64.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.31 -0.244 . . . . 0.0 110.891 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -96.44 -27.1 15.06 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.324 0.649 . . . . 0.0 109.515 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.6 tp -68.11 148.7 50.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.193 1.397 . . . . 0.0 109.286 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.74 -101.99 2.65 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.62 1.105 . . . . 0.0 111.158 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -135.07 171.19 14.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.313 1.845 . . . . 0.0 111.221 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -64.12 136.82 57.59 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.421 1.088 . . . . 0.0 110.189 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -117.19 -52.63 2.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.152 0.981 . . . . 0.0 113.168 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -157.59 158.4 35.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.098 0.863 . . . . 0.0 111.695 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.05 137.99 45.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 119.241 0.928 . . . . 0.0 111.165 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.57 165.19 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.487 1.915 . . . . 0.0 111.09 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.58 65.81 0.07 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.156 0.982 . . . . 0.0 111.192 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -157.98 167.76 29.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 t -144.18 148.39 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -142.05 166.61 24.24 Favored 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 120.872 -1.143 . . . . 0.0 108.558 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.09 129.72 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.63 168.86 18.75 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.179 0.9 . . . . 0.0 111.203 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -101.65 102.14 12.77 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.3 t -50.77 -19.19 0.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 129.361 3.064 . . . . 0.0 115.965 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.7 m -55.99 -46.95 80.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.3 m -123.98 -23.24 4.66 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.144 1.777 . . . . 0.0 114.276 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 103.7 7.87 41.14 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.289 1.899 . . . . 0.0 112.864 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 113.2 1.54 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.675 1.737 . . . . 0.0 112.942 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 p -63.2 140.56 58.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.154 0.982 . . . . 0.0 108.567 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.89 147.34 34.31 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.48 159.72 19.61 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.479 2.786 . . . . 0.0 110.089 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -64.44 -17.61 63.97 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 121.377 -0.827 . . . . 0.0 111.708 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.6 p -74.53 -11.14 60.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.367 -0.833 . . . . 0.0 111.711 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -111.1 -3.89 15.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.32 1.448 . . . . 0.0 112.251 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.6 m0 . . . . . 0 N--CA 1.465 0.303 0 C-N-CA 125.375 1.47 . . . . 0.0 114.397 -179.702 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 99.8 m -139.96 130.43 25.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -113.54 105.31 13.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.407 1.883 . . . . 0.0 107.547 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -110.3 127.89 55.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.941 0.896 . . . . 0.0 109.736 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -96.75 126.98 42.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.478 1.911 . . . . 0.0 107.399 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -75.66 100.96 4.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.896 1.331 . . . . 0.0 111.522 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -95.4 159.28 22.47 Favored Glycine 0 N--CA 1.431 -1.649 1 C-N-CA 130.727 4.013 . . . . 0.0 108.335 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.78 152.46 45.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 124.16 1.933 . . . . 0.0 111.029 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 67.7 mt -96.68 141.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.868 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -135.38 151.7 50.73 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.549 1.54 . . . . 0.0 109.233 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.9 p -77.48 173.27 12.17 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.246 1.018 . . . . 0.0 110.798 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 60.1 mt -126.34 137.52 57.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -67.49 124.21 22.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.48 1.512 . . . . 0.0 108.883 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.84 12.24 84.38 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 117.922 -1.488 . . . . 0.0 114.666 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -141.4 142.7 33.71 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.743 1.772 . . . . 0.0 111.255 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 24.5 m -90.02 151.24 21.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.837 0.827 . . . . 0.0 109.114 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -31.83 67.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.088 0.955 . . . . 0.0 111.183 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.4 p -68.69 -10.03 53.82 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 129.352 3.061 . . . . 0.0 114.624 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -120.51 -46.79 2.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.836 1.254 . . . . 0.0 107.764 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.16 147.91 5.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.593 0.711 . . . . 0.0 110.571 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -152.83 176.16 12.11 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.167 0.587 . . . . 0.0 110.098 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.64 137.63 47.18 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.457 HG13 HG12 ' A' ' 214' ' ' ILE . 8.9 p -130.02 130.23 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 125.26 1.424 . . . . 0.0 110.879 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.54 107.68 4.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.457 HG12 HG13 ' A' ' 212' ' ' VAL . 33.0 mm -120.74 120.7 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 52.98 45.53 28.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.421 0.688 . . . . 0.0 109.901 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 64.27 13.3 7.85 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.537 1.535 . . . . 0.0 112.623 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.414 ' HB3' ' HE2' ' A' ' 219' ' ' LYS . 0.4 OUTLIER -125.18 122.15 36.22 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.165 -0.959 . . . . 0.0 108.687 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -69.42 115.93 9.25 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 120.512 -1.368 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 217' ' ' ASP . 66.3 mmtt -111.02 145.81 37.81 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.467 1.507 . . . . 0.0 113.09 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -80.64 128.8 34.03 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.929 1.291 . . . . 0.0 111.547 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -115.29 141.62 47.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.05 143.35 50.84 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.508 0.723 . . . . 0.0 110.535 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -55.41 138.53 45.78 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 CA--C 1.536 0.416 0 C-N-CA 126.84 2.056 . . . . 0.0 105.761 176.469 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.632 ' CD2' HD13 ' A' ' 198' ' ' ILE . 88.9 m-85 -59.17 146.43 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 98.5 t -150.29 120.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.164 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.741 HG21 ' OH ' ' A' ' 195' ' ' TYR . 4.8 mp -68.13 118.17 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.135 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.34 123.62 13.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -20.36 66.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -90.47 -33.11 16.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.04 104.67 6.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -67.18 -13.59 62.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.722 ' O ' HD12 ' A' ' 140' ' ' ILE . 47.6 ptt85 -94.89 -7.13 40.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.854 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -101.71 159.93 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.6 mm -128.02 131.52 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.139 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -107.7 103.65 12.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -135.79 129.77 33.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.2 mtt 59.69 39.73 20.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 63.4 20.46 63.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.443 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -113.43 172.81 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 36.3 mm -131.36 129.01 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -125.42 152.31 45.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 t -121.18 152.04 39.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 129' ' ' ARG . 2.7 mt -123.26 111.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.122 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -92.74 -90.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -169.86 93.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 26.4 m -140.64 104.63 4.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 m -62.94 113.18 2.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.83 119.48 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.4 m -84.74 171.41 12.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.77 -26.31 64.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.09 -25.1 68.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -104.66 -26.12 12.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.61 137.75 58.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.38 -105.78 2.65 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.516 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -134.24 169.92 16.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.93 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -56.23 142.09 38.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -125.43 -51.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.953 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -147.37 159.87 43.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 5.3 p -119.56 129.93 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.478 HD11 HD11 ' A' ' 123' ' ' ILE . 3.3 mm? -110.9 166.01 11.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.67 70.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -166.41 175.34 8.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.3 t -144.87 149.45 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.103 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.74 155.54 42.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -124.59 123.32 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.114 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -144.85 155.44 43.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.588 ' CG ' HG22 ' A' ' 166' ' ' VAL . 4.6 t0 -74.34 124.49 26.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.12 -4.35 32.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.588 HG22 ' CG ' ' A' ' 164' ' ' ASP . 27.5 m -77.93 -44.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.16 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.478 ' N ' HG23 ' A' ' 166' ' ' VAL . 6.7 t -123.36 -30.12 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.09 33.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.434 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -69.9 127.93 34.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.844 0.354 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.83 155.11 37.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.47 139.83 35.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.584 0.707 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 154.98 67.1 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.645 2.23 . . . . 0.0 112.366 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -58.98 -21.71 59.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 m -73.86 -7.66 53.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.09 -12.46 14.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 31.8 m0 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.42 HG22 ' CD1' ' A' ' 193' ' ' TRP . 98.9 m -137.77 120.41 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.69 105.52 17.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' TRP . . . . . 0.42 ' CD1' HG22 ' A' ' 191' ' ' THR . 13.5 m0 -110.35 116.78 32.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.96 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -84.55 126.55 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.741 ' OH ' HG21 ' A' ' 123' ' ' ILE . 13.4 m-30 -65.21 103.83 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 213' ' ' GLU . . . -101.28 162.84 17.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.484 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.28 139.35 58.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.798 0.333 . . . . 0.0 110.861 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.632 HD13 ' CD2' ' A' ' 121' ' ' PHE . 10.1 mt -91.21 143.39 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -131.68 143.14 50.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.78 172.26 3.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 71.1 mt -130.8 141.83 45.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -69.3 122.16 18.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 76.02 27.12 62.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -149.34 146.28 27.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.326 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -106.0 145.11 31.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.855 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.491 HD13 ' HB3' ' A' ' 210' ' ' PHE . 0.9 OUTLIER -63.24 -17.15 62.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 67.4 p -82.59 -9.41 59.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.65 -51.56 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.09 146.32 24.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.069 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.638 ' O ' HD22 ' A' ' 220' ' ' LEU . 39.4 p90 -154.44 176.44 12.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -110.4 125.36 53.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.084 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.54 HG11 HG12 ' A' ' 140' ' ' ILE . 6.0 p -117.68 125.39 74.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.142 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.429 ' HB3' ' HA3' ' A' ' 196' ' ' GLY . 18.9 tt0 -70.43 101.55 1.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 48.4 mm -120.39 120.25 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.1 m120 60.53 43.94 12.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.37 14.88 9.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -137.49 122.11 18.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.52 125.06 26.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -116.62 140.69 49.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.638 HD22 ' O ' ' A' ' 210' ' ' PHE . 3.3 tm? -76.37 121.76 23.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.54 139.29 40.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.21 138.33 50.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -64.97 122.12 16.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 94.4 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 179.915 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.063 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -73.9 134.5 43.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 84.2 t -135.2 124.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.9 mp -73.12 140.23 18.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -66.19 127.12 30.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -65.55 -27.05 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.462 -0.774 . . . . 0.0 111.705 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -80.67 -45.5 17.1 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.721 1.209 . . . . 0.0 110.057 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.08 100.59 6.8 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.4 t -62.67 -7.66 5.23 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.872 -1.142 . . . . 0.0 110.95 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -94.3 -4.87 47.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.867 2.067 . . . . 0.0 110.257 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -110.84 158.81 18.28 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.6 mm -125.34 138.41 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.92 103.48 11.71 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 102.923 -2.992 . . . . 0.0 102.923 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -137.69 132.37 32.78 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.1 mtt 57.97 25.35 12.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.995 0.918 . . . . 0.0 111.077 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.42 -0.6 68.58 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.429 -0.795 . . . . 0.0 112.412 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -93.69 166.26 12.3 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.552 1.541 . . . . 0.0 108.006 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.7 mm -123.18 137.18 57.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -131.08 156.77 44.64 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.814 1.246 . . . . 0.0 108.454 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.474 ' HB2' HG11 ' A' ' 224' ' ' VAL . 14.2 t -140.37 155.67 46.68 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 107.986 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.7 mt -114.37 117.8 56.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.284 1.433 . . . . 0.0 110.795 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.6 t -86.63 -111.01 0.05 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -162.46 101.26 1.06 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 103.563 -2.755 . . . . 0.0 103.563 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 49.2 m -134.88 111.82 10.18 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.1 m -70.93 120.54 16.65 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.37 122.41 45.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.5 m -82.2 154.44 25.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.81 -26.9 67.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.54 1.136 . . . . 0.0 112.036 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.72 -19.07 62.78 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.415 -0.803 . . . . 0.0 110.471 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -106.19 -16.22 14.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.46 1.904 . . . . 0.0 110.086 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.8 tp -80.19 118.42 21.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 128.105 2.562 . . . . 0.0 107.103 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.45 -103.78 0.11 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 123.687 0.661 . . . . 0.0 111.486 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.68 170.01 16.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.559 1.144 . . . . 0.0 110.069 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -61.89 142.92 57.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.572 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -125.64 -48.95 1.65 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.559 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.77 160.74 43.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.093 1.315 . . . . 0.0 110.714 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.83 135.19 60.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.835 1.254 . . . . 0.0 111.561 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.8 164.87 12.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.805 2.042 . . . . 0.0 111.522 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.15 54.89 0.06 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.953 0.901 . . . . 0.0 112.124 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.44 172.33 15.13 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.338 -1.476 . . . . 0.0 107.517 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.38 147.53 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -145.18 166.24 26.02 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 120.576 -1.327 . . . . 0.0 108.521 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.1 t -129.24 133.31 65.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -147.97 160.59 42.66 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.48 0.582 . . . . 0.0 111.71 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.34 106.29 7.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.5 t -61.07 -20.25 62.37 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.23 -33.33 19.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 120.823 -1.173 . . . . 0.0 113.978 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.0 t -122.03 -25.45 4.94 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.061 0.945 . . . . 0.0 112.241 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.83 -0.14 56.42 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.064 1.792 . . . . 0.0 112.073 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -52.98 112.23 0.81 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.147 1.474 . . . . 0.0 110.421 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.4 m -70.99 157.67 37.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 119.294 0.952 . . . . 0.0 111.627 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.0 129.28 25.48 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.901 2.08 . . . . 0.0 106.375 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.44 157.73 48.93 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.322 2.681 . . . . 0.0 109.196 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -52.31 -32.27 37.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.892 0.877 . . . . 0.0 112.673 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.4 m -64.74 -12.97 52.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.09 -6.82 15.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.842 2.057 . . . . 0.0 111.747 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.5 m0 . . . . . 0 C--O 1.233 0.229 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.141 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.1 m -154.12 150.81 28.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -127.63 104.76 8.04 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -114.15 117.03 30.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.816 1.246 . . . . 0.0 110.557 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.27 129.38 34.58 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.975 2.11 . . . . 0.0 108.833 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.425 ' CE2' HD13 ' A' ' 123' ' ' ILE . 6.0 m-30 -76.34 100.83 5.27 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.244 0.617 . . . . 0.0 109.776 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.43 158.87 23.04 Favored Glycine 0 CA--C 1.531 1.054 1 C-N-CA 133.483 5.325 . . . . 0.0 107.228 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.85 154.18 42.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 123.87 1.795 . . . . 0.0 111.603 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 58.2 mt -100.83 139.11 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.013 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -131.9 149.54 52.41 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.458 1.503 . . . . 0.0 109.585 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.2 t -78.65 173.65 12.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.241 1.016 . . . . 0.0 109.611 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 75.7 mt -131.49 143.9 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.674 1.189 . . . . 0.0 110.626 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -65.63 131.27 45.94 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.651 1.18 . . . . 0.0 108.877 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 62.92 22.38 64.52 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.152 -1.36 . . . . 0.0 115.22 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -140.23 148.08 40.98 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.122 1.461 . . . . 0.0 107.819 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.1 m -105.87 146.62 29.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.01 -31.31 60.94 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.078 1.351 . . . . 0.0 110.544 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.4 p -70.54 -12.65 61.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.607 1.963 . . . . 0.0 114.729 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -125.06 -39.37 2.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.863 1.665 . . . . 0.0 112.205 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.33 139.74 5.92 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.159 0.983 . . . . 0.0 110.797 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -150.19 174.31 12.94 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.958 0.903 . . . . 0.0 109.534 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.56 138.67 47.8 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.133 0.573 . . . . 0.0 111.864 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.6 p -132.65 131.07 59.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.895 1.278 . . . . 0.0 110.747 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.79 106.23 7.26 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 39.7 mm -122.06 129.81 75.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.653 1.181 . . . . 0.0 110.759 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 53.94 37.75 27.34 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.382 -0.824 . . . . 0.0 112.123 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 74.77 5.51 4.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.246 1.818 . . . . 0.0 111.311 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -130.8 134.9 47.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.74 1.155 . . . . 0.0 112.351 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -70.86 130.24 41.14 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 121.056 -1.027 . . . . 0.0 110.447 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -125.66 148.49 48.99 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.997 1.319 . . . . 0.0 109.617 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.53 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -84.06 126.69 33.31 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.106 1.362 . . . . 0.0 112.065 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -109.78 143.25 39.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 1.1 p -125.67 148.23 49.08 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.47 1.508 . . . . 0.0 111.616 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -55.56 139.98 42.31 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 139' ' ' SER . 7.7 p . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -77.78 121.45 24.07 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 124.822 1.249 . . . . 0.0 108.136 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.2 t -125.86 128.44 72.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 125.58 1.552 . . . . 0.0 109.095 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -72.87 140.03 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -61.63 129.94 43.5 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.247 -0.908 . . . . 0.0 111.098 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -67.33 -11.49 57.75 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.337 -0.852 . . . . 0.0 111.687 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -106.23 -14.54 15.1 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.789 1.236 . . . . 0.0 112.962 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.82 115.21 5.12 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.97 0.805 . . . . 0.0 109.496 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.476 ' HB2' ' CD1' ' A' ' 163' ' ' PHE . 73.6 m -63.81 -17.57 63.24 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.95 -1.093 . . . . 0.0 111.784 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -94.56 -1.7 52.87 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.97 1.708 . . . . 0.0 112.012 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -105.97 156.34 18.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.431 1.014 . . . . 0.0 111.628 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.2 mm -128.03 136.39 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -116.07 107.32 14.78 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.497 2.319 . . . . 0.0 105.657 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -145.07 133.97 22.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.9 mtt 58.22 33.22 22.95 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.396 1.478 . . . . 0.0 111.061 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.1 22.62 70.82 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -116.78 163.84 15.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 28.6 mm -121.6 128.96 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.972 0.909 . . . . 0.0 109.294 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -125.46 157.8 36.02 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.46 ' HB2' HG11 ' A' ' 224' ' ' VAL . 46.9 t -141.96 157.98 44.31 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.828 1.251 . . . . 0.0 108.861 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.3 mt -110.54 130.49 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.23 1.012 . . . . 0.0 109.698 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -106.76 -116.51 0.26 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 102.591 -3.115 . . . . 0.0 102.591 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -157.41 100.06 1.79 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 93.6 m -136.39 109.35 7.65 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.118 1.767 . . . . 0.0 107.004 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.7 m -68.97 125.68 27.41 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.8 t -93.78 113.0 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 120.63 1.559 . . . . 0.0 108.496 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 m -68.56 155.13 40.56 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.704 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.54 -25.41 68.03 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.644 1.178 . . . . 0.0 110.981 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.32 -25.78 63.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.845 0.858 . . . . 0.0 109.848 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -94.57 -33.85 12.87 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.569 1.148 . . . . 0.0 110.151 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.19 121.18 7.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.766 1.626 . . . . 0.0 108.37 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -88.47 -110.52 1.1 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.1 170.15 16.34 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.666 1.186 . . . . 0.0 112.153 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -55.94 128.64 36.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.528 1.531 . . . . 0.0 111.333 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -118.39 -38.39 3.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.661 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.22 161.74 14.63 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 121.256 1.844 . . . . 0.0 111.377 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.03 139.83 47.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 120.066 1.303 . . . . 0.0 110.837 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.43 164.71 12.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.646 1.978 . . . . 0.0 109.145 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -162.11 33.17 0.12 Allowed 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.42 174.02 11.07 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 120.309 -1.494 . . . . 0.0 109.031 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.7 t -139.98 147.85 23.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -144.5 162.46 36.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 87.6 t -127.52 136.46 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 128' ' ' SER . 49.8 p90 -146.63 166.54 26.24 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.29 0.636 . . . . 0.0 111.316 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.85 101.3 13.39 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.1 t -47.75 -22.54 0.55 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 130.179 3.392 . . . . 0.0 116.863 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -57.86 -51.61 68.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 125.65 1.58 . . . . 0.0 109.947 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.443 ' HB2' ' HD3' ' A' ' 169' ' ' LYS 0.257 24.6 m -121.58 -27.54 4.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.471 1.508 . . . . 0.0 112.843 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 111.94 6.98 24.04 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.125 1.345 . . . . 0.0 114.248 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.504 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -53.5 113.0 1.01 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.582 2.191 . . . . 0.0 111.704 -178.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.4 m -69.0 152.74 44.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 119.428 1.013 . . . . 0.0 108.971 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.79 140.92 28.28 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.854 1.662 . . . . 0.0 108.792 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.5 160.36 38.57 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.127 2.551 . . . . 0.0 109.686 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -60.93 -30.36 70.17 Favored 'General case' 0 CA--C 1.519 -0.24 0 O-C-N 121.438 -0.789 . . . . 0.0 110.869 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 p -64.53 -7.06 8.83 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.892 -1.052 . . . . 0.0 113.407 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.87 -8.64 13.7 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.344 1.429 . . . . 0.0 111.08 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.5 m0 . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 -178.175 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 . . . . . 0 N--CA 1.46 0.071 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 95.6 m -144.99 138.12 26.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 126.922 2.089 . . . . 0.0 107.302 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -112.76 110.17 20.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.797 1.639 . . . . 0.0 108.19 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -111.73 118.77 36.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.6 1.16 . . . . 0.0 111.067 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.56 127.08 36.14 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -76.47 101.02 5.43 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.382 1.473 . . . . 0.0 111.421 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.1 159.71 23.67 Favored Glycine 0 N--CA 1.435 -1.378 1 C-N-CA 132.646 4.927 . . . . 0.0 107.546 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.89 154.6 41.22 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 122.972 1.368 . . . . 0.0 112.767 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 54.8 mt -102.74 121.62 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 125.628 1.571 . . . . 0.0 111.874 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -111.31 154.25 24.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.294 1.045 . . . . 0.0 110.309 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.9 t -73.77 172.86 10.73 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.925 1.29 . . . . 0.0 108.163 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.454 ' CD1' HD23 ' A' ' 220' ' ' LEU . 77.7 mt -135.19 132.78 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -59.17 119.85 8.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.209 1.404 . . . . 0.0 108.229 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.13 12.44 84.03 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.261 -1.3 . . . . 0.0 115.308 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -134.56 133.43 40.25 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.863 1.831 . . . . 0.0 109.881 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.8 m -83.59 146.89 28.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -25.21 61.51 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.574 1.15 . . . . 0.0 111.101 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.5 p -75.64 -14.4 60.36 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.825 2.05 . . . . 0.0 113.642 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -119.74 -43.0 2.59 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.986 0.914 . . . . 0.0 111.367 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.62 139.88 8.02 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 118.799 0.727 . . . . 0.0 109.143 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -152.33 176.64 11.41 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.507 1.123 . . . . 0.0 109.515 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.56 131.82 54.71 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.614 1.166 . . . . 0.0 111.845 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.1 129.74 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 C-N-CA 123.958 0.903 . . . . 0.0 109.432 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -74.33 104.76 5.21 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 36.5 mm -121.64 127.2 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 O-C-N 120.49 -1.381 . . . . 0.0 107.511 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 53.28 43.62 31.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.206 0.457 . . . . 0.0 110.304 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.6 t0 61.11 19.13 9.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.362 0.665 . . . . 0.0 112.167 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.09 122.53 24.24 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.753 -1.217 . . . . 0.0 109.188 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.42 115.96 12.3 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.981 -1.074 . . . . 0.0 112.77 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -106.15 152.38 23.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.102 0.961 . . . . 0.0 111.99 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.8 tm? -88.37 119.44 28.8 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.191 1.396 . . . . 0.0 107.939 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.6 148.58 27.16 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.8 p -127.42 151.16 49.17 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.778 0.674 . . . . 0.0 112.26 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -57.58 141.44 48.0 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.46 HG11 ' HB2' ' A' ' 139' ' ' SER . 6.5 p . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -69.76 136.69 51.22 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.106 0.963 . . . . 0.0 108.602 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.6 t -134.98 124.59 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.1 mp -76.44 134.22 29.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.54 134.95 51.1 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.832 1.301 . . . . 0.0 110.544 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.44 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -68.27 -18.56 64.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.486 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -104.09 -36.5 7.69 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.23 0.468 . . . . 0.0 111.354 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.84 105.14 11.64 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 122.202 1.001 . . . . 0.0 109.985 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.7 t -61.73 -11.48 12.27 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.112 1.365 . . . . 0.0 111.825 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -100.02 -8.98 23.19 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.787 1.635 . . . . 0.0 111.873 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -102.16 154.73 18.74 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 119.418 1.008 . . . . 0.0 111.276 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.5 mm -126.58 127.46 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.11 105.31 15.44 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -141.37 136.04 31.05 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.773 -1.204 . . . . 0.0 107.813 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.2 mtt 54.44 21.21 3.14 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.59 0.29 89.27 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.561 1.077 . . . . 0.0 112.336 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -90.13 172.58 8.71 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.282 1.433 . . . . 0.0 108.021 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.8 mm -133.66 124.76 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -119.17 154.21 33.69 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.1 t -138.36 159.45 42.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.2 mt -115.7 134.75 57.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.798 0.808 . . . . 0.0 111.234 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.3 t -104.76 -130.56 0.28 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 101.713 -3.44 . . . . 0.0 101.713 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -154.35 98.81 2.15 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 121.918 2.144 . . . . 0.0 106.672 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 20.6 m -135.76 121.09 19.14 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 128.244 2.618 . . . . 0.0 106.521 177.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.7 m -72.07 123.34 22.62 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 76.1 t -93.88 111.84 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.6 m -77.17 159.77 29.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.438 0.637 . . . . 0.0 109.694 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -64.6 -17.76 64.28 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 111.669 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -77.0 -11.71 59.84 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.755 0.822 . . . . 0.0 109.473 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -115.21 -28.4 6.94 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.381 1.072 . . . . 0.0 109.38 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.95 132.67 50.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.126 2.17 . . . . 0.0 107.148 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -101.39 -98.31 2.34 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.309 0.957 . . . . 0.0 114.289 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -134.68 159.43 41.28 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.272 1.429 . . . . 0.0 111.906 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.0 133.27 55.37 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.832 1.653 . . . . 0.0 109.658 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.79 -43.22 2.9 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 116.538 -1.696 . . . . 0.0 111.69 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -165.5 158.25 15.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 121.144 1.793 . . . . 0.0 110.462 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.22 137.37 44.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.478 HD22 ' O ' ' A' ' 196' ' ' GLY . 5.3 mp -110.17 163.35 13.69 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.951 1.7 . . . . 0.0 110.752 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.0 38.98 0.15 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.5 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 1.9 tt0 -139.78 175.34 9.66 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 120.023 -1.673 . . . . 0.0 110.759 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.2 t -144.88 150.51 16.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -147.09 164.0 34.48 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.848 0.832 . . . . 0.0 109.018 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.0 t -128.78 129.1 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 126.38 1.872 . . . . 0.0 107.412 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -147.89 160.93 42.26 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.07 0.948 . . . . 0.0 112.684 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.51 100.09 12.8 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 102.255 -3.239 . . . . 0.0 102.255 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 12.7 t -47.61 -25.88 1.3 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.154 2.581 . . . . 0.0 116.451 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.3 m -57.68 -45.98 86.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.04 1.736 . . . . 0.0 111.11 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.424 ' HB2' ' HD3' ' A' ' 169' ' ' LYS . 3.2 m -122.73 -21.76 5.53 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.024 1.33 . . . . 0.0 113.09 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.78 10.83 48.76 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.652 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 167' ' ' SER . 0.0 OUTLIER -64.04 112.49 2.99 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.134 1.467 . . . . 0.0 110.669 -178.584 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 44.2 m -72.38 152.03 42.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.647 0.658 . . . . 0.0 109.488 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.59 147.51 36.9 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.79 159.78 31.21 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.18 2.587 . . . . 0.0 109.902 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 ttt-85 -57.39 -32.34 66.73 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 45.0 m -65.19 -8.28 16.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.241 -1.362 . . . . 0.0 113.308 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.99 -9.14 16.32 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.354 1.434 . . . . 0.0 111.672 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.0 m0 . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 127.121 2.168 . . . . 0.0 115.143 -178.821 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.433 ' HG2' HH11 ' A' ' 190' ' ' ARG . 8.2 mtt-85 . . . . . 0 CA--C 1.51 -0.575 0 CA-C-O 120.968 0.413 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.6 m -130.27 117.4 19.76 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.83 105.89 18.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.599 1.959 . . . . 0.0 106.527 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.9 m0 -110.97 116.26 30.89 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 118.496 0.589 . . . . 0.0 110.45 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -81.94 131.77 35.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.5 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.8 m-30 -78.55 107.51 11.26 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.958 1.703 . . . . 0.0 106.807 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.478 ' O ' HD22 ' A' ' 157' ' ' LEU . . . -107.85 159.41 14.43 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 129.532 3.444 . . . . 0.0 112.64 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -66.89 140.88 57.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 124.652 2.168 . . . . 0.0 111.692 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.0 mt -93.13 140.84 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.673 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -136.25 151.3 49.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 123.194 1.474 . . . . 0.0 109.293 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.1 t -75.39 172.92 11.64 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.997 1.719 . . . . 0.0 107.523 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.3 mt -126.93 137.26 58.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -62.96 131.15 47.72 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.13 22.95 72.89 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.842 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -139.3 155.11 47.95 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.778 1.789 . . . . 0.0 108.094 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 57.8 m -106.08 140.41 39.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.485 HD13 ' CB ' ' A' ' 210' ' ' PHE . 0.4 OUTLIER -57.04 -24.65 55.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.144 0.977 . . . . 0.0 109.123 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.4 p -69.71 -14.63 62.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.263 1.825 . . . . 0.0 112.898 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -120.34 -41.34 2.62 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.248 1.019 . . . . 0.0 110.619 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.34 150.72 9.29 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.922 0.889 . . . . 0.0 110.657 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.485 ' CB ' HD13 ' A' ' 206' ' ' LEU . 48.5 p90 -158.38 176.14 12.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.247 1.019 . . . . 0.0 109.752 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.39 136.66 48.46 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 110.844 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.71 128.15 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 124.061 0.945 . . . . 0.0 109.624 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.65 107.36 3.88 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.3 mm -121.85 126.67 74.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 54.78 43.32 30.25 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.25 -4.83 1.2 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.05 1.74 . . . . 0.0 113.006 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -117.04 122.7 44.94 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.623 -1.298 . . . . 0.0 111.632 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -63.04 115.63 4.61 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.37 -1.456 . . . . 0.0 113.537 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -103.97 150.16 24.48 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 126.435 1.894 . . . . 0.0 111.442 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 3.0 tm? -88.79 122.19 31.93 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.607 1.163 . . . . 0.0 108.593 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -106.66 150.22 26.44 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 1.5 p -129.49 152.11 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.51 1.124 . . . . 0.0 110.307 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -69.67 124.05 22.95 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.454 -0.231 0 C-N-CA 123.999 0.92 . . . . 0.0 108.67 179.571 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 103.971 -2.604 . . . . 0.0 103.971 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -69.21 145.1 53.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.647 0.779 . . . . 0.0 110.225 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.0 t -137.95 128.25 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.457 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.6 mp -82.01 129.45 37.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.57 122.22 11.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.769 1.271 . . . . 0.0 109.592 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -59.03 -24.23 62.66 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.212 -0.93 . . . . 0.0 111.843 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -90.68 -31.59 16.54 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.901 1.28 . . . . 0.0 112.196 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.84 100.21 4.69 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.7 p -65.3 -11.34 40.63 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.407 -0.808 . . . . 0.0 111.511 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -90.01 -3.83 57.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.002 2.121 . . . . 0.0 110.209 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -113.57 158.52 20.68 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.356 0.98 . . . . 0.0 109.001 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.5 mm -129.09 139.59 51.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -118.48 108.36 14.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -142.82 140.45 31.31 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.0 mtt 56.87 22.45 7.09 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.656 0.782 . . . . 0.0 112.834 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.22 18.55 78.18 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -123.78 159.65 29.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.311 1.056 . . . . 0.0 108.218 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.1 mm -110.35 140.44 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -131.79 144.37 50.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 t -124.55 148.71 47.63 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 126.804 2.042 . . . . 0.0 107.351 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.6 mt -113.31 123.56 69.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 124.627 1.171 . . . . 0.0 110.026 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -93.36 -143.61 0.23 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -142.16 98.81 3.39 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 102.685 -3.079 . . . . 0.0 102.685 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.9 m -136.54 109.87 7.87 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 111.642 -2.526 . . . . 0.0 106.241 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 m -69.88 131.91 45.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 120.756 1.617 . . . . 0.0 106.752 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.3 t -94.69 114.18 30.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.776 1.63 . . . . 0.0 106.664 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.9 m -71.02 159.34 34.92 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.907 0.384 . . . . 0.0 110.786 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.72 -26.51 67.23 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.238 1.415 . . . . 0.0 111.294 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.1 -13.66 60.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.522 0.729 . . . . 0.0 111.36 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -105.71 -26.74 11.68 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.315 1.446 . . . . 0.0 108.883 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.7 mt -62.01 142.3 57.57 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.42 -103.42 2.46 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -134.99 166.84 22.11 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.086 1.354 . . . . 0.0 109.443 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -58.79 144.38 44.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.609 0.764 . . . . 0.0 109.942 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.23 -49.36 1.94 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 117.265 -1.35 . . . . 0.0 111.217 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.64 157.83 22.43 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 120.745 1.612 . . . . 0.0 110.828 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.4 p -105.59 138.64 29.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.547 1.165 . . . . 0.0 110.408 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.0 mp -113.41 163.16 15.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.536 2.734 . . . . 0.0 108.407 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -172.25 68.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.861 0.864 . . . . 0.0 109.957 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -160.67 175.83 12.21 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.837 -1.165 . . . . 0.0 109.036 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.3 t -144.76 149.28 17.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.71 154.96 40.35 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.5 t -123.63 130.51 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 124.498 1.119 . . . . 0.0 108.077 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -147.86 160.54 42.66 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.609 1.164 . . . . 0.0 111.579 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -85.49 100.98 12.26 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.6 t -56.26 -11.73 1.31 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.109 1.364 . . . . 0.0 114.613 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.3 m -65.74 -40.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.137 -0.977 . . . . 0.0 110.033 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.0 t -124.26 -28.35 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.723 1.209 . . . . 0.0 113.195 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.54 5.78 36.3 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.738 1.637 . . . . 0.0 111.166 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -57.31 112.32 1.36 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.053 1.741 . . . . 0.0 111.026 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.6 p -64.37 154.25 36.03 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.906 1.683 . . . . 0.0 110.749 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.45 152.14 60.75 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.365 1.066 . . . . 0.0 108.365 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.64 162.56 16.6 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.93 3.086 . . . . 0.0 108.513 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -58.75 -28.89 66.32 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.903 -1.123 . . . . 0.0 111.69 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 95.9 p -68.93 -8.8 47.77 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -104.22 -4.76 22.64 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 120.414 -1.429 . . . . 0.0 109.069 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 34.3 m0 . . . . . 0 CA--C 1.551 1.011 0 O-C-N 120.872 -1.142 . . . . 0.0 111.831 179.524 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 10.6 mtt85 . . . . . 0 CA--C 1.519 -0.241 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.7 m -142.14 123.86 15.1 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -100.92 109.1 21.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -110.4 116.21 31.03 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.17 117.51 21.78 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 128.471 2.708 . . . . 0.0 107.463 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.457 ' CE2' HD13 ' A' ' 123' ' ' ILE . 10.3 m-30 -68.78 106.95 2.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.567 1.147 . . . . 0.0 107.986 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -107.56 159.27 14.58 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 129.677 3.513 . . . . 0.0 110.945 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.52 149.65 50.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 124.927 2.299 . . . . 0.0 112.109 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 40.9 mt -98.18 140.94 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 111.752 -2.476 . . . . 0.0 110.713 -176.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -134.04 151.78 51.56 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.986 1.714 . . . . 0.0 109.873 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.3 p -77.63 173.39 12.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 58.8 mt -125.41 141.29 45.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -64.14 132.04 49.27 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.919 1.288 . . . . 0.0 108.076 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.6 18.93 70.55 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 118.554 -1.137 . . . . 0.0 114.69 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -135.87 157.86 45.81 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 120.025 1.912 . . . . 0.0 109.172 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 73.8 m -106.38 140.98 38.45 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.94 -26.54 48.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 77.1 p -68.24 -12.99 61.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.643 2.377 . . . . 0.0 113.866 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -119.99 -42.72 2.58 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 118.833 -0.603 . . . . 0.0 109.532 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.02 155.43 18.57 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.335 0.588 . . . . 0.0 110.765 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -157.54 175.63 13.69 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.577 0.751 . . . . 0.0 109.972 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.75 134.26 53.43 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.887 1.275 . . . . 0.0 110.861 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.04 132.71 56.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.256 1.022 . . . . 0.0 108.345 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -70.18 102.82 2.18 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.508 ' HB ' ' HE2' ' A' ' 219' ' ' LYS . 39.3 mm -121.42 123.16 69.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 O-C-N 121.075 -1.016 . . . . 0.0 108.282 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 53.44 48.39 21.96 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.98 0.912 . . . . 0.0 109.074 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 62.19 9.0 2.93 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.59 1.156 . . . . 0.0 114.081 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -131.19 122.56 26.78 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.189 0.904 . . . . 0.0 109.028 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -61.94 118.71 7.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.286 0.634 . . . . 0.0 109.931 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.508 ' HE2' ' HB ' ' A' ' 214' ' ' ILE . 16.7 mtmm -114.23 149.06 36.39 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.4 1.095 . . . . 0.0 110.088 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -81.29 123.76 28.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.306 1.842 . . . . 0.0 111.871 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -110.3 145.28 37.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.62 145.37 51.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.68 1.192 . . . . 0.0 110.92 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -64.15 120.81 12.8 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 C--N 1.326 -0.427 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.211 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -57.86 138.42 55.72 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.9 2.48 . . . . 0.0 112.818 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.4 t -140.54 142.17 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.5 1.92 . . . . 0.0 106.941 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.46 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.7 mp -90.27 139.63 17.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -68.35 131.46 45.36 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 122.669 1.223 . . . . 0.0 112.495 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -70.19 -16.95 63.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.125 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -93.17 -31.13 14.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.959 1.254 . . . . 0.0 112.517 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.23 110.69 6.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 t -64.85 -14.75 60.47 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.444 1.475 . . . . 0.0 111.311 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -82.26 -5.26 58.41 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.216 1.006 . . . . 0.0 110.689 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -107.37 158.43 17.17 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 118.264 0.484 . . . . 0.0 111.941 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.5 mm -130.18 131.31 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.692 1.197 . . . . 0.0 107.78 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -103.52 97.45 7.49 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -131.37 126.4 35.12 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.839 -1.163 . . . . 0.0 109.339 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.1 mtt 57.16 33.54 23.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.047 1.739 . . . . 0.0 110.554 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.45 0.59 54.5 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.297 -0.877 . . . . 0.0 111.336 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -92.74 161.01 14.71 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -121.15 134.08 65.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -129.84 159.71 35.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.9 t -138.41 156.65 47.38 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.469 1.108 . . . . 0.0 108.045 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.4 mt -112.47 129.92 67.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.842 0.857 . . . . 0.0 109.688 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.4 t -100.54 -110.16 0.2 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . 0.257 8.4 p-10 -162.4 99.03 1.04 Allowed 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 126.966 2.107 . . . . 0.0 107.668 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 97.5 m -137.93 108.34 6.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 115.961 -1.971 . . . . 0.0 109.072 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.6 m -67.29 122.68 18.43 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 122.163 2.256 . . . . 0.0 105.75 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.3 t -99.7 110.99 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.822 1.192 . . . . 0.0 108.036 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -79.38 164.66 23.85 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -61.45 -31.21 71.16 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.204 1.002 . . . . 0.0 111.426 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.28 -16.45 63.57 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.739 1.215 . . . . 0.0 111.384 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.93 -29.21 8.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.386 1.075 . . . . 0.0 110.003 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.1 tp -61.14 142.73 56.5 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.86 1.264 . . . . 0.0 109.082 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -96.51 -102.08 2.01 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.48 166.34 23.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.942 1.697 . . . . 0.0 110.644 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.87 146.48 26.32 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.999 0.92 . . . . 0.0 109.968 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -126.0 -52.33 1.54 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.09 -1.433 . . . . 0.0 112.689 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -157.25 154.66 29.49 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.745 1.612 . . . . 0.0 110.283 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.8 p -111.69 137.12 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 119.129 0.877 . . . . 0.0 110.013 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -112.02 165.03 12.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.535 2.334 . . . . 0.0 109.66 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -169.57 66.29 0.05 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.713 1.205 . . . . 0.0 109.563 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -156.4 173.47 16.84 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.34 147.83 16.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 O-C-N 121.179 -0.95 . . . . 0.0 108.63 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.23 161.41 38.35 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.865 0.757 . . . . 0.0 109.765 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.23 125.29 63.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 126.476 1.911 . . . . 0.0 108.768 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -142.91 163.95 31.4 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.065 1.346 . . . . 0.0 112.099 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.85 110.38 21.32 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.89 -18.84 36.73 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.69 1.596 . . . . 0.0 115.069 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.15 -40.46 82.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 O-C-N 121.284 -0.885 . . . . 0.0 112.044 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.463 ' HB3' ' HE2' ' A' ' 169' ' ' LYS . 0.4 OUTLIER -123.26 -12.98 7.78 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.684 0.794 . . . . 0.0 112.631 -178.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.18 12.67 75.89 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.302 0.953 . . . . 0.0 111.739 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 167' ' ' SER . 25.1 mtmt -71.89 112.62 8.14 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.969 1.308 . . . . 0.0 110.507 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.2 m -73.33 157.48 36.91 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.1 1.36 . . . . 0.0 109.933 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.44 151.68 51.79 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.221 0.608 . . . . 0.0 110.205 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 160.26 39.03 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.461 2.108 . . . . 0.0 108.778 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -60.0 -22.15 62.2 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.924 -1.11 . . . . 0.0 111.186 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -14.64 44.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.033 1.333 . . . . 0.0 112.345 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -116.62 3.15 13.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.052 0.941 . . . . 0.0 112.032 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 24.8 m0 . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -179.642 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 . . . . . 0 C--O 1.233 0.194 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 93.5 m -144.22 124.29 13.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.803 2.041 . . . . 0.0 106.62 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -101.15 112.19 24.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -110.14 116.74 32.08 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.91 1.284 . . . . 0.0 110.658 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -83.2 125.18 31.28 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.676 2.39 . . . . 0.0 107.91 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.46 ' CE2' HD13 ' A' ' 123' ' ' ILE . 2.9 m-30 -77.11 100.91 5.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 213' ' ' GLU . . . -93.95 158.22 23.14 Favored Glycine 0 N--CA 1.438 -1.191 1 C-N-CA 130.806 4.05 . . . . 0.0 107.911 179.058 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -69.05 153.96 42.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.711 1.72 . . . . 0.0 111.041 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.9 mt -99.49 143.12 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 113.158 -1.837 . . . . 0.0 108.593 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -133.15 150.24 52.03 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.927 1.691 . . . . 0.0 109.429 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 19.4 m -79.33 171.59 14.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 69.4 mt -125.61 147.69 30.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 O-C-N 121.0 -1.063 . . . . 0.0 108.502 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 50.8 mtt-85 -67.5 125.59 26.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 65.52 26.78 72.02 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.008 -0.885 . . . . 0.0 114.484 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -141.79 140.52 33.04 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.6 m -94.52 145.68 24.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -20.77 59.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.449 1.1 . . . . 0.0 109.851 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 15.3 p -75.62 -10.81 59.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.716 2.407 . . . . 0.0 113.041 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -125.21 -48.65 1.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.906 1.682 . . . . 0.0 111.251 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.71 144.31 19.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.656 0.662 . . . . 0.0 110.666 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -149.97 175.91 11.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.12 0.568 . . . . 0.0 109.567 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.13 134.57 52.63 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.29 1.036 . . . . 0.0 111.702 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.79 130.59 68.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 C-N-CA 124.706 1.202 . . . . 0.0 110.591 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.403 ' HB3' ' HA3' ' A' ' 196' ' ' GLY . 5.2 tt0 -72.24 107.87 5.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 36.7 mm -121.54 115.04 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.653 1.181 . . . . 0.0 108.94 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 59.46 48.8 9.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.281 1.032 . . . . 0.0 108.477 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.8 t70 64.14 9.48 4.76 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.231 1.013 . . . . 0.0 113.586 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -126.66 122.83 36.08 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.913 -1.117 . . . . 0.0 109.603 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -69.05 121.95 17.72 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.758 -1.214 . . . . 0.0 111.905 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -117.31 144.04 45.29 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.67 1.588 . . . . 0.0 112.883 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.489 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.4 tm? -78.52 132.48 37.23 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.665 0.786 . . . . 0.0 110.357 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -118.69 143.44 46.85 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.3 p -121.55 146.7 46.69 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.887 0.875 . . . . 0.0 111.585 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -61.91 138.36 58.35 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 83.5 t . . . . . 0 N--CA 1.453 -0.306 0 C-N-CA 125.205 1.402 . . . . 0.0 107.612 179.565 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.521 -0.156 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -76.42 115.12 15.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -118.4 129.19 75.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 124.436 1.094 . . . . 0.0 110.067 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.462 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.6 mp -77.99 137.95 21.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -58.51 130.06 44.98 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.495 1.14 . . . . 0.0 110.979 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -12.25 61.25 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.54 -41.75 5.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.385 1.074 . . . . 0.0 108.95 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -116.05 103.91 11.04 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 125.18 1.392 . . . . 0.0 114.1 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.56 ' HB2' ' CD1' ' A' ' 163' ' ' PHE . 67.1 m -68.83 -7.5 34.94 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 119.906 -1.746 . . . . 0.0 111.406 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.33 -9.36 36.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.452 1.901 . . . . 0.0 109.814 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.3 mttt -115.06 160.6 19.43 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 121.116 1.78 . . . . 0.0 113.02 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.2 mm -124.91 144.19 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 C-N-CA 125.267 1.427 . . . . 0.0 107.981 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -116.39 106.17 13.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.86 2.464 . . . . 0.0 104.58 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -135.26 123.56 23.17 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 20.8 mtp 64.8 27.71 12.95 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.387 1.475 . . . . 0.0 109.727 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.75 17.83 73.52 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.721 -1.044 . . . . 0.0 110.917 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -109.19 156.73 19.54 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.1 mm -110.65 134.8 51.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 123.522 0.729 . . . . 0.0 109.801 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -129.83 153.09 48.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.0 t -133.48 158.52 42.9 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.312 1.045 . . . . 0.0 108.529 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.0 mt -117.93 115.99 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.919 1.288 . . . . 0.0 110.369 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -88.78 -125.77 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 102.062 -3.31 . . . . 0.0 102.062 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -152.84 100.41 2.51 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 176.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 55.0 m -134.85 107.2 7.25 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 112.751 -2.022 . . . . 0.0 105.755 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.5 m -65.9 124.04 21.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.6 t -94.71 142.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.1 m -114.77 162.68 16.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.017 1.327 . . . . 0.0 109.442 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.84 -26.72 67.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 111.262 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.42 -21.08 63.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.385 0.674 . . . . 0.0 110.296 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -105.8 -18.9 13.92 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.85 0.86 . . . . 0.0 110.496 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 24.2 mt -67.16 141.6 57.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.513 0.673 . . . . 0.0 109.594 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.48 -101.24 1.84 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -135.5 167.53 20.91 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.936 2.494 . . . . 0.0 109.706 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -63.27 148.16 49.01 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -126.1 -52.58 1.53 Allowed 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 121.254 -0.904 . . . . 0.0 111.744 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -151.59 147.52 26.87 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 119.038 0.835 . . . . 0.0 110.549 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.68 134.41 40.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.4 mp -112.05 159.24 18.67 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.618 2.367 . . . . 0.0 108.78 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -169.56 53.25 0.04 OUTLIER 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.111 0.564 . . . . 0.0 112.225 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -147.38 173.11 12.93 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.785 -1.197 . . . . 0.0 108.985 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.3 t -145.45 145.38 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -141.05 166.1 25.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.6 t -131.08 132.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 128' ' ' SER . 55.1 p90 -144.99 171.62 14.21 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.944 0.878 . . . . 0.0 112.49 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.09 104.67 15.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.819 2.448 . . . . 0.0 105.341 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.0 t -65.07 -11.96 45.29 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.448 1.931 . . . . 0.0 112.721 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.7 m -64.83 -40.48 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 O-C-N 120.513 -1.367 . . . . 0.0 110.683 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.5 t -123.8 -23.6 4.65 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.623 1.169 . . . . 0.0 113.831 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.34 3.24 57.66 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.524 2.012 . . . . 0.0 110.611 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -54.55 113.03 1.14 Allowed 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.634 1.974 . . . . 0.0 109.676 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.2 m -64.33 158.14 24.28 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.382 0.673 . . . . 0.0 110.882 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.27 144.18 48.33 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.545 1.538 . . . . 0.0 107.554 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -81.35 162.43 19.78 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.565 2.843 . . . . 0.0 109.893 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -59.77 -22.32 61.96 Favored 'General case' 0 C--O 1.228 -0.068 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 42.5 m -70.74 -7.86 47.98 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.404 -0.81 . . . . 0.0 111.925 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.88 2.93 12.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.748 1.219 . . . . 0.0 111.732 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.0 m0 . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -179.463 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 . . . . . 0 C--O 1.233 0.214 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.1 m -136.64 136.59 39.26 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.324 1.85 . . . . 0.0 106.778 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -117.78 106.92 13.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.374 1.47 . . . . 0.0 108.931 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -110.25 116.8 32.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.887 2.075 . . . . 0.0 107.657 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.93 116.56 25.08 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.968 2.507 . . . . 0.0 107.093 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.462 ' CE2' HD13 ' A' ' 123' ' ' ILE . 10.5 m-30 -64.88 102.54 0.61 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.644 1.577 . . . . 0.0 109.151 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.26 158.98 17.3 Favored Glycine 0 N--CA 1.435 -1.411 1 C-N-CA 131.264 4.269 . . . . 0.0 107.845 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -66.13 154.25 40.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.282 1.991 . . . . 0.0 114.057 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.4 mt -101.38 141.47 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 112.589 -2.096 . . . . 0.0 109.069 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.1 153.01 49.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.674 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.8 t -78.21 172.68 13.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.142 1.777 . . . . 0.0 106.556 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 18.3 mt -131.47 149.79 33.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 122.751 1.263 . . . . 0.0 113.128 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -69.03 121.03 15.83 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.217 1.807 . . . . 0.0 109.431 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.14 24.77 76.71 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 117.587 -1.674 . . . . 0.0 113.418 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -149.55 144.52 26.29 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.811 1.805 . . . . 0.0 112.358 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.9 m -92.02 151.37 20.5 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.2 -33.53 65.41 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.294 -0.879 . . . . 0.0 110.046 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.3 p -66.21 -14.71 62.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.691 1.996 . . . . 0.0 114.29 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.67 -37.98 4.11 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.47 1.108 . . . . 0.0 110.055 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.35 145.07 2.63 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.141 0.976 . . . . 0.0 110.895 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -148.58 171.68 15.75 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.24 138.16 46.01 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.869 0.468 . . . . 0.0 110.564 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 4.1 p -133.13 129.84 57.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 123.544 0.737 . . . . 0.0 111.719 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -74.86 105.82 6.09 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.5 122.6 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.403 1.481 . . . . 0.0 108.863 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 54.8 44.16 28.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.083 0.856 . . . . 0.0 108.973 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 62.34 6.91 2.06 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.405 1.482 . . . . 0.0 114.282 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.33 121.96 36.42 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -66.39 128.68 37.1 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.265 1.026 . . . . 0.0 110.493 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -123.61 151.14 43.31 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.433 0.693 . . . . 0.0 110.763 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.8 tm? -83.79 117.87 23.56 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.68 1.192 . . . . 0.0 112.452 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -100.54 151.72 21.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.0 p -135.71 150.35 49.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.84 0.856 . . . . 0.0 110.838 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.94 140.37 57.77 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.842 1.257 . . . . 0.0 107.814 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 C--O 1.23 0.069 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.455 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -77.05 137.63 39.08 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.2 t -138.29 129.97 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 126.162 1.785 . . . . 0.0 108.355 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -73.84 140.12 18.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -65.2 130.42 43.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 123.006 1.384 . . . . 0.0 109.455 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -63.47 -24.03 67.65 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.686 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -89.31 -40.71 12.61 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.435 0.694 . . . . 0.0 110.727 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.71 113.15 16.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.719 1.208 . . . . 0.0 111.374 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.5 m -68.12 -11.14 58.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.604 1.962 . . . . 0.0 111.664 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -96.96 -4.33 40.08 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.978 1.711 . . . . 0.0 111.489 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -110.32 157.99 18.91 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.241 0.928 . . . . 0.0 110.632 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.4 mm -124.42 137.95 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -117.21 106.28 13.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.176 1.79 . . . . 0.0 106.48 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -127.42 125.35 40.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.6 mtt 61.94 17.78 9.27 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.721 1.208 . . . . 0.0 110.899 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.41 0.07 88.38 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.758 -1.023 . . . . 0.0 111.369 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -86.52 168.43 13.71 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.1 mm -124.81 132.71 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.646 1.112 . . . . 0.0 109.851 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -126.63 152.79 46.2 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.885 0.874 . . . . 0.0 108.936 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.7 t -137.35 147.17 45.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.227 1.011 . . . . 0.0 108.422 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.53 125.33 62.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 126.433 1.893 . . . . 0.0 110.712 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -91.89 -104.67 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -166.71 99.52 0.57 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 45.8 m -136.23 115.07 12.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.8 m -76.68 123.8 26.69 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 121.227 1.831 . . . . 0.0 106.431 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.82 142.05 14.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.7 m -114.42 164.68 13.62 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.375 1.07 . . . . 0.0 111.125 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -27.66 66.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.587 1.155 . . . . 0.0 112.44 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.08 -13.26 62.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.698 0.799 . . . . 0.0 110.359 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -119.43 -25.86 5.95 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.761 1.224 . . . . 0.0 110.965 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.1 tp -68.1 129.06 38.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.07 -98.17 0.77 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.13 163.39 30.03 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.272 1.429 . . . . 0.0 110.259 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -63.88 143.91 57.48 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -126.23 -47.52 1.61 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -151.46 158.67 43.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.992 1.269 . . . . 0.0 111.037 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.4 p -115.45 139.33 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.1 0.96 . . . . 0.0 108.591 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.26 164.67 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.998 1.719 . . . . 0.0 110.518 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -165.9 54.13 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -154.05 167.86 28.38 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.024 -1.673 . . . . 0.0 106.999 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.5 t -145.17 148.49 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -146.54 164.37 32.79 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.4 t -130.39 131.58 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -138.72 168.18 20.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.525 0.678 . . . . 0.0 111.479 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.497 ' CG ' HG22 ' A' ' 166' ' ' VAL . 53.3 t0 -80.51 111.53 17.0 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.7 t -51.51 -18.69 1.17 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 130.319 3.448 . . . . 0.0 115.074 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.497 HG22 ' CG ' ' A' ' 164' ' ' ASP . 20.9 m -76.9 -52.08 17.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 124.564 1.146 . . . . 0.0 113.46 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.414 ' HB2' ' HD3' ' A' ' 169' ' ' LYS 0.27 18.5 m -121.69 -27.08 4.77 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.186 1.794 . . . . 0.0 113.592 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.75 12.26 13.09 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.38 1.467 . . . . 0.0 113.441 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -57.1 112.45 1.36 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.597 2.198 . . . . 0.0 110.03 -178.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 43.2 p -63.13 151.89 38.86 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.79 145.37 41.1 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 125.147 1.379 . . . . 0.0 107.735 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.02 159.04 27.19 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.299 2.666 . . . . 0.0 108.868 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -55.62 -37.56 68.33 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 125.665 1.586 . . . . 0.0 111.867 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.9 m -63.51 -13.05 37.14 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 118.701 -1.2 . . . . 0.0 113.75 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.31 -15.3 20.82 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.403 1.481 . . . . 0.0 108.933 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.3 m0 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.42 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.6 m -128.59 124.78 36.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -106.25 109.51 21.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -115.51 116.14 27.68 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.13 136.57 32.95 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . 0.253 4.8 m-30 -82.02 101.42 10.31 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.217 1.008 . . . . 0.0 110.967 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -93.38 158.55 23.71 Favored Glycine 0 CA--C 1.532 1.111 1 C-N-CA 135.355 6.217 . . . . 0.0 107.162 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -68.23 156.84 36.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 123.3 1.524 . . . . 0.0 112.757 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 74.3 mt -103.49 139.64 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 126.541 1.936 . . . . 0.0 110.241 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -134.27 153.5 51.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.543 1.537 . . . . 0.0 110.21 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.4 p -76.98 173.02 12.26 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.712 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 43.9 mt -127.22 133.57 67.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 122.198 0.999 . . . . 0.0 108.877 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -62.8 127.87 33.29 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.151 1.78 . . . . 0.0 108.647 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.19 13.23 76.53 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.157 -1.357 . . . . 0.0 114.625 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -137.01 139.2 41.24 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 120.329 2.065 . . . . 0.0 110.725 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.9 m -84.44 144.65 28.62 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -23.13 65.55 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 120.56 -1.337 . . . . 0.0 109.531 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 31.6 p -76.71 -6.85 53.86 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.262 2.225 . . . . 0.0 113.814 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -121.38 -45.99 2.3 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.248 1.019 . . . . 0.0 109.362 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.49 143.21 13.15 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.377 0.535 . . . . 0.0 111.004 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -149.12 175.81 11.02 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.301 -0.25 . . . . 0.0 110.628 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.17 134.4 51.78 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.67 1.188 . . . . 0.0 113.021 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.58 127.85 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 125.326 1.451 . . . . 0.0 111.602 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 218' ' ' PHE . 43.9 tt0 -74.2 110.01 8.15 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 37.0 mm -121.53 117.92 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 56.06 39.88 30.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.14 0.576 . . . . 0.0 110.125 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.4 t70 76.32 -8.39 1.65 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.424 1.889 . . . . 0.0 112.02 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -104.97 122.23 45.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 119.906 -1.746 . . . . 0.0 110.189 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 213' ' ' GLU . 11.9 m-85 -71.03 119.34 15.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -110.27 145.86 36.65 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.564 1.145 . . . . 0.0 111.331 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.8 tm? -82.03 130.51 35.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -120.43 142.15 49.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.2 p -118.61 150.28 39.95 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.599 0.714 . . . . 0.0 110.963 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -64.96 143.63 57.83 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.725 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -73.94 151.64 40.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.1 t -145.87 136.89 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -81.76 134.93 26.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -58.5 119.43 6.99 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.598 1.19 . . . . 0.0 109.964 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -58.24 -22.53 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.174 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -94.54 -21.84 18.6 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.73 1.212 . . . . 0.0 111.955 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.97 104.88 4.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.519 1.128 . . . . 0.0 109.212 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.3 t -69.06 -3.56 13.68 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.522 -1.361 . . . . 0.0 110.867 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -98.13 -3.2 38.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.718 2.007 . . . . 0.0 110.397 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -117.54 169.7 9.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.541 1.136 . . . . 0.0 112.224 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.3 mm -130.32 151.16 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 C-N-CA 126.165 1.786 . . . . 0.0 107.878 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.19 102.5 8.17 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 130.119 3.368 . . . . 0.0 103.603 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -142.7 131.93 23.35 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.643 -1.286 . . . . 0.0 109.589 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.5 mtt 57.61 32.91 22.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.353 1.461 . . . . 0.0 113.026 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.49 7.34 82.75 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.453 -1.193 . . . . 0.0 112.449 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -113.08 168.36 9.77 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.131 1.372 . . . . 0.0 108.099 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -119.54 145.46 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -133.3 155.69 48.94 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.2 t -134.91 151.59 51.01 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.039 1.736 . . . . 0.0 108.22 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.3 mt -112.82 123.34 68.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.956 1.302 . . . . 0.0 108.971 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.1 t -97.72 -118.27 0.13 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 101.884 -3.376 . . . . 0.0 101.884 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -158.05 99.36 1.66 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 120.622 1.555 . . . . 0.0 106.935 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 m -137.95 115.31 11.11 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 127.209 2.204 . . . . 0.0 106.326 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.9 m -71.72 129.79 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.81 111.05 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.5 m -75.45 164.46 26.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.068 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.9 -29.37 70.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.545 0.688 . . . . 0.0 111.753 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.74 -11.61 60.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.594 1.158 . . . . 0.0 111.265 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.77 -24.62 11.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.552 1.541 . . . . 0.0 109.534 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.09 127.92 33.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.825 1.25 . . . . 0.0 111.85 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.63 -106.06 1.31 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -133.77 163.0 30.45 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.128 1.371 . . . . 0.0 109.307 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -60.41 145.65 47.33 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.52 -42.02 1.98 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 116.507 -1.711 . . . . 0.0 114.494 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -161.28 160.86 30.33 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 121.066 1.757 . . . . 0.0 110.489 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.4 p -121.84 133.15 69.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.57 1.148 . . . . 0.0 108.402 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -107.83 166.33 10.78 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.181 2.193 . . . . 0.0 110.591 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -164.08 41.04 0.09 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -138.71 172.23 13.18 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 120.039 -1.663 . . . . 0.0 109.568 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.76 149.36 17.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -145.46 167.02 23.98 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.35 131.89 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -138.02 166.72 23.4 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.461 0.704 . . . . 0.0 110.193 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -86.07 116.03 24.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.38 -14.46 1.91 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 127.032 2.133 . . . . 0.0 115.179 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.4 m -77.34 -46.85 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 124.044 0.937 . . . . 0.0 112.451 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.23 -28.42 3.69 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.37 12.73 16.59 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.067 1.318 . . . . 0.0 112.299 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 112.78 2.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.968 1.384 . . . . 0.0 111.253 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.1 m -69.35 154.75 41.54 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.588 1.085 . . . . 0.0 110.476 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.31 147.66 66.72 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.659 1.584 . . . . 0.0 110.828 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.53 157.71 22.07 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.499 3.466 . . . . 0.0 110.502 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -53.17 -25.1 12.46 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 m -70.54 -22.06 62.65 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 118.056 -0.973 . . . . 0.0 113.468 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.2 -12.45 28.24 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.555 1.525 . . . . 0.0 110.753 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.5 m0 . . . . . 0 N--CA 1.443 -0.824 0 C-N-CA 124.924 1.29 . . . . 0.0 111.771 -179.771 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 49.3 mmt-85 . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 122.19 0.995 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.0 m -122.36 129.39 52.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 126.944 2.098 . . . . 0.0 105.557 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -115.94 106.54 13.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.349 1.859 . . . . 0.0 107.41 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -110.52 117.44 33.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.295 1.838 . . . . 0.0 108.701 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -87.88 127.21 35.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -73.31 101.45 3.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.029 0.932 . . . . 0.0 109.561 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.82 159.06 22.81 Favored Glycine 0 N--CA 1.442 -0.921 1 C-N-CA 132.694 4.95 . . . . 0.0 107.544 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 197' ' ' GLU . 6.6 pt-20 -68.1 151.17 47.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 123.544 1.64 . . . . 0.0 111.536 -176.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 63.9 mt -99.38 143.99 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 C-N-CA 126.463 1.905 . . . . 0.0 110.299 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -137.99 153.27 49.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.734 1.613 . . . . 0.0 110.095 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.8 p -80.47 173.22 12.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 66.4 mt -124.8 136.46 60.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.381 1.072 . . . . 0.0 109.015 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -64.88 119.12 10.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.66 10.89 72.19 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 118.148 -1.362 . . . . 0.0 116.083 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -137.38 130.44 30.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 120.473 2.136 . . . . 0.0 110.295 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 15.0 m -71.49 145.08 49.42 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.62 -24.96 65.91 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.052 0.941 . . . . 0.0 109.158 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 17.1 p -75.53 -9.76 58.86 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.83 2.452 . . . . 0.0 112.798 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -119.77 -47.61 2.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.582 1.153 . . . . 0.0 109.386 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.35 145.38 19.11 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.902 0.774 . . . . 0.0 111.01 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -152.08 175.73 12.26 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.859 -0.526 . . . . 0.0 110.716 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.51 134.71 52.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.871 1.669 . . . . 0.0 112.29 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.427 HG13 HG12 ' A' ' 214' ' ' ILE . 8.0 p -129.83 131.56 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 124.821 1.249 . . . . 0.0 109.436 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.41 106.75 5.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.427 HG12 HG13 ' A' ' 212' ' ' VAL . 28.2 mm -121.42 128.97 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 53.81 36.63 24.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.995 0.816 . . . . 0.0 111.65 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t0 68.74 9.66 7.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.553 1.541 . . . . 0.0 112.825 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -124.92 122.98 38.9 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.519 1.128 . . . . 0.0 108.743 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -69.12 119.37 13.3 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.828 -1.17 . . . . 0.0 110.373 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -116.07 147.19 41.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 123.41 1.576 . . . . 0.0 111.679 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -80.93 122.61 27.46 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.486 1.914 . . . . 0.0 113.074 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -112.45 140.07 47.5 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.3 p -120.54 145.51 47.25 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.621 1.168 . . . . 0.0 110.765 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -60.36 135.41 57.73 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.451 -0.385 0 C-N-CA 122.965 0.506 . . . . 0.0 109.816 178.666 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -70.43 130.7 42.61 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.6 t -131.46 134.92 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.0 mm -69.78 131.53 34.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -68.35 129.39 39.77 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.523 0.678 . . . . 0.0 109.988 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -71.26 -18.37 62.44 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.139 -0.976 . . . . 0.0 110.329 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -82.05 -34.21 29.58 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.644 1.178 . . . . 0.0 111.261 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.38 121.17 9.9 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.5 t -59.35 -25.21 64.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.526 1.057 . . . . 0.0 110.48 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -90.47 3.02 55.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.224 1.81 . . . . 0.0 112.946 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -109.13 155.98 20.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.2 mm -126.69 142.04 44.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -115.25 104.25 11.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 128.111 2.564 . . . . 0.0 105.166 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -132.58 128.63 37.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.8 mtt 61.76 21.77 12.47 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.221 1.408 . . . . 0.0 110.841 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.72 14.64 81.85 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.515 -1.159 . . . . 0.0 111.878 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -113.1 157.92 21.02 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.0 mm -114.65 143.93 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.561 0.696 . . . . 0.0 111.507 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -131.12 155.31 47.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.571 1.948 . . . . 0.0 109.63 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.6 t -145.18 147.38 32.4 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 mt -102.85 120.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 126.665 1.986 . . . . 0.0 112.03 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -90.33 -116.6 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 1 N-CA-C 99.881 -4.118 . . . . 0.0 99.881 176.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -160.25 99.82 1.34 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 2.4 m -136.63 121.41 18.61 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 m -81.24 136.73 35.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 120.671 1.578 . . . . 0.0 107.05 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.35 112.25 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 74.3 m -79.82 166.22 21.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.975 0.91 . . . . 0.0 109.1 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -58.27 -32.01 68.0 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.345 1.058 . . . . 0.0 111.091 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.82 -8.03 39.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.167 1.787 . . . . 0.0 112.044 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -122.33 -12.14 8.27 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 127.72 2.408 . . . . 0.0 110.001 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 20.3 mt -83.09 123.03 29.11 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.23 -101.46 0.84 Allowed Glycine 0 CA--C 1.507 -0.424 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -134.75 167.05 21.57 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.379 1.071 . . . . 0.0 108.8 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -61.02 143.05 56.1 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.0 0.92 . . . . 0.0 111.374 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.06 -41.41 1.94 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 116.907 -1.521 . . . . 0.0 113.3 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -160.27 150.36 18.17 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.707 1.594 . . . . 0.0 110.792 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.1 p -109.26 135.79 47.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.1 mp -110.66 163.21 13.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.934 2.094 . . . . 0.0 110.95 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -165.33 64.34 0.12 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -153.01 173.19 15.73 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.564 -1.335 . . . . 0.0 108.763 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.2 t -149.57 138.07 14.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 126.103 1.761 . . . . 0.0 106.368 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.75 166.05 25.7 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.49 126.9 55.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -142.08 164.01 31.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.561 1.144 . . . . 0.0 110.759 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -92.95 103.57 15.88 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 104.284 -2.488 . . . . 0.0 104.284 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.35 -15.72 0.69 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.365 2.266 . . . . 0.0 116.127 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.6 m -57.71 -51.0 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.168 0.987 . . . . 0.0 108.406 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.2 m -123.45 -26.7 4.19 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.397 1.879 . . . . 0.0 114.437 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 103.4 16.56 20.09 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.499 1.523 . . . . 0.0 113.615 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 113.04 4.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.76 1.78 . . . . 0.0 109.261 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.0 m -75.21 145.25 42.17 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.26 143.07 26.97 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.17 160.51 42.41 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.167 2.578 . . . . 0.0 111.028 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -57.32 -28.62 63.24 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.065 0.546 . . . . 0.0 111.913 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.5 m -61.32 -14.22 25.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.071 0.949 . . . . 0.0 112.148 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -119.12 4.91 11.3 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.903 1.681 . . . . 0.0 111.951 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.8 m0 . . . . . 0 CA--C 1.532 0.261 0 O-C-N 120.752 -1.218 . . . . 0.0 113.895 179.236 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.488 0.661 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.4 m -141.84 132.53 25.58 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.478 1.911 . . . . 0.0 106.018 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -115.35 104.77 12.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -110.63 116.6 31.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.013 1.325 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -83.27 128.23 34.32 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 127.212 2.205 . . . . 0.0 105.861 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.55 102.3 6.02 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.68 159.27 16.84 Favored Glycine 0 N--CA 1.442 -0.96 1 C-N-CA 131.489 4.376 . . . . 0.0 109.918 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.12 154.98 39.9 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 124.294 1.997 . . . . 0.0 113.717 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.4 mt -102.26 140.97 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.299 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -131.58 151.52 51.53 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 109.604 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 11.4 m -76.3 172.27 13.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.778 0.831 . . . . 0.0 108.984 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 78.8 mt -131.91 138.15 53.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.902 0.858 . . . . 0.0 110.509 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -65.5 119.04 10.34 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.22 14.73 76.09 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 118.821 -0.989 . . . . 0.0 115.378 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -140.78 126.2 18.81 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 119.771 1.785 . . . . 0.0 109.782 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 16.3 m -76.48 146.71 38.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.31 -27.8 56.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.541 1.136 . . . . 0.0 110.393 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 36.9 p -74.33 -9.74 58.9 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.433 1.893 . . . . 0.0 114.362 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -120.69 -43.88 2.46 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.26 1.424 . . . . 0.0 109.547 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.15 144.28 14.35 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.115 0.566 . . . . 0.0 110.13 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -148.13 176.38 10.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.803 0.841 . . . . 0.0 109.152 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -108.62 130.73 55.31 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.455 1.102 . . . . 0.0 109.727 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.1 p -124.28 126.97 72.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 124.48 1.112 . . . . 0.0 111.678 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -73.89 108.42 6.7 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 35.4 mm -121.74 120.2 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 54.17 40.39 31.62 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.8 t70 70.68 -4.83 1.57 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.381 2.272 . . . . 0.0 113.2 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.44 ' HB3' ' HE2' ' A' ' 219' ' ' LYS . 37.8 m-20 -106.15 122.26 45.84 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 120.279 -1.513 . . . . 0.0 108.953 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.85 120.49 16.52 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 217' ' ' ASP . 19.5 mmtp -112.46 151.58 29.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.818 1.247 . . . . 0.0 112.671 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.5 tm? -88.81 117.07 27.53 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.067 0.947 . . . . 0.0 110.711 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.89 156.23 17.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.9 143.3 40.77 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 123.158 0.583 . . . . 0.0 109.908 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -54.82 125.82 21.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.865 0.866 . . . . 0.0 110.162 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 C--O 1.218 -0.569 0 C-N-CA 126.387 1.875 . . . . 0.0 107.986 179.828 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.821 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.4 ' CD2' HD13 ' A' ' 198' ' ' ILE . 45.8 m-85 -69.56 140.91 53.89 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.879 1.272 . . . . 0.0 110.264 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.4 t -141.24 141.34 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.479 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.7 mp -80.28 121.13 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -48.61 122.13 5.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.087 0.946 . . . . 0.0 111.475 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -65.72 -17.54 64.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.785 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -94.96 -20.38 19.43 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.956 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.17 122.2 9.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 120.038 1.29 . . . . 0.0 108.127 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.5 m -65.12 -18.86 65.66 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 120.182 -1.574 . . . . 0.0 110.699 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -94.12 -0.48 55.28 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.943 1.297 . . . . 0.0 113.095 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -108.0 159.59 16.44 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.466 0.575 . . . . 0.0 110.104 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.2 mm -126.81 138.51 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -118.63 108.67 15.22 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -146.39 134.1 21.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.8 mtt 58.69 26.91 15.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.747 2.019 . . . . 0.0 113.531 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.17 23.52 71.14 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -121.99 164.7 17.19 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.3 mm -123.77 126.36 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.89 150.19 41.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.7 t -130.75 150.04 52.12 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.004 1.322 . . . . 0.0 109.201 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 mt -111.36 124.21 67.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 125.602 1.561 . . . . 0.0 110.725 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.6 t -95.31 -126.95 0.13 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 103.188 -2.893 . . . . 0.0 103.188 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -149.73 99.37 2.86 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 94.5 m -136.89 111.79 8.88 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 128.094 2.558 . . . . 0.0 109.654 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.1 m -69.05 124.34 23.51 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 54.6 t -94.46 119.58 42.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 119.675 1.125 . . . . 0.0 109.157 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.2 m -80.65 159.13 25.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.643 0.735 . . . . 0.0 109.858 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.35 -29.34 70.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.956 1.302 . . . . 0.0 112.008 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.43 -16.11 61.83 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.311 1.044 . . . . 0.0 111.892 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -103.9 -25.95 12.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.818 0.847 . . . . 0.0 108.867 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 mt -62.14 137.58 58.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.757 1.223 . . . . 0.0 109.923 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -89.39 -105.71 1.12 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -135.04 169.43 17.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.057 1.743 . . . . 0.0 109.805 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -59.68 142.39 53.13 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -125.74 -48.97 1.63 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 116.595 -1.669 . . . . 0.0 111.902 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -155.73 150.81 26.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.9 1.682 . . . . 0.0 112.217 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.8 p -105.5 133.59 49.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 122.482 1.134 . . . . 0.0 111.332 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mp -113.1 161.93 16.53 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.562 2.745 . . . . 0.0 109.702 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.66 48.71 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.569 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 3.5 mt-10 -143.72 176.68 9.05 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.85 2.06 . . . . 0.0 111.579 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.49 150.56 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.593 -1.317 . . . . 0.0 110.508 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.512 ' HE ' ' CB ' ' A' ' 193' ' ' TRP . 0.0 OUTLIER -131.38 157.49 43.28 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.408 1.483 . . . . 0.0 109.606 178.113 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.5 t -140.51 114.18 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -141.58 167.98 20.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.356 0.598 . . . . 0.0 112.212 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.21 104.24 13.23 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.5 m -64.48 -14.99 59.97 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 122.145 2.248 . . . . 0.0 114.526 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.6 m -69.57 -35.17 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 O-C-N 121.823 -0.548 . . . . 0.0 112.001 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.29 -19.19 6.03 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.384 1.473 . . . . 0.0 113.015 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.26 -10.84 69.47 Favored Glycine 0 CA--C 1.543 1.796 0 C-N-CA 126.969 2.223 . . . . 0.0 112.582 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -47.69 115.4 1.13 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 128.369 2.667 . . . . 0.0 113.64 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.6 p -67.04 158.12 31.8 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 109.965 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.0 134.79 24.44 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.49 156.78 49.72 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.672 2.248 . . . . 0.0 110.005 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.437 ' HA ' ' CD1' ' A' ' 176' ' ' TRP . 42.7 ttt180 -56.58 -30.46 63.2 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t -66.96 -7.59 23.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.352 0.978 . . . . 0.0 111.753 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.06 -7.59 14.91 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.14 1.376 . . . . 0.0 110.885 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.437 ' CD1' ' HA ' ' A' ' 173' ' ' ARG . 34.2 m0 . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 99.9 m -139.96 115.65 10.14 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -94.06 112.55 24.38 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' TRP . . . . . 0.512 ' CB ' ' HE ' ' A' ' 161' ' ' ARG . 17.7 m0 -121.9 115.87 23.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.71 138.12 48.28 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.235 1.414 . . . . 0.0 109.151 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.569 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.6 m-30 -88.55 102.01 14.51 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 177.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.31 159.11 17.21 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 130.399 3.857 . . . . 0.0 107.753 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -66.51 158.25 30.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.162 1.934 . . . . 0.0 112.581 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.4 HD13 ' CD2' ' A' ' 121' ' ' PHE . 41.8 mt -105.02 142.09 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.599 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -132.52 151.62 51.85 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.226 1.41 . . . . 0.0 109.654 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 55.2 p -76.23 173.19 11.68 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.1 mt -125.41 146.13 31.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 122.127 0.965 . . . . 0.0 109.316 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -68.65 125.03 25.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.14 26.31 73.39 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.287 1.423 . . . . 0.0 113.867 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -145.93 152.38 39.35 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.6 m -106.64 151.12 25.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.453 HD13 ' HB3' ' A' ' 210' ' ' PHE . 3.0 mm? -55.56 -27.69 50.59 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.122 0.569 . . . . 0.0 110.711 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 7.7 p -71.66 -13.42 61.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.122 2.169 . . . . 0.0 114.443 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -124.69 -38.5 2.37 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.234 1.414 . . . . 0.0 112.077 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.18 142.07 5.77 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.517 1.053 . . . . 0.0 110.528 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.453 ' HB3' HD13 ' A' ' 206' ' ' LEU . 45.6 p90 -154.23 174.5 14.69 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.608 0.363 . . . . 0.0 111.494 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -110.65 132.19 54.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.98 1.312 . . . . 0.0 109.7 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.69 124.95 66.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.467 1.507 . . . . 0.0 109.357 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -71.54 109.51 5.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.37 124.17 71.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 54.26 44.08 29.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.682 0.674 . . . . 0.0 110.006 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 26.7 t70 59.08 20.55 8.45 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.3 0.64 . . . . 0.0 112.059 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.444 ' HB3' ' HE2' ' A' ' 219' ' ' LYS . 0.5 OUTLIER -129.61 122.45 29.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.958 1.303 . . . . 0.0 108.579 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -71.24 117.84 13.27 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.33 -1.481 . . . . 0.0 110.093 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 217' ' ' ASP . 51.0 mmtt -111.38 147.63 34.78 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.708 1.603 . . . . 0.0 110.329 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.4 tm? -80.79 139.44 36.04 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.235 1.014 . . . . 0.0 111.198 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.89 139.35 52.66 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.332 1.453 . . . . 0.0 107.122 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.1 p -126.23 155.48 41.78 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.141 0.976 . . . . 0.0 111.683 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -64.9 143.12 58.16 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.784 -0.572 . . . . 0.0 111.072 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.972 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -68.81 146.4 52.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.4 t -140.02 132.68 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.525 HD13 ' CE2' ' A' ' 195' ' ' TYR . 5.3 mp -77.21 122.58 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -56.85 128.05 34.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.811 1.291 . . . . 0.0 109.507 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 125' ' ' LYS . 20.0 pttm -70.37 -22.89 62.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.444 1.098 . . . . 0.0 110.382 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.07 -42.2 19.54 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 123.637 0.775 . . . . 0.0 109.86 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -133.16 105.62 7.13 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.5 m -62.27 -23.48 66.72 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.189 -1.57 . . . . 0.0 112.478 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -81.27 -2.68 49.86 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.028 1.331 . . . . 0.0 111.125 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -109.89 159.8 16.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.453 0.701 . . . . 0.0 109.848 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.1 mm -125.47 133.0 70.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.31 111.16 23.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 101.477 -3.527 . . . . 0.0 101.477 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -147.8 137.97 22.88 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.16 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.3 mtt 51.72 28.73 5.09 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.22 18.0 79.71 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.406 -0.809 . . . . 0.0 111.522 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -120.43 163.71 17.48 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.472 1.109 . . . . 0.0 108.654 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.6 mm -119.14 134.08 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -126.97 148.92 50.07 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.8 t -131.51 130.32 42.22 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.464 2.306 . . . . 0.0 110.589 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.63 130.39 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.462 1.505 . . . . 0.0 108.819 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.3 t -102.57 -134.88 0.32 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 101.494 -3.521 . . . . 0.0 101.494 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -145.65 98.31 3.11 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 102.526 -3.138 . . . . 0.0 102.526 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.6 m -136.4 111.38 8.88 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 130.752 3.621 . . . . 0.0 108.999 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.9 m -68.7 127.85 34.54 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.714 1.597 . . . . 0.0 107.775 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.6 t -94.66 126.19 47.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.6 m -87.97 159.51 18.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.59 0.71 . . . . 0.0 110.213 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -56.56 -35.6 68.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.843 1.657 . . . . 0.0 109.913 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.56 -19.36 62.08 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.201 1.0 . . . . 0.0 111.809 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.72 -27.87 11.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.227 1.411 . . . . 0.0 110.763 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.97 112.79 2.73 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.596 1.558 . . . . 0.0 109.68 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.48 -102.44 0.08 OUTLIER Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.031 0.824 . . . . 0.0 111.865 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -134.76 161.82 34.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.735 1.214 . . . . 0.0 110.289 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -56.46 130.63 45.73 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.527 1.131 . . . . 0.0 109.969 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -109.11 -48.93 3.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 117.286 -1.34 . . . . 0.0 112.394 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -164.3 158.76 19.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.07 1.304 . . . . 0.0 109.406 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.3 p -108.02 141.12 24.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.579 1.152 . . . . 0.0 111.271 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mp -112.85 163.22 14.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.006 2.523 . . . . 0.0 110.365 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -166.81 39.57 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.544 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 21.4 mt-10 -141.86 176.71 8.72 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.181 -2.199 . . . . 0.0 110.35 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.9 t -138.12 151.47 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 120.071 1.305 . . . . 0.0 111.007 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.495 ' HE ' ' CB ' ' A' ' 193' ' ' TRP . 0.2 OUTLIER -130.34 156.91 43.9 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 120.953 -1.092 . . . . 0.0 109.683 177.742 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.1 t -138.22 113.89 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -134.23 158.3 44.08 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.621 -0.674 . . . . 0.0 110.212 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -85.26 99.99 11.49 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 103.103 -2.925 . . . . 0.0 103.103 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.7 m -59.28 -9.06 1.94 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 126.735 2.014 . . . . 0.0 116.267 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.8 m -66.12 -38.82 82.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.439 ' HB3' ' HE2' ' A' ' 169' ' ' LYS . 0.4 OUTLIER -123.43 -24.12 4.67 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.648 1.579 . . . . 0.0 112.286 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.18 8.53 60.08 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 127.224 2.345 . . . . 0.0 110.564 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 167' ' ' SER . 27.2 mtmt -61.27 115.95 4.22 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.074 1.75 . . . . 0.0 110.253 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 70.4 p -67.28 153.75 42.94 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.119 0.968 . . . . 0.0 112.366 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.58 136.31 26.5 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.2 163.72 24.96 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.548 2.165 . . . . 0.0 110.998 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -58.44 -21.87 52.47 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.578 1.551 . . . . 0.0 114.737 -178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.3 m -80.46 -7.57 59.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.982 0.81 . . . . 0.0 110.517 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -113.1 9.32 18.55 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.648 1.579 . . . . 0.0 110.945 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 39.1 m0 . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 125.254 1.422 . . . . 0.0 114.068 177.943 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.414 0.626 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 37.6 m -139.72 135.67 33.4 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -113.15 106.87 15.17 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.883 1.673 . . . . 0.0 107.321 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' TRP . . . . . 0.495 ' CB ' ' HE ' ' A' ' 161' ' ' ARG . 24.6 m0 -110.78 115.63 29.88 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.612 0.765 . . . . 0.0 110.385 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.21 138.34 38.6 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.777 1.631 . . . . 0.0 106.838 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.544 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.9 m-30 -85.97 105.91 16.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -105.8 158.67 15.62 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 127.801 2.62 . . . . 0.0 108.037 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.11 156.49 36.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 124.741 2.21 . . . . 0.0 113.05 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 38.9 mt -100.9 141.0 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 111.795 -2.457 . . . . 0.0 110.179 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -133.83 152.51 51.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.548 1.539 . . . . 0.0 109.64 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 91.5 p -74.69 172.69 11.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.459 0.704 . . . . 0.0 110.152 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 5.3 mt -127.71 135.46 63.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 121.458 -0.776 . . . . 0.0 110.257 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -65.14 126.15 27.21 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.85 12.44 84.43 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.205 -1.331 . . . . 0.0 116.01 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -138.75 157.75 45.5 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.617 1.709 . . . . 0.0 108.175 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 62.1 m -106.48 145.72 31.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.63 -31.14 64.04 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 29.8 p -66.32 -12.37 56.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.178 1.791 . . . . 0.0 113.903 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -124.66 -35.39 2.73 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.688 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.27 145.36 6.94 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 119.217 0.917 . . . . 0.0 110.964 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.57 173.23 16.61 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.048 0.385 . . . . 0.0 111.221 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.62 132.52 54.06 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 124.509 1.124 . . . . 0.0 111.774 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.81 130.36 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.947 1.299 . . . . 0.0 108.513 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -69.91 103.11 2.13 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 33.8 mm -121.56 123.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.293 1.437 . . . . 0.0 110.251 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 61.52 38.15 15.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.194 0.997 . . . . 0.0 109.317 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 65.31 16.31 10.47 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.617 1.567 . . . . 0.0 111.313 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.56 129.15 38.65 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -67.97 122.23 17.77 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 119.962 -1.711 . . . . 0.0 109.15 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -119.02 146.2 45.23 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.815 1.246 . . . . 0.0 111.387 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -78.83 133.12 37.04 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.937 1.295 . . . . 0.0 112.032 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -121.69 131.31 54.02 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.81 150.21 33.82 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.189 0.596 . . . . 0.0 110.025 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -70.08 122.09 18.73 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.329 -0.302 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.222 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.208 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -75.96 124.56 27.56 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.0 t -124.78 136.88 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 126.029 1.732 . . . . 0.0 107.026 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.404 HD11 HD12 ' A' ' 157' ' ' LEU . 5.1 mp -86.43 138.89 18.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -64.27 123.3 18.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 123.03 1.395 . . . . 0.0 108.419 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -61.02 -27.05 68.04 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.788 1.235 . . . . 0.0 111.105 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -80.87 -46.09 15.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.21 105.61 8.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.428 1.491 . . . . 0.0 112.946 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -58.67 -19.5 39.96 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 120.343 -1.473 . . . . 0.0 112.258 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -85.21 -7.85 58.84 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.278 -0.889 . . . . 0.0 110.658 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -101.41 149.47 24.02 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.838 0.744 . . . . 0.0 109.559 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.1 mm -126.86 119.15 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.09 97.29 9.82 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 128.372 2.669 . . . . 0.0 109.114 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -132.41 142.5 49.31 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 121.576 1.989 . . . . 0.0 109.975 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 8.4 mtt 49.87 23.32 1.02 Allowed 'General case' 0 CA--C 1.544 0.739 0 O-C-N 119.992 -1.693 . . . . 0.0 114.714 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.64 5.25 78.68 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 119.604 1.093 . . . . 0.0 112.089 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -100.23 172.86 6.9 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 125.099 1.36 . . . . 0.0 111.626 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.5 mm -136.4 125.7 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -114.13 161.07 18.24 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.449 ' HB2' HG11 ' A' ' 224' ' ' VAL . 25.9 t -143.04 139.32 30.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.434 1.494 . . . . 0.0 109.999 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.1 mt -100.85 137.68 27.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 123.929 0.892 . . . . 0.0 109.233 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.7 m -118.17 -112.79 0.34 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -159.98 98.72 1.34 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 122.689 2.495 . . . . 0.0 108.109 175.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 54.3 m -137.42 113.88 10.21 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 127.323 2.249 . . . . 0.0 105.537 175.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.6 m -76.61 126.9 31.79 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 104.419 -2.438 . . . . 0.0 104.419 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.7 t -93.72 111.7 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.1 m -74.61 158.27 33.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.959 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.96 -28.82 67.97 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.998 0.519 . . . . 0.0 111.481 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.71 -12.58 61.59 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.94 -0.475 . . . . 0.0 111.222 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -114.04 -24.1 9.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.507 1.523 . . . . 0.0 110.791 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.2 mt -65.63 135.38 54.95 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.62 -106.14 0.91 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 107.401 -2.28 . . . . 0.0 107.401 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.31 167.04 21.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.595 1.958 . . . . 0.0 109.325 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -57.63 150.07 20.18 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.097 0.951 . . . . 0.0 112.532 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -125.99 -50.75 1.57 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.901 -1.524 . . . . 0.0 112.325 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.93 163.17 29.23 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 121.297 1.862 . . . . 0.0 110.619 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.2 139.75 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 119.122 0.874 . . . . 0.0 111.716 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 123' ' ' ILE . 4.4 mm? -110.93 164.8 12.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.452 2.301 . . . . 0.0 110.462 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.6 59.92 0.07 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.086 0.954 . . . . 0.0 112.619 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -156.34 172.8 17.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.879 -1.138 . . . . 0.0 108.287 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 t -143.98 149.41 17.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.91 164.6 31.47 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 63.0 t -131.28 136.74 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -147.62 163.85 35.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.65 0.78 . . . . 0.0 111.994 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.55 100.67 10.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -62.53 -12.35 21.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.5 m -65.58 -44.14 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 121.674 -0.642 . . . . 0.0 110.827 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.442 ' HB2' ' HE2' ' A' ' 169' ' ' LYS . 32.3 m -121.62 -20.57 6.47 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 125.54 1.536 . . . . 0.0 113.233 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.48 5.78 57.74 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.457 1.027 . . . . 0.0 111.753 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.442 ' HE2' ' HB2' ' A' ' 167' ' ' SER . 45.1 mtmt -61.27 112.8 2.29 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.49 1.116 . . . . 0.0 108.162 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 p -63.29 151.31 40.99 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.22 141.68 26.8 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.912 1.285 . . . . 0.0 107.664 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -82.43 160.2 17.18 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.955 2.437 . . . . 0.0 108.488 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 ttp85 -53.12 -27.28 20.02 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.225 1.01 . . . . 0.0 113.372 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.2 t -65.67 -13.66 59.65 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.074 1.749 . . . . 0.0 112.4 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.58 -1.55 13.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 119.706 -1.871 . . . . 0.0 110.598 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.5 m0 . . . . . 0 CA--C 1.541 0.628 0 O-C-N 121.556 -0.715 . . . . 0.0 109.901 179.183 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.1 mtt85 . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 110.661 -0.126 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.9 m -144.86 132.69 21.2 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 127.187 2.195 . . . . 0.0 107.025 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -108.76 109.67 20.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.859 2.063 . . . . 0.0 106.609 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -115.72 116.78 28.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.764 1.225 . . . . 0.0 112.281 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -84.0 133.32 34.68 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.103 1.361 . . . . 0.0 109.318 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.14 101.33 7.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.47 1.108 . . . . 0.0 109.417 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -96.11 158.45 21.79 Favored Glycine 0 CA--C 1.534 1.27 1 C-N-CA 134.549 5.833 . . . . 0.0 107.608 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -68.25 157.16 36.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.338 1.569 . . . . 0.0 113.13 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 62.2 mt -101.11 139.81 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 126.744 2.018 . . . . 0.0 109.583 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -133.1 152.33 51.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.502 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 18.9 t -76.99 172.96 12.35 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 35.8 mt -129.06 141.9 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 122.824 1.297 . . . . 0.0 107.691 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 -65.81 121.49 15.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.175 1.39 . . . . 0.0 109.351 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.54 15.4 80.5 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.395 -1.225 . . . . 0.0 113.612 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -136.49 132.19 34.99 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.992 1.896 . . . . 0.0 110.018 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.4 m -81.13 150.63 28.64 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.77 -29.84 63.01 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.345 -0.847 . . . . 0.0 109.951 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.1 p -67.54 -20.64 65.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.151 2.18 . . . . 0.0 114.025 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -112.13 -41.71 3.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 117.787 -1.101 . . . . 0.0 110.313 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.71 142.69 3.77 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.124 0.874 . . . . 0.0 109.863 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -151.47 175.62 12.11 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.691 0.796 . . . . 0.0 109.426 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.56 132.7 53.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.239 1.415 . . . . 0.0 110.327 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.48 124.77 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 C-N-CA 125.316 1.446 . . . . 0.0 107.836 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -72.9 109.49 6.51 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 50.4 mm -121.83 118.07 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 126.071 1.749 . . . . 0.0 109.224 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.58 47.4 16.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.242 1.017 . . . . 0.0 109.511 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.82 10.98 6.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.52 1.128 . . . . 0.0 111.441 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.26 123.46 38.17 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.205 -1.559 . . . . 0.0 110.588 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -69.79 116.95 10.78 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.02 -1.05 . . . . 0.0 108.565 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -112.55 150.52 31.21 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.019 1.328 . . . . 0.0 109.756 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.2 tm? -82.38 135.07 35.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.21 1.004 . . . . 0.0 109.944 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.03 125.16 44.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.71 152.17 26.86 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.525 0.73 . . . . 0.0 112.001 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -60.8 139.18 58.01 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 122.205 -0.309 . . . . 0.0 110.319 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 139' ' ' SER . 11.4 p . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.227 -0.125 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -64.67 147.45 52.98 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.334 0.97 . . . . 0.0 108.597 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.2 t -150.53 132.11 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 123' ' ' ILE . 5.1 mp -72.18 139.5 19.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -60.31 118.64 6.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -19.59 37.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.749 -0.594 . . . . 0.0 111.749 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -96.04 -19.6 19.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.601 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.8 111.49 5.03 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.843 1.656 . . . . 0.0 108.731 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 163' ' ' PHE . 6.0 t -54.88 -32.83 61.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.055 1.342 . . . . 0.0 112.93 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.5 ptt85 -79.05 -1.27 34.91 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.236 -0.915 . . . . 0.0 112.32 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -110.35 157.09 19.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 118.585 0.629 . . . . 0.0 112.523 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.3 mm -127.31 141.74 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -115.68 103.0 10.25 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 129.404 3.082 . . . . 0.0 104.159 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -143.15 133.88 25.22 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.074 -1.016 . . . . 0.0 109.317 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 22.3 mtp 56.88 30.23 17.56 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.845 1.258 . . . . 0.0 112.615 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.71 8.73 73.12 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.899 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -106.97 168.64 9.06 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.602 1.561 . . . . 0.0 107.635 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.6 mm -120.23 141.2 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -133.04 143.91 49.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.7 t -135.19 151.25 50.47 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.774 1.229 . . . . 0.0 109.112 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 mt -101.0 137.75 27.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.788 0.835 . . . . 0.0 110.419 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.9 t -101.57 -111.17 0.21 Allowed 'General case' 0 CA--C 1.537 0.46 1 N-CA-C 98.714 -4.551 . . . . 0.0 98.714 175.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -166.9 99.12 0.55 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.8 m -135.67 112.97 10.56 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 127.764 2.426 . . . . 0.0 105.583 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.1 m -68.54 123.29 20.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.67 116.14 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.8 m -83.96 158.64 21.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.167 0.508 . . . . 0.0 110.964 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -57.32 -32.75 67.0 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.188 1.795 . . . . 0.0 111.386 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.82 -8.79 55.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.88 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -121.72 -20.93 6.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.436 1.094 . . . . 0.0 109.658 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.0 tp -66.26 151.36 47.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.31 -102.59 2.72 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -134.65 165.15 25.89 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.85 0.86 . . . . 0.0 110.942 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -62.44 143.31 57.24 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -123.59 -52.05 1.82 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.878 -1.058 . . . . 0.0 111.535 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.82 173.86 16.35 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.924 0.783 . . . . 0.0 110.071 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.8 p -129.92 147.29 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.419 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.2 mm? -111.78 166.54 11.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.274 3.029 . . . . 0.0 112.952 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -162.87 45.61 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.68 174.46 10.95 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 119.802 -1.811 . . . . 0.0 108.621 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.0 t -142.22 149.81 19.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.308 1.043 . . . . 0.0 108.351 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -145.18 161.11 40.31 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.893 -1.129 . . . . 0.0 108.847 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 191' ' ' THR . 92.2 t -127.32 126.93 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 128' ' ' SER . 52.9 p90 -148.17 165.34 31.19 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.535 0.734 . . . . 0.0 111.18 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -80.88 109.67 15.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.119 1.767 . . . . 0.0 108.195 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.9 t -50.49 -23.44 2.48 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.713 2.805 . . . . 0.0 115.269 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.47 -39.56 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.4 t -122.12 -24.99 4.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.73 -1.02 52.38 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.89 1.233 . . . . 0.0 112.52 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -51.69 112.35 0.75 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.39 1.876 . . . . 0.0 110.23 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 25.9 p -72.7 156.48 38.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.633 0.73 . . . . 0.0 110.52 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.58 136.79 25.6 Favored Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.81 162.87 32.05 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.722 2.282 . . . . 0.0 109.561 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -58.71 -31.85 68.64 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.558 0.343 . . . . 0.0 111.864 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.8 m -67.54 -4.39 11.46 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.28 -0.93 10.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.829 1.252 . . . . 0.0 110.274 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 42.2 m0 . . . . . 0 N--CA 1.464 0.251 0 O-C-N 120.064 -1.648 . . . . 0.0 111.751 -179.312 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 121.055 0.455 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 0.3 OUTLIER -133.3 147.21 51.88 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 130.721 3.609 . . . . 0.0 105.881 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -129.11 104.94 7.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 102.923 -2.992 . . . . 0.0 102.923 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -111.49 116.21 30.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -83.53 129.34 34.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.261 1.424 . . . . 0.0 107.956 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -74.76 100.71 4.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.497 0.719 . . . . 0.0 109.239 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.3 159.66 27.56 Favored Glycine 0 CA--C 1.53 1.019 1 C-N-CA 132.631 4.92 . . . . 0.0 110.267 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.43 162.7 22.49 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 122.403 1.097 . . . . 0.0 109.304 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 97.4 mt -109.31 131.77 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 127.262 2.225 . . . . 0.0 112.072 -176.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -128.2 149.99 50.21 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.121 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 63.3 m -79.24 172.53 13.68 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.03 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 72.0 mt -128.62 139.02 53.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.315 1.446 . . . . 0.0 107.284 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -68.99 122.18 18.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.18 13.43 77.01 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 118.763 -1.02 . . . . 0.0 113.457 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -139.9 123.78 17.52 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 119.499 1.649 . . . . 0.0 109.988 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 54.8 m -79.6 150.91 30.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.01 -23.54 54.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.878 0.871 . . . . 0.0 110.284 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 17.0 p -76.09 -9.49 58.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.316 2.246 . . . . 0.0 113.513 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -123.95 -47.26 1.93 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.894 1.277 . . . . 0.0 110.081 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.88 148.27 13.77 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -155.14 175.84 13.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -108.36 144.44 35.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.56 124.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.767 2.027 . . . . 0.0 109.172 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -73.97 107.5 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 47.4 mm -121.84 125.76 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 109.76 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 54.32 44.43 28.99 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.013 0.824 . . . . 0.0 109.748 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 65.42 0.21 1.33 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.642 1.977 . . . . 0.0 113.974 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -121.23 127.87 51.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.949 0.795 . . . . 0.0 109.111 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -66.0 136.6 56.27 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.329 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -128.87 145.95 51.07 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.928 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.35 133.08 35.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.899 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -121.71 138.19 54.45 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 23.9 p -120.78 149.41 42.6 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 123.677 0.611 . . . . 0.0 112.632 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -61.12 143.01 56.27 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 177.345 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.786 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.447 ' H ' ' HD1' ' A' ' 121' ' ' PHE . 1.6 p90 -71.59 127.67 33.32 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 129.508 3.123 . . . . 0.0 106.285 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.7 126.11 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.9 mp -68.88 133.17 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -66.27 128.23 35.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.42 -22.4 66.95 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.627 0.771 . . . . 0.0 111.135 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -81.25 -47.33 13.51 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.557 1.143 . . . . 0.0 109.605 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -140.74 106.05 5.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.366 1.466 . . . . 0.0 108.742 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 m -62.69 -12.28 22.63 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 120.362 -1.461 . . . . 0.0 112.259 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -85.13 1.84 46.17 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.417 1.087 . . . . 0.0 109.446 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -113.98 162.11 16.83 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.558 1.143 . . . . 0.0 109.06 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.9 mm -132.94 128.23 56.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -106.16 110.46 22.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.533 2.333 . . . . 0.0 106.567 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -146.26 128.76 16.0 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.455 1.102 . . . . 0.0 108.755 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.2 mtt 60.82 39.94 16.47 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.953 1.701 . . . . 0.0 112.329 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 63.59 21.63 65.06 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.918 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -114.46 173.46 6.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.1 mm -132.9 132.41 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -124.55 156.19 37.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.7 t -131.11 150.62 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.934 1.694 . . . . 0.0 108.949 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.8 mt -120.34 127.63 75.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.9 t -103.97 -104.51 0.3 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -164.76 101.79 0.79 Allowed 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 178.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 86.6 m -135.37 113.66 11.44 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 126.728 2.011 . . . . 0.0 107.38 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.7 m -66.98 115.98 7.3 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.574 1.533 . . . . 0.0 109.399 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 66.7 t -95.27 115.55 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 m -82.26 158.55 23.45 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -63.76 -26.59 68.71 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.972 0.909 . . . . 0.0 111.559 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -66.99 -23.77 65.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.175 0.443 . . . . 0.0 110.533 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -99.82 -21.03 15.91 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.937 0.895 . . . . 0.0 110.014 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.23 148.91 48.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.819 1.248 . . . . 0.0 108.03 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.15 -106.54 2.69 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.37 170.67 15.58 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.62 1.168 . . . . 0.0 110.349 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -56.92 138.0 54.55 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.394 1.478 . . . . 0.0 109.154 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -126.3 -52.89 1.5 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 121' ' ' PHE . 29.5 m-20 -139.66 156.6 46.74 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.548 0.613 . . . . 0.0 110.217 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.3 p -120.36 133.45 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.381 0.61 . . . . 0.0 111.833 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.418 HD21 HD12 ' A' ' 198' ' ' ILE . 4.1 mm? -112.3 164.15 13.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.954 2.102 . . . . 0.0 112.252 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.44 42.05 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.749 1.22 . . . . 0.0 112.536 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.407 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 1.5 tt0 -140.39 175.59 9.47 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 119.068 -2.27 . . . . 0.0 108.987 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 t -143.08 149.52 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.84 165.8 26.53 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.449 HG12 ' HG3' ' A' ' 190' ' ' ARG . 21.3 t -133.75 129.19 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -141.99 157.36 45.04 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 119.881 1.219 . . . . 0.0 111.414 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -62.19 121.17 12.42 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.877 0.871 . . . . 0.0 109.574 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.15 -14.2 59.99 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.52 -38.68 12.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.0 t -123.0 -27.13 4.27 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.24 6.62 53.34 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.258 0.932 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -55.68 114.44 1.87 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.761 1.624 . . . . 0.0 108.517 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.08 132.84 55.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.022 0.828 . . . . 0.0 109.198 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -92.76 144.46 28.62 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.36 153.78 45.37 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.59 2.193 . . . . 0.0 110.201 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -56.95 -36.31 70.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.565 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.6 t -63.39 -2.63 1.59 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -118.18 -1.26 11.39 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.202 1.364 . . . . 0.0 111.966 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 36.5 m0 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 125.242 1.417 . . . . 0.0 113.653 -179.861 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.449 ' HG3' HG12 ' A' ' 162' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.242 0.544 . . . . 0.0 110.351 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.0 m -91.88 137.41 32.39 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.701 2.0 . . . . 0.0 106.388 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -119.48 109.88 16.25 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.842 2.057 . . . . 0.0 106.949 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -115.38 119.62 36.85 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.768 2.027 . . . . 0.0 110.797 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -86.82 134.46 33.55 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 128.363 2.665 . . . . 0.0 110.031 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.444 ' CE2' HD13 ' A' ' 123' ' ' ILE . 3.2 m-30 -80.35 102.28 9.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.475 1.51 . . . . 0.0 110.477 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -95.49 158.66 22.22 Favored Glycine 0 CA--C 1.533 1.196 1 C-N-CA 133.042 5.115 . . . . 0.0 107.475 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.85 159.42 30.44 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 123.62 1.676 . . . . 0.0 110.62 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.418 HD12 HD21 ' A' ' 157' ' ' LEU . 57.7 mt -111.73 141.1 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.705 1.602 . . . . 0.0 109.982 -176.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -134.43 147.5 50.45 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.324 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.61 173.44 6.07 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.8 mt -128.89 141.4 46.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.206 1.403 . . . . 0.0 108.509 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.87 124.7 24.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.4 17.35 76.26 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-O 117.493 -1.726 . . . . 0.0 114.841 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -147.63 134.44 20.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.105 1.952 . . . . 0.0 111.255 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.0 m -84.87 151.16 24.49 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.22 -30.64 62.61 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.327 -0.858 . . . . 0.0 109.864 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 66.9 p -73.18 -4.25 31.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.928 1.691 . . . . 0.0 114.458 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -125.12 -40.98 2.1 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.831 1.652 . . . . 0.0 109.515 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.05 144.6 2.71 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 118.858 0.754 . . . . 0.0 109.736 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -152.41 175.63 12.5 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.966 0.907 . . . . 0.0 109.198 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -112.47 134.72 53.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.041 1.336 . . . . 0.0 110.547 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.5 124.54 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 C-N-CA 124.153 0.981 . . . . 0.0 108.635 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -70.29 104.39 2.66 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 41.5 mm -121.77 133.22 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 54.77 39.7 31.53 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.06 3.31 2.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.837 2.455 . . . . 0.0 113.642 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -119.43 125.29 48.58 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.706 1.203 . . . . 0.0 111.492 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -64.28 113.19 3.43 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.571 0.748 . . . . 0.0 112.635 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -105.97 147.29 28.99 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 122.184 0.992 . . . . 0.0 110.908 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -86.18 123.12 31.11 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.428 1.491 . . . . 0.0 108.805 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -107.54 144.23 34.82 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.7 p -118.05 147.37 43.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.784 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -62.15 142.81 57.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.646 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.031 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -75.11 138.56 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.0 t -139.55 132.01 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 157' ' ' LEU . 5.1 mp -78.64 128.63 38.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 177.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -61.56 122.34 15.0 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.51 1.148 . . . . 0.0 108.892 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.1 pttt -62.27 -23.01 66.46 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.362 -0.836 . . . . 0.0 110.358 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -85.01 -22.92 28.88 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.605 1.162 . . . . 0.0 110.603 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.84 102.45 2.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 119.667 1.122 . . . . 0.0 108.294 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.0 m -57.53 -24.93 58.85 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.884 0.873 . . . . 0.0 112.756 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.6 ptt85 -81.23 -3.79 53.46 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.923 0.889 . . . . 0.0 111.302 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -108.25 151.86 25.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.634 0.73 . . . . 0.0 110.089 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 14.2 mm -120.8 142.02 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -117.45 104.06 10.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.904 2.482 . . . . 0.0 106.051 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -127.26 133.97 50.12 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.0 mtt 56.3 13.44 1.26 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.043 -1.661 . . . . 0.0 113.281 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.73 6.6 65.49 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.879 1.228 . . . . 0.0 110.66 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -97.61 154.11 17.76 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 119.055 1.427 . . . . 0.0 107.917 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mm -118.09 140.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 O-C-N 124.358 1.036 . . . . 0.0 110.058 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -123.35 168.85 11.97 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.76 1.224 . . . . 0.0 110.528 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.47 135.51 25.16 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.453 1.501 . . . . 0.0 109.412 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 mt -97.89 119.0 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.1 t -94.87 -105.25 0.14 Allowed 'General case' 0 C--O 1.234 0.255 1 N-CA-C 99.717 -4.179 . . . . 0.0 99.717 176.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -167.03 99.34 0.53 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 4.5 m -136.29 121.46 19.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 128.332 2.653 . . . . 0.0 103.93 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.5 m -76.59 128.42 34.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.27 111.69 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.435 1.016 . . . . 0.0 109.583 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.2 m -81.96 162.95 22.49 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.027 0.531 . . . . 0.0 110.347 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.44 -27.0 65.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.248 1.819 . . . . 0.0 112.521 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.35 -22.07 61.95 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.204 -0.31 . . . . 0.0 110.213 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.82 -26.79 13.01 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.287 1.035 . . . . 0.0 109.433 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.8 tp -65.08 152.68 42.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -111.2 -102.64 2.67 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 125.037 1.303 . . . . 0.0 109.925 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -134.54 167.49 20.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.532 1.133 . . . . 0.0 110.858 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -60.07 140.93 56.53 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.024 1.33 . . . . 0.0 108.178 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -124.49 -47.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.598 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.99 158.16 40.19 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.325 1.42 . . . . 0.0 111.197 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.35 135.1 57.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.754 0.788 . . . . 0.0 111.292 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.409 HD12 HD11 ' A' ' 123' ' ' ILE . 4.2 mm? -111.27 165.92 11.53 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.041 2.936 . . . . 0.0 110.324 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.46 51.99 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.652 1.181 . . . . 0.0 113.143 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.36 175.85 9.6 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 119.618 -1.926 . . . . 0.0 107.681 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.66 142.58 23.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.93 161.1 38.15 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 191' ' ' THR . 71.6 t -129.89 124.2 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.74 169.24 18.09 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.289 0.95 . . . . 0.0 110.877 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -81.08 117.78 21.95 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -15.74 60.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.7 m -82.96 -41.19 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.0 -1.063 . . . . 0.0 113.779 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.409 ' HB2' ' HD3' ' A' ' 169' ' ' LYS . 68.2 m -122.36 -27.61 4.43 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 125.294 1.438 . . . . 0.0 113.456 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.32 7.59 37.21 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 117.118 1.607 . . . . 0.0 117.118 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.418 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -60.51 113.25 2.33 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.982 1.313 . . . . 0.0 110.551 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.2 p -70.58 149.48 47.04 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.749 1.22 . . . . 0.0 109.793 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.416 HG22 ' CD1' ' A' ' 176' ' ' TRP . 1.2 mp -117.41 139.3 25.94 Favored Pre-proline 0 N--CA 1.44 -0.964 0 C-N-CA 125.527 1.531 . . . . 0.0 107.236 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.56 153.4 20.49 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.798 2.332 . . . . 0.0 109.33 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -51.21 -33.47 27.79 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.821 1.249 . . . . 0.0 111.573 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -3.47 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.556 1.142 . . . . 0.0 113.283 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -129.72 6.93 5.18 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.359 1.863 . . . . 0.0 113.242 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.416 ' CD1' HG22 ' A' ' 171' ' ' ILE . 40.9 m0 . . . . . 0 CA--C 1.547 0.83 0 C-N-CA 124.409 1.083 . . . . 0.0 112.713 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.0 mmp_? . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 28.7 m -128.61 150.77 50.08 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 128.363 2.665 . . . . 0.0 105.99 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -124.37 109.02 12.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -110.44 116.26 31.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.829 1.652 . . . . 0.0 110.903 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.29 123.67 31.03 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 128.119 2.568 . . . . 0.0 107.405 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -72.19 101.18 2.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 118.951 0.796 . . . . 0.0 109.468 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.2 159.0 27.19 Favored Glycine 0 N--CA 1.44 -1.094 1 C-N-CA 131.67 4.462 . . . . 0.0 107.392 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -68.26 160.06 30.03 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.43 1.586 . . . . 0.0 111.267 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 77.6 mt -106.76 141.13 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.136 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -132.91 151.8 51.99 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.574 1.55 . . . . 0.0 110.528 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.4 t -78.29 173.05 12.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.904 0.882 . . . . 0.0 108.662 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.1 mt -129.63 140.3 49.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 122.477 1.132 . . . . 0.0 108.721 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -66.26 119.64 11.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.303 1.441 . . . . 0.0 107.821 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.88 2.44 88.5 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.31 -1.272 . . . . 0.0 114.962 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -126.39 132.79 51.46 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.91 1.855 . . . . 0.0 109.075 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 16.2 m -85.78 150.73 24.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -28.37 63.29 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 124.202 1.001 . . . . 0.0 110.075 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.6 p -72.02 -11.18 60.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.115 2.166 . . . . 0.0 114.195 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -120.47 -47.62 2.33 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.514 1.526 . . . . 0.0 109.549 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.25 144.51 12.76 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 111.084 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -150.05 175.77 11.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.738 0.415 . . . . 0.0 109.984 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.15 128.89 55.39 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.828 0.851 . . . . 0.0 110.324 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.0 128.27 71.74 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 C-N-CA 124.697 1.199 . . . . 0.0 107.855 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.05 110.26 7.2 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.6 mm -121.77 124.08 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 53.5 48.14 22.44 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.092 0.86 . . . . 0.0 109.087 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 65.48 -4.26 0.59 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.649 2.379 . . . . 0.0 115.014 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -114.9 135.59 54.03 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.094 0.861 . . . . 0.0 109.771 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -72.92 115.36 12.13 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.152 0.981 . . . . 0.0 110.26 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 146.98 34.36 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.9 tm? -79.31 136.79 37.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.86 1.264 . . . . 0.0 108.229 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.05 137.36 53.63 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.0 p -121.3 150.38 41.5 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.41 0.444 . . . . 0.0 111.974 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -55.01 133.51 48.59 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.222 -0.367 0 C-N-CA 126.401 1.881 . . . . 0.0 108.017 179.065 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.23 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 155' ' ' ASP . 18.9 p90 -66.43 149.78 49.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 97.3 t -149.72 126.25 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.8 mp -71.94 134.13 30.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.52 117.52 6.32 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -24.49 19.97 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.71 0.804 . . . . 0.0 111.53 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -89.19 -22.59 22.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.368 1.467 . . . . 0.0 112.396 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.11 104.33 3.67 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 119.565 1.075 . . . . 0.0 108.273 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.4 t -60.14 -22.33 62.73 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.342 -0.849 . . . . 0.0 112.814 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.0 ptt85 -80.69 -4.83 55.8 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.35 -0.844 . . . . 0.0 110.598 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -109.6 159.28 17.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.816 0.817 . . . . 0.0 111.409 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.8 mm -130.38 146.77 33.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.04 104.75 9.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -141.06 134.43 29.74 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.05 1.34 . . . . 0.0 109.898 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.0 mtt 58.21 36.42 25.73 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.605 1.162 . . . . 0.0 112.109 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.05 22.85 63.16 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -121.88 161.51 22.66 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mm -116.37 145.24 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -135.15 156.94 48.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.45 ' HB2' HG11 ' A' ' 224' ' ' VAL . 8.0 t -139.19 165.14 27.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.4 mt -117.13 134.75 59.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.714 0.769 . . . . 0.0 110.699 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.31 -114.6 0.2 Allowed 'General case' 0 CA--C 1.539 0.521 1 N-CA-C 99.371 -4.307 . . . . 0.0 99.371 175.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -167.53 100.33 0.49 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 94.5 m -136.25 121.8 19.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.81 2.044 . . . . 0.0 106.75 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 m -71.5 121.45 18.69 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.87 110.68 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.5 m -70.85 159.53 34.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.06 0.457 . . . . 0.0 110.944 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.28 -29.86 69.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.546 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.95 -12.36 60.63 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -108.54 -23.04 12.01 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.485 1.114 . . . . 0.0 109.13 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.46 133.99 53.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.98 -105.86 0.74 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -135.85 166.86 22.31 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.613 1.565 . . . . 0.0 108.601 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -64.63 139.92 58.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -123.26 -48.03 1.99 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.573 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 28.3 m-20 -152.65 166.6 31.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.982 1.265 . . . . 0.0 111.32 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.24 143.17 40.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.572 1.149 . . . . 0.0 111.142 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -111.2 166.5 11.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.875 2.87 . . . . 0.0 112.706 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.15 58.83 0.29 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.182 0.993 . . . . 0.0 112.631 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -161.99 175.98 11.25 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.974 -1.704 . . . . 0.0 111.605 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -144.59 150.12 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.112 1.765 . . . . 0.0 108.557 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.8 164.71 29.36 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.039 1.29 . . . . 0.0 109.236 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.0 t -132.17 132.97 60.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -141.72 168.59 19.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.658 0.783 . . . . 0.0 111.271 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -89.49 102.86 15.54 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 127.022 2.129 . . . . 0.0 108.067 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.7 t -47.03 -21.23 0.2 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 129.507 3.123 . . . . 0.0 114.8 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.03 -50.91 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.432 1.493 . . . . 0.0 110.898 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.9 t -123.21 -23.84 4.81 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.858 1.663 . . . . 0.0 114.05 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.95 0.87 42.04 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.24 1.4 . . . . 0.0 110.364 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -48.13 113.5 0.75 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 127.712 2.405 . . . . 0.0 111.003 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 39.9 p -61.02 154.98 21.27 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.852 1.261 . . . . 0.0 111.299 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.99 142.44 41.19 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.28 1.032 . . . . 0.0 108.826 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.22 157.25 46.2 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.203 2.602 . . . . 0.0 108.98 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -57.68 -32.25 67.16 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.683 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -7.8 9.67 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 118.103 -0.951 . . . . 0.0 113.287 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -110.79 -8.59 14.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.4 1.454 . . . . 0.0 109.835 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.6 m0 . . . . . 0 C--O 1.236 0.363 0 CA-C-N 119.668 1.122 . . . . 0.0 112.176 -178.779 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.2 m -132.64 135.46 45.87 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 127.946 2.499 . . . . 0.0 106.626 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -114.42 108.34 16.75 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -110.23 123.87 50.56 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.591 1.556 . . . . 0.0 109.73 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -90.46 125.2 35.5 Favored 'General case' 0 N--CA 1.441 -0.893 1 C-N-CA 133.244 4.618 . . . . 0.0 109.087 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -77.74 101.88 6.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 127.327 2.251 . . . . 0.0 107.72 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -97.79 159.35 20.89 Favored Glycine 0 CA--C 1.533 1.218 1 C-N-CA 134.377 5.751 . . . . 0.0 108.049 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -66.6 163.19 19.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.939 1.369 . . . . 0.0 110.569 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 73.7 mt -109.31 134.95 49.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 128.138 2.575 . . . . 0.0 111.735 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -130.02 151.29 50.73 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.947 1.299 . . . . 0.0 110.239 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.3 p -78.59 173.53 12.32 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.518 ' CD1' HD23 ' A' ' 220' ' ' LEU . 50.3 mt -128.29 136.59 59.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 O-C-N 121.255 -0.903 . . . . 0.0 109.805 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -63.03 127.34 30.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.3 12.09 84.91 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.478 -1.179 . . . . 0.0 113.915 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -138.85 156.16 47.54 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 120.365 2.083 . . . . 0.0 109.168 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.2 m -103.32 146.62 28.19 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -23.34 58.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.875 0.87 . . . . 0.0 109.74 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 23.7 p -79.11 -9.5 59.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.721 1.608 . . . . 0.0 114.105 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -123.73 -40.63 2.31 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.678 0.791 . . . . 0.0 112.215 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.441 ' HB1' HD21 ' A' ' 220' ' ' LEU . . . -162.48 140.02 8.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -150.57 176.13 11.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -107.93 143.13 37.01 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.45 121.9 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.647 1.579 . . . . 0.0 108.768 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.85 104.37 4.0 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.1 mm -122.15 126.03 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 126.49 1.916 . . . . 0.0 109.273 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 58.54 34.76 24.15 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.844 -1.16 . . . . 0.0 112.236 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 66.1 13.77 9.28 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.366 1.066 . . . . 0.0 113.187 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.62 120.23 21.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.318 1.847 . . . . 0.0 108.634 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -65.6 136.65 56.62 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 120.103 -1.623 . . . . 0.0 109.965 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -127.15 147.9 50.18 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.026 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 201' ' ' ILE . 1.4 tm? -84.86 115.1 22.57 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.056 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.48 147.8 24.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.59 143.18 50.15 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 118.0 0.364 . . . . 0.0 110.571 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -50.86 135.3 24.41 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.209 1.404 . . . . 0.0 110.061 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' A' ' 139' ' ' SER . 4.8 p . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -65.0 118.51 9.22 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.722 1.609 . . . . 0.0 110.103 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.4 t -121.76 135.55 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -83.0 118.93 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -47.4 118.77 2.33 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.187 1.395 . . . . 0.0 110.486 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -59.98 -21.45 61.28 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.507 -0.746 . . . . 0.0 111.701 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -88.53 -20.05 25.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.083 0.953 . . . . 0.0 111.257 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.05 112.25 2.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.965 1.257 . . . . 0.0 110.64 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 m -60.27 -21.91 62.46 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 119.957 -1.714 . . . . 0.0 113.428 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.7 ptt85 -80.84 1.23 31.53 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 120.858 -1.151 . . . . 0.0 110.015 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -111.93 158.68 19.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.867 0.841 . . . . 0.0 110.277 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.0 mm -133.43 127.59 53.89 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 136' ' ' ASN . 4.7 t0 -96.91 105.0 17.05 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 128.086 2.554 . . . . 0.0 104.14 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -139.5 143.11 37.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.083 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 8.9 mtt 55.24 22.87 5.03 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.853 -1.154 . . . . 0.0 113.749 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.04 17.86 71.11 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.504 1.049 . . . . 0.0 110.983 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 8.9 p30 -117.28 173.84 6.46 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 126.588 1.955 . . . . 0.0 112.88 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.2 mm -130.04 132.33 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -119.33 163.55 17.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 t -140.02 148.12 41.39 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.578 1.551 . . . . 0.0 106.925 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 mt -114.08 121.74 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -94.85 -113.5 0.12 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -158.3 99.63 1.63 Allowed 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 65.0 m -136.95 116.42 12.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.004 2.522 . . . . 0.0 104.89 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.6 m -78.35 122.3 25.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 121.235 1.834 . . . . 0.0 106.595 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.7 t -94.67 113.05 28.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.018 1.327 . . . . 0.0 109.225 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.0 m -75.14 163.84 27.13 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.523 1.129 . . . . 0.0 111.18 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.24 -29.34 68.7 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.264 1.025 . . . . 0.0 110.168 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.02 -16.48 64.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.363 0.665 . . . . 0.0 112.062 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -105.35 -30.68 9.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.63 1.572 . . . . 0.0 109.83 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -55.67 127.27 29.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.951 1.3 . . . . 0.0 110.141 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.48 -104.83 1.25 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 125.235 1.398 . . . . 0.0 110.066 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -134.44 168.31 19.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.397 1.479 . . . . 0.0 109.296 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.42 136.95 58.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -115.18 -52.37 2.68 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.414 0.686 . . . . 0.0 111.784 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -160.37 159.9 31.68 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.77 1.168 . . . . 0.0 109.038 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 p -114.75 133.13 61.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.665 1.186 . . . . 0.0 111.402 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.61 164.9 12.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.966 2.106 . . . . 0.0 111.114 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.87 29.36 0.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.85 174.12 6.8 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 119.924 -1.735 . . . . 0.0 108.133 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.9 t -143.67 149.98 17.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.22 164.91 33.45 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.8 t -127.72 131.28 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -144.23 167.81 21.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.442 0.639 . . . . 0.0 110.172 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -79.99 119.16 22.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.1 t -66.21 -13.92 61.07 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.4 m -83.77 -43.61 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.7 m -122.19 -26.97 4.6 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.728 1.211 . . . . 0.0 113.919 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.31 -1.38 31.09 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.49 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -52.86 112.49 0.85 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.36 1.08 . . . . 0.0 111.599 -179.288 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.99 140.57 56.37 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.465 HG22 ' CD1' ' A' ' 176' ' ' TRP . 1.2 mp -106.88 143.39 26.99 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.32 1.848 . . . . 0.0 108.327 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.25 148.53 18.98 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.692 2.928 . . . . 0.0 110.896 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -53.38 -31.5 45.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.752 0.821 . . . . 0.0 112.892 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 t -68.76 -6.23 25.32 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.715 0.806 . . . . 0.0 112.998 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -116.4 -12.71 11.04 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.872 1.669 . . . . 0.0 110.201 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.465 ' CD1' HG22 ' A' ' 171' ' ' ILE . 40.3 m0 . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 . . . . . 0 C--O 1.233 0.208 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.43 HG22 ' CD1' ' A' ' 193' ' ' TRP . 95.5 m -128.66 117.78 21.77 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -95.03 113.12 24.79 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' TRP . . . . . 0.43 ' CD1' HG22 ' A' ' 191' ' ' THR . 12.4 m0 -123.38 124.5 43.06 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.702 1.601 . . . . 0.0 110.256 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.72 135.03 34.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.036 2.134 . . . . 0.0 107.512 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -78.3 100.52 6.76 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.69 159.55 23.1 Favored Glycine 0 N--CA 1.441 -0.984 1 C-N-CA 130.818 4.056 . . . . 0.0 107.514 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -68.14 154.33 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 123.655 1.693 . . . . 0.0 111.61 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.66 141.04 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 112.997 -1.911 . . . . 0.0 108.205 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -134.2 153.63 51.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 112.957 -1.929 . . . . 0.0 108.316 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.72 173.11 12.19 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 81.6 mt -124.14 137.5 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -55.71 119.58 5.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.162 1.385 . . . . 0.0 108.24 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.46 12.1 82.34 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.412 -1.215 . . . . 0.0 115.436 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -126.05 133.01 51.83 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 120.961 2.381 . . . . 0.0 109.568 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 67.9 m -83.53 142.78 30.64 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.47 -32.23 57.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.272 1.029 . . . . 0.0 110.501 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.2 p -70.12 -10.55 59.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.277 1.431 . . . . 0.0 114.516 -178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.02 -41.36 2.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.712 1.205 . . . . 0.0 109.097 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -166.93 151.61 7.3 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.002 0.819 . . . . 0.0 110.258 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -156.48 175.63 13.77 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.113 0.965 . . . . 0.0 109.565 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -112.13 137.0 50.81 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.889 1.276 . . . . 0.0 110.093 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.04 131.63 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.135 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLU . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 218' ' ' PHE . 19.6 tt0 -71.0 106.22 3.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 40.4 mm -122.4 125.16 72.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.1 m120 56.35 36.71 27.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 13.7 t0 70.87 -4.94 1.59 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.539 1.936 . . . . 0.0 112.095 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.6 127.31 52.96 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 118.931 -2.356 . . . . 0.0 110.73 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' PHE . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 213' ' ' GLU . 14.8 m-85 -74.43 116.52 15.21 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.583 -1.323 . . . . 0.0 109.979 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -107.11 147.81 29.57 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.766 0.826 . . . . 0.0 109.809 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.4 tm? -83.85 128.03 34.25 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.49 1.516 . . . . 0.0 109.296 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -111.54 151.72 28.36 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.085 0.954 . . . . 0.0 109.167 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.2 p -133.2 147.9 52.02 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.75 1.22 . . . . 0.0 111.088 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -59.94 128.86 38.96 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.717 -0.615 . . . . 0.0 112.042 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.214 -0.772 0 C-N-CA 125.596 1.558 . . . . 0.0 109.722 -179.726 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.821 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -71.49 132.16 44.34 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 127.719 2.407 . . . . 0.0 106.569 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 93.4 t -133.91 125.54 49.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.514 ' HA ' HD13 ' A' ' 131' ' ' ILE . 3.4 mp -69.4 134.71 29.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -57.4 118.28 4.98 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.73 -18.02 63.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.549 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -94.38 -28.05 15.73 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.076 0.951 . . . . 0.0 111.491 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -138.96 106.73 5.63 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.743 1.217 . . . . 0.0 109.66 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.444 ' HB3' ' CD2' ' A' ' 163' ' ' PHE . 22.7 t -58.74 -24.93 62.43 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 120.592 -1.318 . . . . 0.0 112.687 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -82.53 -1.67 51.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.441 1.096 . . . . 0.0 111.106 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -116.13 159.29 21.95 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.447 0.642 . . . . 0.0 111.934 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 123' ' ' ILE . 30.4 mm -127.54 144.77 36.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -121.4 106.1 11.13 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 128.115 2.566 . . . . 0.0 105.126 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.421 ' HB3' ' CE2' ' A' ' 138' ' ' TYR . 20.9 t80 -138.9 130.92 27.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.7 mtt 60.45 22.54 12.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.259 1.424 . . . . 0.0 112.243 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.61 16.16 79.69 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -109.42 162.58 14.22 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.1 mm -123.3 132.08 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 133' ' ' TYR . 3.2 m-85 -120.33 159.13 25.65 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.7 t -145.65 155.49 43.04 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 mt -111.83 115.98 51.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 123.872 0.869 . . . . 0.0 111.643 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.5 t -87.15 -116.67 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -158.32 99.15 1.61 Allowed 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 55.4 m -137.04 129.6 30.12 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 131.151 3.78 . . . . 0.0 108.188 177.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.0 126.09 31.56 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.64 1.976 . . . . 0.0 107.511 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.2 t -94.77 111.85 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 120.621 1.555 . . . . 0.0 107.425 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.1 m -75.31 156.71 35.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.023 0.916 . . . . 0.0 109.801 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -55.85 -30.87 62.16 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 127.997 2.519 . . . . 0.0 112.885 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -72.86 -26.8 61.59 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.981 0.913 . . . . 0.0 111.455 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -97.84 -19.88 17.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.33 1.052 . . . . 0.0 110.097 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 mt -69.52 123.51 21.49 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.209 1.804 . . . . 0.0 109.504 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.16 -117.92 0.51 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 125.27 1.414 . . . . 0.0 110.96 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -130.13 165.14 22.92 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.535 1.134 . . . . 0.0 111.617 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -60.83 120.54 10.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.634 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -102.83 -52.71 3.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 118.003 -0.998 . . . . 0.0 111.119 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -153.44 166.01 34.04 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.487 0.585 . . . . 0.0 112.037 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.33 138.8 50.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 124.435 1.094 . . . . 0.0 109.324 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.553 HD21 HD12 ' A' ' 198' ' ' ILE . 3.3 mm? -104.74 165.5 11.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.501 2.32 . . . . 0.0 109.598 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -171.07 65.97 0.04 OUTLIER 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.398 0.679 . . . . 0.0 111.881 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.52 166.51 30.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.3 t -145.11 149.73 16.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -146.99 164.83 31.7 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.1 122.18 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.444 ' CD2' ' HB3' ' A' ' 128' ' ' SER . 37.2 p90 -140.0 177.3 8.07 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.376 1.444 . . . . 0.0 113.347 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -84.14 128.93 34.88 Favored 'General case' 0 C--N 1.347 0.488 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.3 t -66.05 -16.64 64.1 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.312 1.415 . . . . 0.0 113.372 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.63 -55.27 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 118.676 0.671 . . . . 0.0 112.468 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.3 m -121.73 -22.19 5.89 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.891 1.276 . . . . 0.0 113.004 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.46 15.3 25.55 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-O 118.455 -1.191 . . . . 0.0 115.714 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.584 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.3 OUTLIER -59.44 116.83 4.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.399 1.599 . . . . 0.0 109.981 179.523 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.08 153.45 41.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.735 1.152 . . . . 0.0 109.424 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.31 142.06 24.82 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.39 147.18 46.37 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.796 2.331 . . . . 0.0 109.959 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -56.54 -30.06 62.65 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.793 -0.567 . . . . 0.0 112.438 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.7 m -66.43 -7.09 17.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.621 1.169 . . . . 0.0 113.19 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -120.34 -4.84 9.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.123 1.769 . . . . 0.0 111.338 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.0 m0 . . . . . 0 N--CA 1.472 0.658 0 O-C-N 121.23 -0.919 . . . . 0.0 113.332 -178.676 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 . . . . . 0 CA--C 1.505 -0.759 0 CA-C-O 121.649 0.738 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.0 m -131.17 131.01 43.75 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -112.56 113.22 25.26 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -114.85 121.41 43.15 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.659 1.584 . . . . 0.0 108.761 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -89.3 131.76 35.24 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 128.905 2.882 . . . . 0.0 106.649 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -80.25 103.17 9.94 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.09 158.55 26.95 Favored Glycine 0 CA--C 1.53 1.03 1 C-N-CA 134.588 5.851 . . . . 0.0 107.056 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.72 160.08 31.01 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.147 1.474 . . . . 0.0 112.301 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.553 HD12 HD21 ' A' ' 157' ' ' LEU . 61.4 mt -109.06 139.02 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 126.12 1.768 . . . . 0.0 111.159 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -130.51 151.13 51.33 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.528 1.531 . . . . 0.0 109.446 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 13.6 p -75.9 174.17 10.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.159 0.584 . . . . 0.0 110.729 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 60.9 mt -132.61 139.43 49.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.135 1.374 . . . . 0.0 108.473 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -55.32 122.88 12.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.532 1.533 . . . . 0.0 109.832 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 66.34 13.27 60.08 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.343 -1.254 . . . . 0.0 115.498 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -131.05 124.37 30.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 120.05 1.925 . . . . 0.0 108.867 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 69.6 m -80.5 151.81 29.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.405 HD13 ' CG ' ' A' ' 210' ' ' PHE . 0.8 OUTLIER -55.39 -26.35 40.97 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.846 1.258 . . . . 0.0 109.472 178.691 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.2 p -70.38 -17.1 63.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.917 2.087 . . . . 0.0 113.377 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -120.54 -43.5 2.49 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.78 1.232 . . . . 0.0 112.009 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.5 146.0 6.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.051 0.94 . . . . 0.0 109.539 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.405 ' CG ' HD13 ' A' ' 206' ' ' LEU . 34.7 p90 -158.26 176.66 12.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.73 1.212 . . . . 0.0 108.805 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.23 132.57 53.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.467 1.507 . . . . 0.0 110.955 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.6 p -129.63 125.96 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 C-N-CA 124.312 1.045 . . . . 0.0 110.62 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -72.53 112.87 8.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 30.0 mm -122.59 119.83 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 55.14 33.61 20.84 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.274 0.943 . . . . 0.0 111.952 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.6 t70 80.33 -9.18 1.42 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.844 2.857 . . . . 0.0 111.977 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.91 122.64 43.14 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.843 -1.16 . . . . 0.0 108.836 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -73.81 112.53 10.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -104.01 145.94 29.43 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.102 0.961 . . . . 0.0 111.434 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.3 tm? -81.66 126.82 32.23 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -116.28 146.39 42.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.9 p -127.58 158.42 37.52 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.415 0.686 . . . . 0.0 111.19 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -64.92 122.11 16.2 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 84.8 t . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 122.671 1.224 . . . . 0.0 108.271 179.784 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.56 141.23 14.44 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 128.561 2.744 . . . . 0.0 105.1 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -70.07 128.4 36.18 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.3 t -132.07 135.36 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -80.93 140.13 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -55.71 127.86 32.05 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.306 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -55.83 -26.94 49.03 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.784 -1.198 . . . . 0.0 111.054 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -101.76 -8.31 21.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.946 1.299 . . . . 0.0 113.634 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.06 107.22 3.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.6 m -64.94 -14.14 59.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.253 1.821 . . . . 0.0 111.846 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -99.6 0.58 42.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.016 1.726 . . . . 0.0 112.029 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -117.69 158.44 24.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.068 0.461 . . . . 0.0 110.33 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.5 mm -126.29 132.61 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.12 99.14 8.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 102.069 -3.308 . . . . 0.0 102.069 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -135.71 127.07 28.45 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.347 -1.471 . . . . 0.0 107.607 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 12.9 mtt 60.44 30.16 19.57 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.558 1.143 . . . . 0.0 109.769 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.12 -0.34 31.5 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 123.808 0.718 . . . . 0.0 111.75 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -90.62 164.37 14.21 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.5 mm -123.99 123.63 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.657 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.66 131.11 53.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.294 1.038 . . . . 0.0 109.039 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.1 t -113.1 151.24 31.03 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.785 1.234 . . . . 0.0 108.374 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.2 mt -110.76 118.59 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.074 0.95 . . . . 0.0 108.744 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.3 t -89.04 -107.75 0.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -160.23 99.48 1.33 Allowed 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 85.5 m -138.33 114.44 10.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 115.865 -2.017 . . . . 0.0 107.128 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.5 m -75.62 125.59 29.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 122.448 2.386 . . . . 0.0 106.617 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.6 t -99.63 111.83 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.868 1.267 . . . . 0.0 108.152 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.9 m -75.77 161.18 29.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.75 0.82 . . . . 0.0 109.733 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.7 -30.48 68.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.42 1.088 . . . . 0.0 112.043 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.87 -24.24 64.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.31 -0.244 . . . . 0.0 110.891 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -96.44 -27.1 15.06 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.324 0.649 . . . . 0.0 109.515 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.6 tp -68.11 148.7 50.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.193 1.397 . . . . 0.0 109.286 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.74 -101.99 2.65 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.62 1.105 . . . . 0.0 111.158 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -135.07 171.19 14.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.313 1.845 . . . . 0.0 111.221 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -64.12 136.82 57.59 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.421 1.088 . . . . 0.0 110.189 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -117.19 -52.63 2.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.152 0.981 . . . . 0.0 113.168 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -157.59 158.4 35.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.098 0.863 . . . . 0.0 111.695 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.05 137.99 45.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 119.241 0.928 . . . . 0.0 111.165 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.57 165.19 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.487 1.915 . . . . 0.0 111.09 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.58 65.81 0.07 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.156 0.982 . . . . 0.0 111.192 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -157.98 167.76 29.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 t -144.18 148.39 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -142.05 166.61 24.24 Favored 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 120.872 -1.143 . . . . 0.0 108.558 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.09 129.72 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.63 168.86 18.75 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.179 0.9 . . . . 0.0 111.203 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -101.65 102.14 12.77 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.3 t -50.77 -19.19 0.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 129.361 3.064 . . . . 0.0 115.965 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.7 m -55.99 -46.95 80.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.3 m -123.98 -23.24 4.66 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.144 1.777 . . . . 0.0 114.276 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 103.7 7.87 41.14 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.289 1.899 . . . . 0.0 112.864 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 113.2 1.54 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.675 1.737 . . . . 0.0 112.942 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 p -63.2 140.56 58.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.154 0.982 . . . . 0.0 108.567 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.89 147.34 34.31 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.48 159.72 19.61 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.479 2.786 . . . . 0.0 110.089 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -64.44 -17.61 63.97 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 121.377 -0.827 . . . . 0.0 111.708 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.6 p -74.53 -11.14 60.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.367 -0.833 . . . . 0.0 111.711 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -111.1 -3.89 15.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.32 1.448 . . . . 0.0 112.251 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -66.08 -7.81 19.76 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.375 1.47 . . . . 0.0 114.397 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -134.84 -53.66 0.07 OUTLIER Glycine 0 CA--C 1.519 0.33 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -86.27 94.59 9.37 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -82.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -170.75 144.81 2.35 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.986 2.514 . . . . 0.0 106.567 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -97.46 -8.95 28.14 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 117.266 -1.349 . . . . 0.0 113.586 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.47 -21.09 0.48 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.83 1.195 . . . . 0.0 111.929 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -48.82 -17.5 0.85 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.21 1.862 . . . . 0.0 116.331 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 186' ' ' SER . 6.9 t 49.39 75.94 0.14 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.848 2.059 . . . . 0.0 110.269 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.38 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.264 1.825 . . . . 0.0 113.005 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 184' ' ' SER . 1.2 t -54.83 -11.84 0.69 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.643 3.177 . . . . 0.0 115.339 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -131.9 26.8 4.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.93 1.692 . . . . 0.0 109.255 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -133.65 118.82 18.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 t -117.23 95.56 5.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.187 0.995 . . . . 0.0 110.311 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -68.06 154.62 41.27 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 99.8 m -139.96 130.43 25.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -113.54 105.31 13.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.407 1.883 . . . . 0.0 107.547 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -110.3 127.89 55.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.941 0.896 . . . . 0.0 109.736 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -96.75 126.98 42.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.478 1.911 . . . . 0.0 107.399 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -75.66 100.96 4.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.896 1.331 . . . . 0.0 111.522 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -95.4 159.28 22.47 Favored Glycine 0 N--CA 1.431 -1.649 1 C-N-CA 130.727 4.013 . . . . 0.0 108.335 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.78 152.46 45.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 124.16 1.933 . . . . 0.0 111.029 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 67.7 mt -96.68 141.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.868 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -135.38 151.7 50.73 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.549 1.54 . . . . 0.0 109.233 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.9 p -77.48 173.27 12.17 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.246 1.018 . . . . 0.0 110.798 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 60.1 mt -126.34 137.52 57.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -67.49 124.21 22.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.48 1.512 . . . . 0.0 108.883 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.84 12.24 84.38 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 117.922 -1.488 . . . . 0.0 114.666 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -141.4 142.7 33.71 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.743 1.772 . . . . 0.0 111.255 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 24.5 m -90.02 151.24 21.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.837 0.827 . . . . 0.0 109.114 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -31.83 67.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.088 0.955 . . . . 0.0 111.183 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.4 p -68.69 -10.03 53.82 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 129.352 3.061 . . . . 0.0 114.624 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -120.51 -46.79 2.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.836 1.254 . . . . 0.0 107.764 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.16 147.91 5.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.593 0.711 . . . . 0.0 110.571 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -152.83 176.16 12.11 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.167 0.587 . . . . 0.0 110.098 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.64 137.63 47.18 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.457 HG13 HG12 ' A' ' 214' ' ' ILE . 8.9 p -130.02 130.23 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 125.26 1.424 . . . . 0.0 110.879 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.54 107.68 4.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.457 HG12 HG13 ' A' ' 212' ' ' VAL . 33.0 mm -120.74 120.7 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 52.98 45.53 28.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.421 0.688 . . . . 0.0 109.901 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 64.27 13.3 7.85 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.537 1.535 . . . . 0.0 112.623 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.414 ' HB3' ' HE2' ' A' ' 219' ' ' LYS . 0.4 OUTLIER -125.18 122.15 36.22 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.165 -0.959 . . . . 0.0 108.687 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -69.42 115.93 9.25 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 120.512 -1.368 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 217' ' ' ASP . 66.3 mmtt -111.02 145.81 37.81 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.467 1.507 . . . . 0.0 113.09 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -80.64 128.8 34.03 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.929 1.291 . . . . 0.0 111.547 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -115.29 141.62 47.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.05 143.35 50.84 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.508 0.723 . . . . 0.0 110.535 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -55.41 138.53 45.78 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.69 161.33 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 126.84 2.056 . . . . 0.0 105.761 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -98.51 9.72 62.69 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.169 -0.957 . . . . 0.0 114.233 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 . . . . . 0 C--O 1.248 0.993 0 CA-C-N 119.187 1.493 . . . . 0.0 108.642 -179.372 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.825 0.345 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.46 130.92 3.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.632 ' CD2' HD13 ' A' ' 198' ' ' ILE . 88.9 m-85 -59.17 146.43 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 98.5 t -150.29 120.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.164 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.741 HG21 ' OH ' ' A' ' 195' ' ' TYR . 4.8 mp -68.13 118.17 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.135 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.34 123.62 13.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -20.36 66.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -90.47 -33.11 16.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.04 104.67 6.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -67.18 -13.59 62.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.722 ' O ' HD12 ' A' ' 140' ' ' ILE . 47.6 ptt85 -94.89 -7.13 40.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.854 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -101.71 159.93 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.6 mm -128.02 131.52 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.139 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -107.7 103.65 12.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -135.79 129.77 33.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.2 mtt 59.69 39.73 20.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 63.4 20.46 63.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.443 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -113.43 172.81 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 36.3 mm -131.36 129.01 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -125.42 152.31 45.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 t -121.18 152.04 39.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 129' ' ' ARG . 2.7 mt -123.26 111.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.122 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -92.74 -90.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -169.86 93.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 26.4 m -140.64 104.63 4.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 m -62.94 113.18 2.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.83 119.48 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.4 m -84.74 171.41 12.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.77 -26.31 64.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.09 -25.1 68.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -104.66 -26.12 12.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.61 137.75 58.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.38 -105.78 2.65 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.516 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -134.24 169.92 16.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.93 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -56.23 142.09 38.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -125.43 -51.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.953 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -147.37 159.87 43.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 5.3 p -119.56 129.93 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.478 HD11 HD11 ' A' ' 123' ' ' ILE . 3.3 mm? -110.9 166.01 11.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.67 70.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -166.41 175.34 8.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.3 t -144.87 149.45 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.103 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.74 155.54 42.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -124.59 123.32 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.114 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -144.85 155.44 43.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.588 ' CG ' HG22 ' A' ' 166' ' ' VAL . 4.6 t0 -74.34 124.49 26.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.12 -4.35 32.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.588 HG22 ' CG ' ' A' ' 164' ' ' ASP . 27.5 m -77.93 -44.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.16 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.478 ' N ' HG23 ' A' ' 166' ' ' VAL . 6.7 t -123.36 -30.12 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.09 33.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.434 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -69.9 127.93 34.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.844 0.354 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.83 155.11 37.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.47 139.83 35.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.584 0.707 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 154.98 67.1 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.645 2.23 . . . . 0.0 112.366 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -58.98 -21.71 59.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 m -73.86 -7.66 53.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.09 -12.46 14.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -57.1 -25.78 59.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -132.92 25.85 3.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.496 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -138.14 73.42 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 110.903 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.42 HG21 ' ND2' ' A' ' 185' ' ' ASN . 3.4 mt -53.2 -65.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.141 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.48 115.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -77.6 -22.5 50.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -75.1 -28.12 60.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 110.15 74.57 0.79 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.436 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.7 m -142.75 62.77 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.42 ' ND2' HG21 ' A' ' 179' ' ' ILE . 4.4 m120 -105.67 51.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.94 -56.3 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -97.17 71.89 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -141.8 140.91 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.6 m -168.92 65.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -68.94 168.88 12.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.42 HG22 ' CD1' ' A' ' 193' ' ' TRP . 98.9 m -137.77 120.41 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.69 105.52 17.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' TRP . . . . . 0.42 ' CD1' HG22 ' A' ' 191' ' ' THR . 13.5 m0 -110.35 116.78 32.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.96 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -84.55 126.55 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.741 ' OH ' HG21 ' A' ' 123' ' ' ILE . 13.4 m-30 -65.21 103.83 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 213' ' ' GLU . . . -101.28 162.84 17.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.484 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.28 139.35 58.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.798 0.333 . . . . 0.0 110.861 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.632 HD13 ' CD2' ' A' ' 121' ' ' PHE . 10.1 mt -91.21 143.39 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -131.68 143.14 50.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.78 172.26 3.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 71.1 mt -130.8 141.83 45.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -69.3 122.16 18.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 76.02 27.12 62.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -149.34 146.28 27.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.326 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -106.0 145.11 31.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.855 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.491 HD13 ' HB3' ' A' ' 210' ' ' PHE . 0.9 OUTLIER -63.24 -17.15 62.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 67.4 p -82.59 -9.41 59.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.65 -51.56 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.09 146.32 24.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.069 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.638 ' O ' HD22 ' A' ' 220' ' ' LEU . 39.4 p90 -154.44 176.44 12.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -110.4 125.36 53.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.084 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.54 HG11 HG12 ' A' ' 140' ' ' ILE . 6.0 p -117.68 125.39 74.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.142 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.429 ' HB3' ' HA3' ' A' ' 196' ' ' GLY . 18.9 tt0 -70.43 101.55 1.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 48.4 mm -120.39 120.25 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.1 m120 60.53 43.94 12.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.37 14.88 9.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -137.49 122.11 18.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.52 125.06 26.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -116.62 140.69 49.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.638 HD22 ' O ' ' A' ' 210' ' ' PHE . 3.3 tm? -76.37 121.76 23.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.54 139.29 40.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.21 138.33 50.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -64.97 122.12 16.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 94.4 t -127.07 129.52 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -100.25 55.4 0.86 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.498 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.994 ' C ' ' O ' ' A' ' 226' ' ' ASN . 5.9 m120 . . . . . 1 C--O 2.0 40.559 1 CA-C-O 161.134 19.54 . . . . 0.0 110.907 -179.902 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.93 141.31 15.31 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 127.728 2.411 . . . . 0.0 106.124 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -73.9 134.5 43.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 84.2 t -135.2 124.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.9 mp -73.12 140.23 18.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -66.19 127.12 30.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -65.55 -27.05 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.462 -0.774 . . . . 0.0 111.705 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -80.67 -45.5 17.1 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.721 1.209 . . . . 0.0 110.057 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.08 100.59 6.8 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.4 t -62.67 -7.66 5.23 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.872 -1.142 . . . . 0.0 110.95 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -94.3 -4.87 47.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.867 2.067 . . . . 0.0 110.257 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -110.84 158.81 18.28 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.6 mm -125.34 138.41 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.92 103.48 11.71 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 102.923 -2.992 . . . . 0.0 102.923 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -137.69 132.37 32.78 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.1 mtt 57.97 25.35 12.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.995 0.918 . . . . 0.0 111.077 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.42 -0.6 68.58 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.429 -0.795 . . . . 0.0 112.412 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -93.69 166.26 12.3 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.552 1.541 . . . . 0.0 108.006 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.7 mm -123.18 137.18 57.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -131.08 156.77 44.64 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.814 1.246 . . . . 0.0 108.454 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.474 ' HB2' HG11 ' A' ' 224' ' ' VAL . 14.2 t -140.37 155.67 46.68 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 107.986 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.7 mt -114.37 117.8 56.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.284 1.433 . . . . 0.0 110.795 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.6 t -86.63 -111.01 0.05 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -162.46 101.26 1.06 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 103.563 -2.755 . . . . 0.0 103.563 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 49.2 m -134.88 111.82 10.18 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.1 m -70.93 120.54 16.65 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.37 122.41 45.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.5 m -82.2 154.44 25.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.81 -26.9 67.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.54 1.136 . . . . 0.0 112.036 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.72 -19.07 62.78 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.415 -0.803 . . . . 0.0 110.471 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -106.19 -16.22 14.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.46 1.904 . . . . 0.0 110.086 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.8 tp -80.19 118.42 21.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 128.105 2.562 . . . . 0.0 107.103 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.45 -103.78 0.11 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 123.687 0.661 . . . . 0.0 111.486 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.68 170.01 16.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.559 1.144 . . . . 0.0 110.069 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -61.89 142.92 57.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.572 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -125.64 -48.95 1.65 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.559 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.77 160.74 43.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.093 1.315 . . . . 0.0 110.714 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.83 135.19 60.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.835 1.254 . . . . 0.0 111.561 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.8 164.87 12.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.805 2.042 . . . . 0.0 111.522 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.15 54.89 0.06 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.953 0.901 . . . . 0.0 112.124 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.44 172.33 15.13 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.338 -1.476 . . . . 0.0 107.517 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.38 147.53 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -145.18 166.24 26.02 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 120.576 -1.327 . . . . 0.0 108.521 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.1 t -129.24 133.31 65.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -147.97 160.59 42.66 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.48 0.582 . . . . 0.0 111.71 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.34 106.29 7.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.5 t -61.07 -20.25 62.37 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.23 -33.33 19.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 120.823 -1.173 . . . . 0.0 113.978 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.0 t -122.03 -25.45 4.94 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.061 0.945 . . . . 0.0 112.241 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.83 -0.14 56.42 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.064 1.792 . . . . 0.0 112.073 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -52.98 112.23 0.81 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.147 1.474 . . . . 0.0 110.421 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.4 m -70.99 157.67 37.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 119.294 0.952 . . . . 0.0 111.627 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.0 129.28 25.48 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.901 2.08 . . . . 0.0 106.375 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.44 157.73 48.93 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.322 2.681 . . . . 0.0 109.196 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -52.31 -32.27 37.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.892 0.877 . . . . 0.0 112.673 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.4 m -64.74 -12.97 52.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.09 -6.82 15.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.842 2.057 . . . . 0.0 111.747 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -56.27 -40.24 73.91 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -106.28 -7.24 35.35 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.219 1.39 . . . . 0.0 112.809 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.76 79.05 1.77 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.219 1.808 . . . . 0.0 112.559 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 43.6 mt -67.16 -42.32 87.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -51.62 106.21 0.13 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.661 1.985 . . . . 0.0 110.436 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -129.14 -21.41 3.27 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 112.838 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -141.21 21.7 2.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.8 0.84 . . . . 0.0 111.109 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 61.23 -4.02 0.41 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 127.608 2.528 . . . . 0.0 115.712 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.8 t -74.71 -80.15 0.08 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.991 1.316 . . . . 0.0 110.442 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 56.24 10.68 0.66 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.034 1.334 . . . . 0.0 112.639 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.2 t -33.72 -59.21 0.41 Allowed 'General case' 0 C--N 1.341 0.211 0 C-N-CA 128.585 2.754 . . . . 0.0 114.759 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -147.57 134.12 19.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -161.68 155.57 21.86 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.246 0.619 . . . . 0.0 109.743 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.3 t -142.1 85.37 1.92 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.845 0.858 . . . . 0.0 108.705 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -80.98 177.93 8.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.1 m -154.12 150.81 28.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -127.63 104.76 8.04 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -114.15 117.03 30.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.816 1.246 . . . . 0.0 110.557 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.27 129.38 34.58 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.975 2.11 . . . . 0.0 108.833 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.425 ' CE2' HD13 ' A' ' 123' ' ' ILE . 6.0 m-30 -76.34 100.83 5.27 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.244 0.617 . . . . 0.0 109.776 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.43 158.87 23.04 Favored Glycine 0 CA--C 1.531 1.054 1 C-N-CA 133.483 5.325 . . . . 0.0 107.228 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.85 154.18 42.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 123.87 1.795 . . . . 0.0 111.603 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 58.2 mt -100.83 139.11 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.013 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -131.9 149.54 52.41 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.458 1.503 . . . . 0.0 109.585 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.2 t -78.65 173.65 12.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.241 1.016 . . . . 0.0 109.611 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 75.7 mt -131.49 143.9 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.674 1.189 . . . . 0.0 110.626 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -65.63 131.27 45.94 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.651 1.18 . . . . 0.0 108.877 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 62.92 22.38 64.52 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.152 -1.36 . . . . 0.0 115.22 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -140.23 148.08 40.98 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.122 1.461 . . . . 0.0 107.819 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.1 m -105.87 146.62 29.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.01 -31.31 60.94 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.078 1.351 . . . . 0.0 110.544 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.4 p -70.54 -12.65 61.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.607 1.963 . . . . 0.0 114.729 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -125.06 -39.37 2.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.863 1.665 . . . . 0.0 112.205 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.33 139.74 5.92 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.159 0.983 . . . . 0.0 110.797 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -150.19 174.31 12.94 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.958 0.903 . . . . 0.0 109.534 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.56 138.67 47.8 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.133 0.573 . . . . 0.0 111.864 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.6 p -132.65 131.07 59.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.895 1.278 . . . . 0.0 110.747 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.79 106.23 7.26 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 39.7 mm -122.06 129.81 75.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.653 1.181 . . . . 0.0 110.759 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 53.94 37.75 27.34 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.382 -0.824 . . . . 0.0 112.123 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 74.77 5.51 4.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.246 1.818 . . . . 0.0 111.311 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -130.8 134.9 47.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.74 1.155 . . . . 0.0 112.351 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -70.86 130.24 41.14 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 121.056 -1.027 . . . . 0.0 110.447 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -125.66 148.49 48.99 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.997 1.319 . . . . 0.0 109.617 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.53 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -84.06 126.69 33.31 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.106 1.362 . . . . 0.0 112.065 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -109.78 143.25 39.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 1.1 p -125.67 148.23 49.08 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.47 1.508 . . . . 0.0 111.616 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -55.56 139.98 42.31 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 139' ' ' SER . 7.7 p -135.09 150.94 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -120.75 19.6 8.93 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.233 1.397 . . . . 0.0 113.243 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 47.1 t30 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 127.827 2.451 . . . . 0.0 105.187 179.789 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.8 t0 . . . . . 0 CA--C 1.518 -0.267 0 CA-C-O 120.632 0.253 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.64 141.26 39.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.084 2.554 . . . . 0.0 104.96 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -77.78 121.45 24.07 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 124.822 1.249 . . . . 0.0 108.136 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.2 t -125.86 128.44 72.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 125.58 1.552 . . . . 0.0 109.095 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -72.87 140.03 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -61.63 129.94 43.5 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.247 -0.908 . . . . 0.0 111.098 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -67.33 -11.49 57.75 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.337 -0.852 . . . . 0.0 111.687 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -106.23 -14.54 15.1 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.789 1.236 . . . . 0.0 112.962 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.82 115.21 5.12 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.97 0.805 . . . . 0.0 109.496 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.476 ' HB2' ' CD1' ' A' ' 163' ' ' PHE . 73.6 m -63.81 -17.57 63.24 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.95 -1.093 . . . . 0.0 111.784 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -94.56 -1.7 52.87 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.97 1.708 . . . . 0.0 112.012 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -105.97 156.34 18.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.431 1.014 . . . . 0.0 111.628 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.2 mm -128.03 136.39 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -116.07 107.32 14.78 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.497 2.319 . . . . 0.0 105.657 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -145.07 133.97 22.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.9 mtt 58.22 33.22 22.95 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.396 1.478 . . . . 0.0 111.061 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.1 22.62 70.82 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -116.78 163.84 15.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 28.6 mm -121.6 128.96 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.972 0.909 . . . . 0.0 109.294 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -125.46 157.8 36.02 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.46 ' HB2' HG11 ' A' ' 224' ' ' VAL . 46.9 t -141.96 157.98 44.31 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.828 1.251 . . . . 0.0 108.861 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.3 mt -110.54 130.49 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.23 1.012 . . . . 0.0 109.698 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -106.76 -116.51 0.26 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 102.591 -3.115 . . . . 0.0 102.591 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -157.41 100.06 1.79 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 93.6 m -136.39 109.35 7.65 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.118 1.767 . . . . 0.0 107.004 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.7 m -68.97 125.68 27.41 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.8 t -93.78 113.0 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 120.63 1.559 . . . . 0.0 108.496 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 m -68.56 155.13 40.56 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.704 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.54 -25.41 68.03 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.644 1.178 . . . . 0.0 110.981 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.32 -25.78 63.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.845 0.858 . . . . 0.0 109.848 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -94.57 -33.85 12.87 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.569 1.148 . . . . 0.0 110.151 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.19 121.18 7.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.766 1.626 . . . . 0.0 108.37 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -88.47 -110.52 1.1 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.1 170.15 16.34 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.666 1.186 . . . . 0.0 112.153 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -55.94 128.64 36.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.528 1.531 . . . . 0.0 111.333 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -118.39 -38.39 3.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.661 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.22 161.74 14.63 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 121.256 1.844 . . . . 0.0 111.377 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.03 139.83 47.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 120.066 1.303 . . . . 0.0 110.837 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.43 164.71 12.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.646 1.978 . . . . 0.0 109.145 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -162.11 33.17 0.12 Allowed 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.42 174.02 11.07 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 120.309 -1.494 . . . . 0.0 109.031 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.7 t -139.98 147.85 23.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -144.5 162.46 36.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 87.6 t -127.52 136.46 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 128' ' ' SER . 49.8 p90 -146.63 166.54 26.24 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.29 0.636 . . . . 0.0 111.316 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.85 101.3 13.39 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.1 t -47.75 -22.54 0.55 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 130.179 3.392 . . . . 0.0 116.863 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -57.86 -51.61 68.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 125.65 1.58 . . . . 0.0 109.947 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.443 ' HB2' ' HD3' ' A' ' 169' ' ' LYS 0.257 24.6 m -121.58 -27.54 4.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.471 1.508 . . . . 0.0 112.843 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 111.94 6.98 24.04 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.125 1.345 . . . . 0.0 114.248 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.504 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -53.5 113.0 1.01 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.582 2.191 . . . . 0.0 111.704 -178.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.4 m -69.0 152.74 44.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 119.428 1.013 . . . . 0.0 108.971 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.79 140.92 28.28 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.854 1.662 . . . . 0.0 108.792 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.5 160.36 38.57 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.127 2.551 . . . . 0.0 109.686 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -60.93 -30.36 70.17 Favored 'General case' 0 CA--C 1.519 -0.24 0 O-C-N 121.438 -0.789 . . . . 0.0 110.869 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 p -64.53 -7.06 8.83 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.892 -1.052 . . . . 0.0 113.407 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.87 -8.64 13.7 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.344 1.429 . . . . 0.0 111.08 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -61.92 -2.61 0.92 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -166.63 16.17 0.08 OUTLIER Glycine 0 CA--C 1.521 0.453 0 C-N-CA 126.137 1.827 . . . . 0.0 110.982 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -124.46 87.42 2.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.29 -77.07 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.564 ' HB3' ' H ' ' A' ' 184' ' ' SER . 3.5 t70 -168.25 157.66 9.44 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.409 1.884 . . . . 0.0 106.802 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 31.8 tttm -46.58 -59.85 2.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.285 1.834 . . . . 0.0 111.304 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -78.07 -39.12 42.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.829 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.13 76.33 0.62 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.564 ' H ' ' HB3' ' A' ' 180' ' ' ASP . 23.8 p -68.11 4.76 1.12 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.859 2.064 . . . . 0.0 112.447 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -50.22 -25.7 3.91 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.806 1.642 . . . . 0.0 113.378 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.4 m -60.06 -9.81 3.58 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.271 1.828 . . . . 0.0 112.281 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -137.85 54.6 1.8 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.614 1.566 . . . . 0.0 109.781 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -133.14 166.89 21.4 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.256 1.822 . . . . 0.0 108.56 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.95 49.08 0.45 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.656 -1.277 . . . . 0.0 111.029 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 -83.52 166.08 18.57 Favored 'General case' 0 N--CA 1.46 0.071 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 95.6 m -144.99 138.12 26.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 126.922 2.089 . . . . 0.0 107.302 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -112.76 110.17 20.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.797 1.639 . . . . 0.0 108.19 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -111.73 118.77 36.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.6 1.16 . . . . 0.0 111.067 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.56 127.08 36.14 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -76.47 101.02 5.43 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.382 1.473 . . . . 0.0 111.421 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.1 159.71 23.67 Favored Glycine 0 N--CA 1.435 -1.378 1 C-N-CA 132.646 4.927 . . . . 0.0 107.546 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.89 154.6 41.22 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 122.972 1.368 . . . . 0.0 112.767 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 54.8 mt -102.74 121.62 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 125.628 1.571 . . . . 0.0 111.874 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -111.31 154.25 24.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.294 1.045 . . . . 0.0 110.309 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.9 t -73.77 172.86 10.73 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.925 1.29 . . . . 0.0 108.163 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.454 ' CD1' HD23 ' A' ' 220' ' ' LEU . 77.7 mt -135.19 132.78 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -59.17 119.85 8.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.209 1.404 . . . . 0.0 108.229 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.13 12.44 84.03 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.261 -1.3 . . . . 0.0 115.308 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -134.56 133.43 40.25 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.863 1.831 . . . . 0.0 109.881 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.8 m -83.59 146.89 28.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -25.21 61.51 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.574 1.15 . . . . 0.0 111.101 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.5 p -75.64 -14.4 60.36 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.825 2.05 . . . . 0.0 113.642 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -119.74 -43.0 2.59 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.986 0.914 . . . . 0.0 111.367 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.62 139.88 8.02 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 118.799 0.727 . . . . 0.0 109.143 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -152.33 176.64 11.41 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.507 1.123 . . . . 0.0 109.515 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.56 131.82 54.71 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.614 1.166 . . . . 0.0 111.845 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.1 129.74 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 C-N-CA 123.958 0.903 . . . . 0.0 109.432 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -74.33 104.76 5.21 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 36.5 mm -121.64 127.2 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 O-C-N 120.49 -1.381 . . . . 0.0 107.511 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 53.28 43.62 31.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.206 0.457 . . . . 0.0 110.304 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.6 t0 61.11 19.13 9.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.362 0.665 . . . . 0.0 112.167 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.09 122.53 24.24 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.753 -1.217 . . . . 0.0 109.188 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.42 115.96 12.3 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.981 -1.074 . . . . 0.0 112.77 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -106.15 152.38 23.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.102 0.961 . . . . 0.0 111.99 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.8 tm? -88.37 119.44 28.8 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.191 1.396 . . . . 0.0 107.939 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.6 148.58 27.16 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.8 p -127.42 151.16 49.17 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.778 0.674 . . . . 0.0 112.26 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -57.58 141.44 48.0 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.46 HG11 ' HB2' ' A' ' 139' ' ' SER . 6.5 p -134.79 146.2 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 50.1 44.38 42.29 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.356 1.455 . . . . 0.0 110.502 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 . . . . . 0 C--O 1.246 0.87 0 CA-C-O 116.794 -1.575 . . . . 0.0 111.227 -178.971 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.512 -0.518 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.86 139.72 24.01 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -69.76 136.69 51.22 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.106 0.963 . . . . 0.0 108.602 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.6 t -134.98 124.59 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.1 mp -76.44 134.22 29.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.54 134.95 51.1 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.832 1.301 . . . . 0.0 110.544 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.44 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -68.27 -18.56 64.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.486 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -104.09 -36.5 7.69 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.23 0.468 . . . . 0.0 111.354 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.84 105.14 11.64 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 122.202 1.001 . . . . 0.0 109.985 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.7 t -61.73 -11.48 12.27 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.112 1.365 . . . . 0.0 111.825 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -100.02 -8.98 23.19 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.787 1.635 . . . . 0.0 111.873 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -102.16 154.73 18.74 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 119.418 1.008 . . . . 0.0 111.276 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.5 mm -126.58 127.46 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.11 105.31 15.44 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -141.37 136.04 31.05 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.773 -1.204 . . . . 0.0 107.813 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.2 mtt 54.44 21.21 3.14 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.59 0.29 89.27 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.561 1.077 . . . . 0.0 112.336 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -90.13 172.58 8.71 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.282 1.433 . . . . 0.0 108.021 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.8 mm -133.66 124.76 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -119.17 154.21 33.69 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.1 t -138.36 159.45 42.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.2 mt -115.7 134.75 57.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.798 0.808 . . . . 0.0 111.234 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.3 t -104.76 -130.56 0.28 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 101.713 -3.44 . . . . 0.0 101.713 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -154.35 98.81 2.15 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 121.918 2.144 . . . . 0.0 106.672 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 20.6 m -135.76 121.09 19.14 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 128.244 2.618 . . . . 0.0 106.521 177.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.7 m -72.07 123.34 22.62 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 76.1 t -93.88 111.84 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.6 m -77.17 159.77 29.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.438 0.637 . . . . 0.0 109.694 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -64.6 -17.76 64.28 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 111.669 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -77.0 -11.71 59.84 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.755 0.822 . . . . 0.0 109.473 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -115.21 -28.4 6.94 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.381 1.072 . . . . 0.0 109.38 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.95 132.67 50.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.126 2.17 . . . . 0.0 107.148 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -101.39 -98.31 2.34 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.309 0.957 . . . . 0.0 114.289 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -134.68 159.43 41.28 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.272 1.429 . . . . 0.0 111.906 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.0 133.27 55.37 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.832 1.653 . . . . 0.0 109.658 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.79 -43.22 2.9 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 116.538 -1.696 . . . . 0.0 111.69 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -165.5 158.25 15.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 121.144 1.793 . . . . 0.0 110.462 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.22 137.37 44.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.478 HD22 ' O ' ' A' ' 196' ' ' GLY . 5.3 mp -110.17 163.35 13.69 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.951 1.7 . . . . 0.0 110.752 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.0 38.98 0.15 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.5 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 1.9 tt0 -139.78 175.34 9.66 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 120.023 -1.673 . . . . 0.0 110.759 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.2 t -144.88 150.51 16.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -147.09 164.0 34.48 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.848 0.832 . . . . 0.0 109.018 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.0 t -128.78 129.1 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 126.38 1.872 . . . . 0.0 107.412 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -147.89 160.93 42.26 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.07 0.948 . . . . 0.0 112.684 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.51 100.09 12.8 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 102.255 -3.239 . . . . 0.0 102.255 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 12.7 t -47.61 -25.88 1.3 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.154 2.581 . . . . 0.0 116.451 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.3 m -57.68 -45.98 86.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.04 1.736 . . . . 0.0 111.11 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.424 ' HB2' ' HD3' ' A' ' 169' ' ' LYS . 3.2 m -122.73 -21.76 5.53 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.024 1.33 . . . . 0.0 113.09 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.78 10.83 48.76 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.652 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 167' ' ' SER . 0.0 OUTLIER -64.04 112.49 2.99 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.134 1.467 . . . . 0.0 110.669 -178.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 44.2 m -72.38 152.03 42.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.647 0.658 . . . . 0.0 109.488 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.59 147.51 36.9 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.79 159.78 31.21 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.18 2.587 . . . . 0.0 109.902 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 ttt-85 -57.39 -32.34 66.73 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 45.0 m -65.19 -8.28 16.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.241 -1.362 . . . . 0.0 113.308 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.99 -9.14 16.32 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.354 1.434 . . . . 0.0 111.672 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -62.96 6.04 0.11 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.121 2.168 . . . . 0.0 115.143 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -159.11 20.5 0.28 Allowed Glycine 0 CA--C 1.524 0.629 0 O-C-N 120.444 -1.41 . . . . 0.0 111.132 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -98.29 40.54 1.18 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.785 1.292 . . . . 0.0 113.177 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 49.7 mm -64.01 -50.38 77.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -137.28 80.27 1.8 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.047 1.739 . . . . 0.0 112.047 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -140.84 -44.99 0.39 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.6 29.33 1.03 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.027 0.931 . . . . 0.0 110.05 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 170.92 -172.86 44.52 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 120.715 -1.24 . . . . 0.0 111.461 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 86.4 p -114.23 162.32 16.7 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.297 1.039 . . . . 0.0 110.984 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -139.74 81.22 1.81 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.1 m -115.05 -5.36 12.48 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 13.67 0.85 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -106.76 173.97 6.09 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.801 1.641 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.8 t -163.11 147.4 11.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.433 ' HG2' HH11 ' A' ' 190' ' ' ARG . 8.2 mtt-85 -137.21 157.44 46.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.097 0.559 . . . . 0.0 110.611 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.6 m -130.27 117.4 19.76 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.83 105.89 18.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.599 1.959 . . . . 0.0 106.527 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.9 m0 -110.97 116.26 30.89 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 118.496 0.589 . . . . 0.0 110.45 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -81.94 131.77 35.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.5 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.8 m-30 -78.55 107.51 11.26 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.958 1.703 . . . . 0.0 106.807 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.478 ' O ' HD22 ' A' ' 157' ' ' LEU . . . -107.85 159.41 14.43 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 129.532 3.444 . . . . 0.0 112.64 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -66.89 140.88 57.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 124.652 2.168 . . . . 0.0 111.692 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.0 mt -93.13 140.84 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.673 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -136.25 151.3 49.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 123.194 1.474 . . . . 0.0 109.293 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.1 t -75.39 172.92 11.64 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.997 1.719 . . . . 0.0 107.523 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.3 mt -126.93 137.26 58.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -62.96 131.15 47.72 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.13 22.95 72.89 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.842 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -139.3 155.11 47.95 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.778 1.789 . . . . 0.0 108.094 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 57.8 m -106.08 140.41 39.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.485 HD13 ' CB ' ' A' ' 210' ' ' PHE . 0.4 OUTLIER -57.04 -24.65 55.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.144 0.977 . . . . 0.0 109.123 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.4 p -69.71 -14.63 62.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.263 1.825 . . . . 0.0 112.898 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -120.34 -41.34 2.62 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.248 1.019 . . . . 0.0 110.619 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.34 150.72 9.29 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.922 0.889 . . . . 0.0 110.657 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.485 ' CB ' HD13 ' A' ' 206' ' ' LEU . 48.5 p90 -158.38 176.14 12.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.247 1.019 . . . . 0.0 109.752 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.39 136.66 48.46 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 110.844 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.71 128.15 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 124.061 0.945 . . . . 0.0 109.624 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.65 107.36 3.88 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.3 mm -121.85 126.67 74.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 54.78 43.32 30.25 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.25 -4.83 1.2 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.05 1.74 . . . . 0.0 113.006 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -117.04 122.7 44.94 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.623 -1.298 . . . . 0.0 111.632 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -63.04 115.63 4.61 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.37 -1.456 . . . . 0.0 113.537 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -103.97 150.16 24.48 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 126.435 1.894 . . . . 0.0 111.442 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 3.0 tm? -88.79 122.19 31.93 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.607 1.163 . . . . 0.0 108.593 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -106.66 150.22 26.44 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 1.5 p -129.49 152.11 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.51 1.124 . . . . 0.0 110.307 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -69.67 124.05 22.95 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.65 107.75 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 123.999 0.92 . . . . 0.0 108.67 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -101.06 12.77 58.96 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.165 1.364 . . . . 0.0 112.508 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 124.895 1.278 . . . . 0.0 107.84 179.563 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.75 130.76 24.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 103.971 -2.604 . . . . 0.0 103.971 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -69.21 145.1 53.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.647 0.779 . . . . 0.0 110.225 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.0 t -137.95 128.25 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.457 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.6 mp -82.01 129.45 37.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.57 122.22 11.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.769 1.271 . . . . 0.0 109.592 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -59.03 -24.23 62.66 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.212 -0.93 . . . . 0.0 111.843 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -90.68 -31.59 16.54 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.901 1.28 . . . . 0.0 112.196 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.84 100.21 4.69 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.7 p -65.3 -11.34 40.63 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.407 -0.808 . . . . 0.0 111.511 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -90.01 -3.83 57.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.002 2.121 . . . . 0.0 110.209 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -113.57 158.52 20.68 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.356 0.98 . . . . 0.0 109.001 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.5 mm -129.09 139.59 51.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -118.48 108.36 14.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -142.82 140.45 31.31 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.0 mtt 56.87 22.45 7.09 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.656 0.782 . . . . 0.0 112.834 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.22 18.55 78.18 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -123.78 159.65 29.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.311 1.056 . . . . 0.0 108.218 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.1 mm -110.35 140.44 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -131.79 144.37 50.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 t -124.55 148.71 47.63 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 126.804 2.042 . . . . 0.0 107.351 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.6 mt -113.31 123.56 69.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 124.627 1.171 . . . . 0.0 110.026 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -93.36 -143.61 0.23 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -142.16 98.81 3.39 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 102.685 -3.079 . . . . 0.0 102.685 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.9 m -136.54 109.87 7.87 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 111.642 -2.526 . . . . 0.0 106.241 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 m -69.88 131.91 45.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 120.756 1.617 . . . . 0.0 106.752 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.3 t -94.69 114.18 30.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.776 1.63 . . . . 0.0 106.664 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.9 m -71.02 159.34 34.92 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.907 0.384 . . . . 0.0 110.786 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.72 -26.51 67.23 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.238 1.415 . . . . 0.0 111.294 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.1 -13.66 60.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.522 0.729 . . . . 0.0 111.36 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -105.71 -26.74 11.68 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.315 1.446 . . . . 0.0 108.883 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.7 mt -62.01 142.3 57.57 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.42 -103.42 2.46 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -134.99 166.84 22.11 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.086 1.354 . . . . 0.0 109.443 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -58.79 144.38 44.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.609 0.764 . . . . 0.0 109.942 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.23 -49.36 1.94 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 117.265 -1.35 . . . . 0.0 111.217 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.64 157.83 22.43 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 120.745 1.612 . . . . 0.0 110.828 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.4 p -105.59 138.64 29.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.547 1.165 . . . . 0.0 110.408 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.0 mp -113.41 163.16 15.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.536 2.734 . . . . 0.0 108.407 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -172.25 68.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.861 0.864 . . . . 0.0 109.957 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -160.67 175.83 12.21 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.837 -1.165 . . . . 0.0 109.036 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.3 t -144.76 149.28 17.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.71 154.96 40.35 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.5 t -123.63 130.51 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 124.498 1.119 . . . . 0.0 108.077 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -147.86 160.54 42.66 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.609 1.164 . . . . 0.0 111.579 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -85.49 100.98 12.26 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.6 t -56.26 -11.73 1.31 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.109 1.364 . . . . 0.0 114.613 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.3 m -65.74 -40.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.137 -0.977 . . . . 0.0 110.033 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.0 t -124.26 -28.35 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.723 1.209 . . . . 0.0 113.195 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.54 5.78 36.3 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.738 1.637 . . . . 0.0 111.166 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -57.31 112.32 1.36 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.053 1.741 . . . . 0.0 111.026 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.6 p -64.37 154.25 36.03 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.906 1.683 . . . . 0.0 110.749 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.45 152.14 60.75 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.365 1.066 . . . . 0.0 108.365 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.64 162.56 16.6 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.93 3.086 . . . . 0.0 108.513 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -58.75 -28.89 66.32 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.903 -1.123 . . . . 0.0 111.69 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 95.9 p -68.93 -8.8 47.77 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -104.22 -4.76 22.64 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 120.414 -1.429 . . . . 0.0 109.069 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -72.34 16.2 0.14 Allowed 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.872 -1.142 . . . . 0.0 111.831 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 121.26 36.43 0.75 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.423 1.487 . . . . 0.0 112.311 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -130.76 38.09 3.74 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.14 1.47 . . . . 0.0 108.192 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 52.8 mt -72.2 -69.29 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.11 52.97 11.79 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.764 1.745 . . . . 0.0 109.832 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -153.05 148.34 26.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.81 3.644 . . . . 0.0 103.665 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.13 28.12 5.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.221 0.608 . . . . 0.0 109.931 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.1 -60.6 5.1 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.143 0.877 . . . . 0.0 112.685 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.1 m -169.24 104.97 0.38 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.442 1.097 . . . . 0.0 109.818 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -118.37 21.25 12.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.09 1.356 . . . . 0.0 110.767 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.6 p -63.52 160.61 16.14 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 129.319 3.047 . . . . 0.0 113.786 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.9 mtmm 45.65 24.24 0.19 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.601 1.96 . . . . 0.0 114.368 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -86.41 130.56 34.46 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.2 t -145.41 87.96 1.83 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 10.6 mtt85 -90.99 161.45 15.14 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.7 m -142.14 123.86 15.1 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -100.92 109.1 21.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -110.4 116.21 31.03 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.17 117.51 21.78 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 128.471 2.708 . . . . 0.0 107.463 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.457 ' CE2' HD13 ' A' ' 123' ' ' ILE . 10.3 m-30 -68.78 106.95 2.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.567 1.147 . . . . 0.0 107.986 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -107.56 159.27 14.58 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 129.677 3.513 . . . . 0.0 110.945 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.52 149.65 50.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 124.927 2.299 . . . . 0.0 112.109 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 40.9 mt -98.18 140.94 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 111.752 -2.476 . . . . 0.0 110.713 -176.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -134.04 151.78 51.56 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.986 1.714 . . . . 0.0 109.873 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.3 p -77.63 173.39 12.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 58.8 mt -125.41 141.29 45.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -64.14 132.04 49.27 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.919 1.288 . . . . 0.0 108.076 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.6 18.93 70.55 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 118.554 -1.137 . . . . 0.0 114.69 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -135.87 157.86 45.81 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 120.025 1.912 . . . . 0.0 109.172 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 73.8 m -106.38 140.98 38.45 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.94 -26.54 48.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 77.1 p -68.24 -12.99 61.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.643 2.377 . . . . 0.0 113.866 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -119.99 -42.72 2.58 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 118.833 -0.603 . . . . 0.0 109.532 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.02 155.43 18.57 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.335 0.588 . . . . 0.0 110.765 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -157.54 175.63 13.69 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.577 0.751 . . . . 0.0 109.972 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.75 134.26 53.43 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.887 1.275 . . . . 0.0 110.861 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.04 132.71 56.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.256 1.022 . . . . 0.0 108.345 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -70.18 102.82 2.18 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.508 ' HB ' ' HE2' ' A' ' 219' ' ' LYS . 39.3 mm -121.42 123.16 69.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 O-C-N 121.075 -1.016 . . . . 0.0 108.282 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 53.44 48.39 21.96 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.98 0.912 . . . . 0.0 109.074 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 62.19 9.0 2.93 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.59 1.156 . . . . 0.0 114.081 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -131.19 122.56 26.78 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.189 0.904 . . . . 0.0 109.028 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -61.94 118.71 7.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.286 0.634 . . . . 0.0 109.931 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.508 ' HE2' ' HB ' ' A' ' 214' ' ' ILE . 16.7 mtmm -114.23 149.06 36.39 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.4 1.095 . . . . 0.0 110.088 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -81.29 123.76 28.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.306 1.842 . . . . 0.0 111.871 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -110.3 145.28 37.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.62 145.37 51.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.68 1.192 . . . . 0.0 110.92 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -64.15 120.81 12.8 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.8 t -136.46 140.54 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -127.3 30.58 4.04 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.404 1.478 . . . . 0.0 112.086 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 C--O 1.247 0.96 0 C-N-CA 126.537 1.935 . . . . 0.0 106.127 179.517 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.36 144.41 42.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.479 2.711 . . . . 0.0 105.613 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -57.86 138.42 55.72 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.9 2.48 . . . . 0.0 112.818 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.4 t -140.54 142.17 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.5 1.92 . . . . 0.0 106.941 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.46 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.7 mp -90.27 139.63 17.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -68.35 131.46 45.36 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 122.669 1.223 . . . . 0.0 112.495 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -70.19 -16.95 63.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.125 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -93.17 -31.13 14.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.959 1.254 . . . . 0.0 112.517 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.23 110.69 6.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 t -64.85 -14.75 60.47 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.444 1.475 . . . . 0.0 111.311 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -82.26 -5.26 58.41 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.216 1.006 . . . . 0.0 110.689 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -107.37 158.43 17.17 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 118.264 0.484 . . . . 0.0 111.941 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.5 mm -130.18 131.31 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.692 1.197 . . . . 0.0 107.78 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -103.52 97.45 7.49 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -131.37 126.4 35.12 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.839 -1.163 . . . . 0.0 109.339 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.1 mtt 57.16 33.54 23.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.047 1.739 . . . . 0.0 110.554 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.45 0.59 54.5 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.297 -0.877 . . . . 0.0 111.336 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -92.74 161.01 14.71 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -121.15 134.08 65.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -129.84 159.71 35.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.9 t -138.41 156.65 47.38 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.469 1.108 . . . . 0.0 108.045 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.4 mt -112.47 129.92 67.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.842 0.857 . . . . 0.0 109.688 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.4 t -100.54 -110.16 0.2 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . 0.257 8.4 p-10 -162.4 99.03 1.04 Allowed 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 126.966 2.107 . . . . 0.0 107.668 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 97.5 m -137.93 108.34 6.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 115.961 -1.971 . . . . 0.0 109.072 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.6 m -67.29 122.68 18.43 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 122.163 2.256 . . . . 0.0 105.75 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.3 t -99.7 110.99 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.822 1.192 . . . . 0.0 108.036 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -79.38 164.66 23.85 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -61.45 -31.21 71.16 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.204 1.002 . . . . 0.0 111.426 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.28 -16.45 63.57 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.739 1.215 . . . . 0.0 111.384 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.93 -29.21 8.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.386 1.075 . . . . 0.0 110.003 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.1 tp -61.14 142.73 56.5 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.86 1.264 . . . . 0.0 109.082 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -96.51 -102.08 2.01 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.48 166.34 23.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.942 1.697 . . . . 0.0 110.644 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.87 146.48 26.32 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.999 0.92 . . . . 0.0 109.968 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -126.0 -52.33 1.54 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.09 -1.433 . . . . 0.0 112.689 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -157.25 154.66 29.49 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.745 1.612 . . . . 0.0 110.283 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.8 p -111.69 137.12 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 119.129 0.877 . . . . 0.0 110.013 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -112.02 165.03 12.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.535 2.334 . . . . 0.0 109.66 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -169.57 66.29 0.05 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.713 1.205 . . . . 0.0 109.563 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -156.4 173.47 16.84 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.34 147.83 16.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 O-C-N 121.179 -0.95 . . . . 0.0 108.63 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.23 161.41 38.35 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.865 0.757 . . . . 0.0 109.765 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.23 125.29 63.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 126.476 1.911 . . . . 0.0 108.768 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -142.91 163.95 31.4 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.065 1.346 . . . . 0.0 112.099 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.85 110.38 21.32 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.89 -18.84 36.73 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.69 1.596 . . . . 0.0 115.069 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.15 -40.46 82.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 O-C-N 121.284 -0.885 . . . . 0.0 112.044 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.463 ' HB3' ' HE2' ' A' ' 169' ' ' LYS . 0.4 OUTLIER -123.26 -12.98 7.78 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.684 0.794 . . . . 0.0 112.631 -178.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.18 12.67 75.89 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.302 0.953 . . . . 0.0 111.739 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 167' ' ' SER . 25.1 mtmt -71.89 112.62 8.14 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.969 1.308 . . . . 0.0 110.507 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.2 m -73.33 157.48 36.91 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.1 1.36 . . . . 0.0 109.933 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.44 151.68 51.79 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.221 0.608 . . . . 0.0 110.205 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 160.26 39.03 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.461 2.108 . . . . 0.0 108.778 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -60.0 -22.15 62.2 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.924 -1.11 . . . . 0.0 111.186 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -14.64 44.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.033 1.333 . . . . 0.0 112.345 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -116.62 3.15 13.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.052 0.941 . . . . 0.0 112.032 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -61.98 -2.8 0.99 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -144.67 9.71 1.87 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.955 1.264 . . . . 0.0 110.774 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.05 92.73 3.21 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.022 1.329 . . . . 0.0 112.247 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 25.7 mm -128.4 -51.15 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.628 1.171 . . . . 0.0 109.834 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -75.54 166.16 23.99 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.7 tttp 62.7 -23.4 0.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -72.35 -18.29 61.77 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.993 1.317 . . . . 0.0 112.689 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 128.06 -157.81 21.28 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.8 m -59.94 -10.35 3.99 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.8 m120 21.86 78.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 129.936 3.294 . . . . 0.0 113.808 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 31.6 t -135.19 -38.03 0.78 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.152 0.981 . . . . 0.0 111.113 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.44 -8.52 56.22 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.278 0.945 . . . . 0.0 112.191 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.495 HE21 ' CZ ' ' A' ' 190' ' ' ARG . 0.6 OUTLIER -72.76 154.16 40.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t -165.22 127.02 2.07 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.495 ' CZ ' HE21 ' A' ' 188' ' ' GLN . 50.4 mtt180 -130.12 169.32 15.48 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.67 0.788 . . . . 0.0 109.988 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 93.5 m -144.22 124.29 13.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.803 2.041 . . . . 0.0 106.62 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -101.15 112.19 24.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -110.14 116.74 32.08 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.91 1.284 . . . . 0.0 110.658 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -83.2 125.18 31.28 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.676 2.39 . . . . 0.0 107.91 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.46 ' CE2' HD13 ' A' ' 123' ' ' ILE . 2.9 m-30 -77.11 100.91 5.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 213' ' ' GLU . . . -93.95 158.22 23.14 Favored Glycine 0 N--CA 1.438 -1.191 1 C-N-CA 130.806 4.05 . . . . 0.0 107.911 179.058 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -69.05 153.96 42.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.711 1.72 . . . . 0.0 111.041 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.9 mt -99.49 143.12 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 113.158 -1.837 . . . . 0.0 108.593 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -133.15 150.24 52.03 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.927 1.691 . . . . 0.0 109.429 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 19.4 m -79.33 171.59 14.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 69.4 mt -125.61 147.69 30.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 O-C-N 121.0 -1.063 . . . . 0.0 108.502 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 50.8 mtt-85 -67.5 125.59 26.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 65.52 26.78 72.02 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.008 -0.885 . . . . 0.0 114.484 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -141.79 140.52 33.04 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.6 m -94.52 145.68 24.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -20.77 59.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.449 1.1 . . . . 0.0 109.851 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 15.3 p -75.62 -10.81 59.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.716 2.407 . . . . 0.0 113.041 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -125.21 -48.65 1.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.906 1.682 . . . . 0.0 111.251 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.71 144.31 19.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.656 0.662 . . . . 0.0 110.666 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -149.97 175.91 11.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.12 0.568 . . . . 0.0 109.567 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.13 134.57 52.63 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.29 1.036 . . . . 0.0 111.702 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.79 130.59 68.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 C-N-CA 124.706 1.202 . . . . 0.0 110.591 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.403 ' HB3' ' HA3' ' A' ' 196' ' ' GLY . 5.2 tt0 -72.24 107.87 5.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 36.7 mm -121.54 115.04 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.653 1.181 . . . . 0.0 108.94 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 59.46 48.8 9.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.281 1.032 . . . . 0.0 108.477 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.8 t70 64.14 9.48 4.76 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.231 1.013 . . . . 0.0 113.586 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -126.66 122.83 36.08 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.913 -1.117 . . . . 0.0 109.603 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -69.05 121.95 17.72 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.758 -1.214 . . . . 0.0 111.905 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -117.31 144.04 45.29 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.67 1.588 . . . . 0.0 112.883 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.489 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.4 tm? -78.52 132.48 37.23 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.665 0.786 . . . . 0.0 110.357 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -118.69 143.44 46.85 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.3 p -121.55 146.7 46.69 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.887 0.875 . . . . 0.0 111.585 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -61.91 138.36 58.35 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 83.5 t -132.13 122.45 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.205 1.402 . . . . 0.0 107.612 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 176.47 47.34 0.06 OUTLIER Glycine 0 C--O 1.228 -0.237 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 . . . . . 0 C--O 1.249 1.039 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.641 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t0 . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.09 138.04 27.98 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -76.42 115.12 15.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -118.4 129.19 75.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 124.436 1.094 . . . . 0.0 110.067 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.462 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.6 mp -77.99 137.95 21.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -58.51 130.06 44.98 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.495 1.14 . . . . 0.0 110.979 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -12.25 61.25 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.54 -41.75 5.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.385 1.074 . . . . 0.0 108.95 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -116.05 103.91 11.04 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 125.18 1.392 . . . . 0.0 114.1 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.56 ' HB2' ' CD1' ' A' ' 163' ' ' PHE . 67.1 m -68.83 -7.5 34.94 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 119.906 -1.746 . . . . 0.0 111.406 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.33 -9.36 36.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.452 1.901 . . . . 0.0 109.814 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.3 mttt -115.06 160.6 19.43 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 121.116 1.78 . . . . 0.0 113.02 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.2 mm -124.91 144.19 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 C-N-CA 125.267 1.427 . . . . 0.0 107.981 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -116.39 106.17 13.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.86 2.464 . . . . 0.0 104.58 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -135.26 123.56 23.17 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 20.8 mtp 64.8 27.71 12.95 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.387 1.475 . . . . 0.0 109.727 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.75 17.83 73.52 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.721 -1.044 . . . . 0.0 110.917 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -109.19 156.73 19.54 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.1 mm -110.65 134.8 51.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 123.522 0.729 . . . . 0.0 109.801 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -129.83 153.09 48.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.0 t -133.48 158.52 42.9 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.312 1.045 . . . . 0.0 108.529 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.0 mt -117.93 115.99 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.919 1.288 . . . . 0.0 110.369 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -88.78 -125.77 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 102.062 -3.31 . . . . 0.0 102.062 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -152.84 100.41 2.51 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 176.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 55.0 m -134.85 107.2 7.25 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 112.751 -2.022 . . . . 0.0 105.755 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.5 m -65.9 124.04 21.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.6 t -94.71 142.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.1 m -114.77 162.68 16.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.017 1.327 . . . . 0.0 109.442 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.84 -26.72 67.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 111.262 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.42 -21.08 63.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.385 0.674 . . . . 0.0 110.296 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -105.8 -18.9 13.92 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.85 0.86 . . . . 0.0 110.496 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 24.2 mt -67.16 141.6 57.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.513 0.673 . . . . 0.0 109.594 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.48 -101.24 1.84 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -135.5 167.53 20.91 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.936 2.494 . . . . 0.0 109.706 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -63.27 148.16 49.01 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -126.1 -52.58 1.53 Allowed 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 121.254 -0.904 . . . . 0.0 111.744 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -151.59 147.52 26.87 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 119.038 0.835 . . . . 0.0 110.549 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.68 134.41 40.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.4 mp -112.05 159.24 18.67 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.618 2.367 . . . . 0.0 108.78 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -169.56 53.25 0.04 OUTLIER 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.111 0.564 . . . . 0.0 112.225 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -147.38 173.11 12.93 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.785 -1.197 . . . . 0.0 108.985 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.3 t -145.45 145.38 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -141.05 166.1 25.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.6 t -131.08 132.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 128' ' ' SER . 55.1 p90 -144.99 171.62 14.21 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.944 0.878 . . . . 0.0 112.49 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.09 104.67 15.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.819 2.448 . . . . 0.0 105.341 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.0 t -65.07 -11.96 45.29 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.448 1.931 . . . . 0.0 112.721 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.7 m -64.83 -40.48 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 O-C-N 120.513 -1.367 . . . . 0.0 110.683 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.5 t -123.8 -23.6 4.65 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.623 1.169 . . . . 0.0 113.831 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.34 3.24 57.66 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.524 2.012 . . . . 0.0 110.611 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -54.55 113.03 1.14 Allowed 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.634 1.974 . . . . 0.0 109.676 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.2 m -64.33 158.14 24.28 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.382 0.673 . . . . 0.0 110.882 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.27 144.18 48.33 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.545 1.538 . . . . 0.0 107.554 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -81.35 162.43 19.78 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.565 2.843 . . . . 0.0 109.893 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -59.77 -22.32 61.96 Favored 'General case' 0 C--O 1.228 -0.068 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 42.5 m -70.74 -7.86 47.98 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.404 -0.81 . . . . 0.0 111.925 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.88 2.93 12.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.748 1.219 . . . . 0.0 111.732 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -69.17 -9.59 53.61 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -135.57 -24.91 0.53 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.035 1.779 . . . . 0.0 109.825 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.63 102.99 7.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 29.1 mm -66.33 -71.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -167.27 162.94 15.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.614 1.166 . . . . 0.0 109.457 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.5 -14.44 2.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 129.014 2.926 . . . . 0.0 113.045 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.14 -36.19 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.545 1.938 . . . . 0.0 113.419 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -110.33 -175.94 20.75 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 124.46 1.029 . . . . 0.0 114.168 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 89.0 p -85.77 154.01 21.89 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.869 0.867 . . . . 0.0 110.663 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -83.28 -39.35 20.96 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 124.282 1.033 . . . . 0.0 108.609 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 33.5 t -49.09 -54.6 15.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.263 1.825 . . . . 0.0 111.896 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -79.14 8.83 5.19 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -129.51 149.3 51.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 120.094 1.315 . . . . 0.0 110.827 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 79.5 p -160.55 160.41 31.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.983 0.913 . . . . 0.0 108.893 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -137.09 171.2 14.86 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.977 1.711 . . . . 0.0 107.963 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.1 m -136.64 136.59 39.26 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.324 1.85 . . . . 0.0 106.778 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -117.78 106.92 13.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.374 1.47 . . . . 0.0 108.931 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -110.25 116.8 32.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.887 2.075 . . . . 0.0 107.657 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.93 116.56 25.08 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.968 2.507 . . . . 0.0 107.093 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.462 ' CE2' HD13 ' A' ' 123' ' ' ILE . 10.5 m-30 -64.88 102.54 0.61 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.644 1.577 . . . . 0.0 109.151 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.26 158.98 17.3 Favored Glycine 0 N--CA 1.435 -1.411 1 C-N-CA 131.264 4.269 . . . . 0.0 107.845 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -66.13 154.25 40.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.282 1.991 . . . . 0.0 114.057 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.4 mt -101.38 141.47 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 112.589 -2.096 . . . . 0.0 109.069 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.1 153.01 49.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.674 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.8 t -78.21 172.68 13.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.142 1.777 . . . . 0.0 106.556 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 18.3 mt -131.47 149.79 33.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 122.751 1.263 . . . . 0.0 113.128 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -69.03 121.03 15.83 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.217 1.807 . . . . 0.0 109.431 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.14 24.77 76.71 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 117.587 -1.674 . . . . 0.0 113.418 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -149.55 144.52 26.29 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.811 1.805 . . . . 0.0 112.358 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.9 m -92.02 151.37 20.5 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.2 -33.53 65.41 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.294 -0.879 . . . . 0.0 110.046 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.3 p -66.21 -14.71 62.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.691 1.996 . . . . 0.0 114.29 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.67 -37.98 4.11 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.47 1.108 . . . . 0.0 110.055 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.35 145.07 2.63 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.141 0.976 . . . . 0.0 110.895 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -148.58 171.68 15.75 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.24 138.16 46.01 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.869 0.468 . . . . 0.0 110.564 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 4.1 p -133.13 129.84 57.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 123.544 0.737 . . . . 0.0 111.719 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -74.86 105.82 6.09 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.5 122.6 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.403 1.481 . . . . 0.0 108.863 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 54.8 44.16 28.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.083 0.856 . . . . 0.0 108.973 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 62.34 6.91 2.06 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.405 1.482 . . . . 0.0 114.282 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.33 121.96 36.42 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -66.39 128.68 37.1 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.265 1.026 . . . . 0.0 110.493 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -123.61 151.14 43.31 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.433 0.693 . . . . 0.0 110.763 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.8 tm? -83.79 117.87 23.56 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.68 1.192 . . . . 0.0 112.452 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -100.54 151.72 21.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.0 p -135.71 150.35 49.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.84 0.856 . . . . 0.0 110.838 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.94 140.37 57.77 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.842 1.257 . . . . 0.0 107.814 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 226' ' ' ASN . 45.1 t -134.54 132.69 54.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -81.62 -12.78 81.2 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.936 -0.924 . . . . 0.0 114.447 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.494 ' H ' HG12 ' A' ' 224' ' ' VAL . 1.8 p-10 . . . . . 0 C--O 1.254 1.296 0 C-N-CA 125.264 1.426 . . . . 0.0 112.175 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.33 151.97 49.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -77.05 137.63 39.08 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.2 t -138.29 129.97 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 126.162 1.785 . . . . 0.0 108.355 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -73.84 140.12 18.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -65.2 130.42 43.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 123.006 1.384 . . . . 0.0 109.455 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -63.47 -24.03 67.65 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.686 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -89.31 -40.71 12.61 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.435 0.694 . . . . 0.0 110.727 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.71 113.15 16.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.719 1.208 . . . . 0.0 111.374 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.5 m -68.12 -11.14 58.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.604 1.962 . . . . 0.0 111.664 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -96.96 -4.33 40.08 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.978 1.711 . . . . 0.0 111.489 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -110.32 157.99 18.91 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.241 0.928 . . . . 0.0 110.632 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.4 mm -124.42 137.95 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -117.21 106.28 13.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.176 1.79 . . . . 0.0 106.48 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -127.42 125.35 40.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.6 mtt 61.94 17.78 9.27 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.721 1.208 . . . . 0.0 110.899 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.41 0.07 88.38 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.758 -1.023 . . . . 0.0 111.369 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -86.52 168.43 13.71 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.1 mm -124.81 132.71 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.646 1.112 . . . . 0.0 109.851 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -126.63 152.79 46.2 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.885 0.874 . . . . 0.0 108.936 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.7 t -137.35 147.17 45.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.227 1.011 . . . . 0.0 108.422 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.53 125.33 62.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 126.433 1.893 . . . . 0.0 110.712 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -91.89 -104.67 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -166.71 99.52 0.57 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 45.8 m -136.23 115.07 12.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.8 m -76.68 123.8 26.69 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 121.227 1.831 . . . . 0.0 106.431 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.82 142.05 14.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.7 m -114.42 164.68 13.62 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.375 1.07 . . . . 0.0 111.125 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -27.66 66.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.587 1.155 . . . . 0.0 112.44 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.08 -13.26 62.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.698 0.799 . . . . 0.0 110.359 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -119.43 -25.86 5.95 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.761 1.224 . . . . 0.0 110.965 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.1 tp -68.1 129.06 38.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.07 -98.17 0.77 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.13 163.39 30.03 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.272 1.429 . . . . 0.0 110.259 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -63.88 143.91 57.48 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -126.23 -47.52 1.61 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -151.46 158.67 43.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.992 1.269 . . . . 0.0 111.037 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.4 p -115.45 139.33 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.1 0.96 . . . . 0.0 108.591 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.26 164.67 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.998 1.719 . . . . 0.0 110.518 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -165.9 54.13 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -154.05 167.86 28.38 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.024 -1.673 . . . . 0.0 106.999 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.5 t -145.17 148.49 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -146.54 164.37 32.79 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.4 t -130.39 131.58 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -138.72 168.18 20.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.525 0.678 . . . . 0.0 111.479 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.497 ' CG ' HG22 ' A' ' 166' ' ' VAL . 53.3 t0 -80.51 111.53 17.0 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.7 t -51.51 -18.69 1.17 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 130.319 3.448 . . . . 0.0 115.074 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.497 HG22 ' CG ' ' A' ' 164' ' ' ASP . 20.9 m -76.9 -52.08 17.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 124.564 1.146 . . . . 0.0 113.46 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.414 ' HB2' ' HD3' ' A' ' 169' ' ' LYS 0.27 18.5 m -121.69 -27.08 4.77 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.186 1.794 . . . . 0.0 113.592 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.75 12.26 13.09 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.38 1.467 . . . . 0.0 113.441 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -57.1 112.45 1.36 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.597 2.198 . . . . 0.0 110.03 -178.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 43.2 p -63.13 151.89 38.86 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.79 145.37 41.1 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 125.147 1.379 . . . . 0.0 107.735 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.02 159.04 27.19 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.299 2.666 . . . . 0.0 108.868 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -55.62 -37.56 68.33 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 125.665 1.586 . . . . 0.0 111.867 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.9 m -63.51 -13.05 37.14 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 118.701 -1.2 . . . . 0.0 113.75 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.31 -15.3 20.82 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.403 1.481 . . . . 0.0 108.933 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -60.99 -11.64 8.79 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -120.34 -20.2 3.68 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.661 1.601 . . . . 0.0 110.32 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.31 71.62 1.47 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.249 1.819 . . . . 0.0 107.794 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.0 mt -50.24 -43.75 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.643 1.177 . . . . 0.0 109.018 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.5 t0 28.4 44.25 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 131.255 3.822 . . . . 0.0 117.35 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -63.03 -59.96 4.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 121.473 -0.767 . . . . 0.0 112.002 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -116.15 3.95 13.56 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.412 1.485 . . . . 0.0 111.7 -178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 93.48 -13.92 66.45 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 120.839 -1.163 . . . . 0.0 111.904 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 74.3 p -144.07 160.54 40.72 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.177 1.391 . . . . 0.0 108.959 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.36 33.29 0.56 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.375 1.083 . . . . 0.0 111.992 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.6 t -69.61 109.98 4.59 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.431 1.493 . . . . 0.0 111.32 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.1 tttm 45.39 31.38 0.85 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.393 2.277 . . . . 0.0 114.721 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -139.31 139.17 37.24 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 t -157.92 159.61 36.73 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.81 177.8 4.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.6 m -128.59 124.78 36.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -106.25 109.51 21.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -115.51 116.14 27.68 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.13 136.57 32.95 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . 0.253 4.8 m-30 -82.02 101.42 10.31 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.217 1.008 . . . . 0.0 110.967 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -93.38 158.55 23.71 Favored Glycine 0 CA--C 1.532 1.111 1 C-N-CA 135.355 6.217 . . . . 0.0 107.162 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -68.23 156.84 36.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 123.3 1.524 . . . . 0.0 112.757 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 74.3 mt -103.49 139.64 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 126.541 1.936 . . . . 0.0 110.241 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -134.27 153.5 51.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.543 1.537 . . . . 0.0 110.21 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.4 p -76.98 173.02 12.26 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.712 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 43.9 mt -127.22 133.57 67.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 122.198 0.999 . . . . 0.0 108.877 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -62.8 127.87 33.29 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.151 1.78 . . . . 0.0 108.647 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.19 13.23 76.53 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.157 -1.357 . . . . 0.0 114.625 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -137.01 139.2 41.24 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 120.329 2.065 . . . . 0.0 110.725 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.9 m -84.44 144.65 28.62 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -23.13 65.55 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 120.56 -1.337 . . . . 0.0 109.531 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 31.6 p -76.71 -6.85 53.86 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.262 2.225 . . . . 0.0 113.814 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -121.38 -45.99 2.3 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.248 1.019 . . . . 0.0 109.362 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.49 143.21 13.15 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.377 0.535 . . . . 0.0 111.004 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -149.12 175.81 11.02 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.301 -0.25 . . . . 0.0 110.628 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.17 134.4 51.78 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.67 1.188 . . . . 0.0 113.021 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.58 127.85 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 125.326 1.451 . . . . 0.0 111.602 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 218' ' ' PHE . 43.9 tt0 -74.2 110.01 8.15 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 37.0 mm -121.53 117.92 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 56.06 39.88 30.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.14 0.576 . . . . 0.0 110.125 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.4 t70 76.32 -8.39 1.65 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.424 1.889 . . . . 0.0 112.02 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -104.97 122.23 45.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 119.906 -1.746 . . . . 0.0 110.189 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 213' ' ' GLU . 11.9 m-85 -71.03 119.34 15.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -110.27 145.86 36.65 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.564 1.145 . . . . 0.0 111.331 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.8 tm? -82.03 130.51 35.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -120.43 142.15 49.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.2 p -118.61 150.28 39.95 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.599 0.714 . . . . 0.0 110.963 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -64.96 143.63 57.83 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 97.4 t -123.51 157.79 29.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -157.67 58.3 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 105.389 -3.085 . . . . 0.0 105.389 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 10.4 m120 . . . . . 0 C--O 1.245 0.826 0 C-N-CA 125.735 1.614 . . . . 0.0 109.552 -179.335 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.509 -0.62 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.06 141.62 24.37 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 128.582 2.753 . . . . 0.0 104.01 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -73.94 151.64 40.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.1 t -145.87 136.89 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -81.76 134.93 26.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -58.5 119.43 6.99 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.598 1.19 . . . . 0.0 109.964 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -58.24 -22.53 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.174 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -94.54 -21.84 18.6 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.73 1.212 . . . . 0.0 111.955 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.97 104.88 4.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.519 1.128 . . . . 0.0 109.212 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.3 t -69.06 -3.56 13.68 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.522 -1.361 . . . . 0.0 110.867 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -98.13 -3.2 38.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.718 2.007 . . . . 0.0 110.397 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -117.54 169.7 9.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.541 1.136 . . . . 0.0 112.224 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.3 mm -130.32 151.16 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 C-N-CA 126.165 1.786 . . . . 0.0 107.878 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.19 102.5 8.17 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 130.119 3.368 . . . . 0.0 103.603 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -142.7 131.93 23.35 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.643 -1.286 . . . . 0.0 109.589 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.5 mtt 57.61 32.91 22.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.353 1.461 . . . . 0.0 113.026 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.49 7.34 82.75 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.453 -1.193 . . . . 0.0 112.449 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -113.08 168.36 9.77 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.131 1.372 . . . . 0.0 108.099 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -119.54 145.46 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -133.3 155.69 48.94 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.2 t -134.91 151.59 51.01 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.039 1.736 . . . . 0.0 108.22 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.3 mt -112.82 123.34 68.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.956 1.302 . . . . 0.0 108.971 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.1 t -97.72 -118.27 0.13 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 101.884 -3.376 . . . . 0.0 101.884 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -158.05 99.36 1.66 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 120.622 1.555 . . . . 0.0 106.935 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 m -137.95 115.31 11.11 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 127.209 2.204 . . . . 0.0 106.326 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.9 m -71.72 129.79 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.81 111.05 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.5 m -75.45 164.46 26.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.068 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.9 -29.37 70.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.545 0.688 . . . . 0.0 111.753 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.74 -11.61 60.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.594 1.158 . . . . 0.0 111.265 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.77 -24.62 11.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.552 1.541 . . . . 0.0 109.534 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.09 127.92 33.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.825 1.25 . . . . 0.0 111.85 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.63 -106.06 1.31 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -133.77 163.0 30.45 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.128 1.371 . . . . 0.0 109.307 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -60.41 145.65 47.33 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.52 -42.02 1.98 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 116.507 -1.711 . . . . 0.0 114.494 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -161.28 160.86 30.33 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 121.066 1.757 . . . . 0.0 110.489 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.4 p -121.84 133.15 69.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.57 1.148 . . . . 0.0 108.402 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -107.83 166.33 10.78 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.181 2.193 . . . . 0.0 110.591 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -164.08 41.04 0.09 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -138.71 172.23 13.18 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 120.039 -1.663 . . . . 0.0 109.568 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.76 149.36 17.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -145.46 167.02 23.98 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.35 131.89 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -138.02 166.72 23.4 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.461 0.704 . . . . 0.0 110.193 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -86.07 116.03 24.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.38 -14.46 1.91 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 127.032 2.133 . . . . 0.0 115.179 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.4 m -77.34 -46.85 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 124.044 0.937 . . . . 0.0 112.451 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.23 -28.42 3.69 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.37 12.73 16.59 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.067 1.318 . . . . 0.0 112.299 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 112.78 2.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.968 1.384 . . . . 0.0 111.253 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.1 m -69.35 154.75 41.54 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.588 1.085 . . . . 0.0 110.476 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.31 147.66 66.72 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.659 1.584 . . . . 0.0 110.828 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.53 157.71 22.07 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.499 3.466 . . . . 0.0 110.502 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -53.17 -25.1 12.46 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 m -70.54 -22.06 62.65 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 118.056 -0.973 . . . . 0.0 113.468 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.2 -12.45 28.24 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.555 1.525 . . . . 0.0 110.753 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.5 m0 -62.38 -10.21 10.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.924 1.29 . . . . 0.0 111.771 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -144.91 6.37 1.58 Allowed Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.155 -1.358 . . . . 0.0 113.336 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.9 96.57 3.55 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.308 2.054 . . . . 0.0 108.062 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.3 mm -73.85 -61.81 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 57.79 51.59 9.07 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.79 2.036 . . . . 0.0 111.684 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -139.04 167.37 22.21 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.681 1.193 . . . . 0.0 110.272 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -59.34 4.68 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.431 2.692 . . . . 0.0 110.839 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 170.08 31.65 0.02 OUTLIER Glycine 0 N--CA 1.468 0.819 0 O-C-N 121.361 -0.837 . . . . 0.0 114.272 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.3 t -65.08 -25.17 67.69 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.644 1.177 . . . . 0.0 112.756 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -79.66 33.06 0.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.247 1.019 . . . . 0.0 111.951 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 44.6 t -78.6 -50.07 12.15 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.92 2.088 . . . . 0.0 111.677 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -125.9 5.86 7.32 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.368 1.867 . . . . 0.0 110.752 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.6 153.22 51.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.919 1.688 . . . . 0.0 108.59 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.1 t -171.44 178.82 3.09 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.914 1.686 . . . . 0.0 107.751 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 49.3 mmt-85 -87.96 177.41 6.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 122.19 0.995 . . . . 0.0 111.632 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.0 m -122.36 129.39 52.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 126.944 2.098 . . . . 0.0 105.557 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -115.94 106.54 13.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.349 1.859 . . . . 0.0 107.41 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -110.52 117.44 33.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.295 1.838 . . . . 0.0 108.701 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -87.88 127.21 35.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -73.31 101.45 3.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.029 0.932 . . . . 0.0 109.561 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.82 159.06 22.81 Favored Glycine 0 N--CA 1.442 -0.921 1 C-N-CA 132.694 4.95 . . . . 0.0 107.544 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 197' ' ' GLU . 6.6 pt-20 -68.1 151.17 47.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 123.544 1.64 . . . . 0.0 111.536 -176.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 63.9 mt -99.38 143.99 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 C-N-CA 126.463 1.905 . . . . 0.0 110.299 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -137.99 153.27 49.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.734 1.613 . . . . 0.0 110.095 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.8 p -80.47 173.22 12.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 66.4 mt -124.8 136.46 60.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.381 1.072 . . . . 0.0 109.015 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -64.88 119.12 10.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.66 10.89 72.19 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 118.148 -1.362 . . . . 0.0 116.083 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -137.38 130.44 30.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 120.473 2.136 . . . . 0.0 110.295 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 15.0 m -71.49 145.08 49.42 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.62 -24.96 65.91 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.052 0.941 . . . . 0.0 109.158 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 17.1 p -75.53 -9.76 58.86 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.83 2.452 . . . . 0.0 112.798 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -119.77 -47.61 2.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.582 1.153 . . . . 0.0 109.386 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.35 145.38 19.11 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.902 0.774 . . . . 0.0 111.01 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -152.08 175.73 12.26 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.859 -0.526 . . . . 0.0 110.716 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.51 134.71 52.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.871 1.669 . . . . 0.0 112.29 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.427 HG13 HG12 ' A' ' 214' ' ' ILE . 8.0 p -129.83 131.56 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 124.821 1.249 . . . . 0.0 109.436 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.41 106.75 5.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.427 HG12 HG13 ' A' ' 212' ' ' VAL . 28.2 mm -121.42 128.97 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 53.81 36.63 24.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.995 0.816 . . . . 0.0 111.65 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t0 68.74 9.66 7.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.553 1.541 . . . . 0.0 112.825 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -124.92 122.98 38.9 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.519 1.128 . . . . 0.0 108.743 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -69.12 119.37 13.3 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.828 -1.17 . . . . 0.0 110.373 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -116.07 147.19 41.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 123.41 1.576 . . . . 0.0 111.679 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -80.93 122.61 27.46 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.486 1.914 . . . . 0.0 113.074 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -112.45 140.07 47.5 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.3 p -120.54 145.51 47.25 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.621 1.168 . . . . 0.0 110.765 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -60.36 135.41 57.73 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 9.8 p -135.75 153.92 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 122.965 0.506 . . . . 0.0 109.816 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.8 -70.15 0.97 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 105.399 -3.08 . . . . 0.0 105.399 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 19.1 p30 . . . . . 0 C--O 1.244 0.787 0 C-N-CA 124.629 1.171 . . . . 0.0 110.901 179.597 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 CA--C 1.519 -0.24 0 CA-C-O 121.787 0.803 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.72 139.86 31.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 128.329 2.652 . . . . 0.0 106.34 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -70.43 130.7 42.61 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.6 t -131.46 134.92 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.0 mm -69.78 131.53 34.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -68.35 129.39 39.77 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.523 0.678 . . . . 0.0 109.988 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -71.26 -18.37 62.44 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.139 -0.976 . . . . 0.0 110.329 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -82.05 -34.21 29.58 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.644 1.178 . . . . 0.0 111.261 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.38 121.17 9.9 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.5 t -59.35 -25.21 64.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.526 1.057 . . . . 0.0 110.48 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -90.47 3.02 55.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.224 1.81 . . . . 0.0 112.946 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -109.13 155.98 20.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.2 mm -126.69 142.04 44.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -115.25 104.25 11.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 128.111 2.564 . . . . 0.0 105.166 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -132.58 128.63 37.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.8 mtt 61.76 21.77 12.47 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.221 1.408 . . . . 0.0 110.841 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.72 14.64 81.85 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.515 -1.159 . . . . 0.0 111.878 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -113.1 157.92 21.02 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.0 mm -114.65 143.93 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.561 0.696 . . . . 0.0 111.507 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -131.12 155.31 47.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.571 1.948 . . . . 0.0 109.63 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.6 t -145.18 147.38 32.4 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 mt -102.85 120.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 126.665 1.986 . . . . 0.0 112.03 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -90.33 -116.6 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 1 N-CA-C 99.881 -4.118 . . . . 0.0 99.881 176.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -160.25 99.82 1.34 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 2.4 m -136.63 121.41 18.61 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 m -81.24 136.73 35.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 120.671 1.578 . . . . 0.0 107.05 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.35 112.25 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 74.3 m -79.82 166.22 21.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.975 0.91 . . . . 0.0 109.1 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -58.27 -32.01 68.0 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.345 1.058 . . . . 0.0 111.091 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.82 -8.03 39.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.167 1.787 . . . . 0.0 112.044 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -122.33 -12.14 8.27 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 127.72 2.408 . . . . 0.0 110.001 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 20.3 mt -83.09 123.03 29.11 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.23 -101.46 0.84 Allowed Glycine 0 CA--C 1.507 -0.424 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -134.75 167.05 21.57 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.379 1.071 . . . . 0.0 108.8 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -61.02 143.05 56.1 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.0 0.92 . . . . 0.0 111.374 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.06 -41.41 1.94 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 116.907 -1.521 . . . . 0.0 113.3 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -160.27 150.36 18.17 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.707 1.594 . . . . 0.0 110.792 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.1 p -109.26 135.79 47.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.1 mp -110.66 163.21 13.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.934 2.094 . . . . 0.0 110.95 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -165.33 64.34 0.12 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -153.01 173.19 15.73 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.564 -1.335 . . . . 0.0 108.763 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.2 t -149.57 138.07 14.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 126.103 1.761 . . . . 0.0 106.368 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.75 166.05 25.7 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.49 126.9 55.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -142.08 164.01 31.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.561 1.144 . . . . 0.0 110.759 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -92.95 103.57 15.88 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 104.284 -2.488 . . . . 0.0 104.284 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.35 -15.72 0.69 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.365 2.266 . . . . 0.0 116.127 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.6 m -57.71 -51.0 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.168 0.987 . . . . 0.0 108.406 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.2 m -123.45 -26.7 4.19 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.397 1.879 . . . . 0.0 114.437 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 103.4 16.56 20.09 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.499 1.523 . . . . 0.0 113.615 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 113.04 4.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.76 1.78 . . . . 0.0 109.261 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.0 m -75.21 145.25 42.17 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.26 143.07 26.97 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.17 160.51 42.41 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.167 2.578 . . . . 0.0 111.028 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -57.32 -28.62 63.24 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.065 0.546 . . . . 0.0 111.913 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.5 m -61.32 -14.22 25.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.071 0.949 . . . . 0.0 112.148 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -119.12 4.91 11.3 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.903 1.681 . . . . 0.0 111.951 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -68.16 -15.98 63.81 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.752 -1.218 . . . . 0.0 113.895 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -127.23 -46.91 0.19 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -81.24 86.76 6.17 Favored 'General case' 0 C--N 1.337 0.024 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 89.3 mt -70.76 -80.82 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.42 161.83 34.34 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.859 1.264 . . . . 0.0 108.731 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -64.19 -37.98 89.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.31 0.644 . . . . 0.0 109.705 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -84.49 -48.94 9.09 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.872 1.669 . . . . 0.0 106.896 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 95.4 3.75 61.24 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.504 1.526 . . . . 0.0 113.892 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.8 p -35.36 -58.67 0.56 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 127.771 2.428 . . . . 0.0 113.843 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 57.96 -9.96 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.034 2.134 . . . . 0.0 116.466 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.5 t -46.58 -23.49 0.4 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -109.64 12.12 24.38 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 121.131 1.787 . . . . 0.0 112.352 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -116.55 160.0 21.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 119.86 1.209 . . . . 0.0 108.792 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.04 84.03 1.45 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -76.57 158.8 30.86 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.488 0.661 . . . . 0.0 110.232 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.4 m -141.84 132.53 25.58 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.478 1.911 . . . . 0.0 106.018 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -115.35 104.77 12.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -110.63 116.6 31.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.013 1.325 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -83.27 128.23 34.32 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 127.212 2.205 . . . . 0.0 105.861 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.55 102.3 6.02 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.68 159.27 16.84 Favored Glycine 0 N--CA 1.442 -0.96 1 C-N-CA 131.489 4.376 . . . . 0.0 109.918 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.12 154.98 39.9 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 124.294 1.997 . . . . 0.0 113.717 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.4 mt -102.26 140.97 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.299 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -131.58 151.52 51.53 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 109.604 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 11.4 m -76.3 172.27 13.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.778 0.831 . . . . 0.0 108.984 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 78.8 mt -131.91 138.15 53.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.902 0.858 . . . . 0.0 110.509 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -65.5 119.04 10.34 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.22 14.73 76.09 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 118.821 -0.989 . . . . 0.0 115.378 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -140.78 126.2 18.81 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 119.771 1.785 . . . . 0.0 109.782 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 16.3 m -76.48 146.71 38.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.31 -27.8 56.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.541 1.136 . . . . 0.0 110.393 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 36.9 p -74.33 -9.74 58.9 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.433 1.893 . . . . 0.0 114.362 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -120.69 -43.88 2.46 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.26 1.424 . . . . 0.0 109.547 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.15 144.28 14.35 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.115 0.566 . . . . 0.0 110.13 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -148.13 176.38 10.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.803 0.841 . . . . 0.0 109.152 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -108.62 130.73 55.31 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.455 1.102 . . . . 0.0 109.727 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.1 p -124.28 126.97 72.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 124.48 1.112 . . . . 0.0 111.678 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -73.89 108.42 6.7 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 35.4 mm -121.74 120.2 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 54.17 40.39 31.62 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.8 t70 70.68 -4.83 1.57 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.381 2.272 . . . . 0.0 113.2 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.44 ' HB3' ' HE2' ' A' ' 219' ' ' LYS . 37.8 m-20 -106.15 122.26 45.84 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 120.279 -1.513 . . . . 0.0 108.953 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.85 120.49 16.52 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 217' ' ' ASP . 19.5 mmtp -112.46 151.58 29.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.818 1.247 . . . . 0.0 112.671 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.5 tm? -88.81 117.07 27.53 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.067 0.947 . . . . 0.0 110.711 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.89 156.23 17.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.9 143.3 40.77 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 123.158 0.583 . . . . 0.0 109.908 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -54.82 125.82 21.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.865 0.866 . . . . 0.0 110.162 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.7 t -134.71 130.52 53.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 C-N-CA 126.387 1.875 . . . . 0.0 107.986 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.97 -15.48 21.13 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.196 -0.78 . . . . 0.0 112.656 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . 0.321 1.0 OUTLIER . . . . . 0 C--O 1.247 0.96 0 C-N-CA 131.199 3.799 . . . . 0.0 113.7 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 CA--C 1.507 -0.687 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.68 152.04 45.03 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.128 1.771 . . . . 0.0 106.568 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.4 ' CD2' HD13 ' A' ' 198' ' ' ILE . 45.8 m-85 -69.56 140.91 53.89 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.879 1.272 . . . . 0.0 110.264 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.4 t -141.24 141.34 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.479 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.7 mp -80.28 121.13 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -48.61 122.13 5.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.087 0.946 . . . . 0.0 111.475 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -65.72 -17.54 64.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.785 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -94.96 -20.38 19.43 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.956 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.17 122.2 9.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 120.038 1.29 . . . . 0.0 108.127 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.5 m -65.12 -18.86 65.66 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 120.182 -1.574 . . . . 0.0 110.699 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -94.12 -0.48 55.28 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.943 1.297 . . . . 0.0 113.095 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -108.0 159.59 16.44 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.466 0.575 . . . . 0.0 110.104 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.2 mm -126.81 138.51 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -118.63 108.67 15.22 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -146.39 134.1 21.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.8 mtt 58.69 26.91 15.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.747 2.019 . . . . 0.0 113.531 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.17 23.52 71.14 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -121.99 164.7 17.19 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.3 mm -123.77 126.36 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.89 150.19 41.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.7 t -130.75 150.04 52.12 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.004 1.322 . . . . 0.0 109.201 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 mt -111.36 124.21 67.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 125.602 1.561 . . . . 0.0 110.725 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.6 t -95.31 -126.95 0.13 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 103.188 -2.893 . . . . 0.0 103.188 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -149.73 99.37 2.86 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 94.5 m -136.89 111.79 8.88 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 128.094 2.558 . . . . 0.0 109.654 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.1 m -69.05 124.34 23.51 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 54.6 t -94.46 119.58 42.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 119.675 1.125 . . . . 0.0 109.157 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.2 m -80.65 159.13 25.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.643 0.735 . . . . 0.0 109.858 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.35 -29.34 70.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.956 1.302 . . . . 0.0 112.008 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.43 -16.11 61.83 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.311 1.044 . . . . 0.0 111.892 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -103.9 -25.95 12.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.818 0.847 . . . . 0.0 108.867 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 mt -62.14 137.58 58.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.757 1.223 . . . . 0.0 109.923 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -89.39 -105.71 1.12 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -135.04 169.43 17.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.057 1.743 . . . . 0.0 109.805 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -59.68 142.39 53.13 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -125.74 -48.97 1.63 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 116.595 -1.669 . . . . 0.0 111.902 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -155.73 150.81 26.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.9 1.682 . . . . 0.0 112.217 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.8 p -105.5 133.59 49.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 122.482 1.134 . . . . 0.0 111.332 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mp -113.1 161.93 16.53 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.562 2.745 . . . . 0.0 109.702 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.66 48.71 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.569 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 3.5 mt-10 -143.72 176.68 9.05 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.85 2.06 . . . . 0.0 111.579 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.49 150.56 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.593 -1.317 . . . . 0.0 110.508 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.512 ' HE ' ' CB ' ' A' ' 193' ' ' TRP . 0.0 OUTLIER -131.38 157.49 43.28 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.408 1.483 . . . . 0.0 109.606 178.113 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.5 t -140.51 114.18 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -141.58 167.98 20.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.356 0.598 . . . . 0.0 112.212 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.21 104.24 13.23 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.5 m -64.48 -14.99 59.97 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 122.145 2.248 . . . . 0.0 114.526 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.6 m -69.57 -35.17 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 O-C-N 121.823 -0.548 . . . . 0.0 112.001 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.29 -19.19 6.03 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.384 1.473 . . . . 0.0 113.015 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.26 -10.84 69.47 Favored Glycine 0 CA--C 1.543 1.796 0 C-N-CA 126.969 2.223 . . . . 0.0 112.582 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -47.69 115.4 1.13 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 128.369 2.667 . . . . 0.0 113.64 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.6 p -67.04 158.12 31.8 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 109.965 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.0 134.79 24.44 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.49 156.78 49.72 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.672 2.248 . . . . 0.0 110.005 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.437 ' HA ' ' CD1' ' A' ' 176' ' ' TRP . 42.7 ttt180 -56.58 -30.46 63.2 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t -66.96 -7.59 23.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.352 0.978 . . . . 0.0 111.753 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.06 -7.59 14.91 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.14 1.376 . . . . 0.0 110.885 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.437 ' CD1' ' HA ' ' A' ' 173' ' ' ARG . 34.2 m0 -60.71 -14.93 24.11 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -119.81 13.03 10.75 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.721 2.105 . . . . 0.0 110.837 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -106.68 76.68 1.13 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.854 1.661 . . . . 0.0 107.558 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 12.6 mm -105.09 -77.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -118.46 66.89 0.77 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.64 1.576 . . . . 0.0 112.731 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -128.8 -4.45 5.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.421 1.488 . . . . 0.0 110.285 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -136.06 5.13 3.03 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.629 1.572 . . . . 0.0 113.866 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 73.92 -1.87 44.94 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.996 1.284 . . . . 0.0 115.196 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.4 m -75.24 -11.82 60.15 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.291 2.046 . . . . 0.0 114.211 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -50.07 -2.06 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.72 2.808 . . . . 0.0 117.945 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.9 m -64.38 -75.92 0.08 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.516 -1.365 . . . . 0.0 110.133 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -93.09 54.69 2.19 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.939 -1.101 . . . . 0.0 110.434 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -135.76 147.31 48.35 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.3 t -168.52 152.37 5.74 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.72 2.008 . . . . 0.0 106.127 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -139.21 174.42 10.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.618 1.567 . . . . 0.0 108.823 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 99.9 m -139.96 115.65 10.14 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -94.06 112.55 24.38 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' TRP . . . . . 0.512 ' CB ' ' HE ' ' A' ' 161' ' ' ARG . 17.7 m0 -121.9 115.87 23.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.71 138.12 48.28 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.235 1.414 . . . . 0.0 109.151 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.569 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.6 m-30 -88.55 102.01 14.51 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 177.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.31 159.11 17.21 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 130.399 3.857 . . . . 0.0 107.753 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -66.51 158.25 30.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.162 1.934 . . . . 0.0 112.581 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.4 HD13 ' CD2' ' A' ' 121' ' ' PHE . 41.8 mt -105.02 142.09 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.599 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -132.52 151.62 51.85 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.226 1.41 . . . . 0.0 109.654 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 55.2 p -76.23 173.19 11.68 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.1 mt -125.41 146.13 31.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 122.127 0.965 . . . . 0.0 109.316 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -68.65 125.03 25.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.14 26.31 73.39 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.287 1.423 . . . . 0.0 113.867 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -145.93 152.38 39.35 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.6 m -106.64 151.12 25.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.453 HD13 ' HB3' ' A' ' 210' ' ' PHE . 3.0 mm? -55.56 -27.69 50.59 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.122 0.569 . . . . 0.0 110.711 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 7.7 p -71.66 -13.42 61.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.122 2.169 . . . . 0.0 114.443 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -124.69 -38.5 2.37 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.234 1.414 . . . . 0.0 112.077 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.18 142.07 5.77 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.517 1.053 . . . . 0.0 110.528 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.453 ' HB3' HD13 ' A' ' 206' ' ' LEU . 45.6 p90 -154.23 174.5 14.69 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.608 0.363 . . . . 0.0 111.494 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -110.65 132.19 54.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.98 1.312 . . . . 0.0 109.7 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.69 124.95 66.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.467 1.507 . . . . 0.0 109.357 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -71.54 109.51 5.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.37 124.17 71.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 54.26 44.08 29.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.682 0.674 . . . . 0.0 110.006 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 26.7 t70 59.08 20.55 8.45 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.3 0.64 . . . . 0.0 112.059 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.444 ' HB3' ' HE2' ' A' ' 219' ' ' LYS . 0.5 OUTLIER -129.61 122.45 29.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.958 1.303 . . . . 0.0 108.579 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -71.24 117.84 13.27 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.33 -1.481 . . . . 0.0 110.093 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 217' ' ' ASP . 51.0 mmtt -111.38 147.63 34.78 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.708 1.603 . . . . 0.0 110.329 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.4 tm? -80.79 139.44 36.04 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.235 1.014 . . . . 0.0 111.198 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.89 139.35 52.66 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.332 1.453 . . . . 0.0 107.122 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.1 p -126.23 155.48 41.78 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.141 0.976 . . . . 0.0 111.683 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -64.9 143.12 58.16 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.784 -0.572 . . . . 0.0 111.072 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.5 163.67 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -105.68 -40.7 1.98 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 125.386 1.47 . . . . 0.0 109.529 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 . . . . . 0 C--O 1.249 1.032 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 179.324 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.518 -0.286 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.86 130.52 39.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -68.81 146.4 52.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.4 t -140.02 132.68 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.525 HD13 ' CE2' ' A' ' 195' ' ' TYR . 5.3 mp -77.21 122.58 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -56.85 128.05 34.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.811 1.291 . . . . 0.0 109.507 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 125' ' ' LYS . 20.0 pttm -70.37 -22.89 62.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.444 1.098 . . . . 0.0 110.382 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.07 -42.2 19.54 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 123.637 0.775 . . . . 0.0 109.86 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -133.16 105.62 7.13 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.5 m -62.27 -23.48 66.72 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.189 -1.57 . . . . 0.0 112.478 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -81.27 -2.68 49.86 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.028 1.331 . . . . 0.0 111.125 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -109.89 159.8 16.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.453 0.701 . . . . 0.0 109.848 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.1 mm -125.47 133.0 70.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.31 111.16 23.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 101.477 -3.527 . . . . 0.0 101.477 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -147.8 137.97 22.88 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.16 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.3 mtt 51.72 28.73 5.09 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.22 18.0 79.71 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.406 -0.809 . . . . 0.0 111.522 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -120.43 163.71 17.48 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.472 1.109 . . . . 0.0 108.654 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.6 mm -119.14 134.08 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -126.97 148.92 50.07 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.8 t -131.51 130.32 42.22 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.464 2.306 . . . . 0.0 110.589 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.63 130.39 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.462 1.505 . . . . 0.0 108.819 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.3 t -102.57 -134.88 0.32 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 101.494 -3.521 . . . . 0.0 101.494 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -145.65 98.31 3.11 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 102.526 -3.138 . . . . 0.0 102.526 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.6 m -136.4 111.38 8.88 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 130.752 3.621 . . . . 0.0 108.999 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.9 m -68.7 127.85 34.54 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.714 1.597 . . . . 0.0 107.775 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.6 t -94.66 126.19 47.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.6 m -87.97 159.51 18.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.59 0.71 . . . . 0.0 110.213 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -56.56 -35.6 68.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.843 1.657 . . . . 0.0 109.913 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.56 -19.36 62.08 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.201 1.0 . . . . 0.0 111.809 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.72 -27.87 11.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.227 1.411 . . . . 0.0 110.763 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.97 112.79 2.73 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.596 1.558 . . . . 0.0 109.68 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.48 -102.44 0.08 OUTLIER Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.031 0.824 . . . . 0.0 111.865 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -134.76 161.82 34.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.735 1.214 . . . . 0.0 110.289 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -56.46 130.63 45.73 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.527 1.131 . . . . 0.0 109.969 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -109.11 -48.93 3.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 117.286 -1.34 . . . . 0.0 112.394 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -164.3 158.76 19.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.07 1.304 . . . . 0.0 109.406 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.3 p -108.02 141.12 24.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.579 1.152 . . . . 0.0 111.271 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mp -112.85 163.22 14.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.006 2.523 . . . . 0.0 110.365 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -166.81 39.57 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.544 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 21.4 mt-10 -141.86 176.71 8.72 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.181 -2.199 . . . . 0.0 110.35 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.9 t -138.12 151.47 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 120.071 1.305 . . . . 0.0 111.007 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.495 ' HE ' ' CB ' ' A' ' 193' ' ' TRP . 0.2 OUTLIER -130.34 156.91 43.9 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 120.953 -1.092 . . . . 0.0 109.683 177.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.1 t -138.22 113.89 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -134.23 158.3 44.08 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.621 -0.674 . . . . 0.0 110.212 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -85.26 99.99 11.49 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 103.103 -2.925 . . . . 0.0 103.103 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.7 m -59.28 -9.06 1.94 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 126.735 2.014 . . . . 0.0 116.267 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.8 m -66.12 -38.82 82.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.439 ' HB3' ' HE2' ' A' ' 169' ' ' LYS . 0.4 OUTLIER -123.43 -24.12 4.67 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.648 1.579 . . . . 0.0 112.286 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.18 8.53 60.08 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 127.224 2.345 . . . . 0.0 110.564 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 167' ' ' SER . 27.2 mtmt -61.27 115.95 4.22 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.074 1.75 . . . . 0.0 110.253 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 70.4 p -67.28 153.75 42.94 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.119 0.968 . . . . 0.0 112.366 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.58 136.31 26.5 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.2 163.72 24.96 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.548 2.165 . . . . 0.0 110.998 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -58.44 -21.87 52.47 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.578 1.551 . . . . 0.0 114.737 -178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.3 m -80.46 -7.57 59.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.982 0.81 . . . . 0.0 110.517 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -113.1 9.32 18.55 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.648 1.579 . . . . 0.0 110.945 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -81.45 -17.25 49.43 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.254 1.422 . . . . 0.0 114.068 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -135.7 -44.22 0.1 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 120.986 -1.072 . . . . 0.0 113.65 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 35.8 ttt-85 -77.98 89.51 4.15 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.4 mm -73.0 -56.23 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.2 t70 39.42 44.12 1.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.97 2.108 . . . . 0.0 112.121 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.11 153.58 34.13 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.041 1.336 . . . . 0.0 111.343 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -54.01 -17.5 2.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.562 2.745 . . . . 0.0 114.321 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -153.01 -59.84 0.01 OUTLIER Glycine 0 C--N 1.337 0.584 0 O-C-N 121.274 -0.891 . . . . 0.0 111.537 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 57.6 m -155.68 166.84 32.28 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 120.912 -1.346 . . . . 0.0 110.729 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -61.4 -22.39 64.95 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.102 0.961 . . . . 0.0 111.3 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 38.5 m -54.47 172.19 0.1 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.667 1.987 . . . . 0.0 113.236 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt 67.24 -5.69 0.69 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 129.06 2.944 . . . . 0.0 113.91 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -80.19 -58.91 2.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.03 1.332 . . . . 0.0 110.081 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.8 m 57.21 56.46 5.17 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 126.301 1.841 . . . . 0.0 111.305 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -70.95 168.84 16.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.695 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 37.6 m -139.72 135.67 33.4 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -113.15 106.87 15.17 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.883 1.673 . . . . 0.0 107.321 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' TRP . . . . . 0.495 ' CB ' ' HE ' ' A' ' 161' ' ' ARG . 24.6 m0 -110.78 115.63 29.88 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.612 0.765 . . . . 0.0 110.385 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.21 138.34 38.6 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.777 1.631 . . . . 0.0 106.838 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.544 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.9 m-30 -85.97 105.91 16.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -105.8 158.67 15.62 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 127.801 2.62 . . . . 0.0 108.037 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.11 156.49 36.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 124.741 2.21 . . . . 0.0 113.05 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 38.9 mt -100.9 141.0 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 111.795 -2.457 . . . . 0.0 110.179 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -133.83 152.51 51.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.548 1.539 . . . . 0.0 109.64 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 91.5 p -74.69 172.69 11.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.459 0.704 . . . . 0.0 110.152 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 5.3 mt -127.71 135.46 63.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 121.458 -0.776 . . . . 0.0 110.257 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -65.14 126.15 27.21 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.85 12.44 84.43 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.205 -1.331 . . . . 0.0 116.01 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -138.75 157.75 45.5 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.617 1.709 . . . . 0.0 108.175 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 62.1 m -106.48 145.72 31.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.63 -31.14 64.04 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 29.8 p -66.32 -12.37 56.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.178 1.791 . . . . 0.0 113.903 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -124.66 -35.39 2.73 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.688 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.27 145.36 6.94 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 119.217 0.917 . . . . 0.0 110.964 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.57 173.23 16.61 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.048 0.385 . . . . 0.0 111.221 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.62 132.52 54.06 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 124.509 1.124 . . . . 0.0 111.774 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.81 130.36 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.947 1.299 . . . . 0.0 108.513 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -69.91 103.11 2.13 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 33.8 mm -121.56 123.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.293 1.437 . . . . 0.0 110.251 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 61.52 38.15 15.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.194 0.997 . . . . 0.0 109.317 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 65.31 16.31 10.47 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.617 1.567 . . . . 0.0 111.313 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.56 129.15 38.65 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -67.97 122.23 17.77 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 119.962 -1.711 . . . . 0.0 109.15 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -119.02 146.2 45.23 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.815 1.246 . . . . 0.0 111.387 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -78.83 133.12 37.04 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.937 1.295 . . . . 0.0 112.032 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -121.69 131.31 54.02 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.81 150.21 33.82 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.189 0.596 . . . . 0.0 110.025 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -70.08 122.09 18.73 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.46 127.25 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -92.72 27.97 10.05 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.448 -1.195 . . . . 0.0 112.85 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 . . . . . 0 C--O 1.245 0.859 0 C-N-CA 126.793 2.037 . . . . 0.0 107.325 -179.349 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 t70 . . . . . 0 N--CA 1.464 0.228 0 CA-C-O 121.173 0.511 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.91 143.58 17.11 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.0 2.12 . . . . 0.0 106.155 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -75.96 124.56 27.56 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.0 t -124.78 136.88 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 126.029 1.732 . . . . 0.0 107.026 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.404 HD11 HD12 ' A' ' 157' ' ' LEU . 5.1 mp -86.43 138.89 18.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -64.27 123.3 18.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 123.03 1.395 . . . . 0.0 108.419 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -61.02 -27.05 68.04 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.788 1.235 . . . . 0.0 111.105 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -80.87 -46.09 15.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.21 105.61 8.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.428 1.491 . . . . 0.0 112.946 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -58.67 -19.5 39.96 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 120.343 -1.473 . . . . 0.0 112.258 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -85.21 -7.85 58.84 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.278 -0.889 . . . . 0.0 110.658 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -101.41 149.47 24.02 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.838 0.744 . . . . 0.0 109.559 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.1 mm -126.86 119.15 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.09 97.29 9.82 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 128.372 2.669 . . . . 0.0 109.114 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -132.41 142.5 49.31 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 121.576 1.989 . . . . 0.0 109.975 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 8.4 mtt 49.87 23.32 1.02 Allowed 'General case' 0 CA--C 1.544 0.739 0 O-C-N 119.992 -1.693 . . . . 0.0 114.714 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.64 5.25 78.68 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 119.604 1.093 . . . . 0.0 112.089 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -100.23 172.86 6.9 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 125.099 1.36 . . . . 0.0 111.626 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.5 mm -136.4 125.7 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -114.13 161.07 18.24 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.449 ' HB2' HG11 ' A' ' 224' ' ' VAL . 25.9 t -143.04 139.32 30.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.434 1.494 . . . . 0.0 109.999 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.1 mt -100.85 137.68 27.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 123.929 0.892 . . . . 0.0 109.233 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.7 m -118.17 -112.79 0.34 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -159.98 98.72 1.34 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 122.689 2.495 . . . . 0.0 108.109 175.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 54.3 m -137.42 113.88 10.21 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 127.323 2.249 . . . . 0.0 105.537 175.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.6 m -76.61 126.9 31.79 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 104.419 -2.438 . . . . 0.0 104.419 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.7 t -93.72 111.7 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.1 m -74.61 158.27 33.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.959 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.96 -28.82 67.97 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.998 0.519 . . . . 0.0 111.481 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.71 -12.58 61.59 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.94 -0.475 . . . . 0.0 111.222 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -114.04 -24.1 9.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.507 1.523 . . . . 0.0 110.791 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.2 mt -65.63 135.38 54.95 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.62 -106.14 0.91 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 107.401 -2.28 . . . . 0.0 107.401 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.31 167.04 21.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.595 1.958 . . . . 0.0 109.325 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -57.63 150.07 20.18 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.097 0.951 . . . . 0.0 112.532 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -125.99 -50.75 1.57 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.901 -1.524 . . . . 0.0 112.325 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.93 163.17 29.23 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 121.297 1.862 . . . . 0.0 110.619 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.2 139.75 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 119.122 0.874 . . . . 0.0 111.716 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 123' ' ' ILE . 4.4 mm? -110.93 164.8 12.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.452 2.301 . . . . 0.0 110.462 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.6 59.92 0.07 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.086 0.954 . . . . 0.0 112.619 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -156.34 172.8 17.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.879 -1.138 . . . . 0.0 108.287 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 t -143.98 149.41 17.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.91 164.6 31.47 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 63.0 t -131.28 136.74 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -147.62 163.85 35.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.65 0.78 . . . . 0.0 111.994 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.55 100.67 10.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -62.53 -12.35 21.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.5 m -65.58 -44.14 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 121.674 -0.642 . . . . 0.0 110.827 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.442 ' HB2' ' HE2' ' A' ' 169' ' ' LYS . 32.3 m -121.62 -20.57 6.47 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 125.54 1.536 . . . . 0.0 113.233 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.48 5.78 57.74 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.457 1.027 . . . . 0.0 111.753 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.442 ' HE2' ' HB2' ' A' ' 167' ' ' SER . 45.1 mtmt -61.27 112.8 2.29 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.49 1.116 . . . . 0.0 108.162 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 p -63.29 151.31 40.99 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.22 141.68 26.8 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.912 1.285 . . . . 0.0 107.664 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -82.43 160.2 17.18 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.955 2.437 . . . . 0.0 108.488 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 ttp85 -53.12 -27.28 20.02 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.225 1.01 . . . . 0.0 113.372 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.2 t -65.67 -13.66 59.65 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.074 1.749 . . . . 0.0 112.4 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.58 -1.55 13.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 119.706 -1.871 . . . . 0.0 110.598 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.5 m0 -68.48 -25.25 64.88 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.556 -0.715 . . . . 0.0 109.901 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 179.25 30.65 0.05 OUTLIER Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.799 1.19 . . . . 0.0 113.341 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -133.24 40.99 3.15 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.676 1.738 . . . . 0.0 110.017 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.7 mp -75.04 -82.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -155.53 -175.56 5.5 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.691 1.597 . . . . 0.0 107.795 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -101.56 -27.32 13.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.377 1.871 . . . . 0.0 109.306 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -97.19 -24.03 15.91 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.234 1.014 . . . . 0.0 110.802 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -30.65 113.64 0.05 OUTLIER Glycine 0 C--N 1.341 0.822 0 C-N-CA 128.407 2.908 . . . . 0.0 113.9 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.6 t -49.14 -39.94 30.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.581 1.952 . . . . 0.0 111.563 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 33.75 57.23 0.57 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.827 2.851 . . . . 0.0 114.01 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.5 t -122.54 -46.18 2.16 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.799 0.84 . . . . 0.0 109.642 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -73.32 16.47 0.18 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.929 1.292 . . . . 0.0 112.05 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -124.33 131.09 53.5 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.406 1.882 . . . . 0.0 108.086 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 90.0 p -131.95 100.24 5.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.701 1.2 . . . . 0.0 109.685 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.1 mtt85 -103.15 173.24 6.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.63 1.172 . . . . 0.0 110.661 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.9 m -144.86 132.69 21.2 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 127.187 2.195 . . . . 0.0 107.025 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -108.76 109.67 20.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.859 2.063 . . . . 0.0 106.609 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -115.72 116.78 28.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.764 1.225 . . . . 0.0 112.281 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -84.0 133.32 34.68 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.103 1.361 . . . . 0.0 109.318 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.14 101.33 7.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.47 1.108 . . . . 0.0 109.417 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -96.11 158.45 21.79 Favored Glycine 0 CA--C 1.534 1.27 1 C-N-CA 134.549 5.833 . . . . 0.0 107.608 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -68.25 157.16 36.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.338 1.569 . . . . 0.0 113.13 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 62.2 mt -101.11 139.81 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 126.744 2.018 . . . . 0.0 109.583 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -133.1 152.33 51.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.502 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 18.9 t -76.99 172.96 12.35 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 35.8 mt -129.06 141.9 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 122.824 1.297 . . . . 0.0 107.691 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 -65.81 121.49 15.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.175 1.39 . . . . 0.0 109.351 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.54 15.4 80.5 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.395 -1.225 . . . . 0.0 113.612 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -136.49 132.19 34.99 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.992 1.896 . . . . 0.0 110.018 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.4 m -81.13 150.63 28.64 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.77 -29.84 63.01 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.345 -0.847 . . . . 0.0 109.951 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.1 p -67.54 -20.64 65.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.151 2.18 . . . . 0.0 114.025 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -112.13 -41.71 3.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 117.787 -1.101 . . . . 0.0 110.313 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.71 142.69 3.77 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.124 0.874 . . . . 0.0 109.863 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -151.47 175.62 12.11 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.691 0.796 . . . . 0.0 109.426 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.56 132.7 53.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.239 1.415 . . . . 0.0 110.327 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.48 124.77 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 C-N-CA 125.316 1.446 . . . . 0.0 107.836 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -72.9 109.49 6.51 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 50.4 mm -121.83 118.07 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 126.071 1.749 . . . . 0.0 109.224 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.58 47.4 16.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.242 1.017 . . . . 0.0 109.511 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.82 10.98 6.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.52 1.128 . . . . 0.0 111.441 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.26 123.46 38.17 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.205 -1.559 . . . . 0.0 110.588 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -69.79 116.95 10.78 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.02 -1.05 . . . . 0.0 108.565 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -112.55 150.52 31.21 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.019 1.328 . . . . 0.0 109.756 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.2 tm? -82.38 135.07 35.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.21 1.004 . . . . 0.0 109.944 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.03 125.16 44.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.71 152.17 26.86 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.525 0.73 . . . . 0.0 112.001 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -60.8 139.18 58.01 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 122.205 -0.309 . . . . 0.0 110.319 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 139' ' ' SER . 11.4 p -130.16 167.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -170.46 23.46 0.09 OUTLIER Glycine 0 CA--C 1.525 0.679 0 CA-C-O 119.366 -0.686 . . . . 0.0 111.628 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 . . . . . 0 C--O 1.249 1.048 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.42 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.223 -0.305 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.48 129.68 2.34 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 127.73 2.412 . . . . 0.0 105.806 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -64.67 147.45 52.98 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.334 0.97 . . . . 0.0 108.597 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.2 t -150.53 132.11 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 123' ' ' ILE . 5.1 mp -72.18 139.5 19.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -60.31 118.64 6.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -19.59 37.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.749 -0.594 . . . . 0.0 111.749 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -96.04 -19.6 19.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.601 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.8 111.49 5.03 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.843 1.656 . . . . 0.0 108.731 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 163' ' ' PHE . 6.0 t -54.88 -32.83 61.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.055 1.342 . . . . 0.0 112.93 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.5 ptt85 -79.05 -1.27 34.91 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.236 -0.915 . . . . 0.0 112.32 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -110.35 157.09 19.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 118.585 0.629 . . . . 0.0 112.523 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.3 mm -127.31 141.74 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -115.68 103.0 10.25 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 129.404 3.082 . . . . 0.0 104.159 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -143.15 133.88 25.22 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.074 -1.016 . . . . 0.0 109.317 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 22.3 mtp 56.88 30.23 17.56 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.845 1.258 . . . . 0.0 112.615 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.71 8.73 73.12 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.899 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -106.97 168.64 9.06 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.602 1.561 . . . . 0.0 107.635 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.6 mm -120.23 141.2 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -133.04 143.91 49.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.7 t -135.19 151.25 50.47 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.774 1.229 . . . . 0.0 109.112 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 mt -101.0 137.75 27.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.788 0.835 . . . . 0.0 110.419 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.9 t -101.57 -111.17 0.21 Allowed 'General case' 0 CA--C 1.537 0.46 1 N-CA-C 98.714 -4.551 . . . . 0.0 98.714 175.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -166.9 99.12 0.55 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.8 m -135.67 112.97 10.56 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 127.764 2.426 . . . . 0.0 105.583 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.1 m -68.54 123.29 20.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.67 116.14 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.8 m -83.96 158.64 21.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.167 0.508 . . . . 0.0 110.964 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -57.32 -32.75 67.0 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.188 1.795 . . . . 0.0 111.386 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.82 -8.79 55.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.88 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -121.72 -20.93 6.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.436 1.094 . . . . 0.0 109.658 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.0 tp -66.26 151.36 47.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.31 -102.59 2.72 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -134.65 165.15 25.89 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.85 0.86 . . . . 0.0 110.942 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -62.44 143.31 57.24 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -123.59 -52.05 1.82 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.878 -1.058 . . . . 0.0 111.535 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.82 173.86 16.35 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.924 0.783 . . . . 0.0 110.071 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.8 p -129.92 147.29 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.419 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.2 mm? -111.78 166.54 11.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.274 3.029 . . . . 0.0 112.952 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -162.87 45.61 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.68 174.46 10.95 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 119.802 -1.811 . . . . 0.0 108.621 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.0 t -142.22 149.81 19.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.308 1.043 . . . . 0.0 108.351 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -145.18 161.11 40.31 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.893 -1.129 . . . . 0.0 108.847 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 191' ' ' THR . 92.2 t -127.32 126.93 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 128' ' ' SER . 52.9 p90 -148.17 165.34 31.19 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.535 0.734 . . . . 0.0 111.18 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -80.88 109.67 15.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.119 1.767 . . . . 0.0 108.195 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.9 t -50.49 -23.44 2.48 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.713 2.805 . . . . 0.0 115.269 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.47 -39.56 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.4 t -122.12 -24.99 4.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.73 -1.02 52.38 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.89 1.233 . . . . 0.0 112.52 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -51.69 112.35 0.75 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.39 1.876 . . . . 0.0 110.23 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 25.9 p -72.7 156.48 38.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.633 0.73 . . . . 0.0 110.52 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.58 136.79 25.6 Favored Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.81 162.87 32.05 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.722 2.282 . . . . 0.0 109.561 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -58.71 -31.85 68.64 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.558 0.343 . . . . 0.0 111.864 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.8 m -67.54 -4.39 11.46 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.28 -0.93 10.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.829 1.252 . . . . 0.0 110.274 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -62.69 -32.84 74.0 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.064 -1.648 . . . . 0.0 111.751 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -151.38 18.31 0.9 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.221 0.915 . . . . 0.0 112.214 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -132.6 68.67 1.49 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 123.242 1.496 . . . . 0.0 108.97 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.2 mt -115.33 -50.61 4.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -143.82 154.74 43.71 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.14 1.776 . . . . 0.0 107.586 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -114.35 -36.87 4.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.691 1.196 . . . . 0.0 110.276 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.96 -25.47 68.15 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 129.347 3.059 . . . . 0.0 111.734 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.35 174.13 23.49 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.37 1.938 . . . . 0.0 110.556 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.464 ' C ' HD22 ' A' ' 185' ' ' ASN . 33.5 t -64.43 162.44 15.15 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 122.157 0.979 . . . . 0.0 111.957 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.464 HD22 ' C ' ' A' ' 184' ' ' SER . 1.5 m120 -130.76 21.33 5.03 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.613 2.365 . . . . 0.0 108.94 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 65.7 p -67.3 -161.16 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.573 1.549 . . . . 0.0 113.678 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -63.55 99.34 0.21 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.975 0.91 . . . . 0.0 109.131 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -109.39 -42.72 4.28 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 127.148 2.179 . . . . 0.0 107.003 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.24 31.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -118.57 175.13 5.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.589 0.756 . . . . 0.0 110.977 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 0.3 OUTLIER -133.3 147.21 51.88 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 130.721 3.609 . . . . 0.0 105.881 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -129.11 104.94 7.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 102.923 -2.992 . . . . 0.0 102.923 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -111.49 116.21 30.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -83.53 129.34 34.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.261 1.424 . . . . 0.0 107.956 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -74.76 100.71 4.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.497 0.719 . . . . 0.0 109.239 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.3 159.66 27.56 Favored Glycine 0 CA--C 1.53 1.019 1 C-N-CA 132.631 4.92 . . . . 0.0 110.267 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.43 162.7 22.49 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 122.403 1.097 . . . . 0.0 109.304 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 97.4 mt -109.31 131.77 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 127.262 2.225 . . . . 0.0 112.072 -176.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -128.2 149.99 50.21 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.121 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 63.3 m -79.24 172.53 13.68 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.03 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 72.0 mt -128.62 139.02 53.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.315 1.446 . . . . 0.0 107.284 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -68.99 122.18 18.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.18 13.43 77.01 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 118.763 -1.02 . . . . 0.0 113.457 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -139.9 123.78 17.52 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 119.499 1.649 . . . . 0.0 109.988 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 54.8 m -79.6 150.91 30.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.01 -23.54 54.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.878 0.871 . . . . 0.0 110.284 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 17.0 p -76.09 -9.49 58.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.316 2.246 . . . . 0.0 113.513 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -123.95 -47.26 1.93 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.894 1.277 . . . . 0.0 110.081 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.88 148.27 13.77 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -155.14 175.84 13.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -108.36 144.44 35.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.56 124.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.767 2.027 . . . . 0.0 109.172 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -73.97 107.5 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 47.4 mm -121.84 125.76 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 109.76 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 54.32 44.43 28.99 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.013 0.824 . . . . 0.0 109.748 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 65.42 0.21 1.33 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.642 1.977 . . . . 0.0 113.974 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -121.23 127.87 51.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.949 0.795 . . . . 0.0 109.111 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -66.0 136.6 56.27 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.329 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -128.87 145.95 51.07 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.928 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.35 133.08 35.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.899 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -121.71 138.19 54.45 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 23.9 p -120.78 149.41 42.6 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 123.677 0.611 . . . . 0.0 112.632 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -61.12 143.01 56.27 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 4.7 t -130.61 151.81 36.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.68 -24.91 76.52 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.187 -0.946 . . . . 0.0 111.936 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 127.251 2.22 . . . . 0.0 105.813 179.148 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 CA--C 1.506 -0.72 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.43 147.09 27.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.372 1.069 . . . . 0.0 108.512 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.447 ' H ' ' HD1' ' A' ' 121' ' ' PHE . 1.6 p90 -71.59 127.67 33.32 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 129.508 3.123 . . . . 0.0 106.285 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.7 126.11 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.9 mp -68.88 133.17 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -66.27 128.23 35.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.42 -22.4 66.95 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.627 0.771 . . . . 0.0 111.135 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -81.25 -47.33 13.51 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.557 1.143 . . . . 0.0 109.605 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -140.74 106.05 5.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.366 1.466 . . . . 0.0 108.742 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 m -62.69 -12.28 22.63 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 120.362 -1.461 . . . . 0.0 112.259 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -85.13 1.84 46.17 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.417 1.087 . . . . 0.0 109.446 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -113.98 162.11 16.83 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.558 1.143 . . . . 0.0 109.06 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.9 mm -132.94 128.23 56.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -106.16 110.46 22.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.533 2.333 . . . . 0.0 106.567 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -146.26 128.76 16.0 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.455 1.102 . . . . 0.0 108.755 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.2 mtt 60.82 39.94 16.47 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.953 1.701 . . . . 0.0 112.329 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 63.59 21.63 65.06 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.918 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -114.46 173.46 6.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.1 mm -132.9 132.41 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -124.55 156.19 37.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.7 t -131.11 150.62 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.934 1.694 . . . . 0.0 108.949 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.8 mt -120.34 127.63 75.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.9 t -103.97 -104.51 0.3 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -164.76 101.79 0.79 Allowed 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 178.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 86.6 m -135.37 113.66 11.44 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 126.728 2.011 . . . . 0.0 107.38 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.7 m -66.98 115.98 7.3 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.574 1.533 . . . . 0.0 109.399 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 66.7 t -95.27 115.55 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 m -82.26 158.55 23.45 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -63.76 -26.59 68.71 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.972 0.909 . . . . 0.0 111.559 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -66.99 -23.77 65.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.175 0.443 . . . . 0.0 110.533 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -99.82 -21.03 15.91 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.937 0.895 . . . . 0.0 110.014 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.23 148.91 48.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.819 1.248 . . . . 0.0 108.03 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.15 -106.54 2.69 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.37 170.67 15.58 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.62 1.168 . . . . 0.0 110.349 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -56.92 138.0 54.55 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.394 1.478 . . . . 0.0 109.154 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -126.3 -52.89 1.5 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 121' ' ' PHE . 29.5 m-20 -139.66 156.6 46.74 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.548 0.613 . . . . 0.0 110.217 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.3 p -120.36 133.45 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.381 0.61 . . . . 0.0 111.833 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.418 HD21 HD12 ' A' ' 198' ' ' ILE . 4.1 mm? -112.3 164.15 13.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.954 2.102 . . . . 0.0 112.252 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.44 42.05 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.749 1.22 . . . . 0.0 112.536 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.407 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 1.5 tt0 -140.39 175.59 9.47 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 119.068 -2.27 . . . . 0.0 108.987 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 t -143.08 149.52 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.84 165.8 26.53 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.449 HG12 ' HG3' ' A' ' 190' ' ' ARG . 21.3 t -133.75 129.19 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -141.99 157.36 45.04 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 119.881 1.219 . . . . 0.0 111.414 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -62.19 121.17 12.42 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.877 0.871 . . . . 0.0 109.574 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.15 -14.2 59.99 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.52 -38.68 12.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.0 t -123.0 -27.13 4.27 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.24 6.62 53.34 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.258 0.932 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -55.68 114.44 1.87 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.761 1.624 . . . . 0.0 108.517 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.08 132.84 55.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.022 0.828 . . . . 0.0 109.198 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -92.76 144.46 28.62 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.36 153.78 45.37 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.59 2.193 . . . . 0.0 110.201 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -56.95 -36.31 70.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.565 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.6 t -63.39 -2.63 1.59 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -118.18 -1.26 11.39 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.202 1.364 . . . . 0.0 111.966 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -68.22 -3.86 12.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.242 1.417 . . . . 0.0 113.653 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 173.89 49.99 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.05 52.63 1.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.759 0.824 . . . . 0.0 108.898 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 16.4 mt -134.43 -59.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 49.62 51.07 17.16 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.273 1.829 . . . . 0.0 108.863 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -73.77 130.63 40.36 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -53.82 -50.76 65.44 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 128.931 2.892 . . . . 0.0 108.696 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -79.59 59.63 4.4 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.154 1.359 . . . . 0.0 111.994 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 61.5 p 28.35 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 131.407 3.883 . . . . 0.0 116.235 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.1 m120 53.32 18.39 1.28 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.397 1.079 . . . . 0.0 111.4 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.1 t -45.18 -44.88 11.23 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.064 2.145 . . . . 0.0 111.773 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.89 -1.39 37.48 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.4 mp0 -142.86 80.26 1.68 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.805 0.842 . . . . 0.0 111.476 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 7.8 t -141.21 154.32 45.75 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.384 1.874 . . . . 0.0 106.838 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.449 ' HG3' HG12 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -144.65 171.56 14.22 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.683 1.193 . . . . 0.0 110.351 -179.397 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.0 m -91.88 137.41 32.39 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.701 2.0 . . . . 0.0 106.388 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -119.48 109.88 16.25 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.842 2.057 . . . . 0.0 106.949 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -115.38 119.62 36.85 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.768 2.027 . . . . 0.0 110.797 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -86.82 134.46 33.55 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 128.363 2.665 . . . . 0.0 110.031 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.444 ' CE2' HD13 ' A' ' 123' ' ' ILE . 3.2 m-30 -80.35 102.28 9.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.475 1.51 . . . . 0.0 110.477 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -95.49 158.66 22.22 Favored Glycine 0 CA--C 1.533 1.196 1 C-N-CA 133.042 5.115 . . . . 0.0 107.475 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.85 159.42 30.44 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 123.62 1.676 . . . . 0.0 110.62 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.418 HD12 HD21 ' A' ' 157' ' ' LEU . 57.7 mt -111.73 141.1 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.705 1.602 . . . . 0.0 109.982 -176.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -134.43 147.5 50.45 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.324 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.61 173.44 6.07 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.8 mt -128.89 141.4 46.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.206 1.403 . . . . 0.0 108.509 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.87 124.7 24.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.4 17.35 76.26 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-O 117.493 -1.726 . . . . 0.0 114.841 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -147.63 134.44 20.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.105 1.952 . . . . 0.0 111.255 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.0 m -84.87 151.16 24.49 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.22 -30.64 62.61 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.327 -0.858 . . . . 0.0 109.864 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 66.9 p -73.18 -4.25 31.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.928 1.691 . . . . 0.0 114.458 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -125.12 -40.98 2.1 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.831 1.652 . . . . 0.0 109.515 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.05 144.6 2.71 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 118.858 0.754 . . . . 0.0 109.736 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -152.41 175.63 12.5 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.966 0.907 . . . . 0.0 109.198 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -112.47 134.72 53.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.041 1.336 . . . . 0.0 110.547 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.5 124.54 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 C-N-CA 124.153 0.981 . . . . 0.0 108.635 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -70.29 104.39 2.66 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 41.5 mm -121.77 133.22 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 54.77 39.7 31.53 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.06 3.31 2.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.837 2.455 . . . . 0.0 113.642 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -119.43 125.29 48.58 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.706 1.203 . . . . 0.0 111.492 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -64.28 113.19 3.43 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.571 0.748 . . . . 0.0 112.635 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -105.97 147.29 28.99 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 122.184 0.992 . . . . 0.0 110.908 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -86.18 123.12 31.11 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.428 1.491 . . . . 0.0 108.805 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -107.54 144.23 34.82 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.7 p -118.05 147.37 43.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.784 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -62.15 142.81 57.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.646 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.0 p -135.85 167.85 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 156.9 -18.05 0.4 Allowed Glycine 0 CA--C 1.525 0.657 0 O-C-N 120.53 -1.356 . . . . 0.0 112.58 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 124.488 1.115 . . . . 0.0 109.443 178.556 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.73 129.0 6.68 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 120.422 1.465 . . . . 0.0 109.777 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -75.11 138.56 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.0 t -139.55 132.01 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 157' ' ' LEU . 5.1 mp -78.64 128.63 38.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 177.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -61.56 122.34 15.0 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.51 1.148 . . . . 0.0 108.892 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.1 pttt -62.27 -23.01 66.46 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.362 -0.836 . . . . 0.0 110.358 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -85.01 -22.92 28.88 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.605 1.162 . . . . 0.0 110.603 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.84 102.45 2.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 119.667 1.122 . . . . 0.0 108.294 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.0 m -57.53 -24.93 58.85 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.884 0.873 . . . . 0.0 112.756 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.6 ptt85 -81.23 -3.79 53.46 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.923 0.889 . . . . 0.0 111.302 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -108.25 151.86 25.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.634 0.73 . . . . 0.0 110.089 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 14.2 mm -120.8 142.02 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -117.45 104.06 10.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.904 2.482 . . . . 0.0 106.051 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -127.26 133.97 50.12 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.0 mtt 56.3 13.44 1.26 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.043 -1.661 . . . . 0.0 113.281 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.73 6.6 65.49 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.879 1.228 . . . . 0.0 110.66 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -97.61 154.11 17.76 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 119.055 1.427 . . . . 0.0 107.917 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mm -118.09 140.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 O-C-N 124.358 1.036 . . . . 0.0 110.058 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -123.35 168.85 11.97 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.76 1.224 . . . . 0.0 110.528 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.47 135.51 25.16 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.453 1.501 . . . . 0.0 109.412 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 mt -97.89 119.0 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.1 t -94.87 -105.25 0.14 Allowed 'General case' 0 C--O 1.234 0.255 1 N-CA-C 99.717 -4.179 . . . . 0.0 99.717 176.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -167.03 99.34 0.53 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 4.5 m -136.29 121.46 19.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 128.332 2.653 . . . . 0.0 103.93 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.5 m -76.59 128.42 34.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.27 111.69 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.435 1.016 . . . . 0.0 109.583 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.2 m -81.96 162.95 22.49 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.027 0.531 . . . . 0.0 110.347 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.44 -27.0 65.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.248 1.819 . . . . 0.0 112.521 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.35 -22.07 61.95 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.204 -0.31 . . . . 0.0 110.213 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.82 -26.79 13.01 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.287 1.035 . . . . 0.0 109.433 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.8 tp -65.08 152.68 42.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -111.2 -102.64 2.67 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 125.037 1.303 . . . . 0.0 109.925 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -134.54 167.49 20.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.532 1.133 . . . . 0.0 110.858 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -60.07 140.93 56.53 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.024 1.33 . . . . 0.0 108.178 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -124.49 -47.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.598 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.99 158.16 40.19 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.325 1.42 . . . . 0.0 111.197 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.35 135.1 57.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.754 0.788 . . . . 0.0 111.292 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.409 HD12 HD11 ' A' ' 123' ' ' ILE . 4.2 mm? -111.27 165.92 11.53 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.041 2.936 . . . . 0.0 110.324 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.46 51.99 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.652 1.181 . . . . 0.0 113.143 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.36 175.85 9.6 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 119.618 -1.926 . . . . 0.0 107.681 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.66 142.58 23.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.93 161.1 38.15 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 191' ' ' THR . 71.6 t -129.89 124.2 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.74 169.24 18.09 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.289 0.95 . . . . 0.0 110.877 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -81.08 117.78 21.95 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -15.74 60.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.7 m -82.96 -41.19 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.0 -1.063 . . . . 0.0 113.779 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.409 ' HB2' ' HD3' ' A' ' 169' ' ' LYS . 68.2 m -122.36 -27.61 4.43 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 125.294 1.438 . . . . 0.0 113.456 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.32 7.59 37.21 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 117.118 1.607 . . . . 0.0 117.118 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.418 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -60.51 113.25 2.33 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.982 1.313 . . . . 0.0 110.551 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.2 p -70.58 149.48 47.04 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.749 1.22 . . . . 0.0 109.793 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.416 HG22 ' CD1' ' A' ' 176' ' ' TRP . 1.2 mp -117.41 139.3 25.94 Favored Pre-proline 0 N--CA 1.44 -0.964 0 C-N-CA 125.527 1.531 . . . . 0.0 107.236 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.56 153.4 20.49 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.798 2.332 . . . . 0.0 109.33 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -51.21 -33.47 27.79 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.821 1.249 . . . . 0.0 111.573 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -3.47 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.556 1.142 . . . . 0.0 113.283 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -129.72 6.93 5.18 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.359 1.863 . . . . 0.0 113.242 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.416 ' CD1' HG22 ' A' ' 171' ' ' ILE . 40.9 m0 -62.76 3.33 0.23 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.409 1.083 . . . . 0.0 112.713 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.72 19.2 5.77 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 117.928 -1.485 . . . . 0.0 113.594 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.364 0.4 OUTLIER -89.93 18.27 5.91 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.231 2.016 . . . . 0.0 113.751 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 179' ' ' ILE . 5.0 mp -70.06 -55.8 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 54.8 35.26 23.75 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.254 2.221 . . . . 0.0 114.348 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -167.42 1.61 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.96 -33.48 75.48 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -48.82 126.23 16.74 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.7 p -74.89 58.35 0.84 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.75 2.02 . . . . 0.0 110.171 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -65.26 -8.02 15.86 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 115.795 -2.05 . . . . 0.0 113.79 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.8 t -5.72 -72.19 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 130.323 3.449 . . . . 0.0 111.071 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.83 -5.99 2.17 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.796 0.838 . . . . 0.0 112.191 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 55.79 9.53 0.44 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.147 2.979 . . . . 0.0 111.721 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t 78.27 39.93 0.14 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.423 2.689 . . . . 0.0 109.808 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.0 mmp_? -104.7 177.56 4.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.403 1.481 . . . . 0.0 107.817 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 28.7 m -128.61 150.77 50.08 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 128.363 2.665 . . . . 0.0 105.99 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -124.37 109.02 12.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -110.44 116.26 31.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.829 1.652 . . . . 0.0 110.903 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.29 123.67 31.03 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 128.119 2.568 . . . . 0.0 107.405 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -72.19 101.18 2.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 118.951 0.796 . . . . 0.0 109.468 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.2 159.0 27.19 Favored Glycine 0 N--CA 1.44 -1.094 1 C-N-CA 131.67 4.462 . . . . 0.0 107.392 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -68.26 160.06 30.03 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.43 1.586 . . . . 0.0 111.267 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 77.6 mt -106.76 141.13 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.136 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -132.91 151.8 51.99 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.574 1.55 . . . . 0.0 110.528 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.4 t -78.29 173.05 12.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.904 0.882 . . . . 0.0 108.662 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.1 mt -129.63 140.3 49.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 122.477 1.132 . . . . 0.0 108.721 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -66.26 119.64 11.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.303 1.441 . . . . 0.0 107.821 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.88 2.44 88.5 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.31 -1.272 . . . . 0.0 114.962 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -126.39 132.79 51.46 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.91 1.855 . . . . 0.0 109.075 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 16.2 m -85.78 150.73 24.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -28.37 63.29 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 124.202 1.001 . . . . 0.0 110.075 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.6 p -72.02 -11.18 60.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.115 2.166 . . . . 0.0 114.195 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -120.47 -47.62 2.33 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.514 1.526 . . . . 0.0 109.549 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.25 144.51 12.76 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 111.084 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -150.05 175.77 11.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.738 0.415 . . . . 0.0 109.984 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.15 128.89 55.39 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.828 0.851 . . . . 0.0 110.324 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.0 128.27 71.74 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 C-N-CA 124.697 1.199 . . . . 0.0 107.855 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.05 110.26 7.2 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.6 mm -121.77 124.08 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 53.5 48.14 22.44 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.092 0.86 . . . . 0.0 109.087 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 65.48 -4.26 0.59 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.649 2.379 . . . . 0.0 115.014 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -114.9 135.59 54.03 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.094 0.861 . . . . 0.0 109.771 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -72.92 115.36 12.13 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.152 0.981 . . . . 0.0 110.26 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 146.98 34.36 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.9 tm? -79.31 136.79 37.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.86 1.264 . . . . 0.0 108.229 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.05 137.36 53.63 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.0 p -121.3 150.38 41.5 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.41 0.444 . . . . 0.0 111.974 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -55.01 133.51 48.59 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.0 p -134.81 137.76 50.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 126.401 1.881 . . . . 0.0 108.017 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 60.25 16.58 42.67 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.371 -1.238 . . . . 0.0 115.475 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.6 m120 . . . . . 0 C--O 1.25 1.117 0 C-N-CA 129.259 3.024 . . . . 0.0 113.335 179.647 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.5 131.42 15.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 128.972 2.909 . . . . 0.0 105.995 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 155' ' ' ASP . 18.9 p90 -66.43 149.78 49.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 97.3 t -149.72 126.25 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.8 mp -71.94 134.13 30.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.52 117.52 6.32 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -24.49 19.97 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.71 0.804 . . . . 0.0 111.53 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -89.19 -22.59 22.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.368 1.467 . . . . 0.0 112.396 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.11 104.33 3.67 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 119.565 1.075 . . . . 0.0 108.273 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.4 t -60.14 -22.33 62.73 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.342 -0.849 . . . . 0.0 112.814 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.0 ptt85 -80.69 -4.83 55.8 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.35 -0.844 . . . . 0.0 110.598 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -109.6 159.28 17.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.816 0.817 . . . . 0.0 111.409 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.8 mm -130.38 146.77 33.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.04 104.75 9.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -141.06 134.43 29.74 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.05 1.34 . . . . 0.0 109.898 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.0 mtt 58.21 36.42 25.73 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.605 1.162 . . . . 0.0 112.109 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.05 22.85 63.16 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -121.88 161.51 22.66 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mm -116.37 145.24 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -135.15 156.94 48.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.45 ' HB2' HG11 ' A' ' 224' ' ' VAL . 8.0 t -139.19 165.14 27.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.4 mt -117.13 134.75 59.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.714 0.769 . . . . 0.0 110.699 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.31 -114.6 0.2 Allowed 'General case' 0 CA--C 1.539 0.521 1 N-CA-C 99.371 -4.307 . . . . 0.0 99.371 175.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -167.53 100.33 0.49 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 94.5 m -136.25 121.8 19.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.81 2.044 . . . . 0.0 106.75 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 m -71.5 121.45 18.69 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.87 110.68 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.5 m -70.85 159.53 34.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.06 0.457 . . . . 0.0 110.944 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.28 -29.86 69.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.546 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.95 -12.36 60.63 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -108.54 -23.04 12.01 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.485 1.114 . . . . 0.0 109.13 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.46 133.99 53.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.98 -105.86 0.74 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -135.85 166.86 22.31 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.613 1.565 . . . . 0.0 108.601 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -64.63 139.92 58.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -123.26 -48.03 1.99 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.573 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 28.3 m-20 -152.65 166.6 31.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.982 1.265 . . . . 0.0 111.32 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.24 143.17 40.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.572 1.149 . . . . 0.0 111.142 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -111.2 166.5 11.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.875 2.87 . . . . 0.0 112.706 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.15 58.83 0.29 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.182 0.993 . . . . 0.0 112.631 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -161.99 175.98 11.25 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.974 -1.704 . . . . 0.0 111.605 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -144.59 150.12 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.112 1.765 . . . . 0.0 108.557 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.8 164.71 29.36 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.039 1.29 . . . . 0.0 109.236 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.0 t -132.17 132.97 60.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -141.72 168.59 19.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.658 0.783 . . . . 0.0 111.271 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -89.49 102.86 15.54 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 127.022 2.129 . . . . 0.0 108.067 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.7 t -47.03 -21.23 0.2 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 129.507 3.123 . . . . 0.0 114.8 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.03 -50.91 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.432 1.493 . . . . 0.0 110.898 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.9 t -123.21 -23.84 4.81 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.858 1.663 . . . . 0.0 114.05 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.95 0.87 42.04 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.24 1.4 . . . . 0.0 110.364 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -48.13 113.5 0.75 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 127.712 2.405 . . . . 0.0 111.003 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 39.9 p -61.02 154.98 21.27 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.852 1.261 . . . . 0.0 111.299 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.99 142.44 41.19 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.28 1.032 . . . . 0.0 108.826 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.22 157.25 46.2 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.203 2.602 . . . . 0.0 108.98 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -57.68 -32.25 67.16 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.683 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -7.8 9.67 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 118.103 -0.951 . . . . 0.0 113.287 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -110.79 -8.59 14.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.4 1.454 . . . . 0.0 109.835 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.6 m0 -59.43 -38.1 79.81 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 119.668 1.122 . . . . 0.0 112.176 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -112.34 2.18 26.6 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.248 1.404 . . . . 0.0 111.254 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.98 42.97 3.23 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.373 1.469 . . . . 0.0 108.022 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.6 mt -63.71 -48.71 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -119.9 179.11 4.36 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 130.302 3.441 . . . . 0.0 112.574 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -126.74 -20.73 4.22 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.904 2.482 . . . . 0.0 112.25 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.41 -14.47 60.46 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.632 2.373 . . . . 0.0 113.356 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 77.39 30.5 53.89 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.31 157.34 20.05 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.518 1.927 . . . . 0.0 106.743 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -126.54 91.53 3.37 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.564 0.746 . . . . 0.0 109.902 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.0 t -94.98 -69.57 0.75 Allowed 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 125.155 1.382 . . . . 0.0 108.243 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -73.75 6.7 2.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.031 1.733 . . . . 0.0 115.448 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -144.4 151.23 38.97 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.832 1.253 . . . . 0.0 109.243 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.2 t -162.0 125.13 3.03 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -118.33 177.94 4.63 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.795 -1.191 . . . . 0.0 110.56 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.2 m -132.64 135.46 45.87 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 127.946 2.499 . . . . 0.0 106.626 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -114.42 108.34 16.75 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -110.23 123.87 50.56 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.591 1.556 . . . . 0.0 109.73 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -90.46 125.2 35.5 Favored 'General case' 0 N--CA 1.441 -0.893 1 C-N-CA 133.244 4.618 . . . . 0.0 109.087 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -77.74 101.88 6.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 127.327 2.251 . . . . 0.0 107.72 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -97.79 159.35 20.89 Favored Glycine 0 CA--C 1.533 1.218 1 C-N-CA 134.377 5.751 . . . . 0.0 108.049 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -66.6 163.19 19.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.939 1.369 . . . . 0.0 110.569 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 73.7 mt -109.31 134.95 49.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 128.138 2.575 . . . . 0.0 111.735 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -130.02 151.29 50.73 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.947 1.299 . . . . 0.0 110.239 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.3 p -78.59 173.53 12.32 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.518 ' CD1' HD23 ' A' ' 220' ' ' LEU . 50.3 mt -128.29 136.59 59.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 O-C-N 121.255 -0.903 . . . . 0.0 109.805 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -63.03 127.34 30.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.3 12.09 84.91 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.478 -1.179 . . . . 0.0 113.915 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -138.85 156.16 47.54 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 120.365 2.083 . . . . 0.0 109.168 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.2 m -103.32 146.62 28.19 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -23.34 58.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.875 0.87 . . . . 0.0 109.74 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 23.7 p -79.11 -9.5 59.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.721 1.608 . . . . 0.0 114.105 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -123.73 -40.63 2.31 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.678 0.791 . . . . 0.0 112.215 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.441 ' HB1' HD21 ' A' ' 220' ' ' LEU . . . -162.48 140.02 8.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -150.57 176.13 11.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -107.93 143.13 37.01 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.45 121.9 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.647 1.579 . . . . 0.0 108.768 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.85 104.37 4.0 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.1 mm -122.15 126.03 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 126.49 1.916 . . . . 0.0 109.273 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 58.54 34.76 24.15 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.844 -1.16 . . . . 0.0 112.236 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 66.1 13.77 9.28 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.366 1.066 . . . . 0.0 113.187 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.62 120.23 21.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.318 1.847 . . . . 0.0 108.634 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -65.6 136.65 56.62 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 120.103 -1.623 . . . . 0.0 109.965 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -127.15 147.9 50.18 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.026 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 201' ' ' ILE . 1.4 tm? -84.86 115.1 22.57 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.056 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.48 147.8 24.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.59 143.18 50.15 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 118.0 0.364 . . . . 0.0 110.571 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -50.86 135.3 24.41 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.209 1.404 . . . . 0.0 110.061 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' A' ' 139' ' ' SER . 4.8 p -135.27 158.92 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -133.12 32.85 2.68 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.3 t30 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 127.299 2.24 . . . . 0.0 108.452 -178.169 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.04 141.82 25.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.663 1.574 . . . . 0.0 108.966 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -65.0 118.51 9.22 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.722 1.609 . . . . 0.0 110.103 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.4 t -121.76 135.55 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -83.0 118.93 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -47.4 118.77 2.33 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.187 1.395 . . . . 0.0 110.486 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -59.98 -21.45 61.28 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.507 -0.746 . . . . 0.0 111.701 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -88.53 -20.05 25.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.083 0.953 . . . . 0.0 111.257 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.05 112.25 2.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.965 1.257 . . . . 0.0 110.64 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 m -60.27 -21.91 62.46 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 119.957 -1.714 . . . . 0.0 113.428 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.7 ptt85 -80.84 1.23 31.53 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 120.858 -1.151 . . . . 0.0 110.015 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -111.93 158.68 19.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.867 0.841 . . . . 0.0 110.277 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.0 mm -133.43 127.59 53.89 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 136' ' ' ASN . 4.7 t0 -96.91 105.0 17.05 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 128.086 2.554 . . . . 0.0 104.14 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -139.5 143.11 37.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.083 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 8.9 mtt 55.24 22.87 5.03 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.853 -1.154 . . . . 0.0 113.749 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.04 17.86 71.11 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.504 1.049 . . . . 0.0 110.983 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 8.9 p30 -117.28 173.84 6.46 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 126.588 1.955 . . . . 0.0 112.88 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.2 mm -130.04 132.33 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -119.33 163.55 17.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 t -140.02 148.12 41.39 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.578 1.551 . . . . 0.0 106.925 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 mt -114.08 121.74 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -94.85 -113.5 0.12 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -158.3 99.63 1.63 Allowed 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 65.0 m -136.95 116.42 12.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.004 2.522 . . . . 0.0 104.89 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.6 m -78.35 122.3 25.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 121.235 1.834 . . . . 0.0 106.595 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.7 t -94.67 113.05 28.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.018 1.327 . . . . 0.0 109.225 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.0 m -75.14 163.84 27.13 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.523 1.129 . . . . 0.0 111.18 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.24 -29.34 68.7 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.264 1.025 . . . . 0.0 110.168 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.02 -16.48 64.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.363 0.665 . . . . 0.0 112.062 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -105.35 -30.68 9.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.63 1.572 . . . . 0.0 109.83 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -55.67 127.27 29.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.951 1.3 . . . . 0.0 110.141 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.48 -104.83 1.25 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 125.235 1.398 . . . . 0.0 110.066 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -134.44 168.31 19.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.397 1.479 . . . . 0.0 109.296 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.42 136.95 58.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -115.18 -52.37 2.68 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.414 0.686 . . . . 0.0 111.784 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -160.37 159.9 31.68 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.77 1.168 . . . . 0.0 109.038 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 p -114.75 133.13 61.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.665 1.186 . . . . 0.0 111.402 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.61 164.9 12.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.966 2.106 . . . . 0.0 111.114 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.87 29.36 0.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.85 174.12 6.8 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 119.924 -1.735 . . . . 0.0 108.133 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.9 t -143.67 149.98 17.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.22 164.91 33.45 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.8 t -127.72 131.28 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -144.23 167.81 21.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.442 0.639 . . . . 0.0 110.172 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -79.99 119.16 22.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.1 t -66.21 -13.92 61.07 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.4 m -83.77 -43.61 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.7 m -122.19 -26.97 4.6 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.728 1.211 . . . . 0.0 113.919 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.31 -1.38 31.09 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.49 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -52.86 112.49 0.85 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.36 1.08 . . . . 0.0 111.599 -179.288 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.99 140.57 56.37 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.465 HG22 ' CD1' ' A' ' 176' ' ' TRP . 1.2 mp -106.88 143.39 26.99 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.32 1.848 . . . . 0.0 108.327 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.25 148.53 18.98 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.692 2.928 . . . . 0.0 110.896 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -53.38 -31.5 45.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.752 0.821 . . . . 0.0 112.892 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 t -68.76 -6.23 25.32 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.715 0.806 . . . . 0.0 112.998 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -116.4 -12.71 11.04 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.872 1.669 . . . . 0.0 110.201 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.465 ' CD1' HG22 ' A' ' 171' ' ' ILE . 40.3 m0 -52.7 -40.26 62.79 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -114.22 13.06 21.58 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.077 1.322 . . . . 0.0 111.823 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -134.48 79.83 1.82 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.3 mm -50.43 -77.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 126.741 2.016 . . . . 0.0 109.424 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -170.67 174.45 4.99 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.165 0.986 . . . . 0.0 108.834 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 181' ' ' LYS . 10.9 mmpt? -114.05 -54.38 2.6 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.838 2.055 . . . . 0.0 106.54 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.31 -48.84 31.12 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.019 1.328 . . . . 0.0 108.958 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -83.92 163.06 39.62 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-O 121.758 0.643 . . . . 0.0 112.238 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.1 m -141.52 142.41 33.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.952 0.901 . . . . 0.0 109.911 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -74.07 92.03 2.13 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.961 0.904 . . . . 0.0 109.96 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.9 m -117.02 -27.93 6.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -139.27 12.89 2.6 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.74 1.216 . . . . 0.0 111.76 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -117.29 163.39 16.4 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.414 1.086 . . . . 0.0 110.55 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.21 108.84 0.17 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -75.57 177.42 6.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.43 HG22 ' CD1' ' A' ' 193' ' ' TRP . 95.5 m -128.66 117.78 21.77 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -95.03 113.12 24.79 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' TRP . . . . . 0.43 ' CD1' HG22 ' A' ' 191' ' ' THR . 12.4 m0 -123.38 124.5 43.06 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.702 1.601 . . . . 0.0 110.256 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.72 135.03 34.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.036 2.134 . . . . 0.0 107.512 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -78.3 100.52 6.76 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.69 159.55 23.1 Favored Glycine 0 N--CA 1.441 -0.984 1 C-N-CA 130.818 4.056 . . . . 0.0 107.514 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -68.14 154.33 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 123.655 1.693 . . . . 0.0 111.61 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.66 141.04 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 112.997 -1.911 . . . . 0.0 108.205 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -134.2 153.63 51.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 112.957 -1.929 . . . . 0.0 108.316 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.72 173.11 12.19 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 81.6 mt -124.14 137.5 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -55.71 119.58 5.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.162 1.385 . . . . 0.0 108.24 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.46 12.1 82.34 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.412 -1.215 . . . . 0.0 115.436 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -126.05 133.01 51.83 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 120.961 2.381 . . . . 0.0 109.568 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 67.9 m -83.53 142.78 30.64 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.47 -32.23 57.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.272 1.029 . . . . 0.0 110.501 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.2 p -70.12 -10.55 59.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.277 1.431 . . . . 0.0 114.516 -178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.02 -41.36 2.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.712 1.205 . . . . 0.0 109.097 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -166.93 151.61 7.3 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.002 0.819 . . . . 0.0 110.258 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -156.48 175.63 13.77 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.113 0.965 . . . . 0.0 109.565 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -112.13 137.0 50.81 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.889 1.276 . . . . 0.0 110.093 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.04 131.63 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.135 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 218' ' ' PHE . 19.6 tt0 -71.0 106.22 3.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 40.4 mm -122.4 125.16 72.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.1 m120 56.35 36.71 27.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 13.7 t0 70.87 -4.94 1.59 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.539 1.936 . . . . 0.0 112.095 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.6 127.31 52.96 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 118.931 -2.356 . . . . 0.0 110.73 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' PHE . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 213' ' ' GLU . 14.8 m-85 -74.43 116.52 15.21 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.583 -1.323 . . . . 0.0 109.979 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -107.11 147.81 29.57 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.766 0.826 . . . . 0.0 109.809 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.4 tm? -83.85 128.03 34.25 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.49 1.516 . . . . 0.0 109.296 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -111.54 151.72 28.36 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.085 0.954 . . . . 0.0 109.167 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.2 p -133.2 147.9 52.02 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.75 1.22 . . . . 0.0 111.088 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -59.94 128.86 38.96 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.717 -0.615 . . . . 0.0 112.042 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.5 t -135.14 133.59 53.12 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 C-N-CA 125.596 1.558 . . . . 0.0 109.722 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -105.36 60.35 0.4 Allowed Glycine 0 CA--C 1.519 0.333 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 124.996 1.319 . . . . 0.0 107.634 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.505 -0.76 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.28 149.86 41.82 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.273 2.229 . . . . 0.0 107.307 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -71.49 132.16 44.34 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 127.719 2.407 . . . . 0.0 106.569 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 93.4 t -133.91 125.54 49.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.514 ' HA ' HD13 ' A' ' 131' ' ' ILE . 3.4 mp -69.4 134.71 29.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -57.4 118.28 4.98 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.73 -18.02 63.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.549 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -94.38 -28.05 15.73 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.076 0.951 . . . . 0.0 111.491 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -138.96 106.73 5.63 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.743 1.217 . . . . 0.0 109.66 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.444 ' HB3' ' CD2' ' A' ' 163' ' ' PHE . 22.7 t -58.74 -24.93 62.43 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 120.592 -1.318 . . . . 0.0 112.687 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -82.53 -1.67 51.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.441 1.096 . . . . 0.0 111.106 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -116.13 159.29 21.95 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.447 0.642 . . . . 0.0 111.934 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 123' ' ' ILE . 30.4 mm -127.54 144.77 36.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -121.4 106.1 11.13 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 128.115 2.566 . . . . 0.0 105.126 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.421 ' HB3' ' CE2' ' A' ' 138' ' ' TYR . 20.9 t80 -138.9 130.92 27.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.7 mtt 60.45 22.54 12.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.259 1.424 . . . . 0.0 112.243 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.61 16.16 79.69 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -109.42 162.58 14.22 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.1 mm -123.3 132.08 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 133' ' ' TYR . 3.2 m-85 -120.33 159.13 25.65 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.7 t -145.65 155.49 43.04 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 mt -111.83 115.98 51.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 123.872 0.869 . . . . 0.0 111.643 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.5 t -87.15 -116.67 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -158.32 99.15 1.61 Allowed 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 55.4 m -137.04 129.6 30.12 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 131.151 3.78 . . . . 0.0 108.188 177.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.0 126.09 31.56 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.64 1.976 . . . . 0.0 107.511 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.2 t -94.77 111.85 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 120.621 1.555 . . . . 0.0 107.425 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.1 m -75.31 156.71 35.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.023 0.916 . . . . 0.0 109.801 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -55.85 -30.87 62.16 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 127.997 2.519 . . . . 0.0 112.885 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -72.86 -26.8 61.59 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.981 0.913 . . . . 0.0 111.455 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -97.84 -19.88 17.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.33 1.052 . . . . 0.0 110.097 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 mt -69.52 123.51 21.49 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.209 1.804 . . . . 0.0 109.504 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.16 -117.92 0.51 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 125.27 1.414 . . . . 0.0 110.96 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -130.13 165.14 22.92 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.535 1.134 . . . . 0.0 111.617 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -60.83 120.54 10.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.634 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -102.83 -52.71 3.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 118.003 -0.998 . . . . 0.0 111.119 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -153.44 166.01 34.04 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.487 0.585 . . . . 0.0 112.037 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.33 138.8 50.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 124.435 1.094 . . . . 0.0 109.324 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.553 HD21 HD12 ' A' ' 198' ' ' ILE . 3.3 mm? -104.74 165.5 11.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.501 2.32 . . . . 0.0 109.598 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -171.07 65.97 0.04 OUTLIER 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.398 0.679 . . . . 0.0 111.881 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.52 166.51 30.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.3 t -145.11 149.73 16.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -146.99 164.83 31.7 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.1 122.18 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.444 ' CD2' ' HB3' ' A' ' 128' ' ' SER . 37.2 p90 -140.0 177.3 8.07 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.376 1.444 . . . . 0.0 113.347 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -84.14 128.93 34.88 Favored 'General case' 0 C--N 1.347 0.488 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.3 t -66.05 -16.64 64.1 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.312 1.415 . . . . 0.0 113.372 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.63 -55.27 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 118.676 0.671 . . . . 0.0 112.468 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.3 m -121.73 -22.19 5.89 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.891 1.276 . . . . 0.0 113.004 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.46 15.3 25.55 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-O 118.455 -1.191 . . . . 0.0 115.714 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.584 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.3 OUTLIER -59.44 116.83 4.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.399 1.599 . . . . 0.0 109.981 179.523 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.08 153.45 41.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.735 1.152 . . . . 0.0 109.424 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.31 142.06 24.82 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.39 147.18 46.37 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.796 2.331 . . . . 0.0 109.959 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -56.54 -30.06 62.65 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.793 -0.567 . . . . 0.0 112.438 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.7 m -66.43 -7.09 17.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.621 1.169 . . . . 0.0 113.19 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -120.34 -4.84 9.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.123 1.769 . . . . 0.0 111.338 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -58.37 -35.05 71.38 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.23 -0.919 . . . . 0.0 113.332 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -133.94 13.52 4.71 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.805 1.193 . . . . 0.0 111.322 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.67 91.11 2.8 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.586 ' CD1' ' H ' ' A' ' 187' ' ' LYS . 15.7 mt -123.5 -92.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -114.61 -168.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.646 1.978 . . . . 0.0 106.493 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -62.87 173.23 1.4 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.241 1.417 . . . . 0.0 107.771 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.41 11.48 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.4 2.28 . . . . 0.0 116.132 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -74.79 -164.13 11.53 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 127.161 2.315 . . . . 0.0 112.12 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.7 m -78.52 -9.07 59.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.523 1.529 . . . . 0.0 114.82 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -89.06 70.62 8.46 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 75.1 m -157.29 149.82 23.07 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 120.927 -1.108 . . . . 0.0 109.411 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.586 ' H ' ' CD1' ' A' ' 179' ' ' ILE . 20.7 pttm 42.66 31.6 0.31 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.818 2.447 . . . . 0.0 112.957 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -91.22 130.3 37.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 75.7 33.16 0.65 Allowed 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 126.786 2.034 . . . . 0.0 111.285 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -130.85 149.47 52.47 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.649 0.738 . . . . 0.0 110.157 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.0 m -131.17 131.01 43.75 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -112.56 113.22 25.26 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -114.85 121.41 43.15 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.659 1.584 . . . . 0.0 108.761 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -89.3 131.76 35.24 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 128.905 2.882 . . . . 0.0 106.649 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -80.25 103.17 9.94 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.09 158.55 26.95 Favored Glycine 0 CA--C 1.53 1.03 1 C-N-CA 134.588 5.851 . . . . 0.0 107.056 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.72 160.08 31.01 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.147 1.474 . . . . 0.0 112.301 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.553 HD12 HD21 ' A' ' 157' ' ' LEU . 61.4 mt -109.06 139.02 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 126.12 1.768 . . . . 0.0 111.159 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -130.51 151.13 51.33 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.528 1.531 . . . . 0.0 109.446 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 13.6 p -75.9 174.17 10.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.159 0.584 . . . . 0.0 110.729 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 60.9 mt -132.61 139.43 49.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.135 1.374 . . . . 0.0 108.473 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -55.32 122.88 12.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.532 1.533 . . . . 0.0 109.832 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 66.34 13.27 60.08 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.343 -1.254 . . . . 0.0 115.498 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -131.05 124.37 30.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 120.05 1.925 . . . . 0.0 108.867 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 69.6 m -80.5 151.81 29.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.405 HD13 ' CG ' ' A' ' 210' ' ' PHE . 0.8 OUTLIER -55.39 -26.35 40.97 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.846 1.258 . . . . 0.0 109.472 178.691 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.2 p -70.38 -17.1 63.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.917 2.087 . . . . 0.0 113.377 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -120.54 -43.5 2.49 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.78 1.232 . . . . 0.0 112.009 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.5 146.0 6.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.051 0.94 . . . . 0.0 109.539 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.405 ' CG ' HD13 ' A' ' 206' ' ' LEU . 34.7 p90 -158.26 176.66 12.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.73 1.212 . . . . 0.0 108.805 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.23 132.57 53.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.467 1.507 . . . . 0.0 110.955 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.6 p -129.63 125.96 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 C-N-CA 124.312 1.045 . . . . 0.0 110.62 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -72.53 112.87 8.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 30.0 mm -122.59 119.83 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 55.14 33.61 20.84 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.274 0.943 . . . . 0.0 111.952 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.6 t70 80.33 -9.18 1.42 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.844 2.857 . . . . 0.0 111.977 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.91 122.64 43.14 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.843 -1.16 . . . . 0.0 108.836 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -73.81 112.53 10.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -104.01 145.94 29.43 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.102 0.961 . . . . 0.0 111.434 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.3 tm? -81.66 126.82 32.23 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -116.28 146.39 42.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.9 p -127.58 158.42 37.52 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.415 0.686 . . . . 0.0 111.19 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -64.92 122.11 16.2 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.56 101.29 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.671 1.224 . . . . 0.0 108.271 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -114.82 15.39 19.22 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.66 1.6 . . . . 0.0 112.454 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.6 m120 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 127.671 2.388 . . . . 0.0 107.598 -179.605 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.285 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -70.07 128.4 36.18 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.3 t -132.07 135.36 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -80.93 140.13 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -55.71 127.86 32.05 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.306 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -55.83 -26.94 49.03 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.784 -1.198 . . . . 0.0 111.054 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -101.76 -8.31 21.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.946 1.299 . . . . 0.0 113.634 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.06 107.22 3.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.6 m -64.94 -14.14 59.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.253 1.821 . . . . 0.0 111.846 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -99.6 0.58 42.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.016 1.726 . . . . 0.0 112.029 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -117.69 158.44 24.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.068 0.461 . . . . 0.0 110.33 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.5 mm -126.29 132.61 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.12 99.14 8.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 102.069 -3.308 . . . . 0.0 102.069 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -135.71 127.07 28.45 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.347 -1.471 . . . . 0.0 107.607 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 12.9 mtt 60.44 30.16 19.57 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.558 1.143 . . . . 0.0 109.769 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.12 -0.34 31.5 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 123.808 0.718 . . . . 0.0 111.75 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -90.62 164.37 14.21 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.5 mm -123.99 123.63 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.657 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.66 131.11 53.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.294 1.038 . . . . 0.0 109.039 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.1 t -113.1 151.24 31.03 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.785 1.234 . . . . 0.0 108.374 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.2 mt -110.76 118.59 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.074 0.95 . . . . 0.0 108.744 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.3 t -89.04 -107.75 0.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -160.23 99.48 1.33 Allowed 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 85.5 m -138.33 114.44 10.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 115.865 -2.017 . . . . 0.0 107.128 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.5 m -75.62 125.59 29.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 122.448 2.386 . . . . 0.0 106.617 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.6 t -99.63 111.83 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.868 1.267 . . . . 0.0 108.152 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.9 m -75.77 161.18 29.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.75 0.82 . . . . 0.0 109.733 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.7 -30.48 68.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.42 1.088 . . . . 0.0 112.043 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.87 -24.24 64.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.31 -0.244 . . . . 0.0 110.891 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -96.44 -27.1 15.06 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.324 0.649 . . . . 0.0 109.515 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.6 tp -68.11 148.7 50.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.193 1.397 . . . . 0.0 109.286 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.74 -101.99 2.65 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.62 1.105 . . . . 0.0 111.158 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -135.07 171.19 14.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.313 1.845 . . . . 0.0 111.221 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -64.12 136.82 57.59 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.421 1.088 . . . . 0.0 110.189 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -117.19 -52.63 2.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.152 0.981 . . . . 0.0 113.168 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -157.59 158.4 35.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.098 0.863 . . . . 0.0 111.695 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.05 137.99 45.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 119.241 0.928 . . . . 0.0 111.165 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.57 165.19 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.487 1.915 . . . . 0.0 111.09 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.58 65.81 0.07 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.156 0.982 . . . . 0.0 111.192 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -157.98 167.76 29.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 t -144.18 148.39 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -142.05 166.61 24.24 Favored 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 120.872 -1.143 . . . . 0.0 108.558 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.09 129.72 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.63 168.86 18.75 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.179 0.9 . . . . 0.0 111.203 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -101.65 102.14 12.77 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.3 t -50.77 -19.19 0.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 129.361 3.064 . . . . 0.0 115.965 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.7 m -55.99 -46.95 80.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.3 m -123.98 -23.24 4.66 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.144 1.777 . . . . 0.0 114.276 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 103.7 7.87 41.14 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.289 1.899 . . . . 0.0 112.864 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 113.2 1.54 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.675 1.737 . . . . 0.0 112.942 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 p -63.2 140.56 58.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.154 0.982 . . . . 0.0 108.567 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.89 147.34 34.31 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.48 159.72 19.61 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.479 2.786 . . . . 0.0 110.089 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -64.44 -17.61 63.97 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 121.377 -0.827 . . . . 0.0 111.708 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.6 p -74.53 -11.14 60.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.367 -0.833 . . . . 0.0 111.711 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -111.1 -3.89 15.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.32 1.448 . . . . 0.0 112.251 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.6 m0 . . . . . 0 N--CA 1.465 0.303 0 C-N-CA 125.375 1.47 . . . . 0.0 114.397 -179.702 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 99.8 m -139.96 130.43 25.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -113.54 105.31 13.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.407 1.883 . . . . 0.0 107.547 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -110.3 127.89 55.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.941 0.896 . . . . 0.0 109.736 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -96.75 126.98 42.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.478 1.911 . . . . 0.0 107.399 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -75.66 100.96 4.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.896 1.331 . . . . 0.0 111.522 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -95.4 159.28 22.47 Favored Glycine 0 N--CA 1.431 -1.649 1 C-N-CA 130.727 4.013 . . . . 0.0 108.335 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.78 152.46 45.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 124.16 1.933 . . . . 0.0 111.029 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 67.7 mt -96.68 141.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.868 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -135.38 151.7 50.73 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.549 1.54 . . . . 0.0 109.233 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.9 p -77.48 173.27 12.17 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.246 1.018 . . . . 0.0 110.798 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 60.1 mt -126.34 137.52 57.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -67.49 124.21 22.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.48 1.512 . . . . 0.0 108.883 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.84 12.24 84.38 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 117.922 -1.488 . . . . 0.0 114.666 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -141.4 142.7 33.71 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.743 1.772 . . . . 0.0 111.255 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 24.5 m -90.02 151.24 21.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.837 0.827 . . . . 0.0 109.114 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -31.83 67.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.088 0.955 . . . . 0.0 111.183 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.4 p -68.69 -10.03 53.82 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 129.352 3.061 . . . . 0.0 114.624 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -120.51 -46.79 2.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.836 1.254 . . . . 0.0 107.764 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.16 147.91 5.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.593 0.711 . . . . 0.0 110.571 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -152.83 176.16 12.11 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.167 0.587 . . . . 0.0 110.098 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.64 137.63 47.18 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.457 HG13 HG12 ' A' ' 214' ' ' ILE . 8.9 p -130.02 130.23 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 125.26 1.424 . . . . 0.0 110.879 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.54 107.68 4.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.457 HG12 HG13 ' A' ' 212' ' ' VAL . 33.0 mm -120.74 120.7 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 52.98 45.53 28.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.421 0.688 . . . . 0.0 109.901 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 64.27 13.3 7.85 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.537 1.535 . . . . 0.0 112.623 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.414 ' HB3' ' HE2' ' A' ' 219' ' ' LYS . 0.4 OUTLIER -125.18 122.15 36.22 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.165 -0.959 . . . . 0.0 108.687 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -69.42 115.93 9.25 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 120.512 -1.368 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 217' ' ' ASP . 66.3 mmtt -111.02 145.81 37.81 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.467 1.507 . . . . 0.0 113.09 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -80.64 128.8 34.03 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.929 1.291 . . . . 0.0 111.547 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -115.29 141.62 47.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.05 143.35 50.84 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.508 0.723 . . . . 0.0 110.535 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -55.41 138.53 45.78 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 CA--C 1.536 0.416 0 C-N-CA 126.84 2.056 . . . . 0.0 105.761 176.469 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.632 ' CD2' HD13 ' A' ' 198' ' ' ILE . 88.9 m-85 -59.17 146.43 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 98.5 t -150.29 120.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.164 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.741 HG21 ' OH ' ' A' ' 195' ' ' TYR . 4.8 mp -68.13 118.17 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.135 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.34 123.62 13.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -20.36 66.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -90.47 -33.11 16.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.04 104.67 6.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -67.18 -13.59 62.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.722 ' O ' HD12 ' A' ' 140' ' ' ILE . 47.6 ptt85 -94.89 -7.13 40.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.854 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -101.71 159.93 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.6 mm -128.02 131.52 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.139 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -107.7 103.65 12.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -135.79 129.77 33.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.2 mtt 59.69 39.73 20.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 63.4 20.46 63.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.443 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -113.43 172.81 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 36.3 mm -131.36 129.01 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -125.42 152.31 45.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 t -121.18 152.04 39.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 129' ' ' ARG . 2.7 mt -123.26 111.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.122 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -92.74 -90.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -169.86 93.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 26.4 m -140.64 104.63 4.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 m -62.94 113.18 2.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.83 119.48 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.4 m -84.74 171.41 12.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.77 -26.31 64.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.09 -25.1 68.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -104.66 -26.12 12.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.61 137.75 58.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.38 -105.78 2.65 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.516 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -134.24 169.92 16.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.93 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -56.23 142.09 38.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -125.43 -51.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.953 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -147.37 159.87 43.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 5.3 p -119.56 129.93 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.478 HD11 HD11 ' A' ' 123' ' ' ILE . 3.3 mm? -110.9 166.01 11.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.67 70.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -166.41 175.34 8.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.3 t -144.87 149.45 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.103 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.74 155.54 42.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -124.59 123.32 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.114 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -144.85 155.44 43.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.588 ' CG ' HG22 ' A' ' 166' ' ' VAL . 4.6 t0 -74.34 124.49 26.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.12 -4.35 32.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.588 HG22 ' CG ' ' A' ' 164' ' ' ASP . 27.5 m -77.93 -44.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.16 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.478 ' N ' HG23 ' A' ' 166' ' ' VAL . 6.7 t -123.36 -30.12 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.09 33.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.434 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -69.9 127.93 34.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.844 0.354 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.83 155.11 37.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.47 139.83 35.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.584 0.707 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 154.98 67.1 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.645 2.23 . . . . 0.0 112.366 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -58.98 -21.71 59.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 m -73.86 -7.66 53.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.09 -12.46 14.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 31.8 m0 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.42 HG22 ' CD1' ' A' ' 193' ' ' TRP . 98.9 m -137.77 120.41 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.69 105.52 17.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . 0.42 ' CD1' HG22 ' A' ' 191' ' ' THR . 13.5 m0 -110.35 116.78 32.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.96 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -84.55 126.55 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.741 ' OH ' HG21 ' A' ' 123' ' ' ILE . 13.4 m-30 -65.21 103.83 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 213' ' ' GLU . . . -101.28 162.84 17.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.484 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.28 139.35 58.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.798 0.333 . . . . 0.0 110.861 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.632 HD13 ' CD2' ' A' ' 121' ' ' PHE . 10.1 mt -91.21 143.39 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -131.68 143.14 50.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.78 172.26 3.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 71.1 mt -130.8 141.83 45.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -69.3 122.16 18.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 76.02 27.12 62.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -149.34 146.28 27.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.326 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -106.0 145.11 31.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.855 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.491 HD13 ' HB3' ' A' ' 210' ' ' PHE . 0.9 OUTLIER -63.24 -17.15 62.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 67.4 p -82.59 -9.41 59.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.65 -51.56 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.09 146.32 24.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.069 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.638 ' O ' HD22 ' A' ' 220' ' ' LEU . 39.4 p90 -154.44 176.44 12.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -110.4 125.36 53.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.084 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.54 HG11 HG12 ' A' ' 140' ' ' ILE . 6.0 p -117.68 125.39 74.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.142 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.429 ' HB3' ' HA3' ' A' ' 196' ' ' GLY . 18.9 tt0 -70.43 101.55 1.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 48.4 mm -120.39 120.25 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 60.53 43.94 12.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.37 14.88 9.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -137.49 122.11 18.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.52 125.06 26.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -116.62 140.69 49.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.638 HD22 ' O ' ' A' ' 210' ' ' PHE . 3.3 tm? -76.37 121.76 23.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.54 139.29 40.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.21 138.33 50.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -64.97 122.12 16.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 94.4 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 179.915 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.063 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -73.9 134.5 43.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 84.2 t -135.2 124.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.9 mp -73.12 140.23 18.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -66.19 127.12 30.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -65.55 -27.05 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.462 -0.774 . . . . 0.0 111.705 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -80.67 -45.5 17.1 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.721 1.209 . . . . 0.0 110.057 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.08 100.59 6.8 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.4 t -62.67 -7.66 5.23 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.872 -1.142 . . . . 0.0 110.95 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -94.3 -4.87 47.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.867 2.067 . . . . 0.0 110.257 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -110.84 158.81 18.28 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.6 mm -125.34 138.41 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.92 103.48 11.71 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 102.923 -2.992 . . . . 0.0 102.923 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -137.69 132.37 32.78 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.1 mtt 57.97 25.35 12.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.995 0.918 . . . . 0.0 111.077 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.42 -0.6 68.58 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.429 -0.795 . . . . 0.0 112.412 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -93.69 166.26 12.3 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.552 1.541 . . . . 0.0 108.006 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.7 mm -123.18 137.18 57.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -131.08 156.77 44.64 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.814 1.246 . . . . 0.0 108.454 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.474 ' HB2' HG11 ' A' ' 224' ' ' VAL . 14.2 t -140.37 155.67 46.68 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 107.986 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.7 mt -114.37 117.8 56.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.284 1.433 . . . . 0.0 110.795 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.6 t -86.63 -111.01 0.05 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -162.46 101.26 1.06 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 103.563 -2.755 . . . . 0.0 103.563 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 49.2 m -134.88 111.82 10.18 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.1 m -70.93 120.54 16.65 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.37 122.41 45.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.5 m -82.2 154.44 25.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.81 -26.9 67.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.54 1.136 . . . . 0.0 112.036 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.72 -19.07 62.78 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.415 -0.803 . . . . 0.0 110.471 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -106.19 -16.22 14.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.46 1.904 . . . . 0.0 110.086 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.8 tp -80.19 118.42 21.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 128.105 2.562 . . . . 0.0 107.103 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.45 -103.78 0.11 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 123.687 0.661 . . . . 0.0 111.486 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.68 170.01 16.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.559 1.144 . . . . 0.0 110.069 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -61.89 142.92 57.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.572 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -125.64 -48.95 1.65 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.559 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.77 160.74 43.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.093 1.315 . . . . 0.0 110.714 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.83 135.19 60.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.835 1.254 . . . . 0.0 111.561 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.8 164.87 12.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.805 2.042 . . . . 0.0 111.522 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.15 54.89 0.06 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.953 0.901 . . . . 0.0 112.124 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.44 172.33 15.13 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.338 -1.476 . . . . 0.0 107.517 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.38 147.53 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -145.18 166.24 26.02 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 120.576 -1.327 . . . . 0.0 108.521 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.1 t -129.24 133.31 65.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -147.97 160.59 42.66 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.48 0.582 . . . . 0.0 111.71 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.34 106.29 7.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.5 t -61.07 -20.25 62.37 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.23 -33.33 19.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 120.823 -1.173 . . . . 0.0 113.978 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.0 t -122.03 -25.45 4.94 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.061 0.945 . . . . 0.0 112.241 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.83 -0.14 56.42 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.064 1.792 . . . . 0.0 112.073 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -52.98 112.23 0.81 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.147 1.474 . . . . 0.0 110.421 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.4 m -70.99 157.67 37.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 119.294 0.952 . . . . 0.0 111.627 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.0 129.28 25.48 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.901 2.08 . . . . 0.0 106.375 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.44 157.73 48.93 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.322 2.681 . . . . 0.0 109.196 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -52.31 -32.27 37.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.892 0.877 . . . . 0.0 112.673 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.4 m -64.74 -12.97 52.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.09 -6.82 15.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.842 2.057 . . . . 0.0 111.747 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.5 m0 . . . . . 0 C--O 1.233 0.229 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.141 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.1 m -154.12 150.81 28.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -127.63 104.76 8.04 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -114.15 117.03 30.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.816 1.246 . . . . 0.0 110.557 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.27 129.38 34.58 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.975 2.11 . . . . 0.0 108.833 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.425 ' CE2' HD13 ' A' ' 123' ' ' ILE . 6.0 m-30 -76.34 100.83 5.27 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.244 0.617 . . . . 0.0 109.776 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.43 158.87 23.04 Favored Glycine 0 CA--C 1.531 1.054 1 C-N-CA 133.483 5.325 . . . . 0.0 107.228 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.85 154.18 42.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 123.87 1.795 . . . . 0.0 111.603 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 58.2 mt -100.83 139.11 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.013 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -131.9 149.54 52.41 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.458 1.503 . . . . 0.0 109.585 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.2 t -78.65 173.65 12.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.241 1.016 . . . . 0.0 109.611 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 75.7 mt -131.49 143.9 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.674 1.189 . . . . 0.0 110.626 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -65.63 131.27 45.94 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.651 1.18 . . . . 0.0 108.877 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 62.92 22.38 64.52 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.152 -1.36 . . . . 0.0 115.22 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -140.23 148.08 40.98 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.122 1.461 . . . . 0.0 107.819 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.1 m -105.87 146.62 29.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.01 -31.31 60.94 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.078 1.351 . . . . 0.0 110.544 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.4 p -70.54 -12.65 61.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.607 1.963 . . . . 0.0 114.729 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -125.06 -39.37 2.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.863 1.665 . . . . 0.0 112.205 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.33 139.74 5.92 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.159 0.983 . . . . 0.0 110.797 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -150.19 174.31 12.94 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.958 0.903 . . . . 0.0 109.534 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.56 138.67 47.8 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.133 0.573 . . . . 0.0 111.864 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.6 p -132.65 131.07 59.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.895 1.278 . . . . 0.0 110.747 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.79 106.23 7.26 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 39.7 mm -122.06 129.81 75.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.653 1.181 . . . . 0.0 110.759 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 53.94 37.75 27.34 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.382 -0.824 . . . . 0.0 112.123 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 74.77 5.51 4.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.246 1.818 . . . . 0.0 111.311 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -130.8 134.9 47.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.74 1.155 . . . . 0.0 112.351 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -70.86 130.24 41.14 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 121.056 -1.027 . . . . 0.0 110.447 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -125.66 148.49 48.99 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.997 1.319 . . . . 0.0 109.617 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.53 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -84.06 126.69 33.31 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.106 1.362 . . . . 0.0 112.065 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -109.78 143.25 39.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 1.1 p -125.67 148.23 49.08 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.47 1.508 . . . . 0.0 111.616 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -55.56 139.98 42.31 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 139' ' ' SER . 7.7 p . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -77.78 121.45 24.07 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 124.822 1.249 . . . . 0.0 108.136 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.2 t -125.86 128.44 72.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 125.58 1.552 . . . . 0.0 109.095 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -72.87 140.03 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -61.63 129.94 43.5 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.247 -0.908 . . . . 0.0 111.098 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -67.33 -11.49 57.75 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.337 -0.852 . . . . 0.0 111.687 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -106.23 -14.54 15.1 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.789 1.236 . . . . 0.0 112.962 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.82 115.21 5.12 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.97 0.805 . . . . 0.0 109.496 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.476 ' HB2' ' CD1' ' A' ' 163' ' ' PHE . 73.6 m -63.81 -17.57 63.24 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.95 -1.093 . . . . 0.0 111.784 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -94.56 -1.7 52.87 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.97 1.708 . . . . 0.0 112.012 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -105.97 156.34 18.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.431 1.014 . . . . 0.0 111.628 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.2 mm -128.03 136.39 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -116.07 107.32 14.78 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.497 2.319 . . . . 0.0 105.657 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -145.07 133.97 22.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.9 mtt 58.22 33.22 22.95 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.396 1.478 . . . . 0.0 111.061 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.1 22.62 70.82 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -116.78 163.84 15.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 28.6 mm -121.6 128.96 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.972 0.909 . . . . 0.0 109.294 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -125.46 157.8 36.02 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.46 ' HB2' HG11 ' A' ' 224' ' ' VAL . 46.9 t -141.96 157.98 44.31 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.828 1.251 . . . . 0.0 108.861 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.3 mt -110.54 130.49 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.23 1.012 . . . . 0.0 109.698 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -106.76 -116.51 0.26 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 102.591 -3.115 . . . . 0.0 102.591 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -157.41 100.06 1.79 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 93.6 m -136.39 109.35 7.65 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.118 1.767 . . . . 0.0 107.004 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.7 m -68.97 125.68 27.41 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.8 t -93.78 113.0 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 120.63 1.559 . . . . 0.0 108.496 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 m -68.56 155.13 40.56 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.704 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.54 -25.41 68.03 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.644 1.178 . . . . 0.0 110.981 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.32 -25.78 63.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.845 0.858 . . . . 0.0 109.848 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -94.57 -33.85 12.87 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.569 1.148 . . . . 0.0 110.151 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.19 121.18 7.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.766 1.626 . . . . 0.0 108.37 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -88.47 -110.52 1.1 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.1 170.15 16.34 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.666 1.186 . . . . 0.0 112.153 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -55.94 128.64 36.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.528 1.531 . . . . 0.0 111.333 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -118.39 -38.39 3.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.661 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.22 161.74 14.63 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 121.256 1.844 . . . . 0.0 111.377 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.03 139.83 47.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 120.066 1.303 . . . . 0.0 110.837 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.43 164.71 12.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.646 1.978 . . . . 0.0 109.145 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -162.11 33.17 0.12 Allowed 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.42 174.02 11.07 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 120.309 -1.494 . . . . 0.0 109.031 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.7 t -139.98 147.85 23.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -144.5 162.46 36.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 87.6 t -127.52 136.46 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 128' ' ' SER . 49.8 p90 -146.63 166.54 26.24 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.29 0.636 . . . . 0.0 111.316 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.85 101.3 13.39 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.1 t -47.75 -22.54 0.55 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 130.179 3.392 . . . . 0.0 116.863 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -57.86 -51.61 68.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 125.65 1.58 . . . . 0.0 109.947 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.443 ' HB2' ' HD3' ' A' ' 169' ' ' LYS 0.257 24.6 m -121.58 -27.54 4.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.471 1.508 . . . . 0.0 112.843 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 111.94 6.98 24.04 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.125 1.345 . . . . 0.0 114.248 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.504 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -53.5 113.0 1.01 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.582 2.191 . . . . 0.0 111.704 -178.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.4 m -69.0 152.74 44.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 119.428 1.013 . . . . 0.0 108.971 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.79 140.92 28.28 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.854 1.662 . . . . 0.0 108.792 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.5 160.36 38.57 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.127 2.551 . . . . 0.0 109.686 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -60.93 -30.36 70.17 Favored 'General case' 0 CA--C 1.519 -0.24 0 O-C-N 121.438 -0.789 . . . . 0.0 110.869 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 p -64.53 -7.06 8.83 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.892 -1.052 . . . . 0.0 113.407 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.87 -8.64 13.7 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.344 1.429 . . . . 0.0 111.08 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.5 m0 . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 -178.175 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 . . . . . 0 N--CA 1.46 0.071 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 95.6 m -144.99 138.12 26.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 126.922 2.089 . . . . 0.0 107.302 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -112.76 110.17 20.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.797 1.639 . . . . 0.0 108.19 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -111.73 118.77 36.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.6 1.16 . . . . 0.0 111.067 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.56 127.08 36.14 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -76.47 101.02 5.43 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.382 1.473 . . . . 0.0 111.421 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.1 159.71 23.67 Favored Glycine 0 N--CA 1.435 -1.378 1 C-N-CA 132.646 4.927 . . . . 0.0 107.546 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.89 154.6 41.22 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 122.972 1.368 . . . . 0.0 112.767 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 54.8 mt -102.74 121.62 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 125.628 1.571 . . . . 0.0 111.874 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -111.31 154.25 24.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.294 1.045 . . . . 0.0 110.309 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.9 t -73.77 172.86 10.73 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.925 1.29 . . . . 0.0 108.163 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.454 ' CD1' HD23 ' A' ' 220' ' ' LEU . 77.7 mt -135.19 132.78 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -59.17 119.85 8.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.209 1.404 . . . . 0.0 108.229 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.13 12.44 84.03 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.261 -1.3 . . . . 0.0 115.308 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -134.56 133.43 40.25 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.863 1.831 . . . . 0.0 109.881 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.8 m -83.59 146.89 28.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -25.21 61.51 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.574 1.15 . . . . 0.0 111.101 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.5 p -75.64 -14.4 60.36 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.825 2.05 . . . . 0.0 113.642 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -119.74 -43.0 2.59 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.986 0.914 . . . . 0.0 111.367 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.62 139.88 8.02 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 118.799 0.727 . . . . 0.0 109.143 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -152.33 176.64 11.41 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.507 1.123 . . . . 0.0 109.515 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.56 131.82 54.71 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.614 1.166 . . . . 0.0 111.845 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.1 129.74 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 C-N-CA 123.958 0.903 . . . . 0.0 109.432 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -74.33 104.76 5.21 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 36.5 mm -121.64 127.2 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 O-C-N 120.49 -1.381 . . . . 0.0 107.511 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 53.28 43.62 31.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.206 0.457 . . . . 0.0 110.304 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.6 t0 61.11 19.13 9.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.362 0.665 . . . . 0.0 112.167 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.09 122.53 24.24 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.753 -1.217 . . . . 0.0 109.188 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.42 115.96 12.3 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.981 -1.074 . . . . 0.0 112.77 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -106.15 152.38 23.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.102 0.961 . . . . 0.0 111.99 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.8 tm? -88.37 119.44 28.8 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.191 1.396 . . . . 0.0 107.939 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.6 148.58 27.16 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.8 p -127.42 151.16 49.17 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.778 0.674 . . . . 0.0 112.26 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -57.58 141.44 48.0 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.46 HG11 ' HB2' ' A' ' 139' ' ' SER . 6.5 p . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -69.76 136.69 51.22 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.106 0.963 . . . . 0.0 108.602 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.6 t -134.98 124.59 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.1 mp -76.44 134.22 29.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.54 134.95 51.1 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.832 1.301 . . . . 0.0 110.544 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.44 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -68.27 -18.56 64.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.486 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -104.09 -36.5 7.69 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.23 0.468 . . . . 0.0 111.354 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.84 105.14 11.64 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 122.202 1.001 . . . . 0.0 109.985 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.7 t -61.73 -11.48 12.27 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.112 1.365 . . . . 0.0 111.825 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -100.02 -8.98 23.19 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.787 1.635 . . . . 0.0 111.873 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -102.16 154.73 18.74 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 119.418 1.008 . . . . 0.0 111.276 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.5 mm -126.58 127.46 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.11 105.31 15.44 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -141.37 136.04 31.05 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.773 -1.204 . . . . 0.0 107.813 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.2 mtt 54.44 21.21 3.14 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.59 0.29 89.27 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.561 1.077 . . . . 0.0 112.336 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -90.13 172.58 8.71 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.282 1.433 . . . . 0.0 108.021 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.8 mm -133.66 124.76 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -119.17 154.21 33.69 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.1 t -138.36 159.45 42.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.2 mt -115.7 134.75 57.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.798 0.808 . . . . 0.0 111.234 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.3 t -104.76 -130.56 0.28 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 101.713 -3.44 . . . . 0.0 101.713 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -154.35 98.81 2.15 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 121.918 2.144 . . . . 0.0 106.672 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 20.6 m -135.76 121.09 19.14 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 128.244 2.618 . . . . 0.0 106.521 177.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.7 m -72.07 123.34 22.62 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 76.1 t -93.88 111.84 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.6 m -77.17 159.77 29.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.438 0.637 . . . . 0.0 109.694 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -64.6 -17.76 64.28 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 111.669 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -77.0 -11.71 59.84 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.755 0.822 . . . . 0.0 109.473 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -115.21 -28.4 6.94 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.381 1.072 . . . . 0.0 109.38 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.95 132.67 50.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.126 2.17 . . . . 0.0 107.148 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -101.39 -98.31 2.34 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.309 0.957 . . . . 0.0 114.289 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -134.68 159.43 41.28 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.272 1.429 . . . . 0.0 111.906 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.0 133.27 55.37 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.832 1.653 . . . . 0.0 109.658 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.79 -43.22 2.9 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 116.538 -1.696 . . . . 0.0 111.69 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -165.5 158.25 15.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 121.144 1.793 . . . . 0.0 110.462 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.22 137.37 44.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.478 HD22 ' O ' ' A' ' 196' ' ' GLY . 5.3 mp -110.17 163.35 13.69 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.951 1.7 . . . . 0.0 110.752 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.0 38.98 0.15 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.5 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 1.9 tt0 -139.78 175.34 9.66 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 120.023 -1.673 . . . . 0.0 110.759 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.2 t -144.88 150.51 16.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -147.09 164.0 34.48 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.848 0.832 . . . . 0.0 109.018 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.0 t -128.78 129.1 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 126.38 1.872 . . . . 0.0 107.412 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -147.89 160.93 42.26 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.07 0.948 . . . . 0.0 112.684 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.51 100.09 12.8 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 102.255 -3.239 . . . . 0.0 102.255 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 12.7 t -47.61 -25.88 1.3 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.154 2.581 . . . . 0.0 116.451 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.3 m -57.68 -45.98 86.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.04 1.736 . . . . 0.0 111.11 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.424 ' HB2' ' HD3' ' A' ' 169' ' ' LYS . 3.2 m -122.73 -21.76 5.53 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.024 1.33 . . . . 0.0 113.09 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.78 10.83 48.76 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.652 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 167' ' ' SER . 0.0 OUTLIER -64.04 112.49 2.99 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.134 1.467 . . . . 0.0 110.669 -178.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 44.2 m -72.38 152.03 42.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.647 0.658 . . . . 0.0 109.488 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.59 147.51 36.9 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.79 159.78 31.21 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.18 2.587 . . . . 0.0 109.902 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 ttt-85 -57.39 -32.34 66.73 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 45.0 m -65.19 -8.28 16.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.241 -1.362 . . . . 0.0 113.308 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.99 -9.14 16.32 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.354 1.434 . . . . 0.0 111.672 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.0 m0 . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 127.121 2.168 . . . . 0.0 115.143 -178.821 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.433 ' HG2' HH11 ' A' ' 190' ' ' ARG . 8.2 mtt-85 . . . . . 0 CA--C 1.51 -0.575 0 CA-C-O 120.968 0.413 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.6 m -130.27 117.4 19.76 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.83 105.89 18.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.599 1.959 . . . . 0.0 106.527 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.9 m0 -110.97 116.26 30.89 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 118.496 0.589 . . . . 0.0 110.45 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -81.94 131.77 35.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.5 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.8 m-30 -78.55 107.51 11.26 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.958 1.703 . . . . 0.0 106.807 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.478 ' O ' HD22 ' A' ' 157' ' ' LEU . . . -107.85 159.41 14.43 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 129.532 3.444 . . . . 0.0 112.64 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -66.89 140.88 57.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 124.652 2.168 . . . . 0.0 111.692 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.0 mt -93.13 140.84 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.673 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -136.25 151.3 49.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 123.194 1.474 . . . . 0.0 109.293 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.1 t -75.39 172.92 11.64 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.997 1.719 . . . . 0.0 107.523 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.3 mt -126.93 137.26 58.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -62.96 131.15 47.72 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.13 22.95 72.89 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.842 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -139.3 155.11 47.95 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.778 1.789 . . . . 0.0 108.094 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 57.8 m -106.08 140.41 39.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.485 HD13 ' CB ' ' A' ' 210' ' ' PHE . 0.4 OUTLIER -57.04 -24.65 55.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.144 0.977 . . . . 0.0 109.123 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.4 p -69.71 -14.63 62.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.263 1.825 . . . . 0.0 112.898 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -120.34 -41.34 2.62 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.248 1.019 . . . . 0.0 110.619 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.34 150.72 9.29 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.922 0.889 . . . . 0.0 110.657 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.485 ' CB ' HD13 ' A' ' 206' ' ' LEU . 48.5 p90 -158.38 176.14 12.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.247 1.019 . . . . 0.0 109.752 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.39 136.66 48.46 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 110.844 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.71 128.15 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 124.061 0.945 . . . . 0.0 109.624 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.65 107.36 3.88 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.3 mm -121.85 126.67 74.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 54.78 43.32 30.25 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.25 -4.83 1.2 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.05 1.74 . . . . 0.0 113.006 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -117.04 122.7 44.94 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.623 -1.298 . . . . 0.0 111.632 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -63.04 115.63 4.61 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.37 -1.456 . . . . 0.0 113.537 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -103.97 150.16 24.48 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 126.435 1.894 . . . . 0.0 111.442 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 3.0 tm? -88.79 122.19 31.93 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.607 1.163 . . . . 0.0 108.593 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -106.66 150.22 26.44 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 1.5 p -129.49 152.11 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.51 1.124 . . . . 0.0 110.307 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -69.67 124.05 22.95 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.454 -0.231 0 C-N-CA 123.999 0.92 . . . . 0.0 108.67 179.571 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 103.971 -2.604 . . . . 0.0 103.971 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -69.21 145.1 53.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.647 0.779 . . . . 0.0 110.225 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.0 t -137.95 128.25 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.457 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.6 mp -82.01 129.45 37.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.57 122.22 11.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.769 1.271 . . . . 0.0 109.592 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -59.03 -24.23 62.66 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.212 -0.93 . . . . 0.0 111.843 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -90.68 -31.59 16.54 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.901 1.28 . . . . 0.0 112.196 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.84 100.21 4.69 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.7 p -65.3 -11.34 40.63 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.407 -0.808 . . . . 0.0 111.511 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -90.01 -3.83 57.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.002 2.121 . . . . 0.0 110.209 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -113.57 158.52 20.68 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.356 0.98 . . . . 0.0 109.001 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.5 mm -129.09 139.59 51.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -118.48 108.36 14.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -142.82 140.45 31.31 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.0 mtt 56.87 22.45 7.09 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.656 0.782 . . . . 0.0 112.834 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.22 18.55 78.18 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -123.78 159.65 29.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.311 1.056 . . . . 0.0 108.218 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.1 mm -110.35 140.44 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -131.79 144.37 50.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 t -124.55 148.71 47.63 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 126.804 2.042 . . . . 0.0 107.351 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.6 mt -113.31 123.56 69.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 124.627 1.171 . . . . 0.0 110.026 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -93.36 -143.61 0.23 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -142.16 98.81 3.39 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 102.685 -3.079 . . . . 0.0 102.685 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.9 m -136.54 109.87 7.87 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 111.642 -2.526 . . . . 0.0 106.241 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 m -69.88 131.91 45.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 120.756 1.617 . . . . 0.0 106.752 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.3 t -94.69 114.18 30.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.776 1.63 . . . . 0.0 106.664 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.9 m -71.02 159.34 34.92 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.907 0.384 . . . . 0.0 110.786 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.72 -26.51 67.23 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.238 1.415 . . . . 0.0 111.294 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.1 -13.66 60.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.522 0.729 . . . . 0.0 111.36 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -105.71 -26.74 11.68 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.315 1.446 . . . . 0.0 108.883 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.7 mt -62.01 142.3 57.57 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.42 -103.42 2.46 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -134.99 166.84 22.11 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.086 1.354 . . . . 0.0 109.443 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -58.79 144.38 44.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.609 0.764 . . . . 0.0 109.942 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.23 -49.36 1.94 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 117.265 -1.35 . . . . 0.0 111.217 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.64 157.83 22.43 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 120.745 1.612 . . . . 0.0 110.828 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.4 p -105.59 138.64 29.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.547 1.165 . . . . 0.0 110.408 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.0 mp -113.41 163.16 15.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.536 2.734 . . . . 0.0 108.407 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -172.25 68.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.861 0.864 . . . . 0.0 109.957 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -160.67 175.83 12.21 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.837 -1.165 . . . . 0.0 109.036 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.3 t -144.76 149.28 17.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.71 154.96 40.35 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.5 t -123.63 130.51 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 124.498 1.119 . . . . 0.0 108.077 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -147.86 160.54 42.66 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.609 1.164 . . . . 0.0 111.579 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -85.49 100.98 12.26 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.6 t -56.26 -11.73 1.31 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.109 1.364 . . . . 0.0 114.613 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.3 m -65.74 -40.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.137 -0.977 . . . . 0.0 110.033 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.0 t -124.26 -28.35 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.723 1.209 . . . . 0.0 113.195 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.54 5.78 36.3 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.738 1.637 . . . . 0.0 111.166 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -57.31 112.32 1.36 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.053 1.741 . . . . 0.0 111.026 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.6 p -64.37 154.25 36.03 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.906 1.683 . . . . 0.0 110.749 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.45 152.14 60.75 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.365 1.066 . . . . 0.0 108.365 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.64 162.56 16.6 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.93 3.086 . . . . 0.0 108.513 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -58.75 -28.89 66.32 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.903 -1.123 . . . . 0.0 111.69 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 95.9 p -68.93 -8.8 47.77 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -104.22 -4.76 22.64 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 120.414 -1.429 . . . . 0.0 109.069 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 34.3 m0 . . . . . 0 CA--C 1.551 1.011 0 O-C-N 120.872 -1.142 . . . . 0.0 111.831 179.524 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 10.6 mtt85 . . . . . 0 CA--C 1.519 -0.241 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.7 m -142.14 123.86 15.1 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -100.92 109.1 21.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -110.4 116.21 31.03 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.17 117.51 21.78 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 128.471 2.708 . . . . 0.0 107.463 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.457 ' CE2' HD13 ' A' ' 123' ' ' ILE . 10.3 m-30 -68.78 106.95 2.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.567 1.147 . . . . 0.0 107.986 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -107.56 159.27 14.58 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 129.677 3.513 . . . . 0.0 110.945 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.52 149.65 50.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 124.927 2.299 . . . . 0.0 112.109 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 40.9 mt -98.18 140.94 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 111.752 -2.476 . . . . 0.0 110.713 -176.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -134.04 151.78 51.56 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.986 1.714 . . . . 0.0 109.873 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.3 p -77.63 173.39 12.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 58.8 mt -125.41 141.29 45.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -64.14 132.04 49.27 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.919 1.288 . . . . 0.0 108.076 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.6 18.93 70.55 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 118.554 -1.137 . . . . 0.0 114.69 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -135.87 157.86 45.81 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 120.025 1.912 . . . . 0.0 109.172 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 73.8 m -106.38 140.98 38.45 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.94 -26.54 48.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 77.1 p -68.24 -12.99 61.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.643 2.377 . . . . 0.0 113.866 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -119.99 -42.72 2.58 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 118.833 -0.603 . . . . 0.0 109.532 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.02 155.43 18.57 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.335 0.588 . . . . 0.0 110.765 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -157.54 175.63 13.69 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.577 0.751 . . . . 0.0 109.972 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.75 134.26 53.43 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.887 1.275 . . . . 0.0 110.861 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.04 132.71 56.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.256 1.022 . . . . 0.0 108.345 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -70.18 102.82 2.18 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.508 ' HB ' ' HE2' ' A' ' 219' ' ' LYS . 39.3 mm -121.42 123.16 69.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 O-C-N 121.075 -1.016 . . . . 0.0 108.282 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 53.44 48.39 21.96 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.98 0.912 . . . . 0.0 109.074 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 62.19 9.0 2.93 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.59 1.156 . . . . 0.0 114.081 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -131.19 122.56 26.78 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.189 0.904 . . . . 0.0 109.028 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -61.94 118.71 7.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.286 0.634 . . . . 0.0 109.931 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.508 ' HE2' ' HB ' ' A' ' 214' ' ' ILE . 16.7 mtmm -114.23 149.06 36.39 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.4 1.095 . . . . 0.0 110.088 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -81.29 123.76 28.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.306 1.842 . . . . 0.0 111.871 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -110.3 145.28 37.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.62 145.37 51.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.68 1.192 . . . . 0.0 110.92 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -64.15 120.81 12.8 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 C--N 1.326 -0.427 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.211 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -57.86 138.42 55.72 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.9 2.48 . . . . 0.0 112.818 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.4 t -140.54 142.17 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.5 1.92 . . . . 0.0 106.941 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.46 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.7 mp -90.27 139.63 17.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -68.35 131.46 45.36 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 122.669 1.223 . . . . 0.0 112.495 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -70.19 -16.95 63.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.125 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -93.17 -31.13 14.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.959 1.254 . . . . 0.0 112.517 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.23 110.69 6.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 t -64.85 -14.75 60.47 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.444 1.475 . . . . 0.0 111.311 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -82.26 -5.26 58.41 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.216 1.006 . . . . 0.0 110.689 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -107.37 158.43 17.17 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 118.264 0.484 . . . . 0.0 111.941 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.5 mm -130.18 131.31 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.692 1.197 . . . . 0.0 107.78 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -103.52 97.45 7.49 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -131.37 126.4 35.12 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.839 -1.163 . . . . 0.0 109.339 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.1 mtt 57.16 33.54 23.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.047 1.739 . . . . 0.0 110.554 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.45 0.59 54.5 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.297 -0.877 . . . . 0.0 111.336 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -92.74 161.01 14.71 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -121.15 134.08 65.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -129.84 159.71 35.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.9 t -138.41 156.65 47.38 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.469 1.108 . . . . 0.0 108.045 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.4 mt -112.47 129.92 67.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.842 0.857 . . . . 0.0 109.688 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.4 t -100.54 -110.16 0.2 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . 0.257 8.4 p-10 -162.4 99.03 1.04 Allowed 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 126.966 2.107 . . . . 0.0 107.668 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 97.5 m -137.93 108.34 6.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 115.961 -1.971 . . . . 0.0 109.072 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.6 m -67.29 122.68 18.43 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 122.163 2.256 . . . . 0.0 105.75 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.3 t -99.7 110.99 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.822 1.192 . . . . 0.0 108.036 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -79.38 164.66 23.85 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -61.45 -31.21 71.16 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.204 1.002 . . . . 0.0 111.426 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.28 -16.45 63.57 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.739 1.215 . . . . 0.0 111.384 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.93 -29.21 8.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.386 1.075 . . . . 0.0 110.003 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.1 tp -61.14 142.73 56.5 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.86 1.264 . . . . 0.0 109.082 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -96.51 -102.08 2.01 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.48 166.34 23.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.942 1.697 . . . . 0.0 110.644 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.87 146.48 26.32 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.999 0.92 . . . . 0.0 109.968 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -126.0 -52.33 1.54 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.09 -1.433 . . . . 0.0 112.689 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -157.25 154.66 29.49 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.745 1.612 . . . . 0.0 110.283 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.8 p -111.69 137.12 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 119.129 0.877 . . . . 0.0 110.013 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -112.02 165.03 12.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.535 2.334 . . . . 0.0 109.66 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -169.57 66.29 0.05 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.713 1.205 . . . . 0.0 109.563 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -156.4 173.47 16.84 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.34 147.83 16.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 O-C-N 121.179 -0.95 . . . . 0.0 108.63 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.23 161.41 38.35 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.865 0.757 . . . . 0.0 109.765 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.23 125.29 63.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 126.476 1.911 . . . . 0.0 108.768 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -142.91 163.95 31.4 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.065 1.346 . . . . 0.0 112.099 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.85 110.38 21.32 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.89 -18.84 36.73 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.69 1.596 . . . . 0.0 115.069 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.15 -40.46 82.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 O-C-N 121.284 -0.885 . . . . 0.0 112.044 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.463 ' HB3' ' HE2' ' A' ' 169' ' ' LYS . 0.4 OUTLIER -123.26 -12.98 7.78 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.684 0.794 . . . . 0.0 112.631 -178.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.18 12.67 75.89 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.302 0.953 . . . . 0.0 111.739 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 167' ' ' SER . 25.1 mtmt -71.89 112.62 8.14 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.969 1.308 . . . . 0.0 110.507 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.2 m -73.33 157.48 36.91 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.1 1.36 . . . . 0.0 109.933 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.44 151.68 51.79 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.221 0.608 . . . . 0.0 110.205 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 160.26 39.03 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.461 2.108 . . . . 0.0 108.778 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -60.0 -22.15 62.2 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.924 -1.11 . . . . 0.0 111.186 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -14.64 44.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.033 1.333 . . . . 0.0 112.345 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -116.62 3.15 13.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.052 0.941 . . . . 0.0 112.032 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 24.8 m0 . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -179.642 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 . . . . . 0 C--O 1.233 0.194 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 93.5 m -144.22 124.29 13.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.803 2.041 . . . . 0.0 106.62 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -101.15 112.19 24.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -110.14 116.74 32.08 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.91 1.284 . . . . 0.0 110.658 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -83.2 125.18 31.28 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.676 2.39 . . . . 0.0 107.91 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.46 ' CE2' HD13 ' A' ' 123' ' ' ILE . 2.9 m-30 -77.11 100.91 5.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 213' ' ' GLU . . . -93.95 158.22 23.14 Favored Glycine 0 N--CA 1.438 -1.191 1 C-N-CA 130.806 4.05 . . . . 0.0 107.911 179.058 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -69.05 153.96 42.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.711 1.72 . . . . 0.0 111.041 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.9 mt -99.49 143.12 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 113.158 -1.837 . . . . 0.0 108.593 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -133.15 150.24 52.03 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.927 1.691 . . . . 0.0 109.429 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 19.4 m -79.33 171.59 14.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 69.4 mt -125.61 147.69 30.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 O-C-N 121.0 -1.063 . . . . 0.0 108.502 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 50.8 mtt-85 -67.5 125.59 26.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 65.52 26.78 72.02 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.008 -0.885 . . . . 0.0 114.484 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -141.79 140.52 33.04 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.6 m -94.52 145.68 24.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -20.77 59.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.449 1.1 . . . . 0.0 109.851 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 15.3 p -75.62 -10.81 59.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.716 2.407 . . . . 0.0 113.041 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -125.21 -48.65 1.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.906 1.682 . . . . 0.0 111.251 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.71 144.31 19.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.656 0.662 . . . . 0.0 110.666 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -149.97 175.91 11.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.12 0.568 . . . . 0.0 109.567 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.13 134.57 52.63 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.29 1.036 . . . . 0.0 111.702 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.79 130.59 68.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 C-N-CA 124.706 1.202 . . . . 0.0 110.591 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.403 ' HB3' ' HA3' ' A' ' 196' ' ' GLY . 5.2 tt0 -72.24 107.87 5.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 36.7 mm -121.54 115.04 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.653 1.181 . . . . 0.0 108.94 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 59.46 48.8 9.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.281 1.032 . . . . 0.0 108.477 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.8 t70 64.14 9.48 4.76 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.231 1.013 . . . . 0.0 113.586 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -126.66 122.83 36.08 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.913 -1.117 . . . . 0.0 109.603 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -69.05 121.95 17.72 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.758 -1.214 . . . . 0.0 111.905 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -117.31 144.04 45.29 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.67 1.588 . . . . 0.0 112.883 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.489 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.4 tm? -78.52 132.48 37.23 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.665 0.786 . . . . 0.0 110.357 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -118.69 143.44 46.85 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.3 p -121.55 146.7 46.69 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.887 0.875 . . . . 0.0 111.585 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -61.91 138.36 58.35 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 83.5 t . . . . . 0 N--CA 1.453 -0.306 0 C-N-CA 125.205 1.402 . . . . 0.0 107.612 179.565 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.521 -0.156 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -76.42 115.12 15.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -118.4 129.19 75.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 124.436 1.094 . . . . 0.0 110.067 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.462 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.6 mp -77.99 137.95 21.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -58.51 130.06 44.98 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.495 1.14 . . . . 0.0 110.979 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -12.25 61.25 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.54 -41.75 5.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.385 1.074 . . . . 0.0 108.95 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -116.05 103.91 11.04 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 125.18 1.392 . . . . 0.0 114.1 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.56 ' HB2' ' CD1' ' A' ' 163' ' ' PHE . 67.1 m -68.83 -7.5 34.94 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 119.906 -1.746 . . . . 0.0 111.406 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.33 -9.36 36.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.452 1.901 . . . . 0.0 109.814 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.3 mttt -115.06 160.6 19.43 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 121.116 1.78 . . . . 0.0 113.02 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.2 mm -124.91 144.19 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 C-N-CA 125.267 1.427 . . . . 0.0 107.981 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -116.39 106.17 13.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.86 2.464 . . . . 0.0 104.58 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -135.26 123.56 23.17 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 20.8 mtp 64.8 27.71 12.95 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.387 1.475 . . . . 0.0 109.727 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.75 17.83 73.52 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.721 -1.044 . . . . 0.0 110.917 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -109.19 156.73 19.54 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.1 mm -110.65 134.8 51.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 123.522 0.729 . . . . 0.0 109.801 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -129.83 153.09 48.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.0 t -133.48 158.52 42.9 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.312 1.045 . . . . 0.0 108.529 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.0 mt -117.93 115.99 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.919 1.288 . . . . 0.0 110.369 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -88.78 -125.77 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 102.062 -3.31 . . . . 0.0 102.062 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -152.84 100.41 2.51 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 176.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 55.0 m -134.85 107.2 7.25 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 112.751 -2.022 . . . . 0.0 105.755 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.5 m -65.9 124.04 21.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.6 t -94.71 142.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.1 m -114.77 162.68 16.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.017 1.327 . . . . 0.0 109.442 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.84 -26.72 67.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 111.262 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.42 -21.08 63.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.385 0.674 . . . . 0.0 110.296 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -105.8 -18.9 13.92 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.85 0.86 . . . . 0.0 110.496 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 24.2 mt -67.16 141.6 57.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.513 0.673 . . . . 0.0 109.594 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.48 -101.24 1.84 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -135.5 167.53 20.91 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.936 2.494 . . . . 0.0 109.706 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -63.27 148.16 49.01 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -126.1 -52.58 1.53 Allowed 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 121.254 -0.904 . . . . 0.0 111.744 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -151.59 147.52 26.87 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 119.038 0.835 . . . . 0.0 110.549 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.68 134.41 40.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.4 mp -112.05 159.24 18.67 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.618 2.367 . . . . 0.0 108.78 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -169.56 53.25 0.04 OUTLIER 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.111 0.564 . . . . 0.0 112.225 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -147.38 173.11 12.93 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.785 -1.197 . . . . 0.0 108.985 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.3 t -145.45 145.38 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -141.05 166.1 25.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.6 t -131.08 132.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 128' ' ' SER . 55.1 p90 -144.99 171.62 14.21 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.944 0.878 . . . . 0.0 112.49 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.09 104.67 15.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.819 2.448 . . . . 0.0 105.341 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.0 t -65.07 -11.96 45.29 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.448 1.931 . . . . 0.0 112.721 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.7 m -64.83 -40.48 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 O-C-N 120.513 -1.367 . . . . 0.0 110.683 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.5 t -123.8 -23.6 4.65 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.623 1.169 . . . . 0.0 113.831 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.34 3.24 57.66 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.524 2.012 . . . . 0.0 110.611 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -54.55 113.03 1.14 Allowed 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.634 1.974 . . . . 0.0 109.676 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.2 m -64.33 158.14 24.28 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.382 0.673 . . . . 0.0 110.882 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.27 144.18 48.33 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.545 1.538 . . . . 0.0 107.554 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -81.35 162.43 19.78 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.565 2.843 . . . . 0.0 109.893 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -59.77 -22.32 61.96 Favored 'General case' 0 C--O 1.228 -0.068 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 42.5 m -70.74 -7.86 47.98 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.404 -0.81 . . . . 0.0 111.925 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.88 2.93 12.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.748 1.219 . . . . 0.0 111.732 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.0 m0 . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -179.463 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 . . . . . 0 C--O 1.233 0.214 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.1 m -136.64 136.59 39.26 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.324 1.85 . . . . 0.0 106.778 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -117.78 106.92 13.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.374 1.47 . . . . 0.0 108.931 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -110.25 116.8 32.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.887 2.075 . . . . 0.0 107.657 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.93 116.56 25.08 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.968 2.507 . . . . 0.0 107.093 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.462 ' CE2' HD13 ' A' ' 123' ' ' ILE . 10.5 m-30 -64.88 102.54 0.61 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.644 1.577 . . . . 0.0 109.151 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.26 158.98 17.3 Favored Glycine 0 N--CA 1.435 -1.411 1 C-N-CA 131.264 4.269 . . . . 0.0 107.845 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -66.13 154.25 40.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.282 1.991 . . . . 0.0 114.057 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.4 mt -101.38 141.47 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 112.589 -2.096 . . . . 0.0 109.069 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.1 153.01 49.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.674 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.8 t -78.21 172.68 13.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.142 1.777 . . . . 0.0 106.556 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 18.3 mt -131.47 149.79 33.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 122.751 1.263 . . . . 0.0 113.128 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -69.03 121.03 15.83 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.217 1.807 . . . . 0.0 109.431 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.14 24.77 76.71 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 117.587 -1.674 . . . . 0.0 113.418 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -149.55 144.52 26.29 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.811 1.805 . . . . 0.0 112.358 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.9 m -92.02 151.37 20.5 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.2 -33.53 65.41 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.294 -0.879 . . . . 0.0 110.046 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.3 p -66.21 -14.71 62.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.691 1.996 . . . . 0.0 114.29 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.67 -37.98 4.11 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.47 1.108 . . . . 0.0 110.055 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.35 145.07 2.63 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.141 0.976 . . . . 0.0 110.895 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -148.58 171.68 15.75 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.24 138.16 46.01 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.869 0.468 . . . . 0.0 110.564 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 4.1 p -133.13 129.84 57.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 123.544 0.737 . . . . 0.0 111.719 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -74.86 105.82 6.09 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.5 122.6 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.403 1.481 . . . . 0.0 108.863 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 54.8 44.16 28.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.083 0.856 . . . . 0.0 108.973 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 62.34 6.91 2.06 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.405 1.482 . . . . 0.0 114.282 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.33 121.96 36.42 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -66.39 128.68 37.1 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.265 1.026 . . . . 0.0 110.493 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -123.61 151.14 43.31 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.433 0.693 . . . . 0.0 110.763 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.8 tm? -83.79 117.87 23.56 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.68 1.192 . . . . 0.0 112.452 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -100.54 151.72 21.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.0 p -135.71 150.35 49.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.84 0.856 . . . . 0.0 110.838 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.94 140.37 57.77 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.842 1.257 . . . . 0.0 107.814 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 C--O 1.23 0.069 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.455 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -77.05 137.63 39.08 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.2 t -138.29 129.97 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 126.162 1.785 . . . . 0.0 108.355 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -73.84 140.12 18.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -65.2 130.42 43.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 123.006 1.384 . . . . 0.0 109.455 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -63.47 -24.03 67.65 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.686 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -89.31 -40.71 12.61 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.435 0.694 . . . . 0.0 110.727 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.71 113.15 16.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.719 1.208 . . . . 0.0 111.374 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.5 m -68.12 -11.14 58.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.604 1.962 . . . . 0.0 111.664 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -96.96 -4.33 40.08 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.978 1.711 . . . . 0.0 111.489 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -110.32 157.99 18.91 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.241 0.928 . . . . 0.0 110.632 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.4 mm -124.42 137.95 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -117.21 106.28 13.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.176 1.79 . . . . 0.0 106.48 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -127.42 125.35 40.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.6 mtt 61.94 17.78 9.27 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.721 1.208 . . . . 0.0 110.899 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.41 0.07 88.38 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.758 -1.023 . . . . 0.0 111.369 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -86.52 168.43 13.71 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.1 mm -124.81 132.71 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.646 1.112 . . . . 0.0 109.851 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -126.63 152.79 46.2 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.885 0.874 . . . . 0.0 108.936 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.7 t -137.35 147.17 45.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.227 1.011 . . . . 0.0 108.422 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.53 125.33 62.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 126.433 1.893 . . . . 0.0 110.712 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -91.89 -104.67 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -166.71 99.52 0.57 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 45.8 m -136.23 115.07 12.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.8 m -76.68 123.8 26.69 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 121.227 1.831 . . . . 0.0 106.431 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.82 142.05 14.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.7 m -114.42 164.68 13.62 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.375 1.07 . . . . 0.0 111.125 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -27.66 66.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.587 1.155 . . . . 0.0 112.44 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.08 -13.26 62.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.698 0.799 . . . . 0.0 110.359 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -119.43 -25.86 5.95 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.761 1.224 . . . . 0.0 110.965 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.1 tp -68.1 129.06 38.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.07 -98.17 0.77 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.13 163.39 30.03 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.272 1.429 . . . . 0.0 110.259 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -63.88 143.91 57.48 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -126.23 -47.52 1.61 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -151.46 158.67 43.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.992 1.269 . . . . 0.0 111.037 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.4 p -115.45 139.33 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.1 0.96 . . . . 0.0 108.591 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.26 164.67 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.998 1.719 . . . . 0.0 110.518 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -165.9 54.13 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -154.05 167.86 28.38 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.024 -1.673 . . . . 0.0 106.999 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.5 t -145.17 148.49 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -146.54 164.37 32.79 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.4 t -130.39 131.58 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -138.72 168.18 20.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.525 0.678 . . . . 0.0 111.479 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.497 ' CG ' HG22 ' A' ' 166' ' ' VAL . 53.3 t0 -80.51 111.53 17.0 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.7 t -51.51 -18.69 1.17 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 130.319 3.448 . . . . 0.0 115.074 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.497 HG22 ' CG ' ' A' ' 164' ' ' ASP . 20.9 m -76.9 -52.08 17.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 124.564 1.146 . . . . 0.0 113.46 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.414 ' HB2' ' HD3' ' A' ' 169' ' ' LYS 0.27 18.5 m -121.69 -27.08 4.77 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.186 1.794 . . . . 0.0 113.592 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.75 12.26 13.09 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.38 1.467 . . . . 0.0 113.441 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -57.1 112.45 1.36 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.597 2.198 . . . . 0.0 110.03 -178.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 43.2 p -63.13 151.89 38.86 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.79 145.37 41.1 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 125.147 1.379 . . . . 0.0 107.735 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.02 159.04 27.19 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.299 2.666 . . . . 0.0 108.868 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -55.62 -37.56 68.33 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 125.665 1.586 . . . . 0.0 111.867 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.9 m -63.51 -13.05 37.14 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 118.701 -1.2 . . . . 0.0 113.75 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.31 -15.3 20.82 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.403 1.481 . . . . 0.0 108.933 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.3 m0 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.42 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.6 m -128.59 124.78 36.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -106.25 109.51 21.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -115.51 116.14 27.68 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.13 136.57 32.95 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . 0.253 4.8 m-30 -82.02 101.42 10.31 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.217 1.008 . . . . 0.0 110.967 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -93.38 158.55 23.71 Favored Glycine 0 CA--C 1.532 1.111 1 C-N-CA 135.355 6.217 . . . . 0.0 107.162 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -68.23 156.84 36.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 123.3 1.524 . . . . 0.0 112.757 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 74.3 mt -103.49 139.64 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 126.541 1.936 . . . . 0.0 110.241 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -134.27 153.5 51.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.543 1.537 . . . . 0.0 110.21 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.4 p -76.98 173.02 12.26 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.712 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 43.9 mt -127.22 133.57 67.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 122.198 0.999 . . . . 0.0 108.877 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -62.8 127.87 33.29 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.151 1.78 . . . . 0.0 108.647 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.19 13.23 76.53 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.157 -1.357 . . . . 0.0 114.625 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -137.01 139.2 41.24 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 120.329 2.065 . . . . 0.0 110.725 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.9 m -84.44 144.65 28.62 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -23.13 65.55 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 120.56 -1.337 . . . . 0.0 109.531 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 31.6 p -76.71 -6.85 53.86 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.262 2.225 . . . . 0.0 113.814 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -121.38 -45.99 2.3 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.248 1.019 . . . . 0.0 109.362 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.49 143.21 13.15 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.377 0.535 . . . . 0.0 111.004 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -149.12 175.81 11.02 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.301 -0.25 . . . . 0.0 110.628 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.17 134.4 51.78 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.67 1.188 . . . . 0.0 113.021 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.58 127.85 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 125.326 1.451 . . . . 0.0 111.602 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 218' ' ' PHE . 43.9 tt0 -74.2 110.01 8.15 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 37.0 mm -121.53 117.92 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 56.06 39.88 30.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.14 0.576 . . . . 0.0 110.125 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.4 t70 76.32 -8.39 1.65 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.424 1.889 . . . . 0.0 112.02 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -104.97 122.23 45.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 119.906 -1.746 . . . . 0.0 110.189 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 213' ' ' GLU . 11.9 m-85 -71.03 119.34 15.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -110.27 145.86 36.65 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.564 1.145 . . . . 0.0 111.331 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.8 tm? -82.03 130.51 35.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -120.43 142.15 49.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.2 p -118.61 150.28 39.95 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.599 0.714 . . . . 0.0 110.963 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -64.96 143.63 57.83 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.725 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -73.94 151.64 40.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.1 t -145.87 136.89 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -81.76 134.93 26.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -58.5 119.43 6.99 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.598 1.19 . . . . 0.0 109.964 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -58.24 -22.53 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.174 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -94.54 -21.84 18.6 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.73 1.212 . . . . 0.0 111.955 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.97 104.88 4.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.519 1.128 . . . . 0.0 109.212 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.3 t -69.06 -3.56 13.68 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.522 -1.361 . . . . 0.0 110.867 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -98.13 -3.2 38.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.718 2.007 . . . . 0.0 110.397 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -117.54 169.7 9.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.541 1.136 . . . . 0.0 112.224 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.3 mm -130.32 151.16 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 C-N-CA 126.165 1.786 . . . . 0.0 107.878 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.19 102.5 8.17 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 130.119 3.368 . . . . 0.0 103.603 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -142.7 131.93 23.35 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.643 -1.286 . . . . 0.0 109.589 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.5 mtt 57.61 32.91 22.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.353 1.461 . . . . 0.0 113.026 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.49 7.34 82.75 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.453 -1.193 . . . . 0.0 112.449 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -113.08 168.36 9.77 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.131 1.372 . . . . 0.0 108.099 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -119.54 145.46 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -133.3 155.69 48.94 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.2 t -134.91 151.59 51.01 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.039 1.736 . . . . 0.0 108.22 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.3 mt -112.82 123.34 68.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.956 1.302 . . . . 0.0 108.971 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.1 t -97.72 -118.27 0.13 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 101.884 -3.376 . . . . 0.0 101.884 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -158.05 99.36 1.66 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 120.622 1.555 . . . . 0.0 106.935 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 m -137.95 115.31 11.11 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 127.209 2.204 . . . . 0.0 106.326 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.9 m -71.72 129.79 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.81 111.05 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.5 m -75.45 164.46 26.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.068 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.9 -29.37 70.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.545 0.688 . . . . 0.0 111.753 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.74 -11.61 60.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.594 1.158 . . . . 0.0 111.265 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.77 -24.62 11.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.552 1.541 . . . . 0.0 109.534 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.09 127.92 33.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.825 1.25 . . . . 0.0 111.85 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.63 -106.06 1.31 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -133.77 163.0 30.45 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.128 1.371 . . . . 0.0 109.307 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -60.41 145.65 47.33 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.52 -42.02 1.98 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 116.507 -1.711 . . . . 0.0 114.494 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -161.28 160.86 30.33 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 121.066 1.757 . . . . 0.0 110.489 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.4 p -121.84 133.15 69.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.57 1.148 . . . . 0.0 108.402 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -107.83 166.33 10.78 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.181 2.193 . . . . 0.0 110.591 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -164.08 41.04 0.09 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -138.71 172.23 13.18 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 120.039 -1.663 . . . . 0.0 109.568 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.76 149.36 17.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -145.46 167.02 23.98 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.35 131.89 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -138.02 166.72 23.4 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.461 0.704 . . . . 0.0 110.193 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -86.07 116.03 24.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.38 -14.46 1.91 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 127.032 2.133 . . . . 0.0 115.179 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.4 m -77.34 -46.85 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 124.044 0.937 . . . . 0.0 112.451 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.23 -28.42 3.69 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.37 12.73 16.59 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.067 1.318 . . . . 0.0 112.299 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 112.78 2.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.968 1.384 . . . . 0.0 111.253 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.1 m -69.35 154.75 41.54 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.588 1.085 . . . . 0.0 110.476 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.31 147.66 66.72 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.659 1.584 . . . . 0.0 110.828 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.53 157.71 22.07 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.499 3.466 . . . . 0.0 110.502 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -53.17 -25.1 12.46 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 m -70.54 -22.06 62.65 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 118.056 -0.973 . . . . 0.0 113.468 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.2 -12.45 28.24 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.555 1.525 . . . . 0.0 110.753 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.5 m0 . . . . . 0 N--CA 1.443 -0.824 0 C-N-CA 124.924 1.29 . . . . 0.0 111.771 -179.771 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 49.3 mmt-85 . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 122.19 0.995 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.0 m -122.36 129.39 52.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 126.944 2.098 . . . . 0.0 105.557 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -115.94 106.54 13.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.349 1.859 . . . . 0.0 107.41 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -110.52 117.44 33.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.295 1.838 . . . . 0.0 108.701 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -87.88 127.21 35.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -73.31 101.45 3.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.029 0.932 . . . . 0.0 109.561 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.82 159.06 22.81 Favored Glycine 0 N--CA 1.442 -0.921 1 C-N-CA 132.694 4.95 . . . . 0.0 107.544 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 197' ' ' GLU . 6.6 pt-20 -68.1 151.17 47.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 123.544 1.64 . . . . 0.0 111.536 -176.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 63.9 mt -99.38 143.99 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 C-N-CA 126.463 1.905 . . . . 0.0 110.299 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -137.99 153.27 49.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.734 1.613 . . . . 0.0 110.095 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.8 p -80.47 173.22 12.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 66.4 mt -124.8 136.46 60.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.381 1.072 . . . . 0.0 109.015 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -64.88 119.12 10.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.66 10.89 72.19 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 118.148 -1.362 . . . . 0.0 116.083 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -137.38 130.44 30.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 120.473 2.136 . . . . 0.0 110.295 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 15.0 m -71.49 145.08 49.42 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.62 -24.96 65.91 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.052 0.941 . . . . 0.0 109.158 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 17.1 p -75.53 -9.76 58.86 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.83 2.452 . . . . 0.0 112.798 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -119.77 -47.61 2.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.582 1.153 . . . . 0.0 109.386 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.35 145.38 19.11 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.902 0.774 . . . . 0.0 111.01 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -152.08 175.73 12.26 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.859 -0.526 . . . . 0.0 110.716 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.51 134.71 52.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.871 1.669 . . . . 0.0 112.29 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.427 HG13 HG12 ' A' ' 214' ' ' ILE . 8.0 p -129.83 131.56 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 124.821 1.249 . . . . 0.0 109.436 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.41 106.75 5.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.427 HG12 HG13 ' A' ' 212' ' ' VAL . 28.2 mm -121.42 128.97 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 53.81 36.63 24.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.995 0.816 . . . . 0.0 111.65 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t0 68.74 9.66 7.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.553 1.541 . . . . 0.0 112.825 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -124.92 122.98 38.9 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.519 1.128 . . . . 0.0 108.743 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -69.12 119.37 13.3 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.828 -1.17 . . . . 0.0 110.373 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -116.07 147.19 41.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 123.41 1.576 . . . . 0.0 111.679 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -80.93 122.61 27.46 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.486 1.914 . . . . 0.0 113.074 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -112.45 140.07 47.5 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.3 p -120.54 145.51 47.25 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.621 1.168 . . . . 0.0 110.765 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -60.36 135.41 57.73 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.451 -0.385 0 C-N-CA 122.965 0.506 . . . . 0.0 109.816 178.666 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -70.43 130.7 42.61 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.6 t -131.46 134.92 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.0 mm -69.78 131.53 34.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -68.35 129.39 39.77 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.523 0.678 . . . . 0.0 109.988 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -71.26 -18.37 62.44 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.139 -0.976 . . . . 0.0 110.329 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -82.05 -34.21 29.58 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.644 1.178 . . . . 0.0 111.261 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.38 121.17 9.9 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.5 t -59.35 -25.21 64.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.526 1.057 . . . . 0.0 110.48 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -90.47 3.02 55.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.224 1.81 . . . . 0.0 112.946 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -109.13 155.98 20.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.2 mm -126.69 142.04 44.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -115.25 104.25 11.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 128.111 2.564 . . . . 0.0 105.166 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -132.58 128.63 37.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.8 mtt 61.76 21.77 12.47 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.221 1.408 . . . . 0.0 110.841 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.72 14.64 81.85 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.515 -1.159 . . . . 0.0 111.878 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -113.1 157.92 21.02 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.0 mm -114.65 143.93 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.561 0.696 . . . . 0.0 111.507 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -131.12 155.31 47.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.571 1.948 . . . . 0.0 109.63 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.6 t -145.18 147.38 32.4 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 mt -102.85 120.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 126.665 1.986 . . . . 0.0 112.03 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -90.33 -116.6 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 1 N-CA-C 99.881 -4.118 . . . . 0.0 99.881 176.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -160.25 99.82 1.34 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 2.4 m -136.63 121.41 18.61 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 m -81.24 136.73 35.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 120.671 1.578 . . . . 0.0 107.05 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.35 112.25 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 74.3 m -79.82 166.22 21.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.975 0.91 . . . . 0.0 109.1 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -58.27 -32.01 68.0 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.345 1.058 . . . . 0.0 111.091 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.82 -8.03 39.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.167 1.787 . . . . 0.0 112.044 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -122.33 -12.14 8.27 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 127.72 2.408 . . . . 0.0 110.001 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 20.3 mt -83.09 123.03 29.11 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.23 -101.46 0.84 Allowed Glycine 0 CA--C 1.507 -0.424 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -134.75 167.05 21.57 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.379 1.071 . . . . 0.0 108.8 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -61.02 143.05 56.1 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.0 0.92 . . . . 0.0 111.374 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.06 -41.41 1.94 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 116.907 -1.521 . . . . 0.0 113.3 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -160.27 150.36 18.17 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.707 1.594 . . . . 0.0 110.792 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.1 p -109.26 135.79 47.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.1 mp -110.66 163.21 13.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.934 2.094 . . . . 0.0 110.95 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -165.33 64.34 0.12 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -153.01 173.19 15.73 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.564 -1.335 . . . . 0.0 108.763 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.2 t -149.57 138.07 14.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 126.103 1.761 . . . . 0.0 106.368 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.75 166.05 25.7 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.49 126.9 55.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -142.08 164.01 31.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.561 1.144 . . . . 0.0 110.759 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -92.95 103.57 15.88 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 104.284 -2.488 . . . . 0.0 104.284 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.35 -15.72 0.69 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.365 2.266 . . . . 0.0 116.127 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.6 m -57.71 -51.0 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.168 0.987 . . . . 0.0 108.406 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.2 m -123.45 -26.7 4.19 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.397 1.879 . . . . 0.0 114.437 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 103.4 16.56 20.09 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.499 1.523 . . . . 0.0 113.615 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 113.04 4.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.76 1.78 . . . . 0.0 109.261 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.0 m -75.21 145.25 42.17 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.26 143.07 26.97 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.17 160.51 42.41 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.167 2.578 . . . . 0.0 111.028 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -57.32 -28.62 63.24 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.065 0.546 . . . . 0.0 111.913 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.5 m -61.32 -14.22 25.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.071 0.949 . . . . 0.0 112.148 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -119.12 4.91 11.3 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.903 1.681 . . . . 0.0 111.951 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.8 m0 . . . . . 0 CA--C 1.532 0.261 0 O-C-N 120.752 -1.218 . . . . 0.0 113.895 179.236 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.488 0.661 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.4 m -141.84 132.53 25.58 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.478 1.911 . . . . 0.0 106.018 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -115.35 104.77 12.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -110.63 116.6 31.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.013 1.325 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -83.27 128.23 34.32 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 127.212 2.205 . . . . 0.0 105.861 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.55 102.3 6.02 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.68 159.27 16.84 Favored Glycine 0 N--CA 1.442 -0.96 1 C-N-CA 131.489 4.376 . . . . 0.0 109.918 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.12 154.98 39.9 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 124.294 1.997 . . . . 0.0 113.717 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.4 mt -102.26 140.97 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.299 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -131.58 151.52 51.53 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 109.604 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 11.4 m -76.3 172.27 13.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.778 0.831 . . . . 0.0 108.984 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 78.8 mt -131.91 138.15 53.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.902 0.858 . . . . 0.0 110.509 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -65.5 119.04 10.34 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.22 14.73 76.09 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 118.821 -0.989 . . . . 0.0 115.378 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -140.78 126.2 18.81 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 119.771 1.785 . . . . 0.0 109.782 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 16.3 m -76.48 146.71 38.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.31 -27.8 56.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.541 1.136 . . . . 0.0 110.393 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 36.9 p -74.33 -9.74 58.9 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.433 1.893 . . . . 0.0 114.362 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -120.69 -43.88 2.46 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.26 1.424 . . . . 0.0 109.547 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.15 144.28 14.35 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.115 0.566 . . . . 0.0 110.13 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -148.13 176.38 10.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.803 0.841 . . . . 0.0 109.152 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -108.62 130.73 55.31 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.455 1.102 . . . . 0.0 109.727 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.1 p -124.28 126.97 72.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 124.48 1.112 . . . . 0.0 111.678 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -73.89 108.42 6.7 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 35.4 mm -121.74 120.2 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 54.17 40.39 31.62 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.8 t70 70.68 -4.83 1.57 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.381 2.272 . . . . 0.0 113.2 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.44 ' HB3' ' HE2' ' A' ' 219' ' ' LYS . 37.8 m-20 -106.15 122.26 45.84 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 120.279 -1.513 . . . . 0.0 108.953 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.85 120.49 16.52 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 217' ' ' ASP . 19.5 mmtp -112.46 151.58 29.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.818 1.247 . . . . 0.0 112.671 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.5 tm? -88.81 117.07 27.53 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.067 0.947 . . . . 0.0 110.711 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.89 156.23 17.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.9 143.3 40.77 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 123.158 0.583 . . . . 0.0 109.908 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -54.82 125.82 21.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.865 0.866 . . . . 0.0 110.162 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 C--O 1.218 -0.569 0 C-N-CA 126.387 1.875 . . . . 0.0 107.986 179.828 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.821 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.4 ' CD2' HD13 ' A' ' 198' ' ' ILE . 45.8 m-85 -69.56 140.91 53.89 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.879 1.272 . . . . 0.0 110.264 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.4 t -141.24 141.34 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.479 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.7 mp -80.28 121.13 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -48.61 122.13 5.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.087 0.946 . . . . 0.0 111.475 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -65.72 -17.54 64.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.785 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -94.96 -20.38 19.43 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.956 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.17 122.2 9.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 120.038 1.29 . . . . 0.0 108.127 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.5 m -65.12 -18.86 65.66 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 120.182 -1.574 . . . . 0.0 110.699 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -94.12 -0.48 55.28 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.943 1.297 . . . . 0.0 113.095 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -108.0 159.59 16.44 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.466 0.575 . . . . 0.0 110.104 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.2 mm -126.81 138.51 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -118.63 108.67 15.22 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -146.39 134.1 21.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.8 mtt 58.69 26.91 15.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.747 2.019 . . . . 0.0 113.531 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.17 23.52 71.14 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -121.99 164.7 17.19 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.3 mm -123.77 126.36 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.89 150.19 41.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.7 t -130.75 150.04 52.12 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.004 1.322 . . . . 0.0 109.201 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 mt -111.36 124.21 67.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 125.602 1.561 . . . . 0.0 110.725 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.6 t -95.31 -126.95 0.13 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 103.188 -2.893 . . . . 0.0 103.188 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -149.73 99.37 2.86 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 94.5 m -136.89 111.79 8.88 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 128.094 2.558 . . . . 0.0 109.654 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.1 m -69.05 124.34 23.51 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 54.6 t -94.46 119.58 42.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 119.675 1.125 . . . . 0.0 109.157 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.2 m -80.65 159.13 25.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.643 0.735 . . . . 0.0 109.858 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.35 -29.34 70.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.956 1.302 . . . . 0.0 112.008 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.43 -16.11 61.83 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.311 1.044 . . . . 0.0 111.892 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -103.9 -25.95 12.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.818 0.847 . . . . 0.0 108.867 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 mt -62.14 137.58 58.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.757 1.223 . . . . 0.0 109.923 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -89.39 -105.71 1.12 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -135.04 169.43 17.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.057 1.743 . . . . 0.0 109.805 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -59.68 142.39 53.13 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -125.74 -48.97 1.63 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 116.595 -1.669 . . . . 0.0 111.902 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -155.73 150.81 26.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.9 1.682 . . . . 0.0 112.217 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.8 p -105.5 133.59 49.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 122.482 1.134 . . . . 0.0 111.332 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mp -113.1 161.93 16.53 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.562 2.745 . . . . 0.0 109.702 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.66 48.71 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.569 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 3.5 mt-10 -143.72 176.68 9.05 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.85 2.06 . . . . 0.0 111.579 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.49 150.56 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.593 -1.317 . . . . 0.0 110.508 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.512 ' HE ' ' CB ' ' A' ' 193' ' ' TRP . 0.0 OUTLIER -131.38 157.49 43.28 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.408 1.483 . . . . 0.0 109.606 178.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.5 t -140.51 114.18 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -141.58 167.98 20.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.356 0.598 . . . . 0.0 112.212 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.21 104.24 13.23 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.5 m -64.48 -14.99 59.97 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 122.145 2.248 . . . . 0.0 114.526 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.6 m -69.57 -35.17 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 O-C-N 121.823 -0.548 . . . . 0.0 112.001 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.29 -19.19 6.03 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.384 1.473 . . . . 0.0 113.015 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.26 -10.84 69.47 Favored Glycine 0 CA--C 1.543 1.796 0 C-N-CA 126.969 2.223 . . . . 0.0 112.582 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -47.69 115.4 1.13 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 128.369 2.667 . . . . 0.0 113.64 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.6 p -67.04 158.12 31.8 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 109.965 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.0 134.79 24.44 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.49 156.78 49.72 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.672 2.248 . . . . 0.0 110.005 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.437 ' HA ' ' CD1' ' A' ' 176' ' ' TRP . 42.7 ttt180 -56.58 -30.46 63.2 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t -66.96 -7.59 23.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.352 0.978 . . . . 0.0 111.753 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.06 -7.59 14.91 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.14 1.376 . . . . 0.0 110.885 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.437 ' CD1' ' HA ' ' A' ' 173' ' ' ARG . 34.2 m0 . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 99.9 m -139.96 115.65 10.14 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -94.06 112.55 24.38 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . 0.512 ' CB ' ' HE ' ' A' ' 161' ' ' ARG . 17.7 m0 -121.9 115.87 23.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.71 138.12 48.28 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.235 1.414 . . . . 0.0 109.151 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.569 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.6 m-30 -88.55 102.01 14.51 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 177.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.31 159.11 17.21 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 130.399 3.857 . . . . 0.0 107.753 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -66.51 158.25 30.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.162 1.934 . . . . 0.0 112.581 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.4 HD13 ' CD2' ' A' ' 121' ' ' PHE . 41.8 mt -105.02 142.09 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.599 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -132.52 151.62 51.85 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.226 1.41 . . . . 0.0 109.654 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 55.2 p -76.23 173.19 11.68 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.1 mt -125.41 146.13 31.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 122.127 0.965 . . . . 0.0 109.316 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -68.65 125.03 25.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.14 26.31 73.39 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.287 1.423 . . . . 0.0 113.867 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -145.93 152.38 39.35 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.6 m -106.64 151.12 25.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.453 HD13 ' HB3' ' A' ' 210' ' ' PHE . 3.0 mm? -55.56 -27.69 50.59 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.122 0.569 . . . . 0.0 110.711 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 7.7 p -71.66 -13.42 61.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.122 2.169 . . . . 0.0 114.443 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -124.69 -38.5 2.37 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.234 1.414 . . . . 0.0 112.077 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.18 142.07 5.77 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.517 1.053 . . . . 0.0 110.528 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.453 ' HB3' HD13 ' A' ' 206' ' ' LEU . 45.6 p90 -154.23 174.5 14.69 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.608 0.363 . . . . 0.0 111.494 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -110.65 132.19 54.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.98 1.312 . . . . 0.0 109.7 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.69 124.95 66.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.467 1.507 . . . . 0.0 109.357 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -71.54 109.51 5.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.37 124.17 71.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 54.26 44.08 29.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.682 0.674 . . . . 0.0 110.006 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 26.7 t70 59.08 20.55 8.45 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.3 0.64 . . . . 0.0 112.059 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.444 ' HB3' ' HE2' ' A' ' 219' ' ' LYS . 0.5 OUTLIER -129.61 122.45 29.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.958 1.303 . . . . 0.0 108.579 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -71.24 117.84 13.27 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.33 -1.481 . . . . 0.0 110.093 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 217' ' ' ASP . 51.0 mmtt -111.38 147.63 34.78 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.708 1.603 . . . . 0.0 110.329 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.4 tm? -80.79 139.44 36.04 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.235 1.014 . . . . 0.0 111.198 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.89 139.35 52.66 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.332 1.453 . . . . 0.0 107.122 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.1 p -126.23 155.48 41.78 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.141 0.976 . . . . 0.0 111.683 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -64.9 143.12 58.16 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.784 -0.572 . . . . 0.0 111.072 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.972 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -68.81 146.4 52.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.4 t -140.02 132.68 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.525 HD13 ' CE2' ' A' ' 195' ' ' TYR . 5.3 mp -77.21 122.58 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -56.85 128.05 34.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.811 1.291 . . . . 0.0 109.507 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 125' ' ' LYS . 20.0 pttm -70.37 -22.89 62.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.444 1.098 . . . . 0.0 110.382 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.07 -42.2 19.54 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 123.637 0.775 . . . . 0.0 109.86 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -133.16 105.62 7.13 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.5 m -62.27 -23.48 66.72 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.189 -1.57 . . . . 0.0 112.478 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -81.27 -2.68 49.86 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.028 1.331 . . . . 0.0 111.125 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -109.89 159.8 16.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.453 0.701 . . . . 0.0 109.848 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.1 mm -125.47 133.0 70.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.31 111.16 23.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 101.477 -3.527 . . . . 0.0 101.477 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -147.8 137.97 22.88 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.16 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.3 mtt 51.72 28.73 5.09 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.22 18.0 79.71 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.406 -0.809 . . . . 0.0 111.522 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -120.43 163.71 17.48 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.472 1.109 . . . . 0.0 108.654 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.6 mm -119.14 134.08 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -126.97 148.92 50.07 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.8 t -131.51 130.32 42.22 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.464 2.306 . . . . 0.0 110.589 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.63 130.39 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.462 1.505 . . . . 0.0 108.819 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.3 t -102.57 -134.88 0.32 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 101.494 -3.521 . . . . 0.0 101.494 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -145.65 98.31 3.11 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 102.526 -3.138 . . . . 0.0 102.526 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.6 m -136.4 111.38 8.88 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 130.752 3.621 . . . . 0.0 108.999 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.9 m -68.7 127.85 34.54 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.714 1.597 . . . . 0.0 107.775 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.6 t -94.66 126.19 47.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.6 m -87.97 159.51 18.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.59 0.71 . . . . 0.0 110.213 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -56.56 -35.6 68.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.843 1.657 . . . . 0.0 109.913 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.56 -19.36 62.08 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.201 1.0 . . . . 0.0 111.809 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.72 -27.87 11.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.227 1.411 . . . . 0.0 110.763 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.97 112.79 2.73 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.596 1.558 . . . . 0.0 109.68 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.48 -102.44 0.08 OUTLIER Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.031 0.824 . . . . 0.0 111.865 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -134.76 161.82 34.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.735 1.214 . . . . 0.0 110.289 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -56.46 130.63 45.73 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.527 1.131 . . . . 0.0 109.969 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -109.11 -48.93 3.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 117.286 -1.34 . . . . 0.0 112.394 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -164.3 158.76 19.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.07 1.304 . . . . 0.0 109.406 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.3 p -108.02 141.12 24.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.579 1.152 . . . . 0.0 111.271 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mp -112.85 163.22 14.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.006 2.523 . . . . 0.0 110.365 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -166.81 39.57 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.544 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 21.4 mt-10 -141.86 176.71 8.72 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.181 -2.199 . . . . 0.0 110.35 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.9 t -138.12 151.47 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 120.071 1.305 . . . . 0.0 111.007 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.495 ' HE ' ' CB ' ' A' ' 193' ' ' TRP . 0.2 OUTLIER -130.34 156.91 43.9 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 120.953 -1.092 . . . . 0.0 109.683 177.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.1 t -138.22 113.89 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -134.23 158.3 44.08 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.621 -0.674 . . . . 0.0 110.212 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -85.26 99.99 11.49 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 103.103 -2.925 . . . . 0.0 103.103 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.7 m -59.28 -9.06 1.94 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 126.735 2.014 . . . . 0.0 116.267 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.8 m -66.12 -38.82 82.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.439 ' HB3' ' HE2' ' A' ' 169' ' ' LYS . 0.4 OUTLIER -123.43 -24.12 4.67 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.648 1.579 . . . . 0.0 112.286 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.18 8.53 60.08 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 127.224 2.345 . . . . 0.0 110.564 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 167' ' ' SER . 27.2 mtmt -61.27 115.95 4.22 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.074 1.75 . . . . 0.0 110.253 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 70.4 p -67.28 153.75 42.94 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.119 0.968 . . . . 0.0 112.366 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.58 136.31 26.5 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.2 163.72 24.96 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.548 2.165 . . . . 0.0 110.998 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -58.44 -21.87 52.47 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.578 1.551 . . . . 0.0 114.737 -178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.3 m -80.46 -7.57 59.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.982 0.81 . . . . 0.0 110.517 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -113.1 9.32 18.55 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.648 1.579 . . . . 0.0 110.945 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 39.1 m0 . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 125.254 1.422 . . . . 0.0 114.068 177.943 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.414 0.626 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 37.6 m -139.72 135.67 33.4 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -113.15 106.87 15.17 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.883 1.673 . . . . 0.0 107.321 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . 0.495 ' CB ' ' HE ' ' A' ' 161' ' ' ARG . 24.6 m0 -110.78 115.63 29.88 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.612 0.765 . . . . 0.0 110.385 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.21 138.34 38.6 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.777 1.631 . . . . 0.0 106.838 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.544 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.9 m-30 -85.97 105.91 16.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -105.8 158.67 15.62 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 127.801 2.62 . . . . 0.0 108.037 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.11 156.49 36.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 124.741 2.21 . . . . 0.0 113.05 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 38.9 mt -100.9 141.0 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 111.795 -2.457 . . . . 0.0 110.179 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -133.83 152.51 51.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.548 1.539 . . . . 0.0 109.64 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 91.5 p -74.69 172.69 11.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.459 0.704 . . . . 0.0 110.152 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 5.3 mt -127.71 135.46 63.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 121.458 -0.776 . . . . 0.0 110.257 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -65.14 126.15 27.21 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.85 12.44 84.43 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.205 -1.331 . . . . 0.0 116.01 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -138.75 157.75 45.5 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.617 1.709 . . . . 0.0 108.175 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 62.1 m -106.48 145.72 31.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.63 -31.14 64.04 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 29.8 p -66.32 -12.37 56.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.178 1.791 . . . . 0.0 113.903 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -124.66 -35.39 2.73 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.688 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.27 145.36 6.94 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 119.217 0.917 . . . . 0.0 110.964 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.57 173.23 16.61 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.048 0.385 . . . . 0.0 111.221 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.62 132.52 54.06 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 124.509 1.124 . . . . 0.0 111.774 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.81 130.36 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.947 1.299 . . . . 0.0 108.513 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -69.91 103.11 2.13 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 33.8 mm -121.56 123.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.293 1.437 . . . . 0.0 110.251 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 61.52 38.15 15.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.194 0.997 . . . . 0.0 109.317 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 65.31 16.31 10.47 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.617 1.567 . . . . 0.0 111.313 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.56 129.15 38.65 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -67.97 122.23 17.77 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 119.962 -1.711 . . . . 0.0 109.15 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -119.02 146.2 45.23 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.815 1.246 . . . . 0.0 111.387 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -78.83 133.12 37.04 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.937 1.295 . . . . 0.0 112.032 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -121.69 131.31 54.02 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.81 150.21 33.82 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.189 0.596 . . . . 0.0 110.025 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -70.08 122.09 18.73 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.329 -0.302 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.222 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.208 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -75.96 124.56 27.56 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.0 t -124.78 136.88 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 126.029 1.732 . . . . 0.0 107.026 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.404 HD11 HD12 ' A' ' 157' ' ' LEU . 5.1 mp -86.43 138.89 18.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -64.27 123.3 18.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 123.03 1.395 . . . . 0.0 108.419 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -61.02 -27.05 68.04 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.788 1.235 . . . . 0.0 111.105 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -80.87 -46.09 15.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.21 105.61 8.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.428 1.491 . . . . 0.0 112.946 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -58.67 -19.5 39.96 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 120.343 -1.473 . . . . 0.0 112.258 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -85.21 -7.85 58.84 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.278 -0.889 . . . . 0.0 110.658 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -101.41 149.47 24.02 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.838 0.744 . . . . 0.0 109.559 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.1 mm -126.86 119.15 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.09 97.29 9.82 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 128.372 2.669 . . . . 0.0 109.114 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -132.41 142.5 49.31 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 121.576 1.989 . . . . 0.0 109.975 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 8.4 mtt 49.87 23.32 1.02 Allowed 'General case' 0 CA--C 1.544 0.739 0 O-C-N 119.992 -1.693 . . . . 0.0 114.714 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.64 5.25 78.68 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 119.604 1.093 . . . . 0.0 112.089 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -100.23 172.86 6.9 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 125.099 1.36 . . . . 0.0 111.626 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.5 mm -136.4 125.7 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -114.13 161.07 18.24 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.449 ' HB2' HG11 ' A' ' 224' ' ' VAL . 25.9 t -143.04 139.32 30.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.434 1.494 . . . . 0.0 109.999 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.1 mt -100.85 137.68 27.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 123.929 0.892 . . . . 0.0 109.233 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.7 m -118.17 -112.79 0.34 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -159.98 98.72 1.34 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 122.689 2.495 . . . . 0.0 108.109 175.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 54.3 m -137.42 113.88 10.21 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 127.323 2.249 . . . . 0.0 105.537 175.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.6 m -76.61 126.9 31.79 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 104.419 -2.438 . . . . 0.0 104.419 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.7 t -93.72 111.7 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.1 m -74.61 158.27 33.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.959 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.96 -28.82 67.97 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.998 0.519 . . . . 0.0 111.481 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.71 -12.58 61.59 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.94 -0.475 . . . . 0.0 111.222 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -114.04 -24.1 9.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.507 1.523 . . . . 0.0 110.791 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.2 mt -65.63 135.38 54.95 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.62 -106.14 0.91 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 107.401 -2.28 . . . . 0.0 107.401 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.31 167.04 21.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.595 1.958 . . . . 0.0 109.325 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -57.63 150.07 20.18 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.097 0.951 . . . . 0.0 112.532 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -125.99 -50.75 1.57 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.901 -1.524 . . . . 0.0 112.325 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.93 163.17 29.23 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 121.297 1.862 . . . . 0.0 110.619 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.2 139.75 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 119.122 0.874 . . . . 0.0 111.716 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 123' ' ' ILE . 4.4 mm? -110.93 164.8 12.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.452 2.301 . . . . 0.0 110.462 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.6 59.92 0.07 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.086 0.954 . . . . 0.0 112.619 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -156.34 172.8 17.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.879 -1.138 . . . . 0.0 108.287 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 t -143.98 149.41 17.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.91 164.6 31.47 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 63.0 t -131.28 136.74 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -147.62 163.85 35.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.65 0.78 . . . . 0.0 111.994 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.55 100.67 10.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -62.53 -12.35 21.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.5 m -65.58 -44.14 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 121.674 -0.642 . . . . 0.0 110.827 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.442 ' HB2' ' HE2' ' A' ' 169' ' ' LYS . 32.3 m -121.62 -20.57 6.47 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 125.54 1.536 . . . . 0.0 113.233 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.48 5.78 57.74 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.457 1.027 . . . . 0.0 111.753 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.442 ' HE2' ' HB2' ' A' ' 167' ' ' SER . 45.1 mtmt -61.27 112.8 2.29 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.49 1.116 . . . . 0.0 108.162 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 p -63.29 151.31 40.99 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.22 141.68 26.8 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.912 1.285 . . . . 0.0 107.664 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -82.43 160.2 17.18 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.955 2.437 . . . . 0.0 108.488 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 ttp85 -53.12 -27.28 20.02 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.225 1.01 . . . . 0.0 113.372 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.2 t -65.67 -13.66 59.65 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.074 1.749 . . . . 0.0 112.4 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.58 -1.55 13.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 119.706 -1.871 . . . . 0.0 110.598 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.5 m0 . . . . . 0 CA--C 1.541 0.628 0 O-C-N 121.556 -0.715 . . . . 0.0 109.901 179.183 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.1 mtt85 . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 110.661 -0.126 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.9 m -144.86 132.69 21.2 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 127.187 2.195 . . . . 0.0 107.025 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -108.76 109.67 20.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.859 2.063 . . . . 0.0 106.609 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -115.72 116.78 28.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.764 1.225 . . . . 0.0 112.281 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -84.0 133.32 34.68 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.103 1.361 . . . . 0.0 109.318 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.14 101.33 7.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.47 1.108 . . . . 0.0 109.417 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -96.11 158.45 21.79 Favored Glycine 0 CA--C 1.534 1.27 1 C-N-CA 134.549 5.833 . . . . 0.0 107.608 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -68.25 157.16 36.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.338 1.569 . . . . 0.0 113.13 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 62.2 mt -101.11 139.81 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 126.744 2.018 . . . . 0.0 109.583 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -133.1 152.33 51.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.502 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 18.9 t -76.99 172.96 12.35 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 35.8 mt -129.06 141.9 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 122.824 1.297 . . . . 0.0 107.691 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 -65.81 121.49 15.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.175 1.39 . . . . 0.0 109.351 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.54 15.4 80.5 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.395 -1.225 . . . . 0.0 113.612 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -136.49 132.19 34.99 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.992 1.896 . . . . 0.0 110.018 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.4 m -81.13 150.63 28.64 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.77 -29.84 63.01 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.345 -0.847 . . . . 0.0 109.951 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.1 p -67.54 -20.64 65.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.151 2.18 . . . . 0.0 114.025 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -112.13 -41.71 3.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 117.787 -1.101 . . . . 0.0 110.313 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.71 142.69 3.77 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.124 0.874 . . . . 0.0 109.863 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -151.47 175.62 12.11 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.691 0.796 . . . . 0.0 109.426 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.56 132.7 53.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.239 1.415 . . . . 0.0 110.327 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.48 124.77 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 C-N-CA 125.316 1.446 . . . . 0.0 107.836 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -72.9 109.49 6.51 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 50.4 mm -121.83 118.07 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 126.071 1.749 . . . . 0.0 109.224 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.58 47.4 16.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.242 1.017 . . . . 0.0 109.511 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.82 10.98 6.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.52 1.128 . . . . 0.0 111.441 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.26 123.46 38.17 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.205 -1.559 . . . . 0.0 110.588 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -69.79 116.95 10.78 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.02 -1.05 . . . . 0.0 108.565 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -112.55 150.52 31.21 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.019 1.328 . . . . 0.0 109.756 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.2 tm? -82.38 135.07 35.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.21 1.004 . . . . 0.0 109.944 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.03 125.16 44.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.71 152.17 26.86 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.525 0.73 . . . . 0.0 112.001 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -60.8 139.18 58.01 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 122.205 -0.309 . . . . 0.0 110.319 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 139' ' ' SER . 11.4 p . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.227 -0.125 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -64.67 147.45 52.98 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.334 0.97 . . . . 0.0 108.597 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.2 t -150.53 132.11 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 123' ' ' ILE . 5.1 mp -72.18 139.5 19.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -60.31 118.64 6.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -19.59 37.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.749 -0.594 . . . . 0.0 111.749 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -96.04 -19.6 19.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.601 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.8 111.49 5.03 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.843 1.656 . . . . 0.0 108.731 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 163' ' ' PHE . 6.0 t -54.88 -32.83 61.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.055 1.342 . . . . 0.0 112.93 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.5 ptt85 -79.05 -1.27 34.91 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.236 -0.915 . . . . 0.0 112.32 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -110.35 157.09 19.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 118.585 0.629 . . . . 0.0 112.523 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.3 mm -127.31 141.74 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -115.68 103.0 10.25 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 129.404 3.082 . . . . 0.0 104.159 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -143.15 133.88 25.22 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.074 -1.016 . . . . 0.0 109.317 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 22.3 mtp 56.88 30.23 17.56 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.845 1.258 . . . . 0.0 112.615 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.71 8.73 73.12 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.899 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -106.97 168.64 9.06 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.602 1.561 . . . . 0.0 107.635 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.6 mm -120.23 141.2 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -133.04 143.91 49.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.7 t -135.19 151.25 50.47 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.774 1.229 . . . . 0.0 109.112 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 mt -101.0 137.75 27.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.788 0.835 . . . . 0.0 110.419 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.9 t -101.57 -111.17 0.21 Allowed 'General case' 0 CA--C 1.537 0.46 1 N-CA-C 98.714 -4.551 . . . . 0.0 98.714 175.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -166.9 99.12 0.55 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.8 m -135.67 112.97 10.56 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 127.764 2.426 . . . . 0.0 105.583 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.1 m -68.54 123.29 20.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.67 116.14 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.8 m -83.96 158.64 21.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.167 0.508 . . . . 0.0 110.964 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -57.32 -32.75 67.0 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.188 1.795 . . . . 0.0 111.386 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.82 -8.79 55.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.88 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -121.72 -20.93 6.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.436 1.094 . . . . 0.0 109.658 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.0 tp -66.26 151.36 47.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.31 -102.59 2.72 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -134.65 165.15 25.89 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.85 0.86 . . . . 0.0 110.942 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -62.44 143.31 57.24 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -123.59 -52.05 1.82 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.878 -1.058 . . . . 0.0 111.535 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.82 173.86 16.35 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.924 0.783 . . . . 0.0 110.071 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.8 p -129.92 147.29 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.419 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.2 mm? -111.78 166.54 11.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.274 3.029 . . . . 0.0 112.952 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -162.87 45.61 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.68 174.46 10.95 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 119.802 -1.811 . . . . 0.0 108.621 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.0 t -142.22 149.81 19.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.308 1.043 . . . . 0.0 108.351 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -145.18 161.11 40.31 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.893 -1.129 . . . . 0.0 108.847 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 191' ' ' THR . 92.2 t -127.32 126.93 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 128' ' ' SER . 52.9 p90 -148.17 165.34 31.19 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.535 0.734 . . . . 0.0 111.18 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -80.88 109.67 15.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.119 1.767 . . . . 0.0 108.195 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.9 t -50.49 -23.44 2.48 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.713 2.805 . . . . 0.0 115.269 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.47 -39.56 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.4 t -122.12 -24.99 4.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.73 -1.02 52.38 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.89 1.233 . . . . 0.0 112.52 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -51.69 112.35 0.75 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.39 1.876 . . . . 0.0 110.23 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 25.9 p -72.7 156.48 38.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.633 0.73 . . . . 0.0 110.52 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.58 136.79 25.6 Favored Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.81 162.87 32.05 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.722 2.282 . . . . 0.0 109.561 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -58.71 -31.85 68.64 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.558 0.343 . . . . 0.0 111.864 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.8 m -67.54 -4.39 11.46 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.28 -0.93 10.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.829 1.252 . . . . 0.0 110.274 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 42.2 m0 . . . . . 0 N--CA 1.464 0.251 0 O-C-N 120.064 -1.648 . . . . 0.0 111.751 -179.312 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 121.055 0.455 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 0.3 OUTLIER -133.3 147.21 51.88 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 130.721 3.609 . . . . 0.0 105.881 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -129.11 104.94 7.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 102.923 -2.992 . . . . 0.0 102.923 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -111.49 116.21 30.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -83.53 129.34 34.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.261 1.424 . . . . 0.0 107.956 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -74.76 100.71 4.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.497 0.719 . . . . 0.0 109.239 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.3 159.66 27.56 Favored Glycine 0 CA--C 1.53 1.019 1 C-N-CA 132.631 4.92 . . . . 0.0 110.267 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.43 162.7 22.49 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 122.403 1.097 . . . . 0.0 109.304 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 97.4 mt -109.31 131.77 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 127.262 2.225 . . . . 0.0 112.072 -176.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -128.2 149.99 50.21 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.121 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 63.3 m -79.24 172.53 13.68 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.03 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 72.0 mt -128.62 139.02 53.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.315 1.446 . . . . 0.0 107.284 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -68.99 122.18 18.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.18 13.43 77.01 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 118.763 -1.02 . . . . 0.0 113.457 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -139.9 123.78 17.52 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 119.499 1.649 . . . . 0.0 109.988 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 54.8 m -79.6 150.91 30.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.01 -23.54 54.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.878 0.871 . . . . 0.0 110.284 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 17.0 p -76.09 -9.49 58.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.316 2.246 . . . . 0.0 113.513 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -123.95 -47.26 1.93 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.894 1.277 . . . . 0.0 110.081 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.88 148.27 13.77 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -155.14 175.84 13.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -108.36 144.44 35.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.56 124.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.767 2.027 . . . . 0.0 109.172 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -73.97 107.5 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 47.4 mm -121.84 125.76 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 109.76 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 54.32 44.43 28.99 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.013 0.824 . . . . 0.0 109.748 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 65.42 0.21 1.33 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.642 1.977 . . . . 0.0 113.974 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -121.23 127.87 51.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.949 0.795 . . . . 0.0 109.111 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -66.0 136.6 56.27 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.329 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -128.87 145.95 51.07 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.928 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.35 133.08 35.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.899 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -121.71 138.19 54.45 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 23.9 p -120.78 149.41 42.6 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 123.677 0.611 . . . . 0.0 112.632 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -61.12 143.01 56.27 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 177.345 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.786 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.447 ' H ' ' HD1' ' A' ' 121' ' ' PHE . 1.6 p90 -71.59 127.67 33.32 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 129.508 3.123 . . . . 0.0 106.285 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.7 126.11 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.9 mp -68.88 133.17 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -66.27 128.23 35.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.42 -22.4 66.95 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.627 0.771 . . . . 0.0 111.135 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -81.25 -47.33 13.51 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.557 1.143 . . . . 0.0 109.605 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -140.74 106.05 5.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.366 1.466 . . . . 0.0 108.742 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 m -62.69 -12.28 22.63 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 120.362 -1.461 . . . . 0.0 112.259 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -85.13 1.84 46.17 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.417 1.087 . . . . 0.0 109.446 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -113.98 162.11 16.83 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.558 1.143 . . . . 0.0 109.06 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.9 mm -132.94 128.23 56.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -106.16 110.46 22.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.533 2.333 . . . . 0.0 106.567 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -146.26 128.76 16.0 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.455 1.102 . . . . 0.0 108.755 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.2 mtt 60.82 39.94 16.47 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.953 1.701 . . . . 0.0 112.329 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 63.59 21.63 65.06 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.918 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -114.46 173.46 6.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.1 mm -132.9 132.41 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -124.55 156.19 37.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.7 t -131.11 150.62 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.934 1.694 . . . . 0.0 108.949 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.8 mt -120.34 127.63 75.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.9 t -103.97 -104.51 0.3 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -164.76 101.79 0.79 Allowed 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 178.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 86.6 m -135.37 113.66 11.44 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 126.728 2.011 . . . . 0.0 107.38 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.7 m -66.98 115.98 7.3 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.574 1.533 . . . . 0.0 109.399 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 66.7 t -95.27 115.55 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 m -82.26 158.55 23.45 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -63.76 -26.59 68.71 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.972 0.909 . . . . 0.0 111.559 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -66.99 -23.77 65.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.175 0.443 . . . . 0.0 110.533 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -99.82 -21.03 15.91 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.937 0.895 . . . . 0.0 110.014 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.23 148.91 48.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.819 1.248 . . . . 0.0 108.03 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.15 -106.54 2.69 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.37 170.67 15.58 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.62 1.168 . . . . 0.0 110.349 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -56.92 138.0 54.55 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.394 1.478 . . . . 0.0 109.154 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -126.3 -52.89 1.5 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 121' ' ' PHE . 29.5 m-20 -139.66 156.6 46.74 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.548 0.613 . . . . 0.0 110.217 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.3 p -120.36 133.45 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.381 0.61 . . . . 0.0 111.833 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.418 HD21 HD12 ' A' ' 198' ' ' ILE . 4.1 mm? -112.3 164.15 13.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.954 2.102 . . . . 0.0 112.252 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.44 42.05 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.749 1.22 . . . . 0.0 112.536 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.407 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 1.5 tt0 -140.39 175.59 9.47 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 119.068 -2.27 . . . . 0.0 108.987 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 t -143.08 149.52 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.84 165.8 26.53 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.449 HG12 ' HG3' ' A' ' 190' ' ' ARG . 21.3 t -133.75 129.19 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -141.99 157.36 45.04 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 119.881 1.219 . . . . 0.0 111.414 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -62.19 121.17 12.42 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.877 0.871 . . . . 0.0 109.574 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.15 -14.2 59.99 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.52 -38.68 12.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.0 t -123.0 -27.13 4.27 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.24 6.62 53.34 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.258 0.932 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -55.68 114.44 1.87 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.761 1.624 . . . . 0.0 108.517 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.08 132.84 55.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.022 0.828 . . . . 0.0 109.198 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -92.76 144.46 28.62 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.36 153.78 45.37 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.59 2.193 . . . . 0.0 110.201 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -56.95 -36.31 70.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.565 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.6 t -63.39 -2.63 1.59 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -118.18 -1.26 11.39 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.202 1.364 . . . . 0.0 111.966 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 36.5 m0 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 125.242 1.417 . . . . 0.0 113.653 -179.861 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.449 ' HG3' HG12 ' A' ' 162' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.242 0.544 . . . . 0.0 110.351 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.0 m -91.88 137.41 32.39 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.701 2.0 . . . . 0.0 106.388 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -119.48 109.88 16.25 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.842 2.057 . . . . 0.0 106.949 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -115.38 119.62 36.85 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.768 2.027 . . . . 0.0 110.797 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -86.82 134.46 33.55 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 128.363 2.665 . . . . 0.0 110.031 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.444 ' CE2' HD13 ' A' ' 123' ' ' ILE . 3.2 m-30 -80.35 102.28 9.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.475 1.51 . . . . 0.0 110.477 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -95.49 158.66 22.22 Favored Glycine 0 CA--C 1.533 1.196 1 C-N-CA 133.042 5.115 . . . . 0.0 107.475 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.85 159.42 30.44 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 123.62 1.676 . . . . 0.0 110.62 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.418 HD12 HD21 ' A' ' 157' ' ' LEU . 57.7 mt -111.73 141.1 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.705 1.602 . . . . 0.0 109.982 -176.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -134.43 147.5 50.45 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.324 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.61 173.44 6.07 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.8 mt -128.89 141.4 46.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.206 1.403 . . . . 0.0 108.509 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.87 124.7 24.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.4 17.35 76.26 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-O 117.493 -1.726 . . . . 0.0 114.841 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -147.63 134.44 20.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.105 1.952 . . . . 0.0 111.255 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.0 m -84.87 151.16 24.49 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.22 -30.64 62.61 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.327 -0.858 . . . . 0.0 109.864 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 66.9 p -73.18 -4.25 31.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.928 1.691 . . . . 0.0 114.458 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -125.12 -40.98 2.1 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.831 1.652 . . . . 0.0 109.515 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.05 144.6 2.71 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 118.858 0.754 . . . . 0.0 109.736 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -152.41 175.63 12.5 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.966 0.907 . . . . 0.0 109.198 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -112.47 134.72 53.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.041 1.336 . . . . 0.0 110.547 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.5 124.54 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 C-N-CA 124.153 0.981 . . . . 0.0 108.635 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -70.29 104.39 2.66 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 41.5 mm -121.77 133.22 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 54.77 39.7 31.53 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.06 3.31 2.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.837 2.455 . . . . 0.0 113.642 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -119.43 125.29 48.58 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.706 1.203 . . . . 0.0 111.492 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -64.28 113.19 3.43 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.571 0.748 . . . . 0.0 112.635 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -105.97 147.29 28.99 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 122.184 0.992 . . . . 0.0 110.908 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -86.18 123.12 31.11 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.428 1.491 . . . . 0.0 108.805 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -107.54 144.23 34.82 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.7 p -118.05 147.37 43.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.784 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -62.15 142.81 57.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.646 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.031 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -75.11 138.56 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.0 t -139.55 132.01 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 157' ' ' LEU . 5.1 mp -78.64 128.63 38.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 177.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -61.56 122.34 15.0 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.51 1.148 . . . . 0.0 108.892 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.1 pttt -62.27 -23.01 66.46 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.362 -0.836 . . . . 0.0 110.358 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -85.01 -22.92 28.88 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.605 1.162 . . . . 0.0 110.603 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.84 102.45 2.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 119.667 1.122 . . . . 0.0 108.294 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.0 m -57.53 -24.93 58.85 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.884 0.873 . . . . 0.0 112.756 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.6 ptt85 -81.23 -3.79 53.46 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.923 0.889 . . . . 0.0 111.302 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -108.25 151.86 25.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.634 0.73 . . . . 0.0 110.089 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 14.2 mm -120.8 142.02 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -117.45 104.06 10.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.904 2.482 . . . . 0.0 106.051 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -127.26 133.97 50.12 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.0 mtt 56.3 13.44 1.26 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.043 -1.661 . . . . 0.0 113.281 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.73 6.6 65.49 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.879 1.228 . . . . 0.0 110.66 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -97.61 154.11 17.76 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 119.055 1.427 . . . . 0.0 107.917 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mm -118.09 140.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 O-C-N 124.358 1.036 . . . . 0.0 110.058 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -123.35 168.85 11.97 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.76 1.224 . . . . 0.0 110.528 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.47 135.51 25.16 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.453 1.501 . . . . 0.0 109.412 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 mt -97.89 119.0 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.1 t -94.87 -105.25 0.14 Allowed 'General case' 0 C--O 1.234 0.255 1 N-CA-C 99.717 -4.179 . . . . 0.0 99.717 176.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -167.03 99.34 0.53 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 4.5 m -136.29 121.46 19.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 128.332 2.653 . . . . 0.0 103.93 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.5 m -76.59 128.42 34.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.27 111.69 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.435 1.016 . . . . 0.0 109.583 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.2 m -81.96 162.95 22.49 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.027 0.531 . . . . 0.0 110.347 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.44 -27.0 65.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.248 1.819 . . . . 0.0 112.521 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.35 -22.07 61.95 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.204 -0.31 . . . . 0.0 110.213 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.82 -26.79 13.01 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.287 1.035 . . . . 0.0 109.433 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.8 tp -65.08 152.68 42.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -111.2 -102.64 2.67 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 125.037 1.303 . . . . 0.0 109.925 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -134.54 167.49 20.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.532 1.133 . . . . 0.0 110.858 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -60.07 140.93 56.53 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.024 1.33 . . . . 0.0 108.178 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -124.49 -47.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.598 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.99 158.16 40.19 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.325 1.42 . . . . 0.0 111.197 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.35 135.1 57.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.754 0.788 . . . . 0.0 111.292 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.409 HD12 HD11 ' A' ' 123' ' ' ILE . 4.2 mm? -111.27 165.92 11.53 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.041 2.936 . . . . 0.0 110.324 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.46 51.99 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.652 1.181 . . . . 0.0 113.143 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.36 175.85 9.6 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 119.618 -1.926 . . . . 0.0 107.681 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.66 142.58 23.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.93 161.1 38.15 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 191' ' ' THR . 71.6 t -129.89 124.2 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.74 169.24 18.09 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.289 0.95 . . . . 0.0 110.877 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -81.08 117.78 21.95 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -15.74 60.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.7 m -82.96 -41.19 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.0 -1.063 . . . . 0.0 113.779 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.409 ' HB2' ' HD3' ' A' ' 169' ' ' LYS . 68.2 m -122.36 -27.61 4.43 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 125.294 1.438 . . . . 0.0 113.456 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.32 7.59 37.21 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 117.118 1.607 . . . . 0.0 117.118 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.418 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -60.51 113.25 2.33 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.982 1.313 . . . . 0.0 110.551 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.2 p -70.58 149.48 47.04 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.749 1.22 . . . . 0.0 109.793 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.416 HG22 ' CD1' ' A' ' 176' ' ' TRP . 1.2 mp -117.41 139.3 25.94 Favored Pre-proline 0 N--CA 1.44 -0.964 0 C-N-CA 125.527 1.531 . . . . 0.0 107.236 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.56 153.4 20.49 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.798 2.332 . . . . 0.0 109.33 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -51.21 -33.47 27.79 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.821 1.249 . . . . 0.0 111.573 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -3.47 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.556 1.142 . . . . 0.0 113.283 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -129.72 6.93 5.18 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.359 1.863 . . . . 0.0 113.242 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.416 ' CD1' HG22 ' A' ' 171' ' ' ILE . 40.9 m0 . . . . . 0 CA--C 1.547 0.83 0 C-N-CA 124.409 1.083 . . . . 0.0 112.713 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.0 mmp_? . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 28.7 m -128.61 150.77 50.08 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 128.363 2.665 . . . . 0.0 105.99 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -124.37 109.02 12.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -110.44 116.26 31.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.829 1.652 . . . . 0.0 110.903 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.29 123.67 31.03 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 128.119 2.568 . . . . 0.0 107.405 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -72.19 101.18 2.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 118.951 0.796 . . . . 0.0 109.468 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.2 159.0 27.19 Favored Glycine 0 N--CA 1.44 -1.094 1 C-N-CA 131.67 4.462 . . . . 0.0 107.392 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -68.26 160.06 30.03 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.43 1.586 . . . . 0.0 111.267 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 77.6 mt -106.76 141.13 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.136 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -132.91 151.8 51.99 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.574 1.55 . . . . 0.0 110.528 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.4 t -78.29 173.05 12.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.904 0.882 . . . . 0.0 108.662 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.1 mt -129.63 140.3 49.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 122.477 1.132 . . . . 0.0 108.721 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -66.26 119.64 11.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.303 1.441 . . . . 0.0 107.821 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.88 2.44 88.5 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.31 -1.272 . . . . 0.0 114.962 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -126.39 132.79 51.46 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.91 1.855 . . . . 0.0 109.075 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 16.2 m -85.78 150.73 24.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -28.37 63.29 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 124.202 1.001 . . . . 0.0 110.075 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.6 p -72.02 -11.18 60.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.115 2.166 . . . . 0.0 114.195 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -120.47 -47.62 2.33 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.514 1.526 . . . . 0.0 109.549 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.25 144.51 12.76 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 111.084 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -150.05 175.77 11.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.738 0.415 . . . . 0.0 109.984 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.15 128.89 55.39 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.828 0.851 . . . . 0.0 110.324 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.0 128.27 71.74 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 C-N-CA 124.697 1.199 . . . . 0.0 107.855 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.05 110.26 7.2 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.6 mm -121.77 124.08 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 53.5 48.14 22.44 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.092 0.86 . . . . 0.0 109.087 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 65.48 -4.26 0.59 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.649 2.379 . . . . 0.0 115.014 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -114.9 135.59 54.03 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.094 0.861 . . . . 0.0 109.771 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -72.92 115.36 12.13 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.152 0.981 . . . . 0.0 110.26 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 146.98 34.36 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.9 tm? -79.31 136.79 37.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.86 1.264 . . . . 0.0 108.229 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.05 137.36 53.63 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.0 p -121.3 150.38 41.5 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.41 0.444 . . . . 0.0 111.974 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -55.01 133.51 48.59 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.222 -0.367 0 C-N-CA 126.401 1.881 . . . . 0.0 108.017 179.065 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.23 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 155' ' ' ASP . 18.9 p90 -66.43 149.78 49.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 97.3 t -149.72 126.25 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.8 mp -71.94 134.13 30.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.52 117.52 6.32 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -24.49 19.97 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.71 0.804 . . . . 0.0 111.53 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -89.19 -22.59 22.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.368 1.467 . . . . 0.0 112.396 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.11 104.33 3.67 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 119.565 1.075 . . . . 0.0 108.273 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.4 t -60.14 -22.33 62.73 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.342 -0.849 . . . . 0.0 112.814 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.0 ptt85 -80.69 -4.83 55.8 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.35 -0.844 . . . . 0.0 110.598 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -109.6 159.28 17.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.816 0.817 . . . . 0.0 111.409 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.8 mm -130.38 146.77 33.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.04 104.75 9.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -141.06 134.43 29.74 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.05 1.34 . . . . 0.0 109.898 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.0 mtt 58.21 36.42 25.73 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.605 1.162 . . . . 0.0 112.109 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.05 22.85 63.16 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -121.88 161.51 22.66 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mm -116.37 145.24 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -135.15 156.94 48.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.45 ' HB2' HG11 ' A' ' 224' ' ' VAL . 8.0 t -139.19 165.14 27.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.4 mt -117.13 134.75 59.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.714 0.769 . . . . 0.0 110.699 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.31 -114.6 0.2 Allowed 'General case' 0 CA--C 1.539 0.521 1 N-CA-C 99.371 -4.307 . . . . 0.0 99.371 175.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -167.53 100.33 0.49 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 94.5 m -136.25 121.8 19.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.81 2.044 . . . . 0.0 106.75 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 m -71.5 121.45 18.69 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.87 110.68 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.5 m -70.85 159.53 34.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.06 0.457 . . . . 0.0 110.944 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.28 -29.86 69.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.546 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.95 -12.36 60.63 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -108.54 -23.04 12.01 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.485 1.114 . . . . 0.0 109.13 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.46 133.99 53.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.98 -105.86 0.74 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -135.85 166.86 22.31 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.613 1.565 . . . . 0.0 108.601 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -64.63 139.92 58.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -123.26 -48.03 1.99 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.573 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 28.3 m-20 -152.65 166.6 31.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.982 1.265 . . . . 0.0 111.32 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.24 143.17 40.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.572 1.149 . . . . 0.0 111.142 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -111.2 166.5 11.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.875 2.87 . . . . 0.0 112.706 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.15 58.83 0.29 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.182 0.993 . . . . 0.0 112.631 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -161.99 175.98 11.25 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.974 -1.704 . . . . 0.0 111.605 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -144.59 150.12 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.112 1.765 . . . . 0.0 108.557 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.8 164.71 29.36 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.039 1.29 . . . . 0.0 109.236 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.0 t -132.17 132.97 60.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -141.72 168.59 19.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.658 0.783 . . . . 0.0 111.271 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -89.49 102.86 15.54 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 127.022 2.129 . . . . 0.0 108.067 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.7 t -47.03 -21.23 0.2 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 129.507 3.123 . . . . 0.0 114.8 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.03 -50.91 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.432 1.493 . . . . 0.0 110.898 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.9 t -123.21 -23.84 4.81 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.858 1.663 . . . . 0.0 114.05 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.95 0.87 42.04 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.24 1.4 . . . . 0.0 110.364 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -48.13 113.5 0.75 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 127.712 2.405 . . . . 0.0 111.003 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 39.9 p -61.02 154.98 21.27 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.852 1.261 . . . . 0.0 111.299 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.99 142.44 41.19 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.28 1.032 . . . . 0.0 108.826 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.22 157.25 46.2 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.203 2.602 . . . . 0.0 108.98 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -57.68 -32.25 67.16 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.683 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -7.8 9.67 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 118.103 -0.951 . . . . 0.0 113.287 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -110.79 -8.59 14.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.4 1.454 . . . . 0.0 109.835 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.6 m0 . . . . . 0 C--O 1.236 0.363 0 CA-C-N 119.668 1.122 . . . . 0.0 112.176 -178.779 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.2 m -132.64 135.46 45.87 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 127.946 2.499 . . . . 0.0 106.626 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -114.42 108.34 16.75 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -110.23 123.87 50.56 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.591 1.556 . . . . 0.0 109.73 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -90.46 125.2 35.5 Favored 'General case' 0 N--CA 1.441 -0.893 1 C-N-CA 133.244 4.618 . . . . 0.0 109.087 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -77.74 101.88 6.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 127.327 2.251 . . . . 0.0 107.72 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -97.79 159.35 20.89 Favored Glycine 0 CA--C 1.533 1.218 1 C-N-CA 134.377 5.751 . . . . 0.0 108.049 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -66.6 163.19 19.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.939 1.369 . . . . 0.0 110.569 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 73.7 mt -109.31 134.95 49.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 128.138 2.575 . . . . 0.0 111.735 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -130.02 151.29 50.73 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.947 1.299 . . . . 0.0 110.239 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.3 p -78.59 173.53 12.32 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.518 ' CD1' HD23 ' A' ' 220' ' ' LEU . 50.3 mt -128.29 136.59 59.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 O-C-N 121.255 -0.903 . . . . 0.0 109.805 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -63.03 127.34 30.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.3 12.09 84.91 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.478 -1.179 . . . . 0.0 113.915 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -138.85 156.16 47.54 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 120.365 2.083 . . . . 0.0 109.168 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.2 m -103.32 146.62 28.19 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -23.34 58.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.875 0.87 . . . . 0.0 109.74 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 23.7 p -79.11 -9.5 59.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.721 1.608 . . . . 0.0 114.105 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -123.73 -40.63 2.31 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.678 0.791 . . . . 0.0 112.215 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.441 ' HB1' HD21 ' A' ' 220' ' ' LEU . . . -162.48 140.02 8.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -150.57 176.13 11.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -107.93 143.13 37.01 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.45 121.9 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.647 1.579 . . . . 0.0 108.768 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.85 104.37 4.0 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.1 mm -122.15 126.03 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 126.49 1.916 . . . . 0.0 109.273 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 58.54 34.76 24.15 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.844 -1.16 . . . . 0.0 112.236 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 66.1 13.77 9.28 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.366 1.066 . . . . 0.0 113.187 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.62 120.23 21.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.318 1.847 . . . . 0.0 108.634 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -65.6 136.65 56.62 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 120.103 -1.623 . . . . 0.0 109.965 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -127.15 147.9 50.18 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.026 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 201' ' ' ILE . 1.4 tm? -84.86 115.1 22.57 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.056 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.48 147.8 24.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.59 143.18 50.15 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 118.0 0.364 . . . . 0.0 110.571 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -50.86 135.3 24.41 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.209 1.404 . . . . 0.0 110.061 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' A' ' 139' ' ' SER . 4.8 p . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -65.0 118.51 9.22 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.722 1.609 . . . . 0.0 110.103 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.4 t -121.76 135.55 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -83.0 118.93 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -47.4 118.77 2.33 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.187 1.395 . . . . 0.0 110.486 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -59.98 -21.45 61.28 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.507 -0.746 . . . . 0.0 111.701 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -88.53 -20.05 25.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.083 0.953 . . . . 0.0 111.257 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.05 112.25 2.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.965 1.257 . . . . 0.0 110.64 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 m -60.27 -21.91 62.46 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 119.957 -1.714 . . . . 0.0 113.428 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.7 ptt85 -80.84 1.23 31.53 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 120.858 -1.151 . . . . 0.0 110.015 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -111.93 158.68 19.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.867 0.841 . . . . 0.0 110.277 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.0 mm -133.43 127.59 53.89 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 136' ' ' ASN . 4.7 t0 -96.91 105.0 17.05 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 128.086 2.554 . . . . 0.0 104.14 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -139.5 143.11 37.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.083 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 8.9 mtt 55.24 22.87 5.03 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.853 -1.154 . . . . 0.0 113.749 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.04 17.86 71.11 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.504 1.049 . . . . 0.0 110.983 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 8.9 p30 -117.28 173.84 6.46 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 126.588 1.955 . . . . 0.0 112.88 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.2 mm -130.04 132.33 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -119.33 163.55 17.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 t -140.02 148.12 41.39 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.578 1.551 . . . . 0.0 106.925 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 mt -114.08 121.74 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -94.85 -113.5 0.12 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -158.3 99.63 1.63 Allowed 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 65.0 m -136.95 116.42 12.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.004 2.522 . . . . 0.0 104.89 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.6 m -78.35 122.3 25.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 121.235 1.834 . . . . 0.0 106.595 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.7 t -94.67 113.05 28.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.018 1.327 . . . . 0.0 109.225 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.0 m -75.14 163.84 27.13 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.523 1.129 . . . . 0.0 111.18 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.24 -29.34 68.7 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.264 1.025 . . . . 0.0 110.168 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.02 -16.48 64.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.363 0.665 . . . . 0.0 112.062 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -105.35 -30.68 9.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.63 1.572 . . . . 0.0 109.83 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -55.67 127.27 29.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.951 1.3 . . . . 0.0 110.141 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.48 -104.83 1.25 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 125.235 1.398 . . . . 0.0 110.066 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -134.44 168.31 19.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.397 1.479 . . . . 0.0 109.296 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.42 136.95 58.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -115.18 -52.37 2.68 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.414 0.686 . . . . 0.0 111.784 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -160.37 159.9 31.68 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.77 1.168 . . . . 0.0 109.038 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 p -114.75 133.13 61.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.665 1.186 . . . . 0.0 111.402 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.61 164.9 12.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.966 2.106 . . . . 0.0 111.114 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.87 29.36 0.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.85 174.12 6.8 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 119.924 -1.735 . . . . 0.0 108.133 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.9 t -143.67 149.98 17.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.22 164.91 33.45 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.8 t -127.72 131.28 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -144.23 167.81 21.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.442 0.639 . . . . 0.0 110.172 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -79.99 119.16 22.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.1 t -66.21 -13.92 61.07 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.4 m -83.77 -43.61 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.7 m -122.19 -26.97 4.6 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.728 1.211 . . . . 0.0 113.919 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.31 -1.38 31.09 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.49 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -52.86 112.49 0.85 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.36 1.08 . . . . 0.0 111.599 -179.288 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.99 140.57 56.37 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.465 HG22 ' CD1' ' A' ' 176' ' ' TRP . 1.2 mp -106.88 143.39 26.99 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.32 1.848 . . . . 0.0 108.327 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.25 148.53 18.98 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.692 2.928 . . . . 0.0 110.896 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -53.38 -31.5 45.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.752 0.821 . . . . 0.0 112.892 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 t -68.76 -6.23 25.32 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.715 0.806 . . . . 0.0 112.998 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -116.4 -12.71 11.04 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.872 1.669 . . . . 0.0 110.201 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.465 ' CD1' HG22 ' A' ' 171' ' ' ILE . 40.3 m0 . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 . . . . . 0 C--O 1.233 0.208 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.43 HG22 ' CD1' ' A' ' 193' ' ' TRP . 95.5 m -128.66 117.78 21.77 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -95.03 113.12 24.79 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . 0.43 ' CD1' HG22 ' A' ' 191' ' ' THR . 12.4 m0 -123.38 124.5 43.06 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.702 1.601 . . . . 0.0 110.256 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.72 135.03 34.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.036 2.134 . . . . 0.0 107.512 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -78.3 100.52 6.76 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.69 159.55 23.1 Favored Glycine 0 N--CA 1.441 -0.984 1 C-N-CA 130.818 4.056 . . . . 0.0 107.514 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -68.14 154.33 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 123.655 1.693 . . . . 0.0 111.61 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.66 141.04 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 112.997 -1.911 . . . . 0.0 108.205 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -134.2 153.63 51.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 112.957 -1.929 . . . . 0.0 108.316 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.72 173.11 12.19 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 81.6 mt -124.14 137.5 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -55.71 119.58 5.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.162 1.385 . . . . 0.0 108.24 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.46 12.1 82.34 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.412 -1.215 . . . . 0.0 115.436 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -126.05 133.01 51.83 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 120.961 2.381 . . . . 0.0 109.568 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 67.9 m -83.53 142.78 30.64 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.47 -32.23 57.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.272 1.029 . . . . 0.0 110.501 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.2 p -70.12 -10.55 59.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.277 1.431 . . . . 0.0 114.516 -178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.02 -41.36 2.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.712 1.205 . . . . 0.0 109.097 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -166.93 151.61 7.3 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.002 0.819 . . . . 0.0 110.258 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -156.48 175.63 13.77 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.113 0.965 . . . . 0.0 109.565 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -112.13 137.0 50.81 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.889 1.276 . . . . 0.0 110.093 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.04 131.63 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.135 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 218' ' ' PHE . 19.6 tt0 -71.0 106.22 3.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 40.4 mm -122.4 125.16 72.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.1 m120 56.35 36.71 27.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 13.7 t0 70.87 -4.94 1.59 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.539 1.936 . . . . 0.0 112.095 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.6 127.31 52.96 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 118.931 -2.356 . . . . 0.0 110.73 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 213' ' ' GLU . 14.8 m-85 -74.43 116.52 15.21 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.583 -1.323 . . . . 0.0 109.979 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -107.11 147.81 29.57 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.766 0.826 . . . . 0.0 109.809 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.4 tm? -83.85 128.03 34.25 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.49 1.516 . . . . 0.0 109.296 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -111.54 151.72 28.36 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.085 0.954 . . . . 0.0 109.167 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.2 p -133.2 147.9 52.02 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.75 1.22 . . . . 0.0 111.088 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -59.94 128.86 38.96 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.717 -0.615 . . . . 0.0 112.042 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.214 -0.772 0 C-N-CA 125.596 1.558 . . . . 0.0 109.722 -179.726 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.821 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -71.49 132.16 44.34 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 127.719 2.407 . . . . 0.0 106.569 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 93.4 t -133.91 125.54 49.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.514 ' HA ' HD13 ' A' ' 131' ' ' ILE . 3.4 mp -69.4 134.71 29.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -57.4 118.28 4.98 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.73 -18.02 63.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.549 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -94.38 -28.05 15.73 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.076 0.951 . . . . 0.0 111.491 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -138.96 106.73 5.63 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.743 1.217 . . . . 0.0 109.66 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.444 ' HB3' ' CD2' ' A' ' 163' ' ' PHE . 22.7 t -58.74 -24.93 62.43 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 120.592 -1.318 . . . . 0.0 112.687 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -82.53 -1.67 51.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.441 1.096 . . . . 0.0 111.106 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -116.13 159.29 21.95 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.447 0.642 . . . . 0.0 111.934 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 123' ' ' ILE . 30.4 mm -127.54 144.77 36.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -121.4 106.1 11.13 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 128.115 2.566 . . . . 0.0 105.126 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.421 ' HB3' ' CE2' ' A' ' 138' ' ' TYR . 20.9 t80 -138.9 130.92 27.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.7 mtt 60.45 22.54 12.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.259 1.424 . . . . 0.0 112.243 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.61 16.16 79.69 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -109.42 162.58 14.22 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.1 mm -123.3 132.08 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 133' ' ' TYR . 3.2 m-85 -120.33 159.13 25.65 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.7 t -145.65 155.49 43.04 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 mt -111.83 115.98 51.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 123.872 0.869 . . . . 0.0 111.643 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.5 t -87.15 -116.67 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -158.32 99.15 1.61 Allowed 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 55.4 m -137.04 129.6 30.12 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 131.151 3.78 . . . . 0.0 108.188 177.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.0 126.09 31.56 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.64 1.976 . . . . 0.0 107.511 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.2 t -94.77 111.85 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 120.621 1.555 . . . . 0.0 107.425 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.1 m -75.31 156.71 35.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.023 0.916 . . . . 0.0 109.801 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -55.85 -30.87 62.16 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 127.997 2.519 . . . . 0.0 112.885 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -72.86 -26.8 61.59 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.981 0.913 . . . . 0.0 111.455 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -97.84 -19.88 17.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.33 1.052 . . . . 0.0 110.097 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 mt -69.52 123.51 21.49 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.209 1.804 . . . . 0.0 109.504 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.16 -117.92 0.51 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 125.27 1.414 . . . . 0.0 110.96 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -130.13 165.14 22.92 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.535 1.134 . . . . 0.0 111.617 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -60.83 120.54 10.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.634 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -102.83 -52.71 3.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 118.003 -0.998 . . . . 0.0 111.119 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -153.44 166.01 34.04 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.487 0.585 . . . . 0.0 112.037 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.33 138.8 50.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 124.435 1.094 . . . . 0.0 109.324 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.553 HD21 HD12 ' A' ' 198' ' ' ILE . 3.3 mm? -104.74 165.5 11.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.501 2.32 . . . . 0.0 109.598 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -171.07 65.97 0.04 OUTLIER 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.398 0.679 . . . . 0.0 111.881 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.52 166.51 30.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.3 t -145.11 149.73 16.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -146.99 164.83 31.7 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.1 122.18 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.444 ' CD2' ' HB3' ' A' ' 128' ' ' SER . 37.2 p90 -140.0 177.3 8.07 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.376 1.444 . . . . 0.0 113.347 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -84.14 128.93 34.88 Favored 'General case' 0 C--N 1.347 0.488 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.3 t -66.05 -16.64 64.1 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.312 1.415 . . . . 0.0 113.372 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.63 -55.27 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 118.676 0.671 . . . . 0.0 112.468 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.3 m -121.73 -22.19 5.89 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.891 1.276 . . . . 0.0 113.004 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.46 15.3 25.55 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-O 118.455 -1.191 . . . . 0.0 115.714 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.584 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.3 OUTLIER -59.44 116.83 4.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.399 1.599 . . . . 0.0 109.981 179.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.08 153.45 41.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.735 1.152 . . . . 0.0 109.424 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.31 142.06 24.82 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.39 147.18 46.37 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.796 2.331 . . . . 0.0 109.959 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -56.54 -30.06 62.65 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.793 -0.567 . . . . 0.0 112.438 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.7 m -66.43 -7.09 17.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.621 1.169 . . . . 0.0 113.19 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -120.34 -4.84 9.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.123 1.769 . . . . 0.0 111.338 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.0 m0 . . . . . 0 N--CA 1.472 0.658 0 O-C-N 121.23 -0.919 . . . . 0.0 113.332 -178.676 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 . . . . . 0 CA--C 1.505 -0.759 0 CA-C-O 121.649 0.738 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.0 m -131.17 131.01 43.75 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -112.56 113.22 25.26 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -114.85 121.41 43.15 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.659 1.584 . . . . 0.0 108.761 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -89.3 131.76 35.24 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 128.905 2.882 . . . . 0.0 106.649 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -80.25 103.17 9.94 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.09 158.55 26.95 Favored Glycine 0 CA--C 1.53 1.03 1 C-N-CA 134.588 5.851 . . . . 0.0 107.056 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.72 160.08 31.01 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.147 1.474 . . . . 0.0 112.301 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.553 HD12 HD21 ' A' ' 157' ' ' LEU . 61.4 mt -109.06 139.02 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 126.12 1.768 . . . . 0.0 111.159 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -130.51 151.13 51.33 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.528 1.531 . . . . 0.0 109.446 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 13.6 p -75.9 174.17 10.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.159 0.584 . . . . 0.0 110.729 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 60.9 mt -132.61 139.43 49.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.135 1.374 . . . . 0.0 108.473 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -55.32 122.88 12.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.532 1.533 . . . . 0.0 109.832 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 66.34 13.27 60.08 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.343 -1.254 . . . . 0.0 115.498 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -131.05 124.37 30.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 120.05 1.925 . . . . 0.0 108.867 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 69.6 m -80.5 151.81 29.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.405 HD13 ' CG ' ' A' ' 210' ' ' PHE . 0.8 OUTLIER -55.39 -26.35 40.97 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.846 1.258 . . . . 0.0 109.472 178.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.2 p -70.38 -17.1 63.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.917 2.087 . . . . 0.0 113.377 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -120.54 -43.5 2.49 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.78 1.232 . . . . 0.0 112.009 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.5 146.0 6.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.051 0.94 . . . . 0.0 109.539 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.405 ' CG ' HD13 ' A' ' 206' ' ' LEU . 34.7 p90 -158.26 176.66 12.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.73 1.212 . . . . 0.0 108.805 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.23 132.57 53.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.467 1.507 . . . . 0.0 110.955 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.6 p -129.63 125.96 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 C-N-CA 124.312 1.045 . . . . 0.0 110.62 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -72.53 112.87 8.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 30.0 mm -122.59 119.83 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 55.14 33.61 20.84 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.274 0.943 . . . . 0.0 111.952 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.6 t70 80.33 -9.18 1.42 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.844 2.857 . . . . 0.0 111.977 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.91 122.64 43.14 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.843 -1.16 . . . . 0.0 108.836 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -73.81 112.53 10.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -104.01 145.94 29.43 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.102 0.961 . . . . 0.0 111.434 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.3 tm? -81.66 126.82 32.23 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -116.28 146.39 42.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.9 p -127.58 158.42 37.52 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.415 0.686 . . . . 0.0 111.19 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -64.92 122.11 16.2 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 84.8 t . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 122.671 1.224 . . . . 0.0 108.271 179.784 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.56 141.23 14.44 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 128.561 2.744 . . . . 0.0 105.1 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -70.07 128.4 36.18 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.3 t -132.07 135.36 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -80.93 140.13 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -55.71 127.86 32.05 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.306 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -55.83 -26.94 49.03 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.784 -1.198 . . . . 0.0 111.054 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -101.76 -8.31 21.81 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.946 1.299 . . . . 0.0 113.634 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.06 107.22 3.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.6 m -64.94 -14.14 59.2 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.253 1.821 . . . . 0.0 111.846 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -99.6 0.58 42.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.016 1.726 . . . . 0.0 112.029 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -117.69 158.44 24.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.068 0.461 . . . . 0.0 110.33 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.5 mm -126.29 132.61 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.12 99.14 8.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 102.069 -3.308 . . . . 0.0 102.069 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -135.71 127.07 28.45 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 120.347 -1.471 . . . . 0.0 107.607 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 12.9 mtt 60.44 30.16 19.57 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.558 1.143 . . . . 0.0 109.769 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.12 -0.34 31.5 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 123.808 0.718 . . . . 0.0 111.75 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -90.62 164.37 14.21 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.5 mm -123.99 123.63 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 119.172 -0.442 . . . . 0.0 110.657 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.66 131.11 53.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.294 1.038 . . . . 0.0 109.039 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 42.1 t -113.1 151.24 31.03 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.785 1.234 . . . . 0.0 108.374 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.2 mt -110.76 118.59 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 124.074 0.95 . . . . 0.0 108.744 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.3 t -89.04 -107.75 0.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -160.23 99.48 1.33 Allowed 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.601 -1.999 . . . . 0.0 105.601 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 85.5 m -138.33 114.44 10.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 115.865 -2.017 . . . . 0.0 107.128 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.5 m -75.62 125.59 29.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 122.448 2.386 . . . . 0.0 106.617 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.6 t -99.63 111.83 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.868 1.267 . . . . 0.0 108.152 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.9 m -75.77 161.18 29.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.75 0.82 . . . . 0.0 109.733 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -59.7 -30.48 68.82 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.42 1.088 . . . . 0.0 112.043 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.87 -24.24 64.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 122.31 -0.244 . . . . 0.0 110.891 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -96.44 -27.1 15.06 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.324 0.649 . . . . 0.0 109.515 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.6 tp -68.11 148.7 50.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.193 1.397 . . . . 0.0 109.286 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.74 -101.99 2.65 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.62 1.105 . . . . 0.0 111.158 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -135.07 171.19 14.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.313 1.845 . . . . 0.0 111.221 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -64.12 136.82 57.59 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.421 1.088 . . . . 0.0 110.189 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -117.19 -52.63 2.5 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.152 0.981 . . . . 0.0 113.168 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -157.59 158.4 35.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.098 0.863 . . . . 0.0 111.695 -178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.9 p -114.05 137.99 45.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 119.241 0.928 . . . . 0.0 111.165 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.57 165.19 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.487 1.915 . . . . 0.0 111.09 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.58 65.81 0.07 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.156 0.982 . . . . 0.0 111.192 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -157.98 167.76 29.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 26.8 t -144.18 148.39 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -142.05 166.61 24.24 Favored 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 120.872 -1.143 . . . . 0.0 108.558 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.09 129.72 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.63 168.86 18.75 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.179 0.9 . . . . 0.0 111.203 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -101.65 102.14 12.77 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.3 t -50.77 -19.19 0.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 129.361 3.064 . . . . 0.0 115.965 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.7 m -55.99 -46.95 80.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.3 m -123.98 -23.24 4.66 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.144 1.777 . . . . 0.0 114.276 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 103.7 7.87 41.14 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.289 1.899 . . . . 0.0 112.864 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 113.2 1.54 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.675 1.737 . . . . 0.0 112.942 -178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 p -63.2 140.56 58.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.154 0.982 . . . . 0.0 108.567 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.89 147.34 34.31 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.48 159.72 19.61 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.479 2.786 . . . . 0.0 110.089 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -64.44 -17.61 63.97 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 121.377 -0.827 . . . . 0.0 111.708 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.6 p -74.53 -11.14 60.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.367 -0.833 . . . . 0.0 111.711 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -111.1 -3.89 15.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.32 1.448 . . . . 0.0 112.251 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -66.08 -7.81 19.76 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.375 1.47 . . . . 0.0 114.397 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -134.84 -53.66 0.07 OUTLIER Glycine 0 CA--C 1.519 0.33 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -86.27 94.59 9.37 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -82.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -170.75 144.81 2.35 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.986 2.514 . . . . 0.0 106.567 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -97.46 -8.95 28.14 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 117.266 -1.349 . . . . 0.0 113.586 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.47 -21.09 0.48 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.83 1.195 . . . . 0.0 111.929 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -48.82 -17.5 0.85 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.21 1.862 . . . . 0.0 116.331 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 186' ' ' SER . 6.9 t 49.39 75.94 0.14 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.848 2.059 . . . . 0.0 110.269 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.38 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.264 1.825 . . . . 0.0 113.005 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 184' ' ' SER . 1.2 t -54.83 -11.84 0.69 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.643 3.177 . . . . 0.0 115.339 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -131.9 26.8 4.62 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.93 1.692 . . . . 0.0 109.255 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -133.65 118.82 18.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.6 t -117.23 95.56 5.04 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.187 0.995 . . . . 0.0 110.311 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -68.06 154.62 41.27 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 99.8 m -139.96 130.43 25.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -113.54 105.31 13.2 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.407 1.883 . . . . 0.0 107.547 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -110.3 127.89 55.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.941 0.896 . . . . 0.0 109.736 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -96.75 126.98 42.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.478 1.911 . . . . 0.0 107.399 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -75.66 100.96 4.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.896 1.331 . . . . 0.0 111.522 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -95.4 159.28 22.47 Favored Glycine 0 N--CA 1.431 -1.649 1 C-N-CA 130.727 4.013 . . . . 0.0 108.335 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.78 152.46 45.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 124.16 1.933 . . . . 0.0 111.029 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 67.7 mt -96.68 141.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 112.611 -2.086 . . . . 0.0 109.868 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -135.38 151.7 50.73 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.549 1.54 . . . . 0.0 109.233 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.9 p -77.48 173.27 12.17 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.246 1.018 . . . . 0.0 110.798 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 60.1 mt -126.34 137.52 57.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -67.49 124.21 22.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.48 1.512 . . . . 0.0 108.883 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.84 12.24 84.38 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 117.922 -1.488 . . . . 0.0 114.666 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 20.2 mmtp -141.4 142.7 33.71 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.743 1.772 . . . . 0.0 111.255 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 24.5 m -90.02 151.24 21.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.837 0.827 . . . . 0.0 109.114 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -31.83 67.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.088 0.955 . . . . 0.0 111.183 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.4 p -68.69 -10.03 53.82 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 129.352 3.061 . . . . 0.0 114.624 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -120.51 -46.79 2.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.836 1.254 . . . . 0.0 107.764 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.16 147.91 5.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.593 0.711 . . . . 0.0 110.571 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -152.83 176.16 12.11 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.167 0.587 . . . . 0.0 110.098 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.64 137.63 47.18 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.457 HG13 HG12 ' A' ' 214' ' ' ILE . 8.9 p -130.02 130.23 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 125.26 1.424 . . . . 0.0 110.879 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.54 107.68 4.55 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.457 HG12 HG13 ' A' ' 212' ' ' VAL . 33.0 mm -120.74 120.7 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 52.98 45.53 28.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.421 0.688 . . . . 0.0 109.901 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 64.27 13.3 7.85 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.537 1.535 . . . . 0.0 112.623 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.414 ' HB3' ' HE2' ' A' ' 219' ' ' LYS . 0.4 OUTLIER -125.18 122.15 36.22 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.165 -0.959 . . . . 0.0 108.687 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -69.42 115.93 9.25 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 120.512 -1.368 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 217' ' ' ASP . 66.3 mmtt -111.02 145.81 37.81 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.467 1.507 . . . . 0.0 113.09 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -80.64 128.8 34.03 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.929 1.291 . . . . 0.0 111.547 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -115.29 141.62 47.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.05 143.35 50.84 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.508 0.723 . . . . 0.0 110.535 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -55.41 138.53 45.78 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.69 161.33 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 126.84 2.056 . . . . 0.0 105.761 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -98.51 9.72 62.69 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.169 -0.957 . . . . 0.0 114.233 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 C--O 1.248 0.993 0 CA-C-N 119.187 1.493 . . . . 0.0 108.642 -179.372 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.825 0.345 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.46 130.92 3.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.632 ' CD2' HD13 ' A' ' 198' ' ' ILE . 88.9 m-85 -59.17 146.43 38.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 98.5 t -150.29 120.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.164 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.741 HG21 ' OH ' ' A' ' 195' ' ' TYR . 4.8 mp -68.13 118.17 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.135 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -54.34 123.62 13.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -20.36 66.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -90.47 -33.11 16.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.04 104.67 6.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -67.18 -13.59 62.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.722 ' O ' HD12 ' A' ' 140' ' ' ILE . 47.6 ptt85 -94.89 -7.13 40.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.854 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -101.71 159.93 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.6 mm -128.02 131.52 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.139 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -107.7 103.65 12.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -135.79 129.77 33.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.2 mtt 59.69 39.73 20.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 63.4 20.46 63.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.443 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -113.43 172.81 6.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.757 0.313 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 36.3 mm -131.36 129.01 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -125.42 152.31 45.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 t -121.18 152.04 39.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 129' ' ' ARG . 2.7 mt -123.26 111.35 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.122 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -92.74 -90.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -169.86 93.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 26.4 m -140.64 104.63 4.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.4 m -62.94 113.18 2.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.83 119.48 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.4 m -84.74 171.41 12.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.77 -26.31 64.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.09 -25.1 68.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -104.66 -26.12 12.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.5 tp -60.61 137.75 58.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.38 -105.78 2.65 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.516 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -134.24 169.92 16.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.93 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -56.23 142.09 38.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -125.43 -51.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.953 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -147.37 159.87 43.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 5.3 p -119.56 129.93 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.478 HD11 HD11 ' A' ' 123' ' ' ILE . 3.3 mm? -110.9 166.01 11.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.67 70.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -166.41 175.34 8.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.3 t -144.87 149.45 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.103 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.74 155.54 42.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.3 t -124.59 123.32 65.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.114 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -144.85 155.44 43.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.588 ' CG ' HG22 ' A' ' 166' ' ' VAL . 4.6 t0 -74.34 124.49 26.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.12 -4.35 32.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.588 HG22 ' CG ' ' A' ' 164' ' ' ASP . 27.5 m -77.93 -44.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.16 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.478 ' N ' HG23 ' A' ' 166' ' ' VAL . 6.7 t -123.36 -30.12 3.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.79 12.09 33.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.434 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -69.9 127.93 34.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.844 0.354 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.83 155.11 37.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -126.47 139.83 35.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.584 0.707 . . . . 0.0 111.161 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 154.98 67.1 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.645 2.23 . . . . 0.0 112.366 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -58.98 -21.71 59.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 m -73.86 -7.66 53.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.09 -12.46 14.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -57.1 -25.78 59.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -132.92 25.85 3.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.496 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -138.14 73.42 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 110.903 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.42 HG21 ' ND2' ' A' ' 185' ' ' ASN . 3.4 mt -53.2 -65.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.141 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.48 115.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -77.6 -22.5 50.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -75.1 -28.12 60.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 110.15 74.57 0.79 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.436 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.7 m -142.75 62.77 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.42 ' ND2' HG21 ' A' ' 179' ' ' ILE . 4.4 m120 -105.67 51.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.94 -56.3 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -97.17 71.89 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -141.8 140.91 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.6 m -168.92 65.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -68.94 168.88 12.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.42 HG22 ' CD1' ' A' ' 193' ' ' TRP . 98.9 m -137.77 120.41 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.69 105.52 17.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . 0.42 ' CD1' HG22 ' A' ' 191' ' ' THR . 13.5 m0 -110.35 116.78 32.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.96 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -84.55 126.55 33.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.741 ' OH ' HG21 ' A' ' 123' ' ' ILE . 13.4 m-30 -65.21 103.83 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 213' ' ' GLU . . . -101.28 162.84 17.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.484 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.28 139.35 58.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.798 0.333 . . . . 0.0 110.861 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.632 HD13 ' CD2' ' A' ' 121' ' ' PHE . 10.1 mt -91.21 143.39 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -131.68 143.14 50.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.78 172.26 3.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 71.1 mt -130.8 141.83 45.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -69.3 122.16 18.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 76.02 27.12 62.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.48 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 17.2 mmtm -149.34 146.28 27.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.786 0.326 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -106.0 145.11 31.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.855 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.491 HD13 ' HB3' ' A' ' 210' ' ' PHE . 0.9 OUTLIER -63.24 -17.15 62.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 67.4 p -82.59 -9.41 59.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.65 -51.56 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.09 146.32 24.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.069 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.638 ' O ' HD22 ' A' ' 220' ' ' LEU . 39.4 p90 -154.44 176.44 12.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -110.4 125.36 53.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.084 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.54 HG11 HG12 ' A' ' 140' ' ' ILE . 6.0 p -117.68 125.39 74.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.142 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.429 ' HB3' ' HA3' ' A' ' 196' ' ' GLY . 18.9 tt0 -70.43 101.55 1.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.845 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 48.4 mm -120.39 120.25 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.109 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 60.53 43.94 12.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.37 14.88 9.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -137.49 122.11 18.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -71.52 125.06 26.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.913 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -116.62 140.69 49.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.638 HD22 ' O ' ' A' ' 210' ' ' PHE . 3.3 tm? -76.37 121.76 23.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.54 139.29 40.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.21 138.33 50.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -64.97 122.12 16.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 94.4 t -127.07 129.52 71.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -100.25 55.4 0.86 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.498 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.994 ' C ' ' O ' ' A' ' 226' ' ' ASN . 5.9 m120 . . . . . 1 C--O 2.0 40.559 1 CA-C-O 161.134 19.54 . . . . 0.0 110.907 -179.902 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.93 141.31 15.31 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 127.728 2.411 . . . . 0.0 106.124 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -73.9 134.5 43.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 84.2 t -135.2 124.73 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.9 mp -73.12 140.23 18.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -66.19 127.12 30.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -65.55 -27.05 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.462 -0.774 . . . . 0.0 111.705 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -80.67 -45.5 17.1 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.721 1.209 . . . . 0.0 110.057 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.08 100.59 6.8 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.4 t -62.67 -7.66 5.23 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.872 -1.142 . . . . 0.0 110.95 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -94.3 -4.87 47.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.867 2.067 . . . . 0.0 110.257 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -110.84 158.81 18.28 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.6 mm -125.34 138.41 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.92 103.48 11.71 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 102.923 -2.992 . . . . 0.0 102.923 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -137.69 132.37 32.78 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 13.1 mtt 57.97 25.35 12.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.995 0.918 . . . . 0.0 111.077 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.42 -0.6 68.58 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 121.429 -0.795 . . . . 0.0 112.412 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -93.69 166.26 12.3 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.552 1.541 . . . . 0.0 108.006 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.7 mm -123.18 137.18 57.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -131.08 156.77 44.64 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.814 1.246 . . . . 0.0 108.454 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.474 ' HB2' HG11 ' A' ' 224' ' ' VAL . 14.2 t -140.37 155.67 46.68 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.946 1.298 . . . . 0.0 107.986 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.7 mt -114.37 117.8 56.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.284 1.433 . . . . 0.0 110.795 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.6 t -86.63 -111.01 0.05 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -162.46 101.26 1.06 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 103.563 -2.755 . . . . 0.0 103.563 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 49.2 m -134.88 111.82 10.18 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.1 m -70.93 120.54 16.65 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.37 122.41 45.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.5 m -82.2 154.44 25.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.81 -26.9 67.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.54 1.136 . . . . 0.0 112.036 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.72 -19.07 62.78 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.415 -0.803 . . . . 0.0 110.471 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -106.19 -16.22 14.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.46 1.904 . . . . 0.0 110.086 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.8 tp -80.19 118.42 21.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 128.105 2.562 . . . . 0.0 107.103 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -75.45 -103.78 0.11 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 123.687 0.661 . . . . 0.0 111.486 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.68 170.01 16.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.559 1.144 . . . . 0.0 110.069 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -61.89 142.92 57.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.572 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -125.64 -48.95 1.65 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.559 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.77 160.74 43.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.093 1.315 . . . . 0.0 110.714 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.83 135.19 60.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.835 1.254 . . . . 0.0 111.561 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.8 164.87 12.59 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.805 2.042 . . . . 0.0 111.522 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.15 54.89 0.06 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.953 0.901 . . . . 0.0 112.124 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.44 172.33 15.13 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.338 -1.476 . . . . 0.0 107.517 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.38 147.53 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -145.18 166.24 26.02 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 120.576 -1.327 . . . . 0.0 108.521 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.1 t -129.24 133.31 65.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -147.97 160.59 42.66 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.48 0.582 . . . . 0.0 111.71 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.34 106.29 7.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 103.337 -2.838 . . . . 0.0 103.337 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.5 t -61.07 -20.25 62.37 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.23 -33.33 19.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 120.823 -1.173 . . . . 0.0 113.978 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.0 t -122.03 -25.45 4.94 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.061 0.945 . . . . 0.0 112.241 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.83 -0.14 56.42 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.064 1.792 . . . . 0.0 112.073 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -52.98 112.23 0.81 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.147 1.474 . . . . 0.0 110.421 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.4 m -70.99 157.67 37.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 119.294 0.952 . . . . 0.0 111.627 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.0 129.28 25.48 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 126.901 2.08 . . . . 0.0 106.375 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.44 157.73 48.93 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.322 2.681 . . . . 0.0 109.196 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -52.31 -32.27 37.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.892 0.877 . . . . 0.0 112.673 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.4 m -64.74 -12.97 52.93 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.09 -6.82 15.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.842 2.057 . . . . 0.0 111.747 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -56.27 -40.24 73.91 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -106.28 -7.24 35.35 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.219 1.39 . . . . 0.0 112.809 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.76 79.05 1.77 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.219 1.808 . . . . 0.0 112.559 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 43.6 mt -67.16 -42.32 87.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -51.62 106.21 0.13 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.661 1.985 . . . . 0.0 110.436 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -129.14 -21.41 3.27 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.396 1.078 . . . . 0.0 112.838 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -141.21 21.7 2.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.8 0.84 . . . . 0.0 111.109 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 61.23 -4.02 0.41 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 127.608 2.528 . . . . 0.0 115.712 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.8 t -74.71 -80.15 0.08 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.991 1.316 . . . . 0.0 110.442 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 56.24 10.68 0.66 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.034 1.334 . . . . 0.0 112.639 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.2 t -33.72 -59.21 0.41 Allowed 'General case' 0 C--N 1.341 0.211 0 C-N-CA 128.585 2.754 . . . . 0.0 114.759 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -147.57 134.12 19.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -161.68 155.57 21.86 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.246 0.619 . . . . 0.0 109.743 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.3 t -142.1 85.37 1.92 Allowed 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.845 0.858 . . . . 0.0 108.705 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -80.98 177.93 8.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.1 m -154.12 150.81 28.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -127.63 104.76 8.04 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -114.15 117.03 30.06 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.816 1.246 . . . . 0.0 110.557 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.27 129.38 34.58 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.975 2.11 . . . . 0.0 108.833 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.425 ' CE2' HD13 ' A' ' 123' ' ' ILE . 6.0 m-30 -76.34 100.83 5.27 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.244 0.617 . . . . 0.0 109.776 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.43 158.87 23.04 Favored Glycine 0 CA--C 1.531 1.054 1 C-N-CA 133.483 5.325 . . . . 0.0 107.228 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.85 154.18 42.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 123.87 1.795 . . . . 0.0 111.603 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 58.2 mt -100.83 139.11 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.013 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -131.9 149.54 52.41 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.458 1.503 . . . . 0.0 109.585 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.2 t -78.65 173.65 12.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.241 1.016 . . . . 0.0 109.611 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 75.7 mt -131.49 143.9 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.674 1.189 . . . . 0.0 110.626 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -65.63 131.27 45.94 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.651 1.18 . . . . 0.0 108.877 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 62.92 22.38 64.52 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.152 -1.36 . . . . 0.0 115.22 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -140.23 148.08 40.98 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.122 1.461 . . . . 0.0 107.819 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.1 m -105.87 146.62 29.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.01 -31.31 60.94 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.078 1.351 . . . . 0.0 110.544 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.4 p -70.54 -12.65 61.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.607 1.963 . . . . 0.0 114.729 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -125.06 -39.37 2.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.863 1.665 . . . . 0.0 112.205 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.33 139.74 5.92 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 124.159 0.983 . . . . 0.0 110.797 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -150.19 174.31 12.94 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.958 0.903 . . . . 0.0 109.534 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.56 138.67 47.8 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.133 0.573 . . . . 0.0 111.864 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.6 p -132.65 131.07 59.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.895 1.278 . . . . 0.0 110.747 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.79 106.23 7.26 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 39.7 mm -122.06 129.81 75.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.653 1.181 . . . . 0.0 110.759 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 53.94 37.75 27.34 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.382 -0.824 . . . . 0.0 112.123 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 74.77 5.51 4.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.246 1.818 . . . . 0.0 111.311 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -130.8 134.9 47.25 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.74 1.155 . . . . 0.0 112.351 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -70.86 130.24 41.14 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 121.056 -1.027 . . . . 0.0 110.447 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -125.66 148.49 48.99 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.997 1.319 . . . . 0.0 109.617 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.53 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -84.06 126.69 33.31 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.106 1.362 . . . . 0.0 112.065 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -109.78 143.25 39.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 1.1 p -125.67 148.23 49.08 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.47 1.508 . . . . 0.0 111.616 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -55.56 139.98 42.31 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 139' ' ' SER . 7.7 p -135.09 150.94 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -120.75 19.6 8.93 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.233 1.397 . . . . 0.0 113.243 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 47.1 t30 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 127.827 2.451 . . . . 0.0 105.187 179.789 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.8 t0 . . . . . 0 CA--C 1.518 -0.267 0 CA-C-O 120.632 0.253 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.64 141.26 39.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.084 2.554 . . . . 0.0 104.96 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -77.78 121.45 24.07 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 124.822 1.249 . . . . 0.0 108.136 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.2 t -125.86 128.44 72.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 125.58 1.552 . . . . 0.0 109.095 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -72.87 140.03 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -61.63 129.94 43.5 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.247 -0.908 . . . . 0.0 111.098 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -67.33 -11.49 57.75 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.337 -0.852 . . . . 0.0 111.687 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -106.23 -14.54 15.1 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.789 1.236 . . . . 0.0 112.962 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.82 115.21 5.12 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.97 0.805 . . . . 0.0 109.496 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.476 ' HB2' ' CD1' ' A' ' 163' ' ' PHE . 73.6 m -63.81 -17.57 63.24 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.95 -1.093 . . . . 0.0 111.784 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -94.56 -1.7 52.87 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.97 1.708 . . . . 0.0 112.012 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -105.97 156.34 18.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.431 1.014 . . . . 0.0 111.628 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.2 mm -128.03 136.39 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -116.07 107.32 14.78 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.497 2.319 . . . . 0.0 105.657 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -145.07 133.97 22.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.9 mtt 58.22 33.22 22.95 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.396 1.478 . . . . 0.0 111.061 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.1 22.62 70.82 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -116.78 163.84 15.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 28.6 mm -121.6 128.96 75.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.972 0.909 . . . . 0.0 109.294 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -125.46 157.8 36.02 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.46 ' HB2' HG11 ' A' ' 224' ' ' VAL . 46.9 t -141.96 157.98 44.31 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.828 1.251 . . . . 0.0 108.861 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.3 mt -110.54 130.49 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.23 1.012 . . . . 0.0 109.698 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -106.76 -116.51 0.26 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 102.591 -3.115 . . . . 0.0 102.591 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -157.41 100.06 1.79 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 93.6 m -136.39 109.35 7.65 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.118 1.767 . . . . 0.0 107.004 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.7 m -68.97 125.68 27.41 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 90.8 t -93.78 113.0 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 120.63 1.559 . . . . 0.0 108.496 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 20.4 m -68.56 155.13 40.56 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.704 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.54 -25.41 68.03 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.644 1.178 . . . . 0.0 110.981 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.32 -25.78 63.46 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.845 0.858 . . . . 0.0 109.848 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -94.57 -33.85 12.87 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.569 1.148 . . . . 0.0 110.151 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.19 121.18 7.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.766 1.626 . . . . 0.0 108.37 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -88.47 -110.52 1.1 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.1 170.15 16.34 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.666 1.186 . . . . 0.0 112.153 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -55.94 128.64 36.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.528 1.531 . . . . 0.0 111.333 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -118.39 -38.39 3.17 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.661 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.22 161.74 14.63 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 121.256 1.844 . . . . 0.0 111.377 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.03 139.83 47.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 120.066 1.303 . . . . 0.0 110.837 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.43 164.71 12.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.646 1.978 . . . . 0.0 109.145 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -162.11 33.17 0.12 Allowed 'General case' 0 C--O 1.237 0.434 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.42 174.02 11.07 Favored 'General case' 0 C--O 1.218 -0.587 0 O-C-N 120.309 -1.494 . . . . 0.0 109.031 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.7 t -139.98 147.85 23.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -144.5 162.46 36.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 87.6 t -127.52 136.46 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 128' ' ' SER . 49.8 p90 -146.63 166.54 26.24 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.29 0.636 . . . . 0.0 111.316 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.85 101.3 13.39 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.1 t -47.75 -22.54 0.55 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 130.179 3.392 . . . . 0.0 116.863 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.2 m -57.86 -51.61 68.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 125.65 1.58 . . . . 0.0 109.947 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.443 ' HB2' ' HD3' ' A' ' 169' ' ' LYS 0.257 24.6 m -121.58 -27.54 4.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.471 1.508 . . . . 0.0 112.843 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 111.94 6.98 24.04 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.125 1.345 . . . . 0.0 114.248 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.504 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -53.5 113.0 1.01 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.582 2.191 . . . . 0.0 111.704 -178.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.4 m -69.0 152.74 44.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 119.428 1.013 . . . . 0.0 108.971 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.1 mp -117.79 140.92 28.28 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.854 1.662 . . . . 0.0 108.792 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.5 160.36 38.57 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.127 2.551 . . . . 0.0 109.686 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -60.93 -30.36 70.17 Favored 'General case' 0 CA--C 1.519 -0.24 0 O-C-N 121.438 -0.789 . . . . 0.0 110.869 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 p -64.53 -7.06 8.83 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.892 -1.052 . . . . 0.0 113.407 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.87 -8.64 13.7 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.344 1.429 . . . . 0.0 111.08 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -61.92 -2.61 0.92 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -166.63 16.17 0.08 OUTLIER Glycine 0 CA--C 1.521 0.453 0 C-N-CA 126.137 1.827 . . . . 0.0 110.982 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -124.46 87.42 2.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.29 -77.07 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.564 ' HB3' ' H ' ' A' ' 184' ' ' SER . 3.5 t70 -168.25 157.66 9.44 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.409 1.884 . . . . 0.0 106.802 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 31.8 tttm -46.58 -59.85 2.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.285 1.834 . . . . 0.0 111.304 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -78.07 -39.12 42.63 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.829 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.13 76.33 0.62 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.564 ' H ' ' HB3' ' A' ' 180' ' ' ASP . 23.8 p -68.11 4.76 1.12 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.859 2.064 . . . . 0.0 112.447 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -50.22 -25.7 3.91 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 125.806 1.642 . . . . 0.0 113.378 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.4 m -60.06 -9.81 3.58 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.271 1.828 . . . . 0.0 112.281 178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -137.85 54.6 1.8 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.614 1.566 . . . . 0.0 109.781 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -133.14 166.89 21.4 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.256 1.822 . . . . 0.0 108.56 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.95 49.08 0.45 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.656 -1.277 . . . . 0.0 111.029 -178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 -83.52 166.08 18.57 Favored 'General case' 0 N--CA 1.46 0.071 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 95.6 m -144.99 138.12 26.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 126.922 2.089 . . . . 0.0 107.302 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -112.76 110.17 20.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.797 1.639 . . . . 0.0 108.19 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -111.73 118.77 36.52 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.6 1.16 . . . . 0.0 111.067 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.56 127.08 36.14 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -76.47 101.02 5.43 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.382 1.473 . . . . 0.0 111.421 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.1 159.71 23.67 Favored Glycine 0 N--CA 1.435 -1.378 1 C-N-CA 132.646 4.927 . . . . 0.0 107.546 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.89 154.6 41.22 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 122.972 1.368 . . . . 0.0 112.767 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 54.8 mt -102.74 121.62 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 125.628 1.571 . . . . 0.0 111.874 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -111.31 154.25 24.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.294 1.045 . . . . 0.0 110.309 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 1.9 t -73.77 172.86 10.73 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.925 1.29 . . . . 0.0 108.163 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.454 ' CD1' HD23 ' A' ' 220' ' ' LEU . 77.7 mt -135.19 132.78 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 30.7 mtt-85 -59.17 119.85 8.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.209 1.404 . . . . 0.0 108.229 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.13 12.44 84.03 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.261 -1.3 . . . . 0.0 115.308 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -134.56 133.43 40.25 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.863 1.831 . . . . 0.0 109.881 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 21.8 m -83.59 146.89 28.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.27 -25.21 61.51 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.574 1.15 . . . . 0.0 111.101 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 11.5 p -75.64 -14.4 60.36 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.825 2.05 . . . . 0.0 113.642 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -119.74 -43.0 2.59 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.986 0.914 . . . . 0.0 111.367 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.62 139.88 8.02 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 118.799 0.727 . . . . 0.0 109.143 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -152.33 176.64 11.41 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.507 1.123 . . . . 0.0 109.515 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.56 131.82 54.71 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.614 1.166 . . . . 0.0 111.845 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.1 129.74 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 C-N-CA 123.958 0.903 . . . . 0.0 109.432 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -74.33 104.76 5.21 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 36.5 mm -121.64 127.2 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 O-C-N 120.49 -1.381 . . . . 0.0 107.511 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 53.28 43.62 31.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.206 0.457 . . . . 0.0 110.304 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.6 t0 61.11 19.13 9.7 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.362 0.665 . . . . 0.0 112.167 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.09 122.53 24.24 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.753 -1.217 . . . . 0.0 109.188 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -72.42 115.96 12.3 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.981 -1.074 . . . . 0.0 112.77 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -106.15 152.38 23.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.102 0.961 . . . . 0.0 111.99 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.8 tm? -88.37 119.44 28.8 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.191 1.396 . . . . 0.0 107.939 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -105.6 148.58 27.16 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.8 p -127.42 151.16 49.17 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.778 0.674 . . . . 0.0 112.26 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -57.58 141.44 48.0 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.46 HG11 ' HB2' ' A' ' 139' ' ' SER . 6.5 p -134.79 146.2 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 50.1 44.38 42.29 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.356 1.455 . . . . 0.0 110.502 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.464 ' C ' HD22 ' A' ' 226' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--O 1.246 0.87 0 CA-C-O 116.794 -1.575 . . . . 0.0 111.227 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.512 -0.518 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.86 139.72 24.01 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -69.76 136.69 51.22 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 124.106 0.963 . . . . 0.0 108.602 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.6 t -134.98 124.59 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.1 mp -76.44 134.22 29.37 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -55.54 134.95 51.1 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.832 1.301 . . . . 0.0 110.544 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.44 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -68.27 -18.56 64.57 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.486 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -104.09 -36.5 7.69 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.23 0.468 . . . . 0.0 111.354 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.84 105.14 11.64 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 122.202 1.001 . . . . 0.0 109.985 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.7 t -61.73 -11.48 12.27 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.112 1.365 . . . . 0.0 111.825 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -100.02 -8.98 23.19 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.787 1.635 . . . . 0.0 111.873 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -102.16 154.73 18.74 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 119.418 1.008 . . . . 0.0 111.276 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.5 mm -126.58 127.46 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.11 105.31 15.44 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -141.37 136.04 31.05 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.773 -1.204 . . . . 0.0 107.813 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.2 mtt 54.44 21.21 3.14 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.59 0.29 89.27 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.561 1.077 . . . . 0.0 112.336 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -90.13 172.58 8.71 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.282 1.433 . . . . 0.0 108.021 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.8 mm -133.66 124.76 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -119.17 154.21 33.69 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 13.1 t -138.36 159.45 42.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 10.2 mt -115.7 134.75 57.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.798 0.808 . . . . 0.0 111.234 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.3 t -104.76 -130.56 0.28 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 101.713 -3.44 . . . . 0.0 101.713 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -154.35 98.81 2.15 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 121.918 2.144 . . . . 0.0 106.672 175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 20.6 m -135.76 121.09 19.14 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 128.244 2.618 . . . . 0.0 106.521 177.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 23.7 m -72.07 123.34 22.62 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 76.1 t -93.88 111.84 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.6 m -77.17 159.77 29.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.438 0.637 . . . . 0.0 109.694 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -64.6 -17.76 64.28 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.64 1.176 . . . . 0.0 111.669 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -77.0 -11.71 59.84 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.755 0.822 . . . . 0.0 109.473 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -115.21 -28.4 6.94 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.381 1.072 . . . . 0.0 109.38 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.95 132.67 50.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.126 2.17 . . . . 0.0 107.148 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -101.39 -98.31 2.34 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.309 0.957 . . . . 0.0 114.289 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -134.68 159.43 41.28 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.272 1.429 . . . . 0.0 111.906 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.0 133.27 55.37 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.832 1.653 . . . . 0.0 109.658 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.79 -43.22 2.9 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 116.538 -1.696 . . . . 0.0 111.69 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -165.5 158.25 15.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 121.144 1.793 . . . . 0.0 110.462 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.22 137.37 44.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.478 HD22 ' O ' ' A' ' 196' ' ' GLY . 5.3 mp -110.17 163.35 13.69 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.951 1.7 . . . . 0.0 110.752 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.0 38.98 0.15 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.5 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 1.9 tt0 -139.78 175.34 9.66 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 120.023 -1.673 . . . . 0.0 110.759 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.2 t -144.88 150.51 16.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -147.09 164.0 34.48 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.848 0.832 . . . . 0.0 109.018 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.0 t -128.78 129.1 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 126.38 1.872 . . . . 0.0 107.412 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -147.89 160.93 42.26 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.07 0.948 . . . . 0.0 112.684 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.51 100.09 12.8 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 102.255 -3.239 . . . . 0.0 102.255 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 12.7 t -47.61 -25.88 1.3 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.154 2.581 . . . . 0.0 116.451 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.3 m -57.68 -45.98 86.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.04 1.736 . . . . 0.0 111.11 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.424 ' HB2' ' HD3' ' A' ' 169' ' ' LYS . 3.2 m -122.73 -21.76 5.53 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.024 1.33 . . . . 0.0 113.09 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.78 10.83 48.76 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 119.245 -0.753 . . . . 0.0 113.652 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 167' ' ' SER . 0.0 OUTLIER -64.04 112.49 2.99 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.134 1.467 . . . . 0.0 110.669 -178.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 44.2 m -72.38 152.03 42.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.647 0.658 . . . . 0.0 109.488 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.59 147.51 36.9 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.79 159.78 31.21 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.18 2.587 . . . . 0.0 109.902 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 ttt-85 -57.39 -32.34 66.73 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 45.0 m -65.19 -8.28 16.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.241 -1.362 . . . . 0.0 113.308 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.99 -9.14 16.32 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.354 1.434 . . . . 0.0 111.672 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -62.96 6.04 0.11 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.121 2.168 . . . . 0.0 115.143 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -159.11 20.5 0.28 Allowed Glycine 0 CA--C 1.524 0.629 0 O-C-N 120.444 -1.41 . . . . 0.0 111.132 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -98.29 40.54 1.18 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.785 1.292 . . . . 0.0 113.177 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 49.7 mm -64.01 -50.38 77.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -137.28 80.27 1.8 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.047 1.739 . . . . 0.0 112.047 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -140.84 -44.99 0.39 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.6 29.33 1.03 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.027 0.931 . . . . 0.0 110.05 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 170.92 -172.86 44.52 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 120.715 -1.24 . . . . 0.0 111.461 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 86.4 p -114.23 162.32 16.7 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.297 1.039 . . . . 0.0 110.984 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -139.74 81.22 1.81 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.1 m -115.05 -5.36 12.48 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 13.67 0.85 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -106.76 173.97 6.09 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.801 1.641 . . . . 0.0 106.633 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 30.8 t -163.11 147.4 11.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.433 ' HG2' HH11 ' A' ' 190' ' ' ARG . 8.2 mtt-85 -137.21 157.44 46.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 123.097 0.559 . . . . 0.0 110.611 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 20.6 m -130.27 117.4 19.76 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.83 105.89 18.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.599 1.959 . . . . 0.0 106.527 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.9 m0 -110.97 116.26 30.89 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 118.496 0.589 . . . . 0.0 110.45 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -81.94 131.77 35.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.5 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.8 m-30 -78.55 107.51 11.26 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.958 1.703 . . . . 0.0 106.807 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.478 ' O ' HD22 ' A' ' 157' ' ' LEU . . . -107.85 159.41 14.43 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 129.532 3.444 . . . . 0.0 112.64 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -66.89 140.88 57.8 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 124.652 2.168 . . . . 0.0 111.692 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.0 mt -93.13 140.84 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 CA-C-N 111.842 -2.436 . . . . 0.0 109.673 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -136.25 151.3 49.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 123.194 1.474 . . . . 0.0 109.293 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 23.1 t -75.39 172.92 11.64 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.997 1.719 . . . . 0.0 107.523 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.3 mt -126.93 137.26 58.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -62.96 131.15 47.72 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.13 22.95 72.89 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.842 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -139.3 155.11 47.95 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.778 1.789 . . . . 0.0 108.094 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 57.8 m -106.08 140.41 39.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.485 HD13 ' CB ' ' A' ' 210' ' ' PHE . 0.4 OUTLIER -57.04 -24.65 55.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.144 0.977 . . . . 0.0 109.123 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.4 p -69.71 -14.63 62.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.263 1.825 . . . . 0.0 112.898 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -120.34 -41.34 2.62 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.248 1.019 . . . . 0.0 110.619 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.34 150.72 9.29 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.922 0.889 . . . . 0.0 110.657 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.485 ' CB ' HD13 ' A' ' 206' ' ' LEU . 48.5 p90 -158.38 176.14 12.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.247 1.019 . . . . 0.0 109.752 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.39 136.66 48.46 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 110.844 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.71 128.15 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 124.061 0.945 . . . . 0.0 109.624 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.65 107.36 3.88 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.3 mm -121.85 126.67 74.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 54.78 43.32 30.25 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.25 -4.83 1.2 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.05 1.74 . . . . 0.0 113.006 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -117.04 122.7 44.94 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.623 -1.298 . . . . 0.0 111.632 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -63.04 115.63 4.61 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.37 -1.456 . . . . 0.0 113.537 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 219' ' ' LYS . 0.0 OUTLIER -103.97 150.16 24.48 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 126.435 1.894 . . . . 0.0 111.442 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 3.0 tm? -88.79 122.19 31.93 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.607 1.163 . . . . 0.0 108.593 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -106.66 150.22 26.44 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 1.5 p -129.49 152.11 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.51 1.124 . . . . 0.0 110.307 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -69.67 124.05 22.95 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.65 107.75 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 123.999 0.92 . . . . 0.0 108.67 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -101.06 12.77 58.96 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.165 1.364 . . . . 0.0 112.508 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 124.895 1.278 . . . . 0.0 107.84 179.563 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.75 130.76 24.65 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 103.971 -2.604 . . . . 0.0 103.971 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -69.21 145.1 53.48 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.647 0.779 . . . . 0.0 110.225 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 71.0 t -137.95 128.25 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.457 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.6 mp -82.01 129.45 37.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.57 122.22 11.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.769 1.271 . . . . 0.0 109.592 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -59.03 -24.23 62.66 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.212 -0.93 . . . . 0.0 111.843 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -90.68 -31.59 16.54 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.901 1.28 . . . . 0.0 112.196 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.84 100.21 4.69 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.7 p -65.3 -11.34 40.63 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 121.407 -0.808 . . . . 0.0 111.511 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -90.01 -3.83 57.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.002 2.121 . . . . 0.0 110.209 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -113.57 158.52 20.68 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.356 0.98 . . . . 0.0 109.001 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.5 mm -129.09 139.59 51.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -118.48 108.36 14.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -142.82 140.45 31.31 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.0 mtt 56.87 22.45 7.09 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.656 0.782 . . . . 0.0 112.834 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.22 18.55 78.18 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -123.78 159.65 29.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.311 1.056 . . . . 0.0 108.218 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.1 mm -110.35 140.44 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -131.79 144.37 50.89 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 t -124.55 148.71 47.63 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 126.804 2.042 . . . . 0.0 107.351 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.6 mt -113.31 123.56 69.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 124.627 1.171 . . . . 0.0 110.026 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -93.36 -143.61 0.23 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -142.16 98.81 3.39 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 102.685 -3.079 . . . . 0.0 102.685 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.9 m -136.54 109.87 7.87 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 111.642 -2.526 . . . . 0.0 106.241 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 m -69.88 131.91 45.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 120.756 1.617 . . . . 0.0 106.752 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.3 t -94.69 114.18 30.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.776 1.63 . . . . 0.0 106.664 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 49.9 m -71.02 159.34 34.92 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.907 0.384 . . . . 0.0 110.786 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.72 -26.51 67.23 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.238 1.415 . . . . 0.0 111.294 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -76.1 -13.66 60.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.522 0.729 . . . . 0.0 111.36 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -105.71 -26.74 11.68 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.315 1.446 . . . . 0.0 108.883 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.7 mt -62.01 142.3 57.57 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.42 -103.42 2.46 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -134.99 166.84 22.11 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.086 1.354 . . . . 0.0 109.443 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -58.79 144.38 44.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.609 0.764 . . . . 0.0 109.942 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.23 -49.36 1.94 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 117.265 -1.35 . . . . 0.0 111.217 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.64 157.83 22.43 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 120.745 1.612 . . . . 0.0 110.828 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.4 p -105.59 138.64 29.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.547 1.165 . . . . 0.0 110.408 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.0 mp -113.41 163.16 15.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.536 2.734 . . . . 0.0 108.407 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -172.25 68.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.861 0.864 . . . . 0.0 109.957 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -160.67 175.83 12.21 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.837 -1.165 . . . . 0.0 109.036 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.3 t -144.76 149.28 17.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.71 154.96 40.35 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.5 t -123.63 130.51 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 124.498 1.119 . . . . 0.0 108.077 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -147.86 160.54 42.66 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.609 1.164 . . . . 0.0 111.579 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -85.49 100.98 12.26 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.6 t -56.26 -11.73 1.31 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.109 1.364 . . . . 0.0 114.613 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.3 m -65.74 -40.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 121.137 -0.977 . . . . 0.0 110.033 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.0 t -124.26 -28.35 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.723 1.209 . . . . 0.0 113.195 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.54 5.78 36.3 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 125.738 1.637 . . . . 0.0 111.166 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -57.31 112.32 1.36 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 126.053 1.741 . . . . 0.0 111.026 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.6 p -64.37 154.25 36.03 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.906 1.683 . . . . 0.0 110.749 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.45 152.14 60.75 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.365 1.066 . . . . 0.0 108.365 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.64 162.56 16.6 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.93 3.086 . . . . 0.0 108.513 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -58.75 -28.89 66.32 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.903 -1.123 . . . . 0.0 111.69 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 95.9 p -68.93 -8.8 47.77 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -104.22 -4.76 22.64 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 120.414 -1.429 . . . . 0.0 109.069 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -72.34 16.2 0.14 Allowed 'General case' 0 CA--C 1.551 1.011 0 O-C-N 120.872 -1.142 . . . . 0.0 111.831 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 121.26 36.43 0.75 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.423 1.487 . . . . 0.0 112.311 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -130.76 38.09 3.74 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.14 1.47 . . . . 0.0 108.192 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 52.8 mt -72.2 -69.29 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 104.427 -2.435 . . . . 0.0 104.427 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.11 52.97 11.79 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.764 1.745 . . . . 0.0 109.832 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -153.05 148.34 26.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.81 3.644 . . . . 0.0 103.665 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.13 28.12 5.81 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.221 0.608 . . . . 0.0 109.931 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.1 -60.6 5.1 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.143 0.877 . . . . 0.0 112.685 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.1 m -169.24 104.97 0.38 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.442 1.097 . . . . 0.0 109.818 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -118.37 21.25 12.75 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.09 1.356 . . . . 0.0 110.767 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.6 p -63.52 160.61 16.14 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 129.319 3.047 . . . . 0.0 113.786 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 22.9 mtmm 45.65 24.24 0.19 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.601 1.96 . . . . 0.0 114.368 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -86.41 130.56 34.46 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.2 t -145.41 87.96 1.83 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 10.6 mtt85 -90.99 161.45 15.14 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.7 m -142.14 123.86 15.1 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -100.92 109.1 21.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -110.4 116.21 31.03 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.17 117.51 21.78 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 128.471 2.708 . . . . 0.0 107.463 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.457 ' CE2' HD13 ' A' ' 123' ' ' ILE . 10.3 m-30 -68.78 106.95 2.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.567 1.147 . . . . 0.0 107.986 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -107.56 159.27 14.58 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 129.677 3.513 . . . . 0.0 110.945 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.52 149.65 50.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 124.927 2.299 . . . . 0.0 112.109 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 40.9 mt -98.18 140.94 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 111.752 -2.476 . . . . 0.0 110.713 -176.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -134.04 151.78 51.56 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.986 1.714 . . . . 0.0 109.873 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.3 p -77.63 173.39 12.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 58.8 mt -125.41 141.29 45.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -64.14 132.04 49.27 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.919 1.288 . . . . 0.0 108.076 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.6 18.93 70.55 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 118.554 -1.137 . . . . 0.0 114.69 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -135.87 157.86 45.81 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 120.025 1.912 . . . . 0.0 109.172 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 73.8 m -106.38 140.98 38.45 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.94 -26.54 48.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 77.1 p -68.24 -12.99 61.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.643 2.377 . . . . 0.0 113.866 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -119.99 -42.72 2.58 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 118.833 -0.603 . . . . 0.0 109.532 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.02 155.43 18.57 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.335 0.588 . . . . 0.0 110.765 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -157.54 175.63 13.69 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.577 0.751 . . . . 0.0 109.972 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.75 134.26 53.43 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.887 1.275 . . . . 0.0 110.861 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.04 132.71 56.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.256 1.022 . . . . 0.0 108.345 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -70.18 102.82 2.18 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.508 ' HB ' ' HE2' ' A' ' 219' ' ' LYS . 39.3 mm -121.42 123.16 69.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 O-C-N 121.075 -1.016 . . . . 0.0 108.282 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 53.44 48.39 21.96 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.98 0.912 . . . . 0.0 109.074 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 62.19 9.0 2.93 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.59 1.156 . . . . 0.0 114.081 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -131.19 122.56 26.78 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.189 0.904 . . . . 0.0 109.028 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -61.94 118.71 7.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.286 0.634 . . . . 0.0 109.931 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.508 ' HE2' ' HB ' ' A' ' 214' ' ' ILE . 16.7 mtmm -114.23 149.06 36.39 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.4 1.095 . . . . 0.0 110.088 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -81.29 123.76 28.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.306 1.842 . . . . 0.0 111.871 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -110.3 145.28 37.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.62 145.37 51.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.68 1.192 . . . . 0.0 110.92 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -64.15 120.81 12.8 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.8 t -136.46 140.54 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -127.3 30.58 4.04 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.404 1.478 . . . . 0.0 112.086 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 C--O 1.247 0.96 0 C-N-CA 126.537 1.935 . . . . 0.0 106.127 179.517 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.36 144.41 42.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.479 2.711 . . . . 0.0 105.613 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -57.86 138.42 55.72 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.9 2.48 . . . . 0.0 112.818 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.4 t -140.54 142.17 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.5 1.92 . . . . 0.0 106.941 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.46 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.7 mp -90.27 139.63 17.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -68.35 131.46 45.36 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 122.669 1.223 . . . . 0.0 112.495 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -70.19 -16.95 63.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.125 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -93.17 -31.13 14.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.959 1.254 . . . . 0.0 112.517 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.23 110.69 6.08 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 t -64.85 -14.75 60.47 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.444 1.475 . . . . 0.0 111.311 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -82.26 -5.26 58.41 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.216 1.006 . . . . 0.0 110.689 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -107.37 158.43 17.17 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 118.264 0.484 . . . . 0.0 111.941 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 24.5 mm -130.18 131.31 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.692 1.197 . . . . 0.0 107.78 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -103.52 97.45 7.49 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -131.37 126.4 35.12 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 120.839 -1.163 . . . . 0.0 109.339 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 7.1 mtt 57.16 33.54 23.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.047 1.739 . . . . 0.0 110.554 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.45 0.59 54.5 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.297 -0.877 . . . . 0.0 111.336 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -92.74 161.01 14.71 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -121.15 134.08 65.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -129.84 159.71 35.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.9 t -138.41 156.65 47.38 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.469 1.108 . . . . 0.0 108.045 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.4 mt -112.47 129.92 67.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.842 0.857 . . . . 0.0 109.688 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.4 t -100.54 -110.16 0.2 Allowed 'General case' 0 C--O 1.238 0.476 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . 0.257 8.4 p-10 -162.4 99.03 1.04 Allowed 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 126.966 2.107 . . . . 0.0 107.668 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 97.5 m -137.93 108.34 6.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 115.961 -1.971 . . . . 0.0 109.072 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.6 m -67.29 122.68 18.43 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 122.163 2.256 . . . . 0.0 105.75 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.3 t -99.7 110.99 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.822 1.192 . . . . 0.0 108.036 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -79.38 164.66 23.85 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -61.45 -31.21 71.16 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.204 1.002 . . . . 0.0 111.426 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.28 -16.45 63.57 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.739 1.215 . . . . 0.0 111.384 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.93 -29.21 8.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.386 1.075 . . . . 0.0 110.003 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.1 tp -61.14 142.73 56.5 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.86 1.264 . . . . 0.0 109.082 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -96.51 -102.08 2.01 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.48 166.34 23.73 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.942 1.697 . . . . 0.0 110.644 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.87 146.48 26.32 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.999 0.92 . . . . 0.0 109.968 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -126.0 -52.33 1.54 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.09 -1.433 . . . . 0.0 112.689 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -157.25 154.66 29.49 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.745 1.612 . . . . 0.0 110.283 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.8 p -111.69 137.12 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 119.129 0.877 . . . . 0.0 110.013 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -112.02 165.03 12.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.535 2.334 . . . . 0.0 109.66 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -169.57 66.29 0.05 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.713 1.205 . . . . 0.0 109.563 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -156.4 173.47 16.84 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.34 147.83 16.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 O-C-N 121.179 -0.95 . . . . 0.0 108.63 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.23 161.41 38.35 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.865 0.757 . . . . 0.0 109.765 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.23 125.29 63.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 126.476 1.911 . . . . 0.0 108.768 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -142.91 163.95 31.4 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.065 1.346 . . . . 0.0 112.099 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.85 110.38 21.32 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.89 -18.84 36.73 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.69 1.596 . . . . 0.0 115.069 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.15 -40.46 82.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 O-C-N 121.284 -0.885 . . . . 0.0 112.044 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.463 ' HB3' ' HE2' ' A' ' 169' ' ' LYS . 0.4 OUTLIER -123.26 -12.98 7.78 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.684 0.794 . . . . 0.0 112.631 -178.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 84.18 12.67 75.89 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.302 0.953 . . . . 0.0 111.739 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 167' ' ' SER . 25.1 mtmt -71.89 112.62 8.14 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.969 1.308 . . . . 0.0 110.507 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.2 m -73.33 157.48 36.91 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.1 1.36 . . . . 0.0 109.933 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.44 151.68 51.79 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.221 0.608 . . . . 0.0 110.205 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 160.26 39.03 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.461 2.108 . . . . 0.0 108.778 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -60.0 -22.15 62.2 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.924 -1.11 . . . . 0.0 111.186 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -14.64 44.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.033 1.333 . . . . 0.0 112.345 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -116.62 3.15 13.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.052 0.941 . . . . 0.0 112.032 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -61.98 -2.8 0.99 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -144.67 9.71 1.87 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.955 1.264 . . . . 0.0 110.774 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.05 92.73 3.21 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.022 1.329 . . . . 0.0 112.247 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 25.7 mm -128.4 -51.15 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.628 1.171 . . . . 0.0 109.834 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -75.54 166.16 23.99 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.7 tttp 62.7 -23.4 0.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -72.35 -18.29 61.77 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.993 1.317 . . . . 0.0 112.689 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 128.06 -157.81 21.28 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.8 m -59.94 -10.35 3.99 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.8 m120 21.86 78.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 129.936 3.294 . . . . 0.0 113.808 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 31.6 t -135.19 -38.03 0.78 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.152 0.981 . . . . 0.0 111.113 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.44 -8.52 56.22 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.278 0.945 . . . . 0.0 112.191 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.495 HE21 ' CZ ' ' A' ' 190' ' ' ARG . 0.6 OUTLIER -72.76 154.16 40.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.331 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.0 t -165.22 127.02 2.07 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.495 ' CZ ' HE21 ' A' ' 188' ' ' GLN . 50.4 mtt180 -130.12 169.32 15.48 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.67 0.788 . . . . 0.0 109.988 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 93.5 m -144.22 124.29 13.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.803 2.041 . . . . 0.0 106.62 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -101.15 112.19 24.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -110.14 116.74 32.08 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.91 1.284 . . . . 0.0 110.658 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -83.2 125.18 31.28 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.676 2.39 . . . . 0.0 107.91 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.46 ' CE2' HD13 ' A' ' 123' ' ' ILE . 2.9 m-30 -77.11 100.91 5.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 213' ' ' GLU . . . -93.95 158.22 23.14 Favored Glycine 0 N--CA 1.438 -1.191 1 C-N-CA 130.806 4.05 . . . . 0.0 107.911 179.058 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -69.05 153.96 42.88 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.711 1.72 . . . . 0.0 111.041 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.9 mt -99.49 143.12 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 113.158 -1.837 . . . . 0.0 108.593 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -133.15 150.24 52.03 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.927 1.691 . . . . 0.0 109.429 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 19.4 m -79.33 171.59 14.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 69.4 mt -125.61 147.69 30.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 O-C-N 121.0 -1.063 . . . . 0.0 108.502 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 50.8 mtt-85 -67.5 125.59 26.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 65.52 26.78 72.02 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.008 -0.885 . . . . 0.0 114.484 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -141.79 140.52 33.04 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 17.6 m -94.52 145.68 24.63 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -20.77 59.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.449 1.1 . . . . 0.0 109.851 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 15.3 p -75.62 -10.81 59.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.716 2.407 . . . . 0.0 113.041 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -125.21 -48.65 1.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.906 1.682 . . . . 0.0 111.251 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.71 144.31 19.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.656 0.662 . . . . 0.0 110.666 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -149.97 175.91 11.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.12 0.568 . . . . 0.0 109.567 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.13 134.57 52.63 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.29 1.036 . . . . 0.0 111.702 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.79 130.59 68.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 C-N-CA 124.706 1.202 . . . . 0.0 110.591 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.403 ' HB3' ' HA3' ' A' ' 196' ' ' GLY . 5.2 tt0 -72.24 107.87 5.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 36.7 mm -121.54 115.04 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.653 1.181 . . . . 0.0 108.94 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 59.46 48.8 9.39 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.281 1.032 . . . . 0.0 108.477 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.8 t70 64.14 9.48 4.76 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.231 1.013 . . . . 0.0 113.586 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -126.66 122.83 36.08 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.913 -1.117 . . . . 0.0 109.603 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -69.05 121.95 17.72 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.758 -1.214 . . . . 0.0 111.905 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -117.31 144.04 45.29 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.67 1.588 . . . . 0.0 112.883 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.489 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.4 tm? -78.52 132.48 37.23 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.665 0.786 . . . . 0.0 110.357 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -118.69 143.44 46.85 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.3 p -121.55 146.7 46.69 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.887 0.875 . . . . 0.0 111.585 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -61.91 138.36 58.35 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 83.5 t -132.13 122.45 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 125.205 1.402 . . . . 0.0 107.612 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 176.47 47.34 0.06 OUTLIER Glycine 0 C--O 1.228 -0.237 0 N-CA-C 110.814 -0.915 . . . . 0.0 110.814 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 . . . . . 0 C--O 1.249 1.039 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.641 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t0 . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.09 138.04 27.98 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -76.42 115.12 15.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -118.4 129.19 75.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 124.436 1.094 . . . . 0.0 110.067 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.462 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.6 mp -77.99 137.95 21.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -58.51 130.06 44.98 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.495 1.14 . . . . 0.0 110.979 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -12.25 61.25 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.54 -41.75 5.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.385 1.074 . . . . 0.0 108.95 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -116.05 103.91 11.04 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 125.18 1.392 . . . . 0.0 114.1 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.56 ' HB2' ' CD1' ' A' ' 163' ' ' PHE . 67.1 m -68.83 -7.5 34.94 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 119.906 -1.746 . . . . 0.0 111.406 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.33 -9.36 36.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.452 1.901 . . . . 0.0 109.814 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.3 mttt -115.06 160.6 19.43 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 121.116 1.78 . . . . 0.0 113.02 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 31.2 mm -124.91 144.19 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 C-N-CA 125.267 1.427 . . . . 0.0 107.981 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -116.39 106.17 13.33 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 127.86 2.464 . . . . 0.0 104.58 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -135.26 123.56 23.17 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 20.8 mtp 64.8 27.71 12.95 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.387 1.475 . . . . 0.0 109.727 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 69.75 17.83 73.52 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.721 -1.044 . . . . 0.0 110.917 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -109.19 156.73 19.54 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.1 mm -110.65 134.8 51.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 123.522 0.729 . . . . 0.0 109.801 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -129.83 153.09 48.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.0 t -133.48 158.52 42.9 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.312 1.045 . . . . 0.0 108.529 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.0 mt -117.93 115.99 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.919 1.288 . . . . 0.0 110.369 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -88.78 -125.77 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 102.062 -3.31 . . . . 0.0 102.062 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -152.84 100.41 2.51 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 176.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 55.0 m -134.85 107.2 7.25 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 112.751 -2.022 . . . . 0.0 105.755 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.5 m -65.9 124.04 21.43 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.6 t -94.71 142.1 14.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.1 m -114.77 162.68 16.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.017 1.327 . . . . 0.0 109.442 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.84 -26.72 67.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 111.262 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.42 -21.08 63.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.385 0.674 . . . . 0.0 110.296 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -105.8 -18.9 13.92 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.85 0.86 . . . . 0.0 110.496 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 24.2 mt -67.16 141.6 57.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.513 0.673 . . . . 0.0 109.594 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.48 -101.24 1.84 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -135.5 167.53 20.91 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.936 2.494 . . . . 0.0 109.706 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -63.27 148.16 49.01 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -126.1 -52.58 1.53 Allowed 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 121.254 -0.904 . . . . 0.0 111.744 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -151.59 147.52 26.87 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 119.038 0.835 . . . . 0.0 110.549 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.68 134.41 40.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.4 mp -112.05 159.24 18.67 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.618 2.367 . . . . 0.0 108.78 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -169.56 53.25 0.04 OUTLIER 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.111 0.564 . . . . 0.0 112.225 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -147.38 173.11 12.93 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.785 -1.197 . . . . 0.0 108.985 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.3 t -145.45 145.38 20.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -141.05 166.1 25.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 61.6 t -131.08 132.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 128' ' ' SER . 55.1 p90 -144.99 171.62 14.21 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.944 0.878 . . . . 0.0 112.49 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.09 104.67 15.2 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.819 2.448 . . . . 0.0 105.341 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.0 t -65.07 -11.96 45.29 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.448 1.931 . . . . 0.0 112.721 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.7 m -64.83 -40.48 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 O-C-N 120.513 -1.367 . . . . 0.0 110.683 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.5 t -123.8 -23.6 4.65 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.623 1.169 . . . . 0.0 113.831 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.34 3.24 57.66 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.524 2.012 . . . . 0.0 110.611 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -54.55 113.03 1.14 Allowed 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.634 1.974 . . . . 0.0 109.676 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.2 m -64.33 158.14 24.28 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.382 0.673 . . . . 0.0 110.882 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.27 144.18 48.33 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.545 1.538 . . . . 0.0 107.554 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -81.35 162.43 19.78 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.565 2.843 . . . . 0.0 109.893 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -59.77 -22.32 61.96 Favored 'General case' 0 C--O 1.228 -0.068 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 42.5 m -70.74 -7.86 47.98 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.404 -0.81 . . . . 0.0 111.925 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.88 2.93 12.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.748 1.219 . . . . 0.0 111.732 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -69.17 -9.59 53.61 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -135.57 -24.91 0.53 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.035 1.779 . . . . 0.0 109.825 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.63 102.99 7.3 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 29.1 mm -66.33 -71.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -167.27 162.94 15.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.614 1.166 . . . . 0.0 109.457 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.5 -14.44 2.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 129.014 2.926 . . . . 0.0 113.045 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.14 -36.19 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.545 1.938 . . . . 0.0 113.419 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -110.33 -175.94 20.75 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 124.46 1.029 . . . . 0.0 114.168 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 89.0 p -85.77 154.01 21.89 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.869 0.867 . . . . 0.0 110.663 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -83.28 -39.35 20.96 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 124.282 1.033 . . . . 0.0 108.609 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 33.5 t -49.09 -54.6 15.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.263 1.825 . . . . 0.0 111.896 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -79.14 8.83 5.19 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -129.51 149.3 51.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 120.094 1.315 . . . . 0.0 110.827 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 79.5 p -160.55 160.41 31.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.983 0.913 . . . . 0.0 108.893 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -137.09 171.2 14.86 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.977 1.711 . . . . 0.0 107.963 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.1 m -136.64 136.59 39.26 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.324 1.85 . . . . 0.0 106.778 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -117.78 106.92 13.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.374 1.47 . . . . 0.0 108.931 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -110.25 116.8 32.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.887 2.075 . . . . 0.0 107.657 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.93 116.56 25.08 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.968 2.507 . . . . 0.0 107.093 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.462 ' CE2' HD13 ' A' ' 123' ' ' ILE . 10.5 m-30 -64.88 102.54 0.61 Allowed 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.644 1.577 . . . . 0.0 109.151 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.26 158.98 17.3 Favored Glycine 0 N--CA 1.435 -1.411 1 C-N-CA 131.264 4.269 . . . . 0.0 107.845 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -66.13 154.25 40.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.282 1.991 . . . . 0.0 114.057 -174.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 46.4 mt -101.38 141.47 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 112.589 -2.096 . . . . 0.0 109.069 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.1 153.01 49.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.674 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 12.8 t -78.21 172.68 13.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.142 1.777 . . . . 0.0 106.556 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 18.3 mt -131.47 149.79 33.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 122.751 1.263 . . . . 0.0 113.128 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 60.4 mtt-85 -69.03 121.03 15.83 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.217 1.807 . . . . 0.0 109.431 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.14 24.77 76.71 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 117.587 -1.674 . . . . 0.0 113.418 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -149.55 144.52 26.29 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.811 1.805 . . . . 0.0 112.358 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.9 m -92.02 151.37 20.5 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.2 -33.53 65.41 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.294 -0.879 . . . . 0.0 110.046 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.3 p -66.21 -14.71 62.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.691 1.996 . . . . 0.0 114.29 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -114.67 -37.98 4.11 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.47 1.108 . . . . 0.0 110.055 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.35 145.07 2.63 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.141 0.976 . . . . 0.0 110.895 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -148.58 171.68 15.75 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.24 138.16 46.01 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.869 0.468 . . . . 0.0 110.564 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 4.1 p -133.13 129.84 57.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 123.544 0.737 . . . . 0.0 111.719 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -74.86 105.82 6.09 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.5 122.6 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.403 1.481 . . . . 0.0 108.863 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 54.8 44.16 28.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.083 0.856 . . . . 0.0 108.973 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 62.34 6.91 2.06 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.405 1.482 . . . . 0.0 114.282 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.33 121.96 36.42 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -66.39 128.68 37.1 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.265 1.026 . . . . 0.0 110.493 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -123.61 151.14 43.31 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.433 0.693 . . . . 0.0 110.763 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.8 tm? -83.79 117.87 23.56 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.68 1.192 . . . . 0.0 112.452 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -100.54 151.72 21.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.0 p -135.71 150.35 49.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.84 0.856 . . . . 0.0 110.838 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -60.94 140.37 57.77 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.842 1.257 . . . . 0.0 107.814 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 226' ' ' ASN . 45.1 t -134.54 132.69 54.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -81.62 -12.78 81.2 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.936 -0.924 . . . . 0.0 114.447 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.494 ' H ' HG12 ' A' ' 224' ' ' VAL . 1.8 p-10 . . . . . 0 C--O 1.254 1.296 0 C-N-CA 125.264 1.426 . . . . 0.0 112.175 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.33 151.97 49.21 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -77.05 137.63 39.08 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.2 t -138.29 129.97 37.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 126.162 1.785 . . . . 0.0 108.355 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -73.84 140.12 18.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -65.2 130.42 43.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 123.006 1.384 . . . . 0.0 109.455 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -63.47 -24.03 67.65 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.686 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -89.31 -40.71 12.61 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.435 0.694 . . . . 0.0 110.727 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.71 113.15 16.28 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.719 1.208 . . . . 0.0 111.374 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.5 m -68.12 -11.14 58.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.604 1.962 . . . . 0.0 111.664 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -96.96 -4.33 40.08 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.978 1.711 . . . . 0.0 111.489 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -110.32 157.99 18.91 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.241 0.928 . . . . 0.0 110.632 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.4 mm -124.42 137.95 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -117.21 106.28 13.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.176 1.79 . . . . 0.0 106.48 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -127.42 125.35 40.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.6 mtt 61.94 17.78 9.27 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.721 1.208 . . . . 0.0 110.899 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.41 0.07 88.38 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.758 -1.023 . . . . 0.0 111.369 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -86.52 168.43 13.71 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.1 mm -124.81 132.71 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 119.646 1.112 . . . . 0.0 109.851 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -126.63 152.79 46.2 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.885 0.874 . . . . 0.0 108.936 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.7 t -137.35 147.17 45.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.227 1.011 . . . . 0.0 108.422 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.53 125.33 62.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 126.433 1.893 . . . . 0.0 110.712 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.4 t -91.89 -104.67 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -166.71 99.52 0.57 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 45.8 m -136.23 115.07 12.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.8 m -76.68 123.8 26.69 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 121.227 1.831 . . . . 0.0 106.431 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.82 142.05 14.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.7 m -114.42 164.68 13.62 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.375 1.07 . . . . 0.0 111.125 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.67 -27.66 66.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.587 1.155 . . . . 0.0 112.44 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.08 -13.26 62.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.698 0.799 . . . . 0.0 110.359 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -119.43 -25.86 5.95 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 124.761 1.224 . . . . 0.0 110.965 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.1 tp -68.1 129.06 38.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.07 -98.17 0.77 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -135.13 163.39 30.03 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.272 1.429 . . . . 0.0 110.259 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -63.88 143.91 57.48 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -126.23 -47.52 1.61 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -151.46 158.67 43.96 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.992 1.269 . . . . 0.0 111.037 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.4 p -115.45 139.33 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.1 0.96 . . . . 0.0 108.591 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.26 164.67 11.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.998 1.719 . . . . 0.0 110.518 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -165.9 54.13 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -154.05 167.86 28.38 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 120.024 -1.673 . . . . 0.0 106.999 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.5 t -145.17 148.49 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -146.54 164.37 32.79 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.4 t -130.39 131.58 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -138.72 168.18 20.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.525 0.678 . . . . 0.0 111.479 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.497 ' CG ' HG22 ' A' ' 166' ' ' VAL . 53.3 t0 -80.51 111.53 17.0 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.7 t -51.51 -18.69 1.17 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 130.319 3.448 . . . . 0.0 115.074 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.497 HG22 ' CG ' ' A' ' 164' ' ' ASP . 20.9 m -76.9 -52.08 17.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 124.564 1.146 . . . . 0.0 113.46 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.414 ' HB2' ' HD3' ' A' ' 169' ' ' LYS 0.27 18.5 m -121.69 -27.08 4.77 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.186 1.794 . . . . 0.0 113.592 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.75 12.26 13.09 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.38 1.467 . . . . 0.0 113.441 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -57.1 112.45 1.36 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.597 2.198 . . . . 0.0 110.03 -178.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 43.2 p -63.13 151.89 38.86 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.79 145.37 41.1 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 125.147 1.379 . . . . 0.0 107.735 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.02 159.04 27.19 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.299 2.666 . . . . 0.0 108.868 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -55.62 -37.56 68.33 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 125.665 1.586 . . . . 0.0 111.867 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.9 m -63.51 -13.05 37.14 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 118.701 -1.2 . . . . 0.0 113.75 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.31 -15.3 20.82 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.403 1.481 . . . . 0.0 108.933 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -60.99 -11.64 8.79 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -120.34 -20.2 3.68 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.661 1.601 . . . . 0.0 110.32 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.31 71.62 1.47 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.249 1.819 . . . . 0.0 107.794 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.0 mt -50.24 -43.75 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.643 1.177 . . . . 0.0 109.018 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.5 t0 28.4 44.25 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 131.255 3.822 . . . . 0.0 117.35 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -63.03 -59.96 4.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 121.473 -0.767 . . . . 0.0 112.002 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -116.15 3.95 13.56 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.412 1.485 . . . . 0.0 111.7 -178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 93.48 -13.92 66.45 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 120.839 -1.163 . . . . 0.0 111.904 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 74.3 p -144.07 160.54 40.72 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.177 1.391 . . . . 0.0 108.959 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.36 33.29 0.56 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.375 1.083 . . . . 0.0 111.992 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.6 t -69.61 109.98 4.59 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.431 1.493 . . . . 0.0 111.32 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 38.1 tttm 45.39 31.38 0.85 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.393 2.277 . . . . 0.0 114.721 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -139.31 139.17 37.24 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 t -157.92 159.61 36.73 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.81 177.8 4.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.6 m -128.59 124.78 36.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -106.25 109.51 21.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 34.8 m0 -115.51 116.14 27.68 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.13 136.57 32.95 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . 0.253 4.8 m-30 -82.02 101.42 10.31 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 122.217 1.008 . . . . 0.0 110.967 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -93.38 158.55 23.71 Favored Glycine 0 CA--C 1.532 1.111 1 C-N-CA 135.355 6.217 . . . . 0.0 107.162 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -68.23 156.84 36.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 123.3 1.524 . . . . 0.0 112.757 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 74.3 mt -103.49 139.64 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 126.541 1.936 . . . . 0.0 110.241 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -134.27 153.5 51.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.543 1.537 . . . . 0.0 110.21 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.4 p -76.98 173.02 12.26 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.712 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 43.9 mt -127.22 133.57 67.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 122.198 0.999 . . . . 0.0 108.877 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -62.8 127.87 33.29 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.151 1.78 . . . . 0.0 108.647 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.19 13.23 76.53 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.157 -1.357 . . . . 0.0 114.625 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -137.01 139.2 41.24 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 120.329 2.065 . . . . 0.0 110.725 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.9 m -84.44 144.65 28.62 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -23.13 65.55 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 120.56 -1.337 . . . . 0.0 109.531 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 31.6 p -76.71 -6.85 53.86 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.262 2.225 . . . . 0.0 113.814 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -121.38 -45.99 2.3 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.248 1.019 . . . . 0.0 109.362 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.49 143.21 13.15 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.377 0.535 . . . . 0.0 111.004 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -149.12 175.81 11.02 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.301 -0.25 . . . . 0.0 110.628 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.17 134.4 51.78 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.67 1.188 . . . . 0.0 113.021 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.58 127.85 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 125.326 1.451 . . . . 0.0 111.602 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 218' ' ' PHE . 43.9 tt0 -74.2 110.01 8.15 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 37.0 mm -121.53 117.92 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 56.06 39.88 30.36 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.14 0.576 . . . . 0.0 110.125 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.4 t70 76.32 -8.39 1.65 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.424 1.889 . . . . 0.0 112.02 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -104.97 122.23 45.4 Favored 'General case' 0 CA--C 1.52 -0.209 0 O-C-N 119.906 -1.746 . . . . 0.0 110.189 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 213' ' ' GLU . 11.9 m-85 -71.03 119.34 15.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -110.27 145.86 36.65 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.564 1.145 . . . . 0.0 111.331 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.8 tm? -82.03 130.51 35.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -120.43 142.15 49.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.2 p -118.61 150.28 39.95 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.599 0.714 . . . . 0.0 110.963 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -64.96 143.63 57.83 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 97.4 t -123.51 157.79 29.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -157.67 58.3 0.35 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 105.389 -3.085 . . . . 0.0 105.389 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 10.4 m120 . . . . . 0 C--O 1.245 0.826 0 C-N-CA 125.735 1.614 . . . . 0.0 109.552 -179.335 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.509 -0.62 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.06 141.62 24.37 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 128.582 2.753 . . . . 0.0 104.01 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -73.94 151.64 40.32 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.1 t -145.87 136.89 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -81.76 134.93 26.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -58.5 119.43 6.99 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.598 1.19 . . . . 0.0 109.964 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -58.24 -22.53 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.174 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -94.54 -21.84 18.6 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.73 1.212 . . . . 0.0 111.955 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -141.97 104.88 4.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.519 1.128 . . . . 0.0 109.212 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.3 t -69.06 -3.56 13.68 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.522 -1.361 . . . . 0.0 110.867 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 45.7 ptt85 -98.13 -3.2 38.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.718 2.007 . . . . 0.0 110.397 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -117.54 169.7 9.33 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.541 1.136 . . . . 0.0 112.224 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.3 mm -130.32 151.16 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 C-N-CA 126.165 1.786 . . . . 0.0 107.878 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.19 102.5 8.17 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 130.119 3.368 . . . . 0.0 103.603 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -142.7 131.93 23.35 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 120.643 -1.286 . . . . 0.0 109.589 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.5 mtt 57.61 32.91 22.55 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.353 1.461 . . . . 0.0 113.026 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.49 7.34 82.75 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.453 -1.193 . . . . 0.0 112.449 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -113.08 168.36 9.77 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.131 1.372 . . . . 0.0 108.099 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -119.54 145.46 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -133.3 155.69 48.94 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.2 t -134.91 151.59 51.01 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.039 1.736 . . . . 0.0 108.22 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.3 mt -112.82 123.34 68.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.956 1.302 . . . . 0.0 108.971 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.1 t -97.72 -118.27 0.13 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 101.884 -3.376 . . . . 0.0 101.884 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -158.05 99.36 1.66 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 120.622 1.555 . . . . 0.0 106.935 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 m -137.95 115.31 11.11 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 127.209 2.204 . . . . 0.0 106.326 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.9 m -71.72 129.79 39.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.81 111.05 24.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 66.5 m -75.45 164.46 26.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.068 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.9 -29.37 70.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.545 0.688 . . . . 0.0 111.753 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -72.74 -11.61 60.69 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.594 1.158 . . . . 0.0 111.265 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.77 -24.62 11.62 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.552 1.541 . . . . 0.0 109.534 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.09 127.92 33.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.825 1.25 . . . . 0.0 111.85 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.63 -106.06 1.31 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -133.77 163.0 30.45 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.128 1.371 . . . . 0.0 109.307 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -60.41 145.65 47.33 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.52 -42.02 1.98 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 116.507 -1.711 . . . . 0.0 114.494 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -161.28 160.86 30.33 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 121.066 1.757 . . . . 0.0 110.489 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.4 p -121.84 133.15 69.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.57 1.148 . . . . 0.0 108.402 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -107.83 166.33 10.78 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.181 2.193 . . . . 0.0 110.591 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -164.08 41.04 0.09 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -138.71 172.23 13.18 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 120.039 -1.663 . . . . 0.0 109.568 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.76 149.36 17.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -145.46 167.02 23.98 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.35 131.89 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -138.02 166.72 23.4 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.461 0.704 . . . . 0.0 110.193 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -86.07 116.03 24.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.38 -14.46 1.91 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 127.032 2.133 . . . . 0.0 115.179 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.4 m -77.34 -46.85 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 124.044 0.937 . . . . 0.0 112.451 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.23 -28.42 3.69 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.37 12.73 16.59 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.067 1.318 . . . . 0.0 112.299 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 112.78 2.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.968 1.384 . . . . 0.0 111.253 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 47.1 m -69.35 154.75 41.54 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.588 1.085 . . . . 0.0 110.476 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.31 147.66 66.72 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.659 1.584 . . . . 0.0 110.828 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.53 157.71 22.07 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 124.499 3.466 . . . . 0.0 110.502 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -53.17 -25.1 12.46 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 m -70.54 -22.06 62.65 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 118.056 -0.973 . . . . 0.0 113.468 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.2 -12.45 28.24 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.555 1.525 . . . . 0.0 110.753 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.5 m0 -62.38 -10.21 10.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.924 1.29 . . . . 0.0 111.771 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -144.91 6.37 1.58 Allowed Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.155 -1.358 . . . . 0.0 113.336 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.9 96.57 3.55 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.308 2.054 . . . . 0.0 108.062 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.3 mm -73.85 -61.81 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 57.79 51.59 9.07 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.79 2.036 . . . . 0.0 111.684 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -139.04 167.37 22.21 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.681 1.193 . . . . 0.0 110.272 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -59.34 4.68 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.431 2.692 . . . . 0.0 110.839 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 170.08 31.65 0.02 OUTLIER Glycine 0 N--CA 1.468 0.819 0 O-C-N 121.361 -0.837 . . . . 0.0 114.272 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.3 t -65.08 -25.17 67.69 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.644 1.177 . . . . 0.0 112.756 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -79.66 33.06 0.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.247 1.019 . . . . 0.0 111.951 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 44.6 t -78.6 -50.07 12.15 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.92 2.088 . . . . 0.0 111.677 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -125.9 5.86 7.32 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.368 1.867 . . . . 0.0 110.752 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.6 153.22 51.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.919 1.688 . . . . 0.0 108.59 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.1 t -171.44 178.82 3.09 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.914 1.686 . . . . 0.0 107.751 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 49.3 mmt-85 -87.96 177.41 6.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 122.19 0.995 . . . . 0.0 111.632 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.0 m -122.36 129.39 52.07 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 126.944 2.098 . . . . 0.0 105.557 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -115.94 106.54 13.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.349 1.859 . . . . 0.0 107.41 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -110.52 117.44 33.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.295 1.838 . . . . 0.0 108.701 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -87.88 127.21 35.35 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -73.31 101.45 3.42 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.029 0.932 . . . . 0.0 109.561 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.82 159.06 22.81 Favored Glycine 0 N--CA 1.442 -0.921 1 C-N-CA 132.694 4.95 . . . . 0.0 107.544 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' A' ' 197' ' ' GLU . 6.6 pt-20 -68.1 151.17 47.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 123.544 1.64 . . . . 0.0 111.536 -176.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 63.9 mt -99.38 143.99 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 C-N-CA 126.463 1.905 . . . . 0.0 110.299 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -137.99 153.27 49.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.734 1.613 . . . . 0.0 110.095 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.8 p -80.47 173.22 12.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 66.4 mt -124.8 136.46 60.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.381 1.072 . . . . 0.0 109.015 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -64.88 119.12 10.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.66 10.89 72.19 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-O 118.148 -1.362 . . . . 0.0 116.083 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -137.38 130.44 30.63 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 120.473 2.136 . . . . 0.0 110.295 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 15.0 m -71.49 145.08 49.42 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.62 -24.96 65.91 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.052 0.941 . . . . 0.0 109.158 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 17.1 p -75.53 -9.76 58.86 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 127.83 2.452 . . . . 0.0 112.798 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -119.77 -47.61 2.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.582 1.153 . . . . 0.0 109.386 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.35 145.38 19.11 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.902 0.774 . . . . 0.0 111.01 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -152.08 175.73 12.26 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.859 -0.526 . . . . 0.0 110.716 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -111.51 134.71 52.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.871 1.669 . . . . 0.0 112.29 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.427 HG13 HG12 ' A' ' 214' ' ' ILE . 8.0 p -129.83 131.56 66.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 124.821 1.249 . . . . 0.0 109.436 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.41 106.75 5.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.427 HG12 HG13 ' A' ' 212' ' ' VAL . 28.2 mm -121.42 128.97 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 53.81 36.63 24.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.995 0.816 . . . . 0.0 111.65 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.9 t0 68.74 9.66 7.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.553 1.541 . . . . 0.0 112.825 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -124.92 122.98 38.9 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.519 1.128 . . . . 0.0 108.743 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -69.12 119.37 13.3 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.828 -1.17 . . . . 0.0 110.373 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -116.07 147.19 41.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 123.41 1.576 . . . . 0.0 111.679 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -80.93 122.61 27.46 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 126.486 1.914 . . . . 0.0 113.074 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -112.45 140.07 47.5 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.3 p -120.54 145.51 47.25 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.621 1.168 . . . . 0.0 110.765 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -60.36 135.41 57.73 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 9.8 p -135.75 153.92 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 122.965 0.506 . . . . 0.0 109.816 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 95.8 -70.15 0.97 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 105.399 -3.08 . . . . 0.0 105.399 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.244 0.787 0 C-N-CA 124.629 1.171 . . . . 0.0 110.901 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 CA--C 1.519 -0.24 0 CA-C-O 121.787 0.803 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.72 139.86 31.26 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 128.329 2.652 . . . . 0.0 106.34 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -70.43 130.7 42.61 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.6 t -131.46 134.92 60.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.0 mm -69.78 131.53 34.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -68.35 129.39 39.77 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.523 0.678 . . . . 0.0 109.988 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -71.26 -18.37 62.44 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.139 -0.976 . . . . 0.0 110.329 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -82.05 -34.21 29.58 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.644 1.178 . . . . 0.0 111.261 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.38 121.17 9.9 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.5 t -59.35 -25.21 64.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.526 1.057 . . . . 0.0 110.48 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -90.47 3.02 55.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.224 1.81 . . . . 0.0 112.946 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -109.13 155.98 20.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.2 mm -126.69 142.04 44.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -115.25 104.25 11.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 128.111 2.564 . . . . 0.0 105.166 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -132.58 128.63 37.61 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 19.8 mtt 61.76 21.77 12.47 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.221 1.408 . . . . 0.0 110.841 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.72 14.64 81.85 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.515 -1.159 . . . . 0.0 111.878 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -113.1 157.92 21.02 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.0 mm -114.65 143.93 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.561 0.696 . . . . 0.0 111.507 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -131.12 155.31 47.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.571 1.948 . . . . 0.0 109.63 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.6 t -145.18 147.38 32.4 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.9 mt -102.85 120.24 52.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 126.665 1.986 . . . . 0.0 112.03 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.2 t -90.33 -116.6 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 1 N-CA-C 99.881 -4.118 . . . . 0.0 99.881 176.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -160.25 99.82 1.34 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 2.4 m -136.63 121.41 18.61 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 176.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 m -81.24 136.73 35.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 120.671 1.578 . . . . 0.0 107.05 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.4 t -103.35 112.25 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 74.3 m -79.82 166.22 21.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.975 0.91 . . . . 0.0 109.1 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -58.27 -32.01 68.0 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.345 1.058 . . . . 0.0 111.091 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.82 -8.03 39.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.167 1.787 . . . . 0.0 112.044 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -122.33 -12.14 8.27 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 127.72 2.408 . . . . 0.0 110.001 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 20.3 mt -83.09 123.03 29.11 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.23 -101.46 0.84 Allowed Glycine 0 CA--C 1.507 -0.424 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -134.75 167.05 21.57 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.379 1.071 . . . . 0.0 108.8 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -61.02 143.05 56.1 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.0 0.92 . . . . 0.0 111.374 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.06 -41.41 1.94 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 116.907 -1.521 . . . . 0.0 113.3 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -160.27 150.36 18.17 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.707 1.594 . . . . 0.0 110.792 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.1 p -109.26 135.79 47.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.1 mp -110.66 163.21 13.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.934 2.094 . . . . 0.0 110.95 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -165.33 64.34 0.12 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -153.01 173.19 15.73 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.564 -1.335 . . . . 0.0 108.763 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.2 t -149.57 138.07 14.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 126.103 1.761 . . . . 0.0 106.368 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.75 166.05 25.7 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.8 t -132.49 126.9 55.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -142.08 164.01 31.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.561 1.144 . . . . 0.0 110.759 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -92.95 103.57 15.88 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 104.284 -2.488 . . . . 0.0 104.284 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.35 -15.72 0.69 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.365 2.266 . . . . 0.0 116.127 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.6 m -57.71 -51.0 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.168 0.987 . . . . 0.0 108.406 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.2 m -123.45 -26.7 4.19 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.397 1.879 . . . . 0.0 114.437 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 103.4 16.56 20.09 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.499 1.523 . . . . 0.0 113.615 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 113.04 4.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.76 1.78 . . . . 0.0 109.261 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 6.0 m -75.21 145.25 42.17 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.26 143.07 26.97 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.17 160.51 42.41 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.167 2.578 . . . . 0.0 111.028 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -57.32 -28.62 63.24 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.065 0.546 . . . . 0.0 111.913 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.5 m -61.32 -14.22 25.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.071 0.949 . . . . 0.0 112.148 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -119.12 4.91 11.3 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.903 1.681 . . . . 0.0 111.951 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -68.16 -15.98 63.81 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.752 -1.218 . . . . 0.0 113.895 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -127.23 -46.91 0.19 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -81.24 86.76 6.17 Favored 'General case' 0 C--N 1.337 0.024 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 89.3 mt -70.76 -80.82 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.42 161.83 34.34 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.859 1.264 . . . . 0.0 108.731 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -64.19 -37.98 89.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.31 0.644 . . . . 0.0 109.705 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -84.49 -48.94 9.09 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.872 1.669 . . . . 0.0 106.896 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 95.4 3.75 61.24 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.504 1.526 . . . . 0.0 113.892 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.8 p -35.36 -58.67 0.56 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 127.771 2.428 . . . . 0.0 113.843 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 57.96 -9.96 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.034 2.134 . . . . 0.0 116.466 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.5 t -46.58 -23.49 0.4 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -109.64 12.12 24.38 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 121.131 1.787 . . . . 0.0 112.352 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -116.55 160.0 21.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 119.86 1.209 . . . . 0.0 108.792 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.04 84.03 1.45 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -76.57 158.8 30.86 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.488 0.661 . . . . 0.0 110.232 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.4 m -141.84 132.53 25.58 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.478 1.911 . . . . 0.0 106.018 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -115.35 104.77 12.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -110.63 116.6 31.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.013 1.325 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -83.27 128.23 34.32 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 127.212 2.205 . . . . 0.0 105.861 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -76.55 102.3 6.02 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.68 159.27 16.84 Favored Glycine 0 N--CA 1.442 -0.96 1 C-N-CA 131.489 4.376 . . . . 0.0 109.918 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -67.12 154.98 39.9 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 124.294 1.997 . . . . 0.0 113.717 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 50.4 mt -102.26 140.97 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.299 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -131.58 151.52 51.53 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 109.604 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 11.4 m -76.3 172.27 13.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.778 0.831 . . . . 0.0 108.984 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 78.8 mt -131.91 138.15 53.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.902 0.858 . . . . 0.0 110.509 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -65.5 119.04 10.34 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.22 14.73 76.09 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 118.821 -0.989 . . . . 0.0 115.378 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -140.78 126.2 18.81 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 119.771 1.785 . . . . 0.0 109.782 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 16.3 m -76.48 146.71 38.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.31 -27.8 56.78 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.541 1.136 . . . . 0.0 110.393 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 36.9 p -74.33 -9.74 58.9 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.433 1.893 . . . . 0.0 114.362 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -120.69 -43.88 2.46 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.26 1.424 . . . . 0.0 109.547 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.15 144.28 14.35 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.115 0.566 . . . . 0.0 110.13 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -148.13 176.38 10.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.803 0.841 . . . . 0.0 109.152 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -108.62 130.73 55.31 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.455 1.102 . . . . 0.0 109.727 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.1 p -124.28 126.97 72.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 124.48 1.112 . . . . 0.0 111.678 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -73.89 108.42 6.7 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 35.4 mm -121.74 120.2 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 54.17 40.39 31.62 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.8 t70 70.68 -4.83 1.57 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.381 2.272 . . . . 0.0 113.2 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.44 ' HB3' ' HE2' ' A' ' 219' ' ' LYS . 37.8 m-20 -106.15 122.26 45.84 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 120.279 -1.513 . . . . 0.0 108.953 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.85 120.49 16.52 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.291 -0.881 . . . . 0.0 110.22 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 217' ' ' ASP . 19.5 mmtp -112.46 151.58 29.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.818 1.247 . . . . 0.0 112.671 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.406 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.5 tm? -88.81 117.07 27.53 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.067 0.947 . . . . 0.0 110.711 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.89 156.23 17.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.9 143.3 40.77 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 123.158 0.583 . . . . 0.0 109.908 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -54.82 125.82 21.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.865 0.866 . . . . 0.0 110.162 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.7 t -134.71 130.52 53.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 C-N-CA 126.387 1.875 . . . . 0.0 107.986 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.97 -15.48 21.13 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 119.196 -0.78 . . . . 0.0 112.656 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . 0.321 1.0 OUTLIER . . . . . 0 C--O 1.247 0.96 0 C-N-CA 131.199 3.799 . . . . 0.0 113.7 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 t0 . . . . . 0 CA--C 1.507 -0.687 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.68 152.04 45.03 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.128 1.771 . . . . 0.0 106.568 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.4 ' CD2' HD13 ' A' ' 198' ' ' ILE . 45.8 m-85 -69.56 140.91 53.89 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.879 1.272 . . . . 0.0 110.264 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 85.4 t -141.24 141.34 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.479 HD13 ' CE2' ' A' ' 195' ' ' TYR . 4.7 mp -80.28 121.13 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 102.536 -3.135 . . . . 0.0 102.536 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -48.61 122.13 5.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 122.087 0.946 . . . . 0.0 111.475 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -65.72 -17.54 64.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.785 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -94.96 -20.38 19.43 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.956 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.17 122.2 9.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 120.038 1.29 . . . . 0.0 108.127 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.5 m -65.12 -18.86 65.66 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 120.182 -1.574 . . . . 0.0 110.699 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -94.12 -0.48 55.28 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.943 1.297 . . . . 0.0 113.095 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -108.0 159.59 16.44 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.466 0.575 . . . . 0.0 110.104 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.2 mm -126.81 138.51 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -118.63 108.67 15.22 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -146.39 134.1 21.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.8 mtt 58.69 26.91 15.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.747 2.019 . . . . 0.0 113.531 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.17 23.52 71.14 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -121.99 164.7 17.19 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.3 mm -123.77 126.36 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.89 150.19 41.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 29.7 t -130.75 150.04 52.12 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.004 1.322 . . . . 0.0 109.201 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 mt -111.36 124.21 67.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 125.602 1.561 . . . . 0.0 110.725 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.6 t -95.31 -126.95 0.13 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 103.188 -2.893 . . . . 0.0 103.188 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -149.73 99.37 2.86 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 94.5 m -136.89 111.79 8.88 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 128.094 2.558 . . . . 0.0 109.654 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.1 m -69.05 124.34 23.51 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 54.6 t -94.46 119.58 42.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 119.675 1.125 . . . . 0.0 109.157 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 50.2 m -80.65 159.13 25.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.643 0.735 . . . . 0.0 109.858 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.35 -29.34 70.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.956 1.302 . . . . 0.0 112.008 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -72.43 -16.11 61.83 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.311 1.044 . . . . 0.0 111.892 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -103.9 -25.95 12.85 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.818 0.847 . . . . 0.0 108.867 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.9 mt -62.14 137.58 58.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.757 1.223 . . . . 0.0 109.923 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -89.39 -105.71 1.12 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -135.04 169.43 17.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.057 1.743 . . . . 0.0 109.805 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -59.68 142.39 53.13 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -125.74 -48.97 1.63 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 116.595 -1.669 . . . . 0.0 111.902 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -155.73 150.81 26.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.9 1.682 . . . . 0.0 112.217 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.8 p -105.5 133.59 49.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 122.482 1.134 . . . . 0.0 111.332 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mp -113.1 161.93 16.53 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.562 2.745 . . . . 0.0 109.702 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.66 48.71 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.569 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 3.5 mt-10 -143.72 176.68 9.05 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.85 2.06 . . . . 0.0 111.579 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.49 150.56 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 120.593 -1.317 . . . . 0.0 110.508 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.512 ' HE ' ' CB ' ' A' ' 193' ' ' TRP . 0.0 OUTLIER -131.38 157.49 43.28 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.408 1.483 . . . . 0.0 109.606 178.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.5 t -140.51 114.18 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -141.58 167.98 20.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.356 0.598 . . . . 0.0 112.212 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -83.21 104.24 13.23 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.5 m -64.48 -14.99 59.97 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 122.145 2.248 . . . . 0.0 114.526 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.6 m -69.57 -35.17 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 O-C-N 121.823 -0.548 . . . . 0.0 112.001 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.29 -19.19 6.03 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.384 1.473 . . . . 0.0 113.015 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.26 -10.84 69.47 Favored Glycine 0 CA--C 1.543 1.796 0 C-N-CA 126.969 2.223 . . . . 0.0 112.582 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -47.69 115.4 1.13 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 128.369 2.667 . . . . 0.0 113.64 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.6 p -67.04 158.12 31.8 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 109.965 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.0 134.79 24.44 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.49 156.78 49.72 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.672 2.248 . . . . 0.0 110.005 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.437 ' HA ' ' CD1' ' A' ' 176' ' ' TRP . 42.7 ttt180 -56.58 -30.46 63.2 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t -66.96 -7.59 23.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.352 0.978 . . . . 0.0 111.753 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.06 -7.59 14.91 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.14 1.376 . . . . 0.0 110.885 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.437 ' CD1' ' HA ' ' A' ' 173' ' ' ARG . 34.2 m0 -60.71 -14.93 24.11 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -119.81 13.03 10.75 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.721 2.105 . . . . 0.0 110.837 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.1 mmt85 -106.68 76.68 1.13 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.854 1.661 . . . . 0.0 107.558 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 12.6 mm -105.09 -77.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -118.46 66.89 0.77 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.64 1.576 . . . . 0.0 112.731 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -128.8 -4.45 5.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.421 1.488 . . . . 0.0 110.285 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -136.06 5.13 3.03 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.629 1.572 . . . . 0.0 113.866 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 73.92 -1.87 44.94 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.996 1.284 . . . . 0.0 115.196 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.4 m -75.24 -11.82 60.15 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.291 2.046 . . . . 0.0 114.211 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -50.07 -2.06 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.72 2.808 . . . . 0.0 117.945 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.9 m -64.38 -75.92 0.08 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.516 -1.365 . . . . 0.0 110.133 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -93.09 54.69 2.19 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.939 -1.101 . . . . 0.0 110.434 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -135.76 147.31 48.35 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 21.3 t -168.52 152.37 5.74 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.72 2.008 . . . . 0.0 106.127 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -139.21 174.42 10.53 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.618 1.567 . . . . 0.0 108.823 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 99.9 m -139.96 115.65 10.14 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -94.06 112.55 24.38 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . 0.512 ' CB ' ' HE ' ' A' ' 161' ' ' ARG . 17.7 m0 -121.9 115.87 23.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.71 138.12 48.28 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.235 1.414 . . . . 0.0 109.151 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.569 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.6 m-30 -88.55 102.01 14.51 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 177.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -103.31 159.11 17.21 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 130.399 3.857 . . . . 0.0 107.753 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -66.51 158.25 30.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.162 1.934 . . . . 0.0 112.581 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.4 HD13 ' CD2' ' A' ' 121' ' ' PHE . 41.8 mt -105.02 142.09 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 112.994 -1.912 . . . . 0.0 109.599 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -132.52 151.62 51.85 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.226 1.41 . . . . 0.0 109.654 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 55.2 p -76.23 173.19 11.68 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.1 mt -125.41 146.13 31.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 122.127 0.965 . . . . 0.0 109.316 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -68.65 125.03 25.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.14 26.31 73.39 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.287 1.423 . . . . 0.0 113.867 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -145.93 152.38 39.35 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 13.6 m -106.64 151.12 25.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.453 HD13 ' HB3' ' A' ' 210' ' ' PHE . 3.0 mm? -55.56 -27.69 50.59 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.122 0.569 . . . . 0.0 110.711 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 7.7 p -71.66 -13.42 61.74 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.122 2.169 . . . . 0.0 114.443 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -124.69 -38.5 2.37 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.234 1.414 . . . . 0.0 112.077 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.18 142.07 5.77 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.517 1.053 . . . . 0.0 110.528 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.453 ' HB3' HD13 ' A' ' 206' ' ' LEU . 45.6 p90 -154.23 174.5 14.69 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 122.608 0.363 . . . . 0.0 111.494 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -110.65 132.19 54.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.98 1.312 . . . . 0.0 109.7 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.69 124.95 66.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.467 1.507 . . . . 0.0 109.357 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -71.54 109.51 5.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.37 124.17 71.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 54.26 44.08 29.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.682 0.674 . . . . 0.0 110.006 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 26.7 t70 59.08 20.55 8.45 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.3 0.64 . . . . 0.0 112.059 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.444 ' HB3' ' HE2' ' A' ' 219' ' ' LYS . 0.5 OUTLIER -129.61 122.45 29.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.958 1.303 . . . . 0.0 108.579 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -71.24 117.84 13.27 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.33 -1.481 . . . . 0.0 110.093 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 217' ' ' ASP . 51.0 mmtt -111.38 147.63 34.78 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.708 1.603 . . . . 0.0 110.329 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.4 tm? -80.79 139.44 36.04 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.235 1.014 . . . . 0.0 111.198 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.89 139.35 52.66 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.332 1.453 . . . . 0.0 107.122 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.1 p -126.23 155.48 41.78 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.141 0.976 . . . . 0.0 111.683 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -64.9 143.12 58.16 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.784 -0.572 . . . . 0.0 111.072 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.5 163.67 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -105.68 -40.7 1.98 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 125.386 1.47 . . . . 0.0 109.529 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.032 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.518 -0.286 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.86 130.52 39.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -68.81 146.4 52.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.4 t -140.02 132.68 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.525 HD13 ' CE2' ' A' ' 195' ' ' TYR . 5.3 mp -77.21 122.58 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -56.85 128.05 34.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.811 1.291 . . . . 0.0 109.507 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 125' ' ' LYS . 20.0 pttm -70.37 -22.89 62.72 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.444 1.098 . . . . 0.0 110.382 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.07 -42.2 19.54 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 123.637 0.775 . . . . 0.0 109.86 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -133.16 105.62 7.13 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.5 m -62.27 -23.48 66.72 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.189 -1.57 . . . . 0.0 112.478 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -81.27 -2.68 49.86 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.028 1.331 . . . . 0.0 111.125 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -109.89 159.8 16.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.453 0.701 . . . . 0.0 109.848 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 19.1 mm -125.47 133.0 70.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.31 111.16 23.79 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 101.477 -3.527 . . . . 0.0 101.477 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -147.8 137.97 22.88 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.364 -0.835 . . . . 0.0 109.16 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.3 mtt 51.72 28.73 5.09 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.22 18.0 79.71 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.406 -0.809 . . . . 0.0 111.522 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -120.43 163.71 17.48 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.472 1.109 . . . . 0.0 108.654 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.6 mm -119.14 134.08 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -126.97 148.92 50.07 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 9.8 t -131.51 130.32 42.22 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.464 2.306 . . . . 0.0 110.589 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.63 130.39 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.462 1.505 . . . . 0.0 108.819 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.3 t -102.57 -134.88 0.32 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 101.494 -3.521 . . . . 0.0 101.494 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -145.65 98.31 3.11 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 102.526 -3.138 . . . . 0.0 102.526 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 98.6 m -136.4 111.38 8.88 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 130.752 3.621 . . . . 0.0 108.999 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 32.9 m -68.7 127.85 34.54 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 120.714 1.597 . . . . 0.0 107.775 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.6 t -94.66 126.19 47.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.6 m -87.97 159.51 18.28 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.59 0.71 . . . . 0.0 110.213 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -56.56 -35.6 68.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.843 1.657 . . . . 0.0 109.913 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.56 -19.36 62.08 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.201 1.0 . . . . 0.0 111.809 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -105.72 -27.87 11.04 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.227 1.411 . . . . 0.0 110.763 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.97 112.79 2.73 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 125.596 1.558 . . . . 0.0 109.68 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.48 -102.44 0.08 OUTLIER Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.031 0.824 . . . . 0.0 111.865 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -134.76 161.82 34.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.735 1.214 . . . . 0.0 110.289 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -56.46 130.63 45.73 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.527 1.131 . . . . 0.0 109.969 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -109.11 -48.93 3.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 117.286 -1.34 . . . . 0.0 112.394 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -164.3 158.76 19.13 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.07 1.304 . . . . 0.0 109.406 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.3 p -108.02 141.12 24.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.579 1.152 . . . . 0.0 111.271 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.2 mp -112.85 163.22 14.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.006 2.523 . . . . 0.0 110.365 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -166.81 39.57 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.544 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 21.4 mt-10 -141.86 176.71 8.72 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.181 -2.199 . . . . 0.0 110.35 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.9 t -138.12 151.47 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 120.071 1.305 . . . . 0.0 111.007 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.495 ' HE ' ' CB ' ' A' ' 193' ' ' TRP . 0.2 OUTLIER -130.34 156.91 43.9 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 120.953 -1.092 . . . . 0.0 109.683 177.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.1 t -138.22 113.89 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -134.23 158.3 44.08 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.621 -0.674 . . . . 0.0 110.212 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -85.26 99.99 11.49 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 103.103 -2.925 . . . . 0.0 103.103 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.7 m -59.28 -9.06 1.94 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 126.735 2.014 . . . . 0.0 116.267 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.8 m -66.12 -38.82 82.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.439 ' HB3' ' HE2' ' A' ' 169' ' ' LYS . 0.4 OUTLIER -123.43 -24.12 4.67 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.648 1.579 . . . . 0.0 112.286 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.18 8.53 60.08 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 127.224 2.345 . . . . 0.0 110.564 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 167' ' ' SER . 27.2 mtmt -61.27 115.95 4.22 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.074 1.75 . . . . 0.0 110.253 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 70.4 p -67.28 153.75 42.94 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.119 0.968 . . . . 0.0 112.366 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.58 136.31 26.5 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.2 163.72 24.96 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.548 2.165 . . . . 0.0 110.998 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -58.44 -21.87 52.47 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.578 1.551 . . . . 0.0 114.737 -178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.3 m -80.46 -7.57 59.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.982 0.81 . . . . 0.0 110.517 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -113.1 9.32 18.55 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.648 1.579 . . . . 0.0 110.945 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -81.45 -17.25 49.43 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.254 1.422 . . . . 0.0 114.068 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -135.7 -44.22 0.1 Allowed Glycine 0 CA--C 1.527 0.784 0 O-C-N 120.986 -1.072 . . . . 0.0 113.65 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 35.8 ttt-85 -77.98 89.51 4.15 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.4 mm -73.0 -56.23 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.2 t70 39.42 44.12 1.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.97 2.108 . . . . 0.0 112.121 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.11 153.58 34.13 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.041 1.336 . . . . 0.0 111.343 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -54.01 -17.5 2.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.562 2.745 . . . . 0.0 114.321 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -153.01 -59.84 0.01 OUTLIER Glycine 0 C--N 1.337 0.584 0 O-C-N 121.274 -0.891 . . . . 0.0 111.537 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 57.6 m -155.68 166.84 32.28 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 120.912 -1.346 . . . . 0.0 110.729 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -61.4 -22.39 64.95 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.102 0.961 . . . . 0.0 111.3 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 38.5 m -54.47 172.19 0.1 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.667 1.987 . . . . 0.0 113.236 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt 67.24 -5.69 0.69 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 129.06 2.944 . . . . 0.0 113.91 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -80.19 -58.91 2.92 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.03 1.332 . . . . 0.0 110.081 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.8 m 57.21 56.46 5.17 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 126.301 1.841 . . . . 0.0 111.305 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -70.95 168.84 16.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.695 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 37.6 m -139.72 135.67 33.4 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -113.15 106.87 15.17 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.883 1.673 . . . . 0.0 107.321 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . 0.495 ' CB ' ' HE ' ' A' ' 161' ' ' ARG . 24.6 m0 -110.78 115.63 29.88 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.612 0.765 . . . . 0.0 110.385 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -78.21 138.34 38.6 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.777 1.631 . . . . 0.0 106.838 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.544 ' HB2' ' H ' ' A' ' 159' ' ' GLU . 4.9 m-30 -85.97 105.91 16.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -105.8 158.67 15.62 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 127.801 2.62 . . . . 0.0 108.037 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.11 156.49 36.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 124.741 2.21 . . . . 0.0 113.05 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 38.9 mt -100.9 141.0 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 111.795 -2.457 . . . . 0.0 110.179 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -133.83 152.51 51.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.548 1.539 . . . . 0.0 109.64 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 91.5 p -74.69 172.69 11.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.459 0.704 . . . . 0.0 110.152 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 5.3 mt -127.71 135.46 63.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 121.458 -0.776 . . . . 0.0 110.257 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -65.14 126.15 27.21 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.85 12.44 84.43 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.205 -1.331 . . . . 0.0 116.01 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -138.75 157.75 45.5 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.617 1.709 . . . . 0.0 108.175 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 62.1 m -106.48 145.72 31.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.63 -31.14 64.04 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 29.8 p -66.32 -12.37 56.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.178 1.791 . . . . 0.0 113.903 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -124.66 -35.39 2.73 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.688 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.27 145.36 6.94 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 119.217 0.917 . . . . 0.0 110.964 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.57 173.23 16.61 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.048 0.385 . . . . 0.0 111.221 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.62 132.52 54.06 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 124.509 1.124 . . . . 0.0 111.774 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.81 130.36 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.947 1.299 . . . . 0.0 108.513 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -69.91 103.11 2.13 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 33.8 mm -121.56 123.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.293 1.437 . . . . 0.0 110.251 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 61.52 38.15 15.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.194 0.997 . . . . 0.0 109.317 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 65.31 16.31 10.47 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.617 1.567 . . . . 0.0 111.313 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.56 129.15 38.65 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -67.97 122.23 17.77 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 119.962 -1.711 . . . . 0.0 109.15 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -119.02 146.2 45.23 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.815 1.246 . . . . 0.0 111.387 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -78.83 133.12 37.04 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.937 1.295 . . . . 0.0 112.032 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -121.69 131.31 54.02 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.81 150.21 33.82 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.189 0.596 . . . . 0.0 110.025 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -70.08 122.09 18.73 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.46 127.25 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -92.72 27.97 10.05 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.448 -1.195 . . . . 0.0 112.85 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 . . . . . 0 C--O 1.245 0.859 0 C-N-CA 126.793 2.037 . . . . 0.0 107.325 -179.349 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.7 t70 . . . . . 0 N--CA 1.464 0.228 0 CA-C-O 121.173 0.511 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.91 143.58 17.11 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.0 2.12 . . . . 0.0 106.155 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -75.96 124.56 27.56 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 72.0 t -124.78 136.88 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 126.029 1.732 . . . . 0.0 107.026 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.404 HD11 HD12 ' A' ' 157' ' ' LEU . 5.1 mp -86.43 138.89 18.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -64.27 123.3 18.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 123.03 1.395 . . . . 0.0 108.419 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -61.02 -27.05 68.04 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.788 1.235 . . . . 0.0 111.105 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -80.87 -46.09 15.8 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.21 105.61 8.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.428 1.491 . . . . 0.0 112.946 -177.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -58.67 -19.5 39.96 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 120.343 -1.473 . . . . 0.0 112.258 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -85.21 -7.85 58.84 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.278 -0.889 . . . . 0.0 110.658 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -101.41 149.47 24.02 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.838 0.744 . . . . 0.0 109.559 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 25.1 mm -126.86 119.15 52.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.09 97.29 9.82 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 128.372 2.669 . . . . 0.0 109.114 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -132.41 142.5 49.31 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 121.576 1.989 . . . . 0.0 109.975 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 8.4 mtt 49.87 23.32 1.02 Allowed 'General case' 0 CA--C 1.544 0.739 0 O-C-N 119.992 -1.693 . . . . 0.0 114.714 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.64 5.25 78.68 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 119.604 1.093 . . . . 0.0 112.089 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -100.23 172.86 6.9 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 125.099 1.36 . . . . 0.0 111.626 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.5 mm -136.4 125.7 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -114.13 161.07 18.24 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.449 ' HB2' HG11 ' A' ' 224' ' ' VAL . 25.9 t -143.04 139.32 30.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.434 1.494 . . . . 0.0 109.999 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.1 mt -100.85 137.68 27.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 123.929 0.892 . . . . 0.0 109.233 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 52.7 m -118.17 -112.79 0.34 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -159.98 98.72 1.34 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 122.689 2.495 . . . . 0.0 108.109 175.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 54.3 m -137.42 113.88 10.21 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 127.323 2.249 . . . . 0.0 105.537 175.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.6 m -76.61 126.9 31.79 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 104.419 -2.438 . . . . 0.0 104.419 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.7 t -93.72 111.7 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.1 m -74.61 158.27 33.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.959 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.96 -28.82 67.97 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 122.998 0.519 . . . . 0.0 111.481 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.71 -12.58 61.59 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.94 -0.475 . . . . 0.0 111.222 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -114.04 -24.1 9.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.507 1.523 . . . . 0.0 110.791 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.2 mt -65.63 135.38 54.95 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.62 -106.14 0.91 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 107.401 -2.28 . . . . 0.0 107.401 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.31 167.04 21.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.595 1.958 . . . . 0.0 109.325 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -57.63 150.07 20.18 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.097 0.951 . . . . 0.0 112.532 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -125.99 -50.75 1.57 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.901 -1.524 . . . . 0.0 112.325 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -161.93 163.17 29.23 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 121.297 1.862 . . . . 0.0 110.619 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.2 139.75 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 119.122 0.874 . . . . 0.0 111.716 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 123' ' ' ILE . 4.4 mm? -110.93 164.8 12.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.452 2.301 . . . . 0.0 110.462 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.6 59.92 0.07 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.086 0.954 . . . . 0.0 112.619 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -156.34 172.8 17.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.879 -1.138 . . . . 0.0 108.287 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.3 t -143.98 149.41 17.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.91 164.6 31.47 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 63.0 t -131.28 136.74 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -147.62 163.85 35.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.65 0.78 . . . . 0.0 111.994 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.55 100.67 10.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -62.53 -12.35 21.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.5 m -65.58 -44.14 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 121.674 -0.642 . . . . 0.0 110.827 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.442 ' HB2' ' HE2' ' A' ' 169' ' ' LYS . 32.3 m -121.62 -20.57 6.47 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 125.54 1.536 . . . . 0.0 113.233 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.48 5.78 57.74 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.457 1.027 . . . . 0.0 111.753 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.442 ' HE2' ' HB2' ' A' ' 167' ' ' SER . 45.1 mtmt -61.27 112.8 2.29 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.49 1.116 . . . . 0.0 108.162 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.8 p -63.29 151.31 40.99 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.22 141.68 26.8 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.912 1.285 . . . . 0.0 107.664 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -82.43 160.2 17.18 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.955 2.437 . . . . 0.0 108.488 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.4 ttp85 -53.12 -27.28 20.02 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.225 1.01 . . . . 0.0 113.372 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.2 t -65.67 -13.66 59.65 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.074 1.749 . . . . 0.0 112.4 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.58 -1.55 13.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 119.706 -1.871 . . . . 0.0 110.598 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.5 m0 -68.48 -25.25 64.88 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.556 -0.715 . . . . 0.0 109.901 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 179.25 30.65 0.05 OUTLIER Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.799 1.19 . . . . 0.0 113.341 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -133.24 40.99 3.15 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.676 1.738 . . . . 0.0 110.017 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.7 mp -75.04 -82.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -155.53 -175.56 5.5 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.691 1.597 . . . . 0.0 107.795 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -101.56 -27.32 13.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.377 1.871 . . . . 0.0 109.306 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -97.19 -24.03 15.91 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.234 1.014 . . . . 0.0 110.802 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -30.65 113.64 0.05 OUTLIER Glycine 0 C--N 1.341 0.822 0 C-N-CA 128.407 2.908 . . . . 0.0 113.9 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.6 t -49.14 -39.94 30.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.581 1.952 . . . . 0.0 111.563 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 33.75 57.23 0.57 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.827 2.851 . . . . 0.0 114.01 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.5 t -122.54 -46.18 2.16 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.799 0.84 . . . . 0.0 109.642 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -73.32 16.47 0.18 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.929 1.292 . . . . 0.0 112.05 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -124.33 131.09 53.5 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.406 1.882 . . . . 0.0 108.086 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 90.0 p -131.95 100.24 5.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.701 1.2 . . . . 0.0 109.685 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.1 mtt85 -103.15 173.24 6.39 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.63 1.172 . . . . 0.0 110.661 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.9 m -144.86 132.69 21.2 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 127.187 2.195 . . . . 0.0 107.025 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -108.76 109.67 20.87 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.859 2.063 . . . . 0.0 106.609 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -115.72 116.78 28.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.764 1.225 . . . . 0.0 112.281 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -84.0 133.32 34.68 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.103 1.361 . . . . 0.0 109.318 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -79.14 101.33 7.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.47 1.108 . . . . 0.0 109.417 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -96.11 158.45 21.79 Favored Glycine 0 CA--C 1.534 1.27 1 C-N-CA 134.549 5.833 . . . . 0.0 107.608 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -68.25 157.16 36.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.338 1.569 . . . . 0.0 113.13 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 62.2 mt -101.11 139.81 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 126.744 2.018 . . . . 0.0 109.583 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -133.1 152.33 51.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.502 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 18.9 t -76.99 172.96 12.35 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 35.8 mt -129.06 141.9 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-O 122.824 1.297 . . . . 0.0 107.691 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 73.1 mtp85 -65.81 121.49 15.16 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.175 1.39 . . . . 0.0 109.351 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.54 15.4 80.5 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.395 -1.225 . . . . 0.0 113.612 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -136.49 132.19 34.99 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.992 1.896 . . . . 0.0 110.018 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.4 m -81.13 150.63 28.64 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.77 -29.84 63.01 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.345 -0.847 . . . . 0.0 109.951 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.1 p -67.54 -20.64 65.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.151 2.18 . . . . 0.0 114.025 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -112.13 -41.71 3.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 117.787 -1.101 . . . . 0.0 110.313 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.71 142.69 3.77 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.124 0.874 . . . . 0.0 109.863 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -151.47 175.62 12.11 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.691 0.796 . . . . 0.0 109.426 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.56 132.7 53.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.239 1.415 . . . . 0.0 110.327 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.48 124.77 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 C-N-CA 125.316 1.446 . . . . 0.0 107.836 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -72.9 109.49 6.51 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 50.4 mm -121.83 118.07 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 126.071 1.749 . . . . 0.0 109.224 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.58 47.4 16.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.242 1.017 . . . . 0.0 109.511 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.82 10.98 6.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.52 1.128 . . . . 0.0 111.441 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.26 123.46 38.17 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.205 -1.559 . . . . 0.0 110.588 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -69.79 116.95 10.78 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.02 -1.05 . . . . 0.0 108.565 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -112.55 150.52 31.21 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.019 1.328 . . . . 0.0 109.756 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.2 tm? -82.38 135.07 35.24 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.21 1.004 . . . . 0.0 109.944 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.03 125.16 44.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.71 152.17 26.86 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.525 0.73 . . . . 0.0 112.001 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -60.8 139.18 58.01 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 122.205 -0.309 . . . . 0.0 110.319 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 139' ' ' SER . 11.4 p -130.16 167.17 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -170.46 23.46 0.09 OUTLIER Glycine 0 CA--C 1.525 0.679 0 CA-C-O 119.366 -0.686 . . . . 0.0 111.628 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 . . . . . 0 C--O 1.249 1.048 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.42 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.223 -0.305 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.48 129.68 2.34 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 127.73 2.412 . . . . 0.0 105.806 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -64.67 147.45 52.98 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.334 0.97 . . . . 0.0 108.597 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.2 t -150.53 132.11 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 123' ' ' ILE . 5.1 mp -72.18 139.5 19.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -60.31 118.64 6.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -19.59 37.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.749 -0.594 . . . . 0.0 111.749 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -96.04 -19.6 19.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 117.351 -1.309 . . . . 0.0 112.601 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.8 111.49 5.03 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.843 1.656 . . . . 0.0 108.731 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 163' ' ' PHE . 6.0 t -54.88 -32.83 61.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.055 1.342 . . . . 0.0 112.93 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.5 ptt85 -79.05 -1.27 34.91 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.236 -0.915 . . . . 0.0 112.32 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -110.35 157.09 19.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 118.585 0.629 . . . . 0.0 112.523 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.3 mm -127.31 141.74 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -115.68 103.0 10.25 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 129.404 3.082 . . . . 0.0 104.159 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -143.15 133.88 25.22 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.074 -1.016 . . . . 0.0 109.317 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 22.3 mtp 56.88 30.23 17.56 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.845 1.258 . . . . 0.0 112.615 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 72.71 8.73 73.12 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.899 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -106.97 168.64 9.06 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.602 1.561 . . . . 0.0 107.635 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.6 mm -120.23 141.2 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -133.04 143.91 49.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 27.7 t -135.19 151.25 50.47 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.774 1.229 . . . . 0.0 109.112 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 mt -101.0 137.75 27.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.788 0.835 . . . . 0.0 110.419 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.9 t -101.57 -111.17 0.21 Allowed 'General case' 0 CA--C 1.537 0.46 1 N-CA-C 98.714 -4.551 . . . . 0.0 98.714 175.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -166.9 99.12 0.55 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 174.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.8 m -135.67 112.97 10.56 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 127.764 2.426 . . . . 0.0 105.583 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.1 m -68.54 123.29 20.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.67 116.14 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.8 m -83.96 158.64 21.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.167 0.508 . . . . 0.0 110.964 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -57.32 -32.75 67.0 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.188 1.795 . . . . 0.0 111.386 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.82 -8.79 55.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.88 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -121.72 -20.93 6.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.436 1.094 . . . . 0.0 109.658 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.0 tp -66.26 151.36 47.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.31 -102.59 2.72 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -134.65 165.15 25.89 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.85 0.86 . . . . 0.0 110.942 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -62.44 143.31 57.24 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -123.59 -52.05 1.82 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 117.878 -1.058 . . . . 0.0 111.535 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.82 173.86 16.35 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.924 0.783 . . . . 0.0 110.071 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.8 p -129.92 147.29 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.419 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.2 mm? -111.78 166.54 11.09 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.274 3.029 . . . . 0.0 112.952 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -162.87 45.61 0.13 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.68 174.46 10.95 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 119.802 -1.811 . . . . 0.0 108.621 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.0 t -142.22 149.81 19.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.308 1.043 . . . . 0.0 108.351 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -145.18 161.11 40.31 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.893 -1.129 . . . . 0.0 108.847 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 191' ' ' THR . 92.2 t -127.32 126.93 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 128' ' ' SER . 52.9 p90 -148.17 165.34 31.19 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.535 0.734 . . . . 0.0 111.18 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -80.88 109.67 15.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.119 1.767 . . . . 0.0 108.195 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.9 t -50.49 -23.44 2.48 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.713 2.805 . . . . 0.0 115.269 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.47 -39.56 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.4 t -122.12 -24.99 4.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.73 -1.02 52.38 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.89 1.233 . . . . 0.0 112.52 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -51.69 112.35 0.75 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.39 1.876 . . . . 0.0 110.23 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 25.9 p -72.7 156.48 38.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.633 0.73 . . . . 0.0 110.52 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.58 136.79 25.6 Favored Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.81 162.87 32.05 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.722 2.282 . . . . 0.0 109.561 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -58.71 -31.85 68.64 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.558 0.343 . . . . 0.0 111.864 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.8 m -67.54 -4.39 11.46 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.28 -0.93 10.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.829 1.252 . . . . 0.0 110.274 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -62.69 -32.84 74.0 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.064 -1.648 . . . . 0.0 111.751 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -151.38 18.31 0.9 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.221 0.915 . . . . 0.0 112.214 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -132.6 68.67 1.49 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-O 123.242 1.496 . . . . 0.0 108.97 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 47.2 mt -115.33 -50.61 4.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -143.82 154.74 43.71 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.14 1.776 . . . . 0.0 107.586 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -114.35 -36.87 4.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.691 1.196 . . . . 0.0 110.276 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.96 -25.47 68.15 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 129.347 3.059 . . . . 0.0 111.734 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.35 174.13 23.49 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 126.37 1.938 . . . . 0.0 110.556 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.464 ' C ' HD22 ' A' ' 185' ' ' ASN . 33.5 t -64.43 162.44 15.15 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 122.157 0.979 . . . . 0.0 111.957 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.464 HD22 ' C ' ' A' ' 184' ' ' SER . 1.5 m120 -130.76 21.33 5.03 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.613 2.365 . . . . 0.0 108.94 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 65.7 p -67.3 -161.16 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.573 1.549 . . . . 0.0 113.678 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -63.55 99.34 0.21 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.975 0.91 . . . . 0.0 109.131 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -109.39 -42.72 4.28 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 127.148 2.179 . . . . 0.0 107.003 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.24 31.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -118.57 175.13 5.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.589 0.756 . . . . 0.0 110.977 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 0.3 OUTLIER -133.3 147.21 51.88 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 130.721 3.609 . . . . 0.0 105.881 -179.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -129.11 104.94 7.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 102.923 -2.992 . . . . 0.0 102.923 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -111.49 116.21 30.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -83.53 129.34 34.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.261 1.424 . . . . 0.0 107.956 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -74.76 100.71 4.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.497 0.719 . . . . 0.0 109.239 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.3 159.66 27.56 Favored Glycine 0 CA--C 1.53 1.019 1 C-N-CA 132.631 4.92 . . . . 0.0 110.267 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.43 162.7 22.49 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 122.403 1.097 . . . . 0.0 109.304 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 97.4 mt -109.31 131.77 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 127.262 2.225 . . . . 0.0 112.072 -176.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -128.2 149.99 50.21 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.121 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 63.3 m -79.24 172.53 13.68 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.03 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 72.0 mt -128.62 139.02 53.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.315 1.446 . . . . 0.0 107.284 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -68.99 122.18 18.16 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.18 13.43 77.01 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 118.763 -1.02 . . . . 0.0 113.457 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -139.9 123.78 17.52 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 119.499 1.649 . . . . 0.0 109.988 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 54.8 m -79.6 150.91 30.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.01 -23.54 54.58 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.878 0.871 . . . . 0.0 110.284 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 17.0 p -76.09 -9.49 58.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.316 2.246 . . . . 0.0 113.513 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -123.95 -47.26 1.93 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.894 1.277 . . . . 0.0 110.081 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.88 148.27 13.77 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -155.14 175.84 13.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -108.36 144.44 35.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 6.0 p -134.56 124.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.767 2.027 . . . . 0.0 109.172 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -73.97 107.5 6.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 47.4 mm -121.84 125.76 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 109.76 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 54.32 44.43 28.99 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.013 0.824 . . . . 0.0 109.748 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 65.42 0.21 1.33 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.642 1.977 . . . . 0.0 113.974 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -121.23 127.87 51.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 118.949 0.795 . . . . 0.0 109.111 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -66.0 136.6 56.27 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.194 -0.941 . . . . 0.0 110.329 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -128.87 145.95 51.07 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.928 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.35 133.08 35.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.899 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -121.71 138.19 54.45 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 23.9 p -120.78 149.41 42.6 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 123.677 0.611 . . . . 0.0 112.632 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -61.12 143.01 56.27 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 4.7 t -130.61 151.81 36.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.68 -24.91 76.52 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.187 -0.946 . . . . 0.0 111.936 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 127.251 2.22 . . . . 0.0 105.813 179.148 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 CA--C 1.506 -0.72 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.43 147.09 27.84 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.372 1.069 . . . . 0.0 108.512 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.447 ' H ' ' HD1' ' A' ' 121' ' ' PHE . 1.6 p90 -71.59 127.67 33.32 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 129.508 3.123 . . . . 0.0 106.285 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.7 126.11 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.9 mp -68.88 133.17 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -66.27 128.23 35.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.42 -22.4 66.95 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.627 0.771 . . . . 0.0 111.135 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -81.25 -47.33 13.51 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.557 1.143 . . . . 0.0 109.605 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -140.74 106.05 5.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.366 1.466 . . . . 0.0 108.742 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.5 m -62.69 -12.28 22.63 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 120.362 -1.461 . . . . 0.0 112.259 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -85.13 1.84 46.17 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.417 1.087 . . . . 0.0 109.446 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -113.98 162.11 16.83 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.558 1.143 . . . . 0.0 109.06 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.9 mm -132.94 128.23 56.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -106.16 110.46 22.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.533 2.333 . . . . 0.0 106.567 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -146.26 128.76 16.0 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.455 1.102 . . . . 0.0 108.755 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.2 mtt 60.82 39.94 16.47 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.953 1.701 . . . . 0.0 112.329 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 63.59 21.63 65.06 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.918 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -114.46 173.46 6.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.1 mm -132.9 132.41 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -124.55 156.19 37.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.7 t -131.11 150.62 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.934 1.694 . . . . 0.0 108.949 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.8 mt -120.34 127.63 75.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.9 t -103.97 -104.51 0.3 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -164.76 101.79 0.79 Allowed 'General case' 0 C--O 1.236 0.364 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 178.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 86.6 m -135.37 113.66 11.44 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 126.728 2.011 . . . . 0.0 107.38 177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.7 m -66.98 115.98 7.3 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.574 1.533 . . . . 0.0 109.399 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 66.7 t -95.27 115.55 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 m -82.26 158.55 23.45 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -63.76 -26.59 68.71 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.972 0.909 . . . . 0.0 111.559 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -66.99 -23.77 65.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.175 0.443 . . . . 0.0 110.533 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -99.82 -21.03 15.91 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.937 0.895 . . . . 0.0 110.014 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.23 148.91 48.03 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.819 1.248 . . . . 0.0 108.03 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.15 -106.54 2.69 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.37 170.67 15.58 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.62 1.168 . . . . 0.0 110.349 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -56.92 138.0 54.55 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.394 1.478 . . . . 0.0 109.154 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -126.3 -52.89 1.5 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 121' ' ' PHE . 29.5 m-20 -139.66 156.6 46.74 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.548 0.613 . . . . 0.0 110.217 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.3 p -120.36 133.45 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 121.381 0.61 . . . . 0.0 111.833 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.418 HD21 HD12 ' A' ' 198' ' ' ILE . 4.1 mm? -112.3 164.15 13.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.954 2.102 . . . . 0.0 112.252 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -167.44 42.05 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.749 1.22 . . . . 0.0 112.536 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.407 ' H ' ' HB2' ' A' ' 195' ' ' TYR . 1.5 tt0 -140.39 175.59 9.47 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 119.068 -2.27 . . . . 0.0 108.987 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 t -143.08 149.52 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.84 165.8 26.53 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.449 HG12 ' HG3' ' A' ' 190' ' ' ARG . 21.3 t -133.75 129.19 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -141.99 157.36 45.04 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 119.881 1.219 . . . . 0.0 111.414 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -62.19 121.17 12.42 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.877 0.871 . . . . 0.0 109.574 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.15 -14.2 59.99 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.52 -38.68 12.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.0 t -123.0 -27.13 4.27 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.24 6.62 53.34 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.258 0.932 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -55.68 114.44 1.87 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.761 1.624 . . . . 0.0 108.517 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.08 132.84 55.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.022 0.828 . . . . 0.0 109.198 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -92.76 144.46 28.62 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.36 153.78 45.37 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.59 2.193 . . . . 0.0 110.201 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -56.95 -36.31 70.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.565 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.6 t -63.39 -2.63 1.59 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -118.18 -1.26 11.39 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.202 1.364 . . . . 0.0 111.966 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -68.22 -3.86 12.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.242 1.417 . . . . 0.0 113.653 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 173.89 49.99 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.05 52.63 1.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.759 0.824 . . . . 0.0 108.898 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 16.4 mt -134.43 -59.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 49.62 51.07 17.16 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.273 1.829 . . . . 0.0 108.863 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -73.77 130.63 40.36 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -53.82 -50.76 65.44 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 128.931 2.892 . . . . 0.0 108.696 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -79.59 59.63 4.4 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.154 1.359 . . . . 0.0 111.994 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 61.5 p 28.35 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 131.407 3.883 . . . . 0.0 116.235 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.1 m120 53.32 18.39 1.28 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.397 1.079 . . . . 0.0 111.4 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.1 t -45.18 -44.88 11.23 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.064 2.145 . . . . 0.0 111.773 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.89 -1.39 37.48 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.4 mp0 -142.86 80.26 1.68 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.805 0.842 . . . . 0.0 111.476 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 7.8 t -141.21 154.32 45.75 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.384 1.874 . . . . 0.0 106.838 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.449 ' HG3' HG12 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -144.65 171.56 14.22 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.683 1.193 . . . . 0.0 110.351 -179.397 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.0 m -91.88 137.41 32.39 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 126.701 2.0 . . . . 0.0 106.388 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -119.48 109.88 16.25 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.842 2.057 . . . . 0.0 106.949 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -115.38 119.62 36.85 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.768 2.027 . . . . 0.0 110.797 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -86.82 134.46 33.55 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 128.363 2.665 . . . . 0.0 110.031 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.444 ' CE2' HD13 ' A' ' 123' ' ' ILE . 3.2 m-30 -80.35 102.28 9.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.475 1.51 . . . . 0.0 110.477 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -95.49 158.66 22.22 Favored Glycine 0 CA--C 1.533 1.196 1 C-N-CA 133.042 5.115 . . . . 0.0 107.475 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.85 159.42 30.44 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 123.62 1.676 . . . . 0.0 110.62 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.418 HD12 HD21 ' A' ' 157' ' ' LEU . 57.7 mt -111.73 141.1 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 125.705 1.602 . . . . 0.0 109.982 -176.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -134.43 147.5 50.45 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.324 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.61 173.44 6.07 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 31.8 mt -128.89 141.4 46.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.206 1.403 . . . . 0.0 108.509 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.87 124.7 24.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.4 17.35 76.26 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-O 117.493 -1.726 . . . . 0.0 114.841 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -147.63 134.44 20.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.105 1.952 . . . . 0.0 111.255 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.0 m -84.87 151.16 24.49 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.22 -30.64 62.61 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.327 -0.858 . . . . 0.0 109.864 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 66.9 p -73.18 -4.25 31.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.928 1.691 . . . . 0.0 114.458 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -125.12 -40.98 2.1 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.831 1.652 . . . . 0.0 109.515 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -170.05 144.6 2.71 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 118.858 0.754 . . . . 0.0 109.736 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -152.41 175.63 12.5 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.966 0.907 . . . . 0.0 109.198 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -112.47 134.72 53.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.041 1.336 . . . . 0.0 110.547 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.5 124.54 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 C-N-CA 124.153 0.981 . . . . 0.0 108.635 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -70.29 104.39 2.66 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 41.5 mm -121.77 133.22 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 54.77 39.7 31.53 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.06 3.31 2.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.837 2.455 . . . . 0.0 113.642 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -119.43 125.29 48.58 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.706 1.203 . . . . 0.0 111.492 -177.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -64.28 113.19 3.43 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.571 0.748 . . . . 0.0 112.635 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -105.97 147.29 28.99 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 122.184 0.992 . . . . 0.0 110.908 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.1 tm? -86.18 123.12 31.11 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.428 1.491 . . . . 0.0 108.805 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -107.54 144.23 34.82 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.7 p -118.05 147.37 43.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.784 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -62.15 142.81 57.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.646 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.0 p -135.85 167.85 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 156.9 -18.05 0.4 Allowed Glycine 0 CA--C 1.525 0.657 0 O-C-N 120.53 -1.356 . . . . 0.0 112.58 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 124.488 1.115 . . . . 0.0 109.443 178.556 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.73 129.0 6.68 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 120.422 1.465 . . . . 0.0 109.777 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -75.11 138.56 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.0 t -139.55 132.01 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 157' ' ' LEU . 5.1 mp -78.64 128.63 38.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 177.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -61.56 122.34 15.0 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.51 1.148 . . . . 0.0 108.892 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.1 pttt -62.27 -23.01 66.46 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.362 -0.836 . . . . 0.0 110.358 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -85.01 -22.92 28.88 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.605 1.162 . . . . 0.0 110.603 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.84 102.45 2.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 119.667 1.122 . . . . 0.0 108.294 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.0 m -57.53 -24.93 58.85 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.884 0.873 . . . . 0.0 112.756 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.6 ptt85 -81.23 -3.79 53.46 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.923 0.889 . . . . 0.0 111.302 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -108.25 151.86 25.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.634 0.73 . . . . 0.0 110.089 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 14.2 mm -120.8 142.02 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -117.45 104.06 10.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.904 2.482 . . . . 0.0 106.051 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -127.26 133.97 50.12 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.0 mtt 56.3 13.44 1.26 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.043 -1.661 . . . . 0.0 113.281 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.73 6.6 65.49 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.879 1.228 . . . . 0.0 110.66 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -97.61 154.11 17.76 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 119.055 1.427 . . . . 0.0 107.917 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mm -118.09 140.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 O-C-N 124.358 1.036 . . . . 0.0 110.058 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -123.35 168.85 11.97 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.76 1.224 . . . . 0.0 110.528 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.47 135.51 25.16 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.453 1.501 . . . . 0.0 109.412 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 mt -97.89 119.0 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.1 t -94.87 -105.25 0.14 Allowed 'General case' 0 C--O 1.234 0.255 1 N-CA-C 99.717 -4.179 . . . . 0.0 99.717 176.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -167.03 99.34 0.53 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 4.5 m -136.29 121.46 19.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 128.332 2.653 . . . . 0.0 103.93 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.5 m -76.59 128.42 34.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.27 111.69 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.435 1.016 . . . . 0.0 109.583 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.2 m -81.96 162.95 22.49 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.027 0.531 . . . . 0.0 110.347 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.44 -27.0 65.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.248 1.819 . . . . 0.0 112.521 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.35 -22.07 61.95 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 122.204 -0.31 . . . . 0.0 110.213 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.82 -26.79 13.01 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.287 1.035 . . . . 0.0 109.433 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.8 tp -65.08 152.68 42.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -111.2 -102.64 2.67 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 125.037 1.303 . . . . 0.0 109.925 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -134.54 167.49 20.69 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.532 1.133 . . . . 0.0 110.858 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -60.07 140.93 56.53 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.024 1.33 . . . . 0.0 108.178 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -124.49 -47.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.598 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.99 158.16 40.19 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.325 1.42 . . . . 0.0 111.197 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.35 135.1 57.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.754 0.788 . . . . 0.0 111.292 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.409 HD12 HD11 ' A' ' 123' ' ' ILE . 4.2 mm? -111.27 165.92 11.53 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.041 2.936 . . . . 0.0 110.324 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -168.46 51.99 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.652 1.181 . . . . 0.0 113.143 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.36 175.85 9.6 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 119.618 -1.926 . . . . 0.0 107.681 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.66 142.58 23.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.93 161.1 38.15 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 191' ' ' THR . 71.6 t -129.89 124.2 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.74 169.24 18.09 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 119.289 0.95 . . . . 0.0 110.877 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -81.08 117.78 21.95 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -15.74 60.38 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.7 m -82.96 -41.19 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.0 -1.063 . . . . 0.0 113.779 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.409 ' HB2' ' HD3' ' A' ' 169' ' ' LYS . 68.2 m -122.36 -27.61 4.43 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 125.294 1.438 . . . . 0.0 113.456 -177.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.32 7.59 37.21 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 117.118 1.607 . . . . 0.0 117.118 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.418 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -60.51 113.25 2.33 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.982 1.313 . . . . 0.0 110.551 -179.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 20.2 p -70.58 149.48 47.04 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.749 1.22 . . . . 0.0 109.793 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.416 HG22 ' CD1' ' A' ' 176' ' ' TRP . 1.2 mp -117.41 139.3 25.94 Favored Pre-proline 0 N--CA 1.44 -0.964 0 C-N-CA 125.527 1.531 . . . . 0.0 107.236 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.56 153.4 20.49 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.798 2.332 . . . . 0.0 109.33 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -51.21 -33.47 27.79 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.821 1.249 . . . . 0.0 111.573 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -3.47 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.556 1.142 . . . . 0.0 113.283 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -129.72 6.93 5.18 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.359 1.863 . . . . 0.0 113.242 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.416 ' CD1' HG22 ' A' ' 171' ' ' ILE . 40.9 m0 -62.76 3.33 0.23 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.409 1.083 . . . . 0.0 112.713 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.72 19.2 5.77 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 117.928 -1.485 . . . . 0.0 113.594 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.364 0.4 OUTLIER -89.93 18.27 5.91 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.231 2.016 . . . . 0.0 113.751 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 179' ' ' ILE . 5.0 mp -70.06 -55.8 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 54.8 35.26 23.75 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.254 2.221 . . . . 0.0 114.348 178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.32 -167.42 1.61 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.96 -33.48 75.48 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -48.82 126.23 16.74 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.7 p -74.89 58.35 0.84 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.75 2.02 . . . . 0.0 110.171 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -65.26 -8.02 15.86 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 115.795 -2.05 . . . . 0.0 113.79 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.8 t -5.72 -72.19 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 130.323 3.449 . . . . 0.0 111.071 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.83 -5.99 2.17 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.796 0.838 . . . . 0.0 112.191 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 55.79 9.53 0.44 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.147 2.979 . . . . 0.0 111.721 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t 78.27 39.93 0.14 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.423 2.689 . . . . 0.0 109.808 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 8.0 mmp_? -104.7 177.56 4.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.403 1.481 . . . . 0.0 107.817 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 162' ' ' VAL . 28.7 m -128.61 150.77 50.08 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 128.363 2.665 . . . . 0.0 105.99 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -124.37 109.02 12.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -110.44 116.26 31.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.829 1.652 . . . . 0.0 110.903 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -85.29 123.67 31.03 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 128.119 2.568 . . . . 0.0 107.405 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -72.19 101.18 2.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 118.951 0.796 . . . . 0.0 109.468 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.2 159.0 27.19 Favored Glycine 0 N--CA 1.44 -1.094 1 C-N-CA 131.67 4.462 . . . . 0.0 107.392 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -68.26 160.06 30.03 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.43 1.586 . . . . 0.0 111.267 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 77.6 mt -106.76 141.13 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.136 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -132.91 151.8 51.99 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.574 1.55 . . . . 0.0 110.528 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.4 t -78.29 173.05 12.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.904 0.882 . . . . 0.0 108.662 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.1 mt -129.63 140.3 49.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 122.477 1.132 . . . . 0.0 108.721 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -66.26 119.64 11.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.303 1.441 . . . . 0.0 107.821 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.88 2.44 88.5 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.31 -1.272 . . . . 0.0 114.962 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -126.39 132.79 51.46 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.91 1.855 . . . . 0.0 109.075 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 16.2 m -85.78 150.73 24.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -28.37 63.29 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 124.202 1.001 . . . . 0.0 110.075 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.6 p -72.02 -11.18 60.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.115 2.166 . . . . 0.0 114.195 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -120.47 -47.62 2.33 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.514 1.526 . . . . 0.0 109.549 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.25 144.51 12.76 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.815 0.34 . . . . 0.0 111.084 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -150.05 175.77 11.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 122.738 0.415 . . . . 0.0 109.984 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.15 128.89 55.39 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.828 0.851 . . . . 0.0 110.324 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.0 128.27 71.74 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 C-N-CA 124.697 1.199 . . . . 0.0 107.855 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.05 110.26 7.2 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.6 mm -121.77 124.08 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 53.5 48.14 22.44 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.092 0.86 . . . . 0.0 109.087 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 65.48 -4.26 0.59 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.649 2.379 . . . . 0.0 115.014 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -114.9 135.59 54.03 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 119.094 0.861 . . . . 0.0 109.771 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -72.92 115.36 12.13 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.152 0.981 . . . . 0.0 110.26 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 146.98 34.36 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 1.9 tm? -79.31 136.79 37.11 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.86 1.264 . . . . 0.0 108.229 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.05 137.36 53.63 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.0 p -121.3 150.38 41.5 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.41 0.444 . . . . 0.0 111.974 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -55.01 133.51 48.59 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.0 p -134.81 137.76 50.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 126.401 1.881 . . . . 0.0 108.017 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 60.25 16.58 42.67 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.371 -1.238 . . . . 0.0 115.475 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 20.6 m120 . . . . . 0 C--O 1.25 1.117 0 C-N-CA 129.259 3.024 . . . . 0.0 113.335 179.647 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.5 131.42 15.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 128.972 2.909 . . . . 0.0 105.995 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 155' ' ' ASP . 18.9 p90 -66.43 149.78 49.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 97.3 t -149.72 126.25 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 123' ' ' ILE . 4.8 mp -71.94 134.13 30.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.52 117.52 6.32 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -24.49 19.97 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.71 0.804 . . . . 0.0 111.53 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -89.19 -22.59 22.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.368 1.467 . . . . 0.0 112.396 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.11 104.33 3.67 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 119.565 1.075 . . . . 0.0 108.273 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.4 t -60.14 -22.33 62.73 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.342 -0.849 . . . . 0.0 112.814 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.0 ptt85 -80.69 -4.83 55.8 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.35 -0.844 . . . . 0.0 110.598 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -109.6 159.28 17.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.816 0.817 . . . . 0.0 111.409 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 33.8 mm -130.38 146.77 33.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -123.04 104.75 9.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -141.06 134.43 29.74 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.05 1.34 . . . . 0.0 109.898 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.0 mtt 58.21 36.42 25.73 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.605 1.162 . . . . 0.0 112.109 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.05 22.85 63.16 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -121.88 161.51 22.66 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mm -116.37 145.24 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -135.15 156.94 48.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.45 ' HB2' HG11 ' A' ' 224' ' ' VAL . 8.0 t -139.19 165.14 27.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.4 mt -117.13 134.75 59.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.714 0.769 . . . . 0.0 110.699 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.31 -114.6 0.2 Allowed 'General case' 0 CA--C 1.539 0.521 1 N-CA-C 99.371 -4.307 . . . . 0.0 99.371 175.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -167.53 100.33 0.49 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 94.5 m -136.25 121.8 19.54 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.81 2.044 . . . . 0.0 106.75 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 m -71.5 121.45 18.69 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.87 110.68 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.5 m -70.85 159.53 34.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.06 0.457 . . . . 0.0 110.944 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -60.28 -29.86 69.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.546 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.95 -12.36 60.63 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -108.54 -23.04 12.01 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.485 1.114 . . . . 0.0 109.13 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.8 tp -64.46 133.99 53.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.98 -105.86 0.74 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -135.85 166.86 22.31 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.613 1.565 . . . . 0.0 108.601 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -64.63 139.92 58.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -123.26 -48.03 1.99 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.573 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 121' ' ' PHE . 28.3 m-20 -152.65 166.6 31.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 119.982 1.265 . . . . 0.0 111.32 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.24 143.17 40.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.572 1.149 . . . . 0.0 111.142 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -111.2 166.5 11.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.875 2.87 . . . . 0.0 112.706 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.15 58.83 0.29 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.182 0.993 . . . . 0.0 112.631 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -161.99 175.98 11.25 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.974 -1.704 . . . . 0.0 111.605 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.5 t -144.59 150.12 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.112 1.765 . . . . 0.0 108.557 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.8 164.71 29.36 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.039 1.29 . . . . 0.0 109.236 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.0 t -132.17 132.97 60.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -141.72 168.59 19.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.658 0.783 . . . . 0.0 111.271 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -89.49 102.86 15.54 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 127.022 2.129 . . . . 0.0 108.067 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.7 t -47.03 -21.23 0.2 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 129.507 3.123 . . . . 0.0 114.8 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.03 -50.91 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.432 1.493 . . . . 0.0 110.898 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.9 t -123.21 -23.84 4.81 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.858 1.663 . . . . 0.0 114.05 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 104.95 0.87 42.04 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.24 1.4 . . . . 0.0 110.364 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -48.13 113.5 0.75 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 127.712 2.405 . . . . 0.0 111.003 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 39.9 p -61.02 154.98 21.27 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.852 1.261 . . . . 0.0 111.299 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.99 142.44 41.19 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.28 1.032 . . . . 0.0 108.826 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.22 157.25 46.2 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.203 2.602 . . . . 0.0 108.98 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -57.68 -32.25 67.16 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.683 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -7.8 9.67 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 118.103 -0.951 . . . . 0.0 113.287 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -110.79 -8.59 14.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 120.4 1.454 . . . . 0.0 109.835 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 29.6 m0 -59.43 -38.1 79.81 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 119.668 1.122 . . . . 0.0 112.176 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -112.34 2.18 26.6 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.248 1.404 . . . . 0.0 111.254 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.98 42.97 3.23 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.373 1.469 . . . . 0.0 108.022 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.6 mt -63.71 -48.71 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -119.9 179.11 4.36 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 130.302 3.441 . . . . 0.0 112.574 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -126.74 -20.73 4.22 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.904 2.482 . . . . 0.0 112.25 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.41 -14.47 60.46 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.632 2.373 . . . . 0.0 113.356 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 77.39 30.5 53.89 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.31 157.34 20.05 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.518 1.927 . . . . 0.0 106.743 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -126.54 91.53 3.37 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.564 0.746 . . . . 0.0 109.902 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.0 t -94.98 -69.57 0.75 Allowed 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 125.155 1.382 . . . . 0.0 108.243 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -73.75 6.7 2.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.031 1.733 . . . . 0.0 115.448 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -144.4 151.23 38.97 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.832 1.253 . . . . 0.0 109.243 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.2 t -162.0 125.13 3.03 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -118.33 177.94 4.63 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.795 -1.191 . . . . 0.0 110.56 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.2 m -132.64 135.46 45.87 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 127.946 2.499 . . . . 0.0 106.626 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -114.42 108.34 16.75 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -110.23 123.87 50.56 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.591 1.556 . . . . 0.0 109.73 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -90.46 125.2 35.5 Favored 'General case' 0 N--CA 1.441 -0.893 1 C-N-CA 133.244 4.618 . . . . 0.0 109.087 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -77.74 101.88 6.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 127.327 2.251 . . . . 0.0 107.72 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -97.79 159.35 20.89 Favored Glycine 0 CA--C 1.533 1.218 1 C-N-CA 134.377 5.751 . . . . 0.0 108.049 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -66.6 163.19 19.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.939 1.369 . . . . 0.0 110.569 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 73.7 mt -109.31 134.95 49.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 128.138 2.575 . . . . 0.0 111.735 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -130.02 151.29 50.73 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.947 1.299 . . . . 0.0 110.239 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.3 p -78.59 173.53 12.32 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.518 ' CD1' HD23 ' A' ' 220' ' ' LEU . 50.3 mt -128.29 136.59 59.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 O-C-N 121.255 -0.903 . . . . 0.0 109.805 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -63.03 127.34 30.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.3 12.09 84.91 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-O 118.478 -1.179 . . . . 0.0 113.915 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -138.85 156.16 47.54 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 120.365 2.083 . . . . 0.0 109.168 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.2 m -103.32 146.62 28.19 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -23.34 58.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.875 0.87 . . . . 0.0 109.74 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 23.7 p -79.11 -9.5 59.57 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.721 1.608 . . . . 0.0 114.105 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -123.73 -40.63 2.31 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.678 0.791 . . . . 0.0 112.215 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.441 ' HB1' HD21 ' A' ' 220' ' ' LEU . . . -162.48 140.02 8.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -150.57 176.13 11.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -107.93 143.13 37.01 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.45 121.9 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.647 1.579 . . . . 0.0 108.768 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.85 104.37 4.0 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 43.1 mm -122.15 126.03 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 126.49 1.916 . . . . 0.0 109.273 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 58.54 34.76 24.15 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.844 -1.16 . . . . 0.0 112.236 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 66.1 13.77 9.28 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.366 1.066 . . . . 0.0 113.187 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.62 120.23 21.51 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.318 1.847 . . . . 0.0 108.634 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -65.6 136.65 56.62 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 120.103 -1.623 . . . . 0.0 109.965 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -127.15 147.9 50.18 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.026 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.518 HD23 ' CD1' ' A' ' 201' ' ' ILE . 1.4 tm? -84.86 115.1 22.57 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.056 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.48 147.8 24.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.59 143.18 50.15 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 118.0 0.364 . . . . 0.0 110.571 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -50.86 135.3 24.41 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.209 1.404 . . . . 0.0 110.061 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' A' ' 139' ' ' SER . 4.8 p -135.27 158.92 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -133.12 32.85 2.68 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.3 t30 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 127.299 2.24 . . . . 0.0 108.452 -178.169 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.04 141.82 25.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.663 1.574 . . . . 0.0 108.966 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -65.0 118.51 9.22 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.722 1.609 . . . . 0.0 110.103 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.4 t -121.76 135.55 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -83.0 118.93 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -47.4 118.77 2.33 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.187 1.395 . . . . 0.0 110.486 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -59.98 -21.45 61.28 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.507 -0.746 . . . . 0.0 111.701 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -88.53 -20.05 25.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.083 0.953 . . . . 0.0 111.257 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.05 112.25 2.56 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.965 1.257 . . . . 0.0 110.64 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 m -60.27 -21.91 62.46 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 119.957 -1.714 . . . . 0.0 113.428 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.7 ptt85 -80.84 1.23 31.53 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 120.858 -1.151 . . . . 0.0 110.015 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -111.93 158.68 19.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.867 0.841 . . . . 0.0 110.277 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.0 mm -133.43 127.59 53.89 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 136' ' ' ASN . 4.7 t0 -96.91 105.0 17.05 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 128.086 2.554 . . . . 0.0 104.14 178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -139.5 143.11 37.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.083 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 8.9 mtt 55.24 22.87 5.03 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.853 -1.154 . . . . 0.0 113.749 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.04 17.86 71.11 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.504 1.049 . . . . 0.0 110.983 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 8.9 p30 -117.28 173.84 6.46 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 126.588 1.955 . . . . 0.0 112.88 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.2 mm -130.04 132.33 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -119.33 163.55 17.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 t -140.02 148.12 41.39 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.578 1.551 . . . . 0.0 106.925 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.9 mt -114.08 121.74 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.5 t -94.85 -113.5 0.12 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -158.3 99.63 1.63 Allowed 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 65.0 m -136.95 116.42 12.78 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.004 2.522 . . . . 0.0 104.89 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.6 m -78.35 122.3 25.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 121.235 1.834 . . . . 0.0 106.595 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.7 t -94.67 113.05 28.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.018 1.327 . . . . 0.0 109.225 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.0 m -75.14 163.84 27.13 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.523 1.129 . . . . 0.0 111.18 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.24 -29.34 68.7 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.264 1.025 . . . . 0.0 110.168 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.02 -16.48 64.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.363 0.665 . . . . 0.0 112.062 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -105.35 -30.68 9.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.63 1.572 . . . . 0.0 109.83 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -55.67 127.27 29.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.951 1.3 . . . . 0.0 110.141 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.48 -104.83 1.25 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 125.235 1.398 . . . . 0.0 110.066 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -134.44 168.31 19.17 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.397 1.479 . . . . 0.0 109.296 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.42 136.95 58.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -115.18 -52.37 2.68 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.414 0.686 . . . . 0.0 111.784 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -160.37 159.9 31.68 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.77 1.168 . . . . 0.0 109.038 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 p -114.75 133.13 61.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.665 1.186 . . . . 0.0 111.402 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.61 164.9 12.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.966 2.106 . . . . 0.0 111.114 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -161.87 29.36 0.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.85 174.12 6.8 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 119.924 -1.735 . . . . 0.0 108.133 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.9 t -143.67 149.98 17.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.22 164.91 33.45 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 89.8 t -127.72 131.28 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -144.23 167.81 21.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.442 0.639 . . . . 0.0 110.172 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -79.99 119.16 22.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.1 t -66.21 -13.92 61.07 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.4 m -83.77 -43.61 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.7 m -122.19 -26.97 4.6 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.728 1.211 . . . . 0.0 113.919 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 109.31 -1.38 31.09 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.49 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -52.86 112.49 0.85 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.36 1.08 . . . . 0.0 111.599 -179.288 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.99 140.57 56.37 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.465 HG22 ' CD1' ' A' ' 176' ' ' TRP . 1.2 mp -106.88 143.39 26.99 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.32 1.848 . . . . 0.0 108.327 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.25 148.53 18.98 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.692 2.928 . . . . 0.0 110.896 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -53.38 -31.5 45.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.752 0.821 . . . . 0.0 112.892 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 t -68.76 -6.23 25.32 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.715 0.806 . . . . 0.0 112.998 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -116.4 -12.71 11.04 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.872 1.669 . . . . 0.0 110.201 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.465 ' CD1' HG22 ' A' ' 171' ' ' ILE . 40.3 m0 -52.7 -40.26 62.79 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -114.22 13.06 21.58 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.077 1.322 . . . . 0.0 111.823 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -134.48 79.83 1.82 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.3 mm -50.43 -77.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 126.741 2.016 . . . . 0.0 109.424 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -170.67 174.45 4.99 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.165 0.986 . . . . 0.0 108.834 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 181' ' ' LYS . 10.9 mmpt? -114.05 -54.38 2.6 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.838 2.055 . . . . 0.0 106.54 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.31 -48.84 31.12 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.019 1.328 . . . . 0.0 108.958 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -83.92 163.06 39.62 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-O 121.758 0.643 . . . . 0.0 112.238 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.1 m -141.52 142.41 33.56 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.952 0.901 . . . . 0.0 109.911 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -74.07 92.03 2.13 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.961 0.904 . . . . 0.0 109.96 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.9 m -117.02 -27.93 6.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -139.27 12.89 2.6 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.74 1.216 . . . . 0.0 111.76 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.563 ' NE2' HH22 ' A' ' 190' ' ' ARG . 70.9 mt-30 -117.29 163.39 16.4 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.414 1.086 . . . . 0.0 110.55 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.21 108.84 0.17 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.563 HH22 ' NE2' ' A' ' 188' ' ' GLN . 14.0 mmt180 -75.57 177.42 6.77 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.43 HG22 ' CD1' ' A' ' 193' ' ' TRP . 95.5 m -128.66 117.78 21.77 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -95.03 113.12 24.79 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . 0.43 ' CD1' HG22 ' A' ' 191' ' ' THR . 12.4 m0 -123.38 124.5 43.06 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.702 1.601 . . . . 0.0 110.256 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.72 135.03 34.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.036 2.134 . . . . 0.0 107.512 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -78.3 100.52 6.76 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.69 159.55 23.1 Favored Glycine 0 N--CA 1.441 -0.984 1 C-N-CA 130.818 4.056 . . . . 0.0 107.514 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -68.14 154.33 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 123.655 1.693 . . . . 0.0 111.61 -175.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.66 141.04 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 112.997 -1.911 . . . . 0.0 108.205 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -134.2 153.63 51.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 112.957 -1.929 . . . . 0.0 108.316 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.72 173.11 12.19 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 81.6 mt -124.14 137.5 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -55.71 119.58 5.96 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.162 1.385 . . . . 0.0 108.24 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.46 12.1 82.34 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.412 -1.215 . . . . 0.0 115.436 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -126.05 133.01 51.83 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 120.961 2.381 . . . . 0.0 109.568 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 67.9 m -83.53 142.78 30.64 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.47 -32.23 57.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.272 1.029 . . . . 0.0 110.501 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.2 p -70.12 -10.55 59.13 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.277 1.431 . . . . 0.0 114.516 -178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.02 -41.36 2.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.712 1.205 . . . . 0.0 109.097 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -166.93 151.61 7.3 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.002 0.819 . . . . 0.0 110.258 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -156.48 175.63 13.77 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.113 0.965 . . . . 0.0 109.565 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -112.13 137.0 50.81 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.889 1.276 . . . . 0.0 110.093 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.04 131.63 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.135 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 218' ' ' PHE . 19.6 tt0 -71.0 106.22 3.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 40.4 mm -122.4 125.16 72.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 2.1 m120 56.35 36.71 27.96 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 13.7 t0 70.87 -4.94 1.59 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.539 1.936 . . . . 0.0 112.095 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.6 127.31 52.96 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 118.931 -2.356 . . . . 0.0 110.73 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 213' ' ' GLU . 14.8 m-85 -74.43 116.52 15.21 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.583 -1.323 . . . . 0.0 109.979 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -107.11 147.81 29.57 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.766 0.826 . . . . 0.0 109.809 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.4 tm? -83.85 128.03 34.25 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.49 1.516 . . . . 0.0 109.296 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -111.54 151.72 28.36 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.085 0.954 . . . . 0.0 109.167 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.2 p -133.2 147.9 52.02 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.75 1.22 . . . . 0.0 111.088 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -59.94 128.86 38.96 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.717 -0.615 . . . . 0.0 112.042 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.5 t -135.14 133.59 53.12 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.772 0 C-N-CA 125.596 1.558 . . . . 0.0 109.722 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -105.36 60.35 0.4 Allowed Glycine 0 CA--C 1.519 0.333 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 124.996 1.319 . . . . 0.0 107.634 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.505 -0.76 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.28 149.86 41.82 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.273 2.229 . . . . 0.0 107.307 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -71.49 132.16 44.34 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 127.719 2.407 . . . . 0.0 106.569 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 93.4 t -133.91 125.54 49.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.514 ' HA ' HD13 ' A' ' 131' ' ' ILE . 3.4 mp -69.4 134.71 29.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -57.4 118.28 4.98 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.73 -18.02 63.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.549 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -94.38 -28.05 15.73 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.076 0.951 . . . . 0.0 111.491 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -138.96 106.73 5.63 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.743 1.217 . . . . 0.0 109.66 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.444 ' HB3' ' CD2' ' A' ' 163' ' ' PHE . 22.7 t -58.74 -24.93 62.43 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 120.592 -1.318 . . . . 0.0 112.687 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 18.4 ptt85 -82.53 -1.67 51.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.441 1.096 . . . . 0.0 111.106 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -116.13 159.29 21.95 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.447 0.642 . . . . 0.0 111.934 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 123' ' ' ILE . 30.4 mm -127.54 144.77 36.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -121.4 106.1 11.13 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 128.115 2.566 . . . . 0.0 105.126 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.421 ' HB3' ' CE2' ' A' ' 138' ' ' TYR . 20.9 t80 -138.9 130.92 27.97 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.7 mtt 60.45 22.54 12.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.259 1.424 . . . . 0.0 112.243 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.61 16.16 79.69 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -109.42 162.58 14.22 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.1 mm -123.3 132.08 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 133' ' ' TYR . 3.2 m-85 -120.33 159.13 25.65 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.7 t -145.65 155.49 43.04 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 mt -111.83 115.98 51.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 123.872 0.869 . . . . 0.0 111.643 -177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.5 t -87.15 -116.67 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -158.32 99.15 1.61 Allowed 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 220' ' ' LEU . 55.4 m -137.04 129.6 30.12 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 131.151 3.78 . . . . 0.0 108.188 177.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.0 126.09 31.56 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.64 1.976 . . . . 0.0 107.511 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.2 t -94.77 111.85 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 120.621 1.555 . . . . 0.0 107.425 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.1 m -75.31 156.71 35.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.023 0.916 . . . . 0.0 109.801 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -55.85 -30.87 62.16 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 127.997 2.519 . . . . 0.0 112.885 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -72.86 -26.8 61.59 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.981 0.913 . . . . 0.0 111.455 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -97.84 -19.88 17.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.33 1.052 . . . . 0.0 110.097 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 mt -69.52 123.51 21.49 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.209 1.804 . . . . 0.0 109.504 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.16 -117.92 0.51 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 125.27 1.414 . . . . 0.0 110.96 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -130.13 165.14 22.92 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.535 1.134 . . . . 0.0 111.617 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -60.83 120.54 10.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.634 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -102.83 -52.71 3.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 118.003 -0.998 . . . . 0.0 111.119 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -153.44 166.01 34.04 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.487 0.585 . . . . 0.0 112.037 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.33 138.8 50.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 124.435 1.094 . . . . 0.0 109.324 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.553 HD21 HD12 ' A' ' 198' ' ' ILE . 3.3 mm? -104.74 165.5 11.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.501 2.32 . . . . 0.0 109.598 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -171.07 65.97 0.04 OUTLIER 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.398 0.679 . . . . 0.0 111.881 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.52 166.51 30.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.3 t -145.11 149.73 16.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -146.99 164.83 31.7 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.1 122.18 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.444 ' CD2' ' HB3' ' A' ' 128' ' ' SER . 37.2 p90 -140.0 177.3 8.07 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.376 1.444 . . . . 0.0 113.347 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -84.14 128.93 34.88 Favored 'General case' 0 C--N 1.347 0.488 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.3 t -66.05 -16.64 64.1 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.312 1.415 . . . . 0.0 113.372 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.63 -55.27 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 118.676 0.671 . . . . 0.0 112.468 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.3 m -121.73 -22.19 5.89 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.891 1.276 . . . . 0.0 113.004 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.46 15.3 25.55 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-O 118.455 -1.191 . . . . 0.0 115.714 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.584 ' H ' ' HD3' ' A' ' 169' ' ' LYS . 0.3 OUTLIER -59.44 116.83 4.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.399 1.599 . . . . 0.0 109.981 179.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.08 153.45 41.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.735 1.152 . . . . 0.0 109.424 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.31 142.06 24.82 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.39 147.18 46.37 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.796 2.331 . . . . 0.0 109.959 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -56.54 -30.06 62.65 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.793 -0.567 . . . . 0.0 112.438 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.7 m -66.43 -7.09 17.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.621 1.169 . . . . 0.0 113.19 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -120.34 -4.84 9.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.123 1.769 . . . . 0.0 111.338 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -58.37 -35.05 71.38 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.23 -0.919 . . . . 0.0 113.332 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -133.94 13.52 4.71 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.805 1.193 . . . . 0.0 111.322 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.67 91.11 2.8 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.586 ' CD1' ' H ' ' A' ' 187' ' ' LYS . 15.7 mt -123.5 -92.04 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -114.61 -168.81 1.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.646 1.978 . . . . 0.0 106.493 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -62.87 173.23 1.4 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.241 1.417 . . . . 0.0 107.771 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.41 11.48 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.4 2.28 . . . . 0.0 116.132 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -74.79 -164.13 11.53 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 127.161 2.315 . . . . 0.0 112.12 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.7 m -78.52 -9.07 59.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.523 1.529 . . . . 0.0 114.82 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -89.06 70.62 8.46 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 75.1 m -157.29 149.82 23.07 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 120.927 -1.108 . . . . 0.0 109.411 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.586 ' H ' ' CD1' ' A' ' 179' ' ' ILE . 20.7 pttm 42.66 31.6 0.31 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.818 2.447 . . . . 0.0 112.957 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -91.22 130.3 37.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.5 t 75.7 33.16 0.65 Allowed 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 126.786 2.034 . . . . 0.0 111.285 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -130.85 149.47 52.47 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.649 0.738 . . . . 0.0 110.157 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.0 m -131.17 131.01 43.75 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 104.17 -2.53 . . . . 0.0 104.17 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -112.56 113.22 25.26 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -114.85 121.41 43.15 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.659 1.584 . . . . 0.0 108.761 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -89.3 131.76 35.24 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 128.905 2.882 . . . . 0.0 106.649 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -80.25 103.17 9.94 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -90.09 158.55 26.95 Favored Glycine 0 CA--C 1.53 1.03 1 C-N-CA 134.588 5.851 . . . . 0.0 107.056 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.72 160.08 31.01 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.147 1.474 . . . . 0.0 112.301 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.553 HD12 HD21 ' A' ' 157' ' ' LEU . 61.4 mt -109.06 139.02 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 126.12 1.768 . . . . 0.0 111.159 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -130.51 151.13 51.33 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.528 1.531 . . . . 0.0 109.446 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 13.6 p -75.9 174.17 10.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.159 0.584 . . . . 0.0 110.729 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 60.9 mt -132.61 139.43 49.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.135 1.374 . . . . 0.0 108.473 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -55.32 122.88 12.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.532 1.533 . . . . 0.0 109.832 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 66.34 13.27 60.08 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.343 -1.254 . . . . 0.0 115.498 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -131.05 124.37 30.7 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 120.05 1.925 . . . . 0.0 108.867 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 69.6 m -80.5 151.81 29.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.405 HD13 ' CG ' ' A' ' 210' ' ' PHE . 0.8 OUTLIER -55.39 -26.35 40.97 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.846 1.258 . . . . 0.0 109.472 178.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 25.2 p -70.38 -17.1 63.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.917 2.087 . . . . 0.0 113.377 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -120.54 -43.5 2.49 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.78 1.232 . . . . 0.0 112.009 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.5 146.0 6.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.051 0.94 . . . . 0.0 109.539 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.405 ' CG ' HD13 ' A' ' 206' ' ' LEU . 34.7 p90 -158.26 176.66 12.18 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.73 1.212 . . . . 0.0 108.805 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -109.23 132.57 53.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.467 1.507 . . . . 0.0 110.955 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.6 p -129.63 125.96 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 C-N-CA 124.312 1.045 . . . . 0.0 110.62 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -72.53 112.87 8.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 30.0 mm -122.59 119.83 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 55.14 33.61 20.84 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.274 0.943 . . . . 0.0 111.952 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.6 t70 80.33 -9.18 1.42 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 128.844 2.857 . . . . 0.0 111.977 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.91 122.64 43.14 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 120.843 -1.16 . . . . 0.0 108.836 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -73.81 112.53 10.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -104.01 145.94 29.43 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.102 0.961 . . . . 0.0 111.434 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 143' ' ' THR . 2.3 tm? -81.66 126.82 32.23 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -116.28 146.39 42.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.9 p -127.58 158.42 37.52 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.415 0.686 . . . . 0.0 111.19 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -64.92 122.11 16.2 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.56 101.29 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.671 1.224 . . . . 0.0 108.271 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -114.82 15.39 19.22 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.66 1.6 . . . . 0.0 112.454 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.6 m120 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 127.671 2.388 . . . . 0.0 107.598 -179.605 . . . . . . . . 0 0 . 1 stop_ save_